data_2lpk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lpk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.3 m . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -52.81 -47.64 67.5 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.23 1.012 . . . . 0.0 110.834 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.97 -47.65 77.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 124.004 0.815 . . . . 0.0 111.645 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -66.07 -38.09 87.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.86 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.426 HG11 HD13 ' A' ' 47' ' ' ILE . 96.4 t -72.24 -37.48 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.177 0.591 . . . . 0.0 110.329 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.19 -35.46 80.88 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.104 0.962 . . . . 0.0 110.41 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 59.8 m -66.98 -44.66 79.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.926 173.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.4 -47.09 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.274 0.629 . . . . 0.0 110.896 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.553 HG12 HD13 ' A' ' 43' ' ' ILE . 36.6 mt -61.26 -44.28 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.385 1.074 . . . . 0.0 111.071 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.08 -48.14 64.84 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.015 0.926 . . . . 0.0 112.632 174.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 10' ' ' THR . 46.4 mt-10 -66.64 -32.39 73.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.945 0.898 . . . . 0.0 111.557 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.1 m -71.22 -58.4 3.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.382 0.673 . . . . 0.0 111.591 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.405 ' SG ' HG12 ' A' ' 35' ' ' ILE . 86.4 m -103.65 15.66 28.32 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -167.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 49.83 64.14 1.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.415 1.086 . . . . 0.0 112.051 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.9 pt -142.53 146.07 37.18 Favored Pre-proline 0 N--CA 1.481 1.122 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.688 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.97 125.55 14.36 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.31 2.006 . . . . 0.0 112.162 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -31.79 48.92 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.949 1.3 . . . . 0.0 113.03 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.39 -23.65 60.2 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.378 0.671 . . . . 0.0 111.226 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -84.7 -11.62 55.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.8 0.44 . . . . 0.0 110.933 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mp -83.62 111.84 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.5 p -94.93 161.52 28.14 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 123.41 0.684 . . . . 0.0 109.556 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.17 -25.41 64.08 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.358 2.039 . . . . 0.0 113.668 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.576 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 32.1 mt-10 -102.89 17.66 23.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.947 -0.47 . . . . 0.0 110.734 -175.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -78.38 129.62 35.17 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.263 0.625 . . . . 0.0 110.259 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.4 ' HE2' ' HB ' ' A' ' 71' ' ' THR . 64.3 t-80 -88.55 120.83 30.3 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.11 -41.98 27.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.355 1.062 . . . . 0.0 113.471 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.2 mt -93.22 -60.11 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -63.63 -46.44 85.66 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.207 1.003 . . . . 0.0 111.989 -174.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.7 -64.37 1.15 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.197 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 29' ' ' ALA . 86.1 mt -71.39 -17.6 62.4 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.635 0.774 . . . . 0.0 112.542 -173.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.38 30.57 64.49 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.169 0.293 . . . . 0.0 113.792 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.405 HG12 ' SG ' ' A' ' 16' ' ' CYS . 70.6 mt -101.98 123.04 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.43 1.092 . . . . 0.0 108.915 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.44 158.88 32.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.081 0.467 . . . . 0.0 110.713 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.2 p -64.46 -23.54 67.32 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.601 0.76 . . . . 0.0 112.222 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 pp -70.53 -39.56 73.98 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -68.03 -35.96 79.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.595 0.758 . . . . 0.0 109.461 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -65.56 -27.35 68.37 Favored 'General case' 0 CA--C 1.555 1.152 0 O-C-N 124.06 0.85 . . . . 0.0 111.264 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.74 -45.38 93.01 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.061 0.544 . . . . 0.0 110.272 171.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -65.81 -40.12 91.55 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.989 0.916 . . . . 0.0 110.455 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.553 HD13 HG12 ' A' ' 12' ' ' ILE . 97.3 mt -60.83 -44.99 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.653 0.781 . . . . 0.0 109.784 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.95 -32.8 72.66 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.854 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -72.03 -31.44 66.18 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.361 1.064 . . . . 0.0 110.886 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.2 65.78 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.547 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.455 HD11 HD12 ' A' ' 84' ' ' ILE . 96.0 mt -68.09 -39.14 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 124.002 0.921 . . . . 0.0 110.362 172.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.44 -43.37 75.34 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.697 1.199 . . . . 0.0 110.134 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.08 -53.84 11.61 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.463 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.86 -56.84 12.9 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.53 1.132 . . . . 0.0 113.129 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -88.14 -11.82 45.81 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.956 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.12 32.19 76.15 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.312 0.383 . . . . 0.0 112.342 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.495 HD11 HG21 ' A' ' 84' ' ' ILE . 42.6 pt -110.08 163.91 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.258 1.023 . . . . 0.0 110.056 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -110.75 95.55 5.62 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 87' ' ' LEU . 70.1 mt -72.59 118.88 71.65 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.42 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 2.7 Cg_exo -78.88 59.85 7.5 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.115 2.544 . . . . 0.0 110.139 168.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -35.68 81.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.397 -174.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -57.42 -40.55 78.59 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.78 0.832 . . . . 0.0 112.205 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 56' ' ' PRO . 9.6 ptmm? -77.44 -34.81 54.46 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.418 ' O ' HG22 ' A' ' 64' ' ' VAL . 50.6 m0 -66.67 -43.89 83.31 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.509 0.724 . . . . 0.0 110.704 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.8 m -64.5 -37.37 87.31 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.939 0.896 . . . . 0.0 110.269 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -66.22 -41.73 89.7 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.928 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 39.2 mt-10 -62.37 -43.06 99.71 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.802 0.841 . . . . 0.0 110.854 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 60' ' ' TRP . 77.6 t -55.56 -57.22 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 O-C-N 124.149 0.906 . . . . 0.0 110.533 175.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -66.75 -28.96 68.83 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.145 0.978 . . . . 0.0 112.984 -174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -93.18 7.24 45.09 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.456 0.703 . . . . 0.0 111.555 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.19 11.54 67.52 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 115.017 0.767 . . . . 0.0 115.017 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -70.64 -35.53 72.94 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.235 0.614 . . . . 0.0 109.951 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.07 164.77 29.14 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.721 1.208 . . . . 0.0 109.204 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.6 p -97.92 158.46 15.52 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.259 0.624 . . . . 0.0 109.801 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.4 ' HB ' ' HE2' ' A' ' 28' ' ' HIS . 0.7 OUTLIER -59.54 -43.86 93.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 124.158 0.912 . . . . 0.0 110.567 -175.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.529 ' HA ' HG22 ' A' ' 76' ' ' VAL . 3.1 mp0 -46.74 -49.1 20.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.374 1.47 . . . . 0.0 112.972 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -54.55 -25.44 25.99 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -121.37 -22.17 6.07 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -109.32 12.06 24.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.246 0.618 . . . . 0.0 111.771 -169.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 72' ' ' GLU . 80.2 t -105.58 138.04 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.475 HD12 HD11 ' A' ' 12' ' ' ILE . 4.4 mm? -52.91 -38.38 61.77 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.025 1.33 . . . . 0.0 114.312 -171.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.576 ' HD3' ' HG2' ' A' ' 26' ' ' GLU . 60.1 pttt -71.21 -40.7 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.095 0.558 . . . . 0.0 110.609 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 77.5 m-20 -74.58 -47.16 34.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.238 1.015 . . . . 0.0 109.788 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.6 tp -57.1 -49.43 75.89 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.705 1.202 . . . . 0.0 110.089 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.39 78.61 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.834 0.709 . . . . 0.0 110.939 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -67.44 -44.76 77.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.585 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 18.2 mmm180 -56.73 -44.31 81.52 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.298 0.639 . . . . 0.0 110.738 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.495 HG21 HD11 ' A' ' 53' ' ' ILE . 90.3 mt -62.54 -49.52 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.029 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.04 -32.69 74.32 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.521 1.138 . . . . 0.0 110.625 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 65.6 mt-10 -62.47 -47.14 85.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.839 0.856 . . . . 0.0 110.143 172.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.439 HD12 HD22 ' A' ' 55' ' ' LEU . 81.1 mt -69.16 -31.31 69.87 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.153 0.581 . . . . 0.0 111.552 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 84' ' ' ILE . 77.0 t -68.67 -41.31 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.422 0.689 . . . . 0.0 109.665 176.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.83 -41.49 78.5 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.457 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.39 -39.02 91.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.026 0.93 . . . . 0.0 111.802 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 pttp . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 122.825 0.45 . . . . 0.0 110.301 -177.286 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 8' ' ' VAL . 20.0 m . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -55.82 -43.9 77.39 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.911 0.757 . . . . 0.0 111.226 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -52.84 -49.74 65.14 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 123.73 0.643 . . . . 0.0 110.736 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -65.88 -40.21 91.4 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.071 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 4' ' ' THR . 67.2 t -66.71 -44.27 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 122.871 0.468 . . . . 0.0 110.315 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.01 96.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.15 0.98 . . . . 0.0 110.877 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -60.92 -47.69 85.27 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.644 0.778 . . . . 0.0 110.925 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.54 -50.77 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.445 0.698 . . . . 0.0 111.418 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.459 HG23 HD13 ' A' ' 18' ' ' ILE . 50.9 mt -57.46 -45.62 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.672 0.789 . . . . 0.0 110.553 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.528 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.14 -58.17 7.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.352 1.061 . . . . 0.0 112.662 174.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -64.84 -26.91 68.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.229 1.011 . . . . 0.0 112.052 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -76.88 -53.47 7.84 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.256 0.623 . . . . 0.0 110.695 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.484 ' SG ' HG12 ' A' ' 35' ' ' ILE . 37.7 t -100.04 9.2 43.25 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -166.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t70 55.65 59.83 3.64 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.761 0.791 . . . . 0.0 111.151 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.528 HG13 ' HA ' ' A' ' 13' ' ' ALA . 11.5 pt -141.78 148.19 48.42 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 123.729 0.812 . . . . 0.0 109.712 -177.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.24 125.41 11.34 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.661 2.241 . . . . 0.0 110.568 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.614 ' HA ' HD11 ' A' ' 23' ' ' ILE . 7.6 ptt180 -68.61 -17.07 64.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.07 -24.85 60.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.388 0.675 . . . . 0.0 110.479 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -80.95 -13.24 59.08 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.613 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.614 HD11 ' HA ' ' A' ' 20' ' ' ARG . 2.7 mp -86.64 117.7 31.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.5 p -100.32 161.69 23.28 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.802 0.841 . . . . 0.0 109.045 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.7 -16.05 50.52 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 121.733 1.622 . . . . 0.0 112.823 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.69 3.33 50.26 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.791 -0.568 . . . . 0.0 111.064 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.7 m -77.78 135.81 38.03 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.432 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 59.5 t-80 -81.07 113.81 19.51 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.24 -23.17 55.02 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.432 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 61.9 mt -97.79 -54.13 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.171 0.588 . . . . 0.0 110.007 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.23 -43.67 41.08 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.826 0.851 . . . . 0.0 112.563 -167.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.81 -51.55 11.14 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.788 0.435 . . . . 0.0 110.049 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.9 mt -78.02 -5.78 52.43 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.926 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.65 27.93 73.57 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.566 0.541 . . . . 0.0 113.246 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.484 HG12 ' SG ' ' A' ' 16' ' ' CYS . 81.4 mt -95.86 124.29 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.976 0.911 . . . . 0.0 108.615 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.52 157.46 34.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.489 0.316 . . . . 0.0 110.999 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.442 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.6 m -63.02 -22.78 67.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.632 0.773 . . . . 0.0 110.75 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.5 mt -65.31 -51.37 61.08 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.75 0.82 . . . . 0.0 109.908 174.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.52 -31.46 71.58 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.58 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -74.91 -24.99 58.6 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.305 0.642 . . . . 0.0 110.973 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 HD13 ' A' ' 57' ' ' LEU . 80.1 mt -61.63 -42.27 98.65 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.061 0.544 . . . . 0.0 109.86 169.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -72.27 -37.42 69.05 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.888 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.446 HG22 HG12 ' A' ' 12' ' ' ILE . 67.5 mt -58.85 -50.74 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.817 174.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.24 -27.5 63.51 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.533 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -61.01 -46.35 91.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.803 0.841 . . . . 0.0 110.483 169.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.27 -34.87 76.96 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.141 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.2 mt -69.0 -44.04 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.932 0.893 . . . . 0.0 110.679 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -51.35 -48.6 62.39 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.388 1.475 . . . . 0.0 110.257 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -76.84 -38.58 53.55 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.572 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.87 -54.92 38.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.286 0.634 . . . . 0.0 112.304 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -84.58 -9.93 57.85 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.616 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.65 29.78 69.27 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 123.53 0.519 . . . . 0.0 112.858 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.526 HD12 HG23 ' A' ' 84' ' ' ILE . 42.6 pt -107.53 176.5 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.506 1.122 . . . . 0.0 109.735 -174.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.54 96.26 5.06 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.65 116.79 61.06 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 123.705 0.802 . . . . 0.0 109.859 171.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -84.3 57.4 5.24 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 122.651 2.234 . . . . 0.0 110.41 168.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.483 HD13 HD23 ' A' ' 41' ' ' LEU . 2.0 tm? -59.7 -41.76 91.46 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.516 1.127 . . . . 0.0 109.931 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 11.6 pt-20 -61.39 -39.27 90.1 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 124.24 0.963 . . . . 0.0 110.959 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -46.76 79.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.777 0.831 . . . . 0.0 110.107 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.453 ' O ' HG22 ' A' ' 64' ' ' VAL . 52.5 m0 -60.16 -40.14 88.88 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.936 1.397 . . . . 0.0 110.861 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 34.8 m -68.21 -35.15 77.52 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.494 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 17.0 mm100 -73.15 -29.69 63.05 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.855 0.462 . . . . 0.0 110.521 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.47 ' HG2' ' HE3' ' A' ' 68' ' ' LYS . 49.0 mt-10 -65.78 -41.54 91.9 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.747 0.419 . . . . 0.0 110.199 173.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.605 HG12 HG22 ' A' ' 71' ' ' THR . 98.7 t -61.07 -43.15 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.6 175.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -62.08 -39.64 93.14 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.107 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -87.55 -5.18 58.88 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.674 0.79 . . . . 0.0 112.586 -174.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.96 12.01 85.03 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 115.042 0.777 . . . . 0.0 115.042 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.47 ' HE3' ' HG2' ' A' ' 63' ' ' GLU . 55.1 mtmt -79.68 -26.97 40.81 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 117.725 0.762 . . . . 0.0 111.059 172.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -136.53 174.54 10.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.056 0.942 . . . . 0.0 109.327 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.7 m -133.86 148.57 51.29 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.485 1.114 . . . . 0.0 108.757 174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.605 HG22 HG12 ' A' ' 64' ' ' VAL . 4.1 p -58.42 93.1 0.02 OUTLIER 'General case' 0 C--N 1.362 1.146 0 C-N-CA 123.512 0.725 . . . . 0.0 109.887 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.0 tm-20 175.86 -63.81 0.01 OUTLIER 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.134 1.374 . . . . 0.0 107.978 -174.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -51.26 -29.36 14.35 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.763 -1.562 . . . . 0.0 114.06 -173.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -132.92 0.61 3.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.061 0.544 . . . . 0.0 111.136 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -121.28 5.35 10.25 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.29 0.636 . . . . 0.0 111.295 -165.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 72' ' ' GLU . 71.7 t -105.34 146.1 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.39 -43.77 64.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.901 1.28 . . . . 0.0 114.251 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -68.95 -42.32 76.83 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.754 0.422 . . . . 0.0 110.322 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 5.6 m120 -65.32 -47.33 76.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.447 0.699 . . . . 0.0 110.597 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.88 -50.77 69.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 110.223 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.415 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -62.43 -28.25 69.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.665 0.786 . . . . 0.0 111.261 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -69.99 -45.35 67.47 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.736 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 15.3 mmm180 -57.71 -46.63 84.13 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.331 0.652 . . . . 0.0 110.383 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.526 HG23 HD12 ' A' ' 53' ' ' ILE . 89.9 mt -59.08 -47.94 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 113.778 -1.556 . . . . 0.0 110.694 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.07 -46.34 82.57 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.079 0.862 . . . . 0.0 111.205 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 49.1 mt-10 -63.76 -35.28 80.08 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.101 0.56 . . . . 0.0 111.111 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.4 -32.09 62.57 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.976 0.51 . . . . 0.0 112.154 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 84' ' ' ILE . 98.0 t -64.72 -41.47 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-O 121.732 0.777 . . . . 0.0 109.405 171.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.62 -45.52 78.84 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.648 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.71 90.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.31 1.044 . . . . 0.0 112.145 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.6 pttp . . . . . 0 N--CA 1.477 0.919 0 C-N-CA 122.453 0.301 . . . . 0.0 110.415 -179.584 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 8' ' ' VAL . 7.0 m . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -54.39 -50.26 67.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.35 0.66 . . . . 0.0 111.247 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.01 -42.0 98.68 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.574 0.546 . . . . 0.0 110.721 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -58.84 -48.27 81.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.724 0.81 . . . . 0.0 111.082 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 4' ' ' THR . 94.9 t -67.48 -44.87 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.57 0.748 . . . . 0.0 110.852 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.46 90.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.288 1.035 . . . . 0.0 110.375 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.478 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 92.8 m -63.4 -44.9 93.35 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.758 0.823 . . . . 0.0 111.29 175.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 47' ' ' ILE . 95.2 mt -58.71 -48.16 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 122.967 0.507 . . . . 0.0 111.485 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.451 HG21 HD13 ' A' ' 18' ' ' ILE . 57.1 mt -58.46 -45.88 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.645 0.778 . . . . 0.0 109.996 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.506 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.77 -51.84 62.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.853 1.261 . . . . 0.0 113.683 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 10' ' ' THR . 22.2 mm-40 -66.26 -27.78 68.21 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.386 0.675 . . . . 0.0 112.129 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.479 HG23 HG12 ' A' ' 43' ' ' ILE . 96.1 m -76.56 -51.63 11.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.929 0.492 . . . . 0.0 111.054 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.6 m -99.59 7.03 45.59 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.59 0.756 . . . . 0.0 112.515 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 48.25 70.6 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.526 1.13 . . . . 0.0 111.749 -174.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.506 HG13 ' HA ' ' A' ' 13' ' ' ALA . 10.3 pt -144.78 146.58 32.24 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 124.138 0.975 . . . . 0.0 109.605 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.428 ' HG2' ' HG1' ' A' ' 22' ' ' THR . 41.0 Cg_endo -66.45 116.69 4.2 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.919 2.413 . . . . 0.0 112.207 176.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -23.91 67.44 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -170.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -90.76 -6.36 54.48 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.142 0.577 . . . . 0.0 110.891 -171.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.428 ' HG1' ' HG2' ' A' ' 19' ' ' PRO . 66.4 p -89.02 -13.03 39.72 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 167.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -79.19 105.77 9.1 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -77.25 159.94 76.74 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.435 0.694 . . . . 0.0 109.735 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.57 -17.02 58.13 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 121.988 1.792 . . . . 0.0 112.196 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -99.74 9.85 42.36 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 122.909 0.484 . . . . 0.0 110.427 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.0 m -72.13 124.33 24.77 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 122.57 0.348 . . . . 0.0 110.07 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -83.6 117.09 22.93 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.473 ' HA ' HD11 ' A' ' 33' ' ' LEU . . . -46.71 -41.43 15.05 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.206 1.003 . . . . 0.0 113.37 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.71 -50.2 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 122.464 0.306 . . . . 0.0 110.457 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.27 -38.33 24.56 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.943 0.897 . . . . 0.0 112.397 -171.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.17 -57.05 2.83 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.186 0.595 . . . . 0.0 110.35 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.473 HD11 ' HA ' ' A' ' 29' ' ' ALA . 88.7 mt -76.29 -10.53 59.47 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.888 0.875 . . . . 0.0 111.977 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.26 30.38 77.61 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 123.412 0.445 . . . . 0.0 113.993 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.1 mt -89.39 126.24 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.27 147.92 38.54 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.213 0.605 . . . . 0.0 110.692 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -60.56 -35.74 76.77 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.726 0.41 . . . . 0.0 111.144 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.443 HD11 ' N ' ' A' ' 39' ' ' ASP . 3.0 pp -73.86 -31.65 63.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.186 0.594 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.443 ' N ' HD11 ' A' ' 38' ' ' LEU . 15.5 t70 -72.82 -35.99 67.41 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.483 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -71.72 -21.78 61.72 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.075 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.8 mt -56.85 -41.72 78.4 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 122.625 0.37 . . . . 0.0 110.426 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.09 -32.62 63.32 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.057 0.943 . . . . 0.0 111.51 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.479 HG12 HG23 ' A' ' 15' ' ' THR . 37.9 mt -65.26 -46.59 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.13 -29.15 67.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.907 0.883 . . . . 0.0 111.143 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -58.21 -50.87 72.04 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.006 1.322 . . . . 0.0 110.786 170.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.92 -33.49 74.78 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.871 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.568 ' HA ' HD11 ' A' ' 11' ' ' ILE . 85.9 mt -67.47 -51.32 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.186 0.594 . . . . 0.0 110.888 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.85 -37.33 86.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.039 0.535 . . . . 0.0 110.344 -170.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -81.38 -29.04 34.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.4 -48.24 76.17 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.322 0.388 . . . . 0.0 111.592 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.412 ' HB2' HG12 ' A' ' 53' ' ' ILE . 86.7 m-85 -83.12 -16.47 46.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.508 0.723 . . . . 0.0 111.821 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.12 37.58 87.25 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.382 0.426 . . . . 0.0 112.519 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.477 HG21 ' HG2' ' A' ' 91' ' ' LYS . 46.3 pt -116.35 172.82 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.585 1.154 . . . . 0.0 111.026 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.62 97.82 6.36 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.385 1.074 . . . . 0.0 108.454 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 84' ' ' ILE . 79.3 mt -73.18 120.42 80.9 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 123.035 0.534 . . . . 0.0 110.071 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.56 57.82 6.7 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.758 2.305 . . . . 0.0 110.835 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -63.83 -40.99 97.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.416 1.086 . . . . 0.0 109.818 -173.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.26 -37.88 88.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.502 0.721 . . . . 0.0 111.371 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -71.01 -37.97 72.63 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.853 0.861 . . . . 0.0 110.238 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -63.59 -52.79 59.42 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.944 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.3 m -62.52 -33.3 74.62 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.084 0.954 . . . . 0.0 110.895 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -63.22 -58.65 6.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.429 0.691 . . . . 0.0 109.837 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 44.4 mt-10 -66.04 -32.23 73.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.854 0.862 . . . . 0.0 111.82 -176.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.8 t -61.63 -55.01 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.683 0.793 . . . . 0.0 110.165 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -78.97 -7.7 58.27 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.699 0.399 . . . . 0.0 111.787 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -92.85 -2.92 55.47 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.342 0.657 . . . . 0.0 110.74 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.71 5.24 86.19 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 115.888 1.115 . . . . 0.0 115.888 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 60.6 mttp -70.43 -31.59 68.84 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.075 0.937 . . . . 0.0 110.277 171.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.43 163.27 32.96 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.326 1.051 . . . . 0.0 108.819 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 p -104.72 162.28 13.43 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.442 0.697 . . . . 0.0 109.643 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.5 p -59.38 -52.5 65.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.157 0.583 . . . . 0.0 112.332 -169.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -56.02 -31.52 63.17 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -50.07 -33.59 18.91 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.36 1.064 . . . . 0.0 113.318 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -122.12 -19.59 6.53 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -111.91 23.4 13.83 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 122.571 0.348 . . . . 0.0 111.198 -171.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.514 HG13 ' HG2' ' A' ' 78' ' ' LYS . 40.3 t -110.27 142.26 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 162.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.17 -41.4 68.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.389 1.476 . . . . 0.0 114.267 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.514 ' HG2' HG13 ' A' ' 76' ' ' VAL . 58.9 pttt -66.77 -37.79 85.29 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 120.786 0.327 . . . . 0.0 110.954 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.44 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 73.3 m-20 -80.39 -37.93 31.3 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.878 0.871 . . . . 0.0 110.817 -176.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.38 -53.21 52.07 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.242 1.017 . . . . 0.0 108.857 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.47 -22.58 65.47 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.689 0.795 . . . . 0.0 111.914 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.11 -53.94 37.66 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.66 0.384 . . . . 0.0 110.058 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 28.1 mmm180 -60.92 -40.37 92.93 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 124.101 0.876 . . . . 0.0 111.205 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.501 HG12 HD23 ' A' ' 55' ' ' LEU . 92.3 mt -61.52 -50.31 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.281 1.032 . . . . 0.0 110.31 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.34 -34.94 78.8 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.118 0.567 . . . . 0.0 111.496 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.85 -44.12 90.94 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.487 0.715 . . . . 0.0 109.981 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.2 -42.04 76.3 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.16 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 84' ' ' ILE . 61.6 t -61.65 -45.69 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 123.464 0.706 . . . . 0.0 110.333 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.98 -43.11 99.3 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.511 176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.01 -42.67 76.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.621 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.477 ' HG2' HG21 ' A' ' 53' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 C-N-CA 122.668 0.387 . . . . 0.0 110.146 -174.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.6 m . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -54.89 -48.13 73.4 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.736 0.647 . . . . 0.0 111.016 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.93 -42.85 94.87 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.785 0.678 . . . . 0.0 110.934 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -57.44 -45.76 84.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.498 0.719 . . . . 0.0 111.221 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.8 t -71.4 -33.97 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 123.712 0.632 . . . . 0.0 110.77 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.86 -36.42 83.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.549 0.739 . . . . 0.0 110.481 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 m -66.82 -44.01 82.27 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.56 0.744 . . . . 0.0 110.739 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.8 mt -56.42 -54.53 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.646 0.778 . . . . 0.0 110.724 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.55 HD12 HD11 ' A' ' 77' ' ' LEU . 35.8 mt -60.08 -45.38 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.15 0.98 . . . . 0.0 110.66 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -51.88 -51.27 57.98 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 123.825 0.703 . . . . 0.0 112.319 174.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -67.86 -30.17 69.47 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.499 0.72 . . . . 0.0 112.332 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -74.81 -61.0 2.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.254 0.622 . . . . 0.0 110.938 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.402 ' HG ' HG12 ' A' ' 35' ' ' ILE . 61.8 m -90.49 10.79 23.93 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.016 0.927 . . . . 0.0 112.953 -168.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.4 t70 48.7 68.09 0.76 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.651 1.18 . . . . 0.0 111.565 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.456 HG13 ' HA ' ' A' ' 13' ' ' ALA . 12.1 pt -145.26 142.96 18.95 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.718 1.207 . . . . 0.0 108.699 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.67 139.36 69.08 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.523 2.149 . . . . 0.0 112.55 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -56.33 -31.5 63.78 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.144 1.378 . . . . 0.0 111.952 -173.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -77.25 -18.81 57.33 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.99 0.516 . . . . 0.0 111.901 -172.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -78.93 -11.32 60.0 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.046 0.385 . . . . 0.0 111.398 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.4 mp -86.18 102.05 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 27' ' ' SER . 64.3 p -81.18 154.04 72.07 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.118 0.567 . . . . 0.0 109.77 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.94 -30.22 83.22 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.335 2.024 . . . . 0.0 112.524 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -97.8 13.08 31.73 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.824 0.45 . . . . 0.0 110.947 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.408 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 46.9 t -72.24 129.67 38.98 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.968 0.507 . . . . 0.0 109.69 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -83.21 114.62 21.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 167.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.69 -41.66 10.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.022 0.929 . . . . 0.0 112.977 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.6 mt -88.62 -59.63 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -172.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.19 -36.46 84.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.739 1.216 . . . . 0.0 112.728 -173.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -98.39 -65.59 0.95 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.282 0.633 . . . . 0.0 110.759 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.48 -18.49 62.98 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.37 41.66 36.83 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 112.366 -0.293 . . . . 0.0 112.366 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.402 HG12 ' HG ' ' A' ' 16' ' ' CYS . 93.5 mt -99.75 107.88 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.25 168.32 18.54 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.4 t -52.46 -37.93 58.14 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.466 1.106 . . . . 0.0 111.783 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.23 -26.06 58.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.056 0.543 . . . . 0.0 111.898 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.4 -41.38 47.98 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 175.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -68.95 -23.13 64.11 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.889 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.4 mt -52.27 -49.86 63.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.159 0.583 . . . . 0.0 111.207 171.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.34 -38.02 71.68 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.826 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.527 HD11 HG12 ' A' ' 12' ' ' ILE . 81.5 mt -65.26 -44.79 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.519 0.728 . . . . 0.0 110.614 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.435 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -70.34 -37.16 74.62 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.284 0.633 . . . . 0.0 110.293 -177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -71.63 -27.57 63.19 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.367 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.72 63.92 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.837 0.351 . . . . 0.0 110.627 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 84' ' ' ILE . 87.0 mt -69.37 -38.19 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.072 0.949 . . . . 0.0 109.793 171.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 5.9 t70 -58.09 -42.81 86.44 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.823 0.849 . . . . 0.0 111.137 174.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.441 ' HB3' ' HZ3' ' A' ' 49' ' ' LYS . 7.5 mtpm? -67.94 -54.06 21.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.931 0.892 . . . . 0.0 110.561 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.13 -55.7 31.7 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.19 0.996 . . . . 0.0 112.605 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -91.05 -13.74 32.64 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.489 0.716 . . . . 0.0 112.433 -171.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.53 34.63 79.47 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-O 121.202 0.335 . . . . 0.0 113.494 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.606 HG23 ' HG2' ' A' ' 91' ' ' LYS . 44.6 pt -120.21 153.03 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.18 0.992 . . . . 0.0 109.149 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -100.59 106.95 18.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.4 mt -69.96 125.05 91.8 Favored Pre-proline 0 C--N 1.348 0.513 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 170.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.409 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 78.0 Cg_endo -78.17 57.25 6.1 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.387 2.058 . . . . 0.0 111.104 172.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.54 -38.37 89.72 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.346 1.058 . . . . 0.0 110.425 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.98 -36.52 79.65 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.638 0.375 . . . . 0.0 111.833 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.551 ' HZ1' ' HB2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -75.31 -37.37 60.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.498 0.719 . . . . 0.0 110.374 178.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.421 ' O ' HG22 ' A' ' 64' ' ' VAL . 48.1 m0 -62.93 -50.97 68.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.925 0.89 . . . . 0.0 110.569 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.3 m -64.0 -31.85 73.18 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.259 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -68.62 -42.89 77.45 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.012 0.525 . . . . 0.0 110.84 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.33 -42.53 99.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.905 0.482 . . . . 0.0 110.615 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 60' ' ' TRP . 61.2 t -61.05 -49.96 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.593 0.711 . . . . 0.0 110.161 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -56.76 -41.44 77.59 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.421 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -99.62 17.38 20.65 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.094 0.958 . . . . 0.0 111.48 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.29 14.22 52.85 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 115.107 0.803 . . . . 0.0 115.107 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -80.78 -24.73 38.4 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.795 0.838 . . . . 0.0 110.396 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.85 173.33 12.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.173 0.989 . . . . 0.0 109.874 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.8 p -106.89 164.76 11.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.293 0.637 . . . . 0.0 109.694 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.0 p -57.45 -49.67 75.51 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.428 0.455 . . . . 0.0 110.475 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HA ' HG22 ' A' ' 76' ' ' VAL . 29.8 mt-10 -39.1 -50.99 1.89 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.711 1.604 . . . . 0.0 113.26 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -59.59 -24.21 63.58 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.334 -1.303 . . . . 0.0 113.288 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -120.01 -22.79 6.57 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.935 0.494 . . . . 0.0 112.026 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.85 19.71 14.98 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.281 0.632 . . . . 0.0 110.749 -167.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 72' ' ' GLU . 79.8 t -105.63 139.97 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 161.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.55 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -56.52 -40.48 75.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.837 1.255 . . . . 0.0 113.936 -172.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.415 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.3 pttt -72.58 -38.7 67.82 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.586 0.355 . . . . 0.0 111.216 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -71.97 -45.69 60.1 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.544 0.738 . . . . 0.0 109.888 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.2 tp -53.73 -48.05 70.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.913 1.285 . . . . 0.0 110.299 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -31.98 73.21 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.673 0.608 . . . . 0.0 111.759 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.98 77.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.769 0.427 . . . . 0.0 110.479 175.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -60.28 -44.75 95.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.319 0.58 . . . . 0.0 111.234 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 47' ' ' ILE . 90.3 mt -65.52 -46.64 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.276 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.54 -38.71 88.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.395 0.678 . . . . 0.0 110.991 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -59.41 -50.87 72.29 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.578 0.549 . . . . 0.0 110.733 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.04 -35.68 81.2 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.69 0.619 . . . . 0.0 112.219 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 84' ' ' ILE . 70.6 t -67.17 -47.26 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.395 0.678 . . . . 0.0 110.546 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.79 -32.4 73.67 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.712 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -46.91 68.93 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 123.482 0.713 . . . . 0.0 111.434 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.606 ' HG2' HG23 ' A' ' 53' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 123.042 0.537 . . . . 0.0 110.626 -174.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -52.9 -51.23 61.95 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.715 0.806 . . . . 0.0 110.866 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -60.86 -44.9 96.41 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.163 0.914 . . . . 0.0 111.421 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -64.81 -40.58 95.45 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.329 0.651 . . . . 0.0 111.44 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.422 HG12 HD12 ' A' ' 47' ' ' ILE . 69.6 t -72.39 -36.57 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.193 0.597 . . . . 0.0 110.474 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.34 -35.47 80.98 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.721 0.808 . . . . 0.0 110.64 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.7 m -65.24 -48.07 74.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.818 0.847 . . . . 0.0 110.896 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.5 mt -58.0 -46.86 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.494 0.718 . . . . 0.0 110.776 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.435 HD13 HD13 ' A' ' 77' ' ' LEU . 55.4 mt -61.89 -48.93 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.673 0.789 . . . . 0.0 110.854 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.554 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.18 -44.46 64.68 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.212 1.005 . . . . 0.0 112.575 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -66.25 -43.74 85.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.143 0.977 . . . . 0.0 111.798 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.9 m -75.49 -50.95 14.15 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.727 0.411 . . . . 0.0 111.527 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.8 m -89.67 3.82 51.47 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.265 1.026 . . . . 0.0 111.886 -174.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.0 t70 50.54 75.0 0.19 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.256 1.422 . . . . 0.0 112.416 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.554 HG13 ' HA ' ' A' ' 13' ' ' ALA . 3.4 pt -148.21 157.5 42.53 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 124.629 1.172 . . . . 0.0 109.474 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.58 137.7 47.18 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.361 2.041 . . . . 0.0 110.993 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -57.63 -30.54 65.45 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.973 0.909 . . . . 0.0 112.5 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.86 -21.65 60.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.994 0.918 . . . . 0.0 111.26 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -80.66 -6.7 58.73 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 122.777 0.431 . . . . 0.0 111.146 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.408 ' CG2' ' HG ' ' A' ' 77' ' ' LEU . 3.8 mp -90.99 112.04 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 170.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.4 p -95.65 160.73 29.72 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 123.32 0.648 . . . . 0.0 110.425 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -60.16 -33.31 95.07 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.23 1.953 . . . . 0.0 112.877 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -94.49 11.24 31.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.945 0.898 . . . . 0.0 110.954 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.8 t -79.22 128.52 33.41 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 123.177 0.591 . . . . 0.0 110.324 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -83.18 118.9 23.92 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.97 -40.77 23.35 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.55 -45.39 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 O-C-N 122.187 -0.32 . . . . 0.0 110.211 -169.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -82.99 -32.8 26.8 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.818 0.847 . . . . 0.0 112.316 -173.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.91 -64.25 1.06 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.366 0.666 . . . . 0.0 109.965 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.43 HD12 HG21 ' A' ' 12' ' ' ILE . 82.8 mt -69.77 -11.19 60.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.155 0.582 . . . . 0.0 111.489 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.84 31.91 79.59 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.55 0.531 . . . . 0.0 113.153 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -82.97 122.95 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -61.36 146.1 49.31 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.746 0.419 . . . . 0.0 110.063 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.428 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 37.3 m -59.65 -34.68 73.12 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.506 0.722 . . . . 0.0 111.807 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.1 mt -73.7 -34.48 64.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.439 0.696 . . . . 0.0 110.032 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -73.89 -30.63 62.72 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.461 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -75.76 -23.67 55.99 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.661 0.384 . . . . 0.0 110.54 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 37' ' ' SER . 96.5 mt -63.76 -39.46 94.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.862 0.465 . . . . 0.0 109.84 169.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -65.97 -45.56 81.23 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.89 0.876 . . . . 0.0 110.619 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.4 mt -62.97 -40.21 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.622 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.94 -35.93 77.35 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.431 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -74.63 -25.17 59.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.609 0.764 . . . . 0.0 110.941 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.97 -41.15 68.06 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.996 0.518 . . . . 0.0 110.559 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.422 HD12 HG12 ' A' ' 8' ' ' VAL . 89.8 mt -65.55 -40.48 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.295 1.038 . . . . 0.0 110.061 173.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -55.27 -47.74 75.05 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.02 1.328 . . . . 0.0 109.714 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -67.84 -50.58 55.87 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.52 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.02 -51.77 68.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.963 0.905 . . . . 0.0 112.114 -172.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.17 -5.26 59.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.908 0.883 . . . . 0.0 111.456 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.3 30.81 75.85 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.193 0.308 . . . . 0.0 113.64 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.36 170.66 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.41 1.084 . . . . 0.0 109.869 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -104.97 111.03 23.66 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 168.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.524 HD22 HG12 ' A' ' 84' ' ' ILE . 42.6 mt -73.9 118.28 68.08 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -79.25 58.38 6.92 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.626 2.217 . . . . 0.0 109.706 170.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.58 -37.15 85.08 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.053 0.941 . . . . 0.0 109.118 -174.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.3 -45.58 90.74 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.383 0.673 . . . . 0.0 111.143 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -62.23 -40.71 97.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.866 0.866 . . . . 0.0 110.462 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.407 ' O ' HG22 ' A' ' 64' ' ' VAL . 54.1 m0 -63.66 -45.87 88.18 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.318 1.011 . . . . 0.0 109.87 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.5 m -62.06 -33.96 75.39 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.054 0.846 . . . . 0.0 110.932 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -72.2 -44.58 62.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.937 0.495 . . . . 0.0 110.513 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.26 -36.39 77.68 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.393 0.677 . . . . 0.0 110.816 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 60' ' ' TRP . 72.9 t -67.14 -49.94 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.829 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -59.23 -44.87 92.31 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.721 0.808 . . . . 0.0 112.063 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -86.35 6.67 28.92 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.981 0.912 . . . . 0.0 111.538 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.94 23.05 67.24 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -75.65 -30.53 59.47 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.372 0.669 . . . . 0.0 109.554 174.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.79 160.47 42.22 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.545 1.138 . . . . 0.0 109.371 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.4 p -83.85 162.83 20.43 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.117 0.567 . . . . 0.0 110.251 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 82.4 p -58.53 -55.43 35.19 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.53 0.681 . . . . 0.0 109.859 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.5 -33.86 64.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.299 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -55.57 -26.74 45.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 123.877 0.736 . . . . 0.0 112.529 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -119.6 -28.69 5.24 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.88 0.472 . . . . 0.0 112.156 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.59 16.95 25.06 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.99 0.516 . . . . 0.0 112.025 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.473 HG11 ' HG2' ' A' ' 78' ' ' LYS . 22.9 t -107.5 142.68 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 167.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 12' ' ' ILE . 4.5 mm? -56.99 -41.69 78.88 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.001 1.32 . . . . 0.0 114.509 -170.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HG2' HG11 ' A' ' 76' ' ' VAL . 61.9 pttt -65.65 -40.72 92.78 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.357 0.599 . . . . 0.0 110.312 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.34 -44.48 44.94 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.735 1.214 . . . . 0.0 110.499 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.69 -51.14 70.74 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.218 1.407 . . . . 0.0 109.977 176.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.85 -33.37 74.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.737 0.815 . . . . 0.0 111.658 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.67 -50.17 65.92 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.566 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -55.1 -46.65 75.53 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.594 1.158 . . . . 0.0 111.688 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.524 HG12 HD22 ' A' ' 55' ' ' LEU . 93.2 mt -60.26 -48.71 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.787 1.235 . . . . 0.0 110.464 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.15 -31.23 71.96 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.884 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.91 -41.86 95.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.116 0.566 . . . . 0.0 110.302 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.94 -27.93 65.16 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.429 0.692 . . . . 0.0 111.186 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.423 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 61.0 t -71.22 -36.36 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.623 0.769 . . . . 0.0 110.234 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.67 84.34 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.007 173.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.25 -40.07 82.07 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.721 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 13.5 ptmm? . . . . . 0 N--CA 1.487 1.386 0 CA-C-N 118.064 0.393 . . . . 0.0 111.334 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 8' ' ' VAL . 90.5 m . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -55.15 -40.45 70.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.994 0.918 . . . . 0.0 111.799 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -56.61 -47.57 79.37 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.295 0.638 . . . . 0.0 110.537 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -66.77 -38.31 86.33 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.82 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 4' ' ' THR . 87.1 t -66.81 -44.16 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.309 0.644 . . . . 0.0 110.616 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.54 -44.91 85.52 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.442 1.097 . . . . 0.0 110.107 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.508 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 57.7 m -59.89 -48.34 82.11 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.559 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -57.83 -47.69 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.743 0.817 . . . . 0.0 111.828 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.474 HG23 HD12 ' A' ' 18' ' ' ILE . 41.0 mt -58.3 -44.27 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.812 0.845 . . . . 0.0 110.526 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . . . -57.87 -44.3 86.55 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.143 0.977 . . . . 0.0 112.569 174.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.1 mm-40 -63.1 -36.22 82.87 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.421 0.688 . . . . 0.0 111.632 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -78.72 -59.44 2.78 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.817 -173.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -101.1 18.13 20.6 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.466 0.706 . . . . 0.0 112.853 -166.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.2 t70 47.72 66.1 1.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.304 1.041 . . . . 0.0 111.9 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.474 HD12 HG23 ' A' ' 12' ' ' ILE . 3.5 pt -142.54 147.34 42.4 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 123.804 0.841 . . . . 0.0 109.739 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.02 116.17 4.57 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.656 2.237 . . . . 0.0 112.361 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.534 ' HA ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -63.41 -17.29 62.5 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -176.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.53 -30.89 70.66 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.729 0.812 . . . . 0.0 110.525 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -85.25 -14.42 46.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.341 0.656 . . . . 0.0 110.781 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 20' ' ' ARG . 1.8 mp -78.01 108.41 11.3 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.8 p -91.27 157.46 42.57 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 123.573 0.749 . . . . 0.0 109.672 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.95 -17.92 56.4 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.237 1.958 . . . . 0.0 112.456 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -100.05 6.53 45.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.192 0.597 . . . . 0.0 110.489 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -78.85 138.72 38.29 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.37 0.668 . . . . 0.0 110.516 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.412 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 50.7 t-80 -86.28 114.04 22.77 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.535 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -51.05 -37.24 44.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.854 0.862 . . . . 0.0 113.212 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.412 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 63.7 mt -89.88 -54.06 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -174.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.76 -39.17 27.34 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.416 0.687 . . . . 0.0 112.544 -168.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -88.25 -55.11 3.88 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 29' ' ' ALA . 73.7 mt -75.09 -8.66 57.19 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.79 29.01 74.18 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.446 0.466 . . . . 0.0 113.82 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -88.04 124.98 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -75.87 160.51 29.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.125 0.57 . . . . 0.0 110.109 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.457 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 15.3 m -57.69 -34.08 69.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.998 0.919 . . . . 0.0 111.782 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.71 -37.61 76.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.86 0.464 . . . . 0.0 110.686 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -67.48 -42.35 83.12 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.54 0.736 . . . . 0.0 109.95 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -65.46 -28.59 69.33 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 124.392 1.057 . . . . 0.0 110.967 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 37' ' ' SER . 70.7 mt -61.79 -42.15 98.63 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.895 0.478 . . . . 0.0 110.749 174.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.46 -35.21 60.94 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.063 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.7 -47.75 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.781 0.676 . . . . 0.0 109.384 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.37 -30.08 63.06 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.098 0.959 . . . . 0.0 110.654 -174.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -62.59 -43.68 98.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.644 0.778 . . . . 0.0 110.89 171.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.4 -31.84 65.88 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.099 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.15 -45.41 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.468 0.707 . . . . 0.0 110.314 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -52.01 -49.29 63.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.877 1.271 . . . . 0.0 110.312 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -72.34 -49.62 32.92 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.014 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.06 98.78 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -89.77 -3.78 57.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.382 0.673 . . . . 0.0 112.378 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.4 45.45 96.38 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 123.779 0.674 . . . . 0.0 113.072 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.54 179.73 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.555 1.142 . . . . 0.0 110.186 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -122.35 113.2 19.07 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.419 HD21 ' HH2' ' A' ' 60' ' ' TRP . 83.4 mt -78.63 125.81 83.78 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 122.797 0.439 . . . . 0.0 110.41 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.19 54.95 5.41 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.205 2.603 . . . . 0.0 110.422 166.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.68 -39.94 86.19 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.91 1.284 . . . . 0.0 109.591 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -56.73 -41.81 78.16 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 124.259 0.974 . . . . 0.0 111.813 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -65.81 -43.48 88.52 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.156 0.582 . . . . 0.0 110.13 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.419 ' HH2' HD21 ' A' ' 55' ' ' LEU . 42.1 m0 -60.73 -50.14 74.66 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.627 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.1 m -60.89 -43.83 97.95 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.134 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -70.38 -40.32 74.03 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.765 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -60.43 -39.6 88.04 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.974 0.51 . . . . 0.0 111.446 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.06 -48.89 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.372 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -66.72 -28.71 68.65 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.133 0.973 . . . . 0.0 112.804 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -80.89 -3.4 51.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.181 0.592 . . . . 0.0 112.474 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.67 21.29 72.79 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 117.465 0.121 . . . . 0.0 113.333 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -79.46 -25.83 41.85 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.727 0.811 . . . . 0.0 110.239 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.71 171.15 19.3 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.27 1.028 . . . . 0.0 108.992 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.9 p -104.81 168.02 9.34 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 171.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.7 p -56.48 -41.78 77.16 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.314 0.384 . . . . 0.0 111.888 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HA ' HG21 ' A' ' 76' ' ' VAL . 14.0 pt-20 -51.09 -40.84 59.34 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -175.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -57.45 -28.77 63.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.594 0.757 . . . . 0.0 112.773 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -114.5 -29.59 6.8 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.748 0.419 . . . . 0.0 112.092 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.08 24.67 12.62 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.556 0.742 . . . . 0.0 111.114 -166.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.495 HG12 ' HG2' ' A' ' 78' ' ' LYS . 43.7 t -104.64 141.25 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 160.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -54.52 -39.59 67.78 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.172 1.389 . . . . 0.0 114.584 -169.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.495 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.7 pttt -64.39 -42.19 96.25 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -75.38 -40.49 57.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.435 1.094 . . . . 0.0 110.155 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.3 tp -61.08 -53.36 58.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.436 1.094 . . . . 0.0 109.453 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.21 -27.36 68.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.618 0.767 . . . . 0.0 112.037 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.66 -48.59 63.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.008 0.523 . . . . 0.0 110.409 174.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -56.88 -46.07 82.09 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 124.443 1.089 . . . . 0.0 110.801 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.448 ' O ' HG21 ' A' ' 88' ' ' VAL . 84.1 mt -64.03 -52.82 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.203 1.001 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.5 -41.77 90.65 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.076 0.95 . . . . 0.0 112.456 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.19 -30.21 68.35 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.376 0.423 . . . . 0.0 110.339 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.92 -35.74 69.76 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.745 0.418 . . . . 0.0 111.666 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 84' ' ' ILE . 61.6 t -65.28 -41.32 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.473 0.654 . . . . 0.0 109.487 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.17 -37.52 81.08 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.85 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.47 97.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.458 0.703 . . . . 0.0 111.587 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.946 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.468 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.6 m . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -54.88 -45.18 74.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.507 1.123 . . . . 0.0 111.447 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.54 -47.03 85.55 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.786 0.679 . . . . 0.0 110.573 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -67.22 -37.85 84.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.056 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.36 -35.15 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.352 0.661 . . . . 0.0 110.511 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.69 91.9 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.554 0.742 . . . . 0.0 109.953 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 56.0 m -63.15 -46.26 88.05 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.013 0.821 . . . . 0.0 110.455 172.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.2 mt -57.8 -46.56 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.211 1.004 . . . . 0.0 111.154 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.541 HG23 HD13 ' A' ' 18' ' ' ILE . 50.6 mt -58.12 -49.81 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.039 0.936 . . . . 0.0 110.747 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.07 -44.4 71.11 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.989 0.916 . . . . 0.0 112.974 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 10' ' ' THR . 18.2 mm-40 -63.84 -32.14 73.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.916 0.886 . . . . 0.0 111.753 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.8 m -86.65 -34.3 19.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.408 0.683 . . . . 0.0 112.095 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.2 m -113.16 1.42 15.25 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.842 0.457 . . . . 0.0 112.167 -164.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 50.27 68.25 0.79 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.259 1.423 . . . . 0.0 112.246 -177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.541 HD13 HG23 ' A' ' 12' ' ' ILE . 11.6 pt -145.97 157.86 49.75 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 124.551 1.14 . . . . 0.0 109.269 -177.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.43 120.71 6.65 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.772 2.315 . . . . 0.0 110.768 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.403 ' HA ' HD11 ' A' ' 23' ' ' ILE . 1.2 ppt_? -64.66 -25.18 67.84 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -170.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -82.98 -11.97 57.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.605 0.762 . . . . 0.0 111.381 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -83.0 -18.38 40.03 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.459 0.303 . . . . 0.0 110.38 173.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.508 HD13 HD12 ' A' ' 18' ' ' ILE . 2.0 mp -74.76 117.06 18.31 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.1 p -91.54 158.84 39.97 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.133 0.973 . . . . 0.0 109.719 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.72 -21.56 56.72 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.414 2.076 . . . . 0.0 113.257 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -92.28 3.75 54.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.287 0.635 . . . . 0.0 111.161 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -71.99 123.15 22.15 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -84.0 119.47 24.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 169.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.63 -44.02 12.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.252 1.021 . . . . 0.0 112.722 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.19 -46.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 120.681 0.277 . . . . 0.0 110.322 -168.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.43 -35.79 24.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.338 0.655 . . . . 0.0 111.978 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -93.59 -55.45 3.27 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.313 0.645 . . . . 0.0 110.612 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.8 mt -82.21 -12.58 58.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.509 0.724 . . . . 0.0 112.218 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.86 34.21 86.47 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 113.897 0.319 . . . . 0.0 113.897 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.1 mt -88.09 125.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.976 0.91 . . . . 0.0 108.675 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -72.39 158.99 34.73 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.443 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 37.6 m -62.21 -26.64 68.47 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.07 0.548 . . . . 0.0 111.637 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.65 -33.76 60.46 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 122.904 0.482 . . . . 0.0 110.384 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.27 -39.18 75.11 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.172 0.589 . . . . 0.0 109.519 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -66.15 -23.65 66.51 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.503 0.721 . . . . 0.0 110.236 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 37' ' ' SER . 90.7 mt -62.61 -37.0 84.56 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.064 0.546 . . . . 0.0 110.714 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -69.99 -39.16 76.06 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.312 0.645 . . . . 0.0 110.2 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.47 HG12 HG12 ' A' ' 12' ' ' ILE . 2.4 mp -60.43 -47.32 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 123.617 0.573 . . . . 0.0 109.661 174.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.78 -37.7 82.4 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.724 0.809 . . . . 0.0 111.173 -174.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.76 -50.18 74.83 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.76 1.224 . . . . 0.0 111.068 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.83 -30.84 70.34 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.729 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.458 HD12 HD13 ' A' ' 84' ' ' ILE . 97.2 mt -65.77 -44.73 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.59 0.756 . . . . 0.0 110.646 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.53 -49.72 64.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.484 1.114 . . . . 0.0 110.803 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -76.52 -48.47 19.33 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.754 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.93 74.81 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.074 0.55 . . . . 0.0 112.375 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -86.74 -3.24 59.02 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.852 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.16 35.52 91.65 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.651 0.594 . . . . 0.0 113.003 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.9 pt -124.94 -177.13 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.712 1.205 . . . . 0.0 109.209 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -130.04 126.06 36.76 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 168.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.9 mt -80.81 128.18 72.52 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -73.02 59.33 3.6 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.933 2.422 . . . . 0.0 110.702 165.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.68 -39.66 89.25 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.368 1.067 . . . . 0.0 109.748 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.77 -44.96 82.31 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 124.005 0.815 . . . . 0.0 110.463 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.7 tppt? -68.8 -44.49 73.46 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 111.259 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -57.61 -52.39 65.6 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.039 0.837 . . . . 0.0 110.55 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.2 m -71.06 -24.78 62.4 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.481 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -69.27 -47.63 64.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.652 0.781 . . . . 0.0 110.725 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 21.2 mm-40 -60.17 -40.57 90.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.499 0.72 . . . . 0.0 110.735 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 53.4 t -59.78 -56.34 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.905 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -62.23 -33.49 74.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.647 0.779 . . . . 0.0 111.908 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -87.44 4.99 41.09 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.347 0.659 . . . . 0.0 111.754 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.45 25.87 70.35 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -91.67 -27.58 18.01 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.275 0.63 . . . . 0.0 110.731 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -139.18 152.06 47.09 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 m -81.57 156.47 25.19 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.007 0.523 . . . . 0.0 109.639 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.5 p -52.93 -46.58 68.16 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.853 0.861 . . . . 0.0 110.856 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.537 ' HA ' HG23 ' A' ' 76' ' ' VAL . 9.3 mm-40 -42.83 -52.75 4.93 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.152 1.381 . . . . 0.0 112.588 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -54.76 -21.25 10.47 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.271 -1.331 . . . . 0.0 114.021 -169.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -121.71 -29.79 4.28 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -108.03 15.04 24.68 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -168.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.537 HG23 ' HA ' ' A' ' 72' ' ' GLU . 71.6 t -103.22 139.56 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -53.35 -38.15 63.03 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.233 1.413 . . . . 0.0 114.023 -173.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HG2' HG11 ' A' ' 76' ' ' VAL . 22.9 pttp -70.33 -41.0 73.81 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 120.769 0.318 . . . . 0.0 111.097 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.44 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 80.1 m-20 -74.81 -34.67 62.42 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.926 0.89 . . . . 0.0 110.241 -177.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.97 -44.76 72.27 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.821 1.248 . . . . 0.0 108.871 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.51 -37.54 78.55 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.877 0.735 . . . . 0.0 111.098 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.73 71.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.672 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 9.6 mmp_? -50.54 -53.01 33.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.197 0.936 . . . . 0.0 111.419 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.458 HD13 HD12 ' A' ' 47' ' ' ILE . 71.2 mt -65.6 -43.9 93.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.625 -175.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.58 -39.64 88.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.623 0.769 . . . . 0.0 111.223 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.91 -35.05 77.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.524 0.73 . . . . 0.0 110.841 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.2 mt -73.67 -30.29 62.81 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.02 0.528 . . . . 0.0 111.352 176.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.504 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 69.5 t -71.02 -36.93 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.637 0.775 . . . . 0.0 109.455 172.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.76 -41.11 83.85 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.23 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.12 -42.63 93.75 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.154 0.981 . . . . 0.0 111.13 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.504 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 43.7 pttt . . . . . 0 C--N 1.357 0.895 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 8' ' ' VAL . 61.8 m . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.23 -46.1 79.68 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.728 0.411 . . . . 0.0 111.602 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.483 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 28.6 m-20 -59.56 -44.87 93.14 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.743 0.652 . . . . 0.0 110.688 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -64.74 -45.9 84.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.169 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 4' ' ' THR . 79.8 t -65.36 -43.89 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.625 0.77 . . . . 0.0 110.458 -175.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.86 97.16 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.132 0.973 . . . . 0.0 111.008 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.2 m -63.83 -42.72 97.56 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.18 0.925 . . . . 0.0 111.258 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.414 HD11 ' HA ' ' A' ' 47' ' ' ILE . 96.7 mt -59.18 -51.01 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.578 0.751 . . . . 0.0 111.122 175.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.661 HG22 HD13 ' A' ' 18' ' ' ILE . 58.4 mt -59.8 -42.35 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.648 0.779 . . . . 0.0 110.534 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.485 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -56.39 -52.51 64.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.729 0.812 . . . . 0.0 112.713 173.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.47 -22.19 63.65 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.631 0.772 . . . . 0.0 112.327 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 m -85.06 -51.05 6.93 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.614 0.366 . . . . 0.0 111.11 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.577 ' SG ' HD13 ' A' ' 43' ' ' ILE . 74.7 m -100.29 7.59 44.29 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -168.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.8 t70 53.44 65.16 1.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.242 1.017 . . . . 0.0 111.871 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.661 HD13 HG22 ' A' ' 12' ' ' ILE . 10.1 pt -141.19 146.49 43.18 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.089 0.955 . . . . 0.0 109.418 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.28 114.33 2.62 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.716 2.277 . . . . 0.0 111.431 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.483 ' NH2' ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -53.61 -29.76 39.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.359 1.064 . . . . 0.0 113.175 -177.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.83 -27.53 62.96 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.191 0.597 . . . . 0.0 111.729 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -81.68 -5.56 58.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.825 0.45 . . . . 0.0 110.717 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.461 HD13 HD12 ' A' ' 18' ' ' ILE . 1.9 mp -86.36 113.49 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 174.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -95.16 165.9 15.95 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.843 0.857 . . . . 0.0 109.243 173.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.08 -18.47 61.94 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.291 1.994 . . . . 0.0 112.336 172.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -94.68 -0.21 54.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 122.948 0.499 . . . . 0.0 110.509 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.4 m -71.74 124.18 24.23 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.015 0.526 . . . . 0.0 110.383 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 49.9 t-80 -85.66 123.18 30.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.83 -45.96 15.28 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.142 0.977 . . . . 0.0 112.207 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 mt -92.59 -48.16 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.4 t70 -76.86 -37.32 55.78 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.664 0.785 . . . . 0.0 112.357 -171.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.71 -59.21 1.86 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.587 0.355 . . . . 0.0 110.563 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.1 mt -75.92 -16.31 60.05 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.023 0.529 . . . . 0.0 112.417 -171.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.82 37.96 56.79 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.124 0.265 . . . . 0.0 113.303 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 39' ' ' ASP . 93.5 mt -96.7 116.5 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.287 1.035 . . . . 0.0 108.928 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.46 164.56 26.45 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.8 m -56.41 -31.95 64.37 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.74 0.816 . . . . 0.0 111.614 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.76 -32.77 65.88 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 122.952 0.501 . . . . 0.0 111.088 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.469 ' HB2' HG22 ' A' ' 35' ' ' ILE . 28.6 m-20 -71.43 -40.99 70.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.965 0.506 . . . . 0.0 109.755 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.54 -22.01 64.52 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.212 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.62 -50.94 68.83 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.327 0.584 . . . . 0.0 110.439 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.42 -34.77 70.62 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.086 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.577 HD13 ' SG ' ' A' ' 16' ' ' CYS . 62.3 mt -63.92 -42.7 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 123.578 0.549 . . . . 0.0 110.192 173.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.46 -36.25 76.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.599 0.76 . . . . 0.0 110.645 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.44 -42.51 98.68 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.023 0.929 . . . . 0.0 110.272 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -42.02 84.16 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.137 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.414 ' HA ' HD11 ' A' ' 11' ' ' ILE . 84.1 mt -64.82 -43.71 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.763 0.825 . . . . 0.0 110.824 175.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -50.17 -54.09 23.26 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.076 1.35 . . . . 0.0 110.961 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -38.99 53.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.843 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.97 -45.37 86.85 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -88.43 -10.61 48.61 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.706 0.802 . . . . 0.0 112.562 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.23 48.57 81.82 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.396 0.435 . . . . 0.0 112.24 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.8 pt -131.26 169.18 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.95 1.3 . . . . 0.0 109.315 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.613 ' HZ3' ' HB2' ' A' ' 54' ' ' LYS . 10.2 mtmp? -110.82 100.8 9.48 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.432 HD22 HD13 ' A' ' 87' ' ' LEU . 83.8 mt -67.94 123.07 86.26 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 122.695 0.398 . . . . 0.0 110.222 174.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.98 61.0 7.71 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.839 2.36 . . . . 0.0 110.124 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.08 -36.88 83.03 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.042 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -58.94 -42.3 89.44 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.553 0.741 . . . . 0.0 110.887 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.58 -52.12 66.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.652 0.781 . . . . 0.0 109.925 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -58.03 -43.77 86.97 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 124.474 1.108 . . . . 0.0 111.036 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -60.26 -47.74 84.7 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.904 0.882 . . . . 0.0 110.718 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -62.84 -40.26 96.9 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.272 0.629 . . . . 0.0 110.779 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.419 ' HG2' ' HD2' ' A' ' 68' ' ' LYS . 48.5 mt-10 -65.28 -41.65 93.96 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.189 0.931 . . . . 0.0 112.031 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.96 -47.4 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.436 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -57.31 -46.71 82.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.246 0.618 . . . . 0.0 111.669 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.08 0.02 50.04 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.239 0.616 . . . . 0.0 112.421 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.09 18.92 75.14 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.436 0.535 . . . . 0.0 114.436 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HD2' ' HG2' ' A' ' 63' ' ' GLU . 62.3 mttm -69.76 -33.93 73.1 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 172.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.83 169.04 19.93 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.993 1.317 . . . . 0.0 108.397 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.5 p -116.12 163.45 15.93 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.08 0.952 . . . . 0.0 109.432 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p -55.71 -54.17 47.56 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 124.057 0.848 . . . . 0.0 112.746 -168.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -30.07 40.22 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -26.81 68.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.814 1.246 . . . . 0.0 111.797 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -115.39 -26.98 7.36 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.215 0.606 . . . . 0.0 111.938 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -108.22 17.98 21.62 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.186 0.595 . . . . 0.0 112.277 -165.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.498 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.0 t -105.71 139.73 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 165.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -52.68 -37.91 59.61 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.917 1.287 . . . . 0.0 114.308 -171.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.498 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.4 pttt -69.76 -45.19 68.63 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 123.163 0.29 . . . . 0.0 110.531 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -68.08 -41.43 81.93 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.165 0.586 . . . . 0.0 110.616 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.09 -50.21 69.21 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.89 1.276 . . . . 0.0 109.536 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.94 71.86 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 123.615 0.572 . . . . 0.0 111.158 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -66.65 -50.6 62.42 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.853 0.461 . . . . 0.0 110.26 175.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.429 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 3.7 mmp_? -53.35 -50.19 65.56 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.861 0.864 . . . . 0.0 111.211 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 88' ' ' VAL . 87.7 mt -64.16 -45.65 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.948 1.299 . . . . 0.0 110.395 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.66 -36.43 78.68 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.155 0.982 . . . . 0.0 111.394 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 29.9 mm-40 -64.94 -43.76 91.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.581 0.752 . . . . 0.0 110.839 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.432 HD13 HD22 ' A' ' 55' ' ' LEU . 67.1 mt -70.89 -27.64 63.95 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.16 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 84' ' ' ILE . 78.7 t -67.83 -37.09 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.504 0.722 . . . . 0.0 110.114 172.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.3 75.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.068 0.547 . . . . 0.0 110.569 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.48 87.28 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.398 0.679 . . . . 0.0 111.275 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.4 m . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -55.93 -48.85 74.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.314 0.646 . . . . 0.0 110.881 173.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.16 -50.11 59.58 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.022 0.826 . . . . 0.0 110.158 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 11' ' ' ILE . 6.1 mmp_? -70.34 -41.4 73.24 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.889 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.99 -40.98 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.162 0.585 . . . . 0.0 110.408 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.02 -37.97 89.38 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.086 0.954 . . . . 0.0 109.98 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.477 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 90.4 m -63.27 -44.21 95.74 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.52 174.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 7' ' ' ARG . 95.7 mt -58.81 -47.35 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.23 0.612 . . . . 0.0 111.359 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.504 HG23 HD13 ' A' ' 18' ' ' ILE . 58.8 mt -57.44 -43.81 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.992 0.517 . . . . 0.0 110.102 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.493 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -57.76 -49.46 76.51 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.729 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 10' ' ' THR . 46.4 mm-40 -66.64 -33.46 75.71 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.297 0.639 . . . . 0.0 111.806 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.5 m -74.03 -50.72 18.49 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.502 0.721 . . . . 0.0 110.933 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.406 ' SG ' HD13 ' A' ' 43' ' ' ILE . 39.8 m -97.37 3.95 50.88 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.812 0.845 . . . . 0.0 113.211 -169.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 45.67 77.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.418 1.087 . . . . 0.0 112.006 -171.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.504 HD13 HG23 ' A' ' 12' ' ' ILE . 7.3 pt -147.74 147.59 27.81 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.021 0.929 . . . . 0.0 109.967 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.14 122.11 10.21 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.911 2.408 . . . . 0.0 111.561 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HG3' ' HA ' ' A' ' 10' ' ' THR . 2.5 tmm_? -64.46 -19.92 65.86 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.538 1.135 . . . . 0.0 112.453 -173.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.55 -22.41 60.09 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.842 0.857 . . . . 0.0 110.557 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.8 p -86.51 -10.68 53.58 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.158 0.583 . . . . 0.0 110.902 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.405 HD13 HD12 ' A' ' 18' ' ' ILE . 2.3 mp -91.76 93.48 4.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.1 p -82.7 164.12 48.44 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 124.107 0.963 . . . . 0.0 109.989 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.85 -21.13 72.87 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.162 1.908 . . . . 0.0 113.172 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -106.85 17.5 23.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.89 0.476 . . . . 0.0 110.409 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.9 m -72.33 120.3 17.74 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.112 0.565 . . . . 0.0 109.65 170.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -84.0 121.97 28.13 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 170.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -40.28 -50.71 2.77 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.886 1.274 . . . . 0.0 113.041 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.0 mt -92.85 -47.43 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 121.109 0.48 . . . . 0.0 110.188 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.51 -38.13 55.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.235 1.014 . . . . 0.0 112.221 -172.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.24 -65.2 0.98 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.359 0.664 . . . . 0.0 110.421 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.37 -12.71 61.57 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.76 0.824 . . . . 0.0 112.633 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.39 24.41 76.76 Favored Glycine 0 C--N 1.354 1.563 0 O-C-N 123.466 0.479 . . . . 0.0 114.235 174.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.9 mt -78.87 124.89 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.441 1.097 . . . . 0.0 109.371 -175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.14 156.23 39.04 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.231 0.612 . . . . 0.0 110.987 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.8 m -63.55 -41.07 98.45 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.826 0.85 . . . . 0.0 111.863 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 pp -71.62 -28.86 64.08 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.927 0.394 . . . . 0.0 110.043 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.71 -36.9 59.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.185 0.994 . . . . 0.0 110.118 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -70.9 -23.32 62.25 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.482 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.64 -41.31 94.68 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.152 0.581 . . . . 0.0 111.091 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.66 -42.82 90.91 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.403 0.681 . . . . 0.0 110.305 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.406 HD13 ' SG ' ' A' ' 16' ' ' CYS . 59.6 mt -62.89 -45.03 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.755 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.81 -33.82 68.85 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.293 0.637 . . . . 0.0 110.532 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -59.9 -39.79 86.57 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.321 1.048 . . . . 0.0 110.435 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.46 -38.03 71.32 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.537 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.6 mt -66.69 -41.71 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.657 0.783 . . . . 0.0 110.383 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -52.11 -47.66 65.19 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.792 1.237 . . . . 0.0 110.694 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.29 -56.05 22.25 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.121 0.888 . . . . 0.0 110.846 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.71 -51.8 68.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.047 0.939 . . . . 0.0 112.302 -171.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -87.49 -14.54 40.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.286 0.634 . . . . 0.0 111.561 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.69 30.43 74.67 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 117.716 0.234 . . . . 0.0 113.329 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.405 HD13 HG22 ' A' ' 84' ' ' ILE . 32.7 pt -109.55 151.14 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.863 0.865 . . . . 0.0 110.967 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -93.34 95.67 9.47 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.442 HD21 HG12 ' A' ' 84' ' ' ILE . 83.8 mt -73.03 119.34 75.08 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.916 173.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -85.7 58.33 4.6 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.618 2.212 . . . . 0.0 109.152 165.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.71 -38.96 89.79 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.819 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -35.89 79.25 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.928 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.561 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.17 -51.13 41.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.221 0.608 . . . . 0.0 109.876 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.413 ' O ' HG21 ' A' ' 64' ' ' VAL . 51.4 m0 -55.57 -48.41 74.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.158 0.983 . . . . 0.0 111.349 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.7 m -62.82 -37.45 86.82 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.574 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -66.7 -43.15 85.17 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.253 0.621 . . . . 0.0 110.637 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 4.9 mm-40 -66.66 -33.88 76.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.589 0.756 . . . . 0.0 110.719 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 60' ' ' TRP . 54.4 t -61.38 -52.73 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.142 172.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -65.51 -27.04 68.19 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.098 0.559 . . . . 0.0 111.599 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.84 1.79 56.66 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.15 0.58 . . . . 0.0 111.702 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.93 12.93 71.89 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -72.6 -26.69 61.78 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 117.722 0.761 . . . . 0.0 110.119 172.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 168.03 22.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.32 1.048 . . . . 0.0 109.684 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.446 ' H ' ' NE2' ' A' ' 73' ' ' GLN . 51.5 p -100.28 163.53 12.35 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 124.266 1.027 . . . . 0.0 108.858 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.407 HG21 HG11 ' A' ' 64' ' ' VAL . 72.1 p -57.33 -43.28 83.22 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.626 0.579 . . . . 0.0 110.356 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HA ' HG21 ' A' ' 76' ' ' VAL . 22.2 mm-40 -41.4 -53.61 3.29 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.369 1.467 . . . . 0.0 112.786 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.446 ' NE2' ' H ' ' A' ' 70' ' ' THR . 50.2 mt-30 -60.75 -21.36 62.92 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.318 -1.31 . . . . 0.0 114.106 -171.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -128.81 -4.38 5.18 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.89 20.09 7.74 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.994 0.518 . . . . 0.0 111.217 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 72' ' ' GLU . 95.8 t -108.99 144.36 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 164.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.86 -35.98 71.71 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -67.67 -40.18 84.49 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 120.889 0.376 . . . . 0.0 110.096 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.1 m120 -73.5 -47.31 42.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.087 0.955 . . . . 0.0 110.316 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.03 -47.88 84.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.954 1.302 . . . . 0.0 109.897 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.07 -36.38 81.49 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.556 0.743 . . . . 0.0 111.841 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.68 81.38 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.06 0.544 . . . . 0.0 110.654 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 24.7 mmm180 -59.39 -48.48 81.49 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.772 0.829 . . . . 0.0 110.637 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 88' ' ' VAL . 97.0 mt -63.87 -43.1 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.699 1.2 . . . . 0.0 110.863 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.06 -39.06 93.6 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.567 0.747 . . . . 0.0 111.045 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -63.58 -40.88 98.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.547 0.739 . . . . 0.0 110.711 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 75.2 mt -70.57 -34.32 72.08 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.963 0.505 . . . . 0.0 112.019 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 84' ' ' ILE . 91.9 t -64.56 -42.64 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-O 121.454 0.645 . . . . 0.0 109.512 174.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.74 -37.63 79.56 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.176 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.36 -44.63 87.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.105 0.962 . . . . 0.0 111.413 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 CA--C 1.542 0.671 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.287 -178.459 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 119.824 -0.131 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -57.56 -48.8 78.33 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 123.007 0.523 . . . . 0.0 111.166 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.81 -44.5 70.25 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.386 0.674 . . . . 0.0 110.862 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -60.2 -54.05 50.47 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.479 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.55 -38.98 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.419 0.688 . . . . 0.0 111.245 -172.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.64 92.13 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.673 1.189 . . . . 0.0 110.339 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 85.9 m -66.63 -40.46 88.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.554 176.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.49 -49.81 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.15 0.432 . . . . 0.0 111.383 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.552 HG12 HG23 ' A' ' 43' ' ' ILE . 51.8 mt -58.79 -41.03 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 122.789 0.435 . . . . 0.0 110.166 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.519 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.74 -60.27 3.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.803 0.841 . . . . 0.0 112.542 173.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 10' ' ' THR . 17.3 mm-40 -65.43 -34.6 78.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.196 0.598 . . . . 0.0 112.146 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.4 m -72.87 -58.6 3.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.189 0.595 . . . . 0.0 110.331 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.7 t -84.99 3.5 38.21 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.06 65.91 1.37 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.405 1.082 . . . . 0.0 111.577 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.519 HG13 ' HA ' ' A' ' 13' ' ' ALA . 10.4 pt -145.3 159.33 49.2 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.801 1.24 . . . . 0.0 109.023 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -75.09 133.77 16.85 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.767 2.312 . . . . 0.0 111.802 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -18.9 65.63 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -81.87 -19.79 40.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.485 0.714 . . . . 0.0 109.873 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 p -79.88 -7.75 58.91 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 122.568 0.347 . . . . 0.0 110.851 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.1 114.06 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.1 p -100.25 160.58 26.67 Favored Pre-proline 0 N--CA 1.488 1.437 0 C-N-CA 123.302 0.641 . . . . 0.0 110.471 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.05 -25.83 58.57 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 122.718 2.278 . . . . 0.0 112.671 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -91.77 1.97 56.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.671 0.788 . . . . 0.0 111.114 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 t -83.01 137.83 33.98 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.302 0.641 . . . . 0.0 111.345 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.503 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 54.7 t-80 -82.8 111.86 19.1 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 165.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.38 -20.25 28.28 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.503 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 84.6 mt -99.57 -41.25 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.599 0.76 . . . . 0.0 110.586 -177.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 32.4 t70 -79.98 -52.0 8.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.416 0.686 . . . . 0.0 112.227 -173.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -74.94 -48.95 21.84 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.365 0.602 . . . . 0.0 111.164 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.5 mt -73.23 -12.78 60.98 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.49 -176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.17 35.57 88.75 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 121.296 0.387 . . . . 0.0 112.662 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.5 mt -99.84 126.08 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -61.34 153.35 26.91 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 118.144 0.429 . . . . 0.0 110.73 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.421 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.4 m -63.61 -29.09 70.38 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.008 0.523 . . . . 0.0 109.988 176.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.57 -39.26 62.36 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.718 0.807 . . . . 0.0 109.96 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.18 -26.65 61.26 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.549 0.74 . . . . 0.0 110.11 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -74.34 -27.67 60.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.722 0.809 . . . . 0.0 110.504 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 37' ' ' SER . 89.8 mt -56.43 -33.44 65.84 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 122.632 0.373 . . . . 0.0 110.869 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.92 -41.61 64.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.666 0.786 . . . . 0.0 110.631 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.552 HG23 HG12 ' A' ' 12' ' ' ILE . 47.9 mt -62.81 -41.06 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.062 0.458 . . . . 0.0 110.175 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.14 -29.95 63.25 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.29 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -59.01 -42.23 89.63 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.969 0.908 . . . . 0.0 109.892 170.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.6 -42.43 74.41 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.338 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.46 -42.84 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.762 0.825 . . . . 0.0 110.597 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.59 -48.22 69.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.892 1.277 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -72.52 -42.77 64.42 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.2 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.44 77.02 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.834 0.854 . . . . 0.0 112.463 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -87.11 -7.94 57.52 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 111.449 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.65 32.82 85.48 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.328 0.392 . . . . 0.0 113.194 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 pt -112.61 169.59 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.198 0.999 . . . . 0.0 110.761 -173.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -104.83 101.71 11.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.488 HD21 HG12 ' A' ' 84' ' ' ILE . 95.7 mt -72.43 114.49 30.28 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 167.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 87.7 Cg_endo -81.94 63.86 8.4 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.037 1.824 . . . . 0.0 109.833 168.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.5 -38.16 88.81 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.035 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.23 -42.67 99.26 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.898 0.479 . . . . 0.0 111.027 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 54.3 tptt -58.75 -47.3 85.13 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.366 1.066 . . . . 0.0 110.79 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.4 ' O ' HG23 ' A' ' 64' ' ' VAL . 53.4 m0 -63.48 -46.03 88.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.554 0.742 . . . . 0.0 110.867 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.5 m -64.85 -32.94 74.87 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.367 1.067 . . . . 0.0 110.965 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.21 -42.32 62.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.438 0.695 . . . . 0.0 109.734 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.32 -35.41 75.57 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.654 0.781 . . . . 0.0 111.046 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 60' ' ' TRP . 85.0 t -64.97 -46.16 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 173.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.31 -40.27 96.87 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.137 0.975 . . . . 0.0 112.825 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.04 -1.67 58.05 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.42 0.688 . . . . 0.0 112.646 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.67 30.52 77.89 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 11.3 mmpt? -77.18 -33.21 56.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.951 0.901 . . . . 0.0 109.444 171.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.64 168.45 20.13 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.673 1.189 . . . . 0.0 108.747 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.5 p -108.9 162.11 14.5 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.61 0.764 . . . . 0.0 111.149 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.0 p -58.07 -64.47 0.9 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.74 0.816 . . . . 0.0 111.797 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -30.49 62.0 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -55.74 -24.84 37.43 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.545 1.138 . . . . 0.0 112.861 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -111.36 -44.0 3.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.313 0.645 . . . . 0.0 111.095 173.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -97.94 21.76 10.21 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.994 0.518 . . . . 0.0 112.306 -163.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.562 HG11 ' HG2' ' A' ' 78' ' ' LYS . 25.5 t -106.01 140.63 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 165.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.37 -39.49 70.16 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -167.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.562 ' HG2' HG11 ' A' ' 76' ' ' VAL . 60.9 pttt -61.34 -43.12 99.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.608 0.718 . . . . 0.0 110.191 176.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.477 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 83.9 m-20 -75.96 -44.97 37.32 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.888 1.275 . . . . 0.0 109.967 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.74 -53.46 57.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.187 1.395 . . . . 0.0 109.836 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.27 70.69 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.453 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.09 76.57 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.978 0.511 . . . . 0.0 111.678 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 3.6 mmp_? -59.81 -49.59 77.12 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.723 0.773 . . . . 0.0 109.806 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.488 HG12 HD21 ' A' ' 55' ' ' LEU . 88.6 mt -58.89 -45.64 91.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.587 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -64.64 -37.23 86.85 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.964 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -66.68 -32.87 74.47 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.803 0.441 . . . . 0.0 110.818 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.16 -30.92 60.87 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.278 0.631 . . . . 0.0 111.702 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.2 t -69.28 -35.57 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.385 0.674 . . . . 0.0 110.119 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.35 -37.92 77.89 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.484 173.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.69 -39.01 93.26 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.865 0.866 . . . . 0.0 111.933 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt . . . . . 0 N--CA 1.477 0.886 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.475 -179.854 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 8' ' ' VAL . 28.0 m . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 119.556 -0.259 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -53.69 -49.04 68.87 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 0.0 111.486 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.36 -42.29 98.46 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.636 0.774 . . . . 0.0 110.795 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -64.24 -42.11 96.68 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.25 0.969 . . . . 0.0 111.22 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 4' ' ' THR . 89.0 t -69.93 -38.26 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.732 0.813 . . . . 0.0 110.685 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.91 81.08 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.229 1.011 . . . . 0.0 110.133 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.4 m -63.89 -44.42 93.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.614 0.766 . . . . 0.0 110.615 171.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 47' ' ' ILE . 95.3 mt -57.39 -50.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.754 0.822 . . . . 0.0 111.269 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.618 HG21 HD13 ' A' ' 18' ' ' ILE . 51.8 mt -60.09 -48.05 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.32 0.648 . . . . 0.0 110.405 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.73 -49.96 64.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.161 0.985 . . . . 0.0 112.675 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -68.19 -42.31 80.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.437 0.695 . . . . 0.0 112.19 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.9 m -68.02 -48.33 66.0 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.646 0.378 . . . . 0.0 110.585 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.601 ' SG ' HD11 ' A' ' 43' ' ' ILE . 34.2 m -91.88 -2.52 56.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.88 0.872 . . . . 0.0 113.157 -171.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.2 t70 52.83 69.64 0.67 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.998 0.919 . . . . 0.0 111.56 -171.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.618 HD13 HG21 ' A' ' 12' ' ' ILE . 9.6 pt -143.53 156.86 59.98 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.782 1.233 . . . . 0.0 108.748 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.95 137.96 39.22 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.58 2.187 . . . . 0.0 111.546 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -62.65 -28.47 69.94 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.722 0.809 . . . . 0.0 111.349 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.85 -21.58 57.1 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.0 0.52 . . . . 0.0 111.071 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.2 p -83.97 1.65 42.62 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.547 0.339 . . . . 0.0 111.101 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.75 111.5 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 168.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.4 p -101.46 161.57 23.18 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.663 0.785 . . . . 0.0 109.869 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.66 -27.2 75.87 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.007 1.805 . . . . 0.0 112.347 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -96.27 2.66 53.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.98 0.512 . . . . 0.0 110.846 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.3 p -74.22 129.33 37.61 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -83.97 115.63 22.41 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -44.61 -39.46 5.02 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.812 1.245 . . . . 0.0 113.96 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.9 mt -95.31 -56.73 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 122.731 0.413 . . . . 0.0 110.486 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -80.01 -23.45 41.49 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.798 0.839 . . . . 0.0 112.965 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -108.25 -61.01 1.65 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.967 0.507 . . . . 0.0 110.915 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.52 -20.01 62.1 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.614 0.765 . . . . 0.0 111.902 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.91 36.42 92.08 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.656 0.598 . . . . 0.0 114.509 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 43' ' ' ILE . 61.1 mt -84.22 123.67 39.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 123.569 0.747 . . . . 0.0 109.038 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.08 149.24 33.07 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.303 0.641 . . . . 0.0 110.323 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.401 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 23.9 m -60.46 -38.66 84.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.203 0.601 . . . . 0.0 110.533 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.29 -29.94 65.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.182 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.28 -36.18 46.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.456 0.703 . . . . 0.0 109.893 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -71.08 -21.99 62.16 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.388 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 37' ' ' SER . 96.3 mt -60.56 -37.87 82.68 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.796 0.438 . . . . 0.0 110.92 170.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -72.9 -40.46 65.53 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.142 0.577 . . . . 0.0 110.391 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.601 HD11 ' SG ' ' A' ' 16' ' ' CYS . 46.4 mt -61.25 -46.31 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 123.694 0.622 . . . . 0.0 110.408 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.4 ' HA ' HD11 ' A' ' 47' ' ' ILE . . . -70.78 -35.27 72.5 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.126 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -65.09 -38.44 90.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.52 0.728 . . . . 0.0 110.813 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.92 -28.11 64.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.365 0.666 . . . . 0.0 111.037 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.488 HG22 HD13 ' A' ' 53' ' ' ILE . 96.9 mt -68.96 -41.42 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.965 0.906 . . . . 0.0 109.602 171.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.2 -39.53 93.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.673 0.789 . . . . 0.0 111.109 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -67.83 -52.19 39.71 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.677 0.791 . . . . 0.0 111.112 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.82 -48.02 75.91 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.255 0.622 . . . . 0.0 112.591 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -90.11 -11.16 42.08 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.548 0.739 . . . . 0.0 112.386 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.2 74.46 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 123.361 0.413 . . . . 0.0 113.08 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.488 HD13 HG22 ' A' ' 47' ' ' ILE . 45.5 pt -108.22 -175.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.157 0.983 . . . . 0.0 110.015 -174.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -138.53 107.9 6.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 167.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.532 HD22 HG12 ' A' ' 84' ' ' ILE . 93.8 mt -69.72 130.4 90.35 Favored Pre-proline 0 C--O 1.243 0.738 0 C-N-CA 123.076 0.55 . . . . 0.0 109.733 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -72.43 59.71 3.25 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 123.344 2.696 . . . . 0.0 110.493 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.71 -45.44 78.74 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.785 0.834 . . . . 0.0 109.866 -171.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -39.57 92.21 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 123.856 0.722 . . . . 0.0 110.926 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.59 -45.33 92.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.227 1.011 . . . . 0.0 110.59 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.406 ' O ' HG21 ' A' ' 64' ' ' VAL . 52.6 m0 -65.74 -45.29 83.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.605 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.5 m -64.43 -31.52 72.76 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.862 0.865 . . . . 0.0 110.221 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.72 -44.57 70.04 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.39 -42.7 96.44 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.753 0.821 . . . . 0.0 111.305 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 60' ' ' TRP . 78.2 t -62.59 -53.82 42.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.342 0.657 . . . . 0.0 110.741 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -66.28 -22.56 66.3 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.836 0.854 . . . . 0.0 112.768 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -98.99 4.72 47.31 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.452 0.701 . . . . 0.0 112.045 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 15.3 65.69 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 115.181 0.833 . . . . 0.0 115.181 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.482 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -78.61 -23.81 45.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.456 0.703 . . . . 0.0 110.588 174.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -146.53 163.14 36.69 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.865 0.866 . . . . 0.0 109.253 173.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.0 p -91.65 165.12 13.48 Favored 'General case' 0 C--O 1.247 0.955 0 C-N-CA 123.404 0.682 . . . . 0.0 110.131 172.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.4 p -57.86 -55.02 40.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.99 0.806 . . . . 0.0 109.896 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.77 -35.6 56.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.872 1.269 . . . . 0.0 113.831 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -55.01 -33.74 62.86 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.878 0.871 . . . . 0.0 112.844 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -117.52 -24.4 7.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.921 0.488 . . . . 0.0 112.085 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.73 26.68 10.38 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.459 0.704 . . . . 0.0 110.494 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.483 HG13 ' HG2' ' A' ' 78' ' ' LYS . 52.3 t -109.76 143.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 158.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.4 -37.6 81.32 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HG2' HG13 ' A' ' 76' ' ' VAL . 22.2 pttp -68.87 -41.88 77.77 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 120.891 0.377 . . . . 0.0 110.286 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.5 m120 -68.2 -47.82 66.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.808 0.843 . . . . 0.0 110.191 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -57.76 -49.18 77.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.14 1.376 . . . . 0.0 110.51 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.51 -34.19 73.73 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.707 0.803 . . . . 0.0 111.975 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.86 87.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.836 0.454 . . . . 0.0 110.931 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 9.1 mmm180 -66.21 -41.33 90.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.52 0.728 . . . . 0.0 111.479 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.532 HG12 HD22 ' A' ' 55' ' ' LEU . 96.4 mt -63.19 -50.08 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.242 1.017 . . . . 0.0 110.517 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -60.6 -44.25 96.5 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.946 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.46 -31.49 70.82 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.753 0.421 . . . . 0.0 110.765 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.425 HD11 HD23 ' A' ' 55' ' ' LEU . 54.7 mt -67.32 -39.88 85.89 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.869 0.467 . . . . 0.0 111.568 173.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.442 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 60.5 t -63.54 -44.1 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.47 94.77 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.567 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.27 -39.11 55.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.517 0.727 . . . . 0.0 112.824 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.442 ' HE3' ' HA ' ' A' ' 88' ' ' VAL . 20.7 pttp . . . . . 0 N--CA 1.488 1.44 0 C-N-CA 122.585 0.354 . . . . 0.0 110.541 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.467 ' O ' HG22 ' A' ' 8' ' ' VAL . 23.4 m . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 119.675 -0.203 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -54.87 -47.82 73.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.475 0.71 . . . . 0.0 111.763 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.07 -43.58 98.68 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.658 0.599 . . . . 0.0 110.951 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -61.73 -44.08 97.62 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.361 0.665 . . . . 0.0 111.823 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 4' ' ' THR . 89.1 t -69.71 -41.32 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.879 0.872 . . . . 0.0 110.46 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.03 93.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.71 0.804 . . . . 0.0 110.85 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.5 m -64.51 -44.75 89.92 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 124.0 0.813 . . . . 0.0 111.227 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 47' ' ' ILE . 96.8 mt -57.26 -51.23 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.001 0.52 . . . . 0.0 110.908 176.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.578 HG12 HG21 ' A' ' 43' ' ' ILE . 32.1 mt -56.67 -48.02 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.986 0.914 . . . . 0.0 110.511 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 20' ' ' ARG . . . -52.66 -59.39 4.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.467 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.48 -24.22 56.89 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.426 -171.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.7 m -82.79 -44.25 15.75 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 117.864 0.302 . . . . 0.0 110.734 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.514 ' HB2' HD11 ' A' ' 43' ' ' ILE . 49.5 t -96.46 -3.71 42.92 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.655 0.782 . . . . 0.0 112.977 -172.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t70 59.65 65.68 1.11 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.455 1.102 . . . . 0.0 111.57 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.1 pt -146.47 150.48 40.7 Favored Pre-proline 0 N--CA 1.486 1.352 0 C-N-CA 124.555 1.142 . . . . 0.0 108.861 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.95 128.69 19.2 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.41 2.073 . . . . 0.0 111.929 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -65.29 -18.25 65.16 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.883 0.473 . . . . 0.0 111.77 178.081 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -79.65 -22.17 43.9 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.512 0.725 . . . . 0.0 109.95 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.0 p -87.21 5.23 39.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.705 0.402 . . . . 0.0 110.75 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.594 HG21 ' HG ' ' A' ' 77' ' ' LEU . 1.8 mp -95.01 130.98 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 166.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.418 ' HG1' ' HB2' ' A' ' 27' ' ' SER . 63.0 p -124.15 159.75 55.43 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 123.802 0.841 . . . . 0.0 110.165 -178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.87 -44.87 44.94 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.284 2.656 . . . . 0.0 113.677 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.96 11.61 29.0 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.906 0.482 . . . . 0.0 110.602 -173.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.418 ' HB2' ' HG1' ' A' ' 24' ' ' THR . 29.0 t -72.92 130.91 41.45 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 123.606 0.762 . . . . 0.0 109.717 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -84.85 117.01 23.62 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.469 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -49.56 -35.11 19.47 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.37 -55.21 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -78.8 -38.16 39.02 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -170.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -87.62 -59.63 2.19 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.732 0.413 . . . . 0.0 110.015 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 29' ' ' ALA . 90.4 mt -70.17 -23.66 63.02 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.38 0.672 . . . . 0.0 111.423 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.2 39.82 96.36 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.781 0.676 . . . . 0.0 113.16 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -72.91 115.34 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.08 144.11 24.81 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.91 0.884 . . . . 0.0 110.226 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 p -55.0 -42.84 72.98 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.957 0.903 . . . . 0.0 112.116 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.1 mt -67.39 -44.79 78.01 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.569 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -64.21 -26.86 68.7 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.984 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -74.06 -34.0 63.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.55 -38.54 90.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.102 0.561 . . . . 0.0 110.189 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.43 -46.0 88.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.029 0.932 . . . . 0.0 110.697 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.578 HG21 HG12 ' A' ' 12' ' ' ILE . 68.2 mt -65.61 -41.64 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.33 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.42 -39.56 74.36 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -54.75 -43.34 72.61 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.483 1.113 . . . . 0.0 110.907 171.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.23 -30.8 66.78 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.195 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.43 ' HA ' HD12 ' A' ' 11' ' ' ILE . 83.8 mt -67.79 -46.1 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.241 0.617 . . . . 0.0 110.438 175.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -56.88 -46.2 82.03 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.723 0.809 . . . . 0.0 110.727 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HB3' ' HZ3' ' A' ' 49' ' ' LYS . 8.4 mtpm? -67.92 -47.04 69.85 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.014 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.34 99.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.188 0.595 . . . . 0.0 112.322 -175.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -92.22 -11.33 35.68 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.498 0.719 . . . . 0.0 112.328 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.98 31.34 69.69 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-O 121.133 0.296 . . . . 0.0 113.171 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.3 pt -119.79 -177.27 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.641 1.176 . . . . 0.0 109.892 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -135.73 107.88 7.22 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 166.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.569 HD22 HG12 ' A' ' 84' ' ' ILE . 88.4 mt -61.77 128.33 90.23 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 168.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.76 59.17 2.73 Favored 'Trans proline' 0 C--N 1.367 1.515 0 C-N-CA 122.946 2.431 . . . . 0.0 111.624 170.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.0 -40.74 94.7 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.056 1.342 . . . . 0.0 109.629 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -57.28 -45.78 83.74 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.006 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -68.79 -43.89 74.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.277 0.631 . . . . 0.0 110.53 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.429 ' O ' HG21 ' A' ' 64' ' ' VAL . 50.4 m0 -59.98 -48.53 81.34 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.308 1.005 . . . . 0.0 111.252 -176.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.2 m -63.97 -35.58 81.15 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 124.258 0.974 . . . . 0.0 110.167 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.38 -38.22 71.55 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.082 0.553 . . . . 0.0 110.86 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.25 -38.25 90.42 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.835 0.854 . . . . 0.0 110.942 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 60' ' ' TRP . 91.6 t -64.53 -44.89 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.825 174.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.81 -46.22 88.12 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.63 0.772 . . . . 0.0 112.437 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.402 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 50.9 m-20 -81.01 -2.54 48.39 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.462 0.705 . . . . 0.0 112.673 -176.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.23 28.89 74.09 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 114.0 0.36 . . . . 0.0 114.0 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.402 ' HG3' ' HB2' ' A' ' 66' ' ' ASP . 95.4 mttt -74.77 -34.01 62.39 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.577 0.751 . . . . 0.0 109.723 171.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.6 163.58 36.81 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.591 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -88.63 154.74 20.07 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.603 1.161 . . . . 0.0 109.493 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -38.85 87.29 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.682 0.793 . . . . 0.0 110.343 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -43.76 -50.74 7.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.618 1.567 . . . . 0.0 111.761 172.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -61.04 -16.12 39.93 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.526 -1.216 . . . . 0.0 114.198 -170.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -126.52 -20.86 4.27 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -117.12 20.73 13.62 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.977 0.511 . . . . 0.0 111.846 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.4 t -97.71 147.17 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 163.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.594 ' HG ' HG21 ' A' ' 23' ' ' ILE . 4.0 mm? -57.69 -54.51 46.01 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.743 1.217 . . . . 0.0 114.225 -172.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -61.1 -36.74 80.48 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.165 0.586 . . . . 0.0 110.776 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 41.3 t-20 -76.33 -46.95 25.29 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.739 -171.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.62 -46.94 85.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.565 1.546 . . . . 0.0 109.716 173.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.59 -33.04 73.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.868 0.867 . . . . 0.0 111.189 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.04 -46.45 71.11 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.766 0.426 . . . . 0.0 110.386 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 12.9 mmp_? -55.87 -46.28 78.3 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.469 0.707 . . . . 0.0 110.753 177.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.569 HG12 HD22 ' A' ' 55' ' ' LEU . 90.1 mt -61.31 -49.55 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.877 1.271 . . . . 0.0 110.205 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.63 -37.81 79.67 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.394 1.077 . . . . 0.0 111.396 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -69.87 -39.53 76.26 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.113 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 55' ' ' LEU . 79.9 mt -67.8 -34.29 76.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 123.417 0.448 . . . . 0.0 110.811 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 84' ' ' ILE . 96.8 t -68.98 -40.25 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.712 0.805 . . . . 0.0 109.526 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.86 -40.53 87.91 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.609 0.764 . . . . 0.0 111.546 177.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.71 -36.35 78.35 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.139 0.975 . . . . 0.0 111.789 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.2 pttp . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 122.384 0.274 . . . . 0.0 110.835 -177.984 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 8' ' ' VAL . 24.9 m . . . . . 0 CA--C 1.548 0.892 0 CA-C-O 120.15 0.024 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -56.89 -51.93 67.15 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.377 0.671 . . . . 0.0 110.468 171.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -58.52 -39.04 79.02 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.82 0.848 . . . . 0.0 111.552 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -57.64 -51.12 70.81 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.894 0.878 . . . . 0.0 111.324 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 4' ' ' THR . 81.0 t -72.26 -36.27 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.717 0.807 . . . . 0.0 111.274 -173.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.0 -42.44 80.32 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.889 0.876 . . . . 0.0 110.488 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 m -65.94 -47.63 74.04 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.796 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.8 mt -55.42 -54.75 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 123.409 0.684 . . . . 0.0 111.462 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.688 HG12 HG23 ' A' ' 43' ' ' ILE . 37.5 mt -57.57 -45.27 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.165 0.986 . . . . 0.0 110.959 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.411 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.19 -54.8 30.7 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.946 0.899 . . . . 0.0 112.812 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.53 -35.99 82.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.607 0.763 . . . . 0.0 111.94 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.0 m -69.59 -57.86 4.67 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 123.715 0.635 . . . . 0.0 110.387 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.557 ' SG ' HD13 ' A' ' 43' ' ' ILE . 81.1 m -96.1 11.97 32.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.553 0.741 . . . . 0.0 112.858 -170.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 42.63 67.69 0.58 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.975 1.31 . . . . 0.0 112.23 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.611 HD13 HG22 ' A' ' 12' ' ' ILE . 17.3 pt -137.61 146.03 51.49 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 124.809 1.244 . . . . 0.0 108.174 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.64 120.26 7.71 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.703 2.268 . . . . 0.0 112.845 -174.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -51.43 -39.91 58.29 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.477 1.511 . . . . 0.0 113.153 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.49 -14.1 58.55 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.241 0.216 . . . . 0.0 111.57 -172.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 p -83.87 1.51 42.87 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-O 120.616 0.246 . . . . 0.0 110.557 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.491 HG22 ' HG ' ' A' ' 77' ' ' LEU . 1.9 mp -86.84 137.6 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 165.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 p -125.98 161.69 49.97 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 123.663 0.785 . . . . 0.0 109.403 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.8 -29.44 80.99 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 121.933 1.755 . . . . 0.0 112.372 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.38 0.78 51.06 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.863 0.465 . . . . 0.0 111.393 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.6 p -75.98 132.67 40.34 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.758 0.253 . . . . 0.0 110.49 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -85.6 118.64 25.24 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.524 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -50.44 -27.88 7.27 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 55.2 mt -101.37 -55.12 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.133 0.492 . . . . 0.0 110.298 -175.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.17 -37.73 81.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.978 0.911 . . . . 0.0 112.018 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -95.7 -60.04 1.74 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.115 0.566 . . . . 0.0 110.859 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 29' ' ' ALA . 90.9 mt -71.87 -8.17 52.77 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.29 34.63 75.27 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.071 0.232 . . . . 0.0 113.52 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 88.3 mt -110.94 114.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.016 0.926 . . . . 0.0 108.802 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.46 156.73 28.59 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.957 0.503 . . . . 0.0 110.335 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.436 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 22.4 m -58.73 -27.89 65.32 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.664 0.786 . . . . 0.0 112.226 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.39 -48.49 67.22 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.014 0.526 . . . . 0.0 109.855 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.51 -33.27 75.51 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.001 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -72.04 -28.45 63.36 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.902 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 37' ' ' SER . 87.8 mt -61.04 -44.76 96.92 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.24 -41.3 98.3 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.161 0.984 . . . . 0.0 111.338 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.688 HG23 HG12 ' A' ' 12' ' ' ILE . 63.3 mt -65.58 -45.18 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-O 121.048 0.452 . . . . 0.0 110.665 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.48 -32.54 70.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.325 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -66.5 -36.72 83.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.582 0.753 . . . . 0.0 110.485 173.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.85 -34.23 77.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.914 0.486 . . . . 0.0 110.63 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.32 -38.45 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.712 0.805 . . . . 0.0 110.381 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -58.2 -44.69 88.23 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.571 0.748 . . . . 0.0 111.314 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -70.73 -44.46 66.78 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.535 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.78 -55.86 22.62 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.785 0.834 . . . . 0.0 112.827 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.513 ' HB2' HG12 ' A' ' 53' ' ' ILE . 97.4 m-85 -90.33 -10.98 42.07 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.326 0.65 . . . . 0.0 112.175 -177.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.14 70.18 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 -173.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.513 HG12 ' HB2' ' A' ' 51' ' ' PHE . 43.9 pt -109.22 -176.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.083 0.953 . . . . 0.0 109.859 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -139.24 110.56 6.97 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 172.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.413 HD22 HG12 ' A' ' 84' ' ' ILE . 84.4 mt -83.58 120.04 74.74 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 170.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.71 58.77 1.12 Allowed 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.952 2.435 . . . . 0.0 112.113 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.445 HD23 ' CE3' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -66.18 -37.69 86.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.804 0.842 . . . . 0.0 110.195 -169.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -35.62 73.06 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.373 0.421 . . . . 0.0 111.203 175.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.593 ' HB2' ' HZ3' ' A' ' 59' ' ' LYS . 3.6 ttmp? -82.39 -29.15 31.03 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 123.253 0.621 . . . . 0.0 110.674 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.445 ' CE3' HD23 ' A' ' 57' ' ' LEU . 45.7 m0 -69.58 -40.62 76.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.365 0.666 . . . . 0.0 109.729 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.4 m -64.22 -34.78 78.89 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.502 173.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -69.33 -47.82 63.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.415 1.086 . . . . 0.0 110.259 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 45.9 mt-10 -61.06 -49.23 78.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.446 1.098 . . . . 0.0 111.56 -177.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.47 -37.54 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.509 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -64.19 -40.06 95.3 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.463 0.705 . . . . 0.0 111.129 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.84 1.67 51.64 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.153 0.981 . . . . 0.0 112.244 -172.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.25 18.49 75.04 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.58 -31.96 67.54 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.72 169.83 17.01 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.581 1.153 . . . . 0.0 109.638 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.8 m -105.15 160.23 15.23 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.467 1.107 . . . . 0.0 110.458 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.0 p -62.63 77.39 0.02 OUTLIER 'General case' 0 C--N 1.364 1.219 0 C-N-CA 124.385 1.074 . . . . 0.0 110.542 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -178.97 -61.78 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.726 -169.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -58.55 -23.96 59.62 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.963 -165.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -119.21 -16.23 9.09 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -111.68 13.11 21.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.907 0.483 . . . . 0.0 112.186 -168.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.45 HG13 ' HG2' ' A' ' 78' ' ' LYS . 54.0 t -106.15 143.04 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 171.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.491 ' HG ' HG22 ' A' ' 23' ' ' ILE . 3.5 mm? -54.67 -42.54 71.48 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.212 1.405 . . . . 0.0 114.094 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HG2' HG13 ' A' ' 76' ' ' VAL . 61.1 pttt -68.38 -39.84 81.6 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 117.712 0.233 . . . . 0.0 111.393 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.24 -44.06 69.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.4 0.68 . . . . 0.0 110.368 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.6 tp -58.17 -52.94 63.46 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.553 1.141 . . . . 0.0 109.896 177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.19 72.19 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.939 0.895 . . . . 0.0 112.334 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.61 -50.42 58.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -53.95 -48.08 70.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.225 1.01 . . . . 0.0 111.403 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.47 HG23 HD13 ' A' ' 53' ' ' ILE . 96.7 mt -58.21 -53.28 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.435 1.094 . . . . 0.0 110.4 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -62.64 -33.24 74.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.01 0.924 . . . . 0.0 112.384 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -64.4 -42.2 96.24 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.287 0.635 . . . . 0.0 110.427 174.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.5 -39.36 77.66 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.58 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 84' ' ' ILE . 87.5 t -66.36 -39.44 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.835 0.854 . . . . 0.0 110.278 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.65 -37.57 88.05 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.307 173.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.67 73.71 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.832 0.853 . . . . 0.0 111.534 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.899 0.381 . . . . 0.0 110.85 -176.488 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 8' ' ' VAL . 58.3 m . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 111.363 0.134 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -56.28 -46.9 79.53 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.266 0.627 . . . . 0.0 111.499 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.29 -46.17 86.58 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.559 0.537 . . . . 0.0 110.859 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -60.71 -45.33 94.61 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.24 0.963 . . . . 0.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 4' ' ' THR . 88.5 t -67.37 -41.01 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.579 0.752 . . . . 0.0 110.288 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.2 99.24 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.902 0.881 . . . . 0.0 111.113 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 84.5 m -62.73 -47.57 82.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.092 0.957 . . . . 0.0 111.255 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 47' ' ' ILE . 88.2 mt -61.04 -50.05 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.318 0.647 . . . . 0.0 111.188 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 18' ' ' ILE . 56.6 mt -57.78 -48.95 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.061 0.544 . . . . 0.0 110.225 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.83 -51.24 30.55 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.64 1.176 . . . . 0.0 112.589 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.29 -32.47 73.21 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.796 0.838 . . . . 0.0 111.962 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 m -89.39 -19.06 25.66 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 122.82 0.448 . . . . 0.0 111.766 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.455 ' SG ' HD11 ' A' ' 43' ' ' ILE . 67.0 m -115.17 -9.49 12.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -168.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 60.1 53.49 4.53 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.223 1.009 . . . . 0.0 111.566 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.475 HD13 HD13 ' A' ' 23' ' ' ILE . 21.7 pt -137.32 149.73 66.62 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 123.268 0.627 . . . . 0.0 110.246 -176.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.62 115.17 4.22 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.69 2.26 . . . . 0.0 111.888 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -16.45 38.22 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -173.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.34 -27.32 62.34 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.647 0.779 . . . . 0.0 111.303 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 p -90.84 -2.17 57.78 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.173 0.589 . . . . 0.0 110.604 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.475 HD13 HD13 ' A' ' 18' ' ' ILE . 1.7 mp -88.17 97.86 7.13 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.9 p -89.51 160.1 42.66 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.062 0.945 . . . . 0.0 110.757 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.13 -26.43 75.81 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.68 2.253 . . . . 0.0 113.044 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.25 1.53 52.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.972 0.509 . . . . 0.0 110.963 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.1 t -77.94 131.33 37.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.126 0.57 . . . . 0.0 109.917 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.4 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 58.0 t-80 -87.14 123.59 32.35 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' HA ' HD11 ' A' ' 33' ' ' LEU . . . -49.12 -39.71 29.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.314 1.046 . . . . 0.0 113.094 175.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.4 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 54.5 mt -91.84 -51.16 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -77.4 -33.45 55.03 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.597 0.759 . . . . 0.0 112.266 -168.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -100.77 -55.52 2.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.983 0.513 . . . . 0.0 110.792 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.435 HD11 ' HA ' ' A' ' 29' ' ' ALA . 65.4 mt -75.06 -6.93 52.09 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.596 0.358 . . . . 0.0 111.893 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.03 33.41 74.39 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.394 0.434 . . . . 0.0 113.816 172.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.431 HG22 HD12 ' A' ' 43' ' ' ILE . 78.3 mt -99.69 121.47 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.614 0.765 . . . . 0.0 108.977 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.59 160.05 33.23 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.681 0.392 . . . . 0.0 110.195 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.2 m -58.51 -44.11 89.37 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.5 0.72 . . . . 0.0 111.857 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.426 HD11 ' N ' ' A' ' 39' ' ' ASP . 3.8 pp -71.94 -30.98 65.88 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.127 0.489 . . . . 0.0 110.33 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.426 ' N ' HD11 ' A' ' 38' ' ' LEU . 18.7 t70 -70.22 -37.06 74.94 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.6 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -74.82 -21.84 59.06 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.271 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.579 HD21 HD11 ' A' ' 57' ' ' LEU . 96.1 mt -56.13 -45.11 79.66 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 122.942 0.497 . . . . 0.0 111.328 173.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -66.0 -39.44 90.29 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.729 0.812 . . . . 0.0 110.775 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.455 HD11 ' SG ' ' A' ' 16' ' ' CYS . 34.9 mt -68.26 -39.32 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.305 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.77 -28.51 60.77 Favored 'General case' 0 C--O 1.209 -1.033 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.66 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -63.55 -41.36 98.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.752 0.821 . . . . 0.0 110.023 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.98 92.76 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.899 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.437 ' HA ' HD12 ' A' ' 11' ' ' ILE . 80.6 mt -72.93 -48.08 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.71 0.804 . . . . 0.0 110.562 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -46.6 -55.45 7.63 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.958 1.703 . . . . 0.0 111.055 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -73.3 -36.06 66.21 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.359 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.45 -37.41 86.8 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.118 0.567 . . . . 0.0 112.342 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -93.28 -6.04 48.42 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.627 0.771 . . . . 0.0 112.087 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.63 34.3 88.04 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.316 0.385 . . . . 0.0 113.234 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.4 pt -121.14 171.09 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.526 1.13 . . . . 0.0 109.573 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -106.99 100.81 10.29 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.527 HD23 HG12 ' A' ' 84' ' ' ILE . 69.6 mt -73.21 117.87 63.89 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 169.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.419 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 3.3 Cg_exo -77.74 50.38 3.23 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.897 2.398 . . . . 0.0 111.318 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.579 HD11 HD21 ' A' ' 41' ' ' LEU . 1.4 tm? -64.33 -43.17 95.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.775 0.83 . . . . 0.0 109.801 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.01 -36.18 82.7 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.888 0.742 . . . . 0.0 110.1 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 85.1 tttt -71.75 -38.56 70.39 Favored 'General case' 0 C--O 1.211 -0.962 0 O-C-N 123.533 0.521 . . . . 0.0 109.752 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.419 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 50.1 m0 -64.56 -33.47 75.99 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.889 0.876 . . . . 0.0 110.866 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.6 m -63.8 -43.48 96.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.477 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -71.63 -31.51 66.95 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.837 0.855 . . . . 0.0 110.998 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 17.8 mm-40 -59.71 -53.89 52.7 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.607 0.763 . . . . 0.0 110.273 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.5 t -61.19 -37.31 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.413 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -61.89 -43.11 99.51 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.593 0.757 . . . . 0.0 111.752 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -88.39 2.16 53.21 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.159 0.584 . . . . 0.0 111.266 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.87 17.96 73.87 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 115.109 0.803 . . . . 0.0 115.109 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -60.4 -40.99 92.94 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.59 0.756 . . . . 0.0 110.169 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.23 174.14 14.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.442 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.0 p -106.45 164.67 11.86 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.645 0.778 . . . . 0.0 109.969 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.4 p -59.11 -50.3 74.57 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.415 0.686 . . . . 0.0 112.759 -168.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.8 pm0 -50.18 -38.44 39.76 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -172.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -55.67 -27.23 48.89 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.443 1.097 . . . . 0.0 112.903 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -117.42 -27.97 6.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.335 0.654 . . . . 0.0 111.647 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -111.3 20.58 17.18 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.071 0.548 . . . . 0.0 112.218 -167.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.443 HG12 ' HG2' ' A' ' 78' ' ' LYS . 51.9 t -107.4 141.39 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 164.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.412 HD13 HD12 ' A' ' 12' ' ' ILE . 4.4 mm? -55.19 -39.17 69.28 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -171.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.8 pttt -65.43 -40.96 93.96 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.098 0.475 . . . . 0.0 110.422 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 92.7 m-20 -77.19 -45.62 26.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.677 1.191 . . . . 0.0 110.34 -173.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.94 -53.21 60.92 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 125.195 1.398 . . . . 0.0 109.782 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.49 -26.7 68.55 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.166 0.586 . . . . 0.0 111.633 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.69 -45.67 71.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.06 0.544 . . . . 0.0 110.369 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 3.5 mmp_? -58.76 -49.56 77.18 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.089 0.556 . . . . 0.0 109.838 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.527 HG12 HD23 ' A' ' 55' ' ' LEU . 83.5 mt -61.19 -52.88 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.59 -176.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.64 -44.27 85.47 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.718 0.807 . . . . 0.0 111.52 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -71.3 -30.15 65.9 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.765 0.666 . . . . 0.0 111.436 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 81.8 mt -68.55 -41.82 79.26 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 117.968 0.349 . . . . 0.0 110.577 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 84' ' ' ILE . 39.4 t -69.43 -30.73 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.82 -36.04 57.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.75 0.82 . . . . 0.0 111.446 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.35 -37.19 84.76 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.773 0.829 . . . . 0.0 110.674 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.2 pttt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.05 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 110.766 -0.087 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -53.7 -47.94 70.02 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.923 0.764 . . . . 0.0 111.211 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.44 -46.22 86.98 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.828 0.705 . . . . 0.0 110.185 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -69.09 -38.87 79.21 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.319 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.2 t -73.16 -37.96 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.621 0.768 . . . . 0.0 111.034 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.51 -32.36 73.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.065 0.946 . . . . 0.0 110.032 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.407 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 98.4 m -65.06 -48.17 74.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.162 170.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.0 mt -58.22 -47.37 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.726 0.41 . . . . 0.0 110.802 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.488 HD13 HD11 ' A' ' 77' ' ' LEU . 42.4 mt -57.47 -49.13 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.179 0.991 . . . . 0.0 110.819 175.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.23 -51.47 62.05 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.126 0.97 . . . . 0.0 113.085 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 10' ' ' THR . 14.0 mm-40 -73.73 -28.38 61.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.191 0.596 . . . . 0.0 111.933 -176.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 83.6 m -75.31 -50.72 15.14 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.942 0.497 . . . . 0.0 110.999 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -94.4 5.11 52.8 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.699 0.799 . . . . 0.0 112.454 -172.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.9 t70 48.85 64.8 1.56 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.912 1.285 . . . . 0.0 111.778 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.451 HD13 HG22 ' A' ' 12' ' ' ILE . 22.9 pt -141.23 145.69 39.6 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 123.94 0.896 . . . . 0.0 109.424 -174.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.47 119.55 6.85 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.065 2.51 . . . . 0.0 112.283 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -50.06 -34.66 22.36 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.882 1.273 . . . . 0.0 111.976 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.01 -25.52 61.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.54 0.736 . . . . 0.0 111.904 -172.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -79.05 -11.71 60.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.804 0.442 . . . . 0.0 111.171 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mp -89.69 101.72 12.43 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 p -80.93 161.35 63.65 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.601 0.76 . . . . 0.0 109.891 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.26 -29.82 85.24 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.44 2.093 . . . . 0.0 112.402 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -105.03 20.14 19.37 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 122.931 0.492 . . . . 0.0 111.072 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.5 m -71.65 128.32 35.43 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -80.93 111.76 17.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.541 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -46.56 -37.79 8.53 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.439 1.096 . . . . 0.0 113.832 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 55.9 mt -91.34 -58.43 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.53 -46.0 42.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.036 0.934 . . . . 0.0 112.242 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -81.54 -56.46 4.01 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.325 0.65 . . . . 0.0 109.698 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.541 HD13 ' HA ' ' A' ' 29' ' ' ALA . 88.4 mt -74.37 -12.77 60.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.233 0.613 . . . . 0.0 111.922 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.3 33.58 82.87 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 113.42 0.128 . . . . 0.0 113.42 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 82.3 mt -104.05 117.17 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.79 156.25 39.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.0 p -58.88 -29.68 67.18 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.936 0.894 . . . . 0.0 111.887 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 39' ' ' ASP . 4.4 pp -71.96 -31.26 66.13 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.144 0.497 . . . . 0.0 110.597 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.403 ' N ' HD12 ' A' ' 38' ' ' LEU . 16.0 t70 -81.91 -35.87 28.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.072 0.949 . . . . 0.0 109.483 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -68.63 -21.39 64.48 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.811 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.3 mt -51.39 -43.52 61.92 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.181 0.593 . . . . 0.0 111.245 171.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.0 -41.37 71.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.719 0.808 . . . . 0.0 111.136 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.441 HD13 HG12 ' A' ' 12' ' ' ILE . 57.3 mt -58.8 -47.79 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 123.449 0.468 . . . . 0.0 110.069 176.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.84 -34.43 69.28 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.772 0.829 . . . . 0.0 110.523 -174.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -62.55 -37.88 87.88 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.614 0.766 . . . . 0.0 110.746 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.89 -40.08 72.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.945 0.498 . . . . 0.0 111.115 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 84' ' ' ILE . 84.9 mt -63.07 -45.99 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.673 0.789 . . . . 0.0 110.228 176.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -50.67 -52.33 40.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.478 1.511 . . . . 0.0 110.75 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 49' ' ' LYS . 7.0 mtpm? -69.95 -42.83 72.69 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.577 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.74 -49.78 73.68 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.589 0.756 . . . . 0.0 111.841 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.442 ' HB3' HG22 ' A' ' 88' ' ' VAL . 83.5 m-85 -86.32 -6.72 58.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.567 0.747 . . . . 0.0 111.182 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.44 29.77 73.11 Favored Glycine 0 C--N 1.356 1.659 0 O-C-N 123.432 0.457 . . . . 0.0 113.229 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.452 HG23 ' HG2' ' A' ' 91' ' ' LYS . 47.5 pt -113.23 174.62 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.261 1.024 . . . . 0.0 110.228 -175.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.32 108.58 17.44 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 169.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.497 HD22 HG12 ' A' ' 84' ' ' ILE . 60.0 mt -79.7 115.61 54.91 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.493 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 82.3 Cg_endo -76.85 54.68 4.62 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 122.211 1.941 . . . . 0.0 111.029 169.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.38 -40.16 95.56 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.387 1.075 . . . . 0.0 109.325 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.24 -40.02 84.62 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.282 175.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 27.1 tptp -71.76 -38.34 70.38 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.967 0.907 . . . . 0.0 110.702 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.493 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 54.6 m0 -65.02 -45.84 83.8 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.899 0.88 . . . . 0.0 110.555 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.7 m -64.42 -33.71 76.5 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.686 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -66.98 -38.89 86.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.05 0.54 . . . . 0.0 110.143 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 19.0 mm-40 -60.16 -41.39 92.7 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.123 0.569 . . . . 0.0 110.845 175.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.417 HG12 HG21 ' A' ' 71' ' ' THR . 59.2 t -64.04 -54.28 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.828 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -65.51 -30.84 71.65 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.53 0.732 . . . . 0.0 112.602 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -90.16 3.63 52.87 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.951 0.5 . . . . 0.0 111.109 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.94 13.16 69.15 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -75.39 -28.2 59.37 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.146 0.578 . . . . 0.0 111.384 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -153.85 171.29 19.18 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.38 0.672 . . . . 0.0 109.817 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.8 m -101.19 157.06 17.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.901 0.88 . . . . 0.0 109.284 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.417 HG21 HG12 ' A' ' 64' ' ' VAL . 13.5 p -52.8 -47.35 67.65 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.617 0.767 . . . . 0.0 111.546 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.463 ' HA ' HG22 ' A' ' 76' ' ' VAL . 12.9 pt-20 -47.11 -41.9 18.14 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -173.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -26.27 67.67 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.197 0.999 . . . . 0.0 111.583 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HH ' ' HG3' ' A' ' 63' ' ' GLU . 31.2 m-85 -113.9 -26.34 8.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.113 0.565 . . . . 0.0 112.423 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.5 23.75 11.04 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.307 0.643 . . . . 0.0 111.116 -164.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 72' ' ' GLU . 55.0 t -107.3 132.22 55.34 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.338 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 162.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.488 HD11 HD13 ' A' ' 12' ' ' ILE . 3.7 mm? -49.8 -32.95 15.22 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.147 1.379 . . . . 0.0 114.693 -168.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HG3' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -80.74 -38.17 29.18 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.732 0.413 . . . . 0.0 111.746 177.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 93.1 m-20 -70.13 -49.92 45.85 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.074 0.55 . . . . 0.0 109.738 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.2 tp -49.7 -50.51 43.54 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.085 1.754 . . . . 0.0 110.981 170.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.59 -36.82 74.6 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.653 0.596 . . . . 0.0 110.826 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.95 79.82 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.866 0.729 . . . . 0.0 111.023 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 5.6 mmp_? -56.36 -53.33 58.61 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.671 0.748 . . . . 0.0 110.438 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.498 ' O ' HG21 ' A' ' 88' ' ' VAL . 66.7 mt -64.94 -45.42 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.41 -176.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.29 -41.44 93.41 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.269 1.028 . . . . 0.0 111.676 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -67.83 -35.13 78.05 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.817 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.0 -31.31 67.79 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.214 0.321 . . . . 0.0 111.227 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 84' ' ' ILE . 60.6 t -69.74 -40.27 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-O 121.262 0.553 . . . . 0.0 109.741 175.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.17 93.84 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.915 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.66 83.41 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.77 0.828 . . . . 0.0 111.469 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.452 ' HG2' HG23 ' A' ' 53' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.228 0 C-N-CA 122.841 0.457 . . . . 0.0 110.291 -175.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.0 m . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -56.17 -42.68 77.44 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.411 0.684 . . . . 0.0 111.623 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -52.94 -51.39 61.53 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.675 0.79 . . . . 0.0 110.31 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.447 ' O ' HG13 ' A' ' 11' ' ' ILE . 37.8 mmt180 -64.7 -43.37 93.69 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.84 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.415 ' HA ' HD13 ' A' ' 11' ' ' ILE . 67.4 t -70.0 -36.45 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.941 0.896 . . . . 0.0 111.246 -175.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.02 -36.53 83.5 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.691 0.796 . . . . 0.0 110.309 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.5 m -66.04 -41.36 90.97 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.254 0.622 . . . . 0.0 111.175 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 7' ' ' ARG . 82.8 mt -56.85 -52.92 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.923 0.489 . . . . 0.0 110.353 174.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 77' ' ' LEU . 39.9 mt -59.67 -44.62 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.8 0.84 . . . . 0.0 110.931 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -50.11 -63.24 1.18 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.415 1.086 . . . . 0.0 113.119 175.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.03 -25.15 66.93 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.722 -174.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.9 m -78.82 -46.64 18.26 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.468 0.707 . . . . 0.0 111.53 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.7 t -102.26 4.61 39.42 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.443 0.697 . . . . 0.0 111.867 -170.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 t70 48.1 76.76 0.11 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.264 1.426 . . . . 0.0 112.185 -170.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.553 HG13 ' HA ' ' A' ' 13' ' ' ALA . 3.3 pt -147.4 141.61 15.97 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.536 1.134 . . . . 0.0 108.765 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.67 125.88 17.06 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.34 2.026 . . . . 0.0 110.741 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.551 ' HA ' HD11 ' A' ' 23' ' ' ILE . 2.2 ppt_? -70.23 -16.15 63.01 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -88.17 -1.76 58.2 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.979 0.512 . . . . 0.0 110.503 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.9 p -89.09 -17.77 28.61 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 117.743 0.247 . . . . 0.0 110.428 165.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.551 HD11 ' HA ' ' A' ' 20' ' ' ARG . 2.1 mp -80.51 111.89 17.81 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.1 p -90.25 158.94 43.03 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.607 0.763 . . . . 0.0 109.188 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.05 -19.52 66.42 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 121.974 1.783 . . . . 0.0 112.128 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.53 8.76 44.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.384 0.674 . . . . 0.0 110.495 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.0 m -70.89 124.87 25.35 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.406 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 64.6 t-80 -80.05 111.82 16.75 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 167.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.05 -36.49 29.29 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mt -93.53 -45.04 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 122.306 0.242 . . . . 0.0 110.871 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.93 -44.19 11.22 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.449 0.7 . . . . 0.0 111.796 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.98 -60.1 2.21 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.362 0.665 . . . . 0.0 109.984 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.82 -17.18 63.38 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.871 0.468 . . . . 0.0 111.543 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.31 37.36 90.68 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.576 0.548 . . . . 0.0 113.812 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.3 mt -93.59 114.67 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.61 156.41 38.16 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 m -57.91 -31.53 66.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.928 0.891 . . . . 0.0 112.637 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.57 -31.83 62.19 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.801 0.44 . . . . 0.0 111.253 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -75.1 -32.69 61.49 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.224 0.61 . . . . 0.0 110.01 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -71.42 -28.5 64.04 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.836 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.78 -41.85 87.64 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.75 0.42 . . . . 0.0 110.38 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.9 -44.18 81.47 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.12 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.27 -46.14 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 122.855 0.462 . . . . 0.0 110.805 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.56 76.36 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.182 0.593 . . . . 0.0 110.549 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -73.43 -25.25 60.44 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.747 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.7 -41.15 72.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.503 0.321 . . . . 0.0 110.324 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.85 -44.5 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.135 0.974 . . . . 0.0 110.218 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -51.47 -48.15 62.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.5 1.52 . . . . 0.0 110.647 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.14 -50.07 65.25 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.19 175.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.44 -51.49 66.75 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.008 0.923 . . . . 0.0 113.253 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -89.45 -6.56 56.4 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.513 0.725 . . . . 0.0 111.683 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.81 39.83 95.32 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-O 121.189 0.327 . . . . 0.0 112.534 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.473 HG22 ' HG2' ' A' ' 91' ' ' LYS . 41.8 pt -122.61 169.64 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.41 1.084 . . . . 0.0 109.493 -175.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -107.45 120.88 43.41 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 mt -90.26 113.61 58.0 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.81 57.1 3.7 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.446 2.764 . . . . 0.0 111.292 171.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.5 -38.68 90.82 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.227 1.011 . . . . 0.0 110.259 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 8.4 pt-20 -58.97 -45.74 89.8 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 124.01 0.819 . . . . 0.0 110.985 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -63.67 -48.23 78.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.814 0.846 . . . . 0.0 109.86 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -53.69 -44.53 69.83 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.366 1.041 . . . . 0.0 110.744 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.1 m -64.42 -45.6 86.86 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.047 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 13.7 mm100 -68.79 -37.51 79.32 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.6 0.36 . . . . 0.0 110.872 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -57.64 -48.06 80.51 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.155 0.982 . . . . 0.0 110.374 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.463 HG13 HG21 ' A' ' 71' ' ' THR . 78.8 t -59.24 -46.73 92.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.304 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -61.06 -37.11 81.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.917 0.487 . . . . 0.0 111.551 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.6 6.15 39.53 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.892 0.877 . . . . 0.0 112.115 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.53 20.85 74.15 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.68 -23.4 45.67 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.317 0.647 . . . . 0.0 110.196 171.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.0 175.07 14.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.176 0.99 . . . . 0.0 109.742 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.8 m -111.57 156.63 21.46 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.463 HG21 HG13 ' A' ' 64' ' ' VAL . 4.6 p -51.28 -40.91 59.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.488 ' HA ' HG21 ' A' ' 76' ' ' VAL . 1.3 mp0 -47.82 -46.98 31.41 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.574 0.75 . . . . 0.0 112.426 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -26.4 62.64 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.243 1.017 . . . . 0.0 113.049 -172.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -117.81 -21.29 8.49 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -119.28 20.72 12.49 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.195 0.598 . . . . 0.0 111.819 -166.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.518 HG11 ' HG2' ' A' ' 78' ' ' LYS . 30.8 t -102.75 139.98 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 163.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.512 HD11 HD12 ' A' ' 12' ' ' ILE . 3.5 mm? -53.99 -37.21 63.77 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.146 1.379 . . . . 0.0 114.304 -168.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HG2' HG11 ' A' ' 76' ' ' VAL . 57.0 pttt -71.86 -37.14 70.28 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.661 0.384 . . . . 0.0 111.294 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -79.26 -35.24 41.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.714 0.806 . . . . 0.0 110.49 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.93 -52.48 59.62 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.568 1.147 . . . . 0.0 108.445 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.24 69.8 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.019 0.824 . . . . 0.0 111.508 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.84 -54.13 30.83 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.531 0.519 . . . . 0.0 109.751 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -50.66 -50.04 55.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.247 0.967 . . . . 0.0 111.111 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 88' ' ' VAL . 72.2 mt -61.34 -48.33 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.122 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.96 -39.71 94.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.912 0.885 . . . . 0.0 111.625 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.37 -40.62 97.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.01 0.924 . . . . 0.0 109.849 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.6 mt -72.89 -28.64 62.6 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.815 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 84' ' ' ILE . 80.2 t -67.86 -37.83 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 123.311 0.644 . . . . 0.0 109.796 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.56 80.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.404 0.682 . . . . 0.0 110.712 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.76 -38.77 80.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.506 0.722 . . . . 0.0 111.255 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.484 ' O ' HG22 ' A' ' 8' ' ' VAL . 30.7 m . . . . . 0 CA--C 1.548 0.881 0 CA-C-O 119.748 -0.167 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.35 -44.43 92.68 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.915 0.486 . . . . 0.0 111.077 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.34 -41.04 68.62 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.934 0.771 . . . . 0.0 111.388 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 11' ' ' ILE . 82.6 mtp180 -74.22 -34.24 63.64 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.795 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 4' ' ' THR . 52.8 t -70.21 -36.31 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 118.733 0.697 . . . . 0.0 109.593 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.98 90.43 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.264 1.026 . . . . 0.0 110.749 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 8.8 m -61.69 -51.15 69.62 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 123.812 0.695 . . . . 0.0 110.863 173.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 7' ' ' ARG . 96.8 mt -55.7 -51.52 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.431 1.092 . . . . 0.0 111.616 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.475 HD12 HD11 ' A' ' 77' ' ' LEU . 35.6 mt -60.71 -46.35 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.514 0.726 . . . . 0.0 111.016 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.55 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -51.78 -48.31 63.82 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.006 0.816 . . . . 0.0 112.596 175.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 10' ' ' THR . 47.8 mt-10 -67.91 -37.04 81.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.711 0.805 . . . . 0.0 112.031 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.8 m -68.44 -54.53 16.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.09 0.556 . . . . 0.0 110.66 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.6 m -91.78 7.49 41.55 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.885 0.874 . . . . 0.0 112.514 -173.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 39.52 74.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.009 1.324 . . . . 0.0 112.469 -170.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.55 HG13 ' HA ' ' A' ' 13' ' ' ALA . 13.8 pt -140.18 142.52 30.34 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.995 1.318 . . . . 0.0 107.838 -177.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.29 131.17 41.43 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.423 2.082 . . . . 0.0 112.322 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -36.38 -42.1 0.31 Allowed 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 126.69 1.996 . . . . 0.0 113.939 176.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.14 -28.98 66.93 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.819 0.848 . . . . 0.0 112.001 -170.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 p -79.36 -4.04 49.06 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.54 97.2 5.96 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.7 p -88.46 162.18 40.31 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.692 0.797 . . . . 0.0 110.213 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.39 -26.76 79.01 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.706 2.271 . . . . 0.0 113.502 176.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.74 5.54 50.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.842 0.857 . . . . 0.0 111.442 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -68.67 120.99 15.54 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.437 0.295 . . . . 0.0 110.305 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -84.36 123.4 30.15 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 167.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -40.27 -50.04 2.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.773 1.229 . . . . 0.0 113.147 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -90.81 -51.34 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.229 0.538 . . . . 0.0 109.908 -169.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.89 -39.57 66.29 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.247 1.019 . . . . 0.0 112.479 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.84 -64.53 1.04 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.365 0.666 . . . . 0.0 110.08 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD13 HG23 ' A' ' 12' ' ' ILE . 73.2 mt -73.9 -17.6 61.01 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.609 0.763 . . . . 0.0 112.216 -174.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.98 34.33 76.5 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 123.083 0.239 . . . . 0.0 113.651 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.5 mt -82.62 139.96 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.574 1.15 . . . . 0.0 109.277 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -92.53 162.16 14.32 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.9 m -54.33 -36.98 64.35 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.317 1.047 . . . . 0.0 112.083 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.38 -40.62 77.3 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.859 0.463 . . . . 0.0 110.364 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -68.63 -35.45 77.31 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.387 0.675 . . . . 0.0 110.459 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.46 -32.71 74.25 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.8 0.687 . . . . 0.0 110.528 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.0 mt -61.21 -42.63 98.94 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.055 0.542 . . . . 0.0 111.255 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -66.97 -42.57 84.91 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.099 0.56 . . . . 0.0 110.723 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.461 HD11 HG12 ' A' ' 12' ' ' ILE . 97.2 mt -57.29 -47.36 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.225 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.13 -38.49 75.56 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.291 -173.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -61.48 -42.56 98.97 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.0 0.92 . . . . 0.0 110.9 174.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.94 -29.26 66.36 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.15 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.468 HD11 HD13 ' A' ' 84' ' ' ILE . 90.3 mt -65.83 -43.52 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.467 0.707 . . . . 0.0 110.307 173.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -58.67 -41.26 85.73 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.425 0.453 . . . . 0.0 110.913 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -69.07 -54.06 17.05 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.556 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.17 -52.8 64.14 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.128 0.971 . . . . 0.0 112.871 -176.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -89.8 -6.75 55.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.843 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.71 31.81 73.65 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.5 0.5 . . . . 0.0 113.448 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.466 HG23 ' HD3' ' A' ' 91' ' ' LYS . 41.3 pt -118.22 -178.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.561 0.745 . . . . 0.0 112.116 -172.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -126.56 106.52 9.49 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.354 1.462 . . . . 0.0 107.489 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.445 HD21 HG12 ' A' ' 84' ' ' ILE . 91.3 mt -72.8 125.99 90.88 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -74.98 60.47 5.43 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.778 2.318 . . . . 0.0 109.634 163.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -40.26 91.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.134 1.374 . . . . 0.0 109.253 -171.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.81 -42.23 92.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.693 0.797 . . . . 0.0 111.012 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -62.75 -47.5 83.29 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.477 1.111 . . . . 0.0 110.031 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -60.07 -44.87 94.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.948 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -65.99 -36.74 84.12 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.9 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -68.66 -37.46 79.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.033 0.533 . . . . 0.0 110.988 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.58 -38.98 92.88 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.546 0.738 . . . . 0.0 111.264 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.9 t -65.51 -49.88 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.457 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -60.47 -32.06 71.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.182 0.993 . . . . 0.0 112.297 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -93.8 0.49 56.31 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.745 0.818 . . . . 0.0 111.871 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.82 16.92 66.7 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.46 -33.73 76.55 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 117.576 0.688 . . . . 0.0 110.156 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.87 166.38 28.69 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.012 0.925 . . . . 0.0 108.967 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.2 p -86.37 164.0 17.31 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 122.749 0.42 . . . . 0.0 110.052 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.7 p -54.2 -49.1 70.15 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.151 0.58 . . . . 0.0 109.632 172.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.473 ' HA ' HG23 ' A' ' 76' ' ' VAL . 28.6 mt-10 -43.35 -47.19 6.72 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.955 1.702 . . . . 0.0 113.52 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -53.68 -28.95 36.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.99 0.916 . . . . 0.0 113.467 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -121.13 -21.05 6.56 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -110.71 15.81 21.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.47 0.708 . . . . 0.0 110.966 -169.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 72' ' ' GLU . 91.3 t -108.21 139.8 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.475 HD11 HD12 ' A' ' 12' ' ' ILE . 3.6 mm? -54.26 -40.11 67.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.338 1.455 . . . . 0.0 114.108 -172.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.429 ' HG2' HG13 ' A' ' 76' ' ' VAL . 62.1 pttt -65.2 -42.02 93.95 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.437 0.461 . . . . 0.0 110.82 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.14 -39.49 40.93 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.537 1.135 . . . . 0.0 111.021 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.2 -49.94 72.24 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.267 1.027 . . . . 0.0 109.248 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.2 -34.68 78.63 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.564 0.746 . . . . 0.0 111.405 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.76 90.05 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.57 0.544 . . . . 0.0 110.505 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -58.7 -48.86 79.69 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.301 0.641 . . . . 0.0 111.267 175.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.468 HD13 HD11 ' A' ' 47' ' ' ILE . 91.2 mt -59.63 -43.02 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.654 1.182 . . . . 0.0 110.292 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.37 -45.38 91.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 110.912 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.39 -33.3 72.82 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.463 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 62.5 mt -70.99 -36.39 72.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.078 0.551 . . . . 0.0 111.742 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 84' ' ' ILE . 94.8 t -64.94 -41.81 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-O 121.657 0.741 . . . . 0.0 109.499 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.94 75.84 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.733 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.7 94.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.147 0.979 . . . . 0.0 112.076 -176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.466 ' HD3' HG23 ' A' ' 53' ' ' ILE . 60.1 pttt . . . . . 0 N--CA 1.48 1.027 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.431 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.46 ' O ' HG21 ' A' ' 8' ' ' VAL . 65.2 m . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -56.76 -42.16 78.85 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.315 0.646 . . . . 0.0 112.013 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.63 -42.19 92.17 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.973 0.509 . . . . 0.0 110.662 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -61.7 -46.3 90.27 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.643 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 4' ' ' THR . 99.5 t -70.0 -38.93 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.113 0.965 . . . . 0.0 111.191 -173.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.2 96.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.98 0.912 . . . . 0.0 110.028 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -63.62 -44.89 92.61 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 111.308 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.49 -51.7 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.394 0.678 . . . . 0.0 110.815 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.563 HG12 HG21 ' A' ' 43' ' ' ILE . 38.7 mt -57.72 -52.83 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.487 0.715 . . . . 0.0 110.664 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.78 -54.93 8.74 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.914 1.286 . . . . 0.0 113.01 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.59 -22.86 60.92 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.255 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.8 m -88.13 -25.64 22.88 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.78 0.432 . . . . 0.0 111.786 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.5 t -113.23 -1.4 14.33 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.91 0.484 . . . . 0.0 111.823 -167.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.31 50.47 7.76 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.191 0.996 . . . . 0.0 111.571 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.51 HD13 HD12 ' A' ' 23' ' ' ILE . 16.3 pt -138.17 156.09 73.99 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 123.761 0.825 . . . . 0.0 109.987 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.77 131.15 16.71 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.591 2.194 . . . . 0.0 110.73 172.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.51 ' HA ' HD13 ' A' ' 23' ' ' ILE . 6.5 ppt_? -68.22 -16.22 63.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.729 0.412 . . . . 0.0 111.312 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.26 -20.63 54.86 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 123.538 0.735 . . . . 0.0 110.487 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -92.05 10.34 29.54 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.083 0.553 . . . . 0.0 110.421 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.51 HD12 HD13 ' A' ' 18' ' ' ILE . 1.9 mp -104.92 127.28 59.56 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 168.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.417 ' HG1' ' HB3' ' A' ' 27' ' ' SER . 27.1 p -121.87 158.22 55.3 Favored Pre-proline 0 N--CA 1.484 1.225 0 C-N-CA 123.981 0.912 . . . . 0.0 109.668 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.53 -32.7 35.93 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.788 2.325 . . . . 0.0 113.399 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.84 -5.87 56.43 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.941 -0.474 . . . . 0.0 111.429 -173.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.417 ' HB3' ' HG1' ' A' ' 24' ' ' THR . 89.8 p -77.19 132.87 38.98 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 122.541 0.336 . . . . 0.0 110.185 -174.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -85.33 126.14 33.5 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 173.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -46.54 -39.6 11.21 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.083 0.953 . . . . 0.0 113.236 175.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.8 mt -96.57 -55.88 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -171.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.37 -43.84 80.41 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.506 0.723 . . . . 0.0 112.578 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -93.57 -57.23 2.64 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.868 0.467 . . . . 0.0 110.302 -172.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 29' ' ' ALA . 62.8 mt -78.91 -7.77 58.27 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.565 0.746 . . . . 0.0 112.44 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.04 25.07 72.0 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 114.443 0.537 . . . . 0.0 114.443 174.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.32 121.56 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.787 0.835 . . . . 0.0 108.776 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.45 157.19 37.57 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 t -58.29 -35.13 71.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.741 0.817 . . . . 0.0 111.701 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 pp -71.7 -30.92 66.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.517 0.327 . . . . 0.0 111.076 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -73.24 -39.76 65.21 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.118 0.567 . . . . 0.0 109.91 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -69.88 -25.9 63.92 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.783 0.677 . . . . 0.0 110.89 -176.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.63 HD22 HD11 ' A' ' 57' ' ' LEU . 93.7 mt -56.83 -42.6 79.92 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.051 0.54 . . . . 0.0 110.615 170.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -75.14 -40.95 59.3 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.064 0.946 . . . . 0.0 110.627 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.563 HG21 HG12 ' A' ' 12' ' ' ILE . 57.0 mt -61.22 -43.61 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.227 0.537 . . . . 0.0 110.319 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 -33.29 63.0 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.963 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -62.69 -34.35 76.95 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.595 0.358 . . . . 0.0 110.347 172.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.95 -34.5 73.5 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.92 0.488 . . . . 0.0 110.8 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.12 -42.87 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.627 0.771 . . . . 0.0 110.35 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -53.08 -51.3 62.29 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.659 0.784 . . . . 0.0 110.635 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -63.46 -50.15 70.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.056 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.88 -48.76 77.61 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.737 0.815 . . . . 0.0 112.395 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -83.61 -10.21 58.39 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.513 0.725 . . . . 0.0 112.22 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.38 30.27 71.43 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.418 0.449 . . . . 0.0 112.988 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 pt -120.01 -176.18 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.022 1.329 . . . . 0.0 109.622 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -137.1 98.63 3.79 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.487 HD23 HD13 ' A' ' 87' ' ' LEU . 85.2 mt -64.01 123.64 82.66 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.489 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 98.2 Cg_endo -76.21 62.08 6.73 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 122.485 2.124 . . . . 0.0 110.587 170.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.63 HD11 HD22 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -62.44 -34.66 77.22 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.348 1.059 . . . . 0.0 109.14 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.52 -43.38 97.17 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.763 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 56.9 tptt -69.09 -39.71 78.84 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 123.632 0.773 . . . . 0.0 110.49 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.41 ' HE3' HD21 ' A' ' 57' ' ' LEU . 54.6 m0 -67.5 -39.84 85.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.494 0.718 . . . . 0.0 110.643 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -61.02 -39.37 89.47 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 124.078 0.861 . . . . 0.0 110.223 173.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -70.13 -43.98 69.84 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.201 1.0 . . . . 0.0 110.157 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.03 -46.81 88.29 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.566 1.147 . . . . 0.0 111.126 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 89.9 t -61.11 -40.0 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -67.92 -30.33 69.62 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.247 0.619 . . . . 0.0 111.767 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -85.04 -1.15 56.5 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.34 15.85 68.49 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 114.198 0.439 . . . . 0.0 114.198 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -72.6 -31.84 65.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.473 0.709 . . . . 0.0 110.779 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -149.07 166.27 29.23 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.756 0.822 . . . . 0.0 109.73 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.1 m -103.16 154.85 18.88 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.4 p -47.04 -49.08 21.94 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 124.209 1.003 . . . . 0.0 112.451 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.549 ' HA ' HG22 ' A' ' 76' ' ' VAL . 40.7 mt-10 -44.82 -42.63 8.04 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -56.46 -27.38 56.74 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.193 0.997 . . . . 0.0 112.818 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -121.7 -22.35 5.86 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.081 0.552 . . . . 0.0 112.037 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -114.7 14.49 17.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.462 0.705 . . . . 0.0 111.31 -167.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 72' ' ' GLU . 53.5 t -107.78 137.03 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 165.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.463 HD13 HD13 ' A' ' 12' ' ' ILE . 4.2 mm? -55.3 -33.88 63.67 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -169.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.49 ' HG2' HG11 ' A' ' 76' ' ' VAL . 60.0 pttt -71.65 -44.41 64.35 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.559 0.344 . . . . 0.0 110.389 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.5 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 60.0 m-80 -72.2 -38.02 69.13 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 123.608 0.763 . . . . 0.0 109.972 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.4 tp -62.5 -48.71 78.36 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 124.984 1.314 . . . . 0.0 109.454 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.31 -33.96 71.74 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.681 0.613 . . . . 0.0 111.146 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.86 -40.48 75.75 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.207 0.603 . . . . 0.0 111.426 175.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 13.6 mmp_? -60.59 -48.27 82.53 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.558 0.743 . . . . 0.0 110.867 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.22 -51.46 70.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.689 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.72 -39.55 94.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.441 0.696 . . . . 0.0 112.115 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.43 -37.79 83.55 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.34 0.4 . . . . 0.0 110.264 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.487 HD13 HD23 ' A' ' 55' ' ' LEU . 84.2 mt -71.03 -32.8 69.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.791 0.436 . . . . 0.0 111.534 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.92 -43.37 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.321 0.581 . . . . 0.0 109.479 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.7 -45.9 87.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.163 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.82 89.29 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.318 1.047 . . . . 0.0 111.674 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.093 0 O-C-N 123.535 0.522 . . . . 0.0 110.283 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 8' ' ' VAL . 17.9 m . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.93 -45.39 90.52 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.765 0.426 . . . . 0.0 111.179 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.93 -42.86 90.78 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.261 0.624 . . . . 0.0 110.902 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -65.87 -41.73 91.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.234 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.412 HG13 HD13 ' A' ' 47' ' ' ILE . 72.7 t -68.83 -40.57 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.436 0.695 . . . . 0.0 110.589 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.67 94.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.841 0.856 . . . . 0.0 110.817 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.8 m -66.41 -41.9 88.59 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.162 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.46 -47.02 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.313 0.645 . . . . 0.0 110.78 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.446 HG22 HD13 ' A' ' 18' ' ' ILE . 42.9 mt -58.22 -46.72 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.559 0.743 . . . . 0.0 110.547 177.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.63 -51.28 65.89 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.031 0.933 . . . . 0.0 112.628 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -73.96 -31.37 62.99 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.2 m -74.45 -57.5 3.89 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.541 ' SG ' HD13 ' A' ' 43' ' ' ILE . 76.1 m -85.23 -5.79 59.3 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 60.0 66.43 0.98 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 122.002 0.906 . . . . 0.0 109.729 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.446 HD13 HG22 ' A' ' 12' ' ' ILE . 12.5 pt -141.72 152.0 61.59 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.835 1.254 . . . . 0.0 108.56 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.511 ' O ' HG21 ' A' ' 22' ' ' THR . 37.9 Cg_endo -66.61 125.1 13.28 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.047 1.831 . . . . 0.0 111.334 175.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HA ' HD12 ' A' ' 23' ' ' ILE . 58.6 ttt180 -53.44 -29.1 33.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.17 0.988 . . . . 0.0 112.565 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.1 pt-20 -65.88 -23.67 66.7 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.487 0.715 . . . . 0.0 112.155 -172.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.511 HG21 ' O ' ' A' ' 19' ' ' PRO . 9.3 t -88.11 2.49 51.89 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.705 0.402 . . . . 0.0 111.512 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 20' ' ' ARG . 3.6 mp -102.0 94.15 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.6 p -88.52 163.76 34.87 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -62.45 -19.67 68.18 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.213 1.942 . . . . 0.0 113.131 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -95.85 3.86 53.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.761 0.424 . . . . 0.0 110.814 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -75.54 130.86 39.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.855 0.359 . . . . 0.0 110.093 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -85.59 122.69 30.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 168.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.73 -41.11 30.97 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.043 0.937 . . . . 0.0 112.817 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.4 mt -93.13 -53.23 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.06 -44.74 65.14 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.707 0.803 . . . . 0.0 111.787 -171.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -89.32 -59.86 2.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.93 0.492 . . . . 0.0 110.372 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 29' ' ' ALA . 71.1 mt -76.04 -10.9 59.79 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.815 0.846 . . . . 0.0 112.902 -171.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.29 33.04 85.65 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 123.316 0.385 . . . . 0.0 113.671 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 82.8 mt -94.13 122.57 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.14 157.88 32.59 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.198 0.599 . . . . 0.0 109.551 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.484 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 27.3 m -59.72 -27.56 66.57 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.444 0.697 . . . . 0.0 111.732 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.12 -40.85 64.59 Favored 'General case' 0 C--N 1.362 1.131 0 C-N-CA 122.928 0.491 . . . . 0.0 110.336 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.71 -36.18 81.87 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.238 0.615 . . . . 0.0 109.63 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -70.13 -27.88 64.92 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 123.762 0.664 . . . . 0.0 110.611 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.2 mt -61.88 -40.33 95.04 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.069 0.395 . . . . 0.0 110.235 173.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -71.84 -39.05 70.02 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 124.021 0.826 . . . . 0.0 110.677 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.541 HD13 ' SG ' ' A' ' 16' ' ' CYS . 77.4 mt -61.94 -47.41 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.114 0.565 . . . . 0.0 109.908 174.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.5 -34.38 72.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.797 0.839 . . . . 0.0 110.341 -173.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -69.01 -37.24 78.58 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.896 0.878 . . . . 0.0 110.721 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.88 -35.83 74.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.662 0.385 . . . . 0.0 110.751 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.412 HD13 HG13 ' A' ' 8' ' ' VAL . 96.5 mt -66.88 -46.24 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.033 0.933 . . . . 0.0 109.891 173.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -51.46 -51.12 57.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.363 1.465 . . . . 0.0 110.357 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -69.13 -47.23 65.62 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.863 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.45 92.87 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.408 0.683 . . . . 0.0 112.464 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.32 -4.43 58.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.548 0.739 . . . . 0.0 111.219 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.45 30.36 77.65 Favored Glycine 0 C--N 1.357 1.719 0 O-C-N 123.233 0.333 . . . . 0.0 113.465 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.3 pt -119.37 163.39 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.45 1.1 . . . . 0.0 109.68 -175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 123.19 42.4 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 164.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.446 HD21 HG12 ' A' ' 84' ' ' ILE . 54.0 mt -78.45 135.67 60.83 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 171.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.458 ' HD3' HD13 ' A' ' 87' ' ' LEU . 4.4 Cg_exo -79.18 44.16 1.64 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 123.302 2.668 . . . . 0.0 111.301 170.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -57.15 -38.4 73.47 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.528 1.131 . . . . 0.0 109.785 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -53.91 -51.49 63.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.985 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 49.9 tptt -66.35 -41.18 89.93 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.585 1.154 . . . . 0.0 110.888 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.424 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 52.2 m0 -59.94 -45.21 93.35 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.167 0.987 . . . . 0.0 110.58 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.7 m -63.62 -39.0 93.26 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.848 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -65.37 -39.51 92.37 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.185 0.594 . . . . 0.0 110.658 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 27.4 mm-40 -56.17 -48.49 76.22 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.215 0.606 . . . . 0.0 111.063 175.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.99 -41.46 89.8 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.124 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -60.0 -43.65 95.05 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.992 0.917 . . . . 0.0 111.785 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -83.01 6.17 19.71 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.41 19.39 64.39 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 114.494 0.558 . . . . 0.0 114.494 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -76.12 -59.47 2.75 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.927 0.891 . . . . 0.0 108.686 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.38 172.04 7.03 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.207 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 p -107.26 170.78 7.75 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.83 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.6 p -62.16 -46.19 90.08 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 119.537 -0.268 . . . . 0.0 110.701 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -53.07 -36.64 60.88 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.574 0.75 . . . . 0.0 112.932 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -25.98 58.83 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.491 1.116 . . . . 0.0 111.346 -175.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -128.96 -7.43 4.94 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -115.48 16.68 16.6 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.226 0.611 . . . . 0.0 111.244 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.464 HG11 ' HG2' ' A' ' 78' ' ' LYS . 54.3 t -103.16 141.33 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 166.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.4 HD11 HD12 ' A' ' 12' ' ' ILE . 4.1 mm? -53.61 -42.29 67.55 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.188 1.395 . . . . 0.0 114.246 -172.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HG2' HG11 ' A' ' 76' ' ' VAL . 60.7 pttt -68.59 -40.05 80.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.826 0.45 . . . . 0.0 110.843 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.413 ' OD1' ' HG3' ' A' ' 78' ' ' LYS . 2.1 m-20 -68.36 -46.2 70.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.049 0.94 . . . . 0.0 109.853 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.4 tp -58.84 -50.47 73.86 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.01 1.324 . . . . 0.0 109.973 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.64 75.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.595 0.758 . . . . 0.0 111.749 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.33 68.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.721 0.408 . . . . 0.0 110.063 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -56.4 -48.24 77.32 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.784 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.446 HG12 HD21 ' A' ' 55' ' ' LEU . 90.3 mt -61.8 -51.36 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.532 1.133 . . . . 0.0 111.227 -175.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.83 -39.58 85.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.888 0.875 . . . . 0.0 111.34 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -63.73 -40.49 96.87 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.038 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.458 HD13 ' HD3' ' A' ' 56' ' ' PRO . 91.7 mt -67.34 -34.44 77.33 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.194 0.598 . . . . 0.0 111.492 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.447 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 57.9 t -65.77 -42.28 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.18 -43.19 98.94 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.536 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.18 -39.67 89.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.097 0.959 . . . . 0.0 112.284 -177.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 41.3 pttt . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 122.545 0.338 . . . . 0.0 110.117 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.573 HG22 ' HB2' ' A' ' 85' ' ' ASP . 24.2 m . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -58.51 -51.57 69.32 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.452 0.701 . . . . 0.0 111.559 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -58.85 -42.92 90.46 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.698 0.624 . . . . 0.0 111.076 -175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.455 ' O ' HG13 ' A' ' 11' ' ' ILE . 92.1 mtt-85 -62.02 -46.81 87.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.691 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 4' ' ' THR . 53.8 t -64.33 -44.53 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.312 0.645 . . . . 0.0 110.367 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.99 85.11 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.231 1.012 . . . . 0.0 110.856 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.1 m -68.72 -41.33 79.19 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.466 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 7' ' ' ARG . 74.2 mt -60.61 -43.98 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.609 0.364 . . . . 0.0 110.766 176.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.6 HG22 HD13 ' A' ' 18' ' ' ILE . 56.2 mt -56.71 -47.48 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.463 0.705 . . . . 0.0 110.194 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' A' ' 20' ' ' ARG . . . -56.75 -51.86 67.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.544 1.138 . . . . 0.0 113.376 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.64 -30.4 71.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.172 0.989 . . . . 0.0 111.865 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -82.81 -46.62 12.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.581 0.352 . . . . 0.0 111.087 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.7 t -93.3 -7.78 43.95 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.483 0.713 . . . . 0.0 112.182 -169.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 56.78 70.18 0.67 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.55 1.14 . . . . 0.0 111.574 -172.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.6 HD13 HG22 ' A' ' 12' ' ' ILE . 10.2 pt -143.75 152.0 54.76 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 125.143 1.377 . . . . 0.0 108.641 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.09 116.77 4.76 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 121.93 1.754 . . . . 0.0 111.709 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.518 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -62.93 -17.17 61.51 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.996 0.919 . . . . 0.0 113.034 -178.254 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.98 -27.18 60.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.329 0.651 . . . . 0.0 110.243 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -83.8 -5.57 59.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.096 0.558 . . . . 0.0 110.724 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.427 HD11 ' HA ' ' A' ' 20' ' ' ARG . 1.9 mp -87.81 120.39 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.9 p -101.53 166.99 11.3 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.724 0.81 . . . . 0.0 109.427 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.14 -17.26 54.51 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 121.889 1.726 . . . . 0.0 112.763 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.66 0.27 49.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.572 0.349 . . . . 0.0 110.331 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -72.6 128.08 34.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.879 0.872 . . . . 0.0 110.109 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -87.3 117.11 25.85 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.513 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -55.16 -35.93 65.29 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -93.04 -44.85 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 121.392 0.615 . . . . 0.0 110.374 -170.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -94.88 -38.38 10.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.13 0.972 . . . . 0.0 111.593 -168.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.24 -50.8 5.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.833 0.453 . . . . 0.0 110.659 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 29' ' ' ALA . 88.8 mt -77.71 -14.59 59.57 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.417 0.687 . . . . 0.0 111.145 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.89 27.97 72.02 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.798 0.686 . . . . 0.0 114.255 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.464 HG21 HD12 ' A' ' 43' ' ' ILE . 89.3 mt -76.77 124.88 35.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.01 152.87 44.98 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.115 0.885 . . . . 0.0 109.805 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.2 m -66.31 -25.96 67.09 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.599 0.759 . . . . 0.0 112.278 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.77 -33.68 62.33 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.34 -42.44 59.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.734 0.814 . . . . 0.0 110.117 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -71.26 -21.95 62.03 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 123.593 0.558 . . . . 0.0 110.603 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.49 -47.14 86.65 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 170.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -71.55 -36.91 71.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.954 0.902 . . . . 0.0 111.437 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 35' ' ' ILE . 52.8 mt -63.4 -50.24 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 123.636 0.585 . . . . 0.0 110.1 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.94 -33.42 72.1 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 123.782 0.676 . . . . 0.0 109.905 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.507 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 45.0 t80 -60.95 -40.84 94.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.401 1.081 . . . . 0.0 111.003 173.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.78 -35.88 59.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.626 0.37 . . . . 0.0 111.317 -178.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.6 mt -65.43 -43.05 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.543 0.737 . . . . 0.0 109.958 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 45' ' ' PHE . 9.8 t70 -50.69 -52.55 39.08 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.665 1.586 . . . . 0.0 110.692 177.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 57.8 mmtt -74.15 -35.66 64.06 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.259 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.03 -43.99 97.18 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.071 0.548 . . . . 0.0 111.812 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -93.01 -0.62 57.14 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.907 0.883 . . . . 0.0 111.556 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.13 43.61 96.94 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 123.754 0.659 . . . . 0.0 113.174 172.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 pt -135.53 173.57 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.245 1.418 . . . . 0.0 109.177 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -104.49 108.53 20.01 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 167.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.529 HD22 HG12 ' A' ' 84' ' ' ILE . 51.9 mt -68.74 121.77 82.41 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 167.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.541 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 93.5 Cg_endo -78.56 57.57 6.37 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.692 2.261 . . . . 0.0 111.682 176.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.99 -37.81 80.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.013 1.325 . . . . 0.0 109.589 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.37 -46.14 89.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.573 1.149 . . . . 0.0 111.264 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 22.1 tptm -68.88 -39.1 79.97 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.169 0.988 . . . . 0.0 111.102 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.442 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 54.5 m0 -62.51 -41.55 98.91 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.62 0.768 . . . . 0.0 109.886 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.9 m -63.01 -39.61 95.29 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.166 0.916 . . . . 0.0 110.498 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.38 -47.71 75.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.051 0.541 . . . . 0.0 110.654 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -58.17 -44.93 88.21 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.98 0.912 . . . . 0.0 112.288 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.9 t -67.5 -50.36 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 122.629 0.372 . . . . 0.0 111.072 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -67.56 -29.7 69.15 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.371 0.669 . . . . 0.0 112.689 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -94.09 5.2 52.47 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.486 0.714 . . . . 0.0 111.428 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.32 21.77 66.72 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 115.802 1.081 . . . . 0.0 115.802 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.489 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -79.57 -22.85 43.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.315 0.646 . . . . 0.0 110.88 173.44 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.04 177.57 9.47 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.738 1.215 . . . . 0.0 108.339 175.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.21 164.89 20.67 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.102 0.961 . . . . 0.0 109.073 173.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.0 p -54.93 -52.21 63.68 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.202 0.938 . . . . 0.0 113.107 -165.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -35.49 63.21 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -172.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -53.22 -27.93 24.45 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.229 1.012 . . . . 0.0 113.02 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -115.75 -31.28 5.86 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.398 0.679 . . . . 0.0 111.834 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -110.98 21.52 16.34 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.866 0.467 . . . . 0.0 112.033 -165.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.503 HG11 ' HG2' ' A' ' 78' ' ' LYS . 24.8 t -106.82 138.24 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 164.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -51.62 -37.87 52.13 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -170.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HG2' HG11 ' A' ' 76' ' ' VAL . 61.8 pttt -69.32 -41.92 76.05 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.059 0.391 . . . . 0.0 110.619 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 76.0 m-20 -76.97 -33.79 57.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.422 1.089 . . . . 0.0 110.04 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -68.04 -54.03 21.35 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.287 1.435 . . . . 0.0 108.331 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.58 -31.01 69.06 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.1 0.875 . . . . 0.0 111.499 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 -52.37 53.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.883 0.473 . . . . 0.0 110.634 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 13.9 mmp_? -54.1 -49.9 68.08 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.233 0.613 . . . . 0.0 110.73 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.529 HG12 HD22 ' A' ' 55' ' ' LEU . 91.9 mt -57.5 -53.65 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 125.246 1.418 . . . . 0.0 110.948 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.573 ' HB2' HG22 ' A' ' 4' ' ' THR . 25.9 t70 -63.18 -34.78 78.39 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.781 0.832 . . . . 0.0 111.831 -176.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -68.15 -36.68 80.05 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.333 0.653 . . . . 0.0 111.128 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.4 mt -68.2 -37.95 81.45 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.867 0.467 . . . . 0.0 110.617 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.467 HG12 ' HE2' ' A' ' 91' ' ' LYS . 58.4 t -68.98 -32.33 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 CA-C-O 121.45 0.643 . . . . 0.0 109.783 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.84 78.81 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.378 173.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.69 92.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.239 1.016 . . . . 0.0 111.561 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.467 ' HE2' HG12 ' A' ' 88' ' ' VAL . 56.0 pttt . . . . . 0 N--CA 1.48 1.05 0 C-N-CA 122.524 0.329 . . . . 0.0 110.353 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.463 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.006 0.432 . . . . 0.0 110.384 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.0 m -78.09 91.6 4.31 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 169.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.4 m -78.38 74.9 4.91 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.106 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.3 m -64.58 -46.36 83.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.009 -1.45 . . . . 0.0 110.15 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -52.81 -47.64 67.5 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.23 1.012 . . . . 0.0 110.834 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.97 -47.65 77.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 124.004 0.815 . . . . 0.0 111.645 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -66.07 -38.09 87.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.86 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG11 HD13 ' A' ' 47' ' ' ILE . 96.4 t -72.24 -37.48 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.177 0.591 . . . . 0.0 110.329 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.19 -35.46 80.88 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.104 0.962 . . . . 0.0 110.41 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.41 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 59.8 m -66.98 -44.66 79.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.926 173.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.4 -47.09 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.274 0.629 . . . . 0.0 110.896 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.553 HG12 HD13 ' A' ' 43' ' ' ILE . 36.6 mt -61.26 -44.28 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.385 1.074 . . . . 0.0 111.071 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.08 -48.14 64.84 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.015 0.926 . . . . 0.0 112.632 174.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 10' ' ' THR . 46.4 mt-10 -66.64 -32.39 73.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.945 0.898 . . . . 0.0 111.557 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.1 m -71.22 -58.4 3.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.382 0.673 . . . . 0.0 111.591 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.405 ' SG ' HG12 ' A' ' 35' ' ' ILE . 86.4 m -103.65 15.66 28.32 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -167.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 49.83 64.14 1.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.415 1.086 . . . . 0.0 112.051 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.9 pt -142.53 146.07 37.18 Favored Pre-proline 0 N--CA 1.481 1.122 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.688 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.97 125.55 14.36 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.31 2.006 . . . . 0.0 112.162 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -31.79 48.92 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.949 1.3 . . . . 0.0 113.03 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.39 -23.65 60.2 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.378 0.671 . . . . 0.0 111.226 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -84.7 -11.62 55.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.8 0.44 . . . . 0.0 110.933 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mp -83.62 111.84 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.5 p -94.93 161.52 28.14 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 123.41 0.684 . . . . 0.0 109.556 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.17 -25.41 64.08 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.358 2.039 . . . . 0.0 113.668 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.576 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 32.1 mt-10 -102.89 17.66 23.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.947 -0.47 . . . . 0.0 110.734 -175.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -78.38 129.62 35.17 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.263 0.625 . . . . 0.0 110.259 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.4 ' HE2' ' HB ' ' A' ' 71' ' ' THR . 64.3 t-80 -88.55 120.83 30.3 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.492 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.11 -41.98 27.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.355 1.062 . . . . 0.0 113.471 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.2 mt -93.22 -60.11 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -63.63 -46.44 85.66 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.207 1.003 . . . . 0.0 111.989 -174.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.7 -64.37 1.15 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.197 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 29' ' ' ALA . 86.1 mt -71.39 -17.6 62.4 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.635 0.774 . . . . 0.0 112.542 -173.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.38 30.57 64.49 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.169 0.293 . . . . 0.0 113.792 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.405 HG12 ' SG ' ' A' ' 16' ' ' CYS . 70.6 mt -101.98 123.04 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.43 1.092 . . . . 0.0 108.915 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.44 158.88 32.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.081 0.467 . . . . 0.0 110.713 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.2 p -64.46 -23.54 67.32 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.601 0.76 . . . . 0.0 112.222 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 pp -70.53 -39.56 73.98 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -68.03 -35.96 79.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.595 0.758 . . . . 0.0 109.461 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -65.56 -27.35 68.37 Favored 'General case' 0 CA--C 1.555 1.152 0 O-C-N 124.06 0.85 . . . . 0.0 111.264 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.74 -45.38 93.01 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.061 0.544 . . . . 0.0 110.272 171.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -65.81 -40.12 91.55 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.989 0.916 . . . . 0.0 110.455 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.553 HD13 HG12 ' A' ' 12' ' ' ILE . 97.3 mt -60.83 -44.99 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.653 0.781 . . . . 0.0 109.784 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.95 -32.8 72.66 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.854 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -72.03 -31.44 66.18 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.361 1.064 . . . . 0.0 110.886 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.2 65.78 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.547 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.455 HD11 HD12 ' A' ' 84' ' ' ILE . 96.0 mt -68.09 -39.14 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 124.002 0.921 . . . . 0.0 110.362 172.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.44 -43.37 75.34 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.697 1.199 . . . . 0.0 110.134 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.08 -53.84 11.61 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.463 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.86 -56.84 12.9 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.53 1.132 . . . . 0.0 113.129 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -88.14 -11.82 45.81 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.956 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.12 32.19 76.15 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.312 0.383 . . . . 0.0 112.342 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.495 HD11 HG21 ' A' ' 84' ' ' ILE . 42.6 pt -110.08 163.91 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.258 1.023 . . . . 0.0 110.056 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -110.75 95.55 5.62 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.439 HD22 HD12 ' A' ' 87' ' ' LEU . 70.1 mt -72.59 118.88 71.65 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.42 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 2.7 Cg_exo -78.88 59.85 7.5 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.115 2.544 . . . . 0.0 110.139 168.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.12 -35.68 81.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.397 -174.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -57.42 -40.55 78.59 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.78 0.832 . . . . 0.0 112.205 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 56' ' ' PRO . 9.6 ptmm? -77.44 -34.81 54.46 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.418 ' O ' HG22 ' A' ' 64' ' ' VAL . 50.6 m0 -66.67 -43.89 83.31 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.509 0.724 . . . . 0.0 110.704 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.8 m -64.5 -37.37 87.31 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.939 0.896 . . . . 0.0 110.269 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -66.22 -41.73 89.7 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.928 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 39.2 mt-10 -62.37 -43.06 99.71 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.802 0.841 . . . . 0.0 110.854 178.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 60' ' ' TRP . 77.6 t -55.56 -57.22 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 O-C-N 124.149 0.906 . . . . 0.0 110.533 175.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -66.75 -28.96 68.83 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.145 0.978 . . . . 0.0 112.984 -174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -93.18 7.24 45.09 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.456 0.703 . . . . 0.0 111.555 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.19 11.54 67.52 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 115.017 0.767 . . . . 0.0 115.017 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -70.64 -35.53 72.94 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.235 0.614 . . . . 0.0 109.951 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.07 164.77 29.14 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.721 1.208 . . . . 0.0 109.204 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.6 p -97.92 158.46 15.52 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.259 0.624 . . . . 0.0 109.801 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.4 ' HB ' ' HE2' ' A' ' 28' ' ' HIS . 0.7 OUTLIER -59.54 -43.86 93.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 124.158 0.912 . . . . 0.0 110.567 -175.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.529 ' HA ' HG22 ' A' ' 76' ' ' VAL . 3.1 mp0 -46.74 -49.1 20.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.374 1.47 . . . . 0.0 112.972 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -54.55 -25.44 25.99 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -121.37 -22.17 6.07 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -109.32 12.06 24.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.246 0.618 . . . . 0.0 111.771 -169.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 72' ' ' GLU . 80.2 t -105.58 138.04 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.475 HD12 HD11 ' A' ' 12' ' ' ILE . 4.4 mm? -52.91 -38.38 61.77 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.025 1.33 . . . . 0.0 114.312 -171.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.576 ' HD3' ' HG2' ' A' ' 26' ' ' GLU . 60.1 pttt -71.21 -40.7 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.095 0.558 . . . . 0.0 110.609 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.457 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 77.5 m-20 -74.58 -47.16 34.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.238 1.015 . . . . 0.0 109.788 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.6 tp -57.1 -49.43 75.89 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.705 1.202 . . . . 0.0 110.089 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.39 78.61 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.834 0.709 . . . . 0.0 110.939 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -67.44 -44.76 77.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.585 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 18.2 mmm180 -56.73 -44.31 81.52 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.298 0.639 . . . . 0.0 110.738 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.495 HG21 HD11 ' A' ' 53' ' ' ILE . 90.3 mt -62.54 -49.52 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.029 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.04 -32.69 74.32 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.521 1.138 . . . . 0.0 110.625 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 65.6 mt-10 -62.47 -47.14 85.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.839 0.856 . . . . 0.0 110.143 172.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.439 HD12 HD22 ' A' ' 55' ' ' LEU . 81.1 mt -69.16 -31.31 69.87 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.153 0.581 . . . . 0.0 111.552 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 84' ' ' ILE . 77.0 t -68.67 -41.31 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.422 0.689 . . . . 0.0 109.665 176.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.83 -41.49 78.5 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.457 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.39 -39.02 91.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.026 0.93 . . . . 0.0 111.802 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -85.33 -26.95 26.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.825 0.45 . . . . 0.0 110.301 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.12 -40.0 21.79 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.466 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 71.23 -55.65 0.65 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.829 1.651 . . . . 0.0 111.33 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.64 163.42 27.74 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 124.539 1.136 . . . . 0.0 109.262 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.97 132.95 55.51 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.287 0.635 . . . . 0.0 111.472 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -90.0 20.4 4.28 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.123 0.969 . . . . 0.0 111.348 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -58.33 123.49 16.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.761 0.824 . . . . 0.0 111.022 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -141.03 112.61 7.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.991 0.917 . . . . 0.0 109.216 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -80.6 151.66 28.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.798 0.839 . . . . 0.0 109.408 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -159.27 171.55 19.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.492 0.717 . . . . 0.0 109.669 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 . . . . . 0 C--O 1.251 1.133 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 172.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.483 ' SD ' HG23 ' A' ' 2' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.483 HG23 ' SD ' ' A' ' 1' ' ' MET . 39.7 p -88.67 94.43 9.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.045 0.538 . . . . 0.0 109.725 177.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.1 p -72.32 172.0 11.13 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.751 0.42 . . . . 0.0 110.407 175.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 8' ' ' VAL . 20.0 m -61.55 -50.79 71.23 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -55.82 -43.9 77.39 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.911 0.757 . . . . 0.0 111.226 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -52.84 -49.74 65.14 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 123.73 0.643 . . . . 0.0 110.736 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -65.88 -40.21 91.4 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.071 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 4' ' ' THR . 67.2 t -66.71 -44.27 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 122.871 0.468 . . . . 0.0 110.315 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.01 96.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.15 0.98 . . . . 0.0 110.877 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -60.92 -47.69 85.27 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.644 0.778 . . . . 0.0 110.925 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.54 -50.77 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.445 0.698 . . . . 0.0 111.418 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.459 HG23 HD13 ' A' ' 18' ' ' ILE . 50.9 mt -57.46 -45.62 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.672 0.789 . . . . 0.0 110.553 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.528 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.14 -58.17 7.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.352 1.061 . . . . 0.0 112.662 174.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -64.84 -26.91 68.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.229 1.011 . . . . 0.0 112.052 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -76.88 -53.47 7.84 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.256 0.623 . . . . 0.0 110.695 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.484 ' SG ' HG12 ' A' ' 35' ' ' ILE . 37.7 t -100.04 9.2 43.25 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -166.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t70 55.65 59.83 3.64 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.761 0.791 . . . . 0.0 111.151 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.528 HG13 ' HA ' ' A' ' 13' ' ' ALA . 11.5 pt -141.78 148.19 48.42 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 123.729 0.812 . . . . 0.0 109.712 -177.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.24 125.41 11.34 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.661 2.241 . . . . 0.0 110.568 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.614 ' HA ' HD11 ' A' ' 23' ' ' ILE . 7.6 ptt180 -68.61 -17.07 64.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.07 -24.85 60.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.388 0.675 . . . . 0.0 110.479 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -80.95 -13.24 59.08 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.613 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.614 HD11 ' HA ' ' A' ' 20' ' ' ARG . 2.7 mp -86.64 117.7 31.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.5 p -100.32 161.69 23.28 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.802 0.841 . . . . 0.0 109.045 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.7 -16.05 50.52 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 121.733 1.622 . . . . 0.0 112.823 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.69 3.33 50.26 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.791 -0.568 . . . . 0.0 111.064 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.7 m -77.78 135.81 38.03 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 59.5 t-80 -81.07 113.81 19.51 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.24 -23.17 55.02 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.432 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 61.9 mt -97.79 -54.13 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.171 0.588 . . . . 0.0 110.007 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.23 -43.67 41.08 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.826 0.851 . . . . 0.0 112.563 -167.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.81 -51.55 11.14 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.788 0.435 . . . . 0.0 110.049 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.9 mt -78.02 -5.78 52.43 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.926 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.65 27.93 73.57 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.566 0.541 . . . . 0.0 113.246 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.484 HG12 ' SG ' ' A' ' 16' ' ' CYS . 81.4 mt -95.86 124.29 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.976 0.911 . . . . 0.0 108.615 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.52 157.46 34.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.489 0.316 . . . . 0.0 110.999 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.442 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.6 m -63.02 -22.78 67.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.632 0.773 . . . . 0.0 110.75 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.5 mt -65.31 -51.37 61.08 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.75 0.82 . . . . 0.0 109.908 174.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.52 -31.46 71.58 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.58 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -74.91 -24.99 58.6 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.305 0.642 . . . . 0.0 110.973 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.483 HD23 HD13 ' A' ' 57' ' ' LEU . 80.1 mt -61.63 -42.27 98.65 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.061 0.544 . . . . 0.0 109.86 169.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -72.27 -37.42 69.05 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.888 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.446 HG22 HG12 ' A' ' 12' ' ' ILE . 67.5 mt -58.85 -50.74 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.817 174.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.24 -27.5 63.51 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.533 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -61.01 -46.35 91.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.803 0.841 . . . . 0.0 110.483 169.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.27 -34.87 76.96 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.141 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.2 mt -69.0 -44.04 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.932 0.893 . . . . 0.0 110.679 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -51.35 -48.6 62.39 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.388 1.475 . . . . 0.0 110.257 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -76.84 -38.58 53.55 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.572 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.87 -54.92 38.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.286 0.634 . . . . 0.0 112.304 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -84.58 -9.93 57.85 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.616 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.65 29.78 69.27 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 123.53 0.519 . . . . 0.0 112.858 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.526 HD12 HG23 ' A' ' 84' ' ' ILE . 42.6 pt -107.53 176.5 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.506 1.122 . . . . 0.0 109.735 -174.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.54 96.26 5.06 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.65 116.79 61.06 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 123.705 0.802 . . . . 0.0 109.859 171.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -84.3 57.4 5.24 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 122.651 2.234 . . . . 0.0 110.41 168.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.483 HD13 HD23 ' A' ' 41' ' ' LEU . 2.0 tm? -59.7 -41.76 91.46 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.516 1.127 . . . . 0.0 109.931 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 11.6 pt-20 -61.39 -39.27 90.1 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 124.24 0.963 . . . . 0.0 110.959 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -46.76 79.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.777 0.831 . . . . 0.0 110.107 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.453 ' O ' HG22 ' A' ' 64' ' ' VAL . 52.5 m0 -60.16 -40.14 88.88 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.936 1.397 . . . . 0.0 110.861 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 34.8 m -68.21 -35.15 77.52 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.494 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.431 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 17.0 mm100 -73.15 -29.69 63.05 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.855 0.462 . . . . 0.0 110.521 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.47 ' HG2' ' HE3' ' A' ' 68' ' ' LYS . 49.0 mt-10 -65.78 -41.54 91.9 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.747 0.419 . . . . 0.0 110.199 173.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.605 HG12 HG22 ' A' ' 71' ' ' THR . 98.7 t -61.07 -43.15 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.6 175.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -62.08 -39.64 93.14 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.107 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -87.55 -5.18 58.88 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.674 0.79 . . . . 0.0 112.586 -174.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.96 12.01 85.03 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 115.042 0.777 . . . . 0.0 115.042 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.47 ' HE3' ' HG2' ' A' ' 63' ' ' GLU . 55.1 mtmt -79.68 -26.97 40.81 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 117.725 0.762 . . . . 0.0 111.059 172.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -136.53 174.54 10.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.056 0.942 . . . . 0.0 109.327 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.7 m -133.86 148.57 51.29 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.485 1.114 . . . . 0.0 108.757 174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.605 HG22 HG12 ' A' ' 64' ' ' VAL . 4.1 p -58.42 93.1 0.02 OUTLIER 'General case' 0 C--N 1.362 1.146 0 C-N-CA 123.512 0.725 . . . . 0.0 109.887 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.0 tm-20 175.86 -63.81 0.01 OUTLIER 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.134 1.374 . . . . 0.0 107.978 -174.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -51.26 -29.36 14.35 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.763 -1.562 . . . . 0.0 114.06 -173.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -132.92 0.61 3.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.061 0.544 . . . . 0.0 111.136 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -121.28 5.35 10.25 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.29 0.636 . . . . 0.0 111.295 -165.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 72' ' ' GLU . 71.7 t -105.34 146.1 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.39 -43.77 64.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.901 1.28 . . . . 0.0 114.251 -174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -68.95 -42.32 76.83 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.754 0.422 . . . . 0.0 110.322 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 5.6 m120 -65.32 -47.33 76.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.447 0.699 . . . . 0.0 110.597 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.88 -50.77 69.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 110.223 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.415 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -62.43 -28.25 69.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.665 0.786 . . . . 0.0 111.261 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -69.99 -45.35 67.47 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.736 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 15.3 mmm180 -57.71 -46.63 84.13 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.331 0.652 . . . . 0.0 110.383 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.526 HG23 HD12 ' A' ' 53' ' ' ILE . 89.9 mt -59.08 -47.94 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 113.778 -1.556 . . . . 0.0 110.694 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.07 -46.34 82.57 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.079 0.862 . . . . 0.0 111.205 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 49.1 mt-10 -63.76 -35.28 80.08 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.101 0.56 . . . . 0.0 111.111 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.4 -32.09 62.57 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.976 0.51 . . . . 0.0 112.154 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 84' ' ' ILE . 98.0 t -64.72 -41.47 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-O 121.732 0.777 . . . . 0.0 109.405 171.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.62 -45.52 78.84 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.648 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.71 90.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.31 1.044 . . . . 0.0 112.145 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -77.75 -18.83 56.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.453 0.301 . . . . 0.0 110.415 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.74 -4.63 61.81 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 174.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.12 10.02 31.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.673 0.789 . . . . 0.0 111.427 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.3 mp -73.13 166.73 22.57 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.476 0.71 . . . . 0.0 111.027 174.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -57.91 -46.9 84.27 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.889 0.876 . . . . 0.0 112.498 -168.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -74.86 98.42 3.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.0 t60 66.48 93.25 0.07 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.977 1.311 . . . . 0.0 110.641 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -79.18 -10.3 59.78 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.223 0.609 . . . . 0.0 111.674 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 77.72 -64.85 0.28 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.866 1.667 . . . . 0.0 111.586 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -72.14 130.96 42.12 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.518 0.727 . . . . 0.0 111.896 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.195 -0.907 . . . . 0.0 108.98 171.1 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tmm? . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.7 t -63.6 87.25 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 122.25 1.024 . . . . 0.0 111.29 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 m -76.67 175.6 9.19 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.327 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.438 ' O ' HG22 ' A' ' 8' ' ' VAL . 7.0 m -56.36 -42.7 78.22 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.767 0.427 . . . . 0.0 110.623 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -54.39 -50.26 67.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.35 0.66 . . . . 0.0 111.247 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.01 -42.0 98.68 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.574 0.546 . . . . 0.0 110.721 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -58.84 -48.27 81.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.724 0.81 . . . . 0.0 111.082 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 4' ' ' THR . 94.9 t -67.48 -44.87 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.57 0.748 . . . . 0.0 110.852 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.46 90.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.288 1.035 . . . . 0.0 110.375 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.478 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 92.8 m -63.4 -44.9 93.35 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.758 0.823 . . . . 0.0 111.29 175.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 47' ' ' ILE . 95.2 mt -58.71 -48.16 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 122.967 0.507 . . . . 0.0 111.485 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.451 HG21 HD13 ' A' ' 18' ' ' ILE . 57.1 mt -58.46 -45.88 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.645 0.778 . . . . 0.0 109.996 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.506 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.77 -51.84 62.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.853 1.261 . . . . 0.0 113.683 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 10' ' ' THR . 22.2 mm-40 -66.26 -27.78 68.21 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.386 0.675 . . . . 0.0 112.129 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.479 HG23 HG12 ' A' ' 43' ' ' ILE . 96.1 m -76.56 -51.63 11.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.929 0.492 . . . . 0.0 111.054 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.6 m -99.59 7.03 45.59 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.59 0.756 . . . . 0.0 112.515 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 48.25 70.6 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.526 1.13 . . . . 0.0 111.749 -174.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.506 HG13 ' HA ' ' A' ' 13' ' ' ALA . 10.3 pt -144.78 146.58 32.24 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 124.138 0.975 . . . . 0.0 109.605 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.428 ' HG2' ' HG1' ' A' ' 22' ' ' THR . 41.0 Cg_endo -66.45 116.69 4.2 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.919 2.413 . . . . 0.0 112.207 176.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -23.91 67.44 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -170.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -90.76 -6.36 54.48 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.142 0.577 . . . . 0.0 110.891 -171.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.428 ' HG1' ' HG2' ' A' ' 19' ' ' PRO . 66.4 p -89.02 -13.03 39.72 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 167.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -79.19 105.77 9.1 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -77.25 159.94 76.74 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.435 0.694 . . . . 0.0 109.735 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.57 -17.02 58.13 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 121.988 1.792 . . . . 0.0 112.196 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -99.74 9.85 42.36 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 122.909 0.484 . . . . 0.0 110.427 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.0 m -72.13 124.33 24.77 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 122.57 0.348 . . . . 0.0 110.07 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -83.6 117.09 22.93 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.473 ' HA ' HD11 ' A' ' 33' ' ' LEU . . . -46.71 -41.43 15.05 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.206 1.003 . . . . 0.0 113.37 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.71 -50.2 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 122.464 0.306 . . . . 0.0 110.457 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.27 -38.33 24.56 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.943 0.897 . . . . 0.0 112.397 -171.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.17 -57.05 2.83 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.186 0.595 . . . . 0.0 110.35 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.473 HD11 ' HA ' ' A' ' 29' ' ' ALA . 88.7 mt -76.29 -10.53 59.47 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.888 0.875 . . . . 0.0 111.977 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.26 30.38 77.61 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 123.412 0.445 . . . . 0.0 113.993 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.1 mt -89.39 126.24 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.27 147.92 38.54 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.213 0.605 . . . . 0.0 110.692 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -60.56 -35.74 76.77 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.726 0.41 . . . . 0.0 111.144 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.443 HD11 ' N ' ' A' ' 39' ' ' ASP . 3.0 pp -73.86 -31.65 63.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.186 0.594 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.443 ' N ' HD11 ' A' ' 38' ' ' LEU . 15.5 t70 -72.82 -35.99 67.41 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.483 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -71.72 -21.78 61.72 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.075 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.8 mt -56.85 -41.72 78.4 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 122.625 0.37 . . . . 0.0 110.426 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.09 -32.62 63.32 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.057 0.943 . . . . 0.0 111.51 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.479 HG12 HG23 ' A' ' 15' ' ' THR . 37.9 mt -65.26 -46.59 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.13 -29.15 67.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.907 0.883 . . . . 0.0 111.143 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -58.21 -50.87 72.04 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.006 1.322 . . . . 0.0 110.786 170.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.92 -33.49 74.78 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.871 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.568 ' HA ' HD11 ' A' ' 11' ' ' ILE . 85.9 mt -67.47 -51.32 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.186 0.594 . . . . 0.0 110.888 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.85 -37.33 86.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.039 0.535 . . . . 0.0 110.344 -170.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -81.38 -29.04 34.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.4 -48.24 76.17 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.322 0.388 . . . . 0.0 111.592 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.412 ' HB2' HG12 ' A' ' 53' ' ' ILE . 86.7 m-85 -83.12 -16.47 46.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.508 0.723 . . . . 0.0 111.821 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.12 37.58 87.25 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.382 0.426 . . . . 0.0 112.519 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.477 HG21 ' HG2' ' A' ' 91' ' ' LYS . 46.3 pt -116.35 172.82 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.585 1.154 . . . . 0.0 111.026 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.62 97.82 6.36 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.385 1.074 . . . . 0.0 108.454 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 84' ' ' ILE . 79.3 mt -73.18 120.42 80.9 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 123.035 0.534 . . . . 0.0 110.071 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.56 57.82 6.7 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.758 2.305 . . . . 0.0 110.835 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -63.83 -40.99 97.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.416 1.086 . . . . 0.0 109.818 -173.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.26 -37.88 88.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.502 0.721 . . . . 0.0 111.371 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -71.01 -37.97 72.63 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.853 0.861 . . . . 0.0 110.238 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -63.59 -52.79 59.42 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.944 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.3 m -62.52 -33.3 74.62 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.084 0.954 . . . . 0.0 110.895 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -63.22 -58.65 6.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.429 0.691 . . . . 0.0 109.837 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 44.4 mt-10 -66.04 -32.23 73.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.854 0.862 . . . . 0.0 111.82 -176.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.8 t -61.63 -55.01 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.683 0.793 . . . . 0.0 110.165 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -78.97 -7.7 58.27 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.699 0.399 . . . . 0.0 111.787 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -92.85 -2.92 55.47 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.342 0.657 . . . . 0.0 110.74 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.71 5.24 86.19 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 115.888 1.115 . . . . 0.0 115.888 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 60.6 mttp -70.43 -31.59 68.84 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.075 0.937 . . . . 0.0 110.277 171.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.43 163.27 32.96 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.326 1.051 . . . . 0.0 108.819 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 p -104.72 162.28 13.43 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.442 0.697 . . . . 0.0 109.643 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.5 p -59.38 -52.5 65.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.157 0.583 . . . . 0.0 112.332 -169.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -56.02 -31.52 63.17 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -50.07 -33.59 18.91 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.36 1.064 . . . . 0.0 113.318 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -122.12 -19.59 6.53 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -111.91 23.4 13.83 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 122.571 0.348 . . . . 0.0 111.198 -171.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.514 HG13 ' HG2' ' A' ' 78' ' ' LYS . 40.3 t -110.27 142.26 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 162.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.17 -41.4 68.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.389 1.476 . . . . 0.0 114.267 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.514 ' HG2' HG13 ' A' ' 76' ' ' VAL . 58.9 pttt -66.77 -37.79 85.29 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 120.786 0.327 . . . . 0.0 110.954 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.44 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 73.3 m-20 -80.39 -37.93 31.3 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.878 0.871 . . . . 0.0 110.817 -176.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.38 -53.21 52.07 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.242 1.017 . . . . 0.0 108.857 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.47 -22.58 65.47 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.689 0.795 . . . . 0.0 111.914 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.11 -53.94 37.66 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.66 0.384 . . . . 0.0 110.058 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 28.1 mmm180 -60.92 -40.37 92.93 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 124.101 0.876 . . . . 0.0 111.205 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.501 HG12 HD23 ' A' ' 55' ' ' LEU . 92.3 mt -61.52 -50.31 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.281 1.032 . . . . 0.0 110.31 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -63.34 -34.94 78.8 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.118 0.567 . . . . 0.0 111.496 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.85 -44.12 90.94 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.487 0.715 . . . . 0.0 109.981 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.2 -42.04 76.3 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.16 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 84' ' ' ILE . 61.6 t -61.65 -45.69 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 123.464 0.706 . . . . 0.0 110.333 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.98 -43.11 99.3 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.511 176.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.01 -42.67 76.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.621 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.477 ' HG2' HG21 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -83.53 -32.17 26.03 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.668 0.387 . . . . 0.0 110.146 -174.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.37 -25.74 74.6 Favored Glycine 0 C--N 1.355 1.625 0 O-C-N 124.088 0.868 . . . . 0.0 112.566 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.81 80.21 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.326 0.65 . . . . 0.0 111.235 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.5 mp -73.99 -34.79 64.33 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.75 0.82 . . . . 0.0 110.644 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -66.14 -39.17 89.65 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.047 174.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.6 t60 68.68 -70.31 0.14 Allowed 'General case' 0 C--N 1.361 1.108 0 C-N-CA 125.635 1.574 . . . . 0.0 110.445 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -68.16 118.14 10.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.587 1.155 . . . . 0.0 110.585 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.35 166.16 23.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.637 0.775 . . . . 0.0 110.109 170.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -66.29 153.85 41.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.097 0.159 . . . . 0.0 111.015 175.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -63.89 107.42 1.22 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 . . . . . 0 CA--C 1.561 1.385 0 O-C-N 124.346 1.029 . . . . 0.0 110.833 -176.695 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.1 p 48.87 27.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 125.076 1.35 . . . . 0.0 112.819 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -72.83 128.98 37.11 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.156 0.982 . . . . 0.0 110.01 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.6 m -57.58 -54.08 50.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.185 0.994 . . . . 0.0 111.652 -172.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -54.89 -48.13 73.4 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.736 0.647 . . . . 0.0 111.016 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.93 -42.85 94.87 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.785 0.678 . . . . 0.0 110.934 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -57.44 -45.76 84.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.498 0.719 . . . . 0.0 111.221 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.8 t -71.4 -33.97 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 123.712 0.632 . . . . 0.0 110.77 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.86 -36.42 83.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.549 0.739 . . . . 0.0 110.481 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 m -66.82 -44.01 82.27 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.56 0.744 . . . . 0.0 110.739 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.8 mt -56.42 -54.53 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.646 0.778 . . . . 0.0 110.724 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.55 HD12 HD11 ' A' ' 77' ' ' LEU . 35.8 mt -60.08 -45.38 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.15 0.98 . . . . 0.0 110.66 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.456 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -51.88 -51.27 57.98 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 123.825 0.703 . . . . 0.0 112.319 174.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -67.86 -30.17 69.47 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.499 0.72 . . . . 0.0 112.332 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -74.81 -61.0 2.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.254 0.622 . . . . 0.0 110.938 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.402 ' HG ' HG12 ' A' ' 35' ' ' ILE . 61.8 m -90.49 10.79 23.93 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.016 0.927 . . . . 0.0 112.953 -168.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.4 t70 48.7 68.09 0.76 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.651 1.18 . . . . 0.0 111.565 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.456 HG13 ' HA ' ' A' ' 13' ' ' ALA . 12.1 pt -145.26 142.96 18.95 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.718 1.207 . . . . 0.0 108.699 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.67 139.36 69.08 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.523 2.149 . . . . 0.0 112.55 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -56.33 -31.5 63.78 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.144 1.378 . . . . 0.0 111.952 -173.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -77.25 -18.81 57.33 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.99 0.516 . . . . 0.0 111.901 -172.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -78.93 -11.32 60.0 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.046 0.385 . . . . 0.0 111.398 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.4 mp -86.18 102.05 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.408 ' OG1' ' HB2' ' A' ' 27' ' ' SER . 64.3 p -81.18 154.04 72.07 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.118 0.567 . . . . 0.0 109.77 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.94 -30.22 83.22 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.335 2.024 . . . . 0.0 112.524 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -97.8 13.08 31.73 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.824 0.45 . . . . 0.0 110.947 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.408 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 46.9 t -72.24 129.67 38.98 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.968 0.507 . . . . 0.0 109.69 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -83.21 114.62 21.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 167.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.69 -41.66 10.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.022 0.929 . . . . 0.0 112.977 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.6 mt -88.62 -59.63 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -172.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.19 -36.46 84.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.739 1.216 . . . . 0.0 112.728 -173.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -98.39 -65.59 0.95 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.282 0.633 . . . . 0.0 110.759 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.48 -18.49 62.98 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.37 41.66 36.83 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 112.366 -0.293 . . . . 0.0 112.366 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.402 HG12 ' HG ' ' A' ' 16' ' ' CYS . 93.5 mt -99.75 107.88 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.25 168.32 18.54 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.4 t -52.46 -37.93 58.14 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.466 1.106 . . . . 0.0 111.783 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.23 -26.06 58.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.056 0.543 . . . . 0.0 111.898 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.4 -41.38 47.98 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 175.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -68.95 -23.13 64.11 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.889 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.4 mt -52.27 -49.86 63.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.159 0.583 . . . . 0.0 111.207 171.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.34 -38.02 71.68 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.826 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.527 HD11 HG12 ' A' ' 12' ' ' ILE . 81.5 mt -65.26 -44.79 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.519 0.728 . . . . 0.0 110.614 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.435 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -70.34 -37.16 74.62 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.284 0.633 . . . . 0.0 110.293 -177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -71.63 -27.57 63.19 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.367 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.72 63.92 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.837 0.351 . . . . 0.0 110.627 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 84' ' ' ILE . 87.0 mt -69.37 -38.19 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.072 0.949 . . . . 0.0 109.793 171.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 5.9 t70 -58.09 -42.81 86.44 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.823 0.849 . . . . 0.0 111.137 174.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.441 ' HB3' ' HZ3' ' A' ' 49' ' ' LYS . 7.5 mtpm? -67.94 -54.06 21.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.931 0.892 . . . . 0.0 110.561 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.13 -55.7 31.7 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.19 0.996 . . . . 0.0 112.605 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -91.05 -13.74 32.64 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.489 0.716 . . . . 0.0 112.433 -171.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.53 34.63 79.47 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-O 121.202 0.335 . . . . 0.0 113.494 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.606 HG23 ' HG2' ' A' ' 91' ' ' LYS . 44.6 pt -120.21 153.03 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.18 0.992 . . . . 0.0 109.149 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HD2' ' HB2' ' A' ' 98' ' ' HIS . 14.0 ptmm? -100.59 106.95 18.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.4 mt -69.96 125.05 91.8 Favored Pre-proline 0 C--N 1.348 0.513 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 170.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.409 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 78.0 Cg_endo -78.17 57.25 6.1 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.387 2.058 . . . . 0.0 111.104 172.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.54 -38.37 89.72 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.346 1.058 . . . . 0.0 110.425 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.98 -36.52 79.65 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.638 0.375 . . . . 0.0 111.833 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.551 ' HZ1' ' HB2' ' A' ' 59' ' ' LYS . 0.1 OUTLIER -75.31 -37.37 60.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.498 0.719 . . . . 0.0 110.374 178.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.421 ' O ' HG22 ' A' ' 64' ' ' VAL . 48.1 m0 -62.93 -50.97 68.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.925 0.89 . . . . 0.0 110.569 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.3 m -64.0 -31.85 73.18 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.259 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -68.62 -42.89 77.45 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.012 0.525 . . . . 0.0 110.84 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.33 -42.53 99.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.905 0.482 . . . . 0.0 110.615 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.421 HG22 ' O ' ' A' ' 60' ' ' TRP . 61.2 t -61.05 -49.96 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.593 0.711 . . . . 0.0 110.161 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -56.76 -41.44 77.59 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.421 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -99.62 17.38 20.65 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.094 0.958 . . . . 0.0 111.48 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.29 14.22 52.85 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 115.107 0.803 . . . . 0.0 115.107 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -80.78 -24.73 38.4 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.795 0.838 . . . . 0.0 110.396 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.85 173.33 12.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.173 0.989 . . . . 0.0 109.874 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.8 p -106.89 164.76 11.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.293 0.637 . . . . 0.0 109.694 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.0 p -57.45 -49.67 75.51 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.428 0.455 . . . . 0.0 110.475 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' HA ' HG22 ' A' ' 76' ' ' VAL . 29.8 mt-10 -39.1 -50.99 1.89 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.711 1.604 . . . . 0.0 113.26 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -59.59 -24.21 63.58 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.334 -1.303 . . . . 0.0 113.288 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -120.01 -22.79 6.57 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.935 0.494 . . . . 0.0 112.026 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.85 19.71 14.98 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.281 0.632 . . . . 0.0 110.749 -167.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.468 HG22 ' HA ' ' A' ' 72' ' ' GLU . 79.8 t -105.63 139.97 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 161.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.55 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -56.52 -40.48 75.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.837 1.255 . . . . 0.0 113.936 -172.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.415 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.3 pttt -72.58 -38.7 67.82 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.586 0.355 . . . . 0.0 111.216 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -71.97 -45.69 60.1 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.544 0.738 . . . . 0.0 109.888 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.2 tp -53.73 -48.05 70.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.913 1.285 . . . . 0.0 110.299 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -31.98 73.21 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.673 0.608 . . . . 0.0 111.759 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.98 77.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.769 0.427 . . . . 0.0 110.479 175.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -60.28 -44.75 95.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.319 0.58 . . . . 0.0 111.234 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 47' ' ' ILE . 90.3 mt -65.52 -46.64 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.276 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.54 -38.71 88.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.395 0.678 . . . . 0.0 110.991 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -59.41 -50.87 72.29 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.578 0.549 . . . . 0.0 110.733 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.04 -35.68 81.2 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.69 0.619 . . . . 0.0 112.219 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 84' ' ' ILE . 70.6 t -67.17 -47.26 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.395 0.678 . . . . 0.0 110.546 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.79 -32.4 73.67 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.712 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -46.91 68.93 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 123.482 0.713 . . . . 0.0 111.434 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.606 ' HG2' HG23 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -79.43 -24.43 42.48 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.042 0.537 . . . . 0.0 110.626 -174.566 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.3 -28.38 73.67 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.887 0.742 . . . . 0.0 112.312 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.04 -63.92 1.15 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.818 0.847 . . . . 0.0 109.661 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 tt -107.13 82.04 1.63 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.29 1.036 . . . . 0.0 108.406 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.72 111.77 2.24 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.343 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -128.52 123.89 34.67 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.934 0.494 . . . . 0.0 111.133 -171.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 64.24 8.51 4.18 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 125.145 1.378 . . . . 0.0 114.076 163.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.535 ' HB2' ' HD2' ' A' ' 54' ' ' LYS . 81.2 t60 -171.74 141.02 1.38 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.577 0.751 . . . . 0.0 110.731 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -133.84 170.96 14.83 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.373 1.069 . . . . 0.0 109.387 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -167.74 104.95 0.5 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 123.342 0.657 . . . . 0.0 110.665 176.029 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtm . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.0 p -63.74 96.03 0.12 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.371 0.669 . . . . 0.0 110.143 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.0 t -146.99 163.87 34.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.775 0.83 . . . . 0.0 109.994 -172.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.9 m -59.52 -41.84 90.9 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 124.013 0.821 . . . . 0.0 110.597 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -52.9 -51.23 61.95 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.715 0.806 . . . . 0.0 110.866 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -60.86 -44.9 96.41 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.163 0.914 . . . . 0.0 111.421 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -64.81 -40.58 95.45 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.329 0.651 . . . . 0.0 111.44 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.422 HG12 HD12 ' A' ' 47' ' ' ILE . 69.6 t -72.39 -36.57 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.193 0.597 . . . . 0.0 110.474 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.34 -35.47 80.98 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.721 0.808 . . . . 0.0 110.64 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.7 m -65.24 -48.07 74.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.818 0.847 . . . . 0.0 110.896 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.5 mt -58.0 -46.86 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.494 0.718 . . . . 0.0 110.776 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.435 HD13 HD13 ' A' ' 77' ' ' LEU . 55.4 mt -61.89 -48.93 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.673 0.789 . . . . 0.0 110.854 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.554 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.18 -44.46 64.68 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.212 1.005 . . . . 0.0 112.575 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -66.25 -43.74 85.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.143 0.977 . . . . 0.0 111.798 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.9 m -75.49 -50.95 14.15 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.727 0.411 . . . . 0.0 111.527 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.8 m -89.67 3.82 51.47 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.265 1.026 . . . . 0.0 111.886 -174.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.0 t70 50.54 75.0 0.19 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.256 1.422 . . . . 0.0 112.416 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.554 HG13 ' HA ' ' A' ' 13' ' ' ALA . 3.4 pt -148.21 157.5 42.53 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 124.629 1.172 . . . . 0.0 109.474 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.58 137.7 47.18 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.361 2.041 . . . . 0.0 110.993 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -57.63 -30.54 65.45 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.973 0.909 . . . . 0.0 112.5 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.86 -21.65 60.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.994 0.918 . . . . 0.0 111.26 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -80.66 -6.7 58.73 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 122.777 0.431 . . . . 0.0 111.146 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.408 ' CG2' ' HG ' ' A' ' 77' ' ' LEU . 3.8 mp -90.99 112.04 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 170.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.4 p -95.65 160.73 29.72 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 123.32 0.648 . . . . 0.0 110.425 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -60.16 -33.31 95.07 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.23 1.953 . . . . 0.0 112.877 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -94.49 11.24 31.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.945 0.898 . . . . 0.0 110.954 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.8 t -79.22 128.52 33.41 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 123.177 0.591 . . . . 0.0 110.324 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -83.18 118.9 23.92 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.97 -40.77 23.35 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.55 -45.39 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 O-C-N 122.187 -0.32 . . . . 0.0 110.211 -169.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -82.99 -32.8 26.8 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.818 0.847 . . . . 0.0 112.316 -173.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.91 -64.25 1.06 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.366 0.666 . . . . 0.0 109.965 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.43 HD12 HG21 ' A' ' 12' ' ' ILE . 82.8 mt -69.77 -11.19 60.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.155 0.582 . . . . 0.0 111.489 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.84 31.91 79.59 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.55 0.531 . . . . 0.0 113.153 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -82.97 122.95 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -61.36 146.1 49.31 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.746 0.419 . . . . 0.0 110.063 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.428 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 37.3 m -59.65 -34.68 73.12 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.506 0.722 . . . . 0.0 111.807 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.1 mt -73.7 -34.48 64.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.439 0.696 . . . . 0.0 110.032 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -73.89 -30.63 62.72 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.461 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -75.76 -23.67 55.99 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.661 0.384 . . . . 0.0 110.54 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 37' ' ' SER . 96.5 mt -63.76 -39.46 94.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.862 0.465 . . . . 0.0 109.84 169.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -65.97 -45.56 81.23 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.89 0.876 . . . . 0.0 110.619 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 63.4 mt -62.97 -40.21 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.622 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.94 -35.93 77.35 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.431 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -74.63 -25.17 59.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.609 0.764 . . . . 0.0 110.941 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.97 -41.15 68.06 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.996 0.518 . . . . 0.0 110.559 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.422 HD12 HG12 ' A' ' 8' ' ' VAL . 89.8 mt -65.55 -40.48 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.295 1.038 . . . . 0.0 110.061 173.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -55.27 -47.74 75.05 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.02 1.328 . . . . 0.0 109.714 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -67.84 -50.58 55.87 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.52 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.02 -51.77 68.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.963 0.905 . . . . 0.0 112.114 -172.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.17 -5.26 59.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.908 0.883 . . . . 0.0 111.456 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.3 30.81 75.85 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.193 0.308 . . . . 0.0 113.64 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.36 170.66 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.41 1.084 . . . . 0.0 109.869 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -104.97 111.03 23.66 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 168.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.524 HD22 HG12 ' A' ' 84' ' ' ILE . 42.6 mt -73.9 118.28 68.08 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -79.25 58.38 6.92 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.626 2.217 . . . . 0.0 109.706 170.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.58 -37.15 85.08 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.053 0.941 . . . . 0.0 109.118 -174.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.3 -45.58 90.74 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.383 0.673 . . . . 0.0 111.143 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -62.23 -40.71 97.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.866 0.866 . . . . 0.0 110.462 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.407 ' O ' HG22 ' A' ' 64' ' ' VAL . 54.1 m0 -63.66 -45.87 88.18 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.318 1.011 . . . . 0.0 109.87 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.5 m -62.06 -33.96 75.39 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.054 0.846 . . . . 0.0 110.932 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -72.2 -44.58 62.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.937 0.495 . . . . 0.0 110.513 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.26 -36.39 77.68 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.393 0.677 . . . . 0.0 110.816 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 60' ' ' TRP . 72.9 t -67.14 -49.94 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.829 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -59.23 -44.87 92.31 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.721 0.808 . . . . 0.0 112.063 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -86.35 6.67 28.92 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.981 0.912 . . . . 0.0 111.538 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.94 23.05 67.24 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -75.65 -30.53 59.47 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.372 0.669 . . . . 0.0 109.554 174.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.79 160.47 42.22 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.545 1.138 . . . . 0.0 109.371 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.4 p -83.85 162.83 20.43 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.117 0.567 . . . . 0.0 110.251 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 82.4 p -58.53 -55.43 35.19 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.53 0.681 . . . . 0.0 109.859 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.5 -33.86 64.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.299 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -55.57 -26.74 45.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 123.877 0.736 . . . . 0.0 112.529 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -119.6 -28.69 5.24 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.88 0.472 . . . . 0.0 112.156 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.59 16.95 25.06 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.99 0.516 . . . . 0.0 112.025 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.473 HG11 ' HG2' ' A' ' 78' ' ' LYS . 22.9 t -107.5 142.68 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 167.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 12' ' ' ILE . 4.5 mm? -56.99 -41.69 78.88 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.001 1.32 . . . . 0.0 114.509 -170.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HG2' HG11 ' A' ' 76' ' ' VAL . 61.9 pttt -65.65 -40.72 92.78 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.357 0.599 . . . . 0.0 110.312 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.34 -44.48 44.94 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.735 1.214 . . . . 0.0 110.499 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.69 -51.14 70.74 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.218 1.407 . . . . 0.0 109.977 176.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.85 -33.37 74.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.737 0.815 . . . . 0.0 111.658 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.67 -50.17 65.92 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.566 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -55.1 -46.65 75.53 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.594 1.158 . . . . 0.0 111.688 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.524 HG12 HD22 ' A' ' 55' ' ' LEU . 93.2 mt -60.26 -48.71 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.787 1.235 . . . . 0.0 110.464 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.15 -31.23 71.96 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.884 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.91 -41.86 95.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.116 0.566 . . . . 0.0 110.302 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.94 -27.93 65.16 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.429 0.692 . . . . 0.0 111.186 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.423 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 61.0 t -71.22 -36.36 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.623 0.769 . . . . 0.0 110.234 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.67 84.34 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.007 173.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.25 -40.07 82.07 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.721 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 13.5 ptmm? -73.31 -19.38 61.05 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 118.064 0.393 . . . . 0.0 111.334 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.41 -18.01 34.77 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.6 -42.03 0.15 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 117.423 0.611 . . . . 0.0 111.491 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.3 mt -92.09 -71.68 0.63 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.768 0.827 . . . . 0.0 112.31 -172.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 91' ' ' LYS . 72.2 mm-40 -62.73 101.71 0.28 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.595 0.712 . . . . 0.0 112.442 -172.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -128.26 35.51 4.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 167.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -105.99 111.83 24.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.068 1.347 . . . . 0.0 108.665 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -80.72 116.33 20.67 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.228 0.537 . . . . 0.0 110.85 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -94.38 -39.04 10.67 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.894 1.278 . . . . 0.0 108.55 165.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -75.71 162.99 27.74 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.09 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 . . . . . 0 C--O 1.25 1.086 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 170.139 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttp . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.2 m -149.97 95.58 2.32 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.876 0.87 . . . . 0.0 108.924 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.3 p -90.66 177.06 6.44 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 123.746 0.818 . . . . 0.0 110.447 172.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 8' ' ' VAL . 90.5 m -60.3 -46.4 89.98 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.356 168.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -55.15 -40.45 70.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.994 0.918 . . . . 0.0 111.799 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -56.61 -47.57 79.37 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.295 0.638 . . . . 0.0 110.537 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -66.77 -38.31 86.33 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.82 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 4' ' ' THR . 87.1 t -66.81 -44.16 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.309 0.644 . . . . 0.0 110.616 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.54 -44.91 85.52 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.442 1.097 . . . . 0.0 110.107 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.508 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 57.7 m -59.89 -48.34 82.11 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.559 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -57.83 -47.69 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.743 0.817 . . . . 0.0 111.828 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.474 HG23 HD12 ' A' ' 18' ' ' ILE . 41.0 mt -58.3 -44.27 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.812 0.845 . . . . 0.0 110.526 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 20' ' ' ARG . . . -57.87 -44.3 86.55 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.143 0.977 . . . . 0.0 112.569 174.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.1 mm-40 -63.1 -36.22 82.87 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.421 0.688 . . . . 0.0 111.632 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -78.72 -59.44 2.78 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.817 -173.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -101.1 18.13 20.6 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.466 0.706 . . . . 0.0 112.853 -166.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.2 t70 47.72 66.1 1.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.304 1.041 . . . . 0.0 111.9 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.474 HD12 HG23 ' A' ' 12' ' ' ILE . 3.5 pt -142.54 147.34 42.4 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 123.804 0.841 . . . . 0.0 109.739 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.02 116.17 4.57 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.656 2.237 . . . . 0.0 112.361 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.534 ' HA ' HD11 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -63.41 -17.29 62.5 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -176.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.53 -30.89 70.66 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.729 0.812 . . . . 0.0 110.525 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -85.25 -14.42 46.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.341 0.656 . . . . 0.0 110.781 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 20' ' ' ARG . 1.8 mp -78.01 108.41 11.3 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.8 p -91.27 157.46 42.57 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 123.573 0.749 . . . . 0.0 109.672 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.95 -17.92 56.4 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.237 1.958 . . . . 0.0 112.456 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -100.05 6.53 45.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.192 0.597 . . . . 0.0 110.489 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -78.85 138.72 38.29 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.37 0.668 . . . . 0.0 110.516 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.412 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 50.7 t-80 -86.28 114.04 22.77 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.535 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -51.05 -37.24 44.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.854 0.862 . . . . 0.0 113.212 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.412 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 63.7 mt -89.88 -54.06 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -174.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.76 -39.17 27.34 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.416 0.687 . . . . 0.0 112.544 -168.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -88.25 -55.11 3.88 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 29' ' ' ALA . 73.7 mt -75.09 -8.66 57.19 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.79 29.01 74.18 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.446 0.466 . . . . 0.0 113.82 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -88.04 124.98 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -75.87 160.51 29.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.125 0.57 . . . . 0.0 110.109 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.457 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 15.3 m -57.69 -34.08 69.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.998 0.919 . . . . 0.0 111.782 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.71 -37.61 76.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.86 0.464 . . . . 0.0 110.686 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -67.48 -42.35 83.12 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.54 0.736 . . . . 0.0 109.95 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -65.46 -28.59 69.33 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 124.392 1.057 . . . . 0.0 110.967 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 37' ' ' SER . 70.7 mt -61.79 -42.15 98.63 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.895 0.478 . . . . 0.0 110.749 174.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.46 -35.21 60.94 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.063 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.7 -47.75 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.781 0.676 . . . . 0.0 109.384 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.37 -30.08 63.06 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.098 0.959 . . . . 0.0 110.654 -174.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -62.59 -43.68 98.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.644 0.778 . . . . 0.0 110.89 171.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.4 -31.84 65.88 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.099 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.15 -45.41 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.468 0.707 . . . . 0.0 110.314 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -52.01 -49.29 63.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.877 1.271 . . . . 0.0 110.312 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -72.34 -49.62 32.92 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.014 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.06 98.78 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -89.77 -3.78 57.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.382 0.673 . . . . 0.0 112.378 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.4 45.45 96.38 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 123.779 0.674 . . . . 0.0 113.072 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.54 179.73 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.555 1.142 . . . . 0.0 110.186 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -122.35 113.2 19.07 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.419 HD21 ' HH2' ' A' ' 60' ' ' TRP . 83.4 mt -78.63 125.81 83.78 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 122.797 0.439 . . . . 0.0 110.41 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.19 54.95 5.41 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.205 2.603 . . . . 0.0 110.422 166.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.68 -39.94 86.19 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.91 1.284 . . . . 0.0 109.591 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -56.73 -41.81 78.16 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 124.259 0.974 . . . . 0.0 111.813 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -65.81 -43.48 88.52 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.156 0.582 . . . . 0.0 110.13 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.419 ' HH2' HD21 ' A' ' 55' ' ' LEU . 42.1 m0 -60.73 -50.14 74.66 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.627 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.1 m -60.89 -43.83 97.95 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.134 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -70.38 -40.32 74.03 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.765 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -60.43 -39.6 88.04 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.974 0.51 . . . . 0.0 111.446 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.06 -48.89 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.372 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -66.72 -28.71 68.65 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.133 0.973 . . . . 0.0 112.804 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -80.89 -3.4 51.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.181 0.592 . . . . 0.0 112.474 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.67 21.29 72.79 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 117.465 0.121 . . . . 0.0 113.333 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -79.46 -25.83 41.85 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.727 0.811 . . . . 0.0 110.239 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.71 171.15 19.3 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.27 1.028 . . . . 0.0 108.992 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.9 p -104.81 168.02 9.34 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 171.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.7 p -56.48 -41.78 77.16 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.314 0.384 . . . . 0.0 111.888 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.41 ' HA ' HG21 ' A' ' 76' ' ' VAL . 14.0 pt-20 -51.09 -40.84 59.34 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -175.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -57.45 -28.77 63.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.594 0.757 . . . . 0.0 112.773 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -114.5 -29.59 6.8 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.748 0.419 . . . . 0.0 112.092 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.08 24.67 12.62 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.556 0.742 . . . . 0.0 111.114 -166.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.495 HG12 ' HG2' ' A' ' 78' ' ' LYS . 43.7 t -104.64 141.25 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 160.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -54.52 -39.59 67.78 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.172 1.389 . . . . 0.0 114.584 -169.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.495 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.7 pttt -64.39 -42.19 96.25 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -75.38 -40.49 57.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.435 1.094 . . . . 0.0 110.155 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.3 tp -61.08 -53.36 58.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.436 1.094 . . . . 0.0 109.453 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.21 -27.36 68.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.618 0.767 . . . . 0.0 112.037 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.66 -48.59 63.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.008 0.523 . . . . 0.0 110.409 174.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -56.88 -46.07 82.09 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 124.443 1.089 . . . . 0.0 110.801 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.448 ' O ' HG21 ' A' ' 88' ' ' VAL . 84.1 mt -64.03 -52.82 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.203 1.001 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.5 -41.77 90.65 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.076 0.95 . . . . 0.0 112.456 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.19 -30.21 68.35 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.376 0.423 . . . . 0.0 110.339 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.92 -35.74 69.76 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.745 0.418 . . . . 0.0 111.666 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 84' ' ' ILE . 61.6 t -65.28 -41.32 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.473 0.654 . . . . 0.0 109.487 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.17 -37.52 81.08 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.85 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.47 97.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.458 0.703 . . . . 0.0 111.587 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -17.58 34.07 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.468 -174.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -25.82 16.9 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.16 -8.61 56.8 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.49 0.716 . . . . 0.0 111.872 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.54 172.55 7.76 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.682 1.593 . . . . 0.0 109.725 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.75 -89.14 0.1 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.51 1.124 . . . . 0.0 110.465 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 64.85 -78.32 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.622 1.569 . . . . 0.0 110.623 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -153.15 43.29 0.61 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -63.11 -77.28 0.05 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.967 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -163.87 113.16 1.23 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.096 0.958 . . . . 0.0 109.969 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -155.85 156.32 34.48 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.816 0.846 . . . . 0.0 109.6 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 24.4 p80 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.028 0.931 . . . . 0.0 109.706 176.83 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtt . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.4 m -83.36 62.14 6.56 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.805 0.812 . . . . 0.0 108.937 173.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 t -69.21 130.07 41.62 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.762 -177.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.6 m -56.62 -47.75 78.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.915 0.886 . . . . 0.0 109.968 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -54.88 -45.18 74.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.507 1.123 . . . . 0.0 111.447 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.54 -47.03 85.55 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.786 0.679 . . . . 0.0 110.573 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.1 mmt-85 -67.22 -37.85 84.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.056 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -73.36 -35.15 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.352 0.661 . . . . 0.0 110.511 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.69 91.9 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.554 0.742 . . . . 0.0 109.953 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 56.0 m -63.15 -46.26 88.05 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.013 0.821 . . . . 0.0 110.455 172.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.2 mt -57.8 -46.56 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.211 1.004 . . . . 0.0 111.154 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.541 HG23 HD13 ' A' ' 18' ' ' ILE . 50.6 mt -58.12 -49.81 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.039 0.936 . . . . 0.0 110.747 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.07 -44.4 71.11 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.989 0.916 . . . . 0.0 112.974 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 10' ' ' THR . 18.2 mm-40 -63.84 -32.14 73.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.916 0.886 . . . . 0.0 111.753 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.8 m -86.65 -34.3 19.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.408 0.683 . . . . 0.0 112.095 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.2 m -113.16 1.42 15.25 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.842 0.457 . . . . 0.0 112.167 -164.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 50.27 68.25 0.79 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.259 1.423 . . . . 0.0 112.246 -177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.541 HD13 HG23 ' A' ' 12' ' ' ILE . 11.6 pt -145.97 157.86 49.75 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 124.551 1.14 . . . . 0.0 109.269 -177.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.43 120.71 6.65 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.772 2.315 . . . . 0.0 110.768 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.403 ' HA ' HD11 ' A' ' 23' ' ' ILE . 1.2 ppt_? -64.66 -25.18 67.84 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -170.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -82.98 -11.97 57.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.605 0.762 . . . . 0.0 111.381 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -83.0 -18.38 40.03 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.459 0.303 . . . . 0.0 110.38 173.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.508 HD13 HD12 ' A' ' 18' ' ' ILE . 2.0 mp -74.76 117.06 18.31 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.1 p -91.54 158.84 39.97 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.133 0.973 . . . . 0.0 109.719 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.72 -21.56 56.72 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.414 2.076 . . . . 0.0 113.257 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -92.28 3.75 54.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.287 0.635 . . . . 0.0 111.161 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -71.99 123.15 22.15 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -84.0 119.47 24.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 169.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.63 -44.02 12.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.252 1.021 . . . . 0.0 112.722 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.19 -46.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 120.681 0.277 . . . . 0.0 110.322 -168.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.43 -35.79 24.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.338 0.655 . . . . 0.0 111.978 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -93.59 -55.45 3.27 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.313 0.645 . . . . 0.0 110.612 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.8 mt -82.21 -12.58 58.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.509 0.724 . . . . 0.0 112.218 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.86 34.21 86.47 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 113.897 0.319 . . . . 0.0 113.897 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.1 mt -88.09 125.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.976 0.91 . . . . 0.0 108.675 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -72.39 158.99 34.73 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.443 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 37.6 m -62.21 -26.64 68.47 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.07 0.548 . . . . 0.0 111.637 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.65 -33.76 60.46 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 122.904 0.482 . . . . 0.0 110.384 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.27 -39.18 75.11 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.172 0.589 . . . . 0.0 109.519 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -66.15 -23.65 66.51 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.503 0.721 . . . . 0.0 110.236 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 37' ' ' SER . 90.7 mt -62.61 -37.0 84.56 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.064 0.546 . . . . 0.0 110.714 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -69.99 -39.16 76.06 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.312 0.645 . . . . 0.0 110.2 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.47 HG12 HG12 ' A' ' 12' ' ' ILE . 2.4 mp -60.43 -47.32 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 123.617 0.573 . . . . 0.0 109.661 174.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.78 -37.7 82.4 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.724 0.809 . . . . 0.0 111.173 -174.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.76 -50.18 74.83 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.76 1.224 . . . . 0.0 111.068 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.83 -30.84 70.34 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.729 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.458 HD12 HD13 ' A' ' 84' ' ' ILE . 97.2 mt -65.77 -44.73 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.59 0.756 . . . . 0.0 110.646 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.53 -49.72 64.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.484 1.114 . . . . 0.0 110.803 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -76.52 -48.47 19.33 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.754 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.93 74.81 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.074 0.55 . . . . 0.0 112.375 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -86.74 -3.24 59.02 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.852 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.16 35.52 91.65 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.651 0.594 . . . . 0.0 113.003 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.9 pt -124.94 -177.13 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.712 1.205 . . . . 0.0 109.209 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -130.04 126.06 36.76 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 168.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.9 mt -80.81 128.18 72.52 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -73.02 59.33 3.6 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.933 2.422 . . . . 0.0 110.702 165.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.68 -39.66 89.25 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.368 1.067 . . . . 0.0 109.748 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.77 -44.96 82.31 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 124.005 0.815 . . . . 0.0 110.463 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.7 tppt? -68.8 -44.49 73.46 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 111.259 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -57.61 -52.39 65.6 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.039 0.837 . . . . 0.0 110.55 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.2 m -71.06 -24.78 62.4 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.481 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -69.27 -47.63 64.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.652 0.781 . . . . 0.0 110.725 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 21.2 mm-40 -60.17 -40.57 90.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.499 0.72 . . . . 0.0 110.735 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 53.4 t -59.78 -56.34 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.905 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -62.23 -33.49 74.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.647 0.779 . . . . 0.0 111.908 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -87.44 4.99 41.09 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.347 0.659 . . . . 0.0 111.754 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.45 25.87 70.35 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -91.67 -27.58 18.01 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.275 0.63 . . . . 0.0 110.731 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -139.18 152.06 47.09 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 m -81.57 156.47 25.19 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.007 0.523 . . . . 0.0 109.639 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.5 p -52.93 -46.58 68.16 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.853 0.861 . . . . 0.0 110.856 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.537 ' HA ' HG23 ' A' ' 76' ' ' VAL . 9.3 mm-40 -42.83 -52.75 4.93 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.152 1.381 . . . . 0.0 112.588 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -54.76 -21.25 10.47 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.271 -1.331 . . . . 0.0 114.021 -169.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -121.71 -29.79 4.28 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -108.03 15.04 24.68 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -168.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.537 HG23 ' HA ' ' A' ' 72' ' ' GLU . 71.6 t -103.22 139.56 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -53.35 -38.15 63.03 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.233 1.413 . . . . 0.0 114.023 -173.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HG2' HG11 ' A' ' 76' ' ' VAL . 22.9 pttp -70.33 -41.0 73.81 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 120.769 0.318 . . . . 0.0 111.097 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.44 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 80.1 m-20 -74.81 -34.67 62.42 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.926 0.89 . . . . 0.0 110.241 -177.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.97 -44.76 72.27 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.821 1.248 . . . . 0.0 108.871 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.51 -37.54 78.55 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.877 0.735 . . . . 0.0 111.098 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.73 71.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.672 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 9.6 mmp_? -50.54 -53.01 33.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.197 0.936 . . . . 0.0 111.419 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.458 HD13 HD12 ' A' ' 47' ' ' ILE . 71.2 mt -65.6 -43.9 93.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.625 -175.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.58 -39.64 88.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.623 0.769 . . . . 0.0 111.223 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.91 -35.05 77.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.524 0.73 . . . . 0.0 110.841 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.2 mt -73.67 -30.29 62.81 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.02 0.528 . . . . 0.0 111.352 176.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.504 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 69.5 t -71.02 -36.93 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.637 0.775 . . . . 0.0 109.455 172.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.76 -41.11 83.85 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.23 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.12 -42.63 93.75 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.154 0.981 . . . . 0.0 111.13 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.504 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 43.7 pttt -76.24 -18.4 59.03 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.23 -31.6 79.62 Favored Glycine 0 C--N 1.358 1.766 0 O-C-N 123.588 0.555 . . . . 0.0 112.231 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.26 65.58 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.09 0.556 . . . . 0.0 110.148 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.98 76.94 8.54 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.913 0.885 . . . . 0.0 110.016 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 90.34 2.61 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.922 177.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -63.05 133.42 54.49 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.363 172.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 75.1 t60 84.34 -35.63 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.27 1.828 . . . . 0.0 111.169 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 49.4 t60 72.44 -62.02 0.48 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.711 1.604 . . . . 0.0 113.358 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -54.79 103.99 0.1 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.893 1.277 . . . . 0.0 112.326 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.4 146.82 43.19 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.474 171.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 65.9 t60 . . . . . 0 C--O 1.254 1.328 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.36 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.5 p -137.91 30.62 2.51 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.305 0.642 . . . . 0.0 111.265 -173.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.9 p -74.16 -177.92 3.16 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.63 0.372 . . . . 0.0 110.596 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 8' ' ' VAL . 61.8 m -53.52 -48.58 68.89 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.452 0.701 . . . . 0.0 112.17 -173.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.23 -46.1 79.68 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.728 0.411 . . . . 0.0 111.602 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.483 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 28.6 m-20 -59.56 -44.87 93.14 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.743 0.652 . . . . 0.0 110.688 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -64.74 -45.9 84.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.169 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 4' ' ' THR . 79.8 t -65.36 -43.89 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.625 0.77 . . . . 0.0 110.458 -175.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.86 97.16 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.132 0.973 . . . . 0.0 111.008 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.2 m -63.83 -42.72 97.56 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.18 0.925 . . . . 0.0 111.258 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.414 HD11 ' HA ' ' A' ' 47' ' ' ILE . 96.7 mt -59.18 -51.01 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.578 0.751 . . . . 0.0 111.122 175.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.661 HG22 HD13 ' A' ' 18' ' ' ILE . 58.4 mt -59.8 -42.35 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.648 0.779 . . . . 0.0 110.534 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.485 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -56.39 -52.51 64.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.729 0.812 . . . . 0.0 112.713 173.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.47 -22.19 63.65 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.631 0.772 . . . . 0.0 112.327 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 m -85.06 -51.05 6.93 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.614 0.366 . . . . 0.0 111.11 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.577 ' SG ' HD13 ' A' ' 43' ' ' ILE . 74.7 m -100.29 7.59 44.29 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -168.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.8 t70 53.44 65.16 1.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.242 1.017 . . . . 0.0 111.871 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.661 HD13 HG22 ' A' ' 12' ' ' ILE . 10.1 pt -141.19 146.49 43.18 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.089 0.955 . . . . 0.0 109.418 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.28 114.33 2.62 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.716 2.277 . . . . 0.0 111.431 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.483 ' NH2' ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -53.61 -29.76 39.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.359 1.064 . . . . 0.0 113.175 -177.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.83 -27.53 62.96 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.191 0.597 . . . . 0.0 111.729 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -81.68 -5.56 58.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.825 0.45 . . . . 0.0 110.717 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.461 HD13 HD12 ' A' ' 18' ' ' ILE . 1.9 mp -86.36 113.49 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 174.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -95.16 165.9 15.95 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.843 0.857 . . . . 0.0 109.243 173.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.08 -18.47 61.94 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.291 1.994 . . . . 0.0 112.336 172.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -94.68 -0.21 54.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 122.948 0.499 . . . . 0.0 110.509 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.4 m -71.74 124.18 24.23 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.015 0.526 . . . . 0.0 110.383 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 49.9 t-80 -85.66 123.18 30.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.83 -45.96 15.28 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.142 0.977 . . . . 0.0 112.207 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 mt -92.59 -48.16 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.406 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.4 t70 -76.86 -37.32 55.78 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.664 0.785 . . . . 0.0 112.357 -171.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.71 -59.21 1.86 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.587 0.355 . . . . 0.0 110.563 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.1 mt -75.92 -16.31 60.05 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.023 0.529 . . . . 0.0 112.417 -171.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.82 37.96 56.79 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.124 0.265 . . . . 0.0 113.303 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.469 HG22 ' HB2' ' A' ' 39' ' ' ASP . 93.5 mt -96.7 116.5 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.287 1.035 . . . . 0.0 108.928 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.46 164.56 26.45 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.8 m -56.41 -31.95 64.37 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.74 0.816 . . . . 0.0 111.614 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.76 -32.77 65.88 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 122.952 0.501 . . . . 0.0 111.088 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.469 ' HB2' HG22 ' A' ' 35' ' ' ILE . 28.6 m-20 -71.43 -40.99 70.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.965 0.506 . . . . 0.0 109.755 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.54 -22.01 64.52 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.212 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.62 -50.94 68.83 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.327 0.584 . . . . 0.0 110.439 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.42 -34.77 70.62 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.086 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.577 HD13 ' SG ' ' A' ' 16' ' ' CYS . 62.3 mt -63.92 -42.7 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 123.578 0.549 . . . . 0.0 110.192 173.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.46 -36.25 76.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.599 0.76 . . . . 0.0 110.645 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.44 -42.51 98.68 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.023 0.929 . . . . 0.0 110.272 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -42.02 84.16 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.137 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.414 ' HA ' HD11 ' A' ' 11' ' ' ILE . 84.1 mt -64.82 -43.71 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.763 0.825 . . . . 0.0 110.824 175.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -50.17 -54.09 23.26 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.076 1.35 . . . . 0.0 110.961 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -38.99 53.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.843 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.97 -45.37 86.85 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -88.43 -10.61 48.61 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.706 0.802 . . . . 0.0 112.562 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.23 48.57 81.82 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.396 0.435 . . . . 0.0 112.24 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.8 pt -131.26 169.18 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.95 1.3 . . . . 0.0 109.315 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.613 ' HZ3' ' HB2' ' A' ' 54' ' ' LYS . 10.2 mtmp? -110.82 100.8 9.48 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.432 HD22 HD13 ' A' ' 87' ' ' LEU . 83.8 mt -67.94 123.07 86.26 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 122.695 0.398 . . . . 0.0 110.222 174.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.98 61.0 7.71 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.839 2.36 . . . . 0.0 110.124 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.08 -36.88 83.03 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.042 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -58.94 -42.3 89.44 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.553 0.741 . . . . 0.0 110.887 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.58 -52.12 66.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.652 0.781 . . . . 0.0 109.925 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -58.03 -43.77 86.97 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 124.474 1.108 . . . . 0.0 111.036 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -60.26 -47.74 84.7 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.904 0.882 . . . . 0.0 110.718 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -62.84 -40.26 96.9 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.272 0.629 . . . . 0.0 110.779 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.419 ' HG2' ' HD2' ' A' ' 68' ' ' LYS . 48.5 mt-10 -65.28 -41.65 93.96 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.189 0.931 . . . . 0.0 112.031 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.96 -47.4 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.436 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -57.31 -46.71 82.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.246 0.618 . . . . 0.0 111.669 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.08 0.02 50.04 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.239 0.616 . . . . 0.0 112.421 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.09 18.92 75.14 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.436 0.535 . . . . 0.0 114.436 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' HD2' ' HG2' ' A' ' 63' ' ' GLU . 62.3 mttm -69.76 -33.93 73.1 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 172.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.83 169.04 19.93 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.993 1.317 . . . . 0.0 108.397 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.5 p -116.12 163.45 15.93 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.08 0.952 . . . . 0.0 109.432 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p -55.71 -54.17 47.56 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 124.057 0.848 . . . . 0.0 112.746 -168.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -30.07 40.22 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -26.81 68.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.814 1.246 . . . . 0.0 111.797 -178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -115.39 -26.98 7.36 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.215 0.606 . . . . 0.0 111.938 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -108.22 17.98 21.62 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.186 0.595 . . . . 0.0 112.277 -165.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.498 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.0 t -105.71 139.73 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 165.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -52.68 -37.91 59.61 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.917 1.287 . . . . 0.0 114.308 -171.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.498 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.4 pttt -69.76 -45.19 68.63 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 123.163 0.29 . . . . 0.0 110.531 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -68.08 -41.43 81.93 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.165 0.586 . . . . 0.0 110.616 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.09 -50.21 69.21 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.89 1.276 . . . . 0.0 109.536 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.94 71.86 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 123.615 0.572 . . . . 0.0 111.158 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -66.65 -50.6 62.42 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.853 0.461 . . . . 0.0 110.26 175.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.429 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 3.7 mmp_? -53.35 -50.19 65.56 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.861 0.864 . . . . 0.0 111.211 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' ' 88' ' ' VAL . 87.7 mt -64.16 -45.65 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.948 1.299 . . . . 0.0 110.395 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.66 -36.43 78.68 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.155 0.982 . . . . 0.0 111.394 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 29.9 mm-40 -64.94 -43.76 91.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.581 0.752 . . . . 0.0 110.839 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.432 HD13 HD22 ' A' ' 55' ' ' LEU . 67.1 mt -70.89 -27.64 63.95 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.16 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 84' ' ' ILE . 78.7 t -67.83 -37.09 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.504 0.722 . . . . 0.0 110.114 172.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.3 75.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.068 0.547 . . . . 0.0 110.569 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.48 87.28 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.398 0.679 . . . . 0.0 111.275 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.47 -24.98 36.42 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.1 -23.55 77.98 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.335 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.34 -76.95 0.28 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 164.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.4 mt -173.31 123.36 0.39 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.931 1.692 . . . . 0.0 108.089 173.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -121.25 -60.02 1.67 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.889 0.875 . . . . 0.0 108.922 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -145.89 46.46 1.26 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.3 t60 75.73 -43.87 0.5 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.486 1.514 . . . . 0.0 113.581 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -71.7 103.63 3.12 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.417 0.687 . . . . 0.0 111.399 -172.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -86.75 -176.95 5.99 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.874 170.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -109.83 83.45 1.76 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t60 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 124.407 1.083 . . . . 0.0 108.936 179.25 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.4 m 61.77 84.21 0.14 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.448 1.099 . . . . 0.0 110.283 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 p -77.18 178.0 7.41 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.711 0.804 . . . . 0.0 111.176 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.4 m -64.94 -40.14 94.58 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -55.93 -48.85 74.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.314 0.646 . . . . 0.0 110.881 173.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.16 -50.11 59.58 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.022 0.826 . . . . 0.0 110.158 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 11' ' ' ILE . 6.1 mmp_? -70.34 -41.4 73.24 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.889 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.3 t -67.99 -40.98 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.162 0.585 . . . . 0.0 110.408 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.02 -37.97 89.38 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.086 0.954 . . . . 0.0 109.98 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.477 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 90.4 m -63.27 -44.21 95.74 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.52 174.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 7' ' ' ARG . 95.7 mt -58.81 -47.35 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.23 0.612 . . . . 0.0 111.359 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.504 HG23 HD13 ' A' ' 18' ' ' ILE . 58.8 mt -57.44 -43.81 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.992 0.517 . . . . 0.0 110.102 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.493 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -57.76 -49.46 76.51 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.729 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 10' ' ' THR . 46.4 mm-40 -66.64 -33.46 75.71 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.297 0.639 . . . . 0.0 111.806 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.5 m -74.03 -50.72 18.49 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.502 0.721 . . . . 0.0 110.933 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.406 ' SG ' HD13 ' A' ' 43' ' ' ILE . 39.8 m -97.37 3.95 50.88 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.812 0.845 . . . . 0.0 113.211 -169.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 45.67 77.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.418 1.087 . . . . 0.0 112.006 -171.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.504 HD13 HG23 ' A' ' 12' ' ' ILE . 7.3 pt -147.74 147.59 27.81 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.021 0.929 . . . . 0.0 109.967 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.14 122.11 10.21 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.911 2.408 . . . . 0.0 111.561 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HG3' ' HA ' ' A' ' 10' ' ' THR . 2.5 tmm_? -64.46 -19.92 65.86 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.538 1.135 . . . . 0.0 112.453 -173.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.55 -22.41 60.09 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.842 0.857 . . . . 0.0 110.557 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.8 p -86.51 -10.68 53.58 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.158 0.583 . . . . 0.0 110.902 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.405 HD13 HD12 ' A' ' 18' ' ' ILE . 2.3 mp -91.76 93.48 4.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.1 p -82.7 164.12 48.44 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 124.107 0.963 . . . . 0.0 109.989 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.85 -21.13 72.87 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.162 1.908 . . . . 0.0 113.172 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -106.85 17.5 23.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.89 0.476 . . . . 0.0 110.409 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.9 m -72.33 120.3 17.74 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.112 0.565 . . . . 0.0 109.65 170.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -84.0 121.97 28.13 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 170.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -40.28 -50.71 2.77 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.886 1.274 . . . . 0.0 113.041 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.0 mt -92.85 -47.43 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 121.109 0.48 . . . . 0.0 110.188 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.51 -38.13 55.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.235 1.014 . . . . 0.0 112.221 -172.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.24 -65.2 0.98 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.359 0.664 . . . . 0.0 110.421 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.37 -12.71 61.57 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.76 0.824 . . . . 0.0 112.633 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.39 24.41 76.76 Favored Glycine 0 C--N 1.354 1.563 0 O-C-N 123.466 0.479 . . . . 0.0 114.235 174.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.9 mt -78.87 124.89 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.441 1.097 . . . . 0.0 109.371 -175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.14 156.23 39.04 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.231 0.612 . . . . 0.0 110.987 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.8 m -63.55 -41.07 98.45 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.826 0.85 . . . . 0.0 111.863 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 pp -71.62 -28.86 64.08 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.927 0.394 . . . . 0.0 110.043 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.71 -36.9 59.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.185 0.994 . . . . 0.0 110.118 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -70.9 -23.32 62.25 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.482 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.64 -41.31 94.68 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.152 0.581 . . . . 0.0 111.091 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.66 -42.82 90.91 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.403 0.681 . . . . 0.0 110.305 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.406 HD13 ' SG ' ' A' ' 16' ' ' CYS . 59.6 mt -62.89 -45.03 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.755 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.81 -33.82 68.85 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.293 0.637 . . . . 0.0 110.532 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -59.9 -39.79 86.57 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.321 1.048 . . . . 0.0 110.435 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.46 -38.03 71.32 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.537 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 97.6 mt -66.69 -41.71 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.657 0.783 . . . . 0.0 110.383 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -52.11 -47.66 65.19 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.792 1.237 . . . . 0.0 110.694 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.29 -56.05 22.25 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.121 0.888 . . . . 0.0 110.846 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.71 -51.8 68.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.047 0.939 . . . . 0.0 112.302 -171.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -87.49 -14.54 40.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.286 0.634 . . . . 0.0 111.561 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.69 30.43 74.67 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 117.716 0.234 . . . . 0.0 113.329 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.405 HD13 HG22 ' A' ' 84' ' ' ILE . 32.7 pt -109.55 151.14 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.863 0.865 . . . . 0.0 110.967 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -93.34 95.67 9.47 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.442 HD21 HG12 ' A' ' 84' ' ' ILE . 83.8 mt -73.03 119.34 75.08 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.916 173.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -85.7 58.33 4.6 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.618 2.212 . . . . 0.0 109.152 165.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.71 -38.96 89.79 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.819 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -35.89 79.25 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.928 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.561 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.17 -51.13 41.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.221 0.608 . . . . 0.0 109.876 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.413 ' O ' HG21 ' A' ' 64' ' ' VAL . 51.4 m0 -55.57 -48.41 74.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.158 0.983 . . . . 0.0 111.349 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.7 m -62.82 -37.45 86.82 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.574 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -66.7 -43.15 85.17 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.253 0.621 . . . . 0.0 110.637 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 4.9 mm-40 -66.66 -33.88 76.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.589 0.756 . . . . 0.0 110.719 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 60' ' ' TRP . 54.4 t -61.38 -52.73 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.142 172.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -65.51 -27.04 68.19 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.098 0.559 . . . . 0.0 111.599 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.84 1.79 56.66 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.15 0.58 . . . . 0.0 111.702 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.93 12.93 71.89 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.8 mttp -72.6 -26.69 61.78 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 117.722 0.761 . . . . 0.0 110.119 172.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 168.03 22.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.32 1.048 . . . . 0.0 109.684 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.446 ' H ' ' NE2' ' A' ' 73' ' ' GLN . 51.5 p -100.28 163.53 12.35 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 124.266 1.027 . . . . 0.0 108.858 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.407 HG21 HG11 ' A' ' 64' ' ' VAL . 72.1 p -57.33 -43.28 83.22 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.626 0.579 . . . . 0.0 110.356 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HA ' HG21 ' A' ' 76' ' ' VAL . 22.2 mm-40 -41.4 -53.61 3.29 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.369 1.467 . . . . 0.0 112.786 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.446 ' NE2' ' H ' ' A' ' 70' ' ' THR . 50.2 mt-30 -60.75 -21.36 62.92 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.318 -1.31 . . . . 0.0 114.106 -171.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -128.81 -4.38 5.18 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.89 20.09 7.74 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.994 0.518 . . . . 0.0 111.217 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 72' ' ' GLU . 95.8 t -108.99 144.36 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 164.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.86 -35.98 71.71 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -67.67 -40.18 84.49 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 120.889 0.376 . . . . 0.0 110.096 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.1 m120 -73.5 -47.31 42.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.087 0.955 . . . . 0.0 110.316 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.03 -47.88 84.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.954 1.302 . . . . 0.0 109.897 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.07 -36.38 81.49 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.556 0.743 . . . . 0.0 111.841 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.68 81.38 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.06 0.544 . . . . 0.0 110.654 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 24.7 mmm180 -59.39 -48.48 81.49 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.772 0.829 . . . . 0.0 110.637 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 88' ' ' VAL . 97.0 mt -63.87 -43.1 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.699 1.2 . . . . 0.0 110.863 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.06 -39.06 93.6 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.567 0.747 . . . . 0.0 111.045 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -63.58 -40.88 98.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.547 0.739 . . . . 0.0 110.711 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 75.2 mt -70.57 -34.32 72.08 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.963 0.505 . . . . 0.0 112.019 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 84' ' ' ILE . 91.9 t -64.56 -42.64 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-O 121.454 0.645 . . . . 0.0 109.512 174.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.74 -37.63 79.56 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.176 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.36 -44.63 87.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.105 0.962 . . . . 0.0 111.413 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -79.42 -17.72 53.74 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.287 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.43 -26.54 35.72 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 175.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.98 9.11 20.53 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.572 1.149 . . . . 0.0 111.932 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.85 169.29 5.3 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.027 0.531 . . . . 0.0 109.763 169.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.95 146.56 52.74 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -83.15 16.08 2.57 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.02 0.928 . . . . 0.0 112.048 -166.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 65.1 m80 58.42 54.59 5.48 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 124.476 1.11 . . . . 0.0 110.513 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -56.15 -34.24 65.95 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.022 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -163.89 104.48 0.91 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -154.91 86.76 1.12 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.557 1.143 . . . . 0.0 108.298 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.8 t60 . . . . . 0 C--O 1.249 1.047 0 C-N-CA 124.24 1.016 . . . . 0.0 108.415 -177.299 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.746 0.308 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 t -140.58 -164.83 1.81 Allowed 'General case' 0 C--O 1.25 1.107 0 C-N-CA 123.771 0.828 . . . . 0.0 109.364 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -58.49 127.56 32.76 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 122.898 0.479 . . . . 0.0 110.335 171.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.3 m -58.1 -34.71 70.48 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.781 0.832 . . . . 0.0 111.097 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -57.56 -48.8 78.33 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 123.007 0.523 . . . . 0.0 111.166 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.81 -44.5 70.25 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.386 0.674 . . . . 0.0 110.862 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -60.2 -54.05 50.47 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.479 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.6 t -67.55 -38.98 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.419 0.688 . . . . 0.0 111.245 -172.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.64 92.13 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.673 1.189 . . . . 0.0 110.339 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 85.9 m -66.63 -40.46 88.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.554 176.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.49 -49.81 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.15 0.432 . . . . 0.0 111.383 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.552 HG12 HG23 ' A' ' 43' ' ' ILE . 51.8 mt -58.79 -41.03 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 122.789 0.435 . . . . 0.0 110.166 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.519 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.74 -60.27 3.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.803 0.841 . . . . 0.0 112.542 173.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 10' ' ' THR . 17.3 mm-40 -65.43 -34.6 78.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.196 0.598 . . . . 0.0 112.146 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.4 m -72.87 -58.6 3.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.189 0.595 . . . . 0.0 110.331 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.7 t -84.99 3.5 38.21 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.06 65.91 1.37 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.405 1.082 . . . . 0.0 111.577 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.519 HG13 ' HA ' ' A' ' 13' ' ' ALA . 10.4 pt -145.3 159.33 49.2 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.801 1.24 . . . . 0.0 109.023 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -75.09 133.77 16.85 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.767 2.312 . . . . 0.0 111.802 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -18.9 65.63 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -81.87 -19.79 40.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.485 0.714 . . . . 0.0 109.873 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 p -79.88 -7.75 58.91 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 122.568 0.347 . . . . 0.0 110.851 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.1 114.06 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.1 p -100.25 160.58 26.67 Favored Pre-proline 0 N--CA 1.488 1.437 0 C-N-CA 123.302 0.641 . . . . 0.0 110.471 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.05 -25.83 58.57 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 122.718 2.278 . . . . 0.0 112.671 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -91.77 1.97 56.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.671 0.788 . . . . 0.0 111.114 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 t -83.01 137.83 33.98 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.302 0.641 . . . . 0.0 111.345 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.503 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 54.7 t-80 -82.8 111.86 19.1 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 165.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.38 -20.25 28.28 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.503 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 84.6 mt -99.57 -41.25 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.599 0.76 . . . . 0.0 110.586 -177.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 32.4 t70 -79.98 -52.0 8.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.416 0.686 . . . . 0.0 112.227 -173.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -74.94 -48.95 21.84 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.365 0.602 . . . . 0.0 111.164 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.5 mt -73.23 -12.78 60.98 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.49 -176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.17 35.57 88.75 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 121.296 0.387 . . . . 0.0 112.662 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.5 mt -99.84 126.08 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -61.34 153.35 26.91 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 118.144 0.429 . . . . 0.0 110.73 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.421 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.4 m -63.61 -29.09 70.38 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.008 0.523 . . . . 0.0 109.988 176.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.57 -39.26 62.36 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.718 0.807 . . . . 0.0 109.96 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.18 -26.65 61.26 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.549 0.74 . . . . 0.0 110.11 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -74.34 -27.67 60.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.722 0.809 . . . . 0.0 110.504 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 37' ' ' SER . 89.8 mt -56.43 -33.44 65.84 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 122.632 0.373 . . . . 0.0 110.869 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.92 -41.61 64.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.666 0.786 . . . . 0.0 110.631 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.552 HG23 HG12 ' A' ' 12' ' ' ILE . 47.9 mt -62.81 -41.06 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.062 0.458 . . . . 0.0 110.175 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.14 -29.95 63.25 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.29 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -59.01 -42.23 89.63 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.969 0.908 . . . . 0.0 109.892 170.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.6 -42.43 74.41 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.338 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.46 -42.84 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.762 0.825 . . . . 0.0 110.597 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.59 -48.22 69.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.892 1.277 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -72.52 -42.77 64.42 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.2 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.44 77.02 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.834 0.854 . . . . 0.0 112.463 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -87.11 -7.94 57.52 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 111.449 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.65 32.82 85.48 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.328 0.392 . . . . 0.0 113.194 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 pt -112.61 169.59 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.198 0.999 . . . . 0.0 110.761 -173.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -104.83 101.71 11.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.488 HD21 HG12 ' A' ' 84' ' ' ILE . 95.7 mt -72.43 114.49 30.28 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 167.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.527 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 87.7 Cg_endo -81.94 63.86 8.4 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.037 1.824 . . . . 0.0 109.833 168.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.5 -38.16 88.81 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.035 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.23 -42.67 99.26 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.898 0.479 . . . . 0.0 111.027 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.527 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 54.3 tptt -58.75 -47.3 85.13 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.366 1.066 . . . . 0.0 110.79 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.4 ' O ' HG23 ' A' ' 64' ' ' VAL . 53.4 m0 -63.48 -46.03 88.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.554 0.742 . . . . 0.0 110.867 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.5 m -64.85 -32.94 74.87 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.367 1.067 . . . . 0.0 110.965 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.21 -42.32 62.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.438 0.695 . . . . 0.0 109.734 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.32 -35.41 75.57 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.654 0.781 . . . . 0.0 111.046 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 60' ' ' TRP . 85.0 t -64.97 -46.16 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 173.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.31 -40.27 96.87 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.137 0.975 . . . . 0.0 112.825 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.04 -1.67 58.05 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.42 0.688 . . . . 0.0 112.646 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.67 30.52 77.89 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 11.3 mmpt? -77.18 -33.21 56.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.951 0.901 . . . . 0.0 109.444 171.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.64 168.45 20.13 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.673 1.189 . . . . 0.0 108.747 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.5 p -108.9 162.11 14.5 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.61 0.764 . . . . 0.0 111.149 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.0 p -58.07 -64.47 0.9 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.74 0.816 . . . . 0.0 111.797 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -30.49 62.0 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -55.74 -24.84 37.43 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.545 1.138 . . . . 0.0 112.861 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -111.36 -44.0 3.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.313 0.645 . . . . 0.0 111.095 173.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -97.94 21.76 10.21 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.994 0.518 . . . . 0.0 112.306 -163.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.562 HG11 ' HG2' ' A' ' 78' ' ' LYS . 25.5 t -106.01 140.63 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 165.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.37 -39.49 70.16 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -167.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.562 ' HG2' HG11 ' A' ' 76' ' ' VAL . 60.9 pttt -61.34 -43.12 99.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.608 0.718 . . . . 0.0 110.191 176.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.477 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 83.9 m-20 -75.96 -44.97 37.32 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.888 1.275 . . . . 0.0 109.967 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.74 -53.46 57.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.187 1.395 . . . . 0.0 109.836 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.27 70.69 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.453 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.09 76.57 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.978 0.511 . . . . 0.0 111.678 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 3.6 mmp_? -59.81 -49.59 77.12 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.723 0.773 . . . . 0.0 109.806 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.488 HG12 HD21 ' A' ' 55' ' ' LEU . 88.6 mt -58.89 -45.64 91.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.587 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -64.64 -37.23 86.85 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.964 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -66.68 -32.87 74.47 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.803 0.441 . . . . 0.0 110.818 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.16 -30.92 60.87 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.278 0.631 . . . . 0.0 111.702 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.2 t -69.28 -35.57 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.385 0.674 . . . . 0.0 110.119 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.35 -37.92 77.89 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.484 173.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.69 -39.01 93.26 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.865 0.866 . . . . 0.0 111.933 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -81.71 -25.03 35.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.475 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.97 -38.95 55.54 Favored Glycine 0 C--N 1.354 1.576 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.48 109.81 14.2 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.0 tp 60.79 -84.08 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.407 1.083 . . . . 0.0 110.596 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 175.69 -53.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.624 1.569 . . . . 0.0 107.012 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.9 m80 73.57 155.7 0.17 Allowed 'General case' 0 C--N 1.358 0.961 0 C-N-CA 125.568 1.547 . . . . 0.0 112.507 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -71.33 118.81 14.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.515 172.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -86.71 61.9 7.08 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.603 0.716 . . . . 0.0 111.296 -170.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -176.96 151.73 0.87 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 125.317 1.447 . . . . 0.0 108.815 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -128.37 72.33 1.43 Allowed 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 171.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.6 t60 . . . . . 0 CA--C 1.55 0.949 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.955 179.669 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.452 ' N ' ' SD ' ' A' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.4 p -138.56 1.82 2.17 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.856 0.862 . . . . 0.0 111.521 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m -66.91 175.16 2.6 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.949 0.5 . . . . 0.0 112.151 -174.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 8' ' ' VAL . 28.0 m -51.71 -48.7 63.46 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.504 0.722 . . . . 0.0 111.102 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -53.69 -49.04 68.87 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 0.0 111.486 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.36 -42.29 98.46 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.636 0.774 . . . . 0.0 110.795 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -64.24 -42.11 96.68 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.25 0.969 . . . . 0.0 111.22 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 4' ' ' THR . 89.0 t -69.93 -38.26 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.732 0.813 . . . . 0.0 110.685 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.91 81.08 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.229 1.011 . . . . 0.0 110.133 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.4 m -63.89 -44.42 93.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.614 0.766 . . . . 0.0 110.615 171.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.462 HD12 ' HA ' ' A' ' 47' ' ' ILE . 95.3 mt -57.39 -50.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.754 0.822 . . . . 0.0 111.269 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.618 HG21 HD13 ' A' ' 18' ' ' ILE . 51.8 mt -60.09 -48.05 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.32 0.648 . . . . 0.0 110.405 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.73 -49.96 64.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.161 0.985 . . . . 0.0 112.675 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -68.19 -42.31 80.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.437 0.695 . . . . 0.0 112.19 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.9 m -68.02 -48.33 66.0 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.646 0.378 . . . . 0.0 110.585 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.601 ' SG ' HD11 ' A' ' 43' ' ' ILE . 34.2 m -91.88 -2.52 56.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.88 0.872 . . . . 0.0 113.157 -171.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.2 t70 52.83 69.64 0.67 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.998 0.919 . . . . 0.0 111.56 -171.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.618 HD13 HG21 ' A' ' 12' ' ' ILE . 9.6 pt -143.53 156.86 59.98 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.782 1.233 . . . . 0.0 108.748 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.95 137.96 39.22 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.58 2.187 . . . . 0.0 111.546 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -62.65 -28.47 69.94 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.722 0.809 . . . . 0.0 111.349 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.85 -21.58 57.1 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.0 0.52 . . . . 0.0 111.071 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.2 p -83.97 1.65 42.62 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.547 0.339 . . . . 0.0 111.101 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.75 111.5 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 168.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.4 p -101.46 161.57 23.18 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.663 0.785 . . . . 0.0 109.869 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.66 -27.2 75.87 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.007 1.805 . . . . 0.0 112.347 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -96.27 2.66 53.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.98 0.512 . . . . 0.0 110.846 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.3 p -74.22 129.33 37.61 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -83.97 115.63 22.41 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -44.61 -39.46 5.02 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.812 1.245 . . . . 0.0 113.96 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.9 mt -95.31 -56.73 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 122.731 0.413 . . . . 0.0 110.486 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -80.01 -23.45 41.49 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.798 0.839 . . . . 0.0 112.965 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -108.25 -61.01 1.65 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.967 0.507 . . . . 0.0 110.915 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.52 -20.01 62.1 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.614 0.765 . . . . 0.0 111.902 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.91 36.42 92.08 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.656 0.598 . . . . 0.0 114.509 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 43' ' ' ILE . 61.1 mt -84.22 123.67 39.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 123.569 0.747 . . . . 0.0 109.038 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.08 149.24 33.07 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.303 0.641 . . . . 0.0 110.323 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.401 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 23.9 m -60.46 -38.66 84.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.203 0.601 . . . . 0.0 110.533 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.29 -29.94 65.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.182 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.28 -36.18 46.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.456 0.703 . . . . 0.0 109.893 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -71.08 -21.99 62.16 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.388 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 37' ' ' SER . 96.3 mt -60.56 -37.87 82.68 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.796 0.438 . . . . 0.0 110.92 170.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -72.9 -40.46 65.53 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.142 0.577 . . . . 0.0 110.391 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.601 HD11 ' SG ' ' A' ' 16' ' ' CYS . 46.4 mt -61.25 -46.31 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 123.694 0.622 . . . . 0.0 110.408 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' HA ' HD11 ' A' ' 47' ' ' ILE . . . -70.78 -35.27 72.5 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.126 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -65.09 -38.44 90.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.52 0.728 . . . . 0.0 110.813 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.92 -28.11 64.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.365 0.666 . . . . 0.0 111.037 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.488 HG22 HD13 ' A' ' 53' ' ' ILE . 96.9 mt -68.96 -41.42 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.965 0.906 . . . . 0.0 109.602 171.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.2 -39.53 93.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.673 0.789 . . . . 0.0 111.109 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -67.83 -52.19 39.71 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.677 0.791 . . . . 0.0 111.112 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.82 -48.02 75.91 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.255 0.622 . . . . 0.0 112.591 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -90.11 -11.16 42.08 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.548 0.739 . . . . 0.0 112.386 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.2 74.46 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 123.361 0.413 . . . . 0.0 113.08 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.488 HD13 HG22 ' A' ' 47' ' ' ILE . 45.5 pt -108.22 -175.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.157 0.983 . . . . 0.0 110.015 -174.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -138.53 107.9 6.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 167.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.532 HD22 HG12 ' A' ' 84' ' ' ILE . 93.8 mt -69.72 130.4 90.35 Favored Pre-proline 0 C--O 1.243 0.738 0 C-N-CA 123.076 0.55 . . . . 0.0 109.733 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -72.43 59.71 3.25 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 123.344 2.696 . . . . 0.0 110.493 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.71 -45.44 78.74 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.785 0.834 . . . . 0.0 109.866 -171.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -39.57 92.21 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 123.856 0.722 . . . . 0.0 110.926 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.59 -45.33 92.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.227 1.011 . . . . 0.0 110.59 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.406 ' O ' HG21 ' A' ' 64' ' ' VAL . 52.6 m0 -65.74 -45.29 83.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.605 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.5 m -64.43 -31.52 72.76 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.862 0.865 . . . . 0.0 110.221 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.72 -44.57 70.04 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.39 -42.7 96.44 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.753 0.821 . . . . 0.0 111.305 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 60' ' ' TRP . 78.2 t -62.59 -53.82 42.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.342 0.657 . . . . 0.0 110.741 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -66.28 -22.56 66.3 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.836 0.854 . . . . 0.0 112.768 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -98.99 4.72 47.31 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.452 0.701 . . . . 0.0 112.045 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 15.3 65.69 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 115.181 0.833 . . . . 0.0 115.181 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.482 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -78.61 -23.81 45.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.456 0.703 . . . . 0.0 110.588 174.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -146.53 163.14 36.69 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.865 0.866 . . . . 0.0 109.253 173.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.0 p -91.65 165.12 13.48 Favored 'General case' 0 C--O 1.247 0.955 0 C-N-CA 123.404 0.682 . . . . 0.0 110.131 172.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.4 p -57.86 -55.02 40.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.99 0.806 . . . . 0.0 109.896 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -52.77 -35.6 56.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.872 1.269 . . . . 0.0 113.831 -175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -55.01 -33.74 62.86 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.878 0.871 . . . . 0.0 112.844 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -117.52 -24.4 7.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.921 0.488 . . . . 0.0 112.085 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.73 26.68 10.38 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.459 0.704 . . . . 0.0 110.494 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.483 HG13 ' HG2' ' A' ' 78' ' ' LYS . 52.3 t -109.76 143.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 158.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.4 -37.6 81.32 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.483 ' HG2' HG13 ' A' ' 76' ' ' VAL . 22.2 pttp -68.87 -41.88 77.77 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 120.891 0.377 . . . . 0.0 110.286 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.5 m120 -68.2 -47.82 66.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.808 0.843 . . . . 0.0 110.191 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -57.76 -49.18 77.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.14 1.376 . . . . 0.0 110.51 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.51 -34.19 73.73 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.707 0.803 . . . . 0.0 111.975 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.86 87.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.836 0.454 . . . . 0.0 110.931 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 9.1 mmm180 -66.21 -41.33 90.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.52 0.728 . . . . 0.0 111.479 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.532 HG12 HD22 ' A' ' 55' ' ' LEU . 96.4 mt -63.19 -50.08 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.242 1.017 . . . . 0.0 110.517 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -60.6 -44.25 96.5 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.946 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.46 -31.49 70.82 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.753 0.421 . . . . 0.0 110.765 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.425 HD11 HD23 ' A' ' 55' ' ' LEU . 54.7 mt -67.32 -39.88 85.89 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.869 0.467 . . . . 0.0 111.568 173.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.442 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 60.5 t -63.54 -44.1 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.47 94.77 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.567 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.27 -39.11 55.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.517 0.727 . . . . 0.0 112.824 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.442 ' HE3' ' HA ' ' A' ' 88' ' ' VAL . 20.7 pttp -72.47 -33.48 67.03 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.585 0.354 . . . . 0.0 110.541 -176.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.68 -26.37 15.33 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.053 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 57.75 -165.74 0.16 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 124.494 1.117 . . . . 0.0 110.682 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.9 119.48 23.99 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -27.85 64.78 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.239 0.616 . . . . 0.0 111.24 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -133.38 133.45 42.45 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 166.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -75.91 76.16 2.82 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.359 0.6 . . . . 0.0 110.839 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -141.89 -178.03 5.49 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.422 1.489 . . . . 0.0 108.271 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -76.96 -15.06 59.77 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 122.108 -0.37 . . . . 0.0 111.763 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 67.07 14.11 9.7 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.021 1.328 . . . . 0.0 111.132 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 C--O 1.249 1.059 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -177.932 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.8 p -82.17 132.5 35.24 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 m -67.1 126.87 30.54 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.467 ' O ' HG22 ' A' ' 8' ' ' VAL . 23.4 m -58.13 -41.2 83.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.734 0.814 . . . . 0.0 111.042 -176.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -54.87 -47.82 73.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.475 0.71 . . . . 0.0 111.763 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.07 -43.58 98.68 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.658 0.599 . . . . 0.0 110.951 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -61.73 -44.08 97.62 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.361 0.665 . . . . 0.0 111.823 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 4' ' ' THR . 89.1 t -69.71 -41.32 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.879 0.872 . . . . 0.0 110.46 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.03 93.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.71 0.804 . . . . 0.0 110.85 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.5 m -64.51 -44.75 89.92 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 124.0 0.813 . . . . 0.0 111.227 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 47' ' ' ILE . 96.8 mt -57.26 -51.23 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.001 0.52 . . . . 0.0 110.908 176.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.578 HG12 HG21 ' A' ' 43' ' ' ILE . 32.1 mt -56.67 -48.02 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.986 0.914 . . . . 0.0 110.511 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.455 ' HB1' ' HB3' ' A' ' 20' ' ' ARG . . . -52.66 -59.39 4.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.467 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.48 -24.22 56.89 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.426 -171.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.7 m -82.79 -44.25 15.75 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 117.864 0.302 . . . . 0.0 110.734 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.514 ' HB2' HD11 ' A' ' 43' ' ' ILE . 49.5 t -96.46 -3.71 42.92 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.655 0.782 . . . . 0.0 112.977 -172.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t70 59.65 65.68 1.11 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.455 1.102 . . . . 0.0 111.57 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.1 pt -146.47 150.48 40.7 Favored Pre-proline 0 N--CA 1.486 1.352 0 C-N-CA 124.555 1.142 . . . . 0.0 108.861 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.95 128.69 19.2 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.41 2.073 . . . . 0.0 111.929 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.455 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -65.29 -18.25 65.16 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.883 0.473 . . . . 0.0 111.77 178.081 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -79.65 -22.17 43.9 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.512 0.725 . . . . 0.0 109.95 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.0 p -87.21 5.23 39.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.705 0.402 . . . . 0.0 110.75 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.594 HG21 ' HG ' ' A' ' 77' ' ' LEU . 1.8 mp -95.01 130.98 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 166.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.418 ' HG1' ' HB2' ' A' ' 27' ' ' SER . 63.0 p -124.15 159.75 55.43 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 123.802 0.841 . . . . 0.0 110.165 -178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.87 -44.87 44.94 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.284 2.656 . . . . 0.0 113.677 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.96 11.61 29.0 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.906 0.482 . . . . 0.0 110.602 -173.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.418 ' HB2' ' HG1' ' A' ' 24' ' ' THR . 29.0 t -72.92 130.91 41.45 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 123.606 0.762 . . . . 0.0 109.717 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -84.85 117.01 23.62 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.469 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -49.56 -35.11 19.47 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.37 -55.21 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -78.8 -38.16 39.02 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -170.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -87.62 -59.63 2.19 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.732 0.413 . . . . 0.0 110.015 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD13 ' HA ' ' A' ' 29' ' ' ALA . 90.4 mt -70.17 -23.66 63.02 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.38 0.672 . . . . 0.0 111.423 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.2 39.82 96.36 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.781 0.676 . . . . 0.0 113.16 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -72.91 115.34 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.08 144.11 24.81 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.91 0.884 . . . . 0.0 110.226 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 p -55.0 -42.84 72.98 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.957 0.903 . . . . 0.0 112.116 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.1 mt -67.39 -44.79 78.01 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.569 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -64.21 -26.86 68.7 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.984 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -74.06 -34.0 63.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.55 -38.54 90.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.102 0.561 . . . . 0.0 110.189 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.43 -46.0 88.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.029 0.932 . . . . 0.0 110.697 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.578 HG21 HG12 ' A' ' 12' ' ' ILE . 68.2 mt -65.61 -41.64 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.33 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.42 -39.56 74.36 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -54.75 -43.34 72.61 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.483 1.113 . . . . 0.0 110.907 171.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.23 -30.8 66.78 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.195 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.43 ' HA ' HD12 ' A' ' 11' ' ' ILE . 83.8 mt -67.79 -46.1 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.241 0.617 . . . . 0.0 110.438 175.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -56.88 -46.2 82.03 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.723 0.809 . . . . 0.0 110.727 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HB3' ' HZ3' ' A' ' 49' ' ' LYS . 8.4 mtpm? -67.92 -47.04 69.85 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.014 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.34 99.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.188 0.595 . . . . 0.0 112.322 -175.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -92.22 -11.33 35.68 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.498 0.719 . . . . 0.0 112.328 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.98 31.34 69.69 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-O 121.133 0.296 . . . . 0.0 113.171 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.3 pt -119.79 -177.27 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.641 1.176 . . . . 0.0 109.892 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -135.73 107.88 7.22 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 166.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.569 HD22 HG12 ' A' ' 84' ' ' ILE . 88.4 mt -61.77 128.33 90.23 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 168.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.76 59.17 2.73 Favored 'Trans proline' 0 C--N 1.367 1.515 0 C-N-CA 122.946 2.431 . . . . 0.0 111.624 170.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.0 -40.74 94.7 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.056 1.342 . . . . 0.0 109.629 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -57.28 -45.78 83.74 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.006 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -68.79 -43.89 74.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.277 0.631 . . . . 0.0 110.53 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.429 ' O ' HG21 ' A' ' 64' ' ' VAL . 50.4 m0 -59.98 -48.53 81.34 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.308 1.005 . . . . 0.0 111.252 -176.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.2 m -63.97 -35.58 81.15 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 124.258 0.974 . . . . 0.0 110.167 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.38 -38.22 71.55 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.082 0.553 . . . . 0.0 110.86 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.25 -38.25 90.42 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.835 0.854 . . . . 0.0 110.942 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 60' ' ' TRP . 91.6 t -64.53 -44.89 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.825 174.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.81 -46.22 88.12 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.63 0.772 . . . . 0.0 112.437 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.402 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 50.9 m-20 -81.01 -2.54 48.39 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.462 0.705 . . . . 0.0 112.673 -176.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.23 28.89 74.09 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 114.0 0.36 . . . . 0.0 114.0 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.402 ' HG3' ' HB2' ' A' ' 66' ' ' ASP . 95.4 mttt -74.77 -34.01 62.39 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.577 0.751 . . . . 0.0 109.723 171.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.6 163.58 36.81 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.591 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -88.63 154.74 20.07 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.603 1.161 . . . . 0.0 109.493 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -38.85 87.29 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.682 0.793 . . . . 0.0 110.343 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -43.76 -50.74 7.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.618 1.567 . . . . 0.0 111.761 172.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -61.04 -16.12 39.93 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.526 -1.216 . . . . 0.0 114.198 -170.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -126.52 -20.86 4.27 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -117.12 20.73 13.62 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.977 0.511 . . . . 0.0 111.846 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.4 t -97.71 147.17 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 163.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.594 ' HG ' HG21 ' A' ' 23' ' ' ILE . 4.0 mm? -57.69 -54.51 46.01 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.743 1.217 . . . . 0.0 114.225 -172.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -61.1 -36.74 80.48 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.165 0.586 . . . . 0.0 110.776 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 41.3 t-20 -76.33 -46.95 25.29 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.739 -171.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.62 -46.94 85.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.565 1.546 . . . . 0.0 109.716 173.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.59 -33.04 73.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.868 0.867 . . . . 0.0 111.189 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.04 -46.45 71.11 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.766 0.426 . . . . 0.0 110.386 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 12.9 mmp_? -55.87 -46.28 78.3 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.469 0.707 . . . . 0.0 110.753 177.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.569 HG12 HD22 ' A' ' 55' ' ' LEU . 90.1 mt -61.31 -49.55 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.877 1.271 . . . . 0.0 110.205 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.63 -37.81 79.67 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.394 1.077 . . . . 0.0 111.396 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -69.87 -39.53 76.26 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.113 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 55' ' ' LEU . 79.9 mt -67.8 -34.29 76.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 123.417 0.448 . . . . 0.0 110.811 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 84' ' ' ILE . 96.8 t -68.98 -40.25 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.712 0.805 . . . . 0.0 109.526 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.86 -40.53 87.91 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.609 0.764 . . . . 0.0 111.546 177.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.71 -36.35 78.35 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.139 0.975 . . . . 0.0 111.789 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -83.94 -31.62 25.5 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.384 0.274 . . . . 0.0 110.835 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.4 -26.16 21.6 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 119.834 -0.426 . . . . 0.0 112.796 -172.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 67.33 117.41 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.248 1.419 . . . . 0.0 111.457 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.21 97.94 0.07 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.647 0.779 . . . . 0.0 110.81 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -68.67 -25.21 64.68 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.901 0.88 . . . . 0.0 110.104 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -130.59 101.18 5.59 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 169.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 40.1 p-80 -83.87 -138.13 0.05 Allowed 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 118.758 -0.639 . . . . 0.0 109.617 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 76.69 -89.9 0.02 OUTLIER 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.384 1.074 . . . . 0.0 108.424 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.7 t60 60.66 -0.57 0.27 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -161.49 165.84 28.06 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.885 0.874 . . . . 0.0 109.649 -172.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.162 -0.923 . . . . 0.0 109.16 175.754 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.0 mtp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.4 p -85.71 89.17 7.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.422 0.63 . . . . 0.0 109.449 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.441 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 7.2 m -70.06 169.12 14.06 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.77 176.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 8' ' ' VAL . 24.9 m -60.56 -35.38 75.9 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.641 0.376 . . . . 0.0 111.059 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -56.89 -51.93 67.15 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.377 0.671 . . . . 0.0 110.468 171.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -58.52 -39.04 79.02 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.82 0.848 . . . . 0.0 111.552 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 3' ' ' SER . 13.0 mmt180 -57.64 -51.12 70.81 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.894 0.878 . . . . 0.0 111.324 174.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 4' ' ' THR . 81.0 t -72.26 -36.27 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.717 0.807 . . . . 0.0 111.274 -173.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.0 -42.44 80.32 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.889 0.876 . . . . 0.0 110.488 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 m -65.94 -47.63 74.04 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.796 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.8 mt -55.42 -54.75 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 123.409 0.684 . . . . 0.0 111.462 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.688 HG12 HG23 ' A' ' 43' ' ' ILE . 37.5 mt -57.57 -45.27 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.165 0.986 . . . . 0.0 110.959 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.411 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.19 -54.8 30.7 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.946 0.899 . . . . 0.0 112.812 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.53 -35.99 82.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.607 0.763 . . . . 0.0 111.94 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.0 m -69.59 -57.86 4.67 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 123.715 0.635 . . . . 0.0 110.387 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.557 ' SG ' HD13 ' A' ' 43' ' ' ILE . 81.1 m -96.1 11.97 32.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.553 0.741 . . . . 0.0 112.858 -170.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 42.63 67.69 0.58 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.975 1.31 . . . . 0.0 112.23 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.611 HD13 HG22 ' A' ' 12' ' ' ILE . 17.3 pt -137.61 146.03 51.49 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 124.809 1.244 . . . . 0.0 108.174 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.64 120.26 7.71 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.703 2.268 . . . . 0.0 112.845 -174.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -51.43 -39.91 58.29 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.477 1.511 . . . . 0.0 113.153 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.49 -14.1 58.55 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.241 0.216 . . . . 0.0 111.57 -172.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 p -83.87 1.51 42.87 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-O 120.616 0.246 . . . . 0.0 110.557 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.491 HG22 ' HG ' ' A' ' 77' ' ' LEU . 1.9 mp -86.84 137.6 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 165.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 p -125.98 161.69 49.97 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 123.663 0.785 . . . . 0.0 109.403 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.8 -29.44 80.99 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 121.933 1.755 . . . . 0.0 112.372 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.38 0.78 51.06 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.863 0.465 . . . . 0.0 111.393 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.6 p -75.98 132.67 40.34 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.758 0.253 . . . . 0.0 110.49 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -85.6 118.64 25.24 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.524 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -50.44 -27.88 7.27 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 55.2 mt -101.37 -55.12 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.133 0.492 . . . . 0.0 110.298 -175.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.17 -37.73 81.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.978 0.911 . . . . 0.0 112.018 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -95.7 -60.04 1.74 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.115 0.566 . . . . 0.0 110.859 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 29' ' ' ALA . 90.9 mt -71.87 -8.17 52.77 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.29 34.63 75.27 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.071 0.232 . . . . 0.0 113.52 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 88.3 mt -110.94 114.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.016 0.926 . . . . 0.0 108.802 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.46 156.73 28.59 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.957 0.503 . . . . 0.0 110.335 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.436 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 22.4 m -58.73 -27.89 65.32 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.664 0.786 . . . . 0.0 112.226 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.39 -48.49 67.22 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.014 0.526 . . . . 0.0 109.855 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.51 -33.27 75.51 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.001 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -72.04 -28.45 63.36 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.902 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 37' ' ' SER . 87.8 mt -61.04 -44.76 96.92 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.24 -41.3 98.3 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.161 0.984 . . . . 0.0 111.338 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.688 HG23 HG12 ' A' ' 12' ' ' ILE . 63.3 mt -65.58 -45.18 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-O 121.048 0.452 . . . . 0.0 110.665 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.48 -32.54 70.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.325 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -66.5 -36.72 83.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.582 0.753 . . . . 0.0 110.485 173.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.85 -34.23 77.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.914 0.486 . . . . 0.0 110.63 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.32 -38.45 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.712 0.805 . . . . 0.0 110.381 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -58.2 -44.69 88.23 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.571 0.748 . . . . 0.0 111.314 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -70.73 -44.46 66.78 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.535 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.78 -55.86 22.62 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.785 0.834 . . . . 0.0 112.827 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.513 ' HB2' HG12 ' A' ' 53' ' ' ILE . 97.4 m-85 -90.33 -10.98 42.07 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.326 0.65 . . . . 0.0 112.175 -177.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.14 70.18 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 -173.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.513 HG12 ' HB2' ' A' ' 51' ' ' PHE . 43.9 pt -109.22 -176.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.083 0.953 . . . . 0.0 109.859 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -139.24 110.56 6.97 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 172.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.413 HD22 HG12 ' A' ' 84' ' ' ILE . 84.4 mt -83.58 120.04 74.74 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 170.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.71 58.77 1.12 Allowed 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.952 2.435 . . . . 0.0 112.113 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.445 HD23 ' CE3' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -66.18 -37.69 86.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.804 0.842 . . . . 0.0 110.195 -169.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -35.62 73.06 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.373 0.421 . . . . 0.0 111.203 175.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.593 ' HB2' ' HZ3' ' A' ' 59' ' ' LYS . 3.6 ttmp? -82.39 -29.15 31.03 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 123.253 0.621 . . . . 0.0 110.674 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.445 ' CE3' HD23 ' A' ' 57' ' ' LEU . 45.7 m0 -69.58 -40.62 76.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.365 0.666 . . . . 0.0 109.729 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.4 m -64.22 -34.78 78.89 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.502 173.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -69.33 -47.82 63.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.415 1.086 . . . . 0.0 110.259 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 45.9 mt-10 -61.06 -49.23 78.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.446 1.098 . . . . 0.0 111.56 -177.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.47 -37.54 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.509 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -64.19 -40.06 95.3 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.463 0.705 . . . . 0.0 111.129 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.84 1.67 51.64 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.153 0.981 . . . . 0.0 112.244 -172.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.25 18.49 75.04 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.58 -31.96 67.54 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.72 169.83 17.01 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.581 1.153 . . . . 0.0 109.638 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.8 m -105.15 160.23 15.23 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.467 1.107 . . . . 0.0 110.458 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.0 p -62.63 77.39 0.02 OUTLIER 'General case' 0 C--N 1.364 1.219 0 C-N-CA 124.385 1.074 . . . . 0.0 110.542 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -178.97 -61.78 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.726 -169.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -58.55 -23.96 59.62 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.963 -165.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -119.21 -16.23 9.09 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -111.68 13.11 21.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.907 0.483 . . . . 0.0 112.186 -168.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.45 HG13 ' HG2' ' A' ' 78' ' ' LYS . 54.0 t -106.15 143.04 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 171.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.491 ' HG ' HG22 ' A' ' 23' ' ' ILE . 3.5 mm? -54.67 -42.54 71.48 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.212 1.405 . . . . 0.0 114.094 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HG2' HG13 ' A' ' 76' ' ' VAL . 61.1 pttt -68.38 -39.84 81.6 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 117.712 0.233 . . . . 0.0 111.393 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.24 -44.06 69.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.4 0.68 . . . . 0.0 110.368 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.6 tp -58.17 -52.94 63.46 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.553 1.141 . . . . 0.0 109.896 177.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.19 72.19 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.939 0.895 . . . . 0.0 112.334 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.61 -50.42 58.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -53.95 -48.08 70.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.225 1.01 . . . . 0.0 111.403 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.47 HG23 HD13 ' A' ' 53' ' ' ILE . 96.7 mt -58.21 -53.28 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.435 1.094 . . . . 0.0 110.4 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -62.64 -33.24 74.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.01 0.924 . . . . 0.0 112.384 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -64.4 -42.2 96.24 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.287 0.635 . . . . 0.0 110.427 174.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.5 -39.36 77.66 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.58 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 84' ' ' ILE . 87.5 t -66.36 -39.44 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.835 0.854 . . . . 0.0 110.278 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.65 -37.57 88.05 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.307 173.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.67 73.71 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.832 0.853 . . . . 0.0 111.534 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -85.84 -33.0 21.43 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.899 0.381 . . . . 0.0 110.85 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.11 -11.01 84.89 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.793 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 58.97 43.09 18.3 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-O 122.21 1.005 . . . . 0.0 110.44 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.7 mt -83.39 22.92 0.97 Allowed 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.667 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -71.84 77.62 0.88 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.869 1.268 . . . . 0.0 109.942 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -161.69 -33.14 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.994 1.318 . . . . 0.0 108.363 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -91.94 124.4 36.02 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 164.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -129.93 3.83 4.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.052 0.541 . . . . 0.0 109.83 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 63.29 -175.76 0.15 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.688 1.195 . . . . 0.0 109.58 -159.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 72.95 -65.3 0.36 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.463 1.105 . . . . 0.0 111.979 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 . . . . . 0 CA--C 1.556 1.174 0 C-N-CA 124.802 1.241 . . . . 0.0 110.948 175.449 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 p -128.86 92.21 3.36 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.75 0.82 . . . . 0.0 109.42 176.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -90.82 -169.44 2.37 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.694 0.798 . . . . 0.0 110.202 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 8' ' ' VAL . 58.3 m -54.24 -46.68 72.64 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.609 0.764 . . . . 0.0 111.363 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -56.28 -46.9 79.53 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.266 0.627 . . . . 0.0 111.499 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.29 -46.17 86.58 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.559 0.537 . . . . 0.0 110.859 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -60.71 -45.33 94.61 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.24 0.963 . . . . 0.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 4' ' ' THR . 88.5 t -67.37 -41.01 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.579 0.752 . . . . 0.0 110.288 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.2 99.24 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.902 0.881 . . . . 0.0 111.113 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 84.5 m -62.73 -47.57 82.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.092 0.957 . . . . 0.0 111.255 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 47' ' ' ILE . 88.2 mt -61.04 -50.05 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.318 0.647 . . . . 0.0 111.188 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 18' ' ' ILE . 56.6 mt -57.78 -48.95 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.061 0.544 . . . . 0.0 110.225 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.83 -51.24 30.55 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.64 1.176 . . . . 0.0 112.589 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.29 -32.47 73.21 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.796 0.838 . . . . 0.0 111.962 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 m -89.39 -19.06 25.66 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 122.82 0.448 . . . . 0.0 111.766 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.455 ' SG ' HD11 ' A' ' 43' ' ' ILE . 67.0 m -115.17 -9.49 12.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -168.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 60.1 53.49 4.53 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.223 1.009 . . . . 0.0 111.566 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.475 HD13 HD13 ' A' ' 23' ' ' ILE . 21.7 pt -137.32 149.73 66.62 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 123.268 0.627 . . . . 0.0 110.246 -176.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.62 115.17 4.22 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.69 2.26 . . . . 0.0 111.888 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.59 -16.45 38.22 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -173.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.34 -27.32 62.34 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.647 0.779 . . . . 0.0 111.303 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 p -90.84 -2.17 57.78 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.173 0.589 . . . . 0.0 110.604 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.475 HD13 HD13 ' A' ' 18' ' ' ILE . 1.7 mp -88.17 97.86 7.13 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.9 p -89.51 160.1 42.66 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.062 0.945 . . . . 0.0 110.757 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.13 -26.43 75.81 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.68 2.253 . . . . 0.0 113.044 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.25 1.53 52.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.972 0.509 . . . . 0.0 110.963 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.1 t -77.94 131.33 37.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.126 0.57 . . . . 0.0 109.917 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.4 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 58.0 t-80 -87.14 123.59 32.35 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' HA ' HD11 ' A' ' 33' ' ' LEU . . . -49.12 -39.71 29.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.314 1.046 . . . . 0.0 113.094 175.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.4 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 54.5 mt -91.84 -51.16 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -77.4 -33.45 55.03 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.597 0.759 . . . . 0.0 112.266 -168.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -100.77 -55.52 2.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.983 0.513 . . . . 0.0 110.792 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.435 HD11 ' HA ' ' A' ' 29' ' ' ALA . 65.4 mt -75.06 -6.93 52.09 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.596 0.358 . . . . 0.0 111.893 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.03 33.41 74.39 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.394 0.434 . . . . 0.0 113.816 172.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.431 HG22 HD12 ' A' ' 43' ' ' ILE . 78.3 mt -99.69 121.47 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.614 0.765 . . . . 0.0 108.977 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.59 160.05 33.23 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.681 0.392 . . . . 0.0 110.195 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.2 m -58.51 -44.11 89.37 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.5 0.72 . . . . 0.0 111.857 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.426 HD11 ' N ' ' A' ' 39' ' ' ASP . 3.8 pp -71.94 -30.98 65.88 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.127 0.489 . . . . 0.0 110.33 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.426 ' N ' HD11 ' A' ' 38' ' ' LEU . 18.7 t70 -70.22 -37.06 74.94 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.6 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -74.82 -21.84 59.06 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.271 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.579 HD21 HD11 ' A' ' 57' ' ' LEU . 96.1 mt -56.13 -45.11 79.66 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 122.942 0.497 . . . . 0.0 111.328 173.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -66.0 -39.44 90.29 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.729 0.812 . . . . 0.0 110.775 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.455 HD11 ' SG ' ' A' ' 16' ' ' CYS . 34.9 mt -68.26 -39.32 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.305 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.77 -28.51 60.77 Favored 'General case' 0 C--O 1.209 -1.033 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.66 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -63.55 -41.36 98.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.752 0.821 . . . . 0.0 110.023 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.98 92.76 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.899 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.437 ' HA ' HD12 ' A' ' 11' ' ' ILE . 80.6 mt -72.93 -48.08 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.71 0.804 . . . . 0.0 110.562 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -46.6 -55.45 7.63 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.958 1.703 . . . . 0.0 111.055 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -73.3 -36.06 66.21 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.359 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.45 -37.41 86.8 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.118 0.567 . . . . 0.0 112.342 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -93.28 -6.04 48.42 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.627 0.771 . . . . 0.0 112.087 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.63 34.3 88.04 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.316 0.385 . . . . 0.0 113.234 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.4 pt -121.14 171.09 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.526 1.13 . . . . 0.0 109.573 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -106.99 100.81 10.29 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.527 HD23 HG12 ' A' ' 84' ' ' ILE . 69.6 mt -73.21 117.87 63.89 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 169.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.419 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 3.3 Cg_exo -77.74 50.38 3.23 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.897 2.398 . . . . 0.0 111.318 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.579 HD11 HD21 ' A' ' 41' ' ' LEU . 1.4 tm? -64.33 -43.17 95.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.775 0.83 . . . . 0.0 109.801 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.01 -36.18 82.7 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.888 0.742 . . . . 0.0 110.1 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 85.1 tttt -71.75 -38.56 70.39 Favored 'General case' 0 C--O 1.211 -0.962 0 O-C-N 123.533 0.521 . . . . 0.0 109.752 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.419 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 50.1 m0 -64.56 -33.47 75.99 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.889 0.876 . . . . 0.0 110.866 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.6 m -63.8 -43.48 96.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.477 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -71.63 -31.51 66.95 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.837 0.855 . . . . 0.0 110.998 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 17.8 mm-40 -59.71 -53.89 52.7 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.607 0.763 . . . . 0.0 110.273 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.5 t -61.19 -37.31 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.413 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -61.89 -43.11 99.51 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.593 0.757 . . . . 0.0 111.752 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -88.39 2.16 53.21 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.159 0.584 . . . . 0.0 111.266 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.87 17.96 73.87 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 115.109 0.803 . . . . 0.0 115.109 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -60.4 -40.99 92.94 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.59 0.756 . . . . 0.0 110.169 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.23 174.14 14.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.442 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.0 p -106.45 164.67 11.86 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.645 0.778 . . . . 0.0 109.969 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.4 p -59.11 -50.3 74.57 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.415 0.686 . . . . 0.0 112.759 -168.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.8 pm0 -50.18 -38.44 39.76 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -172.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -55.67 -27.23 48.89 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.443 1.097 . . . . 0.0 112.903 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -117.42 -27.97 6.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.335 0.654 . . . . 0.0 111.647 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -111.3 20.58 17.18 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.071 0.548 . . . . 0.0 112.218 -167.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.443 HG12 ' HG2' ' A' ' 78' ' ' LYS . 51.9 t -107.4 141.39 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 164.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.412 HD13 HD12 ' A' ' 12' ' ' ILE . 4.4 mm? -55.19 -39.17 69.28 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -171.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.8 pttt -65.43 -40.96 93.96 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.098 0.475 . . . . 0.0 110.422 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 92.7 m-20 -77.19 -45.62 26.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.677 1.191 . . . . 0.0 110.34 -173.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.94 -53.21 60.92 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 125.195 1.398 . . . . 0.0 109.782 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.49 -26.7 68.55 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.166 0.586 . . . . 0.0 111.633 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.69 -45.67 71.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.06 0.544 . . . . 0.0 110.369 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 3.5 mmp_? -58.76 -49.56 77.18 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.089 0.556 . . . . 0.0 109.838 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.527 HG12 HD23 ' A' ' 55' ' ' LEU . 83.5 mt -61.19 -52.88 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.59 -176.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.64 -44.27 85.47 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.718 0.807 . . . . 0.0 111.52 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -71.3 -30.15 65.9 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.765 0.666 . . . . 0.0 111.436 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 81.8 mt -68.55 -41.82 79.26 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 117.968 0.349 . . . . 0.0 110.577 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 84' ' ' ILE . 39.4 t -69.43 -30.73 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.82 -36.04 57.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.75 0.82 . . . . 0.0 111.446 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.35 -37.19 84.76 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.773 0.829 . . . . 0.0 110.674 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -85.5 -20.86 29.05 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.659 ' HA2' ' HB2' ' A' ' 95' ' ' GLU . . . -71.57 -10.25 70.68 Favored Glycine 0 C--N 1.353 1.504 0 C-N-CA 123.762 0.696 . . . . 0.0 113.328 -177.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.59 84.1 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.671 0.748 . . . . 0.0 109.725 167.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.2 tp -89.27 -29.68 19.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.334 1.054 . . . . 0.0 110.84 176.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.659 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . 15.6 mm-40 -92.04 -158.08 0.56 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.85 0.86 . . . . 0.0 110.056 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -67.15 144.11 56.22 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.981 0.512 . . . . 0.0 110.436 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -83.51 120.7 26.25 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -65.12 163.24 15.36 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.02 0.528 . . . . 0.0 111.731 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -75.25 100.33 4.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.375 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -160.34 133.27 6.56 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.135 0.974 . . . . 0.0 109.068 172.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 . . . . . 0 C--O 1.253 1.263 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.514 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.481 ' HE1' ' HB2' ' A' ' 6' ' ' ASP . 0.6 OUTLIER . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.2 m 49.03 30.79 2.99 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 125.099 1.36 . . . . 0.0 112.382 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.4 t -68.91 156.91 37.67 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 121.355 0.598 . . . . 0.0 111.994 -170.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.2 m -54.8 -44.97 74.25 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.766 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -53.7 -47.94 70.02 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.923 0.764 . . . . 0.0 111.211 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.481 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 27.6 t70 -58.44 -46.22 86.98 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.828 0.705 . . . . 0.0 110.185 -175.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -69.09 -38.87 79.21 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.319 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.2 t -73.16 -37.96 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.621 0.768 . . . . 0.0 111.034 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.51 -32.36 73.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.065 0.946 . . . . 0.0 110.032 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.407 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 98.4 m -65.06 -48.17 74.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.162 170.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.0 mt -58.22 -47.37 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.726 0.41 . . . . 0.0 110.802 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.488 HD13 HD11 ' A' ' 77' ' ' LEU . 42.4 mt -57.47 -49.13 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.179 0.991 . . . . 0.0 110.819 175.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.23 -51.47 62.05 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.126 0.97 . . . . 0.0 113.085 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 10' ' ' THR . 14.0 mm-40 -73.73 -28.38 61.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.191 0.596 . . . . 0.0 111.933 -176.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 83.6 m -75.31 -50.72 15.14 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.942 0.497 . . . . 0.0 110.999 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -94.4 5.11 52.8 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.699 0.799 . . . . 0.0 112.454 -172.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.9 t70 48.85 64.8 1.56 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.912 1.285 . . . . 0.0 111.778 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.451 HD13 HG22 ' A' ' 12' ' ' ILE . 22.9 pt -141.23 145.69 39.6 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 123.94 0.896 . . . . 0.0 109.424 -174.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.47 119.55 6.85 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.065 2.51 . . . . 0.0 112.283 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -50.06 -34.66 22.36 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.882 1.273 . . . . 0.0 111.976 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.01 -25.52 61.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.54 0.736 . . . . 0.0 111.904 -172.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -79.05 -11.71 60.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.804 0.442 . . . . 0.0 111.171 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mp -89.69 101.72 12.43 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 p -80.93 161.35 63.65 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.601 0.76 . . . . 0.0 109.891 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.26 -29.82 85.24 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.44 2.093 . . . . 0.0 112.402 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -105.03 20.14 19.37 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 122.931 0.492 . . . . 0.0 111.072 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.5 m -71.65 128.32 35.43 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -80.93 111.76 17.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.541 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -46.56 -37.79 8.53 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.439 1.096 . . . . 0.0 113.832 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 55.9 mt -91.34 -58.43 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.53 -46.0 42.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.036 0.934 . . . . 0.0 112.242 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -81.54 -56.46 4.01 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.325 0.65 . . . . 0.0 109.698 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.541 HD13 ' HA ' ' A' ' 29' ' ' ALA . 88.4 mt -74.37 -12.77 60.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.233 0.613 . . . . 0.0 111.922 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.3 33.58 82.87 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 113.42 0.128 . . . . 0.0 113.42 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 82.3 mt -104.05 117.17 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.79 156.25 39.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.0 p -58.88 -29.68 67.18 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.936 0.894 . . . . 0.0 111.887 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 39' ' ' ASP . 4.4 pp -71.96 -31.26 66.13 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.144 0.497 . . . . 0.0 110.597 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.403 ' N ' HD12 ' A' ' 38' ' ' LEU . 16.0 t70 -81.91 -35.87 28.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.072 0.949 . . . . 0.0 109.483 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -68.63 -21.39 64.48 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.811 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.3 mt -51.39 -43.52 61.92 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.181 0.593 . . . . 0.0 111.245 171.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.0 -41.37 71.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.719 0.808 . . . . 0.0 111.136 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.441 HD13 HG12 ' A' ' 12' ' ' ILE . 57.3 mt -58.8 -47.79 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 123.449 0.468 . . . . 0.0 110.069 176.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.84 -34.43 69.28 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.772 0.829 . . . . 0.0 110.523 -174.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -62.55 -37.88 87.88 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.614 0.766 . . . . 0.0 110.746 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.89 -40.08 72.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.945 0.498 . . . . 0.0 111.115 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 84' ' ' ILE . 84.9 mt -63.07 -45.99 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.673 0.789 . . . . 0.0 110.228 176.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -50.67 -52.33 40.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.478 1.511 . . . . 0.0 110.75 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 49' ' ' LYS . 7.0 mtpm? -69.95 -42.83 72.69 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.577 -178.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.74 -49.78 73.68 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.589 0.756 . . . . 0.0 111.841 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.442 ' HB3' HG22 ' A' ' 88' ' ' VAL . 83.5 m-85 -86.32 -6.72 58.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.567 0.747 . . . . 0.0 111.182 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.44 29.77 73.11 Favored Glycine 0 C--N 1.356 1.659 0 O-C-N 123.432 0.457 . . . . 0.0 113.229 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.452 HG23 ' HG2' ' A' ' 91' ' ' LYS . 47.5 pt -113.23 174.62 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.261 1.024 . . . . 0.0 110.228 -175.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.32 108.58 17.44 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 169.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.497 HD22 HG12 ' A' ' 84' ' ' ILE . 60.0 mt -79.7 115.61 54.91 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.493 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 82.3 Cg_endo -76.85 54.68 4.62 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 122.211 1.941 . . . . 0.0 111.029 169.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.38 -40.16 95.56 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.387 1.075 . . . . 0.0 109.325 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.24 -40.02 84.62 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.282 175.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 27.1 tptp -71.76 -38.34 70.38 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.967 0.907 . . . . 0.0 110.702 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.493 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 54.6 m0 -65.02 -45.84 83.8 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.899 0.88 . . . . 0.0 110.555 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.7 m -64.42 -33.71 76.5 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.686 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -66.98 -38.89 86.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.05 0.54 . . . . 0.0 110.143 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 19.0 mm-40 -60.16 -41.39 92.7 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.123 0.569 . . . . 0.0 110.845 175.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.417 HG12 HG21 ' A' ' 71' ' ' THR . 59.2 t -64.04 -54.28 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.828 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -65.51 -30.84 71.65 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.53 0.732 . . . . 0.0 112.602 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -90.16 3.63 52.87 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.951 0.5 . . . . 0.0 111.109 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.94 13.16 69.15 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -75.39 -28.2 59.37 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.146 0.578 . . . . 0.0 111.384 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -153.85 171.29 19.18 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.38 0.672 . . . . 0.0 109.817 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.8 m -101.19 157.06 17.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.901 0.88 . . . . 0.0 109.284 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.417 HG21 HG12 ' A' ' 64' ' ' VAL . 13.5 p -52.8 -47.35 67.65 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.617 0.767 . . . . 0.0 111.546 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.463 ' HA ' HG22 ' A' ' 76' ' ' VAL . 12.9 pt-20 -47.11 -41.9 18.14 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -173.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -26.27 67.67 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.197 0.999 . . . . 0.0 111.583 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.439 ' HH ' ' HG3' ' A' ' 63' ' ' GLU . 31.2 m-85 -113.9 -26.34 8.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.113 0.565 . . . . 0.0 112.423 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.5 23.75 11.04 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.307 0.643 . . . . 0.0 111.116 -164.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 72' ' ' GLU . 55.0 t -107.3 132.22 55.34 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.338 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 162.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.488 HD11 HD13 ' A' ' 12' ' ' ILE . 3.7 mm? -49.8 -32.95 15.22 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.147 1.379 . . . . 0.0 114.693 -168.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HG3' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -80.74 -38.17 29.18 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.732 0.413 . . . . 0.0 111.746 177.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.46 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 93.1 m-20 -70.13 -49.92 45.85 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.074 0.55 . . . . 0.0 109.738 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.2 tp -49.7 -50.51 43.54 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.085 1.754 . . . . 0.0 110.981 170.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.59 -36.82 74.6 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.653 0.596 . . . . 0.0 110.826 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.95 79.82 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.866 0.729 . . . . 0.0 111.023 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 5.6 mmp_? -56.36 -53.33 58.61 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.671 0.748 . . . . 0.0 110.438 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.498 ' O ' HG21 ' A' ' 88' ' ' VAL . 66.7 mt -64.94 -45.42 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.41 -176.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.29 -41.44 93.41 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.269 1.028 . . . . 0.0 111.676 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -67.83 -35.13 78.05 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.817 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.0 -31.31 67.79 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.214 0.321 . . . . 0.0 111.227 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 84' ' ' ILE . 60.6 t -69.74 -40.27 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-O 121.262 0.553 . . . . 0.0 109.741 175.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.17 93.84 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.915 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.66 83.41 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.77 0.828 . . . . 0.0 111.469 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.452 ' HG2' HG23 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.77 -27.95 50.45 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.841 0.457 . . . . 0.0 110.291 -175.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.35 -34.08 30.13 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.904 0.752 . . . . 0.0 111.263 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.15 -21.46 50.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.636 0.774 . . . . 0.0 110.453 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.9 84.44 0.21 Allowed 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.814 0.845 . . . . 0.0 109.487 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.42 165.7 22.8 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.965 174.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 m80 60.43 26.95 16.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.248 0.619 . . . . 0.0 111.606 -172.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -81.27 -24.92 36.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.19 0.596 . . . . 0.0 110.145 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -71.83 80.29 0.88 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.775 0.83 . . . . 0.0 111.244 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -171.63 142.11 1.55 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.648 1.179 . . . . 0.0 109.126 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -169.91 -24.75 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.486 0.714 . . . . 0.0 110.759 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.715 0.806 . . . . 0.0 109.755 177.42 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.52 ' HB ' ' HB2' ' A' ' 6' ' ' ASP . 33.3 m -140.81 -58.63 0.51 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.288 0.635 . . . . 0.0 110.563 -172.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 6' ' ' ASP . 29.3 t -158.54 -176.05 5.67 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.762 0.825 . . . . 0.0 109.911 -169.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.0 m -59.94 -42.2 93.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.196 0.598 . . . . 0.0 110.18 172.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -56.17 -42.68 77.44 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.411 0.684 . . . . 0.0 111.623 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.52 ' HB2' ' HB ' ' A' ' 2' ' ' THR . 8.8 t70 -52.94 -51.39 61.53 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.675 0.79 . . . . 0.0 110.31 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.447 ' O ' HG13 ' A' ' 11' ' ' ILE . 37.8 mmt180 -64.7 -43.37 93.69 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.84 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.415 ' HA ' HD13 ' A' ' 11' ' ' ILE . 67.4 t -70.0 -36.45 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.941 0.896 . . . . 0.0 111.246 -175.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.02 -36.53 83.5 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.691 0.796 . . . . 0.0 110.309 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.5 m -66.04 -41.36 90.97 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.254 0.622 . . . . 0.0 111.175 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 7' ' ' ARG . 82.8 mt -56.85 -52.92 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.923 0.489 . . . . 0.0 110.353 174.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.512 HD12 HD11 ' A' ' 77' ' ' LEU . 39.9 mt -59.67 -44.62 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.8 0.84 . . . . 0.0 110.931 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -50.11 -63.24 1.18 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.415 1.086 . . . . 0.0 113.119 175.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.03 -25.15 66.93 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.722 -174.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.9 m -78.82 -46.64 18.26 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.468 0.707 . . . . 0.0 111.53 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.7 t -102.26 4.61 39.42 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.443 0.697 . . . . 0.0 111.867 -170.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 t70 48.1 76.76 0.11 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.264 1.426 . . . . 0.0 112.185 -170.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.553 HG13 ' HA ' ' A' ' 13' ' ' ALA . 3.3 pt -147.4 141.61 15.97 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.536 1.134 . . . . 0.0 108.765 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.67 125.88 17.06 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.34 2.026 . . . . 0.0 110.741 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.551 ' HA ' HD11 ' A' ' 23' ' ' ILE . 2.2 ppt_? -70.23 -16.15 63.01 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -88.17 -1.76 58.2 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.979 0.512 . . . . 0.0 110.503 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.9 p -89.09 -17.77 28.61 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 117.743 0.247 . . . . 0.0 110.428 165.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.551 HD11 ' HA ' ' A' ' 20' ' ' ARG . 2.1 mp -80.51 111.89 17.81 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.1 p -90.25 158.94 43.03 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.607 0.763 . . . . 0.0 109.188 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.05 -19.52 66.42 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 121.974 1.783 . . . . 0.0 112.128 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.53 8.76 44.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.384 0.674 . . . . 0.0 110.495 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.0 m -70.89 124.87 25.35 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.406 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 64.6 t-80 -80.05 111.82 16.75 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 167.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.05 -36.49 29.29 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mt -93.53 -45.04 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 122.306 0.242 . . . . 0.0 110.871 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.93 -44.19 11.22 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.449 0.7 . . . . 0.0 111.796 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.98 -60.1 2.21 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.362 0.665 . . . . 0.0 109.984 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.82 -17.18 63.38 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.871 0.468 . . . . 0.0 111.543 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.31 37.36 90.68 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.576 0.548 . . . . 0.0 113.812 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.3 mt -93.59 114.67 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.61 156.41 38.16 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 m -57.91 -31.53 66.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.928 0.891 . . . . 0.0 112.637 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.57 -31.83 62.19 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.801 0.44 . . . . 0.0 111.253 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -75.1 -32.69 61.49 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.224 0.61 . . . . 0.0 110.01 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -71.42 -28.5 64.04 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.836 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.78 -41.85 87.64 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.75 0.42 . . . . 0.0 110.38 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.9 -44.18 81.47 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.12 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.6 mt -65.27 -46.14 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 122.855 0.462 . . . . 0.0 110.805 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.56 76.36 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.182 0.593 . . . . 0.0 110.549 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -73.43 -25.25 60.44 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.747 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.7 -41.15 72.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.503 0.321 . . . . 0.0 110.324 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.85 -44.5 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.135 0.974 . . . . 0.0 110.218 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -51.47 -48.15 62.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.5 1.52 . . . . 0.0 110.647 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.14 -50.07 65.25 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.19 175.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.44 -51.49 66.75 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.008 0.923 . . . . 0.0 113.253 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -89.45 -6.56 56.4 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.513 0.725 . . . . 0.0 111.683 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.81 39.83 95.32 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-O 121.189 0.327 . . . . 0.0 112.534 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.473 HG22 ' HG2' ' A' ' 91' ' ' LYS . 41.8 pt -122.61 169.64 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.41 1.084 . . . . 0.0 109.493 -175.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -107.45 120.88 43.41 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.1 mt -90.26 113.61 58.0 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.81 57.1 3.7 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.446 2.764 . . . . 0.0 111.292 171.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.5 -38.68 90.82 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.227 1.011 . . . . 0.0 110.259 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 8.4 pt-20 -58.97 -45.74 89.8 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 124.01 0.819 . . . . 0.0 110.985 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -63.67 -48.23 78.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.814 0.846 . . . . 0.0 109.86 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.2 m0 -53.69 -44.53 69.83 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.366 1.041 . . . . 0.0 110.744 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.1 m -64.42 -45.6 86.86 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.047 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 13.7 mm100 -68.79 -37.51 79.32 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.6 0.36 . . . . 0.0 110.872 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -57.64 -48.06 80.51 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.155 0.982 . . . . 0.0 110.374 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.463 HG13 HG21 ' A' ' 71' ' ' THR . 78.8 t -59.24 -46.73 92.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.304 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -61.06 -37.11 81.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.917 0.487 . . . . 0.0 111.551 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.6 6.15 39.53 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.892 0.877 . . . . 0.0 112.115 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.53 20.85 74.15 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.68 -23.4 45.67 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.317 0.647 . . . . 0.0 110.196 171.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.0 175.07 14.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.176 0.99 . . . . 0.0 109.742 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.8 m -111.57 156.63 21.46 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.463 HG21 HG13 ' A' ' 64' ' ' VAL . 4.6 p -51.28 -40.91 59.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.488 ' HA ' HG21 ' A' ' 76' ' ' VAL . 1.3 mp0 -47.82 -46.98 31.41 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.574 0.75 . . . . 0.0 112.426 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -26.4 62.64 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.243 1.017 . . . . 0.0 113.049 -172.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -117.81 -21.29 8.49 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -119.28 20.72 12.49 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.195 0.598 . . . . 0.0 111.819 -166.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.518 HG11 ' HG2' ' A' ' 78' ' ' LYS . 30.8 t -102.75 139.98 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 163.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.512 HD11 HD12 ' A' ' 12' ' ' ILE . 3.5 mm? -53.99 -37.21 63.77 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.146 1.379 . . . . 0.0 114.304 -168.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HG2' HG11 ' A' ' 76' ' ' VAL . 57.0 pttt -71.86 -37.14 70.28 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.661 0.384 . . . . 0.0 111.294 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -79.26 -35.24 41.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.714 0.806 . . . . 0.0 110.49 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.93 -52.48 59.62 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.568 1.147 . . . . 0.0 108.445 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.24 69.8 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.019 0.824 . . . . 0.0 111.508 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.84 -54.13 30.83 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.531 0.519 . . . . 0.0 109.751 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -50.66 -50.04 55.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.247 0.967 . . . . 0.0 111.111 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.491 ' O ' HG23 ' A' ' 88' ' ' VAL . 72.2 mt -61.34 -48.33 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.122 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.96 -39.71 94.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.912 0.885 . . . . 0.0 111.625 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.37 -40.62 97.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.01 0.924 . . . . 0.0 109.849 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.6 mt -72.89 -28.64 62.6 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.815 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 84' ' ' ILE . 80.2 t -67.86 -37.83 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 123.311 0.644 . . . . 0.0 109.796 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.56 80.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.404 0.682 . . . . 0.0 110.712 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.76 -38.77 80.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.506 0.722 . . . . 0.0 111.255 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.473 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.06 -21.68 33.7 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.17 8.67 23.09 Favored Glycine 0 C--N 1.352 1.46 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.982 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.68 -21.45 40.28 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.406 0.683 . . . . 0.0 111.329 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.86 -169.54 0.91 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.331 1.053 . . . . 0.0 110.829 171.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -60.38 120.42 9.84 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.664 0.786 . . . . 0.0 112.544 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -75.29 164.07 26.83 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.602 0.761 . . . . 0.0 110.448 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 57.3 52.62 8.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.569 1.148 . . . . 0.0 108.971 -172.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -57.78 117.46 4.27 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.385 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -56.15 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.674 1.233 . . . . 0.0 112.309 -165.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 176.06 -33.51 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.648 1.579 . . . . 0.0 108.911 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 CA--C 1.552 1.054 0 C-N-CA 123.799 0.839 . . . . 0.0 110.199 -179.284 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptm . . . . . 0 N--CA 1.481 1.075 0 CA-C-O 120.526 0.203 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.3 t -87.58 163.05 16.83 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.491 0.717 . . . . 0.0 110.291 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.3 m -154.78 178.77 9.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.734 1.214 . . . . 0.0 109.698 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.484 ' O ' HG22 ' A' ' 8' ' ' VAL . 30.7 m -58.97 -59.22 5.81 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.061 0.545 . . . . 0.0 111.188 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.35 -44.43 92.68 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.915 0.486 . . . . 0.0 111.077 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.34 -41.04 68.62 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.934 0.771 . . . . 0.0 111.388 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.407 ' O ' HG13 ' A' ' 11' ' ' ILE . 82.6 mtp180 -74.22 -34.24 63.64 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.795 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 4' ' ' THR . 52.8 t -70.21 -36.31 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 118.733 0.697 . . . . 0.0 109.593 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.98 90.43 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.264 1.026 . . . . 0.0 110.749 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 8.8 m -61.69 -51.15 69.62 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 123.812 0.695 . . . . 0.0 110.863 173.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 7' ' ' ARG . 96.8 mt -55.7 -51.52 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.431 1.092 . . . . 0.0 111.616 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.475 HD12 HD11 ' A' ' 77' ' ' LEU . 35.6 mt -60.71 -46.35 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.514 0.726 . . . . 0.0 111.016 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.55 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -51.78 -48.31 63.82 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.006 0.816 . . . . 0.0 112.596 175.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 10' ' ' THR . 47.8 mt-10 -67.91 -37.04 81.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.711 0.805 . . . . 0.0 112.031 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.8 m -68.44 -54.53 16.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.09 0.556 . . . . 0.0 110.66 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.6 m -91.78 7.49 41.55 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.885 0.874 . . . . 0.0 112.514 -173.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 39.52 74.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.009 1.324 . . . . 0.0 112.469 -170.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.55 HG13 ' HA ' ' A' ' 13' ' ' ALA . 13.8 pt -140.18 142.52 30.34 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.995 1.318 . . . . 0.0 107.838 -177.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.29 131.17 41.43 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.423 2.082 . . . . 0.0 112.322 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -36.38 -42.1 0.31 Allowed 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 126.69 1.996 . . . . 0.0 113.939 176.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.14 -28.98 66.93 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.819 0.848 . . . . 0.0 112.001 -170.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 p -79.36 -4.04 49.06 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.54 97.2 5.96 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.7 p -88.46 162.18 40.31 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.692 0.797 . . . . 0.0 110.213 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.39 -26.76 79.01 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.706 2.271 . . . . 0.0 113.502 176.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.74 5.54 50.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.842 0.857 . . . . 0.0 111.442 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -68.67 120.99 15.54 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.437 0.295 . . . . 0.0 110.305 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -84.36 123.4 30.15 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 167.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -40.27 -50.04 2.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.773 1.229 . . . . 0.0 113.147 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -90.81 -51.34 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.229 0.538 . . . . 0.0 109.908 -169.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.89 -39.57 66.29 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.247 1.019 . . . . 0.0 112.479 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.84 -64.53 1.04 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.365 0.666 . . . . 0.0 110.08 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD13 HG23 ' A' ' 12' ' ' ILE . 73.2 mt -73.9 -17.6 61.01 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.609 0.763 . . . . 0.0 112.216 -174.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.98 34.33 76.5 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 123.083 0.239 . . . . 0.0 113.651 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.5 mt -82.62 139.96 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.574 1.15 . . . . 0.0 109.277 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -92.53 162.16 14.32 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.9 m -54.33 -36.98 64.35 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.317 1.047 . . . . 0.0 112.083 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.38 -40.62 77.3 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.859 0.463 . . . . 0.0 110.364 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -68.63 -35.45 77.31 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.387 0.675 . . . . 0.0 110.459 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.46 -32.71 74.25 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.8 0.687 . . . . 0.0 110.528 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.0 mt -61.21 -42.63 98.94 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.055 0.542 . . . . 0.0 111.255 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -66.97 -42.57 84.91 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.099 0.56 . . . . 0.0 110.723 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.461 HD11 HG12 ' A' ' 12' ' ' ILE . 97.2 mt -57.29 -47.36 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.225 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.13 -38.49 75.56 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.291 -173.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -61.48 -42.56 98.97 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.0 0.92 . . . . 0.0 110.9 174.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.94 -29.26 66.36 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.15 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.468 HD11 HD13 ' A' ' 84' ' ' ILE . 90.3 mt -65.83 -43.52 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.467 0.707 . . . . 0.0 110.307 173.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -58.67 -41.26 85.73 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.425 0.453 . . . . 0.0 110.913 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -69.07 -54.06 17.05 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.556 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.17 -52.8 64.14 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.128 0.971 . . . . 0.0 112.871 -176.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -89.8 -6.75 55.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.843 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.71 31.81 73.65 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.5 0.5 . . . . 0.0 113.448 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.466 HG23 ' HD3' ' A' ' 91' ' ' LYS . 41.3 pt -118.22 -178.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.561 0.745 . . . . 0.0 112.116 -172.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -126.56 106.52 9.49 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.354 1.462 . . . . 0.0 107.489 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.445 HD21 HG12 ' A' ' 84' ' ' ILE . 91.3 mt -72.8 125.99 90.88 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -74.98 60.47 5.43 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.778 2.318 . . . . 0.0 109.634 163.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -40.26 91.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.134 1.374 . . . . 0.0 109.253 -171.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.81 -42.23 92.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.693 0.797 . . . . 0.0 111.012 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -62.75 -47.5 83.29 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.477 1.111 . . . . 0.0 110.031 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -60.07 -44.87 94.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.948 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -65.99 -36.74 84.12 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.9 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -68.66 -37.46 79.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.033 0.533 . . . . 0.0 110.988 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.58 -38.98 92.88 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.546 0.738 . . . . 0.0 111.264 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.9 t -65.51 -49.88 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.457 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -60.47 -32.06 71.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.182 0.993 . . . . 0.0 112.297 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -93.8 0.49 56.31 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.745 0.818 . . . . 0.0 111.871 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.82 16.92 66.7 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.46 -33.73 76.55 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 117.576 0.688 . . . . 0.0 110.156 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.87 166.38 28.69 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.012 0.925 . . . . 0.0 108.967 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 75.2 p -86.37 164.0 17.31 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 122.749 0.42 . . . . 0.0 110.052 177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.7 p -54.2 -49.1 70.15 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.151 0.58 . . . . 0.0 109.632 172.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.473 ' HA ' HG23 ' A' ' 76' ' ' VAL . 28.6 mt-10 -43.35 -47.19 6.72 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.955 1.702 . . . . 0.0 113.52 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -53.68 -28.95 36.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.99 0.916 . . . . 0.0 113.467 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -121.13 -21.05 6.56 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -110.71 15.81 21.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.47 0.708 . . . . 0.0 110.966 -169.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 72' ' ' GLU . 91.3 t -108.21 139.8 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.475 HD11 HD12 ' A' ' 12' ' ' ILE . 3.6 mm? -54.26 -40.11 67.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.338 1.455 . . . . 0.0 114.108 -172.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.429 ' HG2' HG13 ' A' ' 76' ' ' VAL . 62.1 pttt -65.2 -42.02 93.95 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.437 0.461 . . . . 0.0 110.82 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.14 -39.49 40.93 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.537 1.135 . . . . 0.0 111.021 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.2 -49.94 72.24 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.267 1.027 . . . . 0.0 109.248 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.2 -34.68 78.63 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.564 0.746 . . . . 0.0 111.405 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.76 90.05 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.57 0.544 . . . . 0.0 110.505 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -58.7 -48.86 79.69 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.301 0.641 . . . . 0.0 111.267 175.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.468 HD13 HD11 ' A' ' 47' ' ' ILE . 91.2 mt -59.63 -43.02 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.654 1.182 . . . . 0.0 110.292 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.37 -45.38 91.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 110.912 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.39 -33.3 72.82 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.463 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 62.5 mt -70.99 -36.39 72.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.078 0.551 . . . . 0.0 111.742 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 84' ' ' ILE . 94.8 t -64.94 -41.81 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-O 121.657 0.741 . . . . 0.0 109.499 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.94 75.84 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.733 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.7 94.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.147 0.979 . . . . 0.0 112.076 -176.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.466 ' HD3' HG23 ' A' ' 53' ' ' ILE . 60.1 pttt -70.15 -27.22 64.37 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.431 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.91 -27.65 64.22 Favored Glycine 0 C--N 1.362 1.989 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.3 -82.76 0.02 OUTLIER 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.59 1.556 . . . . 0.0 111.293 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -156.31 89.57 1.13 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.69 -94.03 0.49 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 168.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -155.1 177.59 11.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.633 1.173 . . . . 0.0 109.314 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 72.9 m80 69.67 -75.82 0.07 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.49 1.516 . . . . 0.0 111.387 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 72.54 -61.0 0.51 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 126.124 1.769 . . . . 0.0 109.821 -173.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -130.81 -66.34 0.76 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 167.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -167.89 104.2 0.48 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 18.8 t60 . . . . . 0 C--O 1.248 1.005 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.925 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.4 mtp . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.0 m -139.92 86.09 2.07 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.0 t -82.96 -173.5 4.74 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.873 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.46 ' O ' HG21 ' A' ' 8' ' ' VAL . 65.2 m -50.36 -53.17 31.02 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.295 1.038 . . . . 0.0 111.944 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -56.76 -42.16 78.85 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.315 0.646 . . . . 0.0 112.013 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.63 -42.19 92.17 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.973 0.509 . . . . 0.0 110.662 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -61.7 -46.3 90.27 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.643 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 4' ' ' THR . 99.5 t -70.0 -38.93 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.113 0.965 . . . . 0.0 111.191 -173.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.2 96.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.98 0.912 . . . . 0.0 110.028 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -63.62 -44.89 92.61 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 111.308 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.49 -51.7 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.394 0.678 . . . . 0.0 110.815 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.563 HG12 HG21 ' A' ' 43' ' ' ILE . 38.7 mt -57.72 -52.83 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.487 0.715 . . . . 0.0 110.664 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.78 -54.93 8.74 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.914 1.286 . . . . 0.0 113.01 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.59 -22.86 60.92 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.255 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.8 m -88.13 -25.64 22.88 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.78 0.432 . . . . 0.0 111.786 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.5 t -113.23 -1.4 14.33 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.91 0.484 . . . . 0.0 111.823 -167.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.31 50.47 7.76 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.191 0.996 . . . . 0.0 111.571 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.51 HD13 HD12 ' A' ' 23' ' ' ILE . 16.3 pt -138.17 156.09 73.99 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 123.761 0.825 . . . . 0.0 109.987 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.77 131.15 16.71 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.591 2.194 . . . . 0.0 110.73 172.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.51 ' HA ' HD13 ' A' ' 23' ' ' ILE . 6.5 ppt_? -68.22 -16.22 63.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.729 0.412 . . . . 0.0 111.312 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.26 -20.63 54.86 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 123.538 0.735 . . . . 0.0 110.487 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -92.05 10.34 29.54 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.083 0.553 . . . . 0.0 110.421 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.51 HD12 HD13 ' A' ' 18' ' ' ILE . 1.9 mp -104.92 127.28 59.56 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 168.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.417 ' HG1' ' HB3' ' A' ' 27' ' ' SER . 27.1 p -121.87 158.22 55.3 Favored Pre-proline 0 N--CA 1.484 1.225 0 C-N-CA 123.981 0.912 . . . . 0.0 109.668 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.53 -32.7 35.93 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.788 2.325 . . . . 0.0 113.399 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.84 -5.87 56.43 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.941 -0.474 . . . . 0.0 111.429 -173.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.417 ' HB3' ' HG1' ' A' ' 24' ' ' THR . 89.8 p -77.19 132.87 38.98 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 122.541 0.336 . . . . 0.0 110.185 -174.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -85.33 126.14 33.5 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 173.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -46.54 -39.6 11.21 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.083 0.953 . . . . 0.0 113.236 175.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.8 mt -96.57 -55.88 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -171.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.37 -43.84 80.41 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.506 0.723 . . . . 0.0 112.578 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -93.57 -57.23 2.64 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.868 0.467 . . . . 0.0 110.302 -172.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' A' ' 29' ' ' ALA . 62.8 mt -78.91 -7.77 58.27 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.565 0.746 . . . . 0.0 112.44 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.04 25.07 72.0 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 114.443 0.537 . . . . 0.0 114.443 174.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.32 121.56 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.787 0.835 . . . . 0.0 108.776 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.45 157.19 37.57 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 t -58.29 -35.13 71.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.741 0.817 . . . . 0.0 111.701 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 pp -71.7 -30.92 66.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.517 0.327 . . . . 0.0 111.076 -177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -73.24 -39.76 65.21 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.118 0.567 . . . . 0.0 109.91 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -69.88 -25.9 63.92 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.783 0.677 . . . . 0.0 110.89 -176.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.63 HD22 HD11 ' A' ' 57' ' ' LEU . 93.7 mt -56.83 -42.6 79.92 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.051 0.54 . . . . 0.0 110.615 170.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -75.14 -40.95 59.3 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.064 0.946 . . . . 0.0 110.627 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.563 HG21 HG12 ' A' ' 12' ' ' ILE . 57.0 mt -61.22 -43.61 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.227 0.537 . . . . 0.0 110.319 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 -33.29 63.0 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.963 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -62.69 -34.35 76.95 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.595 0.358 . . . . 0.0 110.347 172.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.95 -34.5 73.5 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.92 0.488 . . . . 0.0 110.8 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.12 -42.87 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.627 0.771 . . . . 0.0 110.35 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -53.08 -51.3 62.29 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.659 0.784 . . . . 0.0 110.635 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -63.46 -50.15 70.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.056 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.88 -48.76 77.61 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.737 0.815 . . . . 0.0 112.395 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -83.61 -10.21 58.39 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.513 0.725 . . . . 0.0 112.22 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.38 30.27 71.43 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.418 0.449 . . . . 0.0 112.988 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 pt -120.01 -176.18 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.022 1.329 . . . . 0.0 109.622 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -137.1 98.63 3.79 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.487 HD23 HD13 ' A' ' 87' ' ' LEU . 85.2 mt -64.01 123.64 82.66 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.489 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 98.2 Cg_endo -76.21 62.08 6.73 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 122.485 2.124 . . . . 0.0 110.587 170.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.63 HD11 HD22 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -62.44 -34.66 77.22 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.348 1.059 . . . . 0.0 109.14 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.52 -43.38 97.17 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.763 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 56.9 tptt -69.09 -39.71 78.84 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 123.632 0.773 . . . . 0.0 110.49 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.41 ' HE3' HD21 ' A' ' 57' ' ' LEU . 54.6 m0 -67.5 -39.84 85.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.494 0.718 . . . . 0.0 110.643 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -61.02 -39.37 89.47 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 124.078 0.861 . . . . 0.0 110.223 173.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -70.13 -43.98 69.84 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.201 1.0 . . . . 0.0 110.157 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.03 -46.81 88.29 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.566 1.147 . . . . 0.0 111.126 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 89.9 t -61.11 -40.0 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -67.92 -30.33 69.62 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.247 0.619 . . . . 0.0 111.767 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -85.04 -1.15 56.5 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.34 15.85 68.49 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 114.198 0.439 . . . . 0.0 114.198 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -72.6 -31.84 65.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.473 0.709 . . . . 0.0 110.779 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -149.07 166.27 29.23 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.756 0.822 . . . . 0.0 109.73 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.1 m -103.16 154.85 18.88 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.4 p -47.04 -49.08 21.94 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 124.209 1.003 . . . . 0.0 112.451 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.549 ' HA ' HG22 ' A' ' 76' ' ' VAL . 40.7 mt-10 -44.82 -42.63 8.04 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -56.46 -27.38 56.74 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.193 0.997 . . . . 0.0 112.818 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -121.7 -22.35 5.86 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.081 0.552 . . . . 0.0 112.037 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -114.7 14.49 17.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.462 0.705 . . . . 0.0 111.31 -167.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 72' ' ' GLU . 53.5 t -107.78 137.03 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 165.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.463 HD13 HD13 ' A' ' 12' ' ' ILE . 4.2 mm? -55.3 -33.88 63.67 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -169.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.49 ' HG2' HG11 ' A' ' 76' ' ' VAL . 60.0 pttt -71.65 -44.41 64.35 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.559 0.344 . . . . 0.0 110.389 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.5 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 60.0 m-80 -72.2 -38.02 69.13 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 123.608 0.763 . . . . 0.0 109.972 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.4 tp -62.5 -48.71 78.36 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 124.984 1.314 . . . . 0.0 109.454 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.31 -33.96 71.74 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.681 0.613 . . . . 0.0 111.146 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.86 -40.48 75.75 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.207 0.603 . . . . 0.0 111.426 175.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 13.6 mmp_? -60.59 -48.27 82.53 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.558 0.743 . . . . 0.0 110.867 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.22 -51.46 70.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.689 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.72 -39.55 94.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.441 0.696 . . . . 0.0 112.115 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.43 -37.79 83.55 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.34 0.4 . . . . 0.0 110.264 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.487 HD13 HD23 ' A' ' 55' ' ' LEU . 84.2 mt -71.03 -32.8 69.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.791 0.436 . . . . 0.0 111.534 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 73.4 t -65.92 -43.37 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.321 0.581 . . . . 0.0 109.479 173.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.7 -45.9 87.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.163 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.82 89.29 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.318 1.047 . . . . 0.0 111.674 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -24.37 62.09 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.535 0.522 . . . . 0.0 110.283 -176.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.03 -17.06 52.83 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.65 5.17 51.97 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.775 0.83 . . . . 0.0 112.465 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.6 mt -69.35 165.05 21.54 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.342 0.657 . . . . 0.0 111.549 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 73.63 5.28 4.89 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.943 1.297 . . . . 0.0 112.0 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -97.27 -79.79 0.45 Allowed 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.487 -0.758 . . . . 0.0 110.485 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -147.26 -52.95 0.21 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.352 0.661 . . . . 0.0 110.887 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -155.8 -57.9 0.1 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.596 0.358 . . . . 0.0 110.532 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -164.78 -52.59 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 71.75 -15.66 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 126.822 2.049 . . . . 0.0 113.761 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 CA--C 1.552 1.034 0 CA-C-O 118.069 -0.967 . . . . 0.0 108.847 -176.238 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 m -76.19 80.86 2.99 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.718 0.77 . . . . 0.0 109.674 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.8 p -166.06 145.76 6.2 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.951 1.3 . . . . 0.0 107.698 -176.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 8' ' ' VAL . 17.9 m -54.34 -60.36 3.45 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -164.023 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.93 -45.39 90.52 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.765 0.426 . . . . 0.0 111.179 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.93 -42.86 90.78 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.261 0.624 . . . . 0.0 110.902 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -65.87 -41.73 91.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.234 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.412 HG13 HD13 ' A' ' 47' ' ' ILE . 72.7 t -68.83 -40.57 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.436 0.695 . . . . 0.0 110.589 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.67 94.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.841 0.856 . . . . 0.0 110.817 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.8 m -66.41 -41.9 88.59 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.162 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.46 -47.02 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.313 0.645 . . . . 0.0 110.78 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.446 HG22 HD13 ' A' ' 18' ' ' ILE . 42.9 mt -58.22 -46.72 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.559 0.743 . . . . 0.0 110.547 177.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.63 -51.28 65.89 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.031 0.933 . . . . 0.0 112.628 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -73.96 -31.37 62.99 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.2 m -74.45 -57.5 3.89 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.541 ' SG ' HD13 ' A' ' 43' ' ' ILE . 76.1 m -85.23 -5.79 59.3 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 60.0 66.43 0.98 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 122.002 0.906 . . . . 0.0 109.729 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.446 HD13 HG22 ' A' ' 12' ' ' ILE . 12.5 pt -141.72 152.0 61.59 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.835 1.254 . . . . 0.0 108.56 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.511 ' O ' HG21 ' A' ' 22' ' ' THR . 37.9 Cg_endo -66.61 125.1 13.28 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.047 1.831 . . . . 0.0 111.334 175.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HA ' HD12 ' A' ' 23' ' ' ILE . 58.6 ttt180 -53.44 -29.1 33.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.17 0.988 . . . . 0.0 112.565 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.439 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.1 pt-20 -65.88 -23.67 66.7 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.487 0.715 . . . . 0.0 112.155 -172.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.511 HG21 ' O ' ' A' ' 19' ' ' PRO . 9.3 t -88.11 2.49 51.89 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.705 0.402 . . . . 0.0 111.512 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 20' ' ' ARG . 3.6 mp -102.0 94.15 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.6 p -88.52 163.76 34.87 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -62.45 -19.67 68.18 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.213 1.942 . . . . 0.0 113.131 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -95.85 3.86 53.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.761 0.424 . . . . 0.0 110.814 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -75.54 130.86 39.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.855 0.359 . . . . 0.0 110.093 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -85.59 122.69 30.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 168.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.73 -41.11 30.97 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.043 0.937 . . . . 0.0 112.817 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.4 mt -93.13 -53.23 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.06 -44.74 65.14 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.707 0.803 . . . . 0.0 111.787 -171.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -89.32 -59.86 2.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.93 0.492 . . . . 0.0 110.372 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.514 HD12 ' HA ' ' A' ' 29' ' ' ALA . 71.1 mt -76.04 -10.9 59.79 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.815 0.846 . . . . 0.0 112.902 -171.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.29 33.04 85.65 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 123.316 0.385 . . . . 0.0 113.671 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 82.8 mt -94.13 122.57 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.14 157.88 32.59 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.198 0.599 . . . . 0.0 109.551 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.484 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 27.3 m -59.72 -27.56 66.57 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.444 0.697 . . . . 0.0 111.732 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.12 -40.85 64.59 Favored 'General case' 0 C--N 1.362 1.131 0 C-N-CA 122.928 0.491 . . . . 0.0 110.336 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.71 -36.18 81.87 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.238 0.615 . . . . 0.0 109.63 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -70.13 -27.88 64.92 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 123.762 0.664 . . . . 0.0 110.611 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.2 mt -61.88 -40.33 95.04 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.069 0.395 . . . . 0.0 110.235 173.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -71.84 -39.05 70.02 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 124.021 0.826 . . . . 0.0 110.677 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.541 HD13 ' SG ' ' A' ' 16' ' ' CYS . 77.4 mt -61.94 -47.41 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.114 0.565 . . . . 0.0 109.908 174.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.5 -34.38 72.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.797 0.839 . . . . 0.0 110.341 -173.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -69.01 -37.24 78.58 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.896 0.878 . . . . 0.0 110.721 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.88 -35.83 74.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.662 0.385 . . . . 0.0 110.751 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.412 HD13 HG13 ' A' ' 8' ' ' VAL . 96.5 mt -66.88 -46.24 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.033 0.933 . . . . 0.0 109.891 173.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -51.46 -51.12 57.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.363 1.465 . . . . 0.0 110.357 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -69.13 -47.23 65.62 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.863 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.45 92.87 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.408 0.683 . . . . 0.0 112.464 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.32 -4.43 58.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.548 0.739 . . . . 0.0 111.219 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.45 30.36 77.65 Favored Glycine 0 C--N 1.357 1.719 0 O-C-N 123.233 0.333 . . . . 0.0 113.465 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.3 pt -119.37 163.39 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.45 1.1 . . . . 0.0 109.68 -175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 123.19 42.4 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 164.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.446 HD21 HG12 ' A' ' 84' ' ' ILE . 54.0 mt -78.45 135.67 60.83 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 171.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.458 ' HD3' HD13 ' A' ' 87' ' ' LEU . 4.4 Cg_exo -79.18 44.16 1.64 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 123.302 2.668 . . . . 0.0 111.301 170.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -57.15 -38.4 73.47 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.528 1.131 . . . . 0.0 109.785 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -53.91 -51.49 63.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.985 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 49.9 tptt -66.35 -41.18 89.93 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.585 1.154 . . . . 0.0 110.888 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.424 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 52.2 m0 -59.94 -45.21 93.35 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.167 0.987 . . . . 0.0 110.58 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.7 m -63.62 -39.0 93.26 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.848 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -65.37 -39.51 92.37 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.185 0.594 . . . . 0.0 110.658 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 27.4 mm-40 -56.17 -48.49 76.22 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.215 0.606 . . . . 0.0 111.063 175.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.99 -41.46 89.8 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.124 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -60.0 -43.65 95.05 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.992 0.917 . . . . 0.0 111.785 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -83.01 6.17 19.71 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.41 19.39 64.39 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 114.494 0.558 . . . . 0.0 114.494 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -76.12 -59.47 2.75 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.927 0.891 . . . . 0.0 108.686 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.38 172.04 7.03 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.207 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 p -107.26 170.78 7.75 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.83 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.6 p -62.16 -46.19 90.08 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 119.537 -0.268 . . . . 0.0 110.701 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -53.07 -36.64 60.88 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.574 0.75 . . . . 0.0 112.932 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -25.98 58.83 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.491 1.116 . . . . 0.0 111.346 -175.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -128.96 -7.43 4.94 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -115.48 16.68 16.6 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.226 0.611 . . . . 0.0 111.244 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.464 HG11 ' HG2' ' A' ' 78' ' ' LYS . 54.3 t -103.16 141.33 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 166.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.4 HD11 HD12 ' A' ' 12' ' ' ILE . 4.1 mm? -53.61 -42.29 67.55 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.188 1.395 . . . . 0.0 114.246 -172.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HG2' HG11 ' A' ' 76' ' ' VAL . 60.7 pttt -68.59 -40.05 80.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.826 0.45 . . . . 0.0 110.843 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.413 ' OD1' ' HG3' ' A' ' 78' ' ' LYS . 2.1 m-20 -68.36 -46.2 70.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.049 0.94 . . . . 0.0 109.853 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.4 tp -58.84 -50.47 73.86 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.01 1.324 . . . . 0.0 109.973 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.64 75.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.595 0.758 . . . . 0.0 111.749 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.33 68.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.721 0.408 . . . . 0.0 110.063 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -56.4 -48.24 77.32 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.784 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.446 HG12 HD21 ' A' ' 55' ' ' LEU . 90.3 mt -61.8 -51.36 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.532 1.133 . . . . 0.0 111.227 -175.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.83 -39.58 85.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.888 0.875 . . . . 0.0 111.34 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -63.73 -40.49 96.87 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.038 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.458 HD13 ' HD3' ' A' ' 56' ' ' PRO . 91.7 mt -67.34 -34.44 77.33 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.194 0.598 . . . . 0.0 111.492 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.447 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 57.9 t -65.77 -42.28 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.18 -43.19 98.94 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.536 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.18 -39.67 89.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.097 0.959 . . . . 0.0 112.284 -177.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.447 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 41.3 pttt -74.83 -21.25 59.39 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.545 0.338 . . . . 0.0 110.117 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.0 -40.98 96.15 Favored Glycine 0 C--N 1.363 2.05 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.02 -175.47 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.453 1.101 . . . . 0.0 113.078 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.37 -28.86 59.68 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.517 172.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -150.45 95.54 2.26 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.27 0.628 . . . . 0.0 109.819 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -85.64 -43.64 13.27 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.681 0.792 . . . . 0.0 108.977 166.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -155.91 -58.18 0.1 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.421 1.088 . . . . 0.0 108.397 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -173.4 121.78 0.35 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -76.68 73.32 3.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.277 0.631 . . . . 0.0 111.741 -170.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -160.78 -57.63 0.05 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.261 1.824 . . . . 0.0 106.785 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 . . . . . 0 CA--C 1.562 1.408 0 C-N-CA 125.384 1.474 . . . . 0.0 111.616 178.802 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mtp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.9 p -75.81 77.37 2.74 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.909 0.883 . . . . 0.0 111.869 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.4 p -82.74 175.79 9.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.286 1.035 . . . . 0.0 108.656 169.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.573 HG22 ' HB2' ' A' ' 85' ' ' ASP . 24.2 m -58.53 -48.34 81.19 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.749 0.704 . . . . 0.0 110.446 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -58.51 -51.57 69.32 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.452 0.701 . . . . 0.0 111.559 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -58.85 -42.92 90.46 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.698 0.624 . . . . 0.0 111.076 -175.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.455 ' O ' HG13 ' A' ' 11' ' ' ILE . 92.1 mtt-85 -62.02 -46.81 87.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.691 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 4' ' ' THR . 53.8 t -64.33 -44.53 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.312 0.645 . . . . 0.0 110.367 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.99 85.11 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.231 1.012 . . . . 0.0 110.856 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.1 m -68.72 -41.33 79.19 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.466 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 7' ' ' ARG . 74.2 mt -60.61 -43.98 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.609 0.364 . . . . 0.0 110.766 176.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.6 HG22 HD13 ' A' ' 18' ' ' ILE . 56.2 mt -56.71 -47.48 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.463 0.705 . . . . 0.0 110.194 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.518 ' HB1' ' HB3' ' A' ' 20' ' ' ARG . . . -56.75 -51.86 67.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.544 1.138 . . . . 0.0 113.376 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.64 -30.4 71.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.172 0.989 . . . . 0.0 111.865 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -82.81 -46.62 12.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.581 0.352 . . . . 0.0 111.087 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.7 t -93.3 -7.78 43.95 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.483 0.713 . . . . 0.0 112.182 -169.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 56.78 70.18 0.67 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.55 1.14 . . . . 0.0 111.574 -172.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.6 HD13 HG22 ' A' ' 12' ' ' ILE . 10.2 pt -143.75 152.0 54.76 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 125.143 1.377 . . . . 0.0 108.641 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.09 116.77 4.76 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 121.93 1.754 . . . . 0.0 111.709 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.518 ' HB3' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -62.93 -17.17 61.51 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.996 0.919 . . . . 0.0 113.034 -178.254 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.98 -27.18 60.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.329 0.651 . . . . 0.0 110.243 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -83.8 -5.57 59.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.096 0.558 . . . . 0.0 110.724 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.427 HD11 ' HA ' ' A' ' 20' ' ' ARG . 1.9 mp -87.81 120.39 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.9 p -101.53 166.99 11.3 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.724 0.81 . . . . 0.0 109.427 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.14 -17.26 54.51 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 121.889 1.726 . . . . 0.0 112.763 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.66 0.27 49.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.572 0.349 . . . . 0.0 110.331 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -72.6 128.08 34.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.879 0.872 . . . . 0.0 110.109 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -87.3 117.11 25.85 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.513 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -55.16 -35.93 65.29 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -93.04 -44.85 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 121.392 0.615 . . . . 0.0 110.374 -170.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -94.88 -38.38 10.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.13 0.972 . . . . 0.0 111.593 -168.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.24 -50.8 5.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.833 0.453 . . . . 0.0 110.659 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.513 HD12 ' HA ' ' A' ' 29' ' ' ALA . 88.8 mt -77.71 -14.59 59.57 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.417 0.687 . . . . 0.0 111.145 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.89 27.97 72.02 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.798 0.686 . . . . 0.0 114.255 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.464 HG21 HD12 ' A' ' 43' ' ' ILE . 89.3 mt -76.77 124.88 35.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.01 152.87 44.98 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.115 0.885 . . . . 0.0 109.805 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.2 m -66.31 -25.96 67.09 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.599 0.759 . . . . 0.0 112.278 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.77 -33.68 62.33 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.34 -42.44 59.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.734 0.814 . . . . 0.0 110.117 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -71.26 -21.95 62.03 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 123.593 0.558 . . . . 0.0 110.603 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.49 -47.14 86.65 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 170.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -71.55 -36.91 71.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.954 0.902 . . . . 0.0 111.437 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 35' ' ' ILE . 52.8 mt -63.4 -50.24 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 123.636 0.585 . . . . 0.0 110.1 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.94 -33.42 72.1 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 123.782 0.676 . . . . 0.0 109.905 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.507 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 45.0 t80 -60.95 -40.84 94.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.401 1.081 . . . . 0.0 111.003 173.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.78 -35.88 59.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.626 0.37 . . . . 0.0 111.317 -178.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 92.6 mt -65.43 -43.05 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.543 0.737 . . . . 0.0 109.958 174.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 45' ' ' PHE . 9.8 t70 -50.69 -52.55 39.08 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.665 1.586 . . . . 0.0 110.692 177.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 57.8 mmtt -74.15 -35.66 64.06 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.259 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.03 -43.99 97.18 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.071 0.548 . . . . 0.0 111.812 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -93.01 -0.62 57.14 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.907 0.883 . . . . 0.0 111.556 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.13 43.61 96.94 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 123.754 0.659 . . . . 0.0 113.174 172.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 pt -135.53 173.57 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.245 1.418 . . . . 0.0 109.177 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -104.49 108.53 20.01 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 167.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD22 HG12 ' A' ' 84' ' ' ILE . 51.9 mt -68.74 121.77 82.41 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 167.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.541 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 93.5 Cg_endo -78.56 57.57 6.37 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.692 2.261 . . . . 0.0 111.682 176.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.99 -37.81 80.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.013 1.325 . . . . 0.0 109.589 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.37 -46.14 89.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.573 1.149 . . . . 0.0 111.264 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 22.1 tptm -68.88 -39.1 79.97 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.169 0.988 . . . . 0.0 111.102 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.442 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 54.5 m0 -62.51 -41.55 98.91 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.62 0.768 . . . . 0.0 109.886 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.9 m -63.01 -39.61 95.29 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.166 0.916 . . . . 0.0 110.498 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.38 -47.71 75.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.051 0.541 . . . . 0.0 110.654 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -58.17 -44.93 88.21 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.98 0.912 . . . . 0.0 112.288 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.9 t -67.5 -50.36 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 122.629 0.372 . . . . 0.0 111.072 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -67.56 -29.7 69.15 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.371 0.669 . . . . 0.0 112.689 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -94.09 5.2 52.47 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.486 0.714 . . . . 0.0 111.428 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.32 21.77 66.72 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 115.802 1.081 . . . . 0.0 115.802 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.489 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -79.57 -22.85 43.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.315 0.646 . . . . 0.0 110.88 173.44 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.04 177.57 9.47 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.738 1.215 . . . . 0.0 108.339 175.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.21 164.89 20.67 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.102 0.961 . . . . 0.0 109.073 173.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.0 p -54.93 -52.21 63.68 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.202 0.938 . . . . 0.0 113.107 -165.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -35.49 63.21 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -172.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -53.22 -27.93 24.45 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.229 1.012 . . . . 0.0 113.02 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -115.75 -31.28 5.86 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.398 0.679 . . . . 0.0 111.834 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -110.98 21.52 16.34 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.866 0.467 . . . . 0.0 112.033 -165.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.503 HG11 ' HG2' ' A' ' 78' ' ' LYS . 24.8 t -106.82 138.24 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 164.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -51.62 -37.87 52.13 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -170.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HG2' HG11 ' A' ' 76' ' ' VAL . 61.8 pttt -69.32 -41.92 76.05 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.059 0.391 . . . . 0.0 110.619 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.505 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 76.0 m-20 -76.97 -33.79 57.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.422 1.089 . . . . 0.0 110.04 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -68.04 -54.03 21.35 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.287 1.435 . . . . 0.0 108.331 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.58 -31.01 69.06 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.1 0.875 . . . . 0.0 111.499 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 -52.37 53.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.883 0.473 . . . . 0.0 110.634 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 13.9 mmp_? -54.1 -49.9 68.08 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.233 0.613 . . . . 0.0 110.73 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.529 HG12 HD22 ' A' ' 55' ' ' LEU . 91.9 mt -57.5 -53.65 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 125.246 1.418 . . . . 0.0 110.948 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.573 ' HB2' HG22 ' A' ' 4' ' ' THR . 25.9 t70 -63.18 -34.78 78.39 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.781 0.832 . . . . 0.0 111.831 -176.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -68.15 -36.68 80.05 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.333 0.653 . . . . 0.0 111.128 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.4 mt -68.2 -37.95 81.45 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.867 0.467 . . . . 0.0 110.617 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.467 HG12 ' HE2' ' A' ' 91' ' ' LYS . 58.4 t -68.98 -32.33 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 CA-C-O 121.45 0.643 . . . . 0.0 109.783 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.465 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . . . -68.93 -40.84 78.81 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.378 173.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.69 92.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.239 1.016 . . . . 0.0 111.561 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.467 ' HE2' HG12 ' A' ' 88' ' ' VAL . 56.0 pttt -83.14 -14.75 52.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.524 0.329 . . . . 0.0 110.353 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.425 ' HA3' ' NE2' ' A' ' 99' ' ' HIS . . . -73.1 -24.33 75.95 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 172.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.37 -9.12 58.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.714 0.806 . . . . 0.0 111.385 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.403 ' HG ' ' HG3' ' A' ' 95' ' ' GLU . 31.5 tp -76.31 -76.22 0.17 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.575 0.75 . . . . 0.0 109.698 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.403 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -162.07 -26.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.204 1.002 . . . . 0.0 110.325 177.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -83.22 177.94 8.31 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.289 0.635 . . . . 0.0 110.091 168.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -121.56 -86.82 0.65 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.293 0.637 . . . . 0.0 109.658 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 55.0 22.43 4.39 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.167 1.387 . . . . 0.0 114.391 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.465 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 30.1 m170 -71.17 -11.52 60.98 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 67.76 -87.6 0.03 OUTLIER 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.322 1.049 . . . . 0.0 109.555 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 . . . . . 0 C--O 1.25 1.091 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -173.422 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 8' ' ' VAL . 88.3 m . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -52.81 -47.64 67.5 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.23 1.012 . . . . 0.0 110.834 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.97 -47.65 77.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 124.004 0.815 . . . . 0.0 111.645 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -66.07 -38.09 87.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.86 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.436 HG13 HD11 ' A' ' 47' ' ' ILE . 96.4 t -72.24 -37.48 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.177 0.591 . . . . 0.0 110.329 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.19 -35.46 80.88 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.104 0.962 . . . . 0.0 110.41 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 59.8 m -66.98 -44.66 79.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.926 173.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.4 -47.09 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.274 0.629 . . . . 0.0 110.896 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.575 HG12 HD13 ' A' ' 43' ' ' ILE . 36.6 mt -61.26 -44.28 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.385 1.074 . . . . 0.0 111.071 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.08 -48.14 64.84 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.015 0.926 . . . . 0.0 112.632 174.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 10' ' ' THR . 46.4 mt-10 -66.64 -32.39 73.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.945 0.898 . . . . 0.0 111.557 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.1 m -71.22 -58.4 3.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.382 0.673 . . . . 0.0 111.591 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.4 m -103.65 15.66 28.32 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -167.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 49.83 64.14 1.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.415 1.086 . . . . 0.0 112.051 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.9 pt -142.53 146.07 37.18 Favored Pre-proline 0 N--CA 1.481 1.122 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.688 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.97 125.55 14.36 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.31 2.006 . . . . 0.0 112.162 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -31.79 48.92 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.949 1.3 . . . . 0.0 113.03 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.39 -23.65 60.2 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.378 0.671 . . . . 0.0 111.226 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -84.7 -11.62 55.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.8 0.44 . . . . 0.0 110.933 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mp -83.62 111.84 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.5 p -94.93 161.52 28.14 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 123.41 0.684 . . . . 0.0 109.556 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.17 -25.41 64.08 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.358 2.039 . . . . 0.0 113.668 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.579 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 32.1 mt-10 -102.89 17.66 23.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.947 -0.47 . . . . 0.0 110.734 -175.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -78.38 129.62 35.17 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.263 0.625 . . . . 0.0 110.259 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.465 ' HE2' ' HB ' ' A' ' 71' ' ' THR . 64.3 t-80 -88.55 120.83 30.3 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.11 -41.98 27.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.355 1.062 . . . . 0.0 113.471 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.2 mt -93.22 -60.11 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -63.63 -46.44 85.66 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.207 1.003 . . . . 0.0 111.989 -174.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.7 -64.37 1.15 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.197 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 29' ' ' ALA . 86.1 mt -71.39 -17.6 62.4 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.635 0.774 . . . . 0.0 112.542 -173.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.38 30.57 64.49 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.169 0.293 . . . . 0.0 113.792 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.6 mt -101.98 123.04 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.43 1.092 . . . . 0.0 108.915 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.44 158.88 32.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.081 0.467 . . . . 0.0 110.713 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.2 p -64.46 -23.54 67.32 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.601 0.76 . . . . 0.0 112.222 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 pp -70.53 -39.56 73.98 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -68.03 -35.96 79.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.595 0.758 . . . . 0.0 109.461 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -65.56 -27.35 68.37 Favored 'General case' 0 CA--C 1.555 1.152 0 O-C-N 124.06 0.85 . . . . 0.0 111.264 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.425 HD23 HD12 ' A' ' 57' ' ' LEU . 92.5 mt -62.74 -45.38 93.01 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.061 0.544 . . . . 0.0 110.272 171.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -65.81 -40.12 91.55 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.989 0.916 . . . . 0.0 110.455 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.575 HD13 HG12 ' A' ' 12' ' ' ILE . 97.3 mt -60.83 -44.99 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.653 0.781 . . . . 0.0 109.784 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -68.95 -32.8 72.66 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.854 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -72.03 -31.44 66.18 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.361 1.064 . . . . 0.0 110.886 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.2 65.78 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.547 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.444 HD13 HD11 ' A' ' 84' ' ' ILE . 96.0 mt -68.09 -39.14 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 124.002 0.921 . . . . 0.0 110.362 172.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.44 -43.37 75.34 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.697 1.199 . . . . 0.0 110.134 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.08 -53.84 11.61 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.463 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.86 -56.84 12.9 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.53 1.132 . . . . 0.0 113.129 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -88.14 -11.82 45.81 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.956 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.12 32.19 76.15 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.312 0.383 . . . . 0.0 112.342 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.543 HD13 HG23 ' A' ' 84' ' ' ILE . 42.6 pt -110.08 163.91 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.258 1.023 . . . . 0.0 110.056 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -110.75 95.55 5.62 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD23 HD12 ' A' ' 87' ' ' LEU . 70.1 mt -72.59 118.88 71.65 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.429 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 2.7 Cg_exo -78.88 59.85 7.5 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.115 2.544 . . . . 0.0 110.139 168.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.425 HD12 HD23 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -65.12 -35.68 81.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.397 -174.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -57.42 -40.55 78.59 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.78 0.832 . . . . 0.0 112.205 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 56' ' ' PRO . 9.6 ptmm? -77.44 -34.81 54.46 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.442 ' O ' HG23 ' A' ' 64' ' ' VAL . 50.6 m0 -66.67 -43.89 83.31 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.509 0.724 . . . . 0.0 110.704 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.8 m -64.5 -37.37 87.31 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.939 0.896 . . . . 0.0 110.269 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -66.22 -41.73 89.7 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.928 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -62.37 -43.06 99.71 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.802 0.841 . . . . 0.0 110.854 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 60' ' ' TRP . 77.6 t -55.56 -57.22 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 O-C-N 124.149 0.906 . . . . 0.0 110.533 175.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -66.75 -28.96 68.83 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.145 0.978 . . . . 0.0 112.984 -174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -93.18 7.24 45.09 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.456 0.703 . . . . 0.0 111.555 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.19 11.54 67.52 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 115.017 0.767 . . . . 0.0 115.017 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -70.64 -35.53 72.94 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.235 0.614 . . . . 0.0 109.951 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.07 164.77 29.14 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.721 1.208 . . . . 0.0 109.204 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.6 p -97.92 158.46 15.52 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.259 0.624 . . . . 0.0 109.801 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.465 ' HB ' ' HE2' ' A' ' 28' ' ' HIS . 0.7 OUTLIER -59.54 -43.86 93.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 124.158 0.912 . . . . 0.0 110.567 -175.2 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.558 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.1 mp0 -46.74 -49.1 20.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.374 1.47 . . . . 0.0 112.972 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -54.55 -25.44 25.99 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -121.37 -22.17 6.07 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -109.32 12.06 24.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.246 0.618 . . . . 0.0 111.771 -169.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 72' ' ' GLU . 80.2 t -105.58 138.04 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.538 HD11 HD12 ' A' ' 12' ' ' ILE . 4.4 mm? -52.91 -38.38 61.77 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.025 1.33 . . . . 0.0 114.312 -171.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.579 ' HD3' ' HG2' ' A' ' 26' ' ' GLU . 60.1 pttt -71.21 -40.7 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.095 0.558 . . . . 0.0 110.609 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 77.5 m-20 -74.58 -47.16 34.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.238 1.015 . . . . 0.0 109.788 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.6 tp -57.1 -49.43 75.89 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.705 1.202 . . . . 0.0 110.089 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.39 78.61 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.834 0.709 . . . . 0.0 110.939 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -67.44 -44.76 77.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.585 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 18.2 mmm180 -56.73 -44.31 81.52 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.298 0.639 . . . . 0.0 110.738 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.543 HG23 HD13 ' A' ' 53' ' ' ILE . 90.3 mt -62.54 -49.52 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.029 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.04 -32.69 74.32 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.521 1.138 . . . . 0.0 110.625 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 65.6 mt-10 -62.47 -47.14 85.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.839 0.856 . . . . 0.0 110.143 172.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.465 HD12 HD23 ' A' ' 55' ' ' LEU . 81.1 mt -69.16 -31.31 69.87 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.153 0.581 . . . . 0.0 111.552 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 84' ' ' ILE . 77.0 t -68.67 -41.31 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.422 0.689 . . . . 0.0 109.665 176.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.83 -41.49 78.5 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.457 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.39 -39.02 91.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.026 0.93 . . . . 0.0 111.802 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 pttp . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 122.825 0.45 . . . . 0.0 110.301 -177.286 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 8' ' ' VAL . 20.0 m . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -55.82 -43.9 77.39 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.911 0.757 . . . . 0.0 111.226 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -52.84 -49.74 65.14 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 123.73 0.643 . . . . 0.0 110.736 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -65.88 -40.21 91.4 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.071 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 4' ' ' THR . 67.2 t -66.71 -44.27 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 122.871 0.468 . . . . 0.0 110.315 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.01 96.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.15 0.98 . . . . 0.0 110.877 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -60.92 -47.69 85.27 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.644 0.778 . . . . 0.0 110.925 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.54 -50.77 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.445 0.698 . . . . 0.0 111.418 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.467 HG12 HG21 ' A' ' 43' ' ' ILE . 50.9 mt -57.46 -45.62 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.672 0.789 . . . . 0.0 110.553 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.14 -58.17 7.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.352 1.061 . . . . 0.0 112.662 174.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -64.84 -26.91 68.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.229 1.011 . . . . 0.0 112.052 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -76.88 -53.47 7.84 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.256 0.623 . . . . 0.0 110.695 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.483 ' SG ' HG12 ' A' ' 35' ' ' ILE . 37.7 t -100.04 9.2 43.25 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -166.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t70 55.65 59.83 3.64 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.761 0.791 . . . . 0.0 111.151 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.532 HG13 ' HA ' ' A' ' 13' ' ' ALA . 11.5 pt -141.78 148.19 48.42 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 123.729 0.812 . . . . 0.0 109.712 -177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.24 125.41 11.34 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.661 2.241 . . . . 0.0 110.568 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.647 ' HA ' HD13 ' A' ' 23' ' ' ILE . 7.6 ptt180 -68.61 -17.07 64.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.07 -24.85 60.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.388 0.675 . . . . 0.0 110.479 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -80.95 -13.24 59.08 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.613 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.647 HD13 ' HA ' ' A' ' 20' ' ' ARG . 2.7 mp -86.64 117.7 31.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.5 p -100.32 161.69 23.28 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.802 0.841 . . . . 0.0 109.045 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.7 -16.05 50.52 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 121.733 1.622 . . . . 0.0 112.823 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.69 3.33 50.26 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.791 -0.568 . . . . 0.0 111.064 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.7 m -77.78 135.81 38.03 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.433 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 59.5 t-80 -81.07 113.81 19.51 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.24 -23.17 55.02 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.433 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 61.9 mt -97.79 -54.13 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.171 0.588 . . . . 0.0 110.007 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.23 -43.67 41.08 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.826 0.851 . . . . 0.0 112.563 -167.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.81 -51.55 11.14 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.788 0.435 . . . . 0.0 110.049 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.9 mt -78.02 -5.78 52.43 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.926 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.65 27.93 73.57 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.566 0.541 . . . . 0.0 113.246 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.483 HG12 ' SG ' ' A' ' 16' ' ' CYS . 81.4 mt -95.86 124.29 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.976 0.911 . . . . 0.0 108.615 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.52 157.46 34.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.489 0.316 . . . . 0.0 110.999 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.449 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.6 m -63.02 -22.78 67.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.632 0.773 . . . . 0.0 110.75 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.5 mt -65.31 -51.37 61.08 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.75 0.82 . . . . 0.0 109.908 174.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.52 -31.46 71.58 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.58 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.405 ' CE2' HD21 ' A' ' 57' ' ' LEU . 30.0 t80 -74.91 -24.99 58.6 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.305 0.642 . . . . 0.0 110.973 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.503 HD23 HD12 ' A' ' 57' ' ' LEU . 80.1 mt -61.63 -42.27 98.65 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.061 0.544 . . . . 0.0 109.86 169.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -72.27 -37.42 69.05 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.888 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.467 HG21 HG12 ' A' ' 12' ' ' ILE . 67.5 mt -58.85 -50.74 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.817 174.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.24 -27.5 63.51 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.533 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -61.01 -46.35 91.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.803 0.841 . . . . 0.0 110.483 169.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.27 -34.87 76.96 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.141 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.2 mt -69.0 -44.04 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.932 0.893 . . . . 0.0 110.679 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -51.35 -48.6 62.39 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.388 1.475 . . . . 0.0 110.257 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -76.84 -38.58 53.55 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.572 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.87 -54.92 38.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.286 0.634 . . . . 0.0 112.304 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -84.58 -9.93 57.85 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.616 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.65 29.78 69.27 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 123.53 0.519 . . . . 0.0 112.858 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.544 HD13 HG23 ' A' ' 84' ' ' ILE . 42.6 pt -107.53 176.5 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.506 1.122 . . . . 0.0 109.735 -174.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.54 96.26 5.06 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.65 116.79 61.06 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 123.705 0.802 . . . . 0.0 109.859 171.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -84.3 57.4 5.24 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 122.651 2.234 . . . . 0.0 110.41 168.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.503 HD12 HD23 ' A' ' 41' ' ' LEU . 2.0 tm? -59.7 -41.76 91.46 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.516 1.127 . . . . 0.0 109.931 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 11.6 pt-20 -61.39 -39.27 90.1 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 124.24 0.963 . . . . 0.0 110.959 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -46.76 79.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.777 0.831 . . . . 0.0 110.107 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.466 ' O ' HG23 ' A' ' 64' ' ' VAL . 52.5 m0 -60.16 -40.14 88.88 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.936 1.397 . . . . 0.0 110.861 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 34.8 m -68.21 -35.15 77.52 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.494 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 90.3 mm-40 -73.15 -29.69 63.05 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.855 0.462 . . . . 0.0 110.521 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.464 ' HG2' ' HE3' ' A' ' 68' ' ' LYS . 49.0 mt-10 -65.78 -41.54 91.9 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.747 0.419 . . . . 0.0 110.199 173.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.663 HG11 HG23 ' A' ' 71' ' ' THR . 98.7 t -61.07 -43.15 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.6 175.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -62.08 -39.64 93.14 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.107 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -87.55 -5.18 58.88 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.674 0.79 . . . . 0.0 112.586 -174.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.96 12.01 85.03 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 115.042 0.777 . . . . 0.0 115.042 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HE3' ' HG2' ' A' ' 63' ' ' GLU . 55.1 mtmt -79.68 -26.97 40.81 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 117.725 0.762 . . . . 0.0 111.059 172.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -136.53 174.54 10.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.056 0.942 . . . . 0.0 109.327 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.7 m -133.86 148.57 51.29 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.485 1.114 . . . . 0.0 108.757 174.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.663 HG23 HG11 ' A' ' 64' ' ' VAL . 4.1 p -58.42 93.1 0.02 OUTLIER 'General case' 0 C--N 1.362 1.146 0 C-N-CA 123.512 0.725 . . . . 0.0 109.887 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.486 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.0 tm-20 175.86 -63.81 0.01 OUTLIER 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.134 1.374 . . . . 0.0 107.978 -174.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -51.26 -29.36 14.35 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.763 -1.562 . . . . 0.0 114.06 -173.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -132.92 0.61 3.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.061 0.544 . . . . 0.0 111.136 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -121.28 5.35 10.25 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.29 0.636 . . . . 0.0 111.295 -165.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 72' ' ' GLU . 71.7 t -105.34 146.1 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.464 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -52.39 -43.77 64.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.901 1.28 . . . . 0.0 114.251 -174.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -68.95 -42.32 76.83 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.754 0.422 . . . . 0.0 110.322 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 5.6 m120 -65.32 -47.33 76.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.447 0.699 . . . . 0.0 110.597 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.88 -50.77 69.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 110.223 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -62.43 -28.25 69.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.665 0.786 . . . . 0.0 111.261 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -69.99 -45.35 67.47 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.736 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 15.3 mmm180 -57.71 -46.63 84.13 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.331 0.652 . . . . 0.0 110.383 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.544 HG23 HD13 ' A' ' 53' ' ' ILE . 89.9 mt -59.08 -47.94 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 113.778 -1.556 . . . . 0.0 110.694 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.07 -46.34 82.57 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.079 0.862 . . . . 0.0 111.205 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 49.1 mt-10 -63.76 -35.28 80.08 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.101 0.56 . . . . 0.0 111.111 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.4 -32.09 62.57 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.976 0.51 . . . . 0.0 112.154 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 84' ' ' ILE . 98.0 t -64.72 -41.47 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-O 121.732 0.777 . . . . 0.0 109.405 171.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.62 -45.52 78.84 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.648 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.71 90.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.31 1.044 . . . . 0.0 112.145 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 88' ' ' VAL . 20.6 pttp . . . . . 0 N--CA 1.477 0.919 0 C-N-CA 122.453 0.301 . . . . 0.0 110.415 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.0 m . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -54.39 -50.26 67.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.35 0.66 . . . . 0.0 111.247 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.01 -42.0 98.68 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.574 0.546 . . . . 0.0 110.721 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -58.84 -48.27 81.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.724 0.81 . . . . 0.0 111.082 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 4' ' ' THR . 94.9 t -67.48 -44.87 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.57 0.748 . . . . 0.0 110.852 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.46 90.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.288 1.035 . . . . 0.0 110.375 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 92.8 m -63.4 -44.9 93.35 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.758 0.823 . . . . 0.0 111.29 175.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.596 HD13 ' HA ' ' A' ' 47' ' ' ILE . 95.2 mt -58.71 -48.16 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 122.967 0.507 . . . . 0.0 111.485 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 18' ' ' ILE . 57.1 mt -58.46 -45.88 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.645 0.778 . . . . 0.0 109.996 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.49 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.77 -51.84 62.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.853 1.261 . . . . 0.0 113.683 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 10' ' ' THR . 22.2 mm-40 -66.26 -27.78 68.21 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.386 0.675 . . . . 0.0 112.129 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 43' ' ' ILE . 96.1 m -76.56 -51.63 11.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.929 0.492 . . . . 0.0 111.054 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.6 m -99.59 7.03 45.59 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.59 0.756 . . . . 0.0 112.515 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 48.25 70.6 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.526 1.13 . . . . 0.0 111.749 -174.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.49 HG13 ' HA ' ' A' ' 13' ' ' ALA . 10.3 pt -144.78 146.58 32.24 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 124.138 0.975 . . . . 0.0 109.605 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.45 116.69 4.2 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.919 2.413 . . . . 0.0 112.207 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -23.91 67.44 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -170.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -90.76 -6.36 54.48 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.142 0.577 . . . . 0.0 110.891 -171.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -89.02 -13.03 39.72 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 167.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.422 HD11 HD12 ' A' ' 18' ' ' ILE . 2.0 mp -79.19 105.77 9.1 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 171.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -77.25 159.94 76.74 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.435 0.694 . . . . 0.0 109.735 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.57 -17.02 58.13 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 121.988 1.792 . . . . 0.0 112.196 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -99.74 9.85 42.36 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 122.909 0.484 . . . . 0.0 110.427 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.0 m -72.13 124.33 24.77 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 122.57 0.348 . . . . 0.0 110.07 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -83.6 117.09 22.93 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.71 -41.43 15.05 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.206 1.003 . . . . 0.0 113.37 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.71 -50.2 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 122.464 0.306 . . . . 0.0 110.457 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.27 -38.33 24.56 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.943 0.897 . . . . 0.0 112.397 -171.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.17 -57.05 2.83 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.186 0.595 . . . . 0.0 110.35 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 29' ' ' ALA . 88.7 mt -76.29 -10.53 59.47 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.888 0.875 . . . . 0.0 111.977 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.26 30.38 77.61 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 123.412 0.445 . . . . 0.0 113.993 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.1 mt -89.39 126.24 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.27 147.92 38.54 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.213 0.605 . . . . 0.0 110.692 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -60.56 -35.74 76.77 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.726 0.41 . . . . 0.0 111.144 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 39' ' ' ASP . 3.0 pp -73.86 -31.65 63.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.186 0.594 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.454 ' N ' HD12 ' A' ' 38' ' ' LEU . 15.5 t70 -72.82 -35.99 67.41 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.483 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -71.72 -21.78 61.72 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.075 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.8 mt -56.85 -41.72 78.4 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 122.625 0.37 . . . . 0.0 110.426 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.09 -32.62 63.32 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.057 0.943 . . . . 0.0 111.51 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.539 HG12 HG21 ' A' ' 15' ' ' THR . 37.9 mt -65.26 -46.59 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.13 -29.15 67.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.907 0.883 . . . . 0.0 111.143 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -58.21 -50.87 72.04 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.006 1.322 . . . . 0.0 110.786 170.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.92 -33.49 74.78 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.871 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.596 ' HA ' HD13 ' A' ' 11' ' ' ILE . 85.9 mt -67.47 -51.32 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.186 0.594 . . . . 0.0 110.888 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.85 -37.33 86.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.039 0.535 . . . . 0.0 110.344 -170.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -81.38 -29.04 34.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.4 -48.24 76.17 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.322 0.388 . . . . 0.0 111.592 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.406 ' HB2' HG12 ' A' ' 53' ' ' ILE . 86.7 m-85 -83.12 -16.47 46.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.508 0.723 . . . . 0.0 111.821 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.12 37.58 87.25 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.382 0.426 . . . . 0.0 112.519 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.479 HG22 ' HG2' ' A' ' 91' ' ' LYS . 46.3 pt -116.35 172.82 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.585 1.154 . . . . 0.0 111.026 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.62 97.82 6.36 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.385 1.074 . . . . 0.0 108.454 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.545 HD21 HG12 ' A' ' 84' ' ' ILE . 79.3 mt -73.18 120.42 80.9 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 123.035 0.534 . . . . 0.0 110.071 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.56 57.82 6.7 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.758 2.305 . . . . 0.0 110.835 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -63.83 -40.99 97.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.416 1.086 . . . . 0.0 109.818 -173.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.26 -37.88 88.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.502 0.721 . . . . 0.0 111.371 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -71.01 -37.97 72.63 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.853 0.861 . . . . 0.0 110.238 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -63.59 -52.79 59.42 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.944 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.3 m -62.52 -33.3 74.62 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.084 0.954 . . . . 0.0 110.895 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -63.22 -58.65 6.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.429 0.691 . . . . 0.0 109.837 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 44.4 mt-10 -66.04 -32.23 73.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.854 0.862 . . . . 0.0 111.82 -176.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.8 t -61.63 -55.01 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.683 0.793 . . . . 0.0 110.165 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -78.97 -7.7 58.27 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.699 0.399 . . . . 0.0 111.787 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -92.85 -2.92 55.47 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.342 0.657 . . . . 0.0 110.74 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.71 5.24 86.19 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 115.888 1.115 . . . . 0.0 115.888 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 60.6 mttp -70.43 -31.59 68.84 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.075 0.937 . . . . 0.0 110.277 171.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.43 163.27 32.96 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.326 1.051 . . . . 0.0 108.819 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 p -104.72 162.28 13.43 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.442 0.697 . . . . 0.0 109.643 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.5 p -59.38 -52.5 65.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.157 0.583 . . . . 0.0 112.332 -169.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -56.02 -31.52 63.17 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -50.07 -33.59 18.91 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.36 1.064 . . . . 0.0 113.318 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -122.12 -19.59 6.53 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -111.91 23.4 13.83 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 122.571 0.348 . . . . 0.0 111.198 -171.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 78' ' ' LYS . 40.3 t -110.27 142.26 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 162.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.17 -41.4 68.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.389 1.476 . . . . 0.0 114.267 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HG2' HG12 ' A' ' 76' ' ' VAL . 58.9 pttt -66.77 -37.79 85.29 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 120.786 0.327 . . . . 0.0 110.954 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 73.3 m-20 -80.39 -37.93 31.3 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.878 0.871 . . . . 0.0 110.817 -176.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.38 -53.21 52.07 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.242 1.017 . . . . 0.0 108.857 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.47 -22.58 65.47 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.689 0.795 . . . . 0.0 111.914 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.11 -53.94 37.66 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.66 0.384 . . . . 0.0 110.058 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 28.1 mmm180 -60.92 -40.37 92.93 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 124.101 0.876 . . . . 0.0 111.205 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.545 HG12 HD21 ' A' ' 55' ' ' LEU . 92.3 mt -61.52 -50.31 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.281 1.032 . . . . 0.0 110.31 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.402 ' HB2' HG21 ' A' ' 4' ' ' THR . 27.6 t70 -63.34 -34.94 78.8 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.118 0.567 . . . . 0.0 111.496 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.85 -44.12 90.94 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.487 0.715 . . . . 0.0 109.981 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.2 -42.04 76.3 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.16 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 84' ' ' ILE . 61.6 t -61.65 -45.69 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 123.464 0.706 . . . . 0.0 110.333 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.98 -43.11 99.3 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.511 176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.01 -42.67 76.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.621 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 C-N-CA 122.668 0.387 . . . . 0.0 110.146 -174.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.6 m . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -54.89 -48.13 73.4 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.736 0.647 . . . . 0.0 111.016 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.93 -42.85 94.87 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.785 0.678 . . . . 0.0 110.934 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -57.44 -45.76 84.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.498 0.719 . . . . 0.0 111.221 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.8 t -71.4 -33.97 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 123.712 0.632 . . . . 0.0 110.77 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.86 -36.42 83.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.549 0.739 . . . . 0.0 110.481 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 m -66.82 -44.01 82.27 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.56 0.744 . . . . 0.0 110.739 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.8 mt -56.42 -54.53 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.646 0.778 . . . . 0.0 110.724 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.578 HD12 HD11 ' A' ' 77' ' ' LEU . 35.8 mt -60.08 -45.38 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.15 0.98 . . . . 0.0 110.66 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -51.88 -51.27 57.98 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 123.825 0.703 . . . . 0.0 112.319 174.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -67.86 -30.17 69.47 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.499 0.72 . . . . 0.0 112.332 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -74.81 -61.0 2.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.254 0.622 . . . . 0.0 110.938 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.8 m -90.49 10.79 23.93 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.016 0.927 . . . . 0.0 112.953 -168.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.4 t70 48.7 68.09 0.76 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.651 1.18 . . . . 0.0 111.565 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.467 HG13 ' HA ' ' A' ' 13' ' ' ALA . 12.1 pt -145.26 142.96 18.95 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.718 1.207 . . . . 0.0 108.699 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.67 139.36 69.08 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.523 2.149 . . . . 0.0 112.55 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -56.33 -31.5 63.78 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.144 1.378 . . . . 0.0 111.952 -173.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -77.25 -18.81 57.33 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.99 0.516 . . . . 0.0 111.901 -172.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -78.93 -11.32 60.0 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.046 0.385 . . . . 0.0 111.398 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.4 mp -86.18 102.05 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 27' ' ' SER . 64.3 p -81.18 154.04 72.07 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.118 0.567 . . . . 0.0 109.77 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.94 -30.22 83.22 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.335 2.024 . . . . 0.0 112.524 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -97.8 13.08 31.73 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.824 0.45 . . . . 0.0 110.947 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.419 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 46.9 t -72.24 129.67 38.98 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.968 0.507 . . . . 0.0 109.69 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -83.21 114.62 21.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 167.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.69 -41.66 10.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.022 0.929 . . . . 0.0 112.977 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.6 mt -88.62 -59.63 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -172.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.19 -36.46 84.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.739 1.216 . . . . 0.0 112.728 -173.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -98.39 -65.59 0.95 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.282 0.633 . . . . 0.0 110.759 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.48 -18.49 62.98 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.37 41.66 36.83 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 112.366 -0.293 . . . . 0.0 112.366 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.5 mt -99.75 107.88 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.25 168.32 18.54 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.4 t -52.46 -37.93 58.14 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.466 1.106 . . . . 0.0 111.783 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.23 -26.06 58.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.056 0.543 . . . . 0.0 111.898 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.4 -41.38 47.98 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 175.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -68.95 -23.13 64.11 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.889 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.4 mt -52.27 -49.86 63.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.159 0.583 . . . . 0.0 111.207 171.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.34 -38.02 71.68 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.826 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.533 HD13 HG12 ' A' ' 12' ' ' ILE . 81.5 mt -65.26 -44.79 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.519 0.728 . . . . 0.0 110.614 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -70.34 -37.16 74.62 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.284 0.633 . . . . 0.0 110.293 -177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -71.63 -27.57 63.19 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.367 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.72 63.92 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.837 0.351 . . . . 0.0 110.627 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 84' ' ' ILE . 87.0 mt -69.37 -38.19 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.072 0.949 . . . . 0.0 109.793 171.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 5.9 t70 -58.09 -42.81 86.44 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.823 0.849 . . . . 0.0 111.137 174.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -67.94 -54.06 21.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.931 0.892 . . . . 0.0 110.561 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.13 -55.7 31.7 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.19 0.996 . . . . 0.0 112.605 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -91.05 -13.74 32.64 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.489 0.716 . . . . 0.0 112.433 -171.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.53 34.63 79.47 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-O 121.202 0.335 . . . . 0.0 113.494 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.638 HG22 ' HG2' ' A' ' 91' ' ' LYS . 44.6 pt -120.21 153.03 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.18 0.992 . . . . 0.0 109.149 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -100.59 106.95 18.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.4 mt -69.96 125.05 91.8 Favored Pre-proline 0 C--N 1.348 0.513 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 170.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 78.0 Cg_endo -78.17 57.25 6.1 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.387 2.058 . . . . 0.0 111.104 172.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.54 -38.37 89.72 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.346 1.058 . . . . 0.0 110.425 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.98 -36.52 79.65 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.638 0.375 . . . . 0.0 111.833 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.31 -37.37 60.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.498 0.719 . . . . 0.0 110.374 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.436 ' O ' HG23 ' A' ' 64' ' ' VAL . 48.1 m0 -62.93 -50.97 68.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.925 0.89 . . . . 0.0 110.569 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.3 m -64.0 -31.85 73.18 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.259 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -68.62 -42.89 77.45 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.012 0.525 . . . . 0.0 110.84 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.33 -42.53 99.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.905 0.482 . . . . 0.0 110.615 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 60' ' ' TRP . 61.2 t -61.05 -49.96 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.593 0.711 . . . . 0.0 110.161 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -56.76 -41.44 77.59 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.421 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -99.62 17.38 20.65 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.094 0.958 . . . . 0.0 111.48 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.29 14.22 52.85 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 115.107 0.803 . . . . 0.0 115.107 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -80.78 -24.73 38.4 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.795 0.838 . . . . 0.0 110.396 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.85 173.33 12.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.173 0.989 . . . . 0.0 109.874 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.8 p -106.89 164.76 11.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.293 0.637 . . . . 0.0 109.694 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.0 p -57.45 -49.67 75.51 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.428 0.455 . . . . 0.0 110.475 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.483 ' HA ' HG23 ' A' ' 76' ' ' VAL . 29.8 mt-10 -39.1 -50.99 1.89 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.711 1.604 . . . . 0.0 113.26 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -59.59 -24.21 63.58 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.334 -1.303 . . . . 0.0 113.288 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -120.01 -22.79 6.57 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.935 0.494 . . . . 0.0 112.026 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.85 19.71 14.98 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.281 0.632 . . . . 0.0 110.749 -167.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' ' 72' ' ' GLU . 79.8 t -105.63 139.97 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 161.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.578 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -56.52 -40.48 75.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.837 1.255 . . . . 0.0 113.936 -172.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.3 pttt -72.58 -38.7 67.82 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.586 0.355 . . . . 0.0 111.216 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -71.97 -45.69 60.1 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.544 0.738 . . . . 0.0 109.888 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.2 tp -53.73 -48.05 70.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.913 1.285 . . . . 0.0 110.299 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -31.98 73.21 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.673 0.608 . . . . 0.0 111.759 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.98 77.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.769 0.427 . . . . 0.0 110.479 175.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -60.28 -44.75 95.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.319 0.58 . . . . 0.0 111.234 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 47' ' ' ILE . 90.3 mt -65.52 -46.64 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.276 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.54 -38.71 88.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.395 0.678 . . . . 0.0 110.991 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -59.41 -50.87 72.29 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.578 0.549 . . . . 0.0 110.733 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.04 -35.68 81.2 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.69 0.619 . . . . 0.0 112.219 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 84' ' ' ILE . 70.6 t -67.17 -47.26 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.395 0.678 . . . . 0.0 110.546 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.79 -32.4 73.67 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.712 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -46.91 68.93 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 123.482 0.713 . . . . 0.0 111.434 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.638 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 123.042 0.537 . . . . 0.0 110.626 -174.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -52.9 -51.23 61.95 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.715 0.806 . . . . 0.0 110.866 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -60.86 -44.9 96.41 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.163 0.914 . . . . 0.0 111.421 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -64.81 -40.58 95.45 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.329 0.651 . . . . 0.0 111.44 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.469 HG13 HD11 ' A' ' 47' ' ' ILE . 69.6 t -72.39 -36.57 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.193 0.597 . . . . 0.0 110.474 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.34 -35.47 80.98 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.721 0.808 . . . . 0.0 110.64 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.7 m -65.24 -48.07 74.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.818 0.847 . . . . 0.0 110.896 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.411 HG22 HG23 ' A' ' 43' ' ' ILE . 78.5 mt -58.0 -46.86 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.494 0.718 . . . . 0.0 110.776 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.454 HD12 HD11 ' A' ' 77' ' ' LEU . 55.4 mt -61.89 -48.93 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.673 0.789 . . . . 0.0 110.854 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.57 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.18 -44.46 64.68 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.212 1.005 . . . . 0.0 112.575 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -66.25 -43.74 85.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.143 0.977 . . . . 0.0 111.798 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.9 m -75.49 -50.95 14.15 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.727 0.411 . . . . 0.0 111.527 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.8 m -89.67 3.82 51.47 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.265 1.026 . . . . 0.0 111.886 -174.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.0 t70 50.54 75.0 0.19 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.256 1.422 . . . . 0.0 112.416 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.57 HG13 ' HA ' ' A' ' 13' ' ' ALA . 3.4 pt -148.21 157.5 42.53 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 124.629 1.172 . . . . 0.0 109.474 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.58 137.7 47.18 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.361 2.041 . . . . 0.0 110.993 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.422 ' HA ' HD13 ' A' ' 23' ' ' ILE . 25.5 ttm180 -57.63 -30.54 65.45 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.973 0.909 . . . . 0.0 112.5 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.86 -21.65 60.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.994 0.918 . . . . 0.0 111.26 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -80.66 -6.7 58.73 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 122.777 0.431 . . . . 0.0 111.146 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 20' ' ' ARG . 3.8 mp -90.99 112.04 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 170.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.4 p -95.65 160.73 29.72 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 123.32 0.648 . . . . 0.0 110.425 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -60.16 -33.31 95.07 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.23 1.953 . . . . 0.0 112.877 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -94.49 11.24 31.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.945 0.898 . . . . 0.0 110.954 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.8 t -79.22 128.52 33.41 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 123.177 0.591 . . . . 0.0 110.324 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -83.18 118.9 23.92 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.97 -40.77 23.35 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.55 -45.39 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 O-C-N 122.187 -0.32 . . . . 0.0 110.211 -169.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -82.99 -32.8 26.8 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.818 0.847 . . . . 0.0 112.316 -173.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.91 -64.25 1.06 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.366 0.666 . . . . 0.0 109.965 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.439 HD13 HG21 ' A' ' 12' ' ' ILE . 82.8 mt -69.77 -11.19 60.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.155 0.582 . . . . 0.0 111.489 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.84 31.91 79.59 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.55 0.531 . . . . 0.0 113.153 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -82.97 122.95 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -61.36 146.1 49.31 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.746 0.419 . . . . 0.0 110.063 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.437 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 37.3 m -59.65 -34.68 73.12 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.506 0.722 . . . . 0.0 111.807 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.1 mt -73.7 -34.48 64.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.439 0.696 . . . . 0.0 110.032 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -73.89 -30.63 62.72 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.461 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -75.76 -23.67 55.99 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.661 0.384 . . . . 0.0 110.54 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 37' ' ' SER . 96.5 mt -63.76 -39.46 94.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.862 0.465 . . . . 0.0 109.84 169.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -65.97 -45.56 81.23 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.89 0.876 . . . . 0.0 110.619 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.411 HG23 HG22 ' A' ' 11' ' ' ILE . 63.4 mt -62.97 -40.21 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.622 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.94 -35.93 77.35 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.431 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -74.63 -25.17 59.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.609 0.764 . . . . 0.0 110.941 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.97 -41.15 68.06 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.996 0.518 . . . . 0.0 110.559 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.469 HD11 HG13 ' A' ' 8' ' ' VAL . 89.8 mt -65.55 -40.48 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.295 1.038 . . . . 0.0 110.061 173.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -55.27 -47.74 75.05 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.02 1.328 . . . . 0.0 109.714 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -67.84 -50.58 55.87 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.52 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.02 -51.77 68.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.963 0.905 . . . . 0.0 112.114 -172.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.17 -5.26 59.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.908 0.883 . . . . 0.0 111.456 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.3 30.81 75.85 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.193 0.308 . . . . 0.0 113.64 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.36 170.66 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.41 1.084 . . . . 0.0 109.869 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -104.97 111.03 23.66 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 168.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.591 HD21 HG12 ' A' ' 84' ' ' ILE . 42.6 mt -73.9 118.28 68.08 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -79.25 58.38 6.92 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.626 2.217 . . . . 0.0 109.706 170.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.58 -37.15 85.08 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.053 0.941 . . . . 0.0 109.118 -174.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.3 -45.58 90.74 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.383 0.673 . . . . 0.0 111.143 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -62.23 -40.71 97.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.866 0.866 . . . . 0.0 110.462 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.45 ' O ' HG23 ' A' ' 64' ' ' VAL . 54.1 m0 -63.66 -45.87 88.18 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.318 1.011 . . . . 0.0 109.87 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.5 m -62.06 -33.96 75.39 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.054 0.846 . . . . 0.0 110.932 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -72.2 -44.58 62.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.937 0.495 . . . . 0.0 110.513 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.26 -36.39 77.68 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.393 0.677 . . . . 0.0 110.816 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 60' ' ' TRP . 72.9 t -67.14 -49.94 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.829 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -59.23 -44.87 92.31 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.721 0.808 . . . . 0.0 112.063 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -86.35 6.67 28.92 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.981 0.912 . . . . 0.0 111.538 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.94 23.05 67.24 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.461 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -75.65 -30.53 59.47 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.372 0.669 . . . . 0.0 109.554 174.473 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.79 160.47 42.22 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.545 1.138 . . . . 0.0 109.371 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.4 p -83.85 162.83 20.43 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.117 0.567 . . . . 0.0 110.251 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 82.4 p -58.53 -55.43 35.19 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.53 0.681 . . . . 0.0 109.859 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.5 -33.86 64.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.299 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -55.57 -26.74 45.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 123.877 0.736 . . . . 0.0 112.529 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -119.6 -28.69 5.24 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.88 0.472 . . . . 0.0 112.156 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.59 16.95 25.06 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.99 0.516 . . . . 0.0 112.025 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.487 HG12 ' HG2' ' A' ' 78' ' ' LYS . 22.9 t -107.5 142.68 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 167.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -56.99 -41.69 78.88 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.001 1.32 . . . . 0.0 114.509 -170.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.9 pttt -65.65 -40.72 92.78 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.357 0.599 . . . . 0.0 110.312 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.34 -44.48 44.94 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.735 1.214 . . . . 0.0 110.499 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.69 -51.14 70.74 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.218 1.407 . . . . 0.0 109.977 176.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.85 -33.37 74.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.737 0.815 . . . . 0.0 111.658 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.67 -50.17 65.92 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.566 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -55.1 -46.65 75.53 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.594 1.158 . . . . 0.0 111.688 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.591 HG12 HD21 ' A' ' 55' ' ' LEU . 93.2 mt -60.26 -48.71 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.787 1.235 . . . . 0.0 110.464 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.15 -31.23 71.96 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.884 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.91 -41.86 95.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.116 0.566 . . . . 0.0 110.302 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.94 -27.93 65.16 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.429 0.692 . . . . 0.0 111.186 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.425 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 61.0 t -71.22 -36.36 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.623 0.769 . . . . 0.0 110.234 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.67 84.34 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.007 173.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.25 -40.07 82.07 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.721 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 13.5 ptmm? . . . . . 0 N--CA 1.487 1.386 0 CA-C-N 118.064 0.393 . . . . 0.0 111.334 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 8' ' ' VAL . 90.5 m . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -55.15 -40.45 70.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.994 0.918 . . . . 0.0 111.799 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -56.61 -47.57 79.37 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.295 0.638 . . . . 0.0 110.537 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -66.77 -38.31 86.33 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.82 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 4' ' ' THR . 87.1 t -66.81 -44.16 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.309 0.644 . . . . 0.0 110.616 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.54 -44.91 85.52 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.442 1.097 . . . . 0.0 110.107 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 57.7 m -59.89 -48.34 82.11 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.559 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -57.83 -47.69 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.743 0.817 . . . . 0.0 111.828 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.478 HG22 HD11 ' A' ' 18' ' ' ILE . 41.0 mt -58.3 -44.27 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.812 0.845 . . . . 0.0 110.526 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . . . -57.87 -44.3 86.55 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.143 0.977 . . . . 0.0 112.569 174.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.1 mm-40 -63.1 -36.22 82.87 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.421 0.688 . . . . 0.0 111.632 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -78.72 -59.44 2.78 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.817 -173.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -101.1 18.13 20.6 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.466 0.706 . . . . 0.0 112.853 -166.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.2 t70 47.72 66.1 1.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.304 1.041 . . . . 0.0 111.9 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 12' ' ' ILE . 3.5 pt -142.54 147.34 42.4 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 123.804 0.841 . . . . 0.0 109.739 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.02 116.17 4.57 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.656 2.237 . . . . 0.0 112.361 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.559 ' HA ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -63.41 -17.29 62.5 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -176.263 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.53 -30.89 70.66 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.729 0.812 . . . . 0.0 110.525 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -85.25 -14.42 46.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.341 0.656 . . . . 0.0 110.781 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.559 HD13 ' HA ' ' A' ' 20' ' ' ARG . 1.8 mp -78.01 108.41 11.3 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.8 p -91.27 157.46 42.57 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 123.573 0.749 . . . . 0.0 109.672 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.95 -17.92 56.4 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.237 1.958 . . . . 0.0 112.456 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -100.05 6.53 45.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.192 0.597 . . . . 0.0 110.489 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -78.85 138.72 38.29 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.37 0.668 . . . . 0.0 110.516 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.411 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 50.7 t-80 -86.28 114.04 22.77 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.547 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -51.05 -37.24 44.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.854 0.862 . . . . 0.0 113.212 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.411 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 63.7 mt -89.88 -54.06 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -174.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.76 -39.17 27.34 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.416 0.687 . . . . 0.0 112.544 -168.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -88.25 -55.11 3.88 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 29' ' ' ALA . 73.7 mt -75.09 -8.66 57.19 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.79 29.01 74.18 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.446 0.466 . . . . 0.0 113.82 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -88.04 124.98 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -75.87 160.51 29.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.125 0.57 . . . . 0.0 110.109 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.464 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 15.3 m -57.69 -34.08 69.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.998 0.919 . . . . 0.0 111.782 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.71 -37.61 76.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.86 0.464 . . . . 0.0 110.686 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -67.48 -42.35 83.12 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.54 0.736 . . . . 0.0 109.95 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -65.46 -28.59 69.33 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 124.392 1.057 . . . . 0.0 110.967 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 37' ' ' SER . 70.7 mt -61.79 -42.15 98.63 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.895 0.478 . . . . 0.0 110.749 174.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.46 -35.21 60.94 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.063 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.7 -47.75 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.781 0.676 . . . . 0.0 109.384 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.37 -30.08 63.06 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.098 0.959 . . . . 0.0 110.654 -174.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -62.59 -43.68 98.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.644 0.778 . . . . 0.0 110.89 171.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.4 -31.84 65.88 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.099 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.15 -45.41 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.468 0.707 . . . . 0.0 110.314 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -52.01 -49.29 63.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.877 1.271 . . . . 0.0 110.312 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -72.34 -49.62 32.92 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.014 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.06 98.78 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -89.77 -3.78 57.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.382 0.673 . . . . 0.0 112.378 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.4 45.45 96.38 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 123.779 0.674 . . . . 0.0 113.072 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.54 179.73 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.555 1.142 . . . . 0.0 110.186 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -122.35 113.2 19.07 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.422 HD22 ' HH2' ' A' ' 60' ' ' TRP . 83.4 mt -78.63 125.81 83.78 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 122.797 0.439 . . . . 0.0 110.41 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.19 54.95 5.41 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.205 2.603 . . . . 0.0 110.422 166.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.68 -39.94 86.19 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.91 1.284 . . . . 0.0 109.591 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -56.73 -41.81 78.16 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 124.259 0.974 . . . . 0.0 111.813 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -65.81 -43.48 88.52 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.156 0.582 . . . . 0.0 110.13 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.422 ' HH2' HD22 ' A' ' 55' ' ' LEU . 42.1 m0 -60.73 -50.14 74.66 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.627 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.1 m -60.89 -43.83 97.95 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.134 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -70.38 -40.32 74.03 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.765 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -60.43 -39.6 88.04 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.974 0.51 . . . . 0.0 111.446 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.06 -48.89 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.372 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -66.72 -28.71 68.65 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.133 0.973 . . . . 0.0 112.804 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -80.89 -3.4 51.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.181 0.592 . . . . 0.0 112.474 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.67 21.29 72.79 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 117.465 0.121 . . . . 0.0 113.333 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -79.46 -25.83 41.85 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.727 0.811 . . . . 0.0 110.239 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.71 171.15 19.3 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.27 1.028 . . . . 0.0 108.992 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.9 p -104.81 168.02 9.34 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 171.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.7 p -56.48 -41.78 77.16 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.314 0.384 . . . . 0.0 111.888 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HA ' HG23 ' A' ' 76' ' ' VAL . 14.0 pt-20 -51.09 -40.84 59.34 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -175.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -57.45 -28.77 63.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.594 0.757 . . . . 0.0 112.773 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -114.5 -29.59 6.8 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.748 0.419 . . . . 0.0 112.092 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.08 24.67 12.62 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.556 0.742 . . . . 0.0 111.114 -166.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.518 HG12 ' HG2' ' A' ' 78' ' ' LYS . 43.7 t -104.64 141.25 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 160.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -54.52 -39.59 67.78 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.172 1.389 . . . . 0.0 114.584 -169.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.7 pttt -64.39 -42.19 96.25 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -75.38 -40.49 57.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.435 1.094 . . . . 0.0 110.155 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.3 tp -61.08 -53.36 58.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.436 1.094 . . . . 0.0 109.453 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.21 -27.36 68.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.618 0.767 . . . . 0.0 112.037 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.66 -48.59 63.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.008 0.523 . . . . 0.0 110.409 174.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.4 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 1.1 mmp_? -56.88 -46.07 82.09 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 124.443 1.089 . . . . 0.0 110.801 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 88' ' ' VAL . 84.1 mt -64.03 -52.82 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.203 1.001 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.5 -41.77 90.65 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.076 0.95 . . . . 0.0 112.456 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.19 -30.21 68.35 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.376 0.423 . . . . 0.0 110.339 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.92 -35.74 69.76 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.745 0.418 . . . . 0.0 111.666 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 84' ' ' ILE . 61.6 t -65.28 -41.32 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.473 0.654 . . . . 0.0 109.487 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.17 -37.52 81.08 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.85 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.47 97.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.458 0.703 . . . . 0.0 111.587 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.946 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.468 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 8' ' ' VAL . 86.6 m . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -54.88 -45.18 74.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.507 1.123 . . . . 0.0 111.447 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.54 -47.03 85.55 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.786 0.679 . . . . 0.0 110.573 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.405 ' HB2' ' HZ ' ' A' ' 51' ' ' PHE . 39.1 mmt-85 -67.22 -37.85 84.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.056 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 4' ' ' THR . 97.8 t -73.36 -35.15 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.352 0.661 . . . . 0.0 110.511 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.69 91.9 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.554 0.742 . . . . 0.0 109.953 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 56.0 m -63.15 -46.26 88.05 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.013 0.821 . . . . 0.0 110.455 172.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.2 mt -57.8 -46.56 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.211 1.004 . . . . 0.0 111.154 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.544 HG22 HD11 ' A' ' 18' ' ' ILE . 50.6 mt -58.12 -49.81 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.039 0.936 . . . . 0.0 110.747 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.07 -44.4 71.11 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.989 0.916 . . . . 0.0 112.974 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 10' ' ' THR . 18.2 mm-40 -63.84 -32.14 73.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.916 0.886 . . . . 0.0 111.753 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.8 m -86.65 -34.3 19.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.408 0.683 . . . . 0.0 112.095 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.2 m -113.16 1.42 15.25 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.842 0.457 . . . . 0.0 112.167 -164.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 50.27 68.25 0.79 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.259 1.423 . . . . 0.0 112.246 -177.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.561 HD12 HD11 ' A' ' 23' ' ' ILE . 11.6 pt -145.97 157.86 49.75 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 124.551 1.14 . . . . 0.0 109.269 -177.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.43 120.71 6.65 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.772 2.315 . . . . 0.0 110.768 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HA ' HD13 ' A' ' 23' ' ' ILE . 1.2 ppt_? -64.66 -25.18 67.84 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -170.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -82.98 -11.97 57.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.605 0.762 . . . . 0.0 111.381 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -83.0 -18.38 40.03 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.459 0.303 . . . . 0.0 110.38 173.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.561 HD11 HD12 ' A' ' 18' ' ' ILE . 2.0 mp -74.76 117.06 18.31 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.1 p -91.54 158.84 39.97 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.133 0.973 . . . . 0.0 109.719 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.72 -21.56 56.72 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.414 2.076 . . . . 0.0 113.257 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -92.28 3.75 54.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.287 0.635 . . . . 0.0 111.161 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -71.99 123.15 22.15 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -84.0 119.47 24.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 169.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.63 -44.02 12.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.252 1.021 . . . . 0.0 112.722 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.19 -46.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 120.681 0.277 . . . . 0.0 110.322 -168.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.43 -35.79 24.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.338 0.655 . . . . 0.0 111.978 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -93.59 -55.45 3.27 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.313 0.645 . . . . 0.0 110.612 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.8 mt -82.21 -12.58 58.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.509 0.724 . . . . 0.0 112.218 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.86 34.21 86.47 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 113.897 0.319 . . . . 0.0 113.897 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 12' ' ' ILE . 90.1 mt -88.09 125.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.976 0.91 . . . . 0.0 108.675 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -72.39 158.99 34.73 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 37.6 m -62.21 -26.64 68.47 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.07 0.548 . . . . 0.0 111.637 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.65 -33.76 60.46 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 122.904 0.482 . . . . 0.0 110.384 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.27 -39.18 75.11 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.172 0.589 . . . . 0.0 109.519 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -66.15 -23.65 66.51 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.503 0.721 . . . . 0.0 110.236 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 37' ' ' SER . 90.7 mt -62.61 -37.0 84.56 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.064 0.546 . . . . 0.0 110.714 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -69.99 -39.16 76.06 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.312 0.645 . . . . 0.0 110.2 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 12' ' ' ILE . 2.4 mp -60.43 -47.32 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 123.617 0.573 . . . . 0.0 109.661 174.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.78 -37.7 82.4 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.724 0.809 . . . . 0.0 111.173 -174.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.76 -50.18 74.83 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.76 1.224 . . . . 0.0 111.068 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.83 -30.84 70.34 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.729 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.503 HD13 HD11 ' A' ' 84' ' ' ILE . 97.2 mt -65.77 -44.73 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.59 0.756 . . . . 0.0 110.646 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.53 -49.72 64.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.484 1.114 . . . . 0.0 110.803 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -76.52 -48.47 19.33 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.754 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.93 74.81 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.074 0.55 . . . . 0.0 112.375 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.405 ' HZ ' ' HB2' ' A' ' 7' ' ' ARG . 98.5 m-85 -86.74 -3.24 59.02 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.852 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.16 35.52 91.65 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.651 0.594 . . . . 0.0 113.003 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.9 pt -124.94 -177.13 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.712 1.205 . . . . 0.0 109.209 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -130.04 126.06 36.76 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 168.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.9 mt -80.81 128.18 72.52 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -73.02 59.33 3.6 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.933 2.422 . . . . 0.0 110.702 165.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.68 -39.66 89.25 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.368 1.067 . . . . 0.0 109.748 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.77 -44.96 82.31 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 124.005 0.815 . . . . 0.0 110.463 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.7 tppt? -68.8 -44.49 73.46 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 111.259 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -57.61 -52.39 65.6 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.039 0.837 . . . . 0.0 110.55 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.2 m -71.06 -24.78 62.4 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.481 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -69.27 -47.63 64.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.652 0.781 . . . . 0.0 110.725 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 21.2 mm-40 -60.17 -40.57 90.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.499 0.72 . . . . 0.0 110.735 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 53.4 t -59.78 -56.34 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.905 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -62.23 -33.49 74.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.647 0.779 . . . . 0.0 111.908 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -87.44 4.99 41.09 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.347 0.659 . . . . 0.0 111.754 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.45 25.87 70.35 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -91.67 -27.58 18.01 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.275 0.63 . . . . 0.0 110.731 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -139.18 152.06 47.09 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 m -81.57 156.47 25.19 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.007 0.523 . . . . 0.0 109.639 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.5 p -52.93 -46.58 68.16 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.853 0.861 . . . . 0.0 110.856 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.544 ' HA ' HG23 ' A' ' 76' ' ' VAL . 9.3 mm-40 -42.83 -52.75 4.93 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.152 1.381 . . . . 0.0 112.588 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -54.76 -21.25 10.47 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.271 -1.331 . . . . 0.0 114.021 -169.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -121.71 -29.79 4.28 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -108.03 15.04 24.68 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -168.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 72' ' ' GLU . 71.6 t -103.22 139.56 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.408 HD11 HD12 ' A' ' 12' ' ' ILE . 3.9 mm? -53.35 -38.15 63.03 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.233 1.413 . . . . 0.0 114.023 -173.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.9 pttp -70.33 -41.0 73.81 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 120.769 0.318 . . . . 0.0 111.097 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 80.1 m-20 -74.81 -34.67 62.42 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.926 0.89 . . . . 0.0 110.241 -177.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.97 -44.76 72.27 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.821 1.248 . . . . 0.0 108.871 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.51 -37.54 78.55 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.877 0.735 . . . . 0.0 111.098 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.73 71.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.672 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 9.6 mmp_? -50.54 -53.01 33.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.197 0.936 . . . . 0.0 111.419 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.503 HD11 HD13 ' A' ' 47' ' ' ILE . 71.2 mt -65.6 -43.9 93.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.625 -175.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.58 -39.64 88.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.623 0.769 . . . . 0.0 111.223 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.91 -35.05 77.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.524 0.73 . . . . 0.0 110.841 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.2 mt -73.67 -30.29 62.81 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.02 0.528 . . . . 0.0 111.352 176.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.497 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 69.5 t -71.02 -36.93 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.637 0.775 . . . . 0.0 109.455 172.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.76 -41.11 83.85 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.23 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.12 -42.63 93.75 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.154 0.981 . . . . 0.0 111.13 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.497 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 43.7 pttt . . . . . 0 C--N 1.357 0.895 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 8' ' ' VAL . 61.8 m . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.23 -46.1 79.68 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.728 0.411 . . . . 0.0 111.602 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.489 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 28.6 m-20 -59.56 -44.87 93.14 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.743 0.652 . . . . 0.0 110.688 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -64.74 -45.9 84.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.169 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 4' ' ' THR . 79.8 t -65.36 -43.89 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.625 0.77 . . . . 0.0 110.458 -175.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.86 97.16 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.132 0.973 . . . . 0.0 111.008 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.2 m -63.83 -42.72 97.56 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.18 0.925 . . . . 0.0 111.258 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 47' ' ' ILE . 96.7 mt -59.18 -51.01 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.578 0.751 . . . . 0.0 111.122 175.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.67 HG22 HD11 ' A' ' 18' ' ' ILE . 58.4 mt -59.8 -42.35 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.648 0.779 . . . . 0.0 110.534 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.485 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -56.39 -52.51 64.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.729 0.812 . . . . 0.0 112.713 173.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.47 -22.19 63.65 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.631 0.772 . . . . 0.0 112.327 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 m -85.06 -51.05 6.93 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.614 0.366 . . . . 0.0 111.11 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.604 ' SG ' HD11 ' A' ' 43' ' ' ILE . 74.7 m -100.29 7.59 44.29 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -168.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.8 t70 53.44 65.16 1.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.242 1.017 . . . . 0.0 111.871 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.67 HD11 HG22 ' A' ' 12' ' ' ILE . 10.1 pt -141.19 146.49 43.18 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.089 0.955 . . . . 0.0 109.418 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.28 114.33 2.62 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.716 2.277 . . . . 0.0 111.431 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.489 ' NH2' ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -53.61 -29.76 39.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.359 1.064 . . . . 0.0 113.175 -177.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.83 -27.53 62.96 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.191 0.597 . . . . 0.0 111.729 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -81.68 -5.56 58.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.825 0.45 . . . . 0.0 110.717 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.48 HD11 HD12 ' A' ' 18' ' ' ILE . 1.9 mp -86.36 113.49 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 174.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -95.16 165.9 15.95 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.843 0.857 . . . . 0.0 109.243 173.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.08 -18.47 61.94 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.291 1.994 . . . . 0.0 112.336 172.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -94.68 -0.21 54.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 122.948 0.499 . . . . 0.0 110.509 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.4 m -71.74 124.18 24.23 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.015 0.526 . . . . 0.0 110.383 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -85.66 123.18 30.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.83 -45.96 15.28 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.142 0.977 . . . . 0.0 112.207 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 mt -92.59 -48.16 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.86 -37.32 55.78 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.664 0.785 . . . . 0.0 112.357 -171.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.71 -59.21 1.86 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.587 0.355 . . . . 0.0 110.563 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.1 mt -75.92 -16.31 60.05 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.023 0.529 . . . . 0.0 112.417 -171.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.82 37.96 56.79 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.124 0.265 . . . . 0.0 113.303 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.51 HG23 ' HB2' ' A' ' 39' ' ' ASP . 93.5 mt -96.7 116.5 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.287 1.035 . . . . 0.0 108.928 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.46 164.56 26.45 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.8 m -56.41 -31.95 64.37 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.74 0.816 . . . . 0.0 111.614 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.76 -32.77 65.88 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 122.952 0.501 . . . . 0.0 111.088 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.51 ' HB2' HG23 ' A' ' 35' ' ' ILE . 28.6 m-20 -71.43 -40.99 70.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.965 0.506 . . . . 0.0 109.755 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.54 -22.01 64.52 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.212 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.62 -50.94 68.83 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.327 0.584 . . . . 0.0 110.439 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.42 -34.77 70.62 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.086 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.604 HD11 ' SG ' ' A' ' 16' ' ' CYS . 62.3 mt -63.92 -42.7 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 123.578 0.549 . . . . 0.0 110.192 173.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.46 -36.25 76.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.599 0.76 . . . . 0.0 110.645 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.44 -42.51 98.68 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.023 0.929 . . . . 0.0 110.272 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -42.02 84.16 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.137 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.408 ' HA ' HD13 ' A' ' 11' ' ' ILE . 84.1 mt -64.82 -43.71 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.763 0.825 . . . . 0.0 110.824 175.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -50.17 -54.09 23.26 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.076 1.35 . . . . 0.0 110.961 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -38.99 53.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.843 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.97 -45.37 86.85 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -88.43 -10.61 48.61 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.706 0.802 . . . . 0.0 112.562 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.23 48.57 81.82 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.396 0.435 . . . . 0.0 112.24 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.401 HG22 ' HG2' ' A' ' 91' ' ' LYS . 44.8 pt -131.26 169.18 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.95 1.3 . . . . 0.0 109.315 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -110.82 100.8 9.48 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.449 HD23 HD12 ' A' ' 87' ' ' LEU . 83.8 mt -67.94 123.07 86.26 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 122.695 0.398 . . . . 0.0 110.222 174.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.98 61.0 7.71 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.839 2.36 . . . . 0.0 110.124 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.08 -36.88 83.03 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.042 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -58.94 -42.3 89.44 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.553 0.741 . . . . 0.0 110.887 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.58 -52.12 66.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.652 0.781 . . . . 0.0 109.925 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -58.03 -43.77 86.97 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 124.474 1.108 . . . . 0.0 111.036 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -60.26 -47.74 84.7 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.904 0.882 . . . . 0.0 110.718 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -62.84 -40.26 96.9 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.272 0.629 . . . . 0.0 110.779 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG2' ' HD2' ' A' ' 68' ' ' LYS . 48.5 mt-10 -65.28 -41.65 93.96 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.189 0.931 . . . . 0.0 112.031 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.96 -47.4 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.436 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -57.31 -46.71 82.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.246 0.618 . . . . 0.0 111.669 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.08 0.02 50.04 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.239 0.616 . . . . 0.0 112.421 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.09 18.92 75.14 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.436 0.535 . . . . 0.0 114.436 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.432 ' HD2' ' HG2' ' A' ' 63' ' ' GLU . 62.3 mttm -69.76 -33.93 73.1 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 172.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.83 169.04 19.93 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.993 1.317 . . . . 0.0 108.397 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.5 p -116.12 163.45 15.93 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.08 0.952 . . . . 0.0 109.432 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p -55.71 -54.17 47.56 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 124.057 0.848 . . . . 0.0 112.746 -168.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -30.07 40.22 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.504 ' HA ' HD22 ' A' ' 79' ' ' ASN . 0.1 OUTLIER -62.37 -26.81 68.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.814 1.246 . . . . 0.0 111.797 -178.51 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -115.39 -26.98 7.36 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.215 0.606 . . . . 0.0 111.938 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -108.22 17.98 21.62 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.186 0.595 . . . . 0.0 112.277 -165.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.51 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.0 t -105.71 139.73 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 165.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 12' ' ' ILE . 3.8 mm? -52.68 -37.91 59.61 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.917 1.287 . . . . 0.0 114.308 -171.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.51 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.4 pttt -69.76 -45.19 68.63 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 123.163 0.29 . . . . 0.0 110.531 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.504 HD22 ' HA ' ' A' ' 73' ' ' GLN . 2.3 m-20 -68.08 -41.43 81.93 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.165 0.586 . . . . 0.0 110.616 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.09 -50.21 69.21 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.89 1.276 . . . . 0.0 109.536 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.94 71.86 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 123.615 0.572 . . . . 0.0 111.158 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -66.65 -50.6 62.42 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.853 0.461 . . . . 0.0 110.26 175.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.435 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 3.7 mmp_? -53.35 -50.19 65.56 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.861 0.864 . . . . 0.0 111.211 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 88' ' ' VAL . 87.7 mt -64.16 -45.65 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.948 1.299 . . . . 0.0 110.395 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.66 -36.43 78.68 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.155 0.982 . . . . 0.0 111.394 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 29.9 mm-40 -64.94 -43.76 91.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.581 0.752 . . . . 0.0 110.839 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.449 HD12 HD23 ' A' ' 55' ' ' LEU . 67.1 mt -70.89 -27.64 63.95 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.16 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 84' ' ' ILE . 78.7 t -67.83 -37.09 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.504 0.722 . . . . 0.0 110.114 172.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.3 75.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.068 0.547 . . . . 0.0 110.569 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.48 87.28 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.398 0.679 . . . . 0.0 111.275 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.401 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 8' ' ' VAL . 43.4 m . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -55.93 -48.85 74.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.314 0.646 . . . . 0.0 110.881 173.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.16 -50.11 59.58 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.022 0.826 . . . . 0.0 110.158 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.414 ' O ' HG13 ' A' ' 11' ' ' ILE . 6.1 mmp_? -70.34 -41.4 73.24 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.889 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 4' ' ' THR . 55.3 t -67.99 -40.98 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.162 0.585 . . . . 0.0 110.408 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.02 -37.97 89.38 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.086 0.954 . . . . 0.0 109.98 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.478 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 90.4 m -63.27 -44.21 95.74 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.52 174.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 7' ' ' ARG . 95.7 mt -58.81 -47.35 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.23 0.612 . . . . 0.0 111.359 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 18' ' ' ILE . 58.8 mt -57.44 -43.81 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.992 0.517 . . . . 0.0 110.102 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.494 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -57.76 -49.46 76.51 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.729 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 10' ' ' THR . 46.4 mm-40 -66.64 -33.46 75.71 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.297 0.639 . . . . 0.0 111.806 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.5 m -74.03 -50.72 18.49 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.502 0.721 . . . . 0.0 110.933 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 43' ' ' ILE . 39.8 m -97.37 3.95 50.88 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.812 0.845 . . . . 0.0 113.211 -169.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 45.67 77.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.418 1.087 . . . . 0.0 112.006 -171.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 12' ' ' ILE . 7.3 pt -147.74 147.59 27.81 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.021 0.929 . . . . 0.0 109.967 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.14 122.11 10.21 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.911 2.408 . . . . 0.0 111.561 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HG3' ' HA ' ' A' ' 10' ' ' THR . 2.5 tmm_? -64.46 -19.92 65.86 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.538 1.135 . . . . 0.0 112.453 -173.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.55 -22.41 60.09 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.842 0.857 . . . . 0.0 110.557 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.8 p -86.51 -10.68 53.58 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.158 0.583 . . . . 0.0 110.902 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.423 HD11 HD12 ' A' ' 18' ' ' ILE . 2.3 mp -91.76 93.48 4.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.1 p -82.7 164.12 48.44 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 124.107 0.963 . . . . 0.0 109.989 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.85 -21.13 72.87 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.162 1.908 . . . . 0.0 113.172 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -106.85 17.5 23.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.89 0.476 . . . . 0.0 110.409 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.9 m -72.33 120.3 17.74 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.112 0.565 . . . . 0.0 109.65 170.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -84.0 121.97 28.13 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 170.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -40.28 -50.71 2.77 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.886 1.274 . . . . 0.0 113.041 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.0 mt -92.85 -47.43 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 121.109 0.48 . . . . 0.0 110.188 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.51 -38.13 55.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.235 1.014 . . . . 0.0 112.221 -172.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.24 -65.2 0.98 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.359 0.664 . . . . 0.0 110.421 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.37 -12.71 61.57 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.76 0.824 . . . . 0.0 112.633 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.39 24.41 76.76 Favored Glycine 0 C--N 1.354 1.563 0 O-C-N 123.466 0.479 . . . . 0.0 114.235 174.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.9 mt -78.87 124.89 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.441 1.097 . . . . 0.0 109.371 -175.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.14 156.23 39.04 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.231 0.612 . . . . 0.0 110.987 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.8 m -63.55 -41.07 98.45 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.826 0.85 . . . . 0.0 111.863 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 pp -71.62 -28.86 64.08 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.927 0.394 . . . . 0.0 110.043 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.71 -36.9 59.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.185 0.994 . . . . 0.0 110.118 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -70.9 -23.32 62.25 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.482 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.64 -41.31 94.68 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.152 0.581 . . . . 0.0 111.091 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.66 -42.82 90.91 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.403 0.681 . . . . 0.0 110.305 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.446 HD11 ' SG ' ' A' ' 16' ' ' CYS . 59.6 mt -62.89 -45.03 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.755 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.81 -33.82 68.85 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.293 0.637 . . . . 0.0 110.532 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -59.9 -39.79 86.57 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.321 1.048 . . . . 0.0 110.435 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.46 -38.03 71.32 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.537 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.405 ' HA ' HD13 ' A' ' 11' ' ' ILE . 97.6 mt -66.69 -41.71 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.657 0.783 . . . . 0.0 110.383 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -52.11 -47.66 65.19 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.792 1.237 . . . . 0.0 110.694 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.29 -56.05 22.25 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.121 0.888 . . . . 0.0 110.846 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.71 -51.8 68.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.047 0.939 . . . . 0.0 112.302 -171.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -87.49 -14.54 40.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.286 0.634 . . . . 0.0 111.561 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.69 30.43 74.67 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 117.716 0.234 . . . . 0.0 113.329 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.412 HD13 HG23 ' A' ' 84' ' ' ILE . 32.7 pt -109.55 151.14 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.863 0.865 . . . . 0.0 110.967 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -93.34 95.67 9.47 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.455 HD21 HG12 ' A' ' 84' ' ' ILE . 83.8 mt -73.03 119.34 75.08 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.916 173.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -85.7 58.33 4.6 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.618 2.212 . . . . 0.0 109.152 165.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.71 -38.96 89.79 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.819 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -35.89 79.25 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.928 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.57 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.17 -51.13 41.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.221 0.608 . . . . 0.0 109.876 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.437 ' O ' HG23 ' A' ' 64' ' ' VAL . 51.4 m0 -55.57 -48.41 74.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.158 0.983 . . . . 0.0 111.349 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.7 m -62.82 -37.45 86.82 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.574 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -66.7 -43.15 85.17 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.253 0.621 . . . . 0.0 110.637 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 4.9 mm-40 -66.66 -33.88 76.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.589 0.756 . . . . 0.0 110.719 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 60' ' ' TRP . 54.4 t -61.38 -52.73 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.142 172.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -65.51 -27.04 68.19 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.098 0.559 . . . . 0.0 111.599 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.84 1.79 56.66 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.15 0.58 . . . . 0.0 111.702 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.93 12.93 71.89 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.8 mttp -72.6 -26.69 61.78 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 117.722 0.761 . . . . 0.0 110.119 172.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 168.03 22.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.32 1.048 . . . . 0.0 109.684 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.5 p -100.28 163.53 12.35 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 124.266 1.027 . . . . 0.0 108.858 172.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.423 HG22 HG11 ' A' ' 64' ' ' VAL . 72.1 p -57.33 -43.28 83.22 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.626 0.579 . . . . 0.0 110.356 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' A' ' 76' ' ' VAL . 22.2 mm-40 -41.4 -53.61 3.29 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.369 1.467 . . . . 0.0 112.786 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -60.75 -21.36 62.92 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.318 -1.31 . . . . 0.0 114.106 -171.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -128.81 -4.38 5.18 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.89 20.09 7.74 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.994 0.518 . . . . 0.0 111.217 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 72' ' ' GLU . 95.8 t -108.99 144.36 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 164.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.86 -35.98 71.71 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -67.67 -40.18 84.49 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 120.889 0.376 . . . . 0.0 110.096 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.1 m120 -73.5 -47.31 42.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.087 0.955 . . . . 0.0 110.316 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.03 -47.88 84.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.954 1.302 . . . . 0.0 109.897 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.07 -36.38 81.49 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.556 0.743 . . . . 0.0 111.841 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.68 81.38 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.06 0.544 . . . . 0.0 110.654 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 24.7 mmm180 -59.39 -48.48 81.49 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.772 0.829 . . . . 0.0 110.637 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 88' ' ' VAL . 97.0 mt -63.87 -43.1 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.699 1.2 . . . . 0.0 110.863 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.06 -39.06 93.6 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.567 0.747 . . . . 0.0 111.045 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -63.58 -40.88 98.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.547 0.739 . . . . 0.0 110.711 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 75.2 mt -70.57 -34.32 72.08 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.963 0.505 . . . . 0.0 112.019 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 84' ' ' ILE . 91.9 t -64.56 -42.64 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-O 121.454 0.645 . . . . 0.0 109.512 174.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.74 -37.63 79.56 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.176 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.36 -44.63 87.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.105 0.962 . . . . 0.0 111.413 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 CA--C 1.542 0.671 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.287 -178.459 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 8' ' ' VAL . 10.3 m . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 119.824 -0.131 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -57.56 -48.8 78.33 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 123.007 0.523 . . . . 0.0 111.166 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.81 -44.5 70.25 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.386 0.674 . . . . 0.0 110.862 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -60.2 -54.05 50.47 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.479 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 4' ' ' THR . 95.6 t -67.55 -38.98 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.419 0.688 . . . . 0.0 111.245 -172.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.64 92.13 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.673 1.189 . . . . 0.0 110.339 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 85.9 m -66.63 -40.46 88.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.554 176.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.49 -49.81 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.15 0.432 . . . . 0.0 111.383 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.567 HG12 HG21 ' A' ' 43' ' ' ILE . 51.8 mt -58.79 -41.03 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 122.789 0.435 . . . . 0.0 110.166 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.74 -60.27 3.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.803 0.841 . . . . 0.0 112.542 173.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 10' ' ' THR . 17.3 mm-40 -65.43 -34.6 78.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.196 0.598 . . . . 0.0 112.146 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.4 m -72.87 -58.6 3.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.189 0.595 . . . . 0.0 110.331 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.7 t -84.99 3.5 38.21 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.06 65.91 1.37 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.405 1.082 . . . . 0.0 111.577 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.545 HG13 ' HA ' ' A' ' 13' ' ' ALA . 10.4 pt -145.3 159.33 49.2 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.801 1.24 . . . . 0.0 109.023 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -75.09 133.77 16.85 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.767 2.312 . . . . 0.0 111.802 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -18.9 65.63 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -81.87 -19.79 40.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.485 0.714 . . . . 0.0 109.873 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 p -79.88 -7.75 58.91 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 122.568 0.347 . . . . 0.0 110.851 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.1 114.06 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.1 p -100.25 160.58 26.67 Favored Pre-proline 0 N--CA 1.488 1.437 0 C-N-CA 123.302 0.641 . . . . 0.0 110.471 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.05 -25.83 58.57 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 122.718 2.278 . . . . 0.0 112.671 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -91.77 1.97 56.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.671 0.788 . . . . 0.0 111.114 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 t -83.01 137.83 33.98 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.302 0.641 . . . . 0.0 111.345 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.516 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 54.7 t-80 -82.8 111.86 19.1 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 165.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.38 -20.25 28.28 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.516 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 84.6 mt -99.57 -41.25 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.599 0.76 . . . . 0.0 110.586 -177.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 32.4 t70 -79.98 -52.0 8.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.416 0.686 . . . . 0.0 112.227 -173.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -74.94 -48.95 21.84 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.365 0.602 . . . . 0.0 111.164 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.5 mt -73.23 -12.78 60.98 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.49 -176.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.17 35.57 88.75 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 121.296 0.387 . . . . 0.0 112.662 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.5 mt -99.84 126.08 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -61.34 153.35 26.91 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 118.144 0.429 . . . . 0.0 110.73 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.4 m -63.61 -29.09 70.38 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.008 0.523 . . . . 0.0 109.988 176.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.57 -39.26 62.36 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.718 0.807 . . . . 0.0 109.96 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.18 -26.65 61.26 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.549 0.74 . . . . 0.0 110.11 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -74.34 -27.67 60.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.722 0.809 . . . . 0.0 110.504 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' SER . 89.8 mt -56.43 -33.44 65.84 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 122.632 0.373 . . . . 0.0 110.869 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.92 -41.61 64.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.666 0.786 . . . . 0.0 110.631 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.567 HG21 HG12 ' A' ' 12' ' ' ILE . 47.9 mt -62.81 -41.06 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.062 0.458 . . . . 0.0 110.175 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.14 -29.95 63.25 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.29 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -59.01 -42.23 89.63 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.969 0.908 . . . . 0.0 109.892 170.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.6 -42.43 74.41 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.338 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.46 -42.84 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.762 0.825 . . . . 0.0 110.597 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.59 -48.22 69.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.892 1.277 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -72.52 -42.77 64.42 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.2 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.44 77.02 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.834 0.854 . . . . 0.0 112.463 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -87.11 -7.94 57.52 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 111.449 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.65 32.82 85.48 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.328 0.392 . . . . 0.0 113.194 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 pt -112.61 169.59 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.198 0.999 . . . . 0.0 110.761 -173.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -104.83 101.71 11.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.516 HD21 HG12 ' A' ' 84' ' ' ILE . 95.7 mt -72.43 114.49 30.28 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 167.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.534 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 87.7 Cg_endo -81.94 63.86 8.4 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.037 1.824 . . . . 0.0 109.833 168.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.5 -38.16 88.81 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.035 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.23 -42.67 99.26 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.898 0.479 . . . . 0.0 111.027 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 54.3 tptt -58.75 -47.3 85.13 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.366 1.066 . . . . 0.0 110.79 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.414 ' O ' HG23 ' A' ' 64' ' ' VAL . 53.4 m0 -63.48 -46.03 88.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.554 0.742 . . . . 0.0 110.867 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.5 m -64.85 -32.94 74.87 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.367 1.067 . . . . 0.0 110.965 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.21 -42.32 62.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.438 0.695 . . . . 0.0 109.734 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.32 -35.41 75.57 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.654 0.781 . . . . 0.0 111.046 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' TRP . 85.0 t -64.97 -46.16 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 173.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.31 -40.27 96.87 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.137 0.975 . . . . 0.0 112.825 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.04 -1.67 58.05 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.42 0.688 . . . . 0.0 112.646 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.67 30.52 77.89 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 11.3 mmpt? -77.18 -33.21 56.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.951 0.901 . . . . 0.0 109.444 171.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.64 168.45 20.13 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.673 1.189 . . . . 0.0 108.747 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.5 p -108.9 162.11 14.5 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.61 0.764 . . . . 0.0 111.149 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.0 p -58.07 -64.47 0.9 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.74 0.816 . . . . 0.0 111.797 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -30.49 62.0 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -55.74 -24.84 37.43 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.545 1.138 . . . . 0.0 112.861 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -111.36 -44.0 3.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.313 0.645 . . . . 0.0 111.095 173.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -97.94 21.76 10.21 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.994 0.518 . . . . 0.0 112.306 -163.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.575 HG12 ' HG2' ' A' ' 78' ' ' LYS . 25.5 t -106.01 140.63 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 165.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.459 HD11 HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -55.37 -39.49 70.16 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -167.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.575 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.9 pttt -61.34 -43.12 99.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.608 0.718 . . . . 0.0 110.191 176.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 83.9 m-20 -75.96 -44.97 37.32 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.888 1.275 . . . . 0.0 109.967 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.74 -53.46 57.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.187 1.395 . . . . 0.0 109.836 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.27 70.69 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.453 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.09 76.57 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.978 0.511 . . . . 0.0 111.678 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 3.6 mmp_? -59.81 -49.59 77.12 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.723 0.773 . . . . 0.0 109.806 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.516 HG12 HD21 ' A' ' 55' ' ' LEU . 88.6 mt -58.89 -45.64 91.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.587 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -64.64 -37.23 86.85 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.964 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -66.68 -32.87 74.47 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.803 0.441 . . . . 0.0 110.818 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.16 -30.92 60.87 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.278 0.631 . . . . 0.0 111.702 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.2 t -69.28 -35.57 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.385 0.674 . . . . 0.0 110.119 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.35 -37.92 77.89 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.484 173.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.69 -39.01 93.26 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.865 0.866 . . . . 0.0 111.933 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt . . . . . 0 N--CA 1.477 0.886 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.475 -179.854 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 8' ' ' VAL . 28.0 m . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 119.556 -0.259 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -53.69 -49.04 68.87 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 0.0 111.486 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.36 -42.29 98.46 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.636 0.774 . . . . 0.0 110.795 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -64.24 -42.11 96.68 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.25 0.969 . . . . 0.0 111.22 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 4' ' ' THR . 89.0 t -69.93 -38.26 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.732 0.813 . . . . 0.0 110.685 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.91 81.08 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.229 1.011 . . . . 0.0 110.133 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.4 m -63.89 -44.42 93.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.614 0.766 . . . . 0.0 110.615 171.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 47' ' ' ILE . 95.3 mt -57.39 -50.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.754 0.822 . . . . 0.0 111.269 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.619 HG22 HD11 ' A' ' 18' ' ' ILE . 51.8 mt -60.09 -48.05 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.32 0.648 . . . . 0.0 110.405 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.73 -49.96 64.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.161 0.985 . . . . 0.0 112.675 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -68.19 -42.31 80.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.437 0.695 . . . . 0.0 112.19 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.9 m -68.02 -48.33 66.0 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.646 0.378 . . . . 0.0 110.585 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 43' ' ' ILE . 34.2 m -91.88 -2.52 56.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.88 0.872 . . . . 0.0 113.157 -171.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.2 t70 52.83 69.64 0.67 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.998 0.919 . . . . 0.0 111.56 -171.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.619 HD11 HG22 ' A' ' 12' ' ' ILE . 9.6 pt -143.53 156.86 59.98 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.782 1.233 . . . . 0.0 108.748 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.95 137.96 39.22 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.58 2.187 . . . . 0.0 111.546 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -62.65 -28.47 69.94 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.722 0.809 . . . . 0.0 111.349 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.85 -21.58 57.1 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.0 0.52 . . . . 0.0 111.071 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.2 p -83.97 1.65 42.62 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.547 0.339 . . . . 0.0 111.101 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.75 111.5 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 168.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.4 p -101.46 161.57 23.18 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.663 0.785 . . . . 0.0 109.869 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.66 -27.2 75.87 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.007 1.805 . . . . 0.0 112.347 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -96.27 2.66 53.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.98 0.512 . . . . 0.0 110.846 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.3 p -74.22 129.33 37.61 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -83.97 115.63 22.41 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -44.61 -39.46 5.02 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.812 1.245 . . . . 0.0 113.96 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.9 mt -95.31 -56.73 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 122.731 0.413 . . . . 0.0 110.486 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -80.01 -23.45 41.49 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.798 0.839 . . . . 0.0 112.965 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -108.25 -61.01 1.65 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.967 0.507 . . . . 0.0 110.915 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.52 -20.01 62.1 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.614 0.765 . . . . 0.0 111.902 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.91 36.42 92.08 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.656 0.598 . . . . 0.0 114.509 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.469 HG21 HD12 ' A' ' 43' ' ' ILE . 61.1 mt -84.22 123.67 39.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 123.569 0.747 . . . . 0.0 109.038 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.08 149.24 33.07 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.303 0.641 . . . . 0.0 110.323 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.408 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 23.9 m -60.46 -38.66 84.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.203 0.601 . . . . 0.0 110.533 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 39' ' ' ASP . 3.4 pp -71.29 -29.94 65.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.182 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.405 ' N ' HD12 ' A' ' 38' ' ' LEU . 20.9 t70 -78.28 -36.18 46.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.456 0.703 . . . . 0.0 109.893 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -71.08 -21.99 62.16 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.388 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 37' ' ' SER . 96.3 mt -60.56 -37.87 82.68 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.796 0.438 . . . . 0.0 110.92 170.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -72.9 -40.46 65.53 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.142 0.577 . . . . 0.0 110.391 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.651 HD11 ' SG ' ' A' ' 16' ' ' CYS . 46.4 mt -61.25 -46.31 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 123.694 0.622 . . . . 0.0 110.408 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -70.78 -35.27 72.5 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.126 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -65.09 -38.44 90.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.52 0.728 . . . . 0.0 110.813 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.92 -28.11 64.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.365 0.666 . . . . 0.0 111.037 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 53' ' ' ILE . 96.9 mt -68.96 -41.42 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.965 0.906 . . . . 0.0 109.602 171.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.2 -39.53 93.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.673 0.789 . . . . 0.0 111.109 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -67.83 -52.19 39.71 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.677 0.791 . . . . 0.0 111.112 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.82 -48.02 75.91 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.255 0.622 . . . . 0.0 112.591 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -90.11 -11.16 42.08 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.548 0.739 . . . . 0.0 112.386 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.2 74.46 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 123.361 0.413 . . . . 0.0 113.08 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 47' ' ' ILE . 45.5 pt -108.22 -175.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.157 0.983 . . . . 0.0 110.015 -174.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -138.53 107.9 6.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 167.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD21 HG12 ' A' ' 84' ' ' ILE . 93.8 mt -69.72 130.4 90.35 Favored Pre-proline 0 C--O 1.243 0.738 0 C-N-CA 123.076 0.55 . . . . 0.0 109.733 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -72.43 59.71 3.25 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 123.344 2.696 . . . . 0.0 110.493 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.71 -45.44 78.74 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.785 0.834 . . . . 0.0 109.866 -171.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -39.57 92.21 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 123.856 0.722 . . . . 0.0 110.926 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.59 -45.33 92.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.227 1.011 . . . . 0.0 110.59 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.429 ' O ' HG23 ' A' ' 64' ' ' VAL . 52.6 m0 -65.74 -45.29 83.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.605 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.5 m -64.43 -31.52 72.76 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.862 0.865 . . . . 0.0 110.221 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.72 -44.57 70.04 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.39 -42.7 96.44 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.753 0.821 . . . . 0.0 111.305 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 60' ' ' TRP . 78.2 t -62.59 -53.82 42.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.342 0.657 . . . . 0.0 110.741 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -66.28 -22.56 66.3 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.836 0.854 . . . . 0.0 112.768 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -98.99 4.72 47.31 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.452 0.701 . . . . 0.0 112.045 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 15.3 65.69 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 115.181 0.833 . . . . 0.0 115.181 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -78.61 -23.81 45.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.456 0.703 . . . . 0.0 110.588 174.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -146.53 163.14 36.69 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.865 0.866 . . . . 0.0 109.253 173.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.0 p -91.65 165.12 13.48 Favored 'General case' 0 C--O 1.247 0.955 0 C-N-CA 123.404 0.682 . . . . 0.0 110.131 172.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.4 p -57.86 -55.02 40.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.99 0.806 . . . . 0.0 109.896 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.417 ' HA ' HG23 ' A' ' 76' ' ' VAL . 14.8 pt-20 -52.77 -35.6 56.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.872 1.269 . . . . 0.0 113.831 -175.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -55.01 -33.74 62.86 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.878 0.871 . . . . 0.0 112.844 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -117.52 -24.4 7.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.921 0.488 . . . . 0.0 112.085 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.73 26.68 10.38 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.459 0.704 . . . . 0.0 110.494 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 78' ' ' LYS . 52.3 t -109.76 143.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 158.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.4 -37.6 81.32 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.499 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.2 pttp -68.87 -41.88 77.77 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 120.891 0.377 . . . . 0.0 110.286 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.5 m120 -68.2 -47.82 66.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.808 0.843 . . . . 0.0 110.191 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -57.76 -49.18 77.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.14 1.376 . . . . 0.0 110.51 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.51 -34.19 73.73 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.707 0.803 . . . . 0.0 111.975 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.86 87.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.836 0.454 . . . . 0.0 110.931 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 9.1 mmm180 -66.21 -41.33 90.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.52 0.728 . . . . 0.0 111.479 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.595 HG12 HD21 ' A' ' 55' ' ' LEU . 96.4 mt -63.19 -50.08 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.242 1.017 . . . . 0.0 110.517 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -60.6 -44.25 96.5 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.946 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.46 -31.49 70.82 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.753 0.421 . . . . 0.0 110.765 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.435 HD12 HD23 ' A' ' 55' ' ' LEU . 54.7 mt -67.32 -39.88 85.89 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.869 0.467 . . . . 0.0 111.568 173.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.454 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 60.5 t -63.54 -44.1 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.47 94.77 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.567 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.27 -39.11 55.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.517 0.727 . . . . 0.0 112.824 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 88' ' ' VAL . 20.7 pttp . . . . . 0 N--CA 1.488 1.44 0 C-N-CA 122.585 0.354 . . . . 0.0 110.541 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.4 m . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 119.675 -0.203 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -54.87 -47.82 73.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.475 0.71 . . . . 0.0 111.763 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.07 -43.58 98.68 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.658 0.599 . . . . 0.0 110.951 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -61.73 -44.08 97.62 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.361 0.665 . . . . 0.0 111.823 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 4' ' ' THR . 89.1 t -69.71 -41.32 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.879 0.872 . . . . 0.0 110.46 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.03 93.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.71 0.804 . . . . 0.0 110.85 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.5 m -64.51 -44.75 89.92 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 124.0 0.813 . . . . 0.0 111.227 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 47' ' ' ILE . 96.8 mt -57.26 -51.23 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.001 0.52 . . . . 0.0 110.908 176.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.6 HG12 HG21 ' A' ' 43' ' ' ILE . 32.1 mt -56.67 -48.02 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.986 0.914 . . . . 0.0 110.511 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . . . -52.66 -59.39 4.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.467 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.48 -24.22 56.89 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.426 -171.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.7 m -82.79 -44.25 15.75 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 117.864 0.302 . . . . 0.0 110.734 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.537 ' HB2' HD11 ' A' ' 43' ' ' ILE . 49.5 t -96.46 -3.71 42.92 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.655 0.782 . . . . 0.0 112.977 -172.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t70 59.65 65.68 1.11 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.455 1.102 . . . . 0.0 111.57 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.1 pt -146.47 150.48 40.7 Favored Pre-proline 0 N--CA 1.486 1.352 0 C-N-CA 124.555 1.142 . . . . 0.0 108.861 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.95 128.69 19.2 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.41 2.073 . . . . 0.0 111.929 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -65.29 -18.25 65.16 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.883 0.473 . . . . 0.0 111.77 178.081 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -79.65 -22.17 43.9 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.512 0.725 . . . . 0.0 109.95 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.0 p -87.21 5.23 39.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.705 0.402 . . . . 0.0 110.75 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.603 HG23 ' HG ' ' A' ' 77' ' ' LEU . 1.8 mp -95.01 130.98 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 166.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -124.15 159.75 55.43 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 123.802 0.841 . . . . 0.0 110.165 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.87 -44.87 44.94 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.284 2.656 . . . . 0.0 113.677 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.96 11.61 29.0 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.906 0.482 . . . . 0.0 110.602 -173.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 t -72.92 130.91 41.45 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 123.606 0.762 . . . . 0.0 109.717 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -84.85 117.01 23.62 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -49.56 -35.11 19.47 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.37 -55.21 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -78.8 -38.16 39.02 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -170.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -87.62 -59.63 2.19 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.732 0.413 . . . . 0.0 110.015 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 29' ' ' ALA . 90.4 mt -70.17 -23.66 63.02 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.38 0.672 . . . . 0.0 111.423 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.2 39.82 96.36 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.781 0.676 . . . . 0.0 113.16 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -72.91 115.34 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.08 144.11 24.81 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.91 0.884 . . . . 0.0 110.226 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 p -55.0 -42.84 72.98 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.957 0.903 . . . . 0.0 112.116 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.1 mt -67.39 -44.79 78.01 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.569 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -64.21 -26.86 68.7 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.984 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -74.06 -34.0 63.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.55 -38.54 90.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.102 0.561 . . . . 0.0 110.189 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.43 -46.0 88.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.029 0.932 . . . . 0.0 110.697 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.6 HG21 HG12 ' A' ' 12' ' ' ILE . 68.2 mt -65.61 -41.64 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.33 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.42 -39.56 74.36 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -54.75 -43.34 72.61 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.483 1.113 . . . . 0.0 110.907 171.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.23 -30.8 66.78 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.195 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.428 ' HA ' HD13 ' A' ' 11' ' ' ILE . 83.8 mt -67.79 -46.1 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.241 0.617 . . . . 0.0 110.438 175.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -56.88 -46.2 82.03 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.723 0.809 . . . . 0.0 110.727 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -67.92 -47.04 69.85 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.014 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.34 99.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.188 0.595 . . . . 0.0 112.322 -175.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -92.22 -11.33 35.68 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.498 0.719 . . . . 0.0 112.328 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.98 31.34 69.69 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-O 121.133 0.296 . . . . 0.0 113.171 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.3 pt -119.79 -177.27 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.641 1.176 . . . . 0.0 109.892 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -135.73 107.88 7.22 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 166.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.651 HD21 HG12 ' A' ' 84' ' ' ILE . 88.4 mt -61.77 128.33 90.23 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 168.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.76 59.17 2.73 Favored 'Trans proline' 0 C--N 1.367 1.515 0 C-N-CA 122.946 2.431 . . . . 0.0 111.624 170.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.0 -40.74 94.7 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.056 1.342 . . . . 0.0 109.629 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -57.28 -45.78 83.74 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.006 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -68.79 -43.89 74.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.277 0.631 . . . . 0.0 110.53 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.448 ' HH2' HD22 ' A' ' 55' ' ' LEU . 50.4 m0 -59.98 -48.53 81.34 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.308 1.005 . . . . 0.0 111.252 -176.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.2 m -63.97 -35.58 81.15 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 124.258 0.974 . . . . 0.0 110.167 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.38 -38.22 71.55 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.082 0.553 . . . . 0.0 110.86 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.25 -38.25 90.42 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.835 0.854 . . . . 0.0 110.942 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 60' ' ' TRP . 91.6 t -64.53 -44.89 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.825 174.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.81 -46.22 88.12 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.63 0.772 . . . . 0.0 112.437 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 50.9 m-20 -81.01 -2.54 48.39 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.462 0.705 . . . . 0.0 112.673 -176.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.23 28.89 74.09 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 114.0 0.36 . . . . 0.0 114.0 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HG3' ' HB2' ' A' ' 66' ' ' ASP . 95.4 mttt -74.77 -34.01 62.39 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.577 0.751 . . . . 0.0 109.723 171.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.6 163.58 36.81 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.591 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -88.63 154.74 20.07 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.603 1.161 . . . . 0.0 109.493 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -38.85 87.29 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.682 0.793 . . . . 0.0 110.343 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -43.76 -50.74 7.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.618 1.567 . . . . 0.0 111.761 172.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.418 ' HA ' ' ND2' ' A' ' 79' ' ' ASN . 44.0 mt-30 -61.04 -16.12 39.93 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.526 -1.216 . . . . 0.0 114.198 -170.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -126.52 -20.86 4.27 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -117.12 20.73 13.62 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.977 0.511 . . . . 0.0 111.846 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.405 HG12 ' HG2' ' A' ' 78' ' ' LYS . 24.4 t -97.71 147.17 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 163.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.603 ' HG ' HG23 ' A' ' 23' ' ' ILE . 4.0 mm? -57.69 -54.51 46.01 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.743 1.217 . . . . 0.0 114.225 -172.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.9 pttt -61.1 -36.74 80.48 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.165 0.586 . . . . 0.0 110.776 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 41.3 t-20 -76.33 -46.95 25.29 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.739 -171.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.62 -46.94 85.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.565 1.546 . . . . 0.0 109.716 173.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.59 -33.04 73.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.868 0.867 . . . . 0.0 111.189 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.04 -46.45 71.11 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.766 0.426 . . . . 0.0 110.386 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 12.9 mmp_? -55.87 -46.28 78.3 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.469 0.707 . . . . 0.0 110.753 177.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.651 HG12 HD21 ' A' ' 55' ' ' LEU . 90.1 mt -61.31 -49.55 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.877 1.271 . . . . 0.0 110.205 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.63 -37.81 79.67 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.394 1.077 . . . . 0.0 111.396 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -69.87 -39.53 76.26 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.113 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.5 HD12 HD23 ' A' ' 55' ' ' LEU . 79.9 mt -67.8 -34.29 76.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 123.417 0.448 . . . . 0.0 110.811 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 84' ' ' ILE . 96.8 t -68.98 -40.25 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.712 0.805 . . . . 0.0 109.526 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.86 -40.53 87.91 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.609 0.764 . . . . 0.0 111.546 177.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.71 -36.35 78.35 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.139 0.975 . . . . 0.0 111.789 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.2 pttp . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 122.384 0.274 . . . . 0.0 110.835 -177.984 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 8' ' ' VAL . 24.9 m . . . . . 0 CA--C 1.548 0.892 0 CA-C-O 120.15 0.024 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -56.89 -51.93 67.15 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.377 0.671 . . . . 0.0 110.468 171.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -58.52 -39.04 79.02 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.82 0.848 . . . . 0.0 111.552 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -57.64 -51.12 70.81 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.894 0.878 . . . . 0.0 111.324 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 4' ' ' THR . 81.0 t -72.26 -36.27 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.717 0.807 . . . . 0.0 111.274 -173.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.0 -42.44 80.32 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.889 0.876 . . . . 0.0 110.488 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 m -65.94 -47.63 74.04 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.796 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.8 mt -55.42 -54.75 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 123.409 0.684 . . . . 0.0 111.462 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.699 HG12 HG21 ' A' ' 43' ' ' ILE . 37.5 mt -57.57 -45.27 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.165 0.986 . . . . 0.0 110.959 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.424 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.19 -54.8 30.7 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.946 0.899 . . . . 0.0 112.812 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.53 -35.99 82.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.607 0.763 . . . . 0.0 111.94 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.0 m -69.59 -57.86 4.67 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 123.715 0.635 . . . . 0.0 110.387 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.573 ' SG ' HD11 ' A' ' 43' ' ' ILE . 81.1 m -96.1 11.97 32.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.553 0.741 . . . . 0.0 112.858 -170.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 42.63 67.69 0.58 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.975 1.31 . . . . 0.0 112.23 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.621 HD11 HG22 ' A' ' 12' ' ' ILE . 17.3 pt -137.61 146.03 51.49 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 124.809 1.244 . . . . 0.0 108.174 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.64 120.26 7.71 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.703 2.268 . . . . 0.0 112.845 -174.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -51.43 -39.91 58.29 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.477 1.511 . . . . 0.0 113.153 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.49 -14.1 58.55 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.241 0.216 . . . . 0.0 111.57 -172.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 p -83.87 1.51 42.87 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-O 120.616 0.246 . . . . 0.0 110.557 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.493 HG23 ' HG ' ' A' ' 77' ' ' LEU . 1.9 mp -86.84 137.6 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 165.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 p -125.98 161.69 49.97 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 123.663 0.785 . . . . 0.0 109.403 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.8 -29.44 80.99 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 121.933 1.755 . . . . 0.0 112.372 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.38 0.78 51.06 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.863 0.465 . . . . 0.0 111.393 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.6 p -75.98 132.67 40.34 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.758 0.253 . . . . 0.0 110.49 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -85.6 118.64 25.24 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.507 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -50.44 -27.88 7.27 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 55.2 mt -101.37 -55.12 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.133 0.492 . . . . 0.0 110.298 -175.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.17 -37.73 81.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.978 0.911 . . . . 0.0 112.018 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -95.7 -60.04 1.74 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.115 0.566 . . . . 0.0 110.859 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 29' ' ' ALA . 90.9 mt -71.87 -8.17 52.77 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.29 34.63 75.27 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.071 0.232 . . . . 0.0 113.52 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 88.3 mt -110.94 114.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.016 0.926 . . . . 0.0 108.802 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.46 156.73 28.59 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.957 0.503 . . . . 0.0 110.335 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.445 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 22.4 m -58.73 -27.89 65.32 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.664 0.786 . . . . 0.0 112.226 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.39 -48.49 67.22 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.014 0.526 . . . . 0.0 109.855 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.51 -33.27 75.51 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.001 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -72.04 -28.45 63.36 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.902 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 37' ' ' SER . 87.8 mt -61.04 -44.76 96.92 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.24 -41.3 98.3 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.161 0.984 . . . . 0.0 111.338 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.699 HG21 HG12 ' A' ' 12' ' ' ILE . 63.3 mt -65.58 -45.18 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-O 121.048 0.452 . . . . 0.0 110.665 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.48 -32.54 70.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.325 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -66.5 -36.72 83.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.582 0.753 . . . . 0.0 110.485 173.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.85 -34.23 77.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.914 0.486 . . . . 0.0 110.63 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.32 -38.45 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.712 0.805 . . . . 0.0 110.381 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -58.2 -44.69 88.23 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.571 0.748 . . . . 0.0 111.314 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -70.73 -44.46 66.78 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.535 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.78 -55.86 22.62 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.785 0.834 . . . . 0.0 112.827 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.517 ' HB2' HG12 ' A' ' 53' ' ' ILE . 97.4 m-85 -90.33 -10.98 42.07 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.326 0.65 . . . . 0.0 112.175 -177.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.14 70.18 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 -173.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 51' ' ' PHE . 43.9 pt -109.22 -176.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.083 0.953 . . . . 0.0 109.859 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -139.24 110.56 6.97 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 172.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.461 HD21 HG12 ' A' ' 84' ' ' ILE . 84.4 mt -83.58 120.04 74.74 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 170.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.71 58.77 1.12 Allowed 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.952 2.435 . . . . 0.0 112.113 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.443 HD22 ' CE3' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -66.18 -37.69 86.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.804 0.842 . . . . 0.0 110.195 -169.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -35.62 73.06 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.373 0.421 . . . . 0.0 111.203 175.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.451 ' NZ ' ' HB2' ' A' ' 59' ' ' LYS . 3.6 ttmp? -82.39 -29.15 31.03 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 123.253 0.621 . . . . 0.0 110.674 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.443 ' CE3' HD22 ' A' ' 57' ' ' LEU . 45.7 m0 -69.58 -40.62 76.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.365 0.666 . . . . 0.0 109.729 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.4 m -64.22 -34.78 78.89 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.502 173.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -69.33 -47.82 63.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.415 1.086 . . . . 0.0 110.259 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 45.9 mt-10 -61.06 -49.23 78.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.446 1.098 . . . . 0.0 111.56 -177.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.47 -37.54 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.509 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -64.19 -40.06 95.3 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.463 0.705 . . . . 0.0 111.129 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.84 1.67 51.64 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.153 0.981 . . . . 0.0 112.244 -172.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.25 18.49 75.04 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.58 -31.96 67.54 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.338 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.72 169.83 17.01 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.581 1.153 . . . . 0.0 109.638 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.8 m -105.15 160.23 15.23 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.467 1.107 . . . . 0.0 110.458 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.0 p -62.63 77.39 0.02 OUTLIER 'General case' 0 C--N 1.364 1.219 0 C-N-CA 124.385 1.074 . . . . 0.0 110.542 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -178.97 -61.78 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.726 -169.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -58.55 -23.96 59.62 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.963 -165.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -119.21 -16.23 9.09 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -111.68 13.11 21.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.907 0.483 . . . . 0.0 112.186 -168.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.0 t -106.15 143.04 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 171.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.493 ' HG ' HG23 ' A' ' 23' ' ' ILE . 3.5 mm? -54.67 -42.54 71.48 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.212 1.405 . . . . 0.0 114.094 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.1 pttt -68.38 -39.84 81.6 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 117.712 0.233 . . . . 0.0 111.393 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.24 -44.06 69.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.4 0.68 . . . . 0.0 110.368 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.6 tp -58.17 -52.94 63.46 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.553 1.141 . . . . 0.0 109.896 177.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.19 72.19 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.939 0.895 . . . . 0.0 112.334 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.61 -50.42 58.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -53.95 -48.08 70.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.225 1.01 . . . . 0.0 111.403 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.467 HG23 HD13 ' A' ' 53' ' ' ILE . 96.7 mt -58.21 -53.28 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.435 1.094 . . . . 0.0 110.4 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -62.64 -33.24 74.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.01 0.924 . . . . 0.0 112.384 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -64.4 -42.2 96.24 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.287 0.635 . . . . 0.0 110.427 174.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.5 -39.36 77.66 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.58 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 84' ' ' ILE . 87.5 t -66.36 -39.44 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.835 0.854 . . . . 0.0 110.278 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.65 -37.57 88.05 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.307 173.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.67 73.71 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.832 0.853 . . . . 0.0 111.534 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.899 0.381 . . . . 0.0 110.85 -176.488 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 8' ' ' VAL . 58.3 m . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 111.363 0.134 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -56.28 -46.9 79.53 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.266 0.627 . . . . 0.0 111.499 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.29 -46.17 86.58 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.559 0.537 . . . . 0.0 110.859 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -60.71 -45.33 94.61 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.24 0.963 . . . . 0.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 4' ' ' THR . 88.5 t -67.37 -41.01 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.579 0.752 . . . . 0.0 110.288 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.2 99.24 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.902 0.881 . . . . 0.0 111.113 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 84.5 m -62.73 -47.57 82.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.092 0.957 . . . . 0.0 111.255 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 47' ' ' ILE . 88.2 mt -61.04 -50.05 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.318 0.647 . . . . 0.0 111.188 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.455 HD12 HD11 ' A' ' 77' ' ' LEU . 56.6 mt -57.78 -48.95 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.061 0.544 . . . . 0.0 110.225 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.83 -51.24 30.55 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.64 1.176 . . . . 0.0 112.589 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.29 -32.47 73.21 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.796 0.838 . . . . 0.0 111.962 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 m -89.39 -19.06 25.66 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 122.82 0.448 . . . . 0.0 111.766 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.431 ' SG ' HD13 ' A' ' 43' ' ' ILE . 67.0 m -115.17 -9.49 12.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -168.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 60.1 53.49 4.53 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.223 1.009 . . . . 0.0 111.566 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.51 HD12 HD11 ' A' ' 23' ' ' ILE . 21.7 pt -137.32 149.73 66.62 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 123.268 0.627 . . . . 0.0 110.246 -176.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.62 115.17 4.22 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.69 2.26 . . . . 0.0 111.888 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.412 ' HA ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -60.59 -16.45 38.22 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -173.632 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.34 -27.32 62.34 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.647 0.779 . . . . 0.0 111.303 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 p -90.84 -2.17 57.78 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.173 0.589 . . . . 0.0 110.604 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 18' ' ' ILE . 1.7 mp -88.17 97.86 7.13 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.9 p -89.51 160.1 42.66 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.062 0.945 . . . . 0.0 110.757 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.13 -26.43 75.81 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.68 2.253 . . . . 0.0 113.044 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.25 1.53 52.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.972 0.509 . . . . 0.0 110.963 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.1 t -77.94 131.33 37.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.126 0.57 . . . . 0.0 109.917 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.403 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 58.0 t-80 -87.14 123.59 32.35 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.447 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -49.12 -39.71 29.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.314 1.046 . . . . 0.0 113.094 175.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 54.5 mt -91.84 -51.16 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -77.4 -33.45 55.03 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.597 0.759 . . . . 0.0 112.266 -168.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -100.77 -55.52 2.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.983 0.513 . . . . 0.0 110.792 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 29' ' ' ALA . 65.4 mt -75.06 -6.93 52.09 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.596 0.358 . . . . 0.0 111.893 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.03 33.41 74.39 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.394 0.434 . . . . 0.0 113.816 172.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.448 HG21 HD12 ' A' ' 43' ' ' ILE . 78.3 mt -99.69 121.47 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.614 0.765 . . . . 0.0 108.977 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.59 160.05 33.23 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.681 0.392 . . . . 0.0 110.195 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.2 m -58.51 -44.11 89.37 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.5 0.72 . . . . 0.0 111.857 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 39' ' ' ASP . 3.8 pp -71.94 -30.98 65.88 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.127 0.489 . . . . 0.0 110.33 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.435 ' N ' HD12 ' A' ' 38' ' ' LEU . 18.7 t70 -70.22 -37.06 74.94 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.6 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -74.82 -21.84 59.06 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.271 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.625 HD23 HD12 ' A' ' 57' ' ' LEU . 96.1 mt -56.13 -45.11 79.66 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 122.942 0.497 . . . . 0.0 111.328 173.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -66.0 -39.44 90.29 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.729 0.812 . . . . 0.0 110.775 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.448 HD12 HG21 ' A' ' 35' ' ' ILE . 34.9 mt -68.26 -39.32 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.305 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.77 -28.51 60.77 Favored 'General case' 0 C--O 1.209 -1.033 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.66 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -63.55 -41.36 98.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.752 0.821 . . . . 0.0 110.023 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.98 92.76 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.899 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.437 ' HA ' HD13 ' A' ' 11' ' ' ILE . 80.6 mt -72.93 -48.08 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.71 0.804 . . . . 0.0 110.562 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -46.6 -55.45 7.63 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.958 1.703 . . . . 0.0 111.055 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -73.3 -36.06 66.21 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.359 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.45 -37.41 86.8 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.118 0.567 . . . . 0.0 112.342 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -93.28 -6.04 48.42 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.627 0.771 . . . . 0.0 112.087 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.63 34.3 88.04 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.316 0.385 . . . . 0.0 113.234 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.4 pt -121.14 171.09 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.526 1.13 . . . . 0.0 109.573 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -106.99 100.81 10.29 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.576 HD21 HG12 ' A' ' 84' ' ' ILE . 69.6 mt -73.21 117.87 63.89 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 169.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.424 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 3.3 Cg_exo -77.74 50.38 3.23 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.897 2.398 . . . . 0.0 111.318 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.625 HD12 HD23 ' A' ' 41' ' ' LEU . 1.4 tm? -64.33 -43.17 95.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.775 0.83 . . . . 0.0 109.801 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.01 -36.18 82.7 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.888 0.742 . . . . 0.0 110.1 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 85.1 tttt -71.75 -38.56 70.39 Favored 'General case' 0 C--O 1.211 -0.962 0 O-C-N 123.533 0.521 . . . . 0.0 109.752 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.424 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 50.1 m0 -64.56 -33.47 75.99 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.889 0.876 . . . . 0.0 110.866 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.6 m -63.8 -43.48 96.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.477 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -71.63 -31.51 66.95 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.837 0.855 . . . . 0.0 110.998 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 17.8 mm-40 -59.71 -53.89 52.7 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.607 0.763 . . . . 0.0 110.273 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.5 t -61.19 -37.31 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.413 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -61.89 -43.11 99.51 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.593 0.757 . . . . 0.0 111.752 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -88.39 2.16 53.21 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.159 0.584 . . . . 0.0 111.266 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.87 17.96 73.87 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 115.109 0.803 . . . . 0.0 115.109 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -60.4 -40.99 92.94 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.59 0.756 . . . . 0.0 110.169 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.23 174.14 14.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.442 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.0 p -106.45 164.67 11.86 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.645 0.778 . . . . 0.0 109.969 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.4 p -59.11 -50.3 74.57 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.415 0.686 . . . . 0.0 112.759 -168.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.8 pm0 -50.18 -38.44 39.76 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -172.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -55.67 -27.23 48.89 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.443 1.097 . . . . 0.0 112.903 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -117.42 -27.97 6.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.335 0.654 . . . . 0.0 111.647 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -111.3 20.58 17.18 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.071 0.548 . . . . 0.0 112.218 -167.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.467 HG12 ' HG2' ' A' ' 78' ' ' LYS . 51.9 t -107.4 141.39 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 164.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.455 HD11 HD12 ' A' ' 12' ' ' ILE . 4.4 mm? -55.19 -39.17 69.28 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -171.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.8 pttt -65.43 -40.96 93.96 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.098 0.475 . . . . 0.0 110.422 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 92.7 m-20 -77.19 -45.62 26.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.677 1.191 . . . . 0.0 110.34 -173.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.94 -53.21 60.92 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 125.195 1.398 . . . . 0.0 109.782 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.49 -26.7 68.55 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.166 0.586 . . . . 0.0 111.633 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.69 -45.67 71.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.06 0.544 . . . . 0.0 110.369 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 3.5 mmp_? -58.76 -49.56 77.18 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.089 0.556 . . . . 0.0 109.838 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.576 HG12 HD21 ' A' ' 55' ' ' LEU . 83.5 mt -61.19 -52.88 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.59 -176.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.64 -44.27 85.47 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.718 0.807 . . . . 0.0 111.52 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -71.3 -30.15 65.9 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.765 0.666 . . . . 0.0 111.436 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 81.8 mt -68.55 -41.82 79.26 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 117.968 0.349 . . . . 0.0 110.577 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 84' ' ' ILE . 39.4 t -69.43 -30.73 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.82 -36.04 57.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.75 0.82 . . . . 0.0 111.446 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.35 -37.19 84.76 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.773 0.829 . . . . 0.0 110.674 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.2 pttt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.05 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 110.766 -0.087 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -53.7 -47.94 70.02 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.923 0.764 . . . . 0.0 111.211 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.44 -46.22 86.98 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.828 0.705 . . . . 0.0 110.185 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -69.09 -38.87 79.21 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.319 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.2 t -73.16 -37.96 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.621 0.768 . . . . 0.0 111.034 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.51 -32.36 73.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.065 0.946 . . . . 0.0 110.032 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 98.4 m -65.06 -48.17 74.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.162 170.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.0 mt -58.22 -47.37 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.726 0.41 . . . . 0.0 110.802 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.535 HD12 HD11 ' A' ' 77' ' ' LEU . 42.4 mt -57.47 -49.13 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.179 0.991 . . . . 0.0 110.819 175.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.23 -51.47 62.05 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.126 0.97 . . . . 0.0 113.085 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 10' ' ' THR . 14.0 mm-40 -73.73 -28.38 61.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.191 0.596 . . . . 0.0 111.933 -176.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 83.6 m -75.31 -50.72 15.14 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.942 0.497 . . . . 0.0 110.999 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -94.4 5.11 52.8 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.699 0.799 . . . . 0.0 112.454 -172.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.9 t70 48.85 64.8 1.56 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.912 1.285 . . . . 0.0 111.778 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 12' ' ' ILE . 22.9 pt -141.23 145.69 39.6 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 123.94 0.896 . . . . 0.0 109.424 -174.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.47 119.55 6.85 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.065 2.51 . . . . 0.0 112.283 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -50.06 -34.66 22.36 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.882 1.273 . . . . 0.0 111.976 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.01 -25.52 61.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.54 0.736 . . . . 0.0 111.904 -172.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -79.05 -11.71 60.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.804 0.442 . . . . 0.0 111.171 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mp -89.69 101.72 12.43 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 p -80.93 161.35 63.65 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.601 0.76 . . . . 0.0 109.891 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.26 -29.82 85.24 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.44 2.093 . . . . 0.0 112.402 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -105.03 20.14 19.37 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 122.931 0.492 . . . . 0.0 111.072 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.5 m -71.65 128.32 35.43 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -80.93 111.76 17.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.54 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.56 -37.79 8.53 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.439 1.096 . . . . 0.0 113.832 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 55.9 mt -91.34 -58.43 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.53 -46.0 42.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.036 0.934 . . . . 0.0 112.242 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -81.54 -56.46 4.01 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.325 0.65 . . . . 0.0 109.698 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 29' ' ' ALA . 88.4 mt -74.37 -12.77 60.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.233 0.613 . . . . 0.0 111.922 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.3 33.58 82.87 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 113.42 0.128 . . . . 0.0 113.42 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 82.3 mt -104.05 117.17 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.79 156.25 39.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.0 p -58.88 -29.68 67.18 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.936 0.894 . . . . 0.0 111.887 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 39' ' ' ASP . 4.4 pp -71.96 -31.26 66.13 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.144 0.497 . . . . 0.0 110.597 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.413 ' N ' HD12 ' A' ' 38' ' ' LEU . 16.0 t70 -81.91 -35.87 28.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.072 0.949 . . . . 0.0 109.483 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -68.63 -21.39 64.48 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.811 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.3 mt -51.39 -43.52 61.92 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.181 0.593 . . . . 0.0 111.245 171.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.0 -41.37 71.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.719 0.808 . . . . 0.0 111.136 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.462 HD13 HG12 ' A' ' 12' ' ' ILE . 57.3 mt -58.8 -47.79 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 123.449 0.468 . . . . 0.0 110.069 176.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 55' ' ' LEU . . . -71.84 -34.43 69.28 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.772 0.829 . . . . 0.0 110.523 -174.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -62.55 -37.88 87.88 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.614 0.766 . . . . 0.0 110.746 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.89 -40.08 72.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.945 0.498 . . . . 0.0 111.115 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.493 HG21 HD13 ' A' ' 84' ' ' ILE . 84.9 mt -63.07 -45.99 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.673 0.789 . . . . 0.0 110.228 176.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -50.67 -52.33 40.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.478 1.511 . . . . 0.0 110.75 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -69.95 -42.83 72.69 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.577 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.74 -49.78 73.68 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.589 0.756 . . . . 0.0 111.841 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.432 ' HB3' HG22 ' A' ' 88' ' ' VAL . 83.5 m-85 -86.32 -6.72 58.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.567 0.747 . . . . 0.0 111.182 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.44 29.77 73.11 Favored Glycine 0 C--N 1.356 1.659 0 O-C-N 123.432 0.457 . . . . 0.0 113.229 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.459 HG22 ' HG2' ' A' ' 91' ' ' LYS . 47.5 pt -113.23 174.62 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.261 1.024 . . . . 0.0 110.228 -175.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -113.32 108.58 17.44 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 169.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.552 HD21 HG12 ' A' ' 84' ' ' ILE . 60.0 mt -79.7 115.61 54.91 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.496 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 82.3 Cg_endo -76.85 54.68 4.62 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 122.211 1.941 . . . . 0.0 111.029 169.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.38 -40.16 95.56 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.387 1.075 . . . . 0.0 109.325 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.24 -40.02 84.62 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.282 175.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 27.1 tptp -71.76 -38.34 70.38 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.967 0.907 . . . . 0.0 110.702 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.496 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 54.6 m0 -65.02 -45.84 83.8 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.899 0.88 . . . . 0.0 110.555 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.7 m -64.42 -33.71 76.5 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.686 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -66.98 -38.89 86.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.05 0.54 . . . . 0.0 110.143 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 19.0 mm-40 -60.16 -41.39 92.7 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.123 0.569 . . . . 0.0 110.845 175.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.445 HG11 HG23 ' A' ' 71' ' ' THR . 59.2 t -64.04 -54.28 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.828 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -65.51 -30.84 71.65 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.53 0.732 . . . . 0.0 112.602 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -90.16 3.63 52.87 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.951 0.5 . . . . 0.0 111.109 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.94 13.16 69.15 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -75.39 -28.2 59.37 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.146 0.578 . . . . 0.0 111.384 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -153.85 171.29 19.18 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.38 0.672 . . . . 0.0 109.817 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.8 m -101.19 157.06 17.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.901 0.88 . . . . 0.0 109.284 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.445 HG23 HG11 ' A' ' 64' ' ' VAL . 13.5 p -52.8 -47.35 67.65 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.617 0.767 . . . . 0.0 111.546 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.479 ' HA ' HG23 ' A' ' 76' ' ' VAL . 12.9 pt-20 -47.11 -41.9 18.14 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -173.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -26.27 67.67 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.197 0.999 . . . . 0.0 111.583 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -113.9 -26.34 8.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.113 0.565 . . . . 0.0 112.423 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.5 23.75 11.04 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.307 0.643 . . . . 0.0 111.116 -164.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.479 HG23 ' HA ' ' A' ' 72' ' ' GLU . 55.0 t -107.3 132.22 55.34 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.338 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 162.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.535 HD11 HD12 ' A' ' 12' ' ' ILE . 3.7 mm? -49.8 -32.95 15.22 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.147 1.379 . . . . 0.0 114.693 -168.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.404 ' HG3' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -80.74 -38.17 29.18 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.732 0.413 . . . . 0.0 111.746 177.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 93.1 m-20 -70.13 -49.92 45.85 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.074 0.55 . . . . 0.0 109.738 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.2 tp -49.7 -50.51 43.54 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.085 1.754 . . . . 0.0 110.981 170.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.59 -36.82 74.6 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.653 0.596 . . . . 0.0 110.826 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.95 79.82 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.866 0.729 . . . . 0.0 111.023 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 5.6 mmp_? -56.36 -53.33 58.61 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.671 0.748 . . . . 0.0 110.438 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.552 HG12 HD21 ' A' ' 55' ' ' LEU . 66.7 mt -64.94 -45.42 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.41 -176.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.29 -41.44 93.41 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.269 1.028 . . . . 0.0 111.676 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -67.83 -35.13 78.05 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.817 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.0 -31.31 67.79 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.214 0.321 . . . . 0.0 111.227 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 84' ' ' ILE . 60.6 t -69.74 -40.27 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-O 121.262 0.553 . . . . 0.0 109.741 175.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.17 93.84 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.915 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.66 83.41 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.77 0.828 . . . . 0.0 111.469 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.459 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.228 0 C-N-CA 122.841 0.457 . . . . 0.0 110.291 -175.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.0 m . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -56.17 -42.68 77.44 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.411 0.684 . . . . 0.0 111.623 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -52.94 -51.39 61.53 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.675 0.79 . . . . 0.0 110.31 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 11' ' ' ILE . 37.8 mmt180 -64.7 -43.37 93.69 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.84 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.437 ' HA ' HD12 ' A' ' 11' ' ' ILE . 67.4 t -70.0 -36.45 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.941 0.896 . . . . 0.0 111.246 -175.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.02 -36.53 83.5 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.691 0.796 . . . . 0.0 110.309 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.5 m -66.04 -41.36 90.97 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.254 0.622 . . . . 0.0 111.175 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 7' ' ' ARG . 82.8 mt -56.85 -52.92 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.923 0.489 . . . . 0.0 110.353 174.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.557 HD12 HD11 ' A' ' 77' ' ' LEU . 39.9 mt -59.67 -44.62 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.8 0.84 . . . . 0.0 110.931 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.564 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -50.11 -63.24 1.18 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.415 1.086 . . . . 0.0 113.119 175.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.03 -25.15 66.93 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.722 -174.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.9 m -78.82 -46.64 18.26 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.468 0.707 . . . . 0.0 111.53 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.7 t -102.26 4.61 39.42 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.443 0.697 . . . . 0.0 111.867 -170.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 t70 48.1 76.76 0.11 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.264 1.426 . . . . 0.0 112.185 -170.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 13' ' ' ALA . 3.3 pt -147.4 141.61 15.97 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.536 1.134 . . . . 0.0 108.765 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.67 125.88 17.06 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.34 2.026 . . . . 0.0 110.741 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.583 ' HA ' HD13 ' A' ' 23' ' ' ILE . 2.2 ppt_? -70.23 -16.15 63.01 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -88.17 -1.76 58.2 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.979 0.512 . . . . 0.0 110.503 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.9 p -89.09 -17.77 28.61 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 117.743 0.247 . . . . 0.0 110.428 165.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.583 HD13 ' HA ' ' A' ' 20' ' ' ARG . 2.1 mp -80.51 111.89 17.81 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.1 p -90.25 158.94 43.03 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.607 0.763 . . . . 0.0 109.188 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.05 -19.52 66.42 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 121.974 1.783 . . . . 0.0 112.128 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.53 8.76 44.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.384 0.674 . . . . 0.0 110.495 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.0 m -70.89 124.87 25.35 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.417 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 64.6 t-80 -80.05 111.82 16.75 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 167.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.05 -36.49 29.29 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mt -93.53 -45.04 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 122.306 0.242 . . . . 0.0 110.871 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.93 -44.19 11.22 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.449 0.7 . . . . 0.0 111.796 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.98 -60.1 2.21 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.362 0.665 . . . . 0.0 109.984 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.82 -17.18 63.38 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.871 0.468 . . . . 0.0 111.543 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.31 37.36 90.68 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.576 0.548 . . . . 0.0 113.812 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.3 mt -93.59 114.67 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.61 156.41 38.16 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 m -57.91 -31.53 66.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.928 0.891 . . . . 0.0 112.637 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.57 -31.83 62.19 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.801 0.44 . . . . 0.0 111.253 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -75.1 -32.69 61.49 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.224 0.61 . . . . 0.0 110.01 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -71.42 -28.5 64.04 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.836 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.78 -41.85 87.64 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.75 0.42 . . . . 0.0 110.38 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.9 -44.18 81.47 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.12 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.417 HD13 HG12 ' A' ' 12' ' ' ILE . 58.6 mt -65.27 -46.14 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 122.855 0.462 . . . . 0.0 110.805 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.56 76.36 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.182 0.593 . . . . 0.0 110.549 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -73.43 -25.25 60.44 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.747 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.7 -41.15 72.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.503 0.321 . . . . 0.0 110.324 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.85 -44.5 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.135 0.974 . . . . 0.0 110.218 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -51.47 -48.15 62.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.5 1.52 . . . . 0.0 110.647 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.14 -50.07 65.25 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.19 175.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.44 -51.49 66.75 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.008 0.923 . . . . 0.0 113.253 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -89.45 -6.56 56.4 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.513 0.725 . . . . 0.0 111.683 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.81 39.83 95.32 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-O 121.189 0.327 . . . . 0.0 112.534 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.478 HG22 ' HG2' ' A' ' 91' ' ' LYS . 41.8 pt -122.61 169.64 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.41 1.084 . . . . 0.0 109.493 -175.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -107.45 120.88 43.41 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.403 HD22 ' HH2' ' A' ' 60' ' ' TRP . 57.1 mt -90.26 113.61 58.0 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.81 57.1 3.7 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.446 2.764 . . . . 0.0 111.292 171.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.5 -38.68 90.82 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.227 1.011 . . . . 0.0 110.259 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 8.4 pt-20 -58.97 -45.74 89.8 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 124.01 0.819 . . . . 0.0 110.985 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -63.67 -48.23 78.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.814 0.846 . . . . 0.0 109.86 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.416 ' O ' HG23 ' A' ' 64' ' ' VAL . 48.2 m0 -53.69 -44.53 69.83 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.366 1.041 . . . . 0.0 110.744 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.1 m -64.42 -45.6 86.86 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.047 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 13.7 mm100 -68.79 -37.51 79.32 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.6 0.36 . . . . 0.0 110.872 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -57.64 -48.06 80.51 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.155 0.982 . . . . 0.0 110.374 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.513 HG11 HG23 ' A' ' 71' ' ' THR . 78.8 t -59.24 -46.73 92.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.304 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -61.06 -37.11 81.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.917 0.487 . . . . 0.0 111.551 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.6 6.15 39.53 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.892 0.877 . . . . 0.0 112.115 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.53 20.85 74.15 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.68 -23.4 45.67 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.317 0.647 . . . . 0.0 110.196 171.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.0 175.07 14.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.176 0.99 . . . . 0.0 109.742 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.8 m -111.57 156.63 21.46 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.513 HG23 HG11 ' A' ' 64' ' ' VAL . 4.6 p -51.28 -40.91 59.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.3 mp0 -47.82 -46.98 31.41 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.574 0.75 . . . . 0.0 112.426 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -26.4 62.64 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.243 1.017 . . . . 0.0 113.049 -172.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -117.81 -21.29 8.49 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -119.28 20.72 12.49 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.195 0.598 . . . . 0.0 111.819 -166.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.523 HG12 ' HG2' ' A' ' 78' ' ' LYS . 30.8 t -102.75 139.98 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 163.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.557 HD11 HD12 ' A' ' 12' ' ' ILE . 3.5 mm? -53.99 -37.21 63.77 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.146 1.379 . . . . 0.0 114.304 -168.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HG2' HG12 ' A' ' 76' ' ' VAL . 57.0 pttt -71.86 -37.14 70.28 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.661 0.384 . . . . 0.0 111.294 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -79.26 -35.24 41.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.714 0.806 . . . . 0.0 110.49 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.93 -52.48 59.62 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.568 1.147 . . . . 0.0 108.445 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.24 69.8 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.019 0.824 . . . . 0.0 111.508 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.84 -54.13 30.83 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.531 0.519 . . . . 0.0 109.751 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -50.66 -50.04 55.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.247 0.967 . . . . 0.0 111.111 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.508 ' O ' HG23 ' A' ' 88' ' ' VAL . 72.2 mt -61.34 -48.33 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.122 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.96 -39.71 94.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.912 0.885 . . . . 0.0 111.625 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.37 -40.62 97.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.01 0.924 . . . . 0.0 109.849 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.6 mt -72.89 -28.64 62.6 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.815 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 84' ' ' ILE . 80.2 t -67.86 -37.83 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 123.311 0.644 . . . . 0.0 109.796 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.56 80.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.404 0.682 . . . . 0.0 110.712 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.76 -38.77 80.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.506 0.722 . . . . 0.0 111.255 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.478 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 8' ' ' VAL . 30.7 m . . . . . 0 CA--C 1.548 0.881 0 CA-C-O 119.748 -0.167 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.35 -44.43 92.68 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.915 0.486 . . . . 0.0 111.077 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.34 -41.04 68.62 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.934 0.771 . . . . 0.0 111.388 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 11' ' ' ILE . 82.6 mtp180 -74.22 -34.24 63.64 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.795 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 4' ' ' THR . 52.8 t -70.21 -36.31 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 118.733 0.697 . . . . 0.0 109.593 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.98 90.43 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.264 1.026 . . . . 0.0 110.749 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 m -61.69 -51.15 69.62 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 123.812 0.695 . . . . 0.0 110.863 173.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 7' ' ' ARG . 96.8 mt -55.7 -51.52 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.431 1.092 . . . . 0.0 111.616 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.53 HD12 HD11 ' A' ' 77' ' ' LEU . 35.6 mt -60.71 -46.35 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.514 0.726 . . . . 0.0 111.016 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.567 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -51.78 -48.31 63.82 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.006 0.816 . . . . 0.0 112.596 175.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.91 -37.04 81.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.711 0.805 . . . . 0.0 112.031 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.8 m -68.44 -54.53 16.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.09 0.556 . . . . 0.0 110.66 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.6 m -91.78 7.49 41.55 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.885 0.874 . . . . 0.0 112.514 -173.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 39.52 74.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.009 1.324 . . . . 0.0 112.469 -170.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.567 HG13 ' HA ' ' A' ' 13' ' ' ALA . 13.8 pt -140.18 142.52 30.34 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.995 1.318 . . . . 0.0 107.838 -177.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.29 131.17 41.43 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.423 2.082 . . . . 0.0 112.322 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -36.38 -42.1 0.31 Allowed 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 126.69 1.996 . . . . 0.0 113.939 176.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.14 -28.98 66.93 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.819 0.848 . . . . 0.0 112.001 -170.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 p -79.36 -4.04 49.06 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.54 97.2 5.96 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.7 p -88.46 162.18 40.31 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.692 0.797 . . . . 0.0 110.213 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.39 -26.76 79.01 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.706 2.271 . . . . 0.0 113.502 176.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.74 5.54 50.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.842 0.857 . . . . 0.0 111.442 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -68.67 120.99 15.54 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.437 0.295 . . . . 0.0 110.305 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -84.36 123.4 30.15 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 167.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -40.27 -50.04 2.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.773 1.229 . . . . 0.0 113.147 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -90.81 -51.34 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.229 0.538 . . . . 0.0 109.908 -169.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.89 -39.57 66.29 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.247 1.019 . . . . 0.0 112.479 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.84 -64.53 1.04 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.365 0.666 . . . . 0.0 110.08 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.47 HD13 HG21 ' A' ' 12' ' ' ILE . 73.2 mt -73.9 -17.6 61.01 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.609 0.763 . . . . 0.0 112.216 -174.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.98 34.33 76.5 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 123.083 0.239 . . . . 0.0 113.651 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.416 HG23 ' HB2' ' A' ' 39' ' ' ASP . 92.5 mt -82.62 139.96 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.574 1.15 . . . . 0.0 109.277 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -92.53 162.16 14.32 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.9 m -54.33 -36.98 64.35 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.317 1.047 . . . . 0.0 112.083 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.38 -40.62 77.3 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.859 0.463 . . . . 0.0 110.364 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.416 ' HB2' HG23 ' A' ' 35' ' ' ILE . 47.4 m-20 -68.63 -35.45 77.31 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.387 0.675 . . . . 0.0 110.459 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.46 -32.71 74.25 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.8 0.687 . . . . 0.0 110.528 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.0 mt -61.21 -42.63 98.94 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.055 0.542 . . . . 0.0 111.255 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -66.97 -42.57 84.91 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.099 0.56 . . . . 0.0 110.723 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.464 HD13 HG12 ' A' ' 12' ' ' ILE . 97.2 mt -57.29 -47.36 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.225 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.13 -38.49 75.56 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.291 -173.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -61.48 -42.56 98.97 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.0 0.92 . . . . 0.0 110.9 174.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.94 -29.26 66.36 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.15 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.473 HD13 HD11 ' A' ' 84' ' ' ILE . 90.3 mt -65.83 -43.52 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.467 0.707 . . . . 0.0 110.307 173.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -58.67 -41.26 85.73 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.425 0.453 . . . . 0.0 110.913 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -69.07 -54.06 17.05 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.556 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.17 -52.8 64.14 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.128 0.971 . . . . 0.0 112.871 -176.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -89.8 -6.75 55.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.843 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.71 31.81 73.65 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.5 0.5 . . . . 0.0 113.448 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.439 HG22 ' HD3' ' A' ' 91' ' ' LYS . 41.3 pt -118.22 -178.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.561 0.745 . . . . 0.0 112.116 -172.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -126.56 106.52 9.49 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.354 1.462 . . . . 0.0 107.489 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.464 HD21 HG12 ' A' ' 84' ' ' ILE . 91.3 mt -72.8 125.99 90.88 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -74.98 60.47 5.43 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.778 2.318 . . . . 0.0 109.634 163.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -40.26 91.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.134 1.374 . . . . 0.0 109.253 -171.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.81 -42.23 92.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.693 0.797 . . . . 0.0 111.012 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -62.75 -47.5 83.29 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.477 1.111 . . . . 0.0 110.031 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -60.07 -44.87 94.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.948 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -65.99 -36.74 84.12 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.9 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -68.66 -37.46 79.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.033 0.533 . . . . 0.0 110.988 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.58 -38.98 92.88 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.546 0.738 . . . . 0.0 111.264 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.9 t -65.51 -49.88 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.457 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -60.47 -32.06 71.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.182 0.993 . . . . 0.0 112.297 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -93.8 0.49 56.31 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.745 0.818 . . . . 0.0 111.871 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.82 16.92 66.7 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.46 -33.73 76.55 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 117.576 0.688 . . . . 0.0 110.156 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.87 166.38 28.69 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.012 0.925 . . . . 0.0 108.967 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 75.2 p -86.37 164.0 17.31 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 122.749 0.42 . . . . 0.0 110.052 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.7 p -54.2 -49.1 70.15 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.151 0.58 . . . . 0.0 109.632 172.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.508 ' HA ' HG23 ' A' ' 76' ' ' VAL . 28.6 mt-10 -43.35 -47.19 6.72 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.955 1.702 . . . . 0.0 113.52 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.402 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 12.0 mm-40 -53.68 -28.95 36.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.99 0.916 . . . . 0.0 113.467 -176.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -121.13 -21.05 6.56 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -110.71 15.81 21.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.47 0.708 . . . . 0.0 110.966 -169.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 72' ' ' GLU . 91.3 t -108.21 139.8 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.53 HD11 HD12 ' A' ' 12' ' ' ILE . 3.6 mm? -54.26 -40.11 67.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.338 1.455 . . . . 0.0 114.108 -172.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.468 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.1 pttt -65.2 -42.02 93.95 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.437 0.461 . . . . 0.0 110.82 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.14 -39.49 40.93 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.537 1.135 . . . . 0.0 111.021 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.2 -49.94 72.24 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.267 1.027 . . . . 0.0 109.248 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.2 -34.68 78.63 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.564 0.746 . . . . 0.0 111.405 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.76 90.05 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.57 0.544 . . . . 0.0 110.505 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.483 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -58.7 -48.86 79.69 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.301 0.641 . . . . 0.0 111.267 175.544 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.473 HD11 HD13 ' A' ' 47' ' ' ILE . 91.2 mt -59.63 -43.02 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.654 1.182 . . . . 0.0 110.292 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.37 -45.38 91.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 110.912 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.39 -33.3 72.82 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.463 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 62.5 mt -70.99 -36.39 72.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.078 0.551 . . . . 0.0 111.742 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 84' ' ' ILE . 94.8 t -64.94 -41.81 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-O 121.657 0.741 . . . . 0.0 109.499 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.94 75.84 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.733 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.7 94.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.147 0.979 . . . . 0.0 112.076 -176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.439 ' HD3' HG22 ' A' ' 53' ' ' ILE . 60.1 pttt . . . . . 0 N--CA 1.48 1.027 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.431 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' HG23 ' A' ' 8' ' ' VAL . 65.2 m . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -56.76 -42.16 78.85 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.315 0.646 . . . . 0.0 112.013 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.63 -42.19 92.17 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.973 0.509 . . . . 0.0 110.662 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -61.7 -46.3 90.27 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.643 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 4' ' ' THR . 99.5 t -70.0 -38.93 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.113 0.965 . . . . 0.0 111.191 -173.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.2 96.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.98 0.912 . . . . 0.0 110.028 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -63.62 -44.89 92.61 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 111.308 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.49 -51.7 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.394 0.678 . . . . 0.0 110.815 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.587 HG12 HG21 ' A' ' 43' ' ' ILE . 38.7 mt -57.72 -52.83 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.487 0.715 . . . . 0.0 110.664 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.78 -54.93 8.74 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.914 1.286 . . . . 0.0 113.01 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.59 -22.86 60.92 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.255 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.8 m -88.13 -25.64 22.88 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.78 0.432 . . . . 0.0 111.786 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.5 t -113.23 -1.4 14.33 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.91 0.484 . . . . 0.0 111.823 -167.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.31 50.47 7.76 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.191 0.996 . . . . 0.0 111.571 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.554 HD12 HD11 ' A' ' 23' ' ' ILE . 16.3 pt -138.17 156.09 73.99 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 123.761 0.825 . . . . 0.0 109.987 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.77 131.15 16.71 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.591 2.194 . . . . 0.0 110.73 172.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HA ' HD13 ' A' ' 23' ' ' ILE . 6.5 ppt_? -68.22 -16.22 63.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.729 0.412 . . . . 0.0 111.312 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.26 -20.63 54.86 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 123.538 0.735 . . . . 0.0 110.487 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -92.05 10.34 29.54 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.083 0.553 . . . . 0.0 110.421 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.554 HD11 HD12 ' A' ' 18' ' ' ILE . 1.9 mp -104.92 127.28 59.56 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 168.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.1 p -121.87 158.22 55.3 Favored Pre-proline 0 N--CA 1.484 1.225 0 C-N-CA 123.981 0.912 . . . . 0.0 109.668 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.53 -32.7 35.93 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.788 2.325 . . . . 0.0 113.399 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.84 -5.87 56.43 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.941 -0.474 . . . . 0.0 111.429 -173.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.8 p -77.19 132.87 38.98 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 122.541 0.336 . . . . 0.0 110.185 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -85.33 126.14 33.5 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 173.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.43 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.54 -39.6 11.21 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.083 0.953 . . . . 0.0 113.236 175.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.8 mt -96.57 -55.88 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -171.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.37 -43.84 80.41 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.506 0.723 . . . . 0.0 112.578 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -93.57 -57.23 2.64 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.868 0.467 . . . . 0.0 110.302 -172.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 29' ' ' ALA . 62.8 mt -78.91 -7.77 58.27 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.565 0.746 . . . . 0.0 112.44 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.04 25.07 72.0 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 114.443 0.537 . . . . 0.0 114.443 174.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.32 121.56 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.787 0.835 . . . . 0.0 108.776 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.45 157.19 37.57 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 t -58.29 -35.13 71.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.741 0.817 . . . . 0.0 111.701 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 41' ' ' LEU . 4.5 pp -71.7 -30.92 66.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.517 0.327 . . . . 0.0 111.076 -177.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -73.24 -39.76 65.21 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.118 0.567 . . . . 0.0 109.91 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -69.88 -25.9 63.92 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.783 0.677 . . . . 0.0 110.89 -176.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.653 HD23 HD12 ' A' ' 57' ' ' LEU . 93.7 mt -56.83 -42.6 79.92 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.051 0.54 . . . . 0.0 110.615 170.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -75.14 -40.95 59.3 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.064 0.946 . . . . 0.0 110.627 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.587 HG21 HG12 ' A' ' 12' ' ' ILE . 57.0 mt -61.22 -43.61 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.227 0.537 . . . . 0.0 110.319 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 -33.29 63.0 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.963 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -62.69 -34.35 76.95 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.595 0.358 . . . . 0.0 110.347 172.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.95 -34.5 73.5 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.92 0.488 . . . . 0.0 110.8 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.12 -42.87 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.627 0.771 . . . . 0.0 110.35 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -53.08 -51.3 62.29 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.659 0.784 . . . . 0.0 110.635 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -63.46 -50.15 70.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.056 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.88 -48.76 77.61 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.737 0.815 . . . . 0.0 112.395 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -83.61 -10.21 58.39 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.513 0.725 . . . . 0.0 112.22 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.38 30.27 71.43 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.418 0.449 . . . . 0.0 112.988 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 pt -120.01 -176.18 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.022 1.329 . . . . 0.0 109.622 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -137.1 98.63 3.79 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.498 HD23 HD12 ' A' ' 87' ' ' LEU . 85.2 mt -64.01 123.64 82.66 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.5 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 98.2 Cg_endo -76.21 62.08 6.73 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 122.485 2.124 . . . . 0.0 110.587 170.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.653 HD12 HD23 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -62.44 -34.66 77.22 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.348 1.059 . . . . 0.0 109.14 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.52 -43.38 97.17 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.763 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 56.9 tptt -69.09 -39.71 78.84 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 123.632 0.773 . . . . 0.0 110.49 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.414 ' HH2' HD22 ' A' ' 55' ' ' LEU . 54.6 m0 -67.5 -39.84 85.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.494 0.718 . . . . 0.0 110.643 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -61.02 -39.37 89.47 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 124.078 0.861 . . . . 0.0 110.223 173.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -70.13 -43.98 69.84 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.201 1.0 . . . . 0.0 110.157 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.03 -46.81 88.29 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.566 1.147 . . . . 0.0 111.126 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 89.9 t -61.11 -40.0 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -67.92 -30.33 69.62 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.247 0.619 . . . . 0.0 111.767 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -85.04 -1.15 56.5 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.34 15.85 68.49 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 114.198 0.439 . . . . 0.0 114.198 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -72.6 -31.84 65.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.473 0.709 . . . . 0.0 110.779 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -149.07 166.27 29.23 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.756 0.822 . . . . 0.0 109.73 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.1 m -103.16 154.85 18.88 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.4 p -47.04 -49.08 21.94 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 124.209 1.003 . . . . 0.0 112.451 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.549 ' HA ' HG23 ' A' ' 76' ' ' VAL . 40.7 mt-10 -44.82 -42.63 8.04 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -56.46 -27.38 56.74 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.193 0.997 . . . . 0.0 112.818 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -121.7 -22.35 5.86 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.081 0.552 . . . . 0.0 112.037 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -114.7 14.49 17.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.462 0.705 . . . . 0.0 111.31 -167.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.549 HG23 ' HA ' ' A' ' 72' ' ' GLU . 53.5 t -107.78 137.03 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 165.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.492 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -55.3 -33.88 63.67 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -169.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.0 pttt -71.65 -44.41 64.35 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.559 0.344 . . . . 0.0 110.389 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 26.2 m120 -72.2 -38.02 69.13 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 123.608 0.763 . . . . 0.0 109.972 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.4 tp -62.5 -48.71 78.36 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 124.984 1.314 . . . . 0.0 109.454 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.31 -33.96 71.74 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.681 0.613 . . . . 0.0 111.146 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.86 -40.48 75.75 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.207 0.603 . . . . 0.0 111.426 175.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 13.6 mmp_? -60.59 -48.27 82.53 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.558 0.743 . . . . 0.0 110.867 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 88' ' ' VAL . 86.7 mt -63.22 -51.46 70.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.689 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.72 -39.55 94.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.441 0.696 . . . . 0.0 112.115 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.43 -37.79 83.55 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.34 0.4 . . . . 0.0 110.264 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.498 HD12 HD23 ' A' ' 55' ' ' LEU . 84.2 mt -71.03 -32.8 69.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.791 0.436 . . . . 0.0 111.534 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 84' ' ' ILE . 73.4 t -65.92 -43.37 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.321 0.581 . . . . 0.0 109.479 173.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.7 -45.9 87.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.163 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.82 89.29 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.318 1.047 . . . . 0.0 111.674 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.093 0 O-C-N 123.535 0.522 . . . . 0.0 110.283 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 8' ' ' VAL . 17.9 m . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.93 -45.39 90.52 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.765 0.426 . . . . 0.0 111.179 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.93 -42.86 90.78 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.261 0.624 . . . . 0.0 110.902 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -65.87 -41.73 91.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.234 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 4' ' ' THR . 72.7 t -68.83 -40.57 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.436 0.695 . . . . 0.0 110.589 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.67 94.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.841 0.856 . . . . 0.0 110.817 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.8 m -66.41 -41.9 88.59 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.162 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.46 -47.02 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.313 0.645 . . . . 0.0 110.78 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 18' ' ' ILE . 42.9 mt -58.22 -46.72 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.559 0.743 . . . . 0.0 110.547 177.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.63 -51.28 65.89 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.031 0.933 . . . . 0.0 112.628 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -73.96 -31.37 62.99 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.2 m -74.45 -57.5 3.89 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.546 ' SG ' HD11 ' A' ' 43' ' ' ILE . 76.1 m -85.23 -5.79 59.3 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 60.0 66.43 0.98 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 122.002 0.906 . . . . 0.0 109.729 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 12' ' ' ILE . 12.5 pt -141.72 152.0 61.59 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.835 1.254 . . . . 0.0 108.56 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.524 ' O ' HG22 ' A' ' 22' ' ' THR . 37.9 Cg_endo -66.61 125.1 13.28 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.047 1.831 . . . . 0.0 111.334 175.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.545 ' HA ' HD13 ' A' ' 23' ' ' ILE . 58.6 ttt180 -53.44 -29.1 33.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.17 0.988 . . . . 0.0 112.565 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.1 pt-20 -65.88 -23.67 66.7 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.487 0.715 . . . . 0.0 112.155 -172.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 19' ' ' PRO . 9.3 t -88.11 2.49 51.89 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.705 0.402 . . . . 0.0 111.512 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.545 HD13 ' HA ' ' A' ' 20' ' ' ARG . 3.6 mp -102.0 94.15 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.6 p -88.52 163.76 34.87 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -62.45 -19.67 68.18 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.213 1.942 . . . . 0.0 113.131 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -95.85 3.86 53.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.761 0.424 . . . . 0.0 110.814 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -75.54 130.86 39.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.855 0.359 . . . . 0.0 110.093 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -85.59 122.69 30.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 168.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.73 -41.11 30.97 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.043 0.937 . . . . 0.0 112.817 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.4 mt -93.13 -53.23 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.06 -44.74 65.14 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.707 0.803 . . . . 0.0 111.787 -171.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -89.32 -59.86 2.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.93 0.492 . . . . 0.0 110.372 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 29' ' ' ALA . 71.1 mt -76.04 -10.9 59.79 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.815 0.846 . . . . 0.0 112.902 -171.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.29 33.04 85.65 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 123.316 0.385 . . . . 0.0 113.671 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 82.8 mt -94.13 122.57 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.14 157.88 32.59 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.198 0.599 . . . . 0.0 109.551 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.498 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 27.3 m -59.72 -27.56 66.57 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.444 0.697 . . . . 0.0 111.732 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.12 -40.85 64.59 Favored 'General case' 0 C--N 1.362 1.131 0 C-N-CA 122.928 0.491 . . . . 0.0 110.336 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.71 -36.18 81.87 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.238 0.615 . . . . 0.0 109.63 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -70.13 -27.88 64.92 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 123.762 0.664 . . . . 0.0 110.611 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.2 mt -61.88 -40.33 95.04 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.069 0.395 . . . . 0.0 110.235 173.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -71.84 -39.05 70.02 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 124.021 0.826 . . . . 0.0 110.677 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.546 HD11 ' SG ' ' A' ' 16' ' ' CYS . 77.4 mt -61.94 -47.41 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.114 0.565 . . . . 0.0 109.908 174.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.5 -34.38 72.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.797 0.839 . . . . 0.0 110.341 -173.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -69.01 -37.24 78.58 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.896 0.878 . . . . 0.0 110.721 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.88 -35.83 74.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.662 0.385 . . . . 0.0 110.751 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.411 HD11 HG13 ' A' ' 8' ' ' VAL . 96.5 mt -66.88 -46.24 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.033 0.933 . . . . 0.0 109.891 173.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -51.46 -51.12 57.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.363 1.465 . . . . 0.0 110.357 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -69.13 -47.23 65.62 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.863 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.45 92.87 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.408 0.683 . . . . 0.0 112.464 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.32 -4.43 58.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.548 0.739 . . . . 0.0 111.219 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.45 30.36 77.65 Favored Glycine 0 C--N 1.357 1.719 0 O-C-N 123.233 0.333 . . . . 0.0 113.465 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.3 pt -119.37 163.39 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.45 1.1 . . . . 0.0 109.68 -175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 123.19 42.4 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 164.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.457 HD21 HG12 ' A' ' 84' ' ' ILE . 54.0 mt -78.45 135.67 60.83 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 171.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.51 ' HD3' HD11 ' A' ' 87' ' ' LEU . 4.4 Cg_exo -79.18 44.16 1.64 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 123.302 2.668 . . . . 0.0 111.301 170.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -57.15 -38.4 73.47 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.528 1.131 . . . . 0.0 109.785 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -53.91 -51.49 63.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.985 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 49.9 tptt -66.35 -41.18 89.93 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.585 1.154 . . . . 0.0 110.888 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.429 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 52.2 m0 -59.94 -45.21 93.35 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.167 0.987 . . . . 0.0 110.58 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.7 m -63.62 -39.0 93.26 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.848 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -65.37 -39.51 92.37 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.185 0.594 . . . . 0.0 110.658 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 27.4 mm-40 -56.17 -48.49 76.22 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.215 0.606 . . . . 0.0 111.063 175.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.99 -41.46 89.8 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.124 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -60.0 -43.65 95.05 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.992 0.917 . . . . 0.0 111.785 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -83.01 6.17 19.71 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.41 19.39 64.39 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 114.494 0.558 . . . . 0.0 114.494 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -76.12 -59.47 2.75 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.927 0.891 . . . . 0.0 108.686 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.38 172.04 7.03 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.207 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 p -107.26 170.78 7.75 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.83 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.6 p -62.16 -46.19 90.08 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 119.537 -0.268 . . . . 0.0 110.701 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -53.07 -36.64 60.88 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.574 0.75 . . . . 0.0 112.932 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -25.98 58.83 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.491 1.116 . . . . 0.0 111.346 -175.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -128.96 -7.43 4.94 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -115.48 16.68 16.6 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.226 0.611 . . . . 0.0 111.244 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.459 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.3 t -103.16 141.33 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 166.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.442 HD11 HD12 ' A' ' 12' ' ' ILE . 4.1 mm? -53.61 -42.29 67.55 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.188 1.395 . . . . 0.0 114.246 -172.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.459 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.7 pttt -68.59 -40.05 80.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.826 0.45 . . . . 0.0 110.843 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.425 ' OD1' ' HG3' ' A' ' 78' ' ' LYS . 2.1 m-20 -68.36 -46.2 70.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.049 0.94 . . . . 0.0 109.853 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.4 tp -58.84 -50.47 73.86 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.01 1.324 . . . . 0.0 109.973 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.64 75.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.595 0.758 . . . . 0.0 111.749 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.33 68.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.721 0.408 . . . . 0.0 110.063 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -56.4 -48.24 77.32 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.784 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.457 HG12 HD21 ' A' ' 55' ' ' LEU . 90.3 mt -61.8 -51.36 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.532 1.133 . . . . 0.0 111.227 -175.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.83 -39.58 85.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.888 0.875 . . . . 0.0 111.34 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -63.73 -40.49 96.87 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.038 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.51 HD11 ' HD3' ' A' ' 56' ' ' PRO . 91.7 mt -67.34 -34.44 77.33 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.194 0.598 . . . . 0.0 111.492 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 84' ' ' ILE . 57.9 t -65.77 -42.28 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.18 -43.19 98.94 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.536 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.18 -39.67 89.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.097 0.959 . . . . 0.0 112.284 -177.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 41.3 pttt . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 122.545 0.338 . . . . 0.0 110.117 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.588 HG21 ' HB2' ' A' ' 85' ' ' ASP . 24.2 m . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -58.51 -51.57 69.32 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.452 0.701 . . . . 0.0 111.559 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -58.85 -42.92 90.46 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.698 0.624 . . . . 0.0 111.076 -175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 11' ' ' ILE . 92.1 mtt-85 -62.02 -46.81 87.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.691 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 4' ' ' THR . 53.8 t -64.33 -44.53 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.312 0.645 . . . . 0.0 110.367 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.99 85.11 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.231 1.012 . . . . 0.0 110.856 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.1 m -68.72 -41.33 79.19 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.466 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 7' ' ' ARG . 74.2 mt -60.61 -43.98 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.609 0.364 . . . . 0.0 110.766 176.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.617 HG22 HD11 ' A' ' 18' ' ' ILE . 56.2 mt -56.71 -47.48 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.463 0.705 . . . . 0.0 110.194 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . . . -56.75 -51.86 67.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.544 1.138 . . . . 0.0 113.376 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.64 -30.4 71.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.172 0.989 . . . . 0.0 111.865 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -82.81 -46.62 12.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.581 0.352 . . . . 0.0 111.087 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.7 t -93.3 -7.78 43.95 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.483 0.713 . . . . 0.0 112.182 -169.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 56.78 70.18 0.67 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.55 1.14 . . . . 0.0 111.574 -172.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.617 HD11 HG22 ' A' ' 12' ' ' ILE . 10.2 pt -143.75 152.0 54.76 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 125.143 1.377 . . . . 0.0 108.641 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.09 116.77 4.76 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 121.93 1.754 . . . . 0.0 111.709 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -62.93 -17.17 61.51 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.996 0.919 . . . . 0.0 113.034 -178.254 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.98 -27.18 60.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.329 0.651 . . . . 0.0 110.243 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -83.8 -5.57 59.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.096 0.558 . . . . 0.0 110.724 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 20' ' ' ARG . 1.9 mp -87.81 120.39 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.9 p -101.53 166.99 11.3 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.724 0.81 . . . . 0.0 109.427 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.14 -17.26 54.51 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 121.889 1.726 . . . . 0.0 112.763 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.66 0.27 49.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.572 0.349 . . . . 0.0 110.331 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -72.6 128.08 34.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.879 0.872 . . . . 0.0 110.109 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -87.3 117.11 25.85 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.518 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -55.16 -35.93 65.29 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -93.04 -44.85 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 121.392 0.615 . . . . 0.0 110.374 -170.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -94.88 -38.38 10.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.13 0.972 . . . . 0.0 111.593 -168.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.24 -50.8 5.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.833 0.453 . . . . 0.0 110.659 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 29' ' ' ALA . 88.8 mt -77.71 -14.59 59.57 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.417 0.687 . . . . 0.0 111.145 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.89 27.97 72.02 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.798 0.686 . . . . 0.0 114.255 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.488 HG21 HD12 ' A' ' 43' ' ' ILE . 89.3 mt -76.77 124.88 35.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.01 152.87 44.98 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.115 0.885 . . . . 0.0 109.805 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.2 m -66.31 -25.96 67.09 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.599 0.759 . . . . 0.0 112.278 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.77 -33.68 62.33 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.34 -42.44 59.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.734 0.814 . . . . 0.0 110.117 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -71.26 -21.95 62.03 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 123.593 0.558 . . . . 0.0 110.603 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.49 -47.14 86.65 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 170.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -71.55 -36.91 71.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.954 0.902 . . . . 0.0 111.437 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.488 HD12 HG21 ' A' ' 35' ' ' ILE . 52.8 mt -63.4 -50.24 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 123.636 0.585 . . . . 0.0 110.1 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.94 -33.42 72.1 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 123.782 0.676 . . . . 0.0 109.905 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.512 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 45.0 t80 -60.95 -40.84 94.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.401 1.081 . . . . 0.0 111.003 173.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.78 -35.88 59.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.626 0.37 . . . . 0.0 111.317 -178.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.412 HD13 HG13 ' A' ' 8' ' ' VAL . 92.6 mt -65.43 -43.05 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.543 0.737 . . . . 0.0 109.958 174.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 45' ' ' PHE . 9.8 t70 -50.69 -52.55 39.08 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.665 1.586 . . . . 0.0 110.692 177.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 57.8 mmtt -74.15 -35.66 64.06 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.259 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.03 -43.99 97.18 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.071 0.548 . . . . 0.0 111.812 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -93.01 -0.62 57.14 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.907 0.883 . . . . 0.0 111.556 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.13 43.61 96.94 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 123.754 0.659 . . . . 0.0 113.174 172.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 pt -135.53 173.57 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.245 1.418 . . . . 0.0 109.177 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -104.49 108.53 20.01 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 167.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD21 HG12 ' A' ' 84' ' ' ILE . 51.9 mt -68.74 121.77 82.41 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 167.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 93.5 Cg_endo -78.56 57.57 6.37 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.692 2.261 . . . . 0.0 111.682 176.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.99 -37.81 80.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.013 1.325 . . . . 0.0 109.589 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.37 -46.14 89.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.573 1.149 . . . . 0.0 111.264 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 22.1 tptm -68.88 -39.1 79.97 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.169 0.988 . . . . 0.0 111.102 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.445 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 54.5 m0 -62.51 -41.55 98.91 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.62 0.768 . . . . 0.0 109.886 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.9 m -63.01 -39.61 95.29 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.166 0.916 . . . . 0.0 110.498 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.38 -47.71 75.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.051 0.541 . . . . 0.0 110.654 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -58.17 -44.93 88.21 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.98 0.912 . . . . 0.0 112.288 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.9 t -67.5 -50.36 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 122.629 0.372 . . . . 0.0 111.072 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -67.56 -29.7 69.15 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.371 0.669 . . . . 0.0 112.689 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -94.09 5.2 52.47 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.486 0.714 . . . . 0.0 111.428 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.32 21.77 66.72 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 115.802 1.081 . . . . 0.0 115.802 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -79.57 -22.85 43.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.315 0.646 . . . . 0.0 110.88 173.44 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.04 177.57 9.47 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.738 1.215 . . . . 0.0 108.339 175.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.21 164.89 20.67 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.102 0.961 . . . . 0.0 109.073 173.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.0 p -54.93 -52.21 63.68 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.202 0.938 . . . . 0.0 113.107 -165.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -35.49 63.21 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -172.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -53.22 -27.93 24.45 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.229 1.012 . . . . 0.0 113.02 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -115.75 -31.28 5.86 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.398 0.679 . . . . 0.0 111.834 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -110.98 21.52 16.34 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.866 0.467 . . . . 0.0 112.033 -165.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.513 HG12 ' HG2' ' A' ' 78' ' ' LYS . 24.8 t -106.82 138.24 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 164.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.442 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -51.62 -37.87 52.13 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -170.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.513 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.8 pttt -69.32 -41.92 76.05 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.059 0.391 . . . . 0.0 110.619 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 76.0 m-20 -76.97 -33.79 57.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.422 1.089 . . . . 0.0 110.04 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -68.04 -54.03 21.35 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.287 1.435 . . . . 0.0 108.331 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.58 -31.01 69.06 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.1 0.875 . . . . 0.0 111.499 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 -52.37 53.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.883 0.473 . . . . 0.0 110.634 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 13.9 mmp_? -54.1 -49.9 68.08 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.233 0.613 . . . . 0.0 110.73 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.605 HG12 HD21 ' A' ' 55' ' ' LEU . 91.9 mt -57.5 -53.65 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 125.246 1.418 . . . . 0.0 110.948 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.588 ' HB2' HG21 ' A' ' 4' ' ' THR . 25.9 t70 -63.18 -34.78 78.39 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.781 0.832 . . . . 0.0 111.831 -176.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -68.15 -36.68 80.05 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.333 0.653 . . . . 0.0 111.128 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.4 mt -68.2 -37.95 81.45 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.867 0.467 . . . . 0.0 110.617 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.497 HG13 ' HE2' ' A' ' 91' ' ' LYS . 58.4 t -68.98 -32.33 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 CA-C-O 121.45 0.643 . . . . 0.0 109.783 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.84 78.81 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.378 173.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.69 92.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.239 1.016 . . . . 0.0 111.561 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.497 ' HE2' HG13 ' A' ' 88' ' ' VAL . 56.0 pttt . . . . . 0 N--CA 1.48 1.05 0 C-N-CA 122.524 0.329 . . . . 0.0 110.353 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.006 0.432 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.0 m -78.09 91.6 4.31 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 169.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.4 m -78.38 74.9 4.91 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.106 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 8' ' ' VAL . 88.3 m -64.58 -46.36 83.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.009 -1.45 . . . . 0.0 110.15 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -52.81 -47.64 67.5 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.23 1.012 . . . . 0.0 110.834 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.97 -47.65 77.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 124.004 0.815 . . . . 0.0 111.645 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -66.07 -38.09 87.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.86 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.436 HG13 HD11 ' A' ' 47' ' ' ILE . 96.4 t -72.24 -37.48 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.177 0.591 . . . . 0.0 110.329 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.19 -35.46 80.88 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.104 0.962 . . . . 0.0 110.41 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 59.8 m -66.98 -44.66 79.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.926 173.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.4 -47.09 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.274 0.629 . . . . 0.0 110.896 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.575 HG12 HD13 ' A' ' 43' ' ' ILE . 36.6 mt -61.26 -44.28 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.385 1.074 . . . . 0.0 111.071 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.08 -48.14 64.84 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.015 0.926 . . . . 0.0 112.632 174.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 10' ' ' THR . 46.4 mt-10 -66.64 -32.39 73.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.945 0.898 . . . . 0.0 111.557 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.1 m -71.22 -58.4 3.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.382 0.673 . . . . 0.0 111.591 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.4 m -103.65 15.66 28.32 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -167.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 49.83 64.14 1.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.415 1.086 . . . . 0.0 112.051 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.9 pt -142.53 146.07 37.18 Favored Pre-proline 0 N--CA 1.481 1.122 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.688 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.97 125.55 14.36 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.31 2.006 . . . . 0.0 112.162 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -31.79 48.92 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.949 1.3 . . . . 0.0 113.03 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.39 -23.65 60.2 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.378 0.671 . . . . 0.0 111.226 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -84.7 -11.62 55.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.8 0.44 . . . . 0.0 110.933 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mp -83.62 111.84 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.5 p -94.93 161.52 28.14 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 123.41 0.684 . . . . 0.0 109.556 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.17 -25.41 64.08 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.358 2.039 . . . . 0.0 113.668 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.579 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 32.1 mt-10 -102.89 17.66 23.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.947 -0.47 . . . . 0.0 110.734 -175.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -78.38 129.62 35.17 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.263 0.625 . . . . 0.0 110.259 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.465 ' HE2' ' HB ' ' A' ' 71' ' ' THR . 64.3 t-80 -88.55 120.83 30.3 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.11 -41.98 27.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.355 1.062 . . . . 0.0 113.471 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.2 mt -93.22 -60.11 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -63.63 -46.44 85.66 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.207 1.003 . . . . 0.0 111.989 -174.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.7 -64.37 1.15 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.197 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 29' ' ' ALA . 86.1 mt -71.39 -17.6 62.4 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.635 0.774 . . . . 0.0 112.542 -173.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.38 30.57 64.49 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.169 0.293 . . . . 0.0 113.792 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.6 mt -101.98 123.04 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.43 1.092 . . . . 0.0 108.915 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.44 158.88 32.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.081 0.467 . . . . 0.0 110.713 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.2 p -64.46 -23.54 67.32 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.601 0.76 . . . . 0.0 112.222 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 pp -70.53 -39.56 73.98 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -68.03 -35.96 79.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.595 0.758 . . . . 0.0 109.461 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -65.56 -27.35 68.37 Favored 'General case' 0 CA--C 1.555 1.152 0 O-C-N 124.06 0.85 . . . . 0.0 111.264 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.425 HD23 HD12 ' A' ' 57' ' ' LEU . 92.5 mt -62.74 -45.38 93.01 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.061 0.544 . . . . 0.0 110.272 171.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -65.81 -40.12 91.55 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.989 0.916 . . . . 0.0 110.455 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.575 HD13 HG12 ' A' ' 12' ' ' ILE . 97.3 mt -60.83 -44.99 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.653 0.781 . . . . 0.0 109.784 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -68.95 -32.8 72.66 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.854 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -72.03 -31.44 66.18 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.361 1.064 . . . . 0.0 110.886 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.2 65.78 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.547 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.444 HD13 HD11 ' A' ' 84' ' ' ILE . 96.0 mt -68.09 -39.14 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 124.002 0.921 . . . . 0.0 110.362 172.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.44 -43.37 75.34 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.697 1.199 . . . . 0.0 110.134 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.08 -53.84 11.61 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.463 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.86 -56.84 12.9 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.53 1.132 . . . . 0.0 113.129 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -88.14 -11.82 45.81 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.956 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.12 32.19 76.15 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.312 0.383 . . . . 0.0 112.342 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.543 HD13 HG23 ' A' ' 84' ' ' ILE . 42.6 pt -110.08 163.91 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.258 1.023 . . . . 0.0 110.056 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -110.75 95.55 5.62 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD23 HD12 ' A' ' 87' ' ' LEU . 70.1 mt -72.59 118.88 71.65 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.429 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 2.7 Cg_exo -78.88 59.85 7.5 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.115 2.544 . . . . 0.0 110.139 168.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.425 HD12 HD23 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -65.12 -35.68 81.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.397 -174.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -57.42 -40.55 78.59 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.78 0.832 . . . . 0.0 112.205 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 56' ' ' PRO . 9.6 ptmm? -77.44 -34.81 54.46 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.442 ' O ' HG23 ' A' ' 64' ' ' VAL . 50.6 m0 -66.67 -43.89 83.31 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.509 0.724 . . . . 0.0 110.704 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.8 m -64.5 -37.37 87.31 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.939 0.896 . . . . 0.0 110.269 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -66.22 -41.73 89.7 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.928 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -62.37 -43.06 99.71 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.802 0.841 . . . . 0.0 110.854 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 60' ' ' TRP . 77.6 t -55.56 -57.22 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 O-C-N 124.149 0.906 . . . . 0.0 110.533 175.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -66.75 -28.96 68.83 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.145 0.978 . . . . 0.0 112.984 -174.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -93.18 7.24 45.09 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.456 0.703 . . . . 0.0 111.555 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.19 11.54 67.52 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 115.017 0.767 . . . . 0.0 115.017 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -70.64 -35.53 72.94 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.235 0.614 . . . . 0.0 109.951 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.07 164.77 29.14 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.721 1.208 . . . . 0.0 109.204 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.6 p -97.92 158.46 15.52 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.259 0.624 . . . . 0.0 109.801 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.465 ' HB ' ' HE2' ' A' ' 28' ' ' HIS . 0.7 OUTLIER -59.54 -43.86 93.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 124.158 0.912 . . . . 0.0 110.567 -175.2 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.558 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.1 mp0 -46.74 -49.1 20.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.374 1.47 . . . . 0.0 112.972 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -54.55 -25.44 25.99 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -121.37 -22.17 6.07 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -109.32 12.06 24.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.246 0.618 . . . . 0.0 111.771 -169.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 72' ' ' GLU . 80.2 t -105.58 138.04 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.538 HD11 HD12 ' A' ' 12' ' ' ILE . 4.4 mm? -52.91 -38.38 61.77 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.025 1.33 . . . . 0.0 114.312 -171.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.579 ' HD3' ' HG2' ' A' ' 26' ' ' GLU . 60.1 pttt -71.21 -40.7 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.095 0.558 . . . . 0.0 110.609 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 77.5 m-20 -74.58 -47.16 34.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.238 1.015 . . . . 0.0 109.788 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.6 tp -57.1 -49.43 75.89 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.705 1.202 . . . . 0.0 110.089 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.39 78.61 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.834 0.709 . . . . 0.0 110.939 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -67.44 -44.76 77.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.585 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 18.2 mmm180 -56.73 -44.31 81.52 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.298 0.639 . . . . 0.0 110.738 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.543 HG23 HD13 ' A' ' 53' ' ' ILE . 90.3 mt -62.54 -49.52 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.029 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.04 -32.69 74.32 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.521 1.138 . . . . 0.0 110.625 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 65.6 mt-10 -62.47 -47.14 85.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.839 0.856 . . . . 0.0 110.143 172.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.465 HD12 HD23 ' A' ' 55' ' ' LEU . 81.1 mt -69.16 -31.31 69.87 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.153 0.581 . . . . 0.0 111.552 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 84' ' ' ILE . 77.0 t -68.67 -41.31 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.422 0.689 . . . . 0.0 109.665 176.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.83 -41.49 78.5 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.457 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.39 -39.02 91.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.026 0.93 . . . . 0.0 111.802 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -85.33 -26.95 26.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.825 0.45 . . . . 0.0 110.301 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.12 -40.0 21.79 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.466 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 71.23 -55.65 0.65 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.829 1.651 . . . . 0.0 111.33 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.64 163.42 27.74 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 124.539 1.136 . . . . 0.0 109.262 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.97 132.95 55.51 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.287 0.635 . . . . 0.0 111.472 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -90.0 20.4 4.28 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.123 0.969 . . . . 0.0 111.348 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -58.33 123.49 16.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.761 0.824 . . . . 0.0 111.022 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -141.03 112.61 7.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.991 0.917 . . . . 0.0 109.216 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -80.6 151.66 28.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.798 0.839 . . . . 0.0 109.408 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -159.27 171.55 19.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.492 0.717 . . . . 0.0 109.669 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 . . . . . 0 C--O 1.251 1.133 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 172.824 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' HG23 ' A' ' 2' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.488 HG23 ' SD ' ' A' ' 1' ' ' MET . 39.7 p -88.67 94.43 9.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.045 0.538 . . . . 0.0 109.725 177.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.1 p -72.32 172.0 11.13 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.751 0.42 . . . . 0.0 110.407 175.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 8' ' ' VAL . 20.0 m -61.55 -50.79 71.23 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -55.82 -43.9 77.39 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.911 0.757 . . . . 0.0 111.226 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -52.84 -49.74 65.14 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 123.73 0.643 . . . . 0.0 110.736 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -65.88 -40.21 91.4 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.071 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 4' ' ' THR . 67.2 t -66.71 -44.27 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 122.871 0.468 . . . . 0.0 110.315 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.01 96.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.15 0.98 . . . . 0.0 110.877 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -60.92 -47.69 85.27 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.644 0.778 . . . . 0.0 110.925 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.54 -50.77 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.445 0.698 . . . . 0.0 111.418 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.467 HG12 HG21 ' A' ' 43' ' ' ILE . 50.9 mt -57.46 -45.62 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.672 0.789 . . . . 0.0 110.553 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.14 -58.17 7.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.352 1.061 . . . . 0.0 112.662 174.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -64.84 -26.91 68.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.229 1.011 . . . . 0.0 112.052 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -76.88 -53.47 7.84 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.256 0.623 . . . . 0.0 110.695 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.483 ' SG ' HG12 ' A' ' 35' ' ' ILE . 37.7 t -100.04 9.2 43.25 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -166.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t70 55.65 59.83 3.64 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.761 0.791 . . . . 0.0 111.151 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.532 HG13 ' HA ' ' A' ' 13' ' ' ALA . 11.5 pt -141.78 148.19 48.42 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 123.729 0.812 . . . . 0.0 109.712 -177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.24 125.41 11.34 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.661 2.241 . . . . 0.0 110.568 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.647 ' HA ' HD13 ' A' ' 23' ' ' ILE . 7.6 ptt180 -68.61 -17.07 64.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.07 -24.85 60.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.388 0.675 . . . . 0.0 110.479 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -80.95 -13.24 59.08 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.613 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.647 HD13 ' HA ' ' A' ' 20' ' ' ARG . 2.7 mp -86.64 117.7 31.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.5 p -100.32 161.69 23.28 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.802 0.841 . . . . 0.0 109.045 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.7 -16.05 50.52 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 121.733 1.622 . . . . 0.0 112.823 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.69 3.33 50.26 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.791 -0.568 . . . . 0.0 111.064 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.7 m -77.78 135.81 38.03 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.433 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 59.5 t-80 -81.07 113.81 19.51 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.24 -23.17 55.02 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.433 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 61.9 mt -97.79 -54.13 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.171 0.588 . . . . 0.0 110.007 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.23 -43.67 41.08 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.826 0.851 . . . . 0.0 112.563 -167.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.81 -51.55 11.14 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.788 0.435 . . . . 0.0 110.049 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.9 mt -78.02 -5.78 52.43 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.926 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.65 27.93 73.57 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.566 0.541 . . . . 0.0 113.246 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.483 HG12 ' SG ' ' A' ' 16' ' ' CYS . 81.4 mt -95.86 124.29 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.976 0.911 . . . . 0.0 108.615 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.52 157.46 34.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.489 0.316 . . . . 0.0 110.999 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.449 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.6 m -63.02 -22.78 67.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.632 0.773 . . . . 0.0 110.75 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.5 mt -65.31 -51.37 61.08 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.75 0.82 . . . . 0.0 109.908 174.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.52 -31.46 71.58 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.58 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.405 ' CE2' HD21 ' A' ' 57' ' ' LEU . 30.0 t80 -74.91 -24.99 58.6 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.305 0.642 . . . . 0.0 110.973 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.503 HD23 HD12 ' A' ' 57' ' ' LEU . 80.1 mt -61.63 -42.27 98.65 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.061 0.544 . . . . 0.0 109.86 169.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -72.27 -37.42 69.05 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.888 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.467 HG21 HG12 ' A' ' 12' ' ' ILE . 67.5 mt -58.85 -50.74 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.817 174.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.24 -27.5 63.51 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.533 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -61.01 -46.35 91.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.803 0.841 . . . . 0.0 110.483 169.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.27 -34.87 76.96 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.141 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.2 mt -69.0 -44.04 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.932 0.893 . . . . 0.0 110.679 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -51.35 -48.6 62.39 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.388 1.475 . . . . 0.0 110.257 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -76.84 -38.58 53.55 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.572 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.87 -54.92 38.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.286 0.634 . . . . 0.0 112.304 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -84.58 -9.93 57.85 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.616 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.65 29.78 69.27 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 123.53 0.519 . . . . 0.0 112.858 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.544 HD13 HG23 ' A' ' 84' ' ' ILE . 42.6 pt -107.53 176.5 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.506 1.122 . . . . 0.0 109.735 -174.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.54 96.26 5.06 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.65 116.79 61.06 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 123.705 0.802 . . . . 0.0 109.859 171.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -84.3 57.4 5.24 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 122.651 2.234 . . . . 0.0 110.41 168.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.503 HD12 HD23 ' A' ' 41' ' ' LEU . 2.0 tm? -59.7 -41.76 91.46 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.516 1.127 . . . . 0.0 109.931 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 11.6 pt-20 -61.39 -39.27 90.1 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 124.24 0.963 . . . . 0.0 110.959 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -46.76 79.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.777 0.831 . . . . 0.0 110.107 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.466 ' O ' HG23 ' A' ' 64' ' ' VAL . 52.5 m0 -60.16 -40.14 88.88 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.936 1.397 . . . . 0.0 110.861 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 34.8 m -68.21 -35.15 77.52 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.494 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 90.3 mm-40 -73.15 -29.69 63.05 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.855 0.462 . . . . 0.0 110.521 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.464 ' HG2' ' HE3' ' A' ' 68' ' ' LYS . 49.0 mt-10 -65.78 -41.54 91.9 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.747 0.419 . . . . 0.0 110.199 173.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.663 HG11 HG23 ' A' ' 71' ' ' THR . 98.7 t -61.07 -43.15 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.6 175.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -62.08 -39.64 93.14 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.107 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -87.55 -5.18 58.88 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.674 0.79 . . . . 0.0 112.586 -174.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.96 12.01 85.03 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 115.042 0.777 . . . . 0.0 115.042 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HE3' ' HG2' ' A' ' 63' ' ' GLU . 55.1 mtmt -79.68 -26.97 40.81 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 117.725 0.762 . . . . 0.0 111.059 172.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -136.53 174.54 10.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.056 0.942 . . . . 0.0 109.327 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.7 m -133.86 148.57 51.29 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.485 1.114 . . . . 0.0 108.757 174.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.663 HG23 HG11 ' A' ' 64' ' ' VAL . 4.1 p -58.42 93.1 0.02 OUTLIER 'General case' 0 C--N 1.362 1.146 0 C-N-CA 123.512 0.725 . . . . 0.0 109.887 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.486 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.0 tm-20 175.86 -63.81 0.01 OUTLIER 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.134 1.374 . . . . 0.0 107.978 -174.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -51.26 -29.36 14.35 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.763 -1.562 . . . . 0.0 114.06 -173.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -132.92 0.61 3.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.061 0.544 . . . . 0.0 111.136 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -121.28 5.35 10.25 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.29 0.636 . . . . 0.0 111.295 -165.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 72' ' ' GLU . 71.7 t -105.34 146.1 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.464 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -52.39 -43.77 64.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.901 1.28 . . . . 0.0 114.251 -174.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -68.95 -42.32 76.83 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.754 0.422 . . . . 0.0 110.322 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 5.6 m120 -65.32 -47.33 76.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.447 0.699 . . . . 0.0 110.597 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.88 -50.77 69.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 110.223 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -62.43 -28.25 69.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.665 0.786 . . . . 0.0 111.261 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -69.99 -45.35 67.47 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.736 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 15.3 mmm180 -57.71 -46.63 84.13 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.331 0.652 . . . . 0.0 110.383 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.544 HG23 HD13 ' A' ' 53' ' ' ILE . 89.9 mt -59.08 -47.94 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 113.778 -1.556 . . . . 0.0 110.694 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.07 -46.34 82.57 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.079 0.862 . . . . 0.0 111.205 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 49.1 mt-10 -63.76 -35.28 80.08 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.101 0.56 . . . . 0.0 111.111 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.4 -32.09 62.57 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.976 0.51 . . . . 0.0 112.154 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 84' ' ' ILE . 98.0 t -64.72 -41.47 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-O 121.732 0.777 . . . . 0.0 109.405 171.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.62 -45.52 78.84 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.648 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.71 90.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.31 1.044 . . . . 0.0 112.145 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 88' ' ' VAL . 20.6 pttp -77.75 -18.83 56.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.453 0.301 . . . . 0.0 110.415 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.74 -4.63 61.81 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 174.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.12 10.02 31.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.673 0.789 . . . . 0.0 111.427 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.3 mp -73.13 166.73 22.57 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.476 0.71 . . . . 0.0 111.027 174.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -57.91 -46.9 84.27 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.889 0.876 . . . . 0.0 112.498 -168.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -74.86 98.42 3.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.0 t60 66.48 93.25 0.07 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.977 1.311 . . . . 0.0 110.641 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -79.18 -10.3 59.78 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.223 0.609 . . . . 0.0 111.674 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 77.72 -64.85 0.28 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.866 1.667 . . . . 0.0 111.586 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -72.14 130.96 42.12 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.518 0.727 . . . . 0.0 111.896 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.195 -0.907 . . . . 0.0 108.98 171.1 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tmm? . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.7 t -63.6 87.25 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 122.25 1.024 . . . . 0.0 111.29 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 m -76.67 175.6 9.19 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.327 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.0 m -56.36 -42.7 78.22 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.767 0.427 . . . . 0.0 110.623 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -54.39 -50.26 67.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.35 0.66 . . . . 0.0 111.247 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.01 -42.0 98.68 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.574 0.546 . . . . 0.0 110.721 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -58.84 -48.27 81.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.724 0.81 . . . . 0.0 111.082 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 4' ' ' THR . 94.9 t -67.48 -44.87 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.57 0.748 . . . . 0.0 110.852 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.46 90.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.288 1.035 . . . . 0.0 110.375 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 92.8 m -63.4 -44.9 93.35 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.758 0.823 . . . . 0.0 111.29 175.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.596 HD13 ' HA ' ' A' ' 47' ' ' ILE . 95.2 mt -58.71 -48.16 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 122.967 0.507 . . . . 0.0 111.485 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 18' ' ' ILE . 57.1 mt -58.46 -45.88 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.645 0.778 . . . . 0.0 109.996 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.49 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.77 -51.84 62.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.853 1.261 . . . . 0.0 113.683 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 10' ' ' THR . 22.2 mm-40 -66.26 -27.78 68.21 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.386 0.675 . . . . 0.0 112.129 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 43' ' ' ILE . 96.1 m -76.56 -51.63 11.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.929 0.492 . . . . 0.0 111.054 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.6 m -99.59 7.03 45.59 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.59 0.756 . . . . 0.0 112.515 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 48.25 70.6 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.526 1.13 . . . . 0.0 111.749 -174.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.49 HG13 ' HA ' ' A' ' 13' ' ' ALA . 10.3 pt -144.78 146.58 32.24 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 124.138 0.975 . . . . 0.0 109.605 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.45 116.69 4.2 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.919 2.413 . . . . 0.0 112.207 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -23.91 67.44 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -170.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -90.76 -6.36 54.48 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.142 0.577 . . . . 0.0 110.891 -171.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -89.02 -13.03 39.72 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 167.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.422 HD11 HD12 ' A' ' 18' ' ' ILE . 2.0 mp -79.19 105.77 9.1 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 171.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -77.25 159.94 76.74 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.435 0.694 . . . . 0.0 109.735 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.57 -17.02 58.13 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 121.988 1.792 . . . . 0.0 112.196 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -99.74 9.85 42.36 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 122.909 0.484 . . . . 0.0 110.427 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.0 m -72.13 124.33 24.77 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 122.57 0.348 . . . . 0.0 110.07 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -83.6 117.09 22.93 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.71 -41.43 15.05 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.206 1.003 . . . . 0.0 113.37 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.71 -50.2 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 122.464 0.306 . . . . 0.0 110.457 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.27 -38.33 24.56 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.943 0.897 . . . . 0.0 112.397 -171.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.17 -57.05 2.83 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.186 0.595 . . . . 0.0 110.35 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 29' ' ' ALA . 88.7 mt -76.29 -10.53 59.47 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.888 0.875 . . . . 0.0 111.977 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.26 30.38 77.61 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 123.412 0.445 . . . . 0.0 113.993 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.1 mt -89.39 126.24 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.27 147.92 38.54 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.213 0.605 . . . . 0.0 110.692 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -60.56 -35.74 76.77 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.726 0.41 . . . . 0.0 111.144 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 39' ' ' ASP . 3.0 pp -73.86 -31.65 63.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.186 0.594 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.454 ' N ' HD12 ' A' ' 38' ' ' LEU . 15.5 t70 -72.82 -35.99 67.41 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.483 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -71.72 -21.78 61.72 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.075 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.8 mt -56.85 -41.72 78.4 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 122.625 0.37 . . . . 0.0 110.426 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.09 -32.62 63.32 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.057 0.943 . . . . 0.0 111.51 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.539 HG12 HG21 ' A' ' 15' ' ' THR . 37.9 mt -65.26 -46.59 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.13 -29.15 67.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.907 0.883 . . . . 0.0 111.143 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -58.21 -50.87 72.04 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.006 1.322 . . . . 0.0 110.786 170.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.92 -33.49 74.78 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.871 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.596 ' HA ' HD13 ' A' ' 11' ' ' ILE . 85.9 mt -67.47 -51.32 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.186 0.594 . . . . 0.0 110.888 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.85 -37.33 86.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.039 0.535 . . . . 0.0 110.344 -170.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -81.38 -29.04 34.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.4 -48.24 76.17 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.322 0.388 . . . . 0.0 111.592 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.406 ' HB2' HG12 ' A' ' 53' ' ' ILE . 86.7 m-85 -83.12 -16.47 46.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.508 0.723 . . . . 0.0 111.821 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.12 37.58 87.25 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.382 0.426 . . . . 0.0 112.519 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.479 HG22 ' HG2' ' A' ' 91' ' ' LYS . 46.3 pt -116.35 172.82 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.585 1.154 . . . . 0.0 111.026 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.62 97.82 6.36 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.385 1.074 . . . . 0.0 108.454 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.545 HD21 HG12 ' A' ' 84' ' ' ILE . 79.3 mt -73.18 120.42 80.9 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 123.035 0.534 . . . . 0.0 110.071 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.56 57.82 6.7 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.758 2.305 . . . . 0.0 110.835 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -63.83 -40.99 97.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.416 1.086 . . . . 0.0 109.818 -173.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.26 -37.88 88.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.502 0.721 . . . . 0.0 111.371 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -71.01 -37.97 72.63 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.853 0.861 . . . . 0.0 110.238 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -63.59 -52.79 59.42 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.944 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.3 m -62.52 -33.3 74.62 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.084 0.954 . . . . 0.0 110.895 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -63.22 -58.65 6.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.429 0.691 . . . . 0.0 109.837 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 44.4 mt-10 -66.04 -32.23 73.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.854 0.862 . . . . 0.0 111.82 -176.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.8 t -61.63 -55.01 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.683 0.793 . . . . 0.0 110.165 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -78.97 -7.7 58.27 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.699 0.399 . . . . 0.0 111.787 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -92.85 -2.92 55.47 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.342 0.657 . . . . 0.0 110.74 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.71 5.24 86.19 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 115.888 1.115 . . . . 0.0 115.888 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 60.6 mttp -70.43 -31.59 68.84 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.075 0.937 . . . . 0.0 110.277 171.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.43 163.27 32.96 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.326 1.051 . . . . 0.0 108.819 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 p -104.72 162.28 13.43 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.442 0.697 . . . . 0.0 109.643 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.5 p -59.38 -52.5 65.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.157 0.583 . . . . 0.0 112.332 -169.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -56.02 -31.52 63.17 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -50.07 -33.59 18.91 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.36 1.064 . . . . 0.0 113.318 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -122.12 -19.59 6.53 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -111.91 23.4 13.83 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 122.571 0.348 . . . . 0.0 111.198 -171.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 78' ' ' LYS . 40.3 t -110.27 142.26 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 162.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.17 -41.4 68.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.389 1.476 . . . . 0.0 114.267 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HG2' HG12 ' A' ' 76' ' ' VAL . 58.9 pttt -66.77 -37.79 85.29 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 120.786 0.327 . . . . 0.0 110.954 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 73.3 m-20 -80.39 -37.93 31.3 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.878 0.871 . . . . 0.0 110.817 -176.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.38 -53.21 52.07 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.242 1.017 . . . . 0.0 108.857 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.47 -22.58 65.47 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.689 0.795 . . . . 0.0 111.914 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.11 -53.94 37.66 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.66 0.384 . . . . 0.0 110.058 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 28.1 mmm180 -60.92 -40.37 92.93 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 124.101 0.876 . . . . 0.0 111.205 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.545 HG12 HD21 ' A' ' 55' ' ' LEU . 92.3 mt -61.52 -50.31 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.281 1.032 . . . . 0.0 110.31 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.402 ' HB2' HG21 ' A' ' 4' ' ' THR . 27.6 t70 -63.34 -34.94 78.8 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.118 0.567 . . . . 0.0 111.496 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.85 -44.12 90.94 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.487 0.715 . . . . 0.0 109.981 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.2 -42.04 76.3 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.16 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 84' ' ' ILE . 61.6 t -61.65 -45.69 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 123.464 0.706 . . . . 0.0 110.333 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.98 -43.11 99.3 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.511 176.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.01 -42.67 76.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.621 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -83.53 -32.17 26.03 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.668 0.387 . . . . 0.0 110.146 -174.144 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.37 -25.74 74.6 Favored Glycine 0 C--N 1.355 1.625 0 O-C-N 124.088 0.868 . . . . 0.0 112.566 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.81 80.21 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.326 0.65 . . . . 0.0 111.235 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.5 mp -73.99 -34.79 64.33 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.75 0.82 . . . . 0.0 110.644 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -66.14 -39.17 89.65 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.047 174.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.6 t60 68.68 -70.31 0.14 Allowed 'General case' 0 C--N 1.361 1.108 0 C-N-CA 125.635 1.574 . . . . 0.0 110.445 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -68.16 118.14 10.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.587 1.155 . . . . 0.0 110.585 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.35 166.16 23.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.637 0.775 . . . . 0.0 110.109 170.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -66.29 153.85 41.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.097 0.159 . . . . 0.0 111.015 175.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -63.89 107.42 1.22 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 . . . . . 0 CA--C 1.561 1.385 0 O-C-N 124.346 1.029 . . . . 0.0 110.833 -176.695 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.1 p 48.87 27.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 125.076 1.35 . . . . 0.0 112.819 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -72.83 128.98 37.11 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.156 0.982 . . . . 0.0 110.01 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.6 m -57.58 -54.08 50.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.185 0.994 . . . . 0.0 111.652 -172.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -54.89 -48.13 73.4 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.736 0.647 . . . . 0.0 111.016 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.93 -42.85 94.87 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.785 0.678 . . . . 0.0 110.934 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -57.44 -45.76 84.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.498 0.719 . . . . 0.0 111.221 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.8 t -71.4 -33.97 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 123.712 0.632 . . . . 0.0 110.77 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.86 -36.42 83.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.549 0.739 . . . . 0.0 110.481 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 m -66.82 -44.01 82.27 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.56 0.744 . . . . 0.0 110.739 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.8 mt -56.42 -54.53 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.646 0.778 . . . . 0.0 110.724 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.578 HD12 HD11 ' A' ' 77' ' ' LEU . 35.8 mt -60.08 -45.38 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.15 0.98 . . . . 0.0 110.66 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -51.88 -51.27 57.98 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 123.825 0.703 . . . . 0.0 112.319 174.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -67.86 -30.17 69.47 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.499 0.72 . . . . 0.0 112.332 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -74.81 -61.0 2.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.254 0.622 . . . . 0.0 110.938 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.8 m -90.49 10.79 23.93 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.016 0.927 . . . . 0.0 112.953 -168.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.4 t70 48.7 68.09 0.76 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.651 1.18 . . . . 0.0 111.565 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.467 HG13 ' HA ' ' A' ' 13' ' ' ALA . 12.1 pt -145.26 142.96 18.95 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.718 1.207 . . . . 0.0 108.699 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.67 139.36 69.08 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.523 2.149 . . . . 0.0 112.55 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -56.33 -31.5 63.78 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.144 1.378 . . . . 0.0 111.952 -173.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -77.25 -18.81 57.33 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.99 0.516 . . . . 0.0 111.901 -172.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -78.93 -11.32 60.0 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.046 0.385 . . . . 0.0 111.398 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.4 mp -86.18 102.05 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 27' ' ' SER . 64.3 p -81.18 154.04 72.07 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.118 0.567 . . . . 0.0 109.77 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.94 -30.22 83.22 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.335 2.024 . . . . 0.0 112.524 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -97.8 13.08 31.73 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.824 0.45 . . . . 0.0 110.947 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.419 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 46.9 t -72.24 129.67 38.98 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.968 0.507 . . . . 0.0 109.69 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -83.21 114.62 21.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 167.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.69 -41.66 10.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.022 0.929 . . . . 0.0 112.977 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.6 mt -88.62 -59.63 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -172.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.19 -36.46 84.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.739 1.216 . . . . 0.0 112.728 -173.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -98.39 -65.59 0.95 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.282 0.633 . . . . 0.0 110.759 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.48 -18.49 62.98 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.37 41.66 36.83 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 112.366 -0.293 . . . . 0.0 112.366 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.5 mt -99.75 107.88 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.25 168.32 18.54 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.4 t -52.46 -37.93 58.14 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.466 1.106 . . . . 0.0 111.783 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.23 -26.06 58.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.056 0.543 . . . . 0.0 111.898 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.4 -41.38 47.98 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 175.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -68.95 -23.13 64.11 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.889 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.4 mt -52.27 -49.86 63.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.159 0.583 . . . . 0.0 111.207 171.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.34 -38.02 71.68 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.826 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.533 HD13 HG12 ' A' ' 12' ' ' ILE . 81.5 mt -65.26 -44.79 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.519 0.728 . . . . 0.0 110.614 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -70.34 -37.16 74.62 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.284 0.633 . . . . 0.0 110.293 -177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -71.63 -27.57 63.19 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.367 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.72 63.92 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.837 0.351 . . . . 0.0 110.627 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 84' ' ' ILE . 87.0 mt -69.37 -38.19 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.072 0.949 . . . . 0.0 109.793 171.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 5.9 t70 -58.09 -42.81 86.44 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.823 0.849 . . . . 0.0 111.137 174.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -67.94 -54.06 21.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.931 0.892 . . . . 0.0 110.561 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.13 -55.7 31.7 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.19 0.996 . . . . 0.0 112.605 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -91.05 -13.74 32.64 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.489 0.716 . . . . 0.0 112.433 -171.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 100' ' ' HIS . . . 68.53 34.63 79.47 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-O 121.202 0.335 . . . . 0.0 113.494 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.638 HG22 ' HG2' ' A' ' 91' ' ' LYS . 44.6 pt -120.21 153.03 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.18 0.992 . . . . 0.0 109.149 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.553 ' HD2' ' HB2' ' A' ' 98' ' ' HIS . 14.0 ptmm? -100.59 106.95 18.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.4 mt -69.96 125.05 91.8 Favored Pre-proline 0 C--N 1.348 0.513 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 170.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 78.0 Cg_endo -78.17 57.25 6.1 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.387 2.058 . . . . 0.0 111.104 172.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.54 -38.37 89.72 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.346 1.058 . . . . 0.0 110.425 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.98 -36.52 79.65 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.638 0.375 . . . . 0.0 111.833 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.31 -37.37 60.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.498 0.719 . . . . 0.0 110.374 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.436 ' O ' HG23 ' A' ' 64' ' ' VAL . 48.1 m0 -62.93 -50.97 68.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.925 0.89 . . . . 0.0 110.569 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.3 m -64.0 -31.85 73.18 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.259 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -68.62 -42.89 77.45 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.012 0.525 . . . . 0.0 110.84 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.33 -42.53 99.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.905 0.482 . . . . 0.0 110.615 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 60' ' ' TRP . 61.2 t -61.05 -49.96 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.593 0.711 . . . . 0.0 110.161 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -56.76 -41.44 77.59 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.421 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -99.62 17.38 20.65 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.094 0.958 . . . . 0.0 111.48 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.29 14.22 52.85 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 115.107 0.803 . . . . 0.0 115.107 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -80.78 -24.73 38.4 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.795 0.838 . . . . 0.0 110.396 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.85 173.33 12.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.173 0.989 . . . . 0.0 109.874 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.8 p -106.89 164.76 11.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.293 0.637 . . . . 0.0 109.694 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.0 p -57.45 -49.67 75.51 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.428 0.455 . . . . 0.0 110.475 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.483 ' HA ' HG23 ' A' ' 76' ' ' VAL . 29.8 mt-10 -39.1 -50.99 1.89 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.711 1.604 . . . . 0.0 113.26 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -59.59 -24.21 63.58 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.334 -1.303 . . . . 0.0 113.288 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -120.01 -22.79 6.57 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.935 0.494 . . . . 0.0 112.026 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.85 19.71 14.98 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.281 0.632 . . . . 0.0 110.749 -167.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' ' 72' ' ' GLU . 79.8 t -105.63 139.97 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 161.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.578 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -56.52 -40.48 75.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.837 1.255 . . . . 0.0 113.936 -172.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.3 pttt -72.58 -38.7 67.82 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.586 0.355 . . . . 0.0 111.216 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -71.97 -45.69 60.1 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.544 0.738 . . . . 0.0 109.888 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.2 tp -53.73 -48.05 70.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.913 1.285 . . . . 0.0 110.299 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -31.98 73.21 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.673 0.608 . . . . 0.0 111.759 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.98 77.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.769 0.427 . . . . 0.0 110.479 175.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -60.28 -44.75 95.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.319 0.58 . . . . 0.0 111.234 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 47' ' ' ILE . 90.3 mt -65.52 -46.64 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.276 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.54 -38.71 88.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.395 0.678 . . . . 0.0 110.991 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -59.41 -50.87 72.29 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.578 0.549 . . . . 0.0 110.733 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.04 -35.68 81.2 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.69 0.619 . . . . 0.0 112.219 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 84' ' ' ILE . 70.6 t -67.17 -47.26 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.395 0.678 . . . . 0.0 110.546 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.79 -32.4 73.67 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.712 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -46.91 68.93 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 123.482 0.713 . . . . 0.0 111.434 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.638 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -79.43 -24.43 42.48 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.042 0.537 . . . . 0.0 110.626 -174.566 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.3 -28.38 73.67 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.887 0.742 . . . . 0.0 112.312 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.04 -63.92 1.15 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.818 0.847 . . . . 0.0 109.661 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 tt -107.13 82.04 1.63 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.29 1.036 . . . . 0.0 108.406 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.72 111.77 2.24 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.343 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -128.52 123.89 34.67 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.934 0.494 . . . . 0.0 111.133 -171.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 64.24 8.51 4.18 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 125.145 1.378 . . . . 0.0 114.076 163.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.553 ' HB2' ' HD2' ' A' ' 54' ' ' LYS . 81.2 t60 -171.74 141.02 1.38 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.577 0.751 . . . . 0.0 110.731 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -133.84 170.96 14.83 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.373 1.069 . . . . 0.0 109.387 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.409 ' HB3' ' HA2' ' A' ' 52' ' ' GLY . 58.7 t-80 -167.74 104.95 0.5 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 123.342 0.657 . . . . 0.0 110.665 176.029 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtm . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.0 p -63.74 96.03 0.12 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.371 0.669 . . . . 0.0 110.143 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 45.0 t -146.99 163.87 34.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.775 0.83 . . . . 0.0 109.994 -172.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.9 m -59.52 -41.84 90.9 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 124.013 0.821 . . . . 0.0 110.597 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -52.9 -51.23 61.95 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.715 0.806 . . . . 0.0 110.866 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -60.86 -44.9 96.41 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.163 0.914 . . . . 0.0 111.421 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 3' ' ' SER . 36.7 mmt180 -64.81 -40.58 95.45 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.329 0.651 . . . . 0.0 111.44 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.469 HG13 HD11 ' A' ' 47' ' ' ILE . 69.6 t -72.39 -36.57 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.193 0.597 . . . . 0.0 110.474 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.34 -35.47 80.98 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.721 0.808 . . . . 0.0 110.64 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.7 m -65.24 -48.07 74.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.818 0.847 . . . . 0.0 110.896 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.411 HG22 HG23 ' A' ' 43' ' ' ILE . 78.5 mt -58.0 -46.86 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.494 0.718 . . . . 0.0 110.776 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.454 HD12 HD11 ' A' ' 77' ' ' LEU . 55.4 mt -61.89 -48.93 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.673 0.789 . . . . 0.0 110.854 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.57 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.18 -44.46 64.68 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.212 1.005 . . . . 0.0 112.575 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -66.25 -43.74 85.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.143 0.977 . . . . 0.0 111.798 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.9 m -75.49 -50.95 14.15 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.727 0.411 . . . . 0.0 111.527 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.8 m -89.67 3.82 51.47 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.265 1.026 . . . . 0.0 111.886 -174.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.0 t70 50.54 75.0 0.19 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.256 1.422 . . . . 0.0 112.416 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.57 HG13 ' HA ' ' A' ' 13' ' ' ALA . 3.4 pt -148.21 157.5 42.53 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 124.629 1.172 . . . . 0.0 109.474 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.58 137.7 47.18 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.361 2.041 . . . . 0.0 110.993 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.422 ' HA ' HD13 ' A' ' 23' ' ' ILE . 25.5 ttm180 -57.63 -30.54 65.45 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.973 0.909 . . . . 0.0 112.5 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.86 -21.65 60.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.994 0.918 . . . . 0.0 111.26 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -80.66 -6.7 58.73 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 122.777 0.431 . . . . 0.0 111.146 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 20' ' ' ARG . 3.8 mp -90.99 112.04 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 170.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.4 p -95.65 160.73 29.72 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 123.32 0.648 . . . . 0.0 110.425 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -60.16 -33.31 95.07 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.23 1.953 . . . . 0.0 112.877 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -94.49 11.24 31.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.945 0.898 . . . . 0.0 110.954 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.8 t -79.22 128.52 33.41 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 123.177 0.591 . . . . 0.0 110.324 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -83.18 118.9 23.92 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.97 -40.77 23.35 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.55 -45.39 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 O-C-N 122.187 -0.32 . . . . 0.0 110.211 -169.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -82.99 -32.8 26.8 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.818 0.847 . . . . 0.0 112.316 -173.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.91 -64.25 1.06 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.366 0.666 . . . . 0.0 109.965 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.439 HD13 HG21 ' A' ' 12' ' ' ILE . 82.8 mt -69.77 -11.19 60.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.155 0.582 . . . . 0.0 111.489 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.84 31.91 79.59 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.55 0.531 . . . . 0.0 113.153 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -82.97 122.95 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -61.36 146.1 49.31 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.746 0.419 . . . . 0.0 110.063 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.437 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 37.3 m -59.65 -34.68 73.12 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.506 0.722 . . . . 0.0 111.807 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.1 mt -73.7 -34.48 64.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.439 0.696 . . . . 0.0 110.032 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -73.89 -30.63 62.72 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.461 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -75.76 -23.67 55.99 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.661 0.384 . . . . 0.0 110.54 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 37' ' ' SER . 96.5 mt -63.76 -39.46 94.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.862 0.465 . . . . 0.0 109.84 169.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -65.97 -45.56 81.23 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.89 0.876 . . . . 0.0 110.619 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.411 HG23 HG22 ' A' ' 11' ' ' ILE . 63.4 mt -62.97 -40.21 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.622 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.94 -35.93 77.35 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.431 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -74.63 -25.17 59.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.609 0.764 . . . . 0.0 110.941 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.97 -41.15 68.06 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.996 0.518 . . . . 0.0 110.559 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.469 HD11 HG13 ' A' ' 8' ' ' VAL . 89.8 mt -65.55 -40.48 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.295 1.038 . . . . 0.0 110.061 173.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -55.27 -47.74 75.05 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.02 1.328 . . . . 0.0 109.714 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HG2' ' HB2' ' A' ' 100' ' ' HIS . 99.5 mttt -67.84 -50.58 55.87 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.52 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.02 -51.77 68.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.963 0.905 . . . . 0.0 112.114 -172.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.17 -5.26 59.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.908 0.883 . . . . 0.0 111.456 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.3 30.81 75.85 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.193 0.308 . . . . 0.0 113.64 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.36 170.66 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.41 1.084 . . . . 0.0 109.869 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -104.97 111.03 23.66 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 168.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.591 HD21 HG12 ' A' ' 84' ' ' ILE . 42.6 mt -73.9 118.28 68.08 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -79.25 58.38 6.92 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.626 2.217 . . . . 0.0 109.706 170.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.58 -37.15 85.08 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.053 0.941 . . . . 0.0 109.118 -174.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.3 -45.58 90.74 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.383 0.673 . . . . 0.0 111.143 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -62.23 -40.71 97.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.866 0.866 . . . . 0.0 110.462 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.45 ' O ' HG23 ' A' ' 64' ' ' VAL . 54.1 m0 -63.66 -45.87 88.18 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.318 1.011 . . . . 0.0 109.87 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.5 m -62.06 -33.96 75.39 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.054 0.846 . . . . 0.0 110.932 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -72.2 -44.58 62.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.937 0.495 . . . . 0.0 110.513 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.26 -36.39 77.68 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.393 0.677 . . . . 0.0 110.816 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 60' ' ' TRP . 72.9 t -67.14 -49.94 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.829 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -59.23 -44.87 92.31 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.721 0.808 . . . . 0.0 112.063 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -86.35 6.67 28.92 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.981 0.912 . . . . 0.0 111.538 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.94 23.05 67.24 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.461 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -75.65 -30.53 59.47 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.372 0.669 . . . . 0.0 109.554 174.473 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.79 160.47 42.22 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.545 1.138 . . . . 0.0 109.371 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.4 p -83.85 162.83 20.43 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.117 0.567 . . . . 0.0 110.251 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 82.4 p -58.53 -55.43 35.19 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.53 0.681 . . . . 0.0 109.859 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.5 -33.86 64.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.299 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -55.57 -26.74 45.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 123.877 0.736 . . . . 0.0 112.529 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -119.6 -28.69 5.24 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.88 0.472 . . . . 0.0 112.156 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.59 16.95 25.06 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.99 0.516 . . . . 0.0 112.025 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.487 HG12 ' HG2' ' A' ' 78' ' ' LYS . 22.9 t -107.5 142.68 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 167.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -56.99 -41.69 78.88 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.001 1.32 . . . . 0.0 114.509 -170.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.9 pttt -65.65 -40.72 92.78 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.357 0.599 . . . . 0.0 110.312 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.34 -44.48 44.94 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.735 1.214 . . . . 0.0 110.499 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.69 -51.14 70.74 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.218 1.407 . . . . 0.0 109.977 176.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.85 -33.37 74.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.737 0.815 . . . . 0.0 111.658 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.67 -50.17 65.92 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.566 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -55.1 -46.65 75.53 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.594 1.158 . . . . 0.0 111.688 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.591 HG12 HD21 ' A' ' 55' ' ' LEU . 93.2 mt -60.26 -48.71 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.787 1.235 . . . . 0.0 110.464 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.15 -31.23 71.96 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.884 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.91 -41.86 95.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.116 0.566 . . . . 0.0 110.302 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.94 -27.93 65.16 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.429 0.692 . . . . 0.0 111.186 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.425 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 61.0 t -71.22 -36.36 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.623 0.769 . . . . 0.0 110.234 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.67 84.34 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.007 173.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.25 -40.07 82.07 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.721 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 13.5 ptmm? -73.31 -19.38 61.05 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 118.064 0.393 . . . . 0.0 111.334 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.41 -18.01 34.77 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.6 -42.03 0.15 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 117.423 0.611 . . . . 0.0 111.491 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.3 mt -92.09 -71.68 0.63 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.768 0.827 . . . . 0.0 112.31 -172.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 91' ' ' LYS . 72.2 mm-40 -62.73 101.71 0.28 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.595 0.712 . . . . 0.0 112.442 -172.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -128.26 35.51 4.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 167.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -105.99 111.83 24.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.068 1.347 . . . . 0.0 108.665 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -80.72 116.33 20.67 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.228 0.537 . . . . 0.0 110.85 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -94.38 -39.04 10.67 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.894 1.278 . . . . 0.0 108.55 165.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.402 ' HB2' ' HG2' ' A' ' 49' ' ' LYS . 2.8 p-80 -75.71 162.99 27.74 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.09 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 . . . . . 0 C--O 1.25 1.086 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 170.139 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttp . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.2 m -149.97 95.58 2.32 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.876 0.87 . . . . 0.0 108.924 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.3 p -90.66 177.06 6.44 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 123.746 0.818 . . . . 0.0 110.447 172.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 8' ' ' VAL . 90.5 m -60.3 -46.4 89.98 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.356 168.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -55.15 -40.45 70.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.994 0.918 . . . . 0.0 111.799 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -56.61 -47.57 79.37 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.295 0.638 . . . . 0.0 110.537 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -66.77 -38.31 86.33 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.82 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 4' ' ' THR . 87.1 t -66.81 -44.16 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.309 0.644 . . . . 0.0 110.616 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.54 -44.91 85.52 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.442 1.097 . . . . 0.0 110.107 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 57.7 m -59.89 -48.34 82.11 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.559 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -57.83 -47.69 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.743 0.817 . . . . 0.0 111.828 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.478 HG22 HD11 ' A' ' 18' ' ' ILE . 41.0 mt -58.3 -44.27 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.812 0.845 . . . . 0.0 110.526 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . . . -57.87 -44.3 86.55 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.143 0.977 . . . . 0.0 112.569 174.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.1 mm-40 -63.1 -36.22 82.87 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.421 0.688 . . . . 0.0 111.632 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -78.72 -59.44 2.78 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.817 -173.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -101.1 18.13 20.6 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.466 0.706 . . . . 0.0 112.853 -166.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.2 t70 47.72 66.1 1.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.304 1.041 . . . . 0.0 111.9 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 12' ' ' ILE . 3.5 pt -142.54 147.34 42.4 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 123.804 0.841 . . . . 0.0 109.739 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.02 116.17 4.57 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.656 2.237 . . . . 0.0 112.361 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.559 ' HA ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -63.41 -17.29 62.5 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -176.263 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.53 -30.89 70.66 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.729 0.812 . . . . 0.0 110.525 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -85.25 -14.42 46.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.341 0.656 . . . . 0.0 110.781 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.559 HD13 ' HA ' ' A' ' 20' ' ' ARG . 1.8 mp -78.01 108.41 11.3 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.8 p -91.27 157.46 42.57 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 123.573 0.749 . . . . 0.0 109.672 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.95 -17.92 56.4 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.237 1.958 . . . . 0.0 112.456 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -100.05 6.53 45.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.192 0.597 . . . . 0.0 110.489 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -78.85 138.72 38.29 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.37 0.668 . . . . 0.0 110.516 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.411 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 50.7 t-80 -86.28 114.04 22.77 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.547 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -51.05 -37.24 44.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.854 0.862 . . . . 0.0 113.212 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.411 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 63.7 mt -89.88 -54.06 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -174.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.76 -39.17 27.34 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.416 0.687 . . . . 0.0 112.544 -168.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -88.25 -55.11 3.88 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 29' ' ' ALA . 73.7 mt -75.09 -8.66 57.19 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.79 29.01 74.18 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.446 0.466 . . . . 0.0 113.82 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -88.04 124.98 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -75.87 160.51 29.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.125 0.57 . . . . 0.0 110.109 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.464 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 15.3 m -57.69 -34.08 69.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.998 0.919 . . . . 0.0 111.782 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.71 -37.61 76.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.86 0.464 . . . . 0.0 110.686 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -67.48 -42.35 83.12 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.54 0.736 . . . . 0.0 109.95 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -65.46 -28.59 69.33 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 124.392 1.057 . . . . 0.0 110.967 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 37' ' ' SER . 70.7 mt -61.79 -42.15 98.63 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.895 0.478 . . . . 0.0 110.749 174.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.46 -35.21 60.94 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.063 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.7 -47.75 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.781 0.676 . . . . 0.0 109.384 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.37 -30.08 63.06 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.098 0.959 . . . . 0.0 110.654 -174.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -62.59 -43.68 98.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.644 0.778 . . . . 0.0 110.89 171.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.4 -31.84 65.88 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.099 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.15 -45.41 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.468 0.707 . . . . 0.0 110.314 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -52.01 -49.29 63.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.877 1.271 . . . . 0.0 110.312 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -72.34 -49.62 32.92 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.014 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.06 98.78 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -89.77 -3.78 57.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.382 0.673 . . . . 0.0 112.378 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.4 45.45 96.38 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 123.779 0.674 . . . . 0.0 113.072 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.54 179.73 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.555 1.142 . . . . 0.0 110.186 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -122.35 113.2 19.07 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.422 HD22 ' HH2' ' A' ' 60' ' ' TRP . 83.4 mt -78.63 125.81 83.78 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 122.797 0.439 . . . . 0.0 110.41 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.19 54.95 5.41 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.205 2.603 . . . . 0.0 110.422 166.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.68 -39.94 86.19 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.91 1.284 . . . . 0.0 109.591 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -56.73 -41.81 78.16 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 124.259 0.974 . . . . 0.0 111.813 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -65.81 -43.48 88.52 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.156 0.582 . . . . 0.0 110.13 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.422 ' HH2' HD22 ' A' ' 55' ' ' LEU . 42.1 m0 -60.73 -50.14 74.66 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.627 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.1 m -60.89 -43.83 97.95 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.134 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -70.38 -40.32 74.03 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.765 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -60.43 -39.6 88.04 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.974 0.51 . . . . 0.0 111.446 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.06 -48.89 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.372 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -66.72 -28.71 68.65 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.133 0.973 . . . . 0.0 112.804 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -80.89 -3.4 51.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.181 0.592 . . . . 0.0 112.474 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.67 21.29 72.79 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 117.465 0.121 . . . . 0.0 113.333 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -79.46 -25.83 41.85 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.727 0.811 . . . . 0.0 110.239 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.71 171.15 19.3 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.27 1.028 . . . . 0.0 108.992 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.9 p -104.81 168.02 9.34 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 171.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.7 p -56.48 -41.78 77.16 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.314 0.384 . . . . 0.0 111.888 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HA ' HG23 ' A' ' 76' ' ' VAL . 14.0 pt-20 -51.09 -40.84 59.34 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -175.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -57.45 -28.77 63.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.594 0.757 . . . . 0.0 112.773 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -114.5 -29.59 6.8 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.748 0.419 . . . . 0.0 112.092 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.08 24.67 12.62 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.556 0.742 . . . . 0.0 111.114 -166.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.518 HG12 ' HG2' ' A' ' 78' ' ' LYS . 43.7 t -104.64 141.25 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 160.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -54.52 -39.59 67.78 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.172 1.389 . . . . 0.0 114.584 -169.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.7 pttt -64.39 -42.19 96.25 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -75.38 -40.49 57.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.435 1.094 . . . . 0.0 110.155 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.3 tp -61.08 -53.36 58.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.436 1.094 . . . . 0.0 109.453 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.21 -27.36 68.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.618 0.767 . . . . 0.0 112.037 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.66 -48.59 63.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.008 0.523 . . . . 0.0 110.409 174.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.4 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 1.1 mmp_? -56.88 -46.07 82.09 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 124.443 1.089 . . . . 0.0 110.801 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 88' ' ' VAL . 84.1 mt -64.03 -52.82 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.203 1.001 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.5 -41.77 90.65 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.076 0.95 . . . . 0.0 112.456 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.19 -30.21 68.35 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.376 0.423 . . . . 0.0 110.339 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.92 -35.74 69.76 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.745 0.418 . . . . 0.0 111.666 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 84' ' ' ILE . 61.6 t -65.28 -41.32 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.473 0.654 . . . . 0.0 109.487 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.17 -37.52 81.08 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.85 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.47 97.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.458 0.703 . . . . 0.0 111.587 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -17.58 34.07 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.468 -174.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -25.82 16.9 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.16 -8.61 56.8 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.49 0.716 . . . . 0.0 111.872 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.54 172.55 7.76 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.682 1.593 . . . . 0.0 109.725 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.75 -89.14 0.1 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.51 1.124 . . . . 0.0 110.465 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 64.85 -78.32 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.622 1.569 . . . . 0.0 110.623 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -153.15 43.29 0.61 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -63.11 -77.28 0.05 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.967 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -163.87 113.16 1.23 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.096 0.958 . . . . 0.0 109.969 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -155.85 156.32 34.48 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.816 0.846 . . . . 0.0 109.6 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 24.4 p80 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.028 0.931 . . . . 0.0 109.706 176.83 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtt . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.4 m -83.36 62.14 6.56 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.805 0.812 . . . . 0.0 108.937 173.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 t -69.21 130.07 41.62 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.762 -177.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 8' ' ' VAL . 86.6 m -56.62 -47.75 78.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.915 0.886 . . . . 0.0 109.968 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -54.88 -45.18 74.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.507 1.123 . . . . 0.0 111.447 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.54 -47.03 85.55 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.786 0.679 . . . . 0.0 110.573 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.405 ' HB2' ' HZ ' ' A' ' 51' ' ' PHE . 39.1 mmt-85 -67.22 -37.85 84.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.056 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 4' ' ' THR . 97.8 t -73.36 -35.15 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.352 0.661 . . . . 0.0 110.511 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.69 91.9 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.554 0.742 . . . . 0.0 109.953 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 56.0 m -63.15 -46.26 88.05 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.013 0.821 . . . . 0.0 110.455 172.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.2 mt -57.8 -46.56 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.211 1.004 . . . . 0.0 111.154 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.544 HG22 HD11 ' A' ' 18' ' ' ILE . 50.6 mt -58.12 -49.81 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.039 0.936 . . . . 0.0 110.747 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.07 -44.4 71.11 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.989 0.916 . . . . 0.0 112.974 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 10' ' ' THR . 18.2 mm-40 -63.84 -32.14 73.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.916 0.886 . . . . 0.0 111.753 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.8 m -86.65 -34.3 19.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.408 0.683 . . . . 0.0 112.095 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.2 m -113.16 1.42 15.25 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.842 0.457 . . . . 0.0 112.167 -164.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 50.27 68.25 0.79 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.259 1.423 . . . . 0.0 112.246 -177.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.561 HD12 HD11 ' A' ' 23' ' ' ILE . 11.6 pt -145.97 157.86 49.75 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 124.551 1.14 . . . . 0.0 109.269 -177.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.43 120.71 6.65 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.772 2.315 . . . . 0.0 110.768 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HA ' HD13 ' A' ' 23' ' ' ILE . 1.2 ppt_? -64.66 -25.18 67.84 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -170.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -82.98 -11.97 57.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.605 0.762 . . . . 0.0 111.381 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -83.0 -18.38 40.03 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.459 0.303 . . . . 0.0 110.38 173.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.561 HD11 HD12 ' A' ' 18' ' ' ILE . 2.0 mp -74.76 117.06 18.31 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.1 p -91.54 158.84 39.97 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.133 0.973 . . . . 0.0 109.719 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.72 -21.56 56.72 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.414 2.076 . . . . 0.0 113.257 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -92.28 3.75 54.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.287 0.635 . . . . 0.0 111.161 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -71.99 123.15 22.15 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -84.0 119.47 24.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 169.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.63 -44.02 12.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.252 1.021 . . . . 0.0 112.722 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.19 -46.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 120.681 0.277 . . . . 0.0 110.322 -168.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.43 -35.79 24.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.338 0.655 . . . . 0.0 111.978 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -93.59 -55.45 3.27 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.313 0.645 . . . . 0.0 110.612 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.8 mt -82.21 -12.58 58.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.509 0.724 . . . . 0.0 112.218 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.86 34.21 86.47 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 113.897 0.319 . . . . 0.0 113.897 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 12' ' ' ILE . 90.1 mt -88.09 125.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.976 0.91 . . . . 0.0 108.675 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -72.39 158.99 34.73 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 37.6 m -62.21 -26.64 68.47 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.07 0.548 . . . . 0.0 111.637 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.65 -33.76 60.46 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 122.904 0.482 . . . . 0.0 110.384 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.27 -39.18 75.11 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.172 0.589 . . . . 0.0 109.519 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -66.15 -23.65 66.51 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.503 0.721 . . . . 0.0 110.236 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 37' ' ' SER . 90.7 mt -62.61 -37.0 84.56 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.064 0.546 . . . . 0.0 110.714 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -69.99 -39.16 76.06 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.312 0.645 . . . . 0.0 110.2 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 12' ' ' ILE . 2.4 mp -60.43 -47.32 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 123.617 0.573 . . . . 0.0 109.661 174.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.78 -37.7 82.4 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.724 0.809 . . . . 0.0 111.173 -174.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.76 -50.18 74.83 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.76 1.224 . . . . 0.0 111.068 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.83 -30.84 70.34 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.729 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.503 HD13 HD11 ' A' ' 84' ' ' ILE . 97.2 mt -65.77 -44.73 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.59 0.756 . . . . 0.0 110.646 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.53 -49.72 64.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.484 1.114 . . . . 0.0 110.803 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -76.52 -48.47 19.33 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.754 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.93 74.81 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.074 0.55 . . . . 0.0 112.375 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.405 ' HZ ' ' HB2' ' A' ' 7' ' ' ARG . 98.5 m-85 -86.74 -3.24 59.02 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.852 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.16 35.52 91.65 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.651 0.594 . . . . 0.0 113.003 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.9 pt -124.94 -177.13 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.712 1.205 . . . . 0.0 109.209 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -130.04 126.06 36.76 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 168.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.9 mt -80.81 128.18 72.52 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -73.02 59.33 3.6 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.933 2.422 . . . . 0.0 110.702 165.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.68 -39.66 89.25 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.368 1.067 . . . . 0.0 109.748 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.77 -44.96 82.31 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 124.005 0.815 . . . . 0.0 110.463 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.7 tppt? -68.8 -44.49 73.46 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 111.259 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -57.61 -52.39 65.6 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.039 0.837 . . . . 0.0 110.55 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.2 m -71.06 -24.78 62.4 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.481 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -69.27 -47.63 64.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.652 0.781 . . . . 0.0 110.725 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 21.2 mm-40 -60.17 -40.57 90.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.499 0.72 . . . . 0.0 110.735 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 53.4 t -59.78 -56.34 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.905 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -62.23 -33.49 74.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.647 0.779 . . . . 0.0 111.908 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -87.44 4.99 41.09 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.347 0.659 . . . . 0.0 111.754 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.45 25.87 70.35 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -91.67 -27.58 18.01 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.275 0.63 . . . . 0.0 110.731 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -139.18 152.06 47.09 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 m -81.57 156.47 25.19 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.007 0.523 . . . . 0.0 109.639 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.5 p -52.93 -46.58 68.16 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.853 0.861 . . . . 0.0 110.856 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.544 ' HA ' HG23 ' A' ' 76' ' ' VAL . 9.3 mm-40 -42.83 -52.75 4.93 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.152 1.381 . . . . 0.0 112.588 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -54.76 -21.25 10.47 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.271 -1.331 . . . . 0.0 114.021 -169.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -121.71 -29.79 4.28 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -108.03 15.04 24.68 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -168.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 72' ' ' GLU . 71.6 t -103.22 139.56 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.408 HD11 HD12 ' A' ' 12' ' ' ILE . 3.9 mm? -53.35 -38.15 63.03 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.233 1.413 . . . . 0.0 114.023 -173.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.9 pttp -70.33 -41.0 73.81 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 120.769 0.318 . . . . 0.0 111.097 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 80.1 m-20 -74.81 -34.67 62.42 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.926 0.89 . . . . 0.0 110.241 -177.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.97 -44.76 72.27 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.821 1.248 . . . . 0.0 108.871 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.51 -37.54 78.55 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.877 0.735 . . . . 0.0 111.098 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.73 71.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.672 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 9.6 mmp_? -50.54 -53.01 33.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.197 0.936 . . . . 0.0 111.419 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.503 HD11 HD13 ' A' ' 47' ' ' ILE . 71.2 mt -65.6 -43.9 93.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.625 -175.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.58 -39.64 88.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.623 0.769 . . . . 0.0 111.223 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.91 -35.05 77.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.524 0.73 . . . . 0.0 110.841 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.2 mt -73.67 -30.29 62.81 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.02 0.528 . . . . 0.0 111.352 176.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.497 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 69.5 t -71.02 -36.93 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.637 0.775 . . . . 0.0 109.455 172.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.76 -41.11 83.85 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.23 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.12 -42.63 93.75 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.154 0.981 . . . . 0.0 111.13 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.497 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 43.7 pttt -76.24 -18.4 59.03 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.23 -31.6 79.62 Favored Glycine 0 C--N 1.358 1.766 0 O-C-N 123.588 0.555 . . . . 0.0 112.231 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.26 65.58 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.09 0.556 . . . . 0.0 110.148 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.98 76.94 8.54 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.913 0.885 . . . . 0.0 110.016 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 90.34 2.61 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.922 177.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -63.05 133.42 54.49 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.363 172.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 75.1 t60 84.34 -35.63 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.27 1.828 . . . . 0.0 111.169 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 49.4 t60 72.44 -62.02 0.48 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.711 1.604 . . . . 0.0 113.358 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -54.79 103.99 0.1 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.893 1.277 . . . . 0.0 112.326 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.4 146.82 43.19 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.474 171.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 65.9 t60 . . . . . 0 C--O 1.254 1.328 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.36 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.5 p -137.91 30.62 2.51 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.305 0.642 . . . . 0.0 111.265 -173.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.9 p -74.16 -177.92 3.16 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.63 0.372 . . . . 0.0 110.596 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 8' ' ' VAL . 61.8 m -53.52 -48.58 68.89 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.452 0.701 . . . . 0.0 112.17 -173.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.23 -46.1 79.68 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.728 0.411 . . . . 0.0 111.602 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.489 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 28.6 m-20 -59.56 -44.87 93.14 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.743 0.652 . . . . 0.0 110.688 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -64.74 -45.9 84.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.169 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 4' ' ' THR . 79.8 t -65.36 -43.89 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.625 0.77 . . . . 0.0 110.458 -175.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.86 97.16 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.132 0.973 . . . . 0.0 111.008 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.2 m -63.83 -42.72 97.56 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.18 0.925 . . . . 0.0 111.258 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 47' ' ' ILE . 96.7 mt -59.18 -51.01 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.578 0.751 . . . . 0.0 111.122 175.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.67 HG22 HD11 ' A' ' 18' ' ' ILE . 58.4 mt -59.8 -42.35 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.648 0.779 . . . . 0.0 110.534 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.485 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -56.39 -52.51 64.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.729 0.812 . . . . 0.0 112.713 173.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.47 -22.19 63.65 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.631 0.772 . . . . 0.0 112.327 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 m -85.06 -51.05 6.93 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.614 0.366 . . . . 0.0 111.11 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.604 ' SG ' HD11 ' A' ' 43' ' ' ILE . 74.7 m -100.29 7.59 44.29 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -168.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.8 t70 53.44 65.16 1.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.242 1.017 . . . . 0.0 111.871 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.67 HD11 HG22 ' A' ' 12' ' ' ILE . 10.1 pt -141.19 146.49 43.18 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.089 0.955 . . . . 0.0 109.418 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.28 114.33 2.62 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.716 2.277 . . . . 0.0 111.431 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.489 ' NH2' ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -53.61 -29.76 39.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.359 1.064 . . . . 0.0 113.175 -177.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.83 -27.53 62.96 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.191 0.597 . . . . 0.0 111.729 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -81.68 -5.56 58.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.825 0.45 . . . . 0.0 110.717 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.48 HD11 HD12 ' A' ' 18' ' ' ILE . 1.9 mp -86.36 113.49 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 174.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -95.16 165.9 15.95 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.843 0.857 . . . . 0.0 109.243 173.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.08 -18.47 61.94 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.291 1.994 . . . . 0.0 112.336 172.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -94.68 -0.21 54.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 122.948 0.499 . . . . 0.0 110.509 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.4 m -71.74 124.18 24.23 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.015 0.526 . . . . 0.0 110.383 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -85.66 123.18 30.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.83 -45.96 15.28 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.142 0.977 . . . . 0.0 112.207 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 mt -92.59 -48.16 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.86 -37.32 55.78 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.664 0.785 . . . . 0.0 112.357 -171.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.71 -59.21 1.86 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.587 0.355 . . . . 0.0 110.563 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.1 mt -75.92 -16.31 60.05 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.023 0.529 . . . . 0.0 112.417 -171.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.82 37.96 56.79 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.124 0.265 . . . . 0.0 113.303 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.51 HG23 ' HB2' ' A' ' 39' ' ' ASP . 93.5 mt -96.7 116.5 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.287 1.035 . . . . 0.0 108.928 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.46 164.56 26.45 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.8 m -56.41 -31.95 64.37 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.74 0.816 . . . . 0.0 111.614 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.76 -32.77 65.88 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 122.952 0.501 . . . . 0.0 111.088 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.51 ' HB2' HG23 ' A' ' 35' ' ' ILE . 28.6 m-20 -71.43 -40.99 70.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.965 0.506 . . . . 0.0 109.755 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.54 -22.01 64.52 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.212 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.62 -50.94 68.83 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.327 0.584 . . . . 0.0 110.439 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.42 -34.77 70.62 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.086 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.604 HD11 ' SG ' ' A' ' 16' ' ' CYS . 62.3 mt -63.92 -42.7 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 123.578 0.549 . . . . 0.0 110.192 173.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.46 -36.25 76.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.599 0.76 . . . . 0.0 110.645 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.44 -42.51 98.68 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.023 0.929 . . . . 0.0 110.272 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -42.02 84.16 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.137 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.408 ' HA ' HD13 ' A' ' 11' ' ' ILE . 84.1 mt -64.82 -43.71 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.763 0.825 . . . . 0.0 110.824 175.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -50.17 -54.09 23.26 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.076 1.35 . . . . 0.0 110.961 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -38.99 53.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.843 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.97 -45.37 86.85 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -88.43 -10.61 48.61 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.706 0.802 . . . . 0.0 112.562 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.23 48.57 81.82 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.396 0.435 . . . . 0.0 112.24 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.401 HG22 ' HG2' ' A' ' 91' ' ' LYS . 44.8 pt -131.26 169.18 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.95 1.3 . . . . 0.0 109.315 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -110.82 100.8 9.48 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.449 HD23 HD12 ' A' ' 87' ' ' LEU . 83.8 mt -67.94 123.07 86.26 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 122.695 0.398 . . . . 0.0 110.222 174.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.98 61.0 7.71 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.839 2.36 . . . . 0.0 110.124 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.08 -36.88 83.03 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.042 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -58.94 -42.3 89.44 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.553 0.741 . . . . 0.0 110.887 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.58 -52.12 66.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.652 0.781 . . . . 0.0 109.925 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -58.03 -43.77 86.97 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 124.474 1.108 . . . . 0.0 111.036 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -60.26 -47.74 84.7 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.904 0.882 . . . . 0.0 110.718 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -62.84 -40.26 96.9 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.272 0.629 . . . . 0.0 110.779 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG2' ' HD2' ' A' ' 68' ' ' LYS . 48.5 mt-10 -65.28 -41.65 93.96 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.189 0.931 . . . . 0.0 112.031 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.96 -47.4 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.436 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -57.31 -46.71 82.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.246 0.618 . . . . 0.0 111.669 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.08 0.02 50.04 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.239 0.616 . . . . 0.0 112.421 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.09 18.92 75.14 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.436 0.535 . . . . 0.0 114.436 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' HD2' ' HG2' ' A' ' 63' ' ' GLU . 62.3 mttm -69.76 -33.93 73.1 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 172.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.83 169.04 19.93 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.993 1.317 . . . . 0.0 108.397 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.5 p -116.12 163.45 15.93 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.08 0.952 . . . . 0.0 109.432 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p -55.71 -54.17 47.56 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 124.057 0.848 . . . . 0.0 112.746 -168.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -30.07 40.22 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.504 ' HA ' HD22 ' A' ' 79' ' ' ASN . 0.1 OUTLIER -62.37 -26.81 68.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.814 1.246 . . . . 0.0 111.797 -178.51 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -115.39 -26.98 7.36 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.215 0.606 . . . . 0.0 111.938 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -108.22 17.98 21.62 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.186 0.595 . . . . 0.0 112.277 -165.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.51 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.0 t -105.71 139.73 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 165.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 12' ' ' ILE . 3.8 mm? -52.68 -37.91 59.61 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.917 1.287 . . . . 0.0 114.308 -171.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.51 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.4 pttt -69.76 -45.19 68.63 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 123.163 0.29 . . . . 0.0 110.531 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.504 HD22 ' HA ' ' A' ' 73' ' ' GLN . 2.3 m-20 -68.08 -41.43 81.93 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.165 0.586 . . . . 0.0 110.616 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.09 -50.21 69.21 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.89 1.276 . . . . 0.0 109.536 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.94 71.86 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 123.615 0.572 . . . . 0.0 111.158 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -66.65 -50.6 62.42 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.853 0.461 . . . . 0.0 110.26 175.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.435 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 3.7 mmp_? -53.35 -50.19 65.56 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.861 0.864 . . . . 0.0 111.211 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 88' ' ' VAL . 87.7 mt -64.16 -45.65 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.948 1.299 . . . . 0.0 110.395 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.66 -36.43 78.68 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.155 0.982 . . . . 0.0 111.394 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 29.9 mm-40 -64.94 -43.76 91.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.581 0.752 . . . . 0.0 110.839 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.449 HD12 HD23 ' A' ' 55' ' ' LEU . 67.1 mt -70.89 -27.64 63.95 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.16 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 84' ' ' ILE . 78.7 t -67.83 -37.09 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.504 0.722 . . . . 0.0 110.114 172.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.3 75.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.068 0.547 . . . . 0.0 110.569 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.48 87.28 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.398 0.679 . . . . 0.0 111.275 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.401 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -81.47 -24.98 36.42 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.1 -23.55 77.98 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.335 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.34 -76.95 0.28 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 164.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.4 mt -173.31 123.36 0.39 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.931 1.692 . . . . 0.0 108.089 173.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -121.25 -60.02 1.67 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.889 0.875 . . . . 0.0 108.922 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -145.89 46.46 1.26 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.3 t60 75.73 -43.87 0.5 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.486 1.514 . . . . 0.0 113.581 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -71.7 103.63 3.12 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.417 0.687 . . . . 0.0 111.399 -172.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -86.75 -176.95 5.99 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.874 170.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -109.83 83.45 1.76 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t60 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 124.407 1.083 . . . . 0.0 108.936 179.25 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.4 m 61.77 84.21 0.14 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.448 1.099 . . . . 0.0 110.283 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 p -77.18 178.0 7.41 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.711 0.804 . . . . 0.0 111.176 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 8' ' ' VAL . 43.4 m -64.94 -40.14 94.58 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -55.93 -48.85 74.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.314 0.646 . . . . 0.0 110.881 173.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.16 -50.11 59.58 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.022 0.826 . . . . 0.0 110.158 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' O ' HG13 ' A' ' 11' ' ' ILE . 6.1 mmp_? -70.34 -41.4 73.24 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.889 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 4' ' ' THR . 55.3 t -67.99 -40.98 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.162 0.585 . . . . 0.0 110.408 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.02 -37.97 89.38 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.086 0.954 . . . . 0.0 109.98 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.478 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 90.4 m -63.27 -44.21 95.74 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.52 174.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 7' ' ' ARG . 95.7 mt -58.81 -47.35 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.23 0.612 . . . . 0.0 111.359 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 18' ' ' ILE . 58.8 mt -57.44 -43.81 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.992 0.517 . . . . 0.0 110.102 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.494 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -57.76 -49.46 76.51 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.729 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 10' ' ' THR . 46.4 mm-40 -66.64 -33.46 75.71 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.297 0.639 . . . . 0.0 111.806 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.5 m -74.03 -50.72 18.49 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.502 0.721 . . . . 0.0 110.933 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 43' ' ' ILE . 39.8 m -97.37 3.95 50.88 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.812 0.845 . . . . 0.0 113.211 -169.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 45.67 77.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.418 1.087 . . . . 0.0 112.006 -171.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 12' ' ' ILE . 7.3 pt -147.74 147.59 27.81 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.021 0.929 . . . . 0.0 109.967 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.14 122.11 10.21 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.911 2.408 . . . . 0.0 111.561 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HG3' ' HA ' ' A' ' 10' ' ' THR . 2.5 tmm_? -64.46 -19.92 65.86 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.538 1.135 . . . . 0.0 112.453 -173.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.55 -22.41 60.09 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.842 0.857 . . . . 0.0 110.557 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.8 p -86.51 -10.68 53.58 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.158 0.583 . . . . 0.0 110.902 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.423 HD11 HD12 ' A' ' 18' ' ' ILE . 2.3 mp -91.76 93.48 4.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.1 p -82.7 164.12 48.44 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 124.107 0.963 . . . . 0.0 109.989 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.85 -21.13 72.87 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.162 1.908 . . . . 0.0 113.172 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -106.85 17.5 23.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.89 0.476 . . . . 0.0 110.409 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.9 m -72.33 120.3 17.74 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.112 0.565 . . . . 0.0 109.65 170.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -84.0 121.97 28.13 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 170.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -40.28 -50.71 2.77 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.886 1.274 . . . . 0.0 113.041 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.0 mt -92.85 -47.43 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 121.109 0.48 . . . . 0.0 110.188 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.51 -38.13 55.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.235 1.014 . . . . 0.0 112.221 -172.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.24 -65.2 0.98 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.359 0.664 . . . . 0.0 110.421 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.37 -12.71 61.57 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.76 0.824 . . . . 0.0 112.633 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.39 24.41 76.76 Favored Glycine 0 C--N 1.354 1.563 0 O-C-N 123.466 0.479 . . . . 0.0 114.235 174.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.9 mt -78.87 124.89 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.441 1.097 . . . . 0.0 109.371 -175.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.14 156.23 39.04 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.231 0.612 . . . . 0.0 110.987 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.8 m -63.55 -41.07 98.45 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.826 0.85 . . . . 0.0 111.863 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 pp -71.62 -28.86 64.08 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.927 0.394 . . . . 0.0 110.043 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.71 -36.9 59.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.185 0.994 . . . . 0.0 110.118 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -70.9 -23.32 62.25 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.482 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.64 -41.31 94.68 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.152 0.581 . . . . 0.0 111.091 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.66 -42.82 90.91 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.403 0.681 . . . . 0.0 110.305 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.446 HD11 ' SG ' ' A' ' 16' ' ' CYS . 59.6 mt -62.89 -45.03 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.755 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.81 -33.82 68.85 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.293 0.637 . . . . 0.0 110.532 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -59.9 -39.79 86.57 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.321 1.048 . . . . 0.0 110.435 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.46 -38.03 71.32 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.537 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.405 ' HA ' HD13 ' A' ' 11' ' ' ILE . 97.6 mt -66.69 -41.71 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.657 0.783 . . . . 0.0 110.383 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -52.11 -47.66 65.19 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.792 1.237 . . . . 0.0 110.694 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.29 -56.05 22.25 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.121 0.888 . . . . 0.0 110.846 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.71 -51.8 68.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.047 0.939 . . . . 0.0 112.302 -171.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -87.49 -14.54 40.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.286 0.634 . . . . 0.0 111.561 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.69 30.43 74.67 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 117.716 0.234 . . . . 0.0 113.329 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.412 HD13 HG23 ' A' ' 84' ' ' ILE . 32.7 pt -109.55 151.14 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.863 0.865 . . . . 0.0 110.967 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -93.34 95.67 9.47 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.455 HD21 HG12 ' A' ' 84' ' ' ILE . 83.8 mt -73.03 119.34 75.08 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.916 173.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -85.7 58.33 4.6 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.618 2.212 . . . . 0.0 109.152 165.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.71 -38.96 89.79 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.819 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -35.89 79.25 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.928 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.57 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.17 -51.13 41.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.221 0.608 . . . . 0.0 109.876 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.437 ' O ' HG23 ' A' ' 64' ' ' VAL . 51.4 m0 -55.57 -48.41 74.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.158 0.983 . . . . 0.0 111.349 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.7 m -62.82 -37.45 86.82 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.574 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -66.7 -43.15 85.17 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.253 0.621 . . . . 0.0 110.637 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 4.9 mm-40 -66.66 -33.88 76.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.589 0.756 . . . . 0.0 110.719 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 60' ' ' TRP . 54.4 t -61.38 -52.73 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.142 172.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -65.51 -27.04 68.19 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.098 0.559 . . . . 0.0 111.599 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.84 1.79 56.66 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.15 0.58 . . . . 0.0 111.702 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.93 12.93 71.89 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.8 mttp -72.6 -26.69 61.78 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 117.722 0.761 . . . . 0.0 110.119 172.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 168.03 22.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.32 1.048 . . . . 0.0 109.684 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 51.5 p -100.28 163.53 12.35 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 124.266 1.027 . . . . 0.0 108.858 172.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.423 HG22 HG11 ' A' ' 64' ' ' VAL . 72.1 p -57.33 -43.28 83.22 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.626 0.579 . . . . 0.0 110.356 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' A' ' 76' ' ' VAL . 22.2 mm-40 -41.4 -53.61 3.29 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.369 1.467 . . . . 0.0 112.786 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -60.75 -21.36 62.92 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.318 -1.31 . . . . 0.0 114.106 -171.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -128.81 -4.38 5.18 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.89 20.09 7.74 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.994 0.518 . . . . 0.0 111.217 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 72' ' ' GLU . 95.8 t -108.99 144.36 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 164.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.86 -35.98 71.71 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -67.67 -40.18 84.49 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 120.889 0.376 . . . . 0.0 110.096 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.1 m120 -73.5 -47.31 42.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.087 0.955 . . . . 0.0 110.316 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.03 -47.88 84.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.954 1.302 . . . . 0.0 109.897 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.07 -36.38 81.49 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.556 0.743 . . . . 0.0 111.841 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.68 81.38 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.06 0.544 . . . . 0.0 110.654 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 24.7 mmm180 -59.39 -48.48 81.49 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.772 0.829 . . . . 0.0 110.637 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 88' ' ' VAL . 97.0 mt -63.87 -43.1 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.699 1.2 . . . . 0.0 110.863 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.06 -39.06 93.6 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.567 0.747 . . . . 0.0 111.045 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -63.58 -40.88 98.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.547 0.739 . . . . 0.0 110.711 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 75.2 mt -70.57 -34.32 72.08 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.963 0.505 . . . . 0.0 112.019 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 84' ' ' ILE . 91.9 t -64.56 -42.64 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-O 121.454 0.645 . . . . 0.0 109.512 174.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.74 -37.63 79.56 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.176 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.36 -44.63 87.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.105 0.962 . . . . 0.0 111.413 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -79.42 -17.72 53.74 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.287 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.43 -26.54 35.72 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 175.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.98 9.11 20.53 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.572 1.149 . . . . 0.0 111.932 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.85 169.29 5.3 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.027 0.531 . . . . 0.0 109.763 169.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.95 146.56 52.74 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -83.15 16.08 2.57 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.02 0.928 . . . . 0.0 112.048 -166.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 65.1 m80 58.42 54.59 5.48 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 124.476 1.11 . . . . 0.0 110.513 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -56.15 -34.24 65.95 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.022 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -163.89 104.48 0.91 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -154.91 86.76 1.12 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.557 1.143 . . . . 0.0 108.298 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.8 t60 . . . . . 0 C--O 1.249 1.047 0 C-N-CA 124.24 1.016 . . . . 0.0 108.415 -177.299 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.746 0.308 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 t -140.58 -164.83 1.81 Allowed 'General case' 0 C--O 1.25 1.107 0 C-N-CA 123.771 0.828 . . . . 0.0 109.364 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -58.49 127.56 32.76 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 122.898 0.479 . . . . 0.0 110.335 171.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 8' ' ' VAL . 10.3 m -58.1 -34.71 70.48 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.781 0.832 . . . . 0.0 111.097 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -57.56 -48.8 78.33 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 123.007 0.523 . . . . 0.0 111.166 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.81 -44.5 70.25 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.386 0.674 . . . . 0.0 110.862 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -60.2 -54.05 50.47 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.479 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 4' ' ' THR . 95.6 t -67.55 -38.98 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.419 0.688 . . . . 0.0 111.245 -172.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.64 92.13 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.673 1.189 . . . . 0.0 110.339 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 85.9 m -66.63 -40.46 88.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.554 176.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.49 -49.81 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.15 0.432 . . . . 0.0 111.383 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.567 HG12 HG21 ' A' ' 43' ' ' ILE . 51.8 mt -58.79 -41.03 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 122.789 0.435 . . . . 0.0 110.166 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.74 -60.27 3.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.803 0.841 . . . . 0.0 112.542 173.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 10' ' ' THR . 17.3 mm-40 -65.43 -34.6 78.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.196 0.598 . . . . 0.0 112.146 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.4 m -72.87 -58.6 3.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.189 0.595 . . . . 0.0 110.331 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.7 t -84.99 3.5 38.21 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.06 65.91 1.37 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.405 1.082 . . . . 0.0 111.577 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.545 HG13 ' HA ' ' A' ' 13' ' ' ALA . 10.4 pt -145.3 159.33 49.2 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.801 1.24 . . . . 0.0 109.023 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -75.09 133.77 16.85 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.767 2.312 . . . . 0.0 111.802 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -18.9 65.63 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -81.87 -19.79 40.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.485 0.714 . . . . 0.0 109.873 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 p -79.88 -7.75 58.91 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 122.568 0.347 . . . . 0.0 110.851 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.1 114.06 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.1 p -100.25 160.58 26.67 Favored Pre-proline 0 N--CA 1.488 1.437 0 C-N-CA 123.302 0.641 . . . . 0.0 110.471 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.05 -25.83 58.57 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 122.718 2.278 . . . . 0.0 112.671 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -91.77 1.97 56.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.671 0.788 . . . . 0.0 111.114 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 t -83.01 137.83 33.98 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.302 0.641 . . . . 0.0 111.345 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.516 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 54.7 t-80 -82.8 111.86 19.1 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 165.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.38 -20.25 28.28 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.516 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 84.6 mt -99.57 -41.25 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.599 0.76 . . . . 0.0 110.586 -177.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 32.4 t70 -79.98 -52.0 8.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.416 0.686 . . . . 0.0 112.227 -173.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -74.94 -48.95 21.84 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.365 0.602 . . . . 0.0 111.164 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.5 mt -73.23 -12.78 60.98 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.49 -176.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.17 35.57 88.75 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 121.296 0.387 . . . . 0.0 112.662 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.5 mt -99.84 126.08 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -61.34 153.35 26.91 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 118.144 0.429 . . . . 0.0 110.73 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.4 m -63.61 -29.09 70.38 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.008 0.523 . . . . 0.0 109.988 176.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.57 -39.26 62.36 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.718 0.807 . . . . 0.0 109.96 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.18 -26.65 61.26 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.549 0.74 . . . . 0.0 110.11 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -74.34 -27.67 60.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.722 0.809 . . . . 0.0 110.504 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' SER . 89.8 mt -56.43 -33.44 65.84 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 122.632 0.373 . . . . 0.0 110.869 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.92 -41.61 64.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.666 0.786 . . . . 0.0 110.631 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.567 HG21 HG12 ' A' ' 12' ' ' ILE . 47.9 mt -62.81 -41.06 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.062 0.458 . . . . 0.0 110.175 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.14 -29.95 63.25 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.29 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -59.01 -42.23 89.63 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.969 0.908 . . . . 0.0 109.892 170.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.6 -42.43 74.41 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.338 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.46 -42.84 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.762 0.825 . . . . 0.0 110.597 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.59 -48.22 69.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.892 1.277 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -72.52 -42.77 64.42 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.2 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.44 77.02 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.834 0.854 . . . . 0.0 112.463 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -87.11 -7.94 57.52 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 111.449 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.65 32.82 85.48 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.328 0.392 . . . . 0.0 113.194 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 pt -112.61 169.59 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.198 0.999 . . . . 0.0 110.761 -173.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -104.83 101.71 11.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.516 HD21 HG12 ' A' ' 84' ' ' ILE . 95.7 mt -72.43 114.49 30.28 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 167.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.534 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 87.7 Cg_endo -81.94 63.86 8.4 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.037 1.824 . . . . 0.0 109.833 168.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.5 -38.16 88.81 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.035 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.23 -42.67 99.26 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.898 0.479 . . . . 0.0 111.027 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 54.3 tptt -58.75 -47.3 85.13 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.366 1.066 . . . . 0.0 110.79 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.414 ' O ' HG23 ' A' ' 64' ' ' VAL . 53.4 m0 -63.48 -46.03 88.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.554 0.742 . . . . 0.0 110.867 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.5 m -64.85 -32.94 74.87 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.367 1.067 . . . . 0.0 110.965 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.21 -42.32 62.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.438 0.695 . . . . 0.0 109.734 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.32 -35.41 75.57 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.654 0.781 . . . . 0.0 111.046 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' TRP . 85.0 t -64.97 -46.16 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 173.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.31 -40.27 96.87 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.137 0.975 . . . . 0.0 112.825 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.04 -1.67 58.05 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.42 0.688 . . . . 0.0 112.646 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.67 30.52 77.89 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 11.3 mmpt? -77.18 -33.21 56.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.951 0.901 . . . . 0.0 109.444 171.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.64 168.45 20.13 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.673 1.189 . . . . 0.0 108.747 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.5 p -108.9 162.11 14.5 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.61 0.764 . . . . 0.0 111.149 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.0 p -58.07 -64.47 0.9 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.74 0.816 . . . . 0.0 111.797 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -30.49 62.0 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -55.74 -24.84 37.43 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.545 1.138 . . . . 0.0 112.861 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -111.36 -44.0 3.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.313 0.645 . . . . 0.0 111.095 173.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -97.94 21.76 10.21 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.994 0.518 . . . . 0.0 112.306 -163.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.575 HG12 ' HG2' ' A' ' 78' ' ' LYS . 25.5 t -106.01 140.63 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 165.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.459 HD11 HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -55.37 -39.49 70.16 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -167.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.575 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.9 pttt -61.34 -43.12 99.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.608 0.718 . . . . 0.0 110.191 176.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 83.9 m-20 -75.96 -44.97 37.32 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.888 1.275 . . . . 0.0 109.967 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.74 -53.46 57.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.187 1.395 . . . . 0.0 109.836 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.27 70.69 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.453 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.09 76.57 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.978 0.511 . . . . 0.0 111.678 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 3.6 mmp_? -59.81 -49.59 77.12 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.723 0.773 . . . . 0.0 109.806 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.516 HG12 HD21 ' A' ' 55' ' ' LEU . 88.6 mt -58.89 -45.64 91.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.587 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -64.64 -37.23 86.85 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.964 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -66.68 -32.87 74.47 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.803 0.441 . . . . 0.0 110.818 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.16 -30.92 60.87 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.278 0.631 . . . . 0.0 111.702 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.2 t -69.28 -35.57 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.385 0.674 . . . . 0.0 110.119 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.35 -37.92 77.89 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.484 173.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.69 -39.01 93.26 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.865 0.866 . . . . 0.0 111.933 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -81.71 -25.03 35.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.475 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.97 -38.95 55.54 Favored Glycine 0 C--N 1.354 1.576 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.48 109.81 14.2 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.0 tp 60.79 -84.08 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.407 1.083 . . . . 0.0 110.596 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 175.69 -53.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.624 1.569 . . . . 0.0 107.012 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.9 m80 73.57 155.7 0.17 Allowed 'General case' 0 C--N 1.358 0.961 0 C-N-CA 125.568 1.547 . . . . 0.0 112.507 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -71.33 118.81 14.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.515 172.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -86.71 61.9 7.08 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.603 0.716 . . . . 0.0 111.296 -170.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -176.96 151.73 0.87 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 125.317 1.447 . . . . 0.0 108.815 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -128.37 72.33 1.43 Allowed 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 171.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.6 t60 . . . . . 0 CA--C 1.55 0.949 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.955 179.669 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.4 p -138.56 1.82 2.17 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.856 0.862 . . . . 0.0 111.521 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m -66.91 175.16 2.6 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.949 0.5 . . . . 0.0 112.151 -174.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 8' ' ' VAL . 28.0 m -51.71 -48.7 63.46 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.504 0.722 . . . . 0.0 111.102 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -53.69 -49.04 68.87 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 0.0 111.486 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.36 -42.29 98.46 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.636 0.774 . . . . 0.0 110.795 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -64.24 -42.11 96.68 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.25 0.969 . . . . 0.0 111.22 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 4' ' ' THR . 89.0 t -69.93 -38.26 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.732 0.813 . . . . 0.0 110.685 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.91 81.08 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.229 1.011 . . . . 0.0 110.133 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.4 m -63.89 -44.42 93.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.614 0.766 . . . . 0.0 110.615 171.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 47' ' ' ILE . 95.3 mt -57.39 -50.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.754 0.822 . . . . 0.0 111.269 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.619 HG22 HD11 ' A' ' 18' ' ' ILE . 51.8 mt -60.09 -48.05 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.32 0.648 . . . . 0.0 110.405 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.73 -49.96 64.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.161 0.985 . . . . 0.0 112.675 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -68.19 -42.31 80.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.437 0.695 . . . . 0.0 112.19 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.9 m -68.02 -48.33 66.0 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.646 0.378 . . . . 0.0 110.585 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 43' ' ' ILE . 34.2 m -91.88 -2.52 56.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.88 0.872 . . . . 0.0 113.157 -171.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.2 t70 52.83 69.64 0.67 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.998 0.919 . . . . 0.0 111.56 -171.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.619 HD11 HG22 ' A' ' 12' ' ' ILE . 9.6 pt -143.53 156.86 59.98 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.782 1.233 . . . . 0.0 108.748 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.95 137.96 39.22 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.58 2.187 . . . . 0.0 111.546 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -62.65 -28.47 69.94 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.722 0.809 . . . . 0.0 111.349 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.85 -21.58 57.1 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.0 0.52 . . . . 0.0 111.071 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.2 p -83.97 1.65 42.62 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.547 0.339 . . . . 0.0 111.101 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.75 111.5 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 168.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.4 p -101.46 161.57 23.18 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.663 0.785 . . . . 0.0 109.869 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.66 -27.2 75.87 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.007 1.805 . . . . 0.0 112.347 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -96.27 2.66 53.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.98 0.512 . . . . 0.0 110.846 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.3 p -74.22 129.33 37.61 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -83.97 115.63 22.41 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -44.61 -39.46 5.02 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.812 1.245 . . . . 0.0 113.96 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.9 mt -95.31 -56.73 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 122.731 0.413 . . . . 0.0 110.486 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -80.01 -23.45 41.49 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.798 0.839 . . . . 0.0 112.965 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -108.25 -61.01 1.65 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.967 0.507 . . . . 0.0 110.915 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.52 -20.01 62.1 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.614 0.765 . . . . 0.0 111.902 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.91 36.42 92.08 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.656 0.598 . . . . 0.0 114.509 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.469 HG21 HD12 ' A' ' 43' ' ' ILE . 61.1 mt -84.22 123.67 39.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 123.569 0.747 . . . . 0.0 109.038 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.08 149.24 33.07 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.303 0.641 . . . . 0.0 110.323 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.408 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 23.9 m -60.46 -38.66 84.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.203 0.601 . . . . 0.0 110.533 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 39' ' ' ASP . 3.4 pp -71.29 -29.94 65.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.182 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.405 ' N ' HD12 ' A' ' 38' ' ' LEU . 20.9 t70 -78.28 -36.18 46.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.456 0.703 . . . . 0.0 109.893 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -71.08 -21.99 62.16 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.388 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 37' ' ' SER . 96.3 mt -60.56 -37.87 82.68 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.796 0.438 . . . . 0.0 110.92 170.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -72.9 -40.46 65.53 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.142 0.577 . . . . 0.0 110.391 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.651 HD11 ' SG ' ' A' ' 16' ' ' CYS . 46.4 mt -61.25 -46.31 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 123.694 0.622 . . . . 0.0 110.408 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -70.78 -35.27 72.5 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.126 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -65.09 -38.44 90.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.52 0.728 . . . . 0.0 110.813 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.92 -28.11 64.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.365 0.666 . . . . 0.0 111.037 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 53' ' ' ILE . 96.9 mt -68.96 -41.42 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.965 0.906 . . . . 0.0 109.602 171.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.2 -39.53 93.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.673 0.789 . . . . 0.0 111.109 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -67.83 -52.19 39.71 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.677 0.791 . . . . 0.0 111.112 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.82 -48.02 75.91 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.255 0.622 . . . . 0.0 112.591 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -90.11 -11.16 42.08 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.548 0.739 . . . . 0.0 112.386 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.2 74.46 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 123.361 0.413 . . . . 0.0 113.08 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 47' ' ' ILE . 45.5 pt -108.22 -175.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.157 0.983 . . . . 0.0 110.015 -174.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -138.53 107.9 6.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 167.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD21 HG12 ' A' ' 84' ' ' ILE . 93.8 mt -69.72 130.4 90.35 Favored Pre-proline 0 C--O 1.243 0.738 0 C-N-CA 123.076 0.55 . . . . 0.0 109.733 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -72.43 59.71 3.25 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 123.344 2.696 . . . . 0.0 110.493 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.71 -45.44 78.74 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.785 0.834 . . . . 0.0 109.866 -171.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -39.57 92.21 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 123.856 0.722 . . . . 0.0 110.926 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.59 -45.33 92.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.227 1.011 . . . . 0.0 110.59 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.429 ' O ' HG23 ' A' ' 64' ' ' VAL . 52.6 m0 -65.74 -45.29 83.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.605 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.5 m -64.43 -31.52 72.76 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.862 0.865 . . . . 0.0 110.221 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.72 -44.57 70.04 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.39 -42.7 96.44 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.753 0.821 . . . . 0.0 111.305 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 60' ' ' TRP . 78.2 t -62.59 -53.82 42.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.342 0.657 . . . . 0.0 110.741 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -66.28 -22.56 66.3 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.836 0.854 . . . . 0.0 112.768 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -98.99 4.72 47.31 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.452 0.701 . . . . 0.0 112.045 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 15.3 65.69 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 115.181 0.833 . . . . 0.0 115.181 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -78.61 -23.81 45.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.456 0.703 . . . . 0.0 110.588 174.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -146.53 163.14 36.69 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.865 0.866 . . . . 0.0 109.253 173.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.0 p -91.65 165.12 13.48 Favored 'General case' 0 C--O 1.247 0.955 0 C-N-CA 123.404 0.682 . . . . 0.0 110.131 172.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.4 p -57.86 -55.02 40.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.99 0.806 . . . . 0.0 109.896 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.417 ' HA ' HG23 ' A' ' 76' ' ' VAL . 14.8 pt-20 -52.77 -35.6 56.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.872 1.269 . . . . 0.0 113.831 -175.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -55.01 -33.74 62.86 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.878 0.871 . . . . 0.0 112.844 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -117.52 -24.4 7.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.921 0.488 . . . . 0.0 112.085 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.73 26.68 10.38 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.459 0.704 . . . . 0.0 110.494 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 78' ' ' LYS . 52.3 t -109.76 143.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 158.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.4 -37.6 81.32 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.499 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.2 pttp -68.87 -41.88 77.77 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 120.891 0.377 . . . . 0.0 110.286 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.5 m120 -68.2 -47.82 66.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.808 0.843 . . . . 0.0 110.191 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -57.76 -49.18 77.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.14 1.376 . . . . 0.0 110.51 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.51 -34.19 73.73 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.707 0.803 . . . . 0.0 111.975 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.86 87.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.836 0.454 . . . . 0.0 110.931 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 9.1 mmm180 -66.21 -41.33 90.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.52 0.728 . . . . 0.0 111.479 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.595 HG12 HD21 ' A' ' 55' ' ' LEU . 96.4 mt -63.19 -50.08 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.242 1.017 . . . . 0.0 110.517 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -60.6 -44.25 96.5 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.946 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.46 -31.49 70.82 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.753 0.421 . . . . 0.0 110.765 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.435 HD12 HD23 ' A' ' 55' ' ' LEU . 54.7 mt -67.32 -39.88 85.89 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.869 0.467 . . . . 0.0 111.568 173.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.454 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 60.5 t -63.54 -44.1 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.47 94.77 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.567 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.27 -39.11 55.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.517 0.727 . . . . 0.0 112.824 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 88' ' ' VAL . 20.7 pttp -72.47 -33.48 67.03 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.585 0.354 . . . . 0.0 110.541 -176.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.68 -26.37 15.33 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.053 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 57.75 -165.74 0.16 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 124.494 1.117 . . . . 0.0 110.682 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.9 119.48 23.99 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -27.85 64.78 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.239 0.616 . . . . 0.0 111.24 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -133.38 133.45 42.45 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 166.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -75.91 76.16 2.82 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.359 0.6 . . . . 0.0 110.839 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -141.89 -178.03 5.49 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.422 1.489 . . . . 0.0 108.271 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -76.96 -15.06 59.77 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 122.108 -0.37 . . . . 0.0 111.763 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 67.07 14.11 9.7 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.021 1.328 . . . . 0.0 111.132 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 C--O 1.249 1.059 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -177.932 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.8 p -82.17 132.5 35.24 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 m -67.1 126.87 30.54 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.4 m -58.13 -41.2 83.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.734 0.814 . . . . 0.0 111.042 -176.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -54.87 -47.82 73.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.475 0.71 . . . . 0.0 111.763 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.07 -43.58 98.68 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.658 0.599 . . . . 0.0 110.951 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -61.73 -44.08 97.62 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.361 0.665 . . . . 0.0 111.823 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 4' ' ' THR . 89.1 t -69.71 -41.32 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.879 0.872 . . . . 0.0 110.46 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.03 93.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.71 0.804 . . . . 0.0 110.85 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.5 m -64.51 -44.75 89.92 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 124.0 0.813 . . . . 0.0 111.227 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 47' ' ' ILE . 96.8 mt -57.26 -51.23 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.001 0.52 . . . . 0.0 110.908 176.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.6 HG12 HG21 ' A' ' 43' ' ' ILE . 32.1 mt -56.67 -48.02 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.986 0.914 . . . . 0.0 110.511 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . . . -52.66 -59.39 4.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.467 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.48 -24.22 56.89 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.426 -171.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.7 m -82.79 -44.25 15.75 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 117.864 0.302 . . . . 0.0 110.734 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.537 ' HB2' HD11 ' A' ' 43' ' ' ILE . 49.5 t -96.46 -3.71 42.92 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.655 0.782 . . . . 0.0 112.977 -172.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t70 59.65 65.68 1.11 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.455 1.102 . . . . 0.0 111.57 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.1 pt -146.47 150.48 40.7 Favored Pre-proline 0 N--CA 1.486 1.352 0 C-N-CA 124.555 1.142 . . . . 0.0 108.861 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.95 128.69 19.2 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.41 2.073 . . . . 0.0 111.929 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -65.29 -18.25 65.16 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.883 0.473 . . . . 0.0 111.77 178.081 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -79.65 -22.17 43.9 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.512 0.725 . . . . 0.0 109.95 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.0 p -87.21 5.23 39.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.705 0.402 . . . . 0.0 110.75 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.603 HG23 ' HG ' ' A' ' 77' ' ' LEU . 1.8 mp -95.01 130.98 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 166.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -124.15 159.75 55.43 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 123.802 0.841 . . . . 0.0 110.165 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.87 -44.87 44.94 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.284 2.656 . . . . 0.0 113.677 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.96 11.61 29.0 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.906 0.482 . . . . 0.0 110.602 -173.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 t -72.92 130.91 41.45 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 123.606 0.762 . . . . 0.0 109.717 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -84.85 117.01 23.62 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -49.56 -35.11 19.47 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.37 -55.21 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -78.8 -38.16 39.02 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -170.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -87.62 -59.63 2.19 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.732 0.413 . . . . 0.0 110.015 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 29' ' ' ALA . 90.4 mt -70.17 -23.66 63.02 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.38 0.672 . . . . 0.0 111.423 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.2 39.82 96.36 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.781 0.676 . . . . 0.0 113.16 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -72.91 115.34 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.08 144.11 24.81 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.91 0.884 . . . . 0.0 110.226 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 p -55.0 -42.84 72.98 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.957 0.903 . . . . 0.0 112.116 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.1 mt -67.39 -44.79 78.01 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.569 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -64.21 -26.86 68.7 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.984 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -74.06 -34.0 63.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.55 -38.54 90.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.102 0.561 . . . . 0.0 110.189 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.43 -46.0 88.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.029 0.932 . . . . 0.0 110.697 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.6 HG21 HG12 ' A' ' 12' ' ' ILE . 68.2 mt -65.61 -41.64 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.33 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.42 -39.56 74.36 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -54.75 -43.34 72.61 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.483 1.113 . . . . 0.0 110.907 171.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.23 -30.8 66.78 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.195 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.428 ' HA ' HD13 ' A' ' 11' ' ' ILE . 83.8 mt -67.79 -46.1 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.241 0.617 . . . . 0.0 110.438 175.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -56.88 -46.2 82.03 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.723 0.809 . . . . 0.0 110.727 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -67.92 -47.04 69.85 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.014 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.34 99.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.188 0.595 . . . . 0.0 112.322 -175.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -92.22 -11.33 35.68 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.498 0.719 . . . . 0.0 112.328 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.98 31.34 69.69 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-O 121.133 0.296 . . . . 0.0 113.171 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.3 pt -119.79 -177.27 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.641 1.176 . . . . 0.0 109.892 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -135.73 107.88 7.22 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 166.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.651 HD21 HG12 ' A' ' 84' ' ' ILE . 88.4 mt -61.77 128.33 90.23 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 168.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.76 59.17 2.73 Favored 'Trans proline' 0 C--N 1.367 1.515 0 C-N-CA 122.946 2.431 . . . . 0.0 111.624 170.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.0 -40.74 94.7 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.056 1.342 . . . . 0.0 109.629 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -57.28 -45.78 83.74 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.006 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -68.79 -43.89 74.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.277 0.631 . . . . 0.0 110.53 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.448 ' HH2' HD22 ' A' ' 55' ' ' LEU . 50.4 m0 -59.98 -48.53 81.34 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.308 1.005 . . . . 0.0 111.252 -176.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.2 m -63.97 -35.58 81.15 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 124.258 0.974 . . . . 0.0 110.167 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.38 -38.22 71.55 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.082 0.553 . . . . 0.0 110.86 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.25 -38.25 90.42 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.835 0.854 . . . . 0.0 110.942 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 60' ' ' TRP . 91.6 t -64.53 -44.89 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.825 174.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.81 -46.22 88.12 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.63 0.772 . . . . 0.0 112.437 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 50.9 m-20 -81.01 -2.54 48.39 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.462 0.705 . . . . 0.0 112.673 -176.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.23 28.89 74.09 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 114.0 0.36 . . . . 0.0 114.0 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HG3' ' HB2' ' A' ' 66' ' ' ASP . 95.4 mttt -74.77 -34.01 62.39 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.577 0.751 . . . . 0.0 109.723 171.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.6 163.58 36.81 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.591 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -88.63 154.74 20.07 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.603 1.161 . . . . 0.0 109.493 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -38.85 87.29 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.682 0.793 . . . . 0.0 110.343 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -43.76 -50.74 7.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.618 1.567 . . . . 0.0 111.761 172.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.418 ' HA ' ' ND2' ' A' ' 79' ' ' ASN . 44.0 mt-30 -61.04 -16.12 39.93 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.526 -1.216 . . . . 0.0 114.198 -170.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -126.52 -20.86 4.27 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -117.12 20.73 13.62 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.977 0.511 . . . . 0.0 111.846 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.405 HG12 ' HG2' ' A' ' 78' ' ' LYS . 24.4 t -97.71 147.17 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 163.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.603 ' HG ' HG23 ' A' ' 23' ' ' ILE . 4.0 mm? -57.69 -54.51 46.01 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.743 1.217 . . . . 0.0 114.225 -172.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.9 pttt -61.1 -36.74 80.48 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.165 0.586 . . . . 0.0 110.776 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 41.3 t-20 -76.33 -46.95 25.29 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.739 -171.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.62 -46.94 85.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.565 1.546 . . . . 0.0 109.716 173.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.59 -33.04 73.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.868 0.867 . . . . 0.0 111.189 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.04 -46.45 71.11 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.766 0.426 . . . . 0.0 110.386 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 12.9 mmp_? -55.87 -46.28 78.3 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.469 0.707 . . . . 0.0 110.753 177.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.651 HG12 HD21 ' A' ' 55' ' ' LEU . 90.1 mt -61.31 -49.55 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.877 1.271 . . . . 0.0 110.205 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.63 -37.81 79.67 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.394 1.077 . . . . 0.0 111.396 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -69.87 -39.53 76.26 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.113 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.5 HD12 HD23 ' A' ' 55' ' ' LEU . 79.9 mt -67.8 -34.29 76.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 123.417 0.448 . . . . 0.0 110.811 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 84' ' ' ILE . 96.8 t -68.98 -40.25 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.712 0.805 . . . . 0.0 109.526 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.86 -40.53 87.91 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.609 0.764 . . . . 0.0 111.546 177.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.71 -36.35 78.35 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.139 0.975 . . . . 0.0 111.789 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -83.94 -31.62 25.5 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.384 0.274 . . . . 0.0 110.835 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.4 -26.16 21.6 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 119.834 -0.426 . . . . 0.0 112.796 -172.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 67.33 117.41 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.248 1.419 . . . . 0.0 111.457 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.21 97.94 0.07 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.647 0.779 . . . . 0.0 110.81 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -68.67 -25.21 64.68 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.901 0.88 . . . . 0.0 110.104 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -130.59 101.18 5.59 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 169.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 40.1 p-80 -83.87 -138.13 0.05 Allowed 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 118.758 -0.639 . . . . 0.0 109.617 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 76.69 -89.9 0.02 OUTLIER 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.384 1.074 . . . . 0.0 108.424 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.7 t60 60.66 -0.57 0.27 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -161.49 165.84 28.06 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.885 0.874 . . . . 0.0 109.649 -172.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.162 -0.923 . . . . 0.0 109.16 175.754 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.0 mtp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.4 p -85.71 89.17 7.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.422 0.63 . . . . 0.0 109.449 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 7.2 m -70.06 169.12 14.06 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.77 176.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 8' ' ' VAL . 24.9 m -60.56 -35.38 75.9 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.641 0.376 . . . . 0.0 111.059 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -56.89 -51.93 67.15 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.377 0.671 . . . . 0.0 110.468 171.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -58.52 -39.04 79.02 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.82 0.848 . . . . 0.0 111.552 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 3' ' ' SER . 13.0 mmt180 -57.64 -51.12 70.81 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.894 0.878 . . . . 0.0 111.324 174.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 4' ' ' THR . 81.0 t -72.26 -36.27 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.717 0.807 . . . . 0.0 111.274 -173.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.0 -42.44 80.32 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.889 0.876 . . . . 0.0 110.488 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 m -65.94 -47.63 74.04 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.796 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.8 mt -55.42 -54.75 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 123.409 0.684 . . . . 0.0 111.462 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.699 HG12 HG21 ' A' ' 43' ' ' ILE . 37.5 mt -57.57 -45.27 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.165 0.986 . . . . 0.0 110.959 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.424 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.19 -54.8 30.7 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.946 0.899 . . . . 0.0 112.812 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.53 -35.99 82.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.607 0.763 . . . . 0.0 111.94 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.0 m -69.59 -57.86 4.67 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 123.715 0.635 . . . . 0.0 110.387 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.573 ' SG ' HD11 ' A' ' 43' ' ' ILE . 81.1 m -96.1 11.97 32.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.553 0.741 . . . . 0.0 112.858 -170.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 42.63 67.69 0.58 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.975 1.31 . . . . 0.0 112.23 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.621 HD11 HG22 ' A' ' 12' ' ' ILE . 17.3 pt -137.61 146.03 51.49 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 124.809 1.244 . . . . 0.0 108.174 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.64 120.26 7.71 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.703 2.268 . . . . 0.0 112.845 -174.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -51.43 -39.91 58.29 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.477 1.511 . . . . 0.0 113.153 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.49 -14.1 58.55 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.241 0.216 . . . . 0.0 111.57 -172.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 p -83.87 1.51 42.87 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-O 120.616 0.246 . . . . 0.0 110.557 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.493 HG23 ' HG ' ' A' ' 77' ' ' LEU . 1.9 mp -86.84 137.6 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 165.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 p -125.98 161.69 49.97 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 123.663 0.785 . . . . 0.0 109.403 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.8 -29.44 80.99 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 121.933 1.755 . . . . 0.0 112.372 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.38 0.78 51.06 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.863 0.465 . . . . 0.0 111.393 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.6 p -75.98 132.67 40.34 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.758 0.253 . . . . 0.0 110.49 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -85.6 118.64 25.24 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -50.44 -27.88 7.27 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 55.2 mt -101.37 -55.12 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.133 0.492 . . . . 0.0 110.298 -175.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.17 -37.73 81.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.978 0.911 . . . . 0.0 112.018 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -95.7 -60.04 1.74 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.115 0.566 . . . . 0.0 110.859 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 29' ' ' ALA . 90.9 mt -71.87 -8.17 52.77 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.29 34.63 75.27 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.071 0.232 . . . . 0.0 113.52 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 88.3 mt -110.94 114.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.016 0.926 . . . . 0.0 108.802 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.46 156.73 28.59 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.957 0.503 . . . . 0.0 110.335 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.445 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 22.4 m -58.73 -27.89 65.32 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.664 0.786 . . . . 0.0 112.226 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.39 -48.49 67.22 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.014 0.526 . . . . 0.0 109.855 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.51 -33.27 75.51 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.001 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -72.04 -28.45 63.36 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.902 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 37' ' ' SER . 87.8 mt -61.04 -44.76 96.92 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.24 -41.3 98.3 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.161 0.984 . . . . 0.0 111.338 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.699 HG21 HG12 ' A' ' 12' ' ' ILE . 63.3 mt -65.58 -45.18 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-O 121.048 0.452 . . . . 0.0 110.665 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.48 -32.54 70.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.325 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -66.5 -36.72 83.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.582 0.753 . . . . 0.0 110.485 173.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.85 -34.23 77.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.914 0.486 . . . . 0.0 110.63 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.32 -38.45 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.712 0.805 . . . . 0.0 110.381 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -58.2 -44.69 88.23 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.571 0.748 . . . . 0.0 111.314 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -70.73 -44.46 66.78 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.535 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.78 -55.86 22.62 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.785 0.834 . . . . 0.0 112.827 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.517 ' HB2' HG12 ' A' ' 53' ' ' ILE . 97.4 m-85 -90.33 -10.98 42.07 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.326 0.65 . . . . 0.0 112.175 -177.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.14 70.18 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 -173.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 51' ' ' PHE . 43.9 pt -109.22 -176.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.083 0.953 . . . . 0.0 109.859 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -139.24 110.56 6.97 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 172.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.461 HD21 HG12 ' A' ' 84' ' ' ILE . 84.4 mt -83.58 120.04 74.74 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 170.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.71 58.77 1.12 Allowed 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.952 2.435 . . . . 0.0 112.113 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.443 HD22 ' CE3' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -66.18 -37.69 86.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.804 0.842 . . . . 0.0 110.195 -169.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -35.62 73.06 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.373 0.421 . . . . 0.0 111.203 175.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' NZ ' ' HB2' ' A' ' 59' ' ' LYS . 3.6 ttmp? -82.39 -29.15 31.03 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 123.253 0.621 . . . . 0.0 110.674 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.443 ' CE3' HD22 ' A' ' 57' ' ' LEU . 45.7 m0 -69.58 -40.62 76.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.365 0.666 . . . . 0.0 109.729 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.4 m -64.22 -34.78 78.89 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.502 173.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -69.33 -47.82 63.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.415 1.086 . . . . 0.0 110.259 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 45.9 mt-10 -61.06 -49.23 78.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.446 1.098 . . . . 0.0 111.56 -177.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.47 -37.54 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.509 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -64.19 -40.06 95.3 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.463 0.705 . . . . 0.0 111.129 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.84 1.67 51.64 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.153 0.981 . . . . 0.0 112.244 -172.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.25 18.49 75.04 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.58 -31.96 67.54 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.338 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.72 169.83 17.01 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.581 1.153 . . . . 0.0 109.638 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.8 m -105.15 160.23 15.23 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.467 1.107 . . . . 0.0 110.458 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.0 p -62.63 77.39 0.02 OUTLIER 'General case' 0 C--N 1.364 1.219 0 C-N-CA 124.385 1.074 . . . . 0.0 110.542 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -178.97 -61.78 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.726 -169.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -58.55 -23.96 59.62 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.963 -165.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -119.21 -16.23 9.09 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -111.68 13.11 21.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.907 0.483 . . . . 0.0 112.186 -168.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.456 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.0 t -106.15 143.04 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 171.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.493 ' HG ' HG23 ' A' ' 23' ' ' ILE . 3.5 mm? -54.67 -42.54 71.48 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.212 1.405 . . . . 0.0 114.094 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.1 pttt -68.38 -39.84 81.6 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 117.712 0.233 . . . . 0.0 111.393 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.24 -44.06 69.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.4 0.68 . . . . 0.0 110.368 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.6 tp -58.17 -52.94 63.46 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.553 1.141 . . . . 0.0 109.896 177.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.19 72.19 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.939 0.895 . . . . 0.0 112.334 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.61 -50.42 58.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -53.95 -48.08 70.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.225 1.01 . . . . 0.0 111.403 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.467 HG23 HD13 ' A' ' 53' ' ' ILE . 96.7 mt -58.21 -53.28 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.435 1.094 . . . . 0.0 110.4 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -62.64 -33.24 74.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.01 0.924 . . . . 0.0 112.384 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -64.4 -42.2 96.24 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.287 0.635 . . . . 0.0 110.427 174.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.5 -39.36 77.66 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.58 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 84' ' ' ILE . 87.5 t -66.36 -39.44 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.835 0.854 . . . . 0.0 110.278 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.65 -37.57 88.05 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.307 173.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.67 73.71 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.832 0.853 . . . . 0.0 111.534 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -85.84 -33.0 21.43 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.899 0.381 . . . . 0.0 110.85 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.11 -11.01 84.89 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.793 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 58.97 43.09 18.3 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-O 122.21 1.005 . . . . 0.0 110.44 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.7 mt -83.39 22.92 0.97 Allowed 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.667 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -71.84 77.62 0.88 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.869 1.268 . . . . 0.0 109.942 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -161.69 -33.14 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.994 1.318 . . . . 0.0 108.363 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -91.94 124.4 36.02 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 164.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -129.93 3.83 4.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.052 0.541 . . . . 0.0 109.83 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 63.29 -175.76 0.15 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.688 1.195 . . . . 0.0 109.58 -159.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 72.95 -65.3 0.36 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.463 1.105 . . . . 0.0 111.979 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 . . . . . 0 CA--C 1.556 1.174 0 C-N-CA 124.802 1.241 . . . . 0.0 110.948 175.449 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 p -128.86 92.21 3.36 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.75 0.82 . . . . 0.0 109.42 176.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -90.82 -169.44 2.37 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.694 0.798 . . . . 0.0 110.202 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 8' ' ' VAL . 58.3 m -54.24 -46.68 72.64 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.609 0.764 . . . . 0.0 111.363 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -56.28 -46.9 79.53 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.266 0.627 . . . . 0.0 111.499 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.29 -46.17 86.58 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.559 0.537 . . . . 0.0 110.859 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -60.71 -45.33 94.61 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.24 0.963 . . . . 0.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 4' ' ' THR . 88.5 t -67.37 -41.01 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.579 0.752 . . . . 0.0 110.288 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.2 99.24 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.902 0.881 . . . . 0.0 111.113 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 84.5 m -62.73 -47.57 82.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.092 0.957 . . . . 0.0 111.255 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 47' ' ' ILE . 88.2 mt -61.04 -50.05 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.318 0.647 . . . . 0.0 111.188 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.455 HD12 HD11 ' A' ' 77' ' ' LEU . 56.6 mt -57.78 -48.95 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.061 0.544 . . . . 0.0 110.225 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.83 -51.24 30.55 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.64 1.176 . . . . 0.0 112.589 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.29 -32.47 73.21 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.796 0.838 . . . . 0.0 111.962 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 m -89.39 -19.06 25.66 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 122.82 0.448 . . . . 0.0 111.766 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.431 ' SG ' HD13 ' A' ' 43' ' ' ILE . 67.0 m -115.17 -9.49 12.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -168.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 60.1 53.49 4.53 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.223 1.009 . . . . 0.0 111.566 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.51 HD12 HD11 ' A' ' 23' ' ' ILE . 21.7 pt -137.32 149.73 66.62 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 123.268 0.627 . . . . 0.0 110.246 -176.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.62 115.17 4.22 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.69 2.26 . . . . 0.0 111.888 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.412 ' HA ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -60.59 -16.45 38.22 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -173.632 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.34 -27.32 62.34 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.647 0.779 . . . . 0.0 111.303 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 p -90.84 -2.17 57.78 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.173 0.589 . . . . 0.0 110.604 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 18' ' ' ILE . 1.7 mp -88.17 97.86 7.13 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.9 p -89.51 160.1 42.66 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.062 0.945 . . . . 0.0 110.757 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.13 -26.43 75.81 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.68 2.253 . . . . 0.0 113.044 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.25 1.53 52.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.972 0.509 . . . . 0.0 110.963 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.1 t -77.94 131.33 37.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.126 0.57 . . . . 0.0 109.917 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.403 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 58.0 t-80 -87.14 123.59 32.35 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.447 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -49.12 -39.71 29.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.314 1.046 . . . . 0.0 113.094 175.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 54.5 mt -91.84 -51.16 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -77.4 -33.45 55.03 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.597 0.759 . . . . 0.0 112.266 -168.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -100.77 -55.52 2.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.983 0.513 . . . . 0.0 110.792 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 29' ' ' ALA . 65.4 mt -75.06 -6.93 52.09 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.596 0.358 . . . . 0.0 111.893 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.03 33.41 74.39 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.394 0.434 . . . . 0.0 113.816 172.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.448 HG21 HD12 ' A' ' 43' ' ' ILE . 78.3 mt -99.69 121.47 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.614 0.765 . . . . 0.0 108.977 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.59 160.05 33.23 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.681 0.392 . . . . 0.0 110.195 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.2 m -58.51 -44.11 89.37 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.5 0.72 . . . . 0.0 111.857 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 39' ' ' ASP . 3.8 pp -71.94 -30.98 65.88 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.127 0.489 . . . . 0.0 110.33 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.435 ' N ' HD12 ' A' ' 38' ' ' LEU . 18.7 t70 -70.22 -37.06 74.94 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.6 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -74.82 -21.84 59.06 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.271 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.625 HD23 HD12 ' A' ' 57' ' ' LEU . 96.1 mt -56.13 -45.11 79.66 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 122.942 0.497 . . . . 0.0 111.328 173.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -66.0 -39.44 90.29 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.729 0.812 . . . . 0.0 110.775 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.448 HD12 HG21 ' A' ' 35' ' ' ILE . 34.9 mt -68.26 -39.32 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.305 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.77 -28.51 60.77 Favored 'General case' 0 C--O 1.209 -1.033 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.66 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -63.55 -41.36 98.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.752 0.821 . . . . 0.0 110.023 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.98 92.76 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.899 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.437 ' HA ' HD13 ' A' ' 11' ' ' ILE . 80.6 mt -72.93 -48.08 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.71 0.804 . . . . 0.0 110.562 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -46.6 -55.45 7.63 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.958 1.703 . . . . 0.0 111.055 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -73.3 -36.06 66.21 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.359 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.45 -37.41 86.8 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.118 0.567 . . . . 0.0 112.342 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -93.28 -6.04 48.42 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.627 0.771 . . . . 0.0 112.087 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.63 34.3 88.04 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.316 0.385 . . . . 0.0 113.234 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.4 pt -121.14 171.09 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.526 1.13 . . . . 0.0 109.573 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -106.99 100.81 10.29 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.576 HD21 HG12 ' A' ' 84' ' ' ILE . 69.6 mt -73.21 117.87 63.89 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 169.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.424 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 3.3 Cg_exo -77.74 50.38 3.23 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.897 2.398 . . . . 0.0 111.318 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.625 HD12 HD23 ' A' ' 41' ' ' LEU . 1.4 tm? -64.33 -43.17 95.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.775 0.83 . . . . 0.0 109.801 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.01 -36.18 82.7 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.888 0.742 . . . . 0.0 110.1 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 85.1 tttt -71.75 -38.56 70.39 Favored 'General case' 0 C--O 1.211 -0.962 0 O-C-N 123.533 0.521 . . . . 0.0 109.752 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.424 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 50.1 m0 -64.56 -33.47 75.99 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.889 0.876 . . . . 0.0 110.866 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.6 m -63.8 -43.48 96.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.477 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -71.63 -31.51 66.95 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.837 0.855 . . . . 0.0 110.998 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 17.8 mm-40 -59.71 -53.89 52.7 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.607 0.763 . . . . 0.0 110.273 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.5 t -61.19 -37.31 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.413 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -61.89 -43.11 99.51 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.593 0.757 . . . . 0.0 111.752 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -88.39 2.16 53.21 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.159 0.584 . . . . 0.0 111.266 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.87 17.96 73.87 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 115.109 0.803 . . . . 0.0 115.109 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -60.4 -40.99 92.94 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.59 0.756 . . . . 0.0 110.169 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.23 174.14 14.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.442 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.0 p -106.45 164.67 11.86 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.645 0.778 . . . . 0.0 109.969 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.4 p -59.11 -50.3 74.57 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.415 0.686 . . . . 0.0 112.759 -168.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.8 pm0 -50.18 -38.44 39.76 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -172.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -55.67 -27.23 48.89 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.443 1.097 . . . . 0.0 112.903 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -117.42 -27.97 6.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.335 0.654 . . . . 0.0 111.647 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -111.3 20.58 17.18 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.071 0.548 . . . . 0.0 112.218 -167.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.467 HG12 ' HG2' ' A' ' 78' ' ' LYS . 51.9 t -107.4 141.39 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 164.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.455 HD11 HD12 ' A' ' 12' ' ' ILE . 4.4 mm? -55.19 -39.17 69.28 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -171.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.8 pttt -65.43 -40.96 93.96 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.098 0.475 . . . . 0.0 110.422 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 92.7 m-20 -77.19 -45.62 26.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.677 1.191 . . . . 0.0 110.34 -173.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.94 -53.21 60.92 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 125.195 1.398 . . . . 0.0 109.782 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.49 -26.7 68.55 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.166 0.586 . . . . 0.0 111.633 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.69 -45.67 71.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.06 0.544 . . . . 0.0 110.369 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 3.5 mmp_? -58.76 -49.56 77.18 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.089 0.556 . . . . 0.0 109.838 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.576 HG12 HD21 ' A' ' 55' ' ' LEU . 83.5 mt -61.19 -52.88 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.59 -176.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.64 -44.27 85.47 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.718 0.807 . . . . 0.0 111.52 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -71.3 -30.15 65.9 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.765 0.666 . . . . 0.0 111.436 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 81.8 mt -68.55 -41.82 79.26 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 117.968 0.349 . . . . 0.0 110.577 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 84' ' ' ILE . 39.4 t -69.43 -30.73 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.82 -36.04 57.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.75 0.82 . . . . 0.0 111.446 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.35 -37.19 84.76 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.773 0.829 . . . . 0.0 110.674 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -85.5 -20.86 29.05 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.662 ' HA2' ' HB2' ' A' ' 95' ' ' GLU . . . -71.57 -10.25 70.68 Favored Glycine 0 C--N 1.353 1.504 0 C-N-CA 123.762 0.696 . . . . 0.0 113.328 -177.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.59 84.1 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.671 0.748 . . . . 0.0 109.725 167.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.2 tp -89.27 -29.68 19.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.334 1.054 . . . . 0.0 110.84 176.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.662 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . 15.6 mm-40 -92.04 -158.08 0.56 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.85 0.86 . . . . 0.0 110.056 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -67.15 144.11 56.22 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.981 0.512 . . . . 0.0 110.436 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -83.51 120.7 26.25 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -65.12 163.24 15.36 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.02 0.528 . . . . 0.0 111.731 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -75.25 100.33 4.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.375 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -160.34 133.27 6.56 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.135 0.974 . . . . 0.0 109.068 172.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 . . . . . 0 C--O 1.253 1.263 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.514 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.2 m 49.03 30.79 2.99 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 125.099 1.36 . . . . 0.0 112.382 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.4 t -68.91 156.91 37.67 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 121.355 0.598 . . . . 0.0 111.994 -170.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.2 m -54.8 -44.97 74.25 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.766 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -53.7 -47.94 70.02 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.923 0.764 . . . . 0.0 111.211 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.44 -46.22 86.98 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.828 0.705 . . . . 0.0 110.185 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -69.09 -38.87 79.21 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.319 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.2 t -73.16 -37.96 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.621 0.768 . . . . 0.0 111.034 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.51 -32.36 73.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.065 0.946 . . . . 0.0 110.032 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 98.4 m -65.06 -48.17 74.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.162 170.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.0 mt -58.22 -47.37 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.726 0.41 . . . . 0.0 110.802 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.535 HD12 HD11 ' A' ' 77' ' ' LEU . 42.4 mt -57.47 -49.13 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.179 0.991 . . . . 0.0 110.819 175.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.23 -51.47 62.05 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.126 0.97 . . . . 0.0 113.085 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 10' ' ' THR . 14.0 mm-40 -73.73 -28.38 61.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.191 0.596 . . . . 0.0 111.933 -176.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 83.6 m -75.31 -50.72 15.14 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.942 0.497 . . . . 0.0 110.999 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -94.4 5.11 52.8 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.699 0.799 . . . . 0.0 112.454 -172.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.9 t70 48.85 64.8 1.56 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.912 1.285 . . . . 0.0 111.778 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 12' ' ' ILE . 22.9 pt -141.23 145.69 39.6 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 123.94 0.896 . . . . 0.0 109.424 -174.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.47 119.55 6.85 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.065 2.51 . . . . 0.0 112.283 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -50.06 -34.66 22.36 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.882 1.273 . . . . 0.0 111.976 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.01 -25.52 61.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.54 0.736 . . . . 0.0 111.904 -172.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -79.05 -11.71 60.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.804 0.442 . . . . 0.0 111.171 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mp -89.69 101.72 12.43 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 p -80.93 161.35 63.65 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.601 0.76 . . . . 0.0 109.891 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.26 -29.82 85.24 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.44 2.093 . . . . 0.0 112.402 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -105.03 20.14 19.37 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 122.931 0.492 . . . . 0.0 111.072 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.5 m -71.65 128.32 35.43 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -80.93 111.76 17.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.54 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.56 -37.79 8.53 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.439 1.096 . . . . 0.0 113.832 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 55.9 mt -91.34 -58.43 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.53 -46.0 42.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.036 0.934 . . . . 0.0 112.242 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -81.54 -56.46 4.01 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.325 0.65 . . . . 0.0 109.698 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 29' ' ' ALA . 88.4 mt -74.37 -12.77 60.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.233 0.613 . . . . 0.0 111.922 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.3 33.58 82.87 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 113.42 0.128 . . . . 0.0 113.42 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 82.3 mt -104.05 117.17 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.79 156.25 39.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.0 p -58.88 -29.68 67.18 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.936 0.894 . . . . 0.0 111.887 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 39' ' ' ASP . 4.4 pp -71.96 -31.26 66.13 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.144 0.497 . . . . 0.0 110.597 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.413 ' N ' HD12 ' A' ' 38' ' ' LEU . 16.0 t70 -81.91 -35.87 28.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.072 0.949 . . . . 0.0 109.483 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -68.63 -21.39 64.48 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.811 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.3 mt -51.39 -43.52 61.92 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.181 0.593 . . . . 0.0 111.245 171.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.0 -41.37 71.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.719 0.808 . . . . 0.0 111.136 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.462 HD13 HG12 ' A' ' 12' ' ' ILE . 57.3 mt -58.8 -47.79 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 123.449 0.468 . . . . 0.0 110.069 176.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 55' ' ' LEU . . . -71.84 -34.43 69.28 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.772 0.829 . . . . 0.0 110.523 -174.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -62.55 -37.88 87.88 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.614 0.766 . . . . 0.0 110.746 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.89 -40.08 72.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.945 0.498 . . . . 0.0 111.115 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.493 HG21 HD13 ' A' ' 84' ' ' ILE . 84.9 mt -63.07 -45.99 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.673 0.789 . . . . 0.0 110.228 176.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -50.67 -52.33 40.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.478 1.511 . . . . 0.0 110.75 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -69.95 -42.83 72.69 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.577 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.74 -49.78 73.68 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.589 0.756 . . . . 0.0 111.841 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.432 ' HB3' HG22 ' A' ' 88' ' ' VAL . 83.5 m-85 -86.32 -6.72 58.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.567 0.747 . . . . 0.0 111.182 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.44 29.77 73.11 Favored Glycine 0 C--N 1.356 1.659 0 O-C-N 123.432 0.457 . . . . 0.0 113.229 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.459 HG22 ' HG2' ' A' ' 91' ' ' LYS . 47.5 pt -113.23 174.62 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.261 1.024 . . . . 0.0 110.228 -175.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -113.32 108.58 17.44 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 169.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.552 HD21 HG12 ' A' ' 84' ' ' ILE . 60.0 mt -79.7 115.61 54.91 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.496 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 82.3 Cg_endo -76.85 54.68 4.62 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 122.211 1.941 . . . . 0.0 111.029 169.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.38 -40.16 95.56 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.387 1.075 . . . . 0.0 109.325 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.24 -40.02 84.62 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.282 175.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 27.1 tptp -71.76 -38.34 70.38 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.967 0.907 . . . . 0.0 110.702 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.496 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 54.6 m0 -65.02 -45.84 83.8 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.899 0.88 . . . . 0.0 110.555 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.7 m -64.42 -33.71 76.5 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.686 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -66.98 -38.89 86.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.05 0.54 . . . . 0.0 110.143 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 19.0 mm-40 -60.16 -41.39 92.7 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.123 0.569 . . . . 0.0 110.845 175.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.445 HG11 HG23 ' A' ' 71' ' ' THR . 59.2 t -64.04 -54.28 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.828 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -65.51 -30.84 71.65 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.53 0.732 . . . . 0.0 112.602 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -90.16 3.63 52.87 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.951 0.5 . . . . 0.0 111.109 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.94 13.16 69.15 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -75.39 -28.2 59.37 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.146 0.578 . . . . 0.0 111.384 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -153.85 171.29 19.18 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.38 0.672 . . . . 0.0 109.817 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.8 m -101.19 157.06 17.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.901 0.88 . . . . 0.0 109.284 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.445 HG23 HG11 ' A' ' 64' ' ' VAL . 13.5 p -52.8 -47.35 67.65 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.617 0.767 . . . . 0.0 111.546 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.479 ' HA ' HG23 ' A' ' 76' ' ' VAL . 12.9 pt-20 -47.11 -41.9 18.14 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -173.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -26.27 67.67 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.197 0.999 . . . . 0.0 111.583 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -113.9 -26.34 8.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.113 0.565 . . . . 0.0 112.423 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.5 23.75 11.04 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.307 0.643 . . . . 0.0 111.116 -164.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.479 HG23 ' HA ' ' A' ' 72' ' ' GLU . 55.0 t -107.3 132.22 55.34 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.338 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 162.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.535 HD11 HD12 ' A' ' 12' ' ' ILE . 3.7 mm? -49.8 -32.95 15.22 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.147 1.379 . . . . 0.0 114.693 -168.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.404 ' HG3' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -80.74 -38.17 29.18 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.732 0.413 . . . . 0.0 111.746 177.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 93.1 m-20 -70.13 -49.92 45.85 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.074 0.55 . . . . 0.0 109.738 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.2 tp -49.7 -50.51 43.54 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.085 1.754 . . . . 0.0 110.981 170.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.59 -36.82 74.6 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.653 0.596 . . . . 0.0 110.826 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.95 79.82 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.866 0.729 . . . . 0.0 111.023 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 5.6 mmp_? -56.36 -53.33 58.61 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.671 0.748 . . . . 0.0 110.438 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.552 HG12 HD21 ' A' ' 55' ' ' LEU . 66.7 mt -64.94 -45.42 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.41 -176.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.29 -41.44 93.41 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.269 1.028 . . . . 0.0 111.676 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -67.83 -35.13 78.05 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.817 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.0 -31.31 67.79 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.214 0.321 . . . . 0.0 111.227 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 84' ' ' ILE . 60.6 t -69.74 -40.27 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-O 121.262 0.553 . . . . 0.0 109.741 175.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.17 93.84 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.915 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.66 83.41 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.77 0.828 . . . . 0.0 111.469 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.459 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.77 -27.95 50.45 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.841 0.457 . . . . 0.0 110.291 -175.596 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.35 -34.08 30.13 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.904 0.752 . . . . 0.0 111.263 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.15 -21.46 50.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.636 0.774 . . . . 0.0 110.453 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.9 84.44 0.21 Allowed 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.814 0.845 . . . . 0.0 109.487 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.42 165.7 22.8 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.965 174.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 m80 60.43 26.95 16.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.248 0.619 . . . . 0.0 111.606 -172.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -81.27 -24.92 36.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.19 0.596 . . . . 0.0 110.145 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -71.83 80.29 0.88 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.775 0.83 . . . . 0.0 111.244 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -171.63 142.11 1.55 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.648 1.179 . . . . 0.0 109.126 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -169.91 -24.75 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.486 0.714 . . . . 0.0 110.759 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.715 0.806 . . . . 0.0 109.755 177.42 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' A' ' 6' ' ' ASP . 33.3 m -140.81 -58.63 0.51 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.288 0.635 . . . . 0.0 110.563 -172.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 6' ' ' ASP . 29.3 t -158.54 -176.05 5.67 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.762 0.825 . . . . 0.0 109.911 -169.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.0 m -59.94 -42.2 93.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.196 0.598 . . . . 0.0 110.18 172.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -56.17 -42.68 77.44 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.411 0.684 . . . . 0.0 111.623 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.519 ' HB2' ' HB ' ' A' ' 2' ' ' THR . 8.8 t70 -52.94 -51.39 61.53 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.675 0.79 . . . . 0.0 110.31 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 11' ' ' ILE . 37.8 mmt180 -64.7 -43.37 93.69 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.84 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.437 ' HA ' HD12 ' A' ' 11' ' ' ILE . 67.4 t -70.0 -36.45 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.941 0.896 . . . . 0.0 111.246 -175.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.02 -36.53 83.5 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.691 0.796 . . . . 0.0 110.309 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.5 m -66.04 -41.36 90.97 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.254 0.622 . . . . 0.0 111.175 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 7' ' ' ARG . 82.8 mt -56.85 -52.92 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.923 0.489 . . . . 0.0 110.353 174.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.557 HD12 HD11 ' A' ' 77' ' ' LEU . 39.9 mt -59.67 -44.62 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.8 0.84 . . . . 0.0 110.931 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.564 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -50.11 -63.24 1.18 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.415 1.086 . . . . 0.0 113.119 175.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.03 -25.15 66.93 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.722 -174.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.9 m -78.82 -46.64 18.26 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.468 0.707 . . . . 0.0 111.53 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.7 t -102.26 4.61 39.42 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.443 0.697 . . . . 0.0 111.867 -170.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 t70 48.1 76.76 0.11 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.264 1.426 . . . . 0.0 112.185 -170.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 13' ' ' ALA . 3.3 pt -147.4 141.61 15.97 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.536 1.134 . . . . 0.0 108.765 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.67 125.88 17.06 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.34 2.026 . . . . 0.0 110.741 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.583 ' HA ' HD13 ' A' ' 23' ' ' ILE . 2.2 ppt_? -70.23 -16.15 63.01 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -88.17 -1.76 58.2 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.979 0.512 . . . . 0.0 110.503 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.9 p -89.09 -17.77 28.61 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 117.743 0.247 . . . . 0.0 110.428 165.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.583 HD13 ' HA ' ' A' ' 20' ' ' ARG . 2.1 mp -80.51 111.89 17.81 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.1 p -90.25 158.94 43.03 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.607 0.763 . . . . 0.0 109.188 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.05 -19.52 66.42 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 121.974 1.783 . . . . 0.0 112.128 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.53 8.76 44.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.384 0.674 . . . . 0.0 110.495 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.0 m -70.89 124.87 25.35 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.417 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 64.6 t-80 -80.05 111.82 16.75 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 167.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.05 -36.49 29.29 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mt -93.53 -45.04 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 122.306 0.242 . . . . 0.0 110.871 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.93 -44.19 11.22 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.449 0.7 . . . . 0.0 111.796 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.98 -60.1 2.21 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.362 0.665 . . . . 0.0 109.984 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.82 -17.18 63.38 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.871 0.468 . . . . 0.0 111.543 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.31 37.36 90.68 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.576 0.548 . . . . 0.0 113.812 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.3 mt -93.59 114.67 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.61 156.41 38.16 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 m -57.91 -31.53 66.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.928 0.891 . . . . 0.0 112.637 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.57 -31.83 62.19 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.801 0.44 . . . . 0.0 111.253 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -75.1 -32.69 61.49 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.224 0.61 . . . . 0.0 110.01 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -71.42 -28.5 64.04 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.836 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.78 -41.85 87.64 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.75 0.42 . . . . 0.0 110.38 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.9 -44.18 81.47 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.12 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.417 HD13 HG12 ' A' ' 12' ' ' ILE . 58.6 mt -65.27 -46.14 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 122.855 0.462 . . . . 0.0 110.805 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.56 76.36 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.182 0.593 . . . . 0.0 110.549 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -73.43 -25.25 60.44 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.747 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.7 -41.15 72.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.503 0.321 . . . . 0.0 110.324 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.85 -44.5 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.135 0.974 . . . . 0.0 110.218 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -51.47 -48.15 62.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.5 1.52 . . . . 0.0 110.647 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.14 -50.07 65.25 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.19 175.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.44 -51.49 66.75 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.008 0.923 . . . . 0.0 113.253 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -89.45 -6.56 56.4 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.513 0.725 . . . . 0.0 111.683 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.81 39.83 95.32 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-O 121.189 0.327 . . . . 0.0 112.534 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.478 HG22 ' HG2' ' A' ' 91' ' ' LYS . 41.8 pt -122.61 169.64 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.41 1.084 . . . . 0.0 109.493 -175.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -107.45 120.88 43.41 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.403 HD22 ' HH2' ' A' ' 60' ' ' TRP . 57.1 mt -90.26 113.61 58.0 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.81 57.1 3.7 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.446 2.764 . . . . 0.0 111.292 171.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.5 -38.68 90.82 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.227 1.011 . . . . 0.0 110.259 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 8.4 pt-20 -58.97 -45.74 89.8 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 124.01 0.819 . . . . 0.0 110.985 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -63.67 -48.23 78.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.814 0.846 . . . . 0.0 109.86 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.416 ' O ' HG23 ' A' ' 64' ' ' VAL . 48.2 m0 -53.69 -44.53 69.83 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.366 1.041 . . . . 0.0 110.744 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.1 m -64.42 -45.6 86.86 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.047 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 13.7 mm100 -68.79 -37.51 79.32 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.6 0.36 . . . . 0.0 110.872 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -57.64 -48.06 80.51 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.155 0.982 . . . . 0.0 110.374 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.513 HG11 HG23 ' A' ' 71' ' ' THR . 78.8 t -59.24 -46.73 92.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.304 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -61.06 -37.11 81.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.917 0.487 . . . . 0.0 111.551 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.6 6.15 39.53 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.892 0.877 . . . . 0.0 112.115 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.53 20.85 74.15 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.68 -23.4 45.67 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.317 0.647 . . . . 0.0 110.196 171.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.0 175.07 14.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.176 0.99 . . . . 0.0 109.742 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.8 m -111.57 156.63 21.46 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.513 HG23 HG11 ' A' ' 64' ' ' VAL . 4.6 p -51.28 -40.91 59.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.3 mp0 -47.82 -46.98 31.41 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.574 0.75 . . . . 0.0 112.426 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -26.4 62.64 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.243 1.017 . . . . 0.0 113.049 -172.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -117.81 -21.29 8.49 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -119.28 20.72 12.49 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.195 0.598 . . . . 0.0 111.819 -166.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.523 HG12 ' HG2' ' A' ' 78' ' ' LYS . 30.8 t -102.75 139.98 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 163.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.557 HD11 HD12 ' A' ' 12' ' ' ILE . 3.5 mm? -53.99 -37.21 63.77 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.146 1.379 . . . . 0.0 114.304 -168.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HG2' HG12 ' A' ' 76' ' ' VAL . 57.0 pttt -71.86 -37.14 70.28 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.661 0.384 . . . . 0.0 111.294 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -79.26 -35.24 41.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.714 0.806 . . . . 0.0 110.49 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.93 -52.48 59.62 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.568 1.147 . . . . 0.0 108.445 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.24 69.8 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.019 0.824 . . . . 0.0 111.508 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.84 -54.13 30.83 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.531 0.519 . . . . 0.0 109.751 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -50.66 -50.04 55.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.247 0.967 . . . . 0.0 111.111 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.508 ' O ' HG23 ' A' ' 88' ' ' VAL . 72.2 mt -61.34 -48.33 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.122 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.96 -39.71 94.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.912 0.885 . . . . 0.0 111.625 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.37 -40.62 97.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.01 0.924 . . . . 0.0 109.849 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.6 mt -72.89 -28.64 62.6 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.815 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 84' ' ' ILE . 80.2 t -67.86 -37.83 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 123.311 0.644 . . . . 0.0 109.796 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.56 80.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.404 0.682 . . . . 0.0 110.712 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.76 -38.77 80.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.506 0.722 . . . . 0.0 111.255 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.478 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.06 -21.68 33.7 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.17 8.67 23.09 Favored Glycine 0 C--N 1.352 1.46 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.982 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.68 -21.45 40.28 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.406 0.683 . . . . 0.0 111.329 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.86 -169.54 0.91 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.331 1.053 . . . . 0.0 110.829 171.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -60.38 120.42 9.84 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.664 0.786 . . . . 0.0 112.544 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -75.29 164.07 26.83 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.602 0.761 . . . . 0.0 110.448 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 57.3 52.62 8.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.569 1.148 . . . . 0.0 108.971 -172.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -57.78 117.46 4.27 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.385 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -56.15 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.674 1.233 . . . . 0.0 112.309 -165.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 176.06 -33.51 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.648 1.579 . . . . 0.0 108.911 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 CA--C 1.552 1.054 0 C-N-CA 123.799 0.839 . . . . 0.0 110.199 -179.284 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptm . . . . . 0 N--CA 1.481 1.075 0 CA-C-O 120.526 0.203 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.3 t -87.58 163.05 16.83 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.491 0.717 . . . . 0.0 110.291 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.438 ' H ' ' HB3' ' A' ' 6' ' ' ASP . 69.3 m -154.78 178.77 9.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.734 1.214 . . . . 0.0 109.698 -177.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 8' ' ' VAL . 30.7 m -58.97 -59.22 5.81 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.061 0.545 . . . . 0.0 111.188 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.35 -44.43 92.68 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.915 0.486 . . . . 0.0 111.077 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 3' ' ' SER . 27.0 t70 -54.34 -41.04 68.62 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.934 0.771 . . . . 0.0 111.388 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 11' ' ' ILE . 82.6 mtp180 -74.22 -34.24 63.64 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.795 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 4' ' ' THR . 52.8 t -70.21 -36.31 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 118.733 0.697 . . . . 0.0 109.593 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.98 90.43 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.264 1.026 . . . . 0.0 110.749 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 m -61.69 -51.15 69.62 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 123.812 0.695 . . . . 0.0 110.863 173.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 7' ' ' ARG . 96.8 mt -55.7 -51.52 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.431 1.092 . . . . 0.0 111.616 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.53 HD12 HD11 ' A' ' 77' ' ' LEU . 35.6 mt -60.71 -46.35 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.514 0.726 . . . . 0.0 111.016 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.567 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -51.78 -48.31 63.82 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.006 0.816 . . . . 0.0 112.596 175.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.91 -37.04 81.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.711 0.805 . . . . 0.0 112.031 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.8 m -68.44 -54.53 16.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.09 0.556 . . . . 0.0 110.66 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.6 m -91.78 7.49 41.55 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.885 0.874 . . . . 0.0 112.514 -173.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 39.52 74.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.009 1.324 . . . . 0.0 112.469 -170.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.567 HG13 ' HA ' ' A' ' 13' ' ' ALA . 13.8 pt -140.18 142.52 30.34 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.995 1.318 . . . . 0.0 107.838 -177.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.29 131.17 41.43 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.423 2.082 . . . . 0.0 112.322 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -36.38 -42.1 0.31 Allowed 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 126.69 1.996 . . . . 0.0 113.939 176.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.14 -28.98 66.93 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.819 0.848 . . . . 0.0 112.001 -170.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 p -79.36 -4.04 49.06 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.54 97.2 5.96 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.7 p -88.46 162.18 40.31 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.692 0.797 . . . . 0.0 110.213 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.39 -26.76 79.01 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.706 2.271 . . . . 0.0 113.502 176.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.74 5.54 50.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.842 0.857 . . . . 0.0 111.442 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -68.67 120.99 15.54 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.437 0.295 . . . . 0.0 110.305 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -84.36 123.4 30.15 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 167.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -40.27 -50.04 2.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.773 1.229 . . . . 0.0 113.147 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -90.81 -51.34 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.229 0.538 . . . . 0.0 109.908 -169.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.89 -39.57 66.29 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.247 1.019 . . . . 0.0 112.479 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.84 -64.53 1.04 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.365 0.666 . . . . 0.0 110.08 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.47 HD13 HG21 ' A' ' 12' ' ' ILE . 73.2 mt -73.9 -17.6 61.01 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.609 0.763 . . . . 0.0 112.216 -174.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.98 34.33 76.5 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 123.083 0.239 . . . . 0.0 113.651 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.416 HG23 ' HB2' ' A' ' 39' ' ' ASP . 92.5 mt -82.62 139.96 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.574 1.15 . . . . 0.0 109.277 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -92.53 162.16 14.32 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.9 m -54.33 -36.98 64.35 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.317 1.047 . . . . 0.0 112.083 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.38 -40.62 77.3 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.859 0.463 . . . . 0.0 110.364 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.416 ' HB2' HG23 ' A' ' 35' ' ' ILE . 47.4 m-20 -68.63 -35.45 77.31 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.387 0.675 . . . . 0.0 110.459 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.46 -32.71 74.25 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.8 0.687 . . . . 0.0 110.528 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.0 mt -61.21 -42.63 98.94 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.055 0.542 . . . . 0.0 111.255 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -66.97 -42.57 84.91 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.099 0.56 . . . . 0.0 110.723 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.464 HD13 HG12 ' A' ' 12' ' ' ILE . 97.2 mt -57.29 -47.36 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.225 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.13 -38.49 75.56 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.291 -173.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -61.48 -42.56 98.97 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.0 0.92 . . . . 0.0 110.9 174.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.94 -29.26 66.36 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.15 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.473 HD13 HD11 ' A' ' 84' ' ' ILE . 90.3 mt -65.83 -43.52 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.467 0.707 . . . . 0.0 110.307 173.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -58.67 -41.26 85.73 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.425 0.453 . . . . 0.0 110.913 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -69.07 -54.06 17.05 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.556 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.17 -52.8 64.14 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.128 0.971 . . . . 0.0 112.871 -176.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -89.8 -6.75 55.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.843 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.71 31.81 73.65 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.5 0.5 . . . . 0.0 113.448 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.439 HG22 ' HD3' ' A' ' 91' ' ' LYS . 41.3 pt -118.22 -178.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.561 0.745 . . . . 0.0 112.116 -172.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -126.56 106.52 9.49 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.354 1.462 . . . . 0.0 107.489 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.464 HD21 HG12 ' A' ' 84' ' ' ILE . 91.3 mt -72.8 125.99 90.88 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -74.98 60.47 5.43 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.778 2.318 . . . . 0.0 109.634 163.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -40.26 91.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.134 1.374 . . . . 0.0 109.253 -171.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.81 -42.23 92.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.693 0.797 . . . . 0.0 111.012 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -62.75 -47.5 83.29 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.477 1.111 . . . . 0.0 110.031 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -60.07 -44.87 94.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.948 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -65.99 -36.74 84.12 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.9 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -68.66 -37.46 79.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.033 0.533 . . . . 0.0 110.988 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.58 -38.98 92.88 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.546 0.738 . . . . 0.0 111.264 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.9 t -65.51 -49.88 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.457 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -60.47 -32.06 71.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.182 0.993 . . . . 0.0 112.297 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -93.8 0.49 56.31 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.745 0.818 . . . . 0.0 111.871 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.82 16.92 66.7 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.46 -33.73 76.55 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 117.576 0.688 . . . . 0.0 110.156 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.87 166.38 28.69 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.012 0.925 . . . . 0.0 108.967 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 75.2 p -86.37 164.0 17.31 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 122.749 0.42 . . . . 0.0 110.052 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.7 p -54.2 -49.1 70.15 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.151 0.58 . . . . 0.0 109.632 172.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.508 ' HA ' HG23 ' A' ' 76' ' ' VAL . 28.6 mt-10 -43.35 -47.19 6.72 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.955 1.702 . . . . 0.0 113.52 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.402 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 12.0 mm-40 -53.68 -28.95 36.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.99 0.916 . . . . 0.0 113.467 -176.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -121.13 -21.05 6.56 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -110.71 15.81 21.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.47 0.708 . . . . 0.0 110.966 -169.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 72' ' ' GLU . 91.3 t -108.21 139.8 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.53 HD11 HD12 ' A' ' 12' ' ' ILE . 3.6 mm? -54.26 -40.11 67.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.338 1.455 . . . . 0.0 114.108 -172.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.468 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.1 pttt -65.2 -42.02 93.95 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.437 0.461 . . . . 0.0 110.82 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.14 -39.49 40.93 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.537 1.135 . . . . 0.0 111.021 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.2 -49.94 72.24 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.267 1.027 . . . . 0.0 109.248 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.2 -34.68 78.63 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.564 0.746 . . . . 0.0 111.405 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.76 90.05 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.57 0.544 . . . . 0.0 110.505 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.483 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -58.7 -48.86 79.69 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.301 0.641 . . . . 0.0 111.267 175.544 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.473 HD11 HD13 ' A' ' 47' ' ' ILE . 91.2 mt -59.63 -43.02 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.654 1.182 . . . . 0.0 110.292 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.37 -45.38 91.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 110.912 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.39 -33.3 72.82 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.463 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 62.5 mt -70.99 -36.39 72.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.078 0.551 . . . . 0.0 111.742 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 84' ' ' ILE . 94.8 t -64.94 -41.81 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-O 121.657 0.741 . . . . 0.0 109.499 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.94 75.84 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.733 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.7 94.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.147 0.979 . . . . 0.0 112.076 -176.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.439 ' HD3' HG22 ' A' ' 53' ' ' ILE . 60.1 pttt -70.15 -27.22 64.37 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.431 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.91 -27.65 64.22 Favored Glycine 0 C--N 1.362 1.989 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.3 -82.76 0.02 OUTLIER 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.59 1.556 . . . . 0.0 111.293 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -156.31 89.57 1.13 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.69 -94.03 0.49 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 168.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -155.1 177.59 11.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.633 1.173 . . . . 0.0 109.314 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 72.9 m80 69.67 -75.82 0.07 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.49 1.516 . . . . 0.0 111.387 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 72.54 -61.0 0.51 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 126.124 1.769 . . . . 0.0 109.821 -173.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -130.81 -66.34 0.76 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 167.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -167.89 104.2 0.48 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 18.8 t60 . . . . . 0 C--O 1.248 1.005 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.925 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.4 mtp . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.0 m -139.92 86.09 2.07 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.0 t -82.96 -173.5 4.74 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.873 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' HG23 ' A' ' 8' ' ' VAL . 65.2 m -50.36 -53.17 31.02 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.295 1.038 . . . . 0.0 111.944 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -56.76 -42.16 78.85 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.315 0.646 . . . . 0.0 112.013 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.63 -42.19 92.17 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.973 0.509 . . . . 0.0 110.662 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -61.7 -46.3 90.27 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.643 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 4' ' ' THR . 99.5 t -70.0 -38.93 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.113 0.965 . . . . 0.0 111.191 -173.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.2 96.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.98 0.912 . . . . 0.0 110.028 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -63.62 -44.89 92.61 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 111.308 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.49 -51.7 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.394 0.678 . . . . 0.0 110.815 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.587 HG12 HG21 ' A' ' 43' ' ' ILE . 38.7 mt -57.72 -52.83 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.487 0.715 . . . . 0.0 110.664 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.78 -54.93 8.74 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.914 1.286 . . . . 0.0 113.01 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.59 -22.86 60.92 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.255 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.8 m -88.13 -25.64 22.88 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.78 0.432 . . . . 0.0 111.786 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.5 t -113.23 -1.4 14.33 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.91 0.484 . . . . 0.0 111.823 -167.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.31 50.47 7.76 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.191 0.996 . . . . 0.0 111.571 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.554 HD12 HD11 ' A' ' 23' ' ' ILE . 16.3 pt -138.17 156.09 73.99 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 123.761 0.825 . . . . 0.0 109.987 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.77 131.15 16.71 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.591 2.194 . . . . 0.0 110.73 172.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HA ' HD13 ' A' ' 23' ' ' ILE . 6.5 ppt_? -68.22 -16.22 63.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.729 0.412 . . . . 0.0 111.312 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.26 -20.63 54.86 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 123.538 0.735 . . . . 0.0 110.487 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -92.05 10.34 29.54 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.083 0.553 . . . . 0.0 110.421 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.554 HD11 HD12 ' A' ' 18' ' ' ILE . 1.9 mp -104.92 127.28 59.56 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 168.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.1 p -121.87 158.22 55.3 Favored Pre-proline 0 N--CA 1.484 1.225 0 C-N-CA 123.981 0.912 . . . . 0.0 109.668 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.53 -32.7 35.93 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.788 2.325 . . . . 0.0 113.399 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.84 -5.87 56.43 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.941 -0.474 . . . . 0.0 111.429 -173.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.8 p -77.19 132.87 38.98 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 122.541 0.336 . . . . 0.0 110.185 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -85.33 126.14 33.5 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 173.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.43 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.54 -39.6 11.21 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.083 0.953 . . . . 0.0 113.236 175.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.8 mt -96.57 -55.88 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -171.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.37 -43.84 80.41 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.506 0.723 . . . . 0.0 112.578 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -93.57 -57.23 2.64 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.868 0.467 . . . . 0.0 110.302 -172.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 29' ' ' ALA . 62.8 mt -78.91 -7.77 58.27 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.565 0.746 . . . . 0.0 112.44 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.04 25.07 72.0 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 114.443 0.537 . . . . 0.0 114.443 174.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.32 121.56 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.787 0.835 . . . . 0.0 108.776 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.45 157.19 37.57 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 t -58.29 -35.13 71.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.741 0.817 . . . . 0.0 111.701 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 41' ' ' LEU . 4.5 pp -71.7 -30.92 66.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.517 0.327 . . . . 0.0 111.076 -177.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -73.24 -39.76 65.21 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.118 0.567 . . . . 0.0 109.91 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -69.88 -25.9 63.92 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.783 0.677 . . . . 0.0 110.89 -176.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.653 HD23 HD12 ' A' ' 57' ' ' LEU . 93.7 mt -56.83 -42.6 79.92 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.051 0.54 . . . . 0.0 110.615 170.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -75.14 -40.95 59.3 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.064 0.946 . . . . 0.0 110.627 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.587 HG21 HG12 ' A' ' 12' ' ' ILE . 57.0 mt -61.22 -43.61 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.227 0.537 . . . . 0.0 110.319 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 -33.29 63.0 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.963 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -62.69 -34.35 76.95 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.595 0.358 . . . . 0.0 110.347 172.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.95 -34.5 73.5 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.92 0.488 . . . . 0.0 110.8 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.12 -42.87 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.627 0.771 . . . . 0.0 110.35 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -53.08 -51.3 62.29 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.659 0.784 . . . . 0.0 110.635 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -63.46 -50.15 70.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.056 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.88 -48.76 77.61 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.737 0.815 . . . . 0.0 112.395 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -83.61 -10.21 58.39 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.513 0.725 . . . . 0.0 112.22 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.38 30.27 71.43 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.418 0.449 . . . . 0.0 112.988 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 pt -120.01 -176.18 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.022 1.329 . . . . 0.0 109.622 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -137.1 98.63 3.79 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD23 HD12 ' A' ' 87' ' ' LEU . 85.2 mt -64.01 123.64 82.66 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.5 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 98.2 Cg_endo -76.21 62.08 6.73 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 122.485 2.124 . . . . 0.0 110.587 170.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.653 HD12 HD23 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -62.44 -34.66 77.22 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.348 1.059 . . . . 0.0 109.14 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.52 -43.38 97.17 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.763 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 56.9 tptt -69.09 -39.71 78.84 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 123.632 0.773 . . . . 0.0 110.49 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.414 ' HH2' HD22 ' A' ' 55' ' ' LEU . 54.6 m0 -67.5 -39.84 85.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.494 0.718 . . . . 0.0 110.643 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -61.02 -39.37 89.47 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 124.078 0.861 . . . . 0.0 110.223 173.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -70.13 -43.98 69.84 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.201 1.0 . . . . 0.0 110.157 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.03 -46.81 88.29 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.566 1.147 . . . . 0.0 111.126 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 89.9 t -61.11 -40.0 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -67.92 -30.33 69.62 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.247 0.619 . . . . 0.0 111.767 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -85.04 -1.15 56.5 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.34 15.85 68.49 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 114.198 0.439 . . . . 0.0 114.198 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -72.6 -31.84 65.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.473 0.709 . . . . 0.0 110.779 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -149.07 166.27 29.23 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.756 0.822 . . . . 0.0 109.73 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.1 m -103.16 154.85 18.88 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.4 p -47.04 -49.08 21.94 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 124.209 1.003 . . . . 0.0 112.451 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.549 ' HA ' HG23 ' A' ' 76' ' ' VAL . 40.7 mt-10 -44.82 -42.63 8.04 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -56.46 -27.38 56.74 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.193 0.997 . . . . 0.0 112.818 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -121.7 -22.35 5.86 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.081 0.552 . . . . 0.0 112.037 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -114.7 14.49 17.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.462 0.705 . . . . 0.0 111.31 -167.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.549 HG23 ' HA ' ' A' ' 72' ' ' GLU . 53.5 t -107.78 137.03 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 165.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.492 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -55.3 -33.88 63.67 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -169.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.0 pttt -71.65 -44.41 64.35 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.559 0.344 . . . . 0.0 110.389 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 26.2 m120 -72.2 -38.02 69.13 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 123.608 0.763 . . . . 0.0 109.972 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.4 tp -62.5 -48.71 78.36 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 124.984 1.314 . . . . 0.0 109.454 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.31 -33.96 71.74 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.681 0.613 . . . . 0.0 111.146 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.86 -40.48 75.75 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.207 0.603 . . . . 0.0 111.426 175.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 13.6 mmp_? -60.59 -48.27 82.53 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.558 0.743 . . . . 0.0 110.867 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 88' ' ' VAL . 86.7 mt -63.22 -51.46 70.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.689 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.72 -39.55 94.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.441 0.696 . . . . 0.0 112.115 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.43 -37.79 83.55 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.34 0.4 . . . . 0.0 110.264 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.498 HD12 HD23 ' A' ' 55' ' ' LEU . 84.2 mt -71.03 -32.8 69.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.791 0.436 . . . . 0.0 111.534 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 84' ' ' ILE . 73.4 t -65.92 -43.37 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.321 0.581 . . . . 0.0 109.479 173.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.7 -45.9 87.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.163 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.82 89.29 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.318 1.047 . . . . 0.0 111.674 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -24.37 62.09 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.535 0.522 . . . . 0.0 110.283 -176.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.03 -17.06 52.83 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.65 5.17 51.97 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.775 0.83 . . . . 0.0 112.465 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.6 mt -69.35 165.05 21.54 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.342 0.657 . . . . 0.0 111.549 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 73.63 5.28 4.89 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.943 1.297 . . . . 0.0 112.0 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -97.27 -79.79 0.45 Allowed 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.487 -0.758 . . . . 0.0 110.485 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -147.26 -52.95 0.21 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.352 0.661 . . . . 0.0 110.887 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -155.8 -57.9 0.1 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.596 0.358 . . . . 0.0 110.532 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -164.78 -52.59 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 71.75 -15.66 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 126.822 2.049 . . . . 0.0 113.761 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 CA--C 1.552 1.034 0 CA-C-O 118.069 -0.967 . . . . 0.0 108.847 -176.238 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.401 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 21.4 m -76.19 80.86 2.99 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.718 0.77 . . . . 0.0 109.674 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.8 p -166.06 145.76 6.2 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.951 1.3 . . . . 0.0 107.698 -176.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 8' ' ' VAL . 17.9 m -54.34 -60.36 3.45 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -164.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.93 -45.39 90.52 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.765 0.426 . . . . 0.0 111.179 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.93 -42.86 90.78 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.261 0.624 . . . . 0.0 110.902 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.401 ' HE ' ' HA ' ' A' ' 2' ' ' THR . 10.9 mmt180 -65.87 -41.73 91.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.234 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 4' ' ' THR . 72.7 t -68.83 -40.57 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.436 0.695 . . . . 0.0 110.589 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.67 94.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.841 0.856 . . . . 0.0 110.817 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.8 m -66.41 -41.9 88.59 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.162 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.46 -47.02 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.313 0.645 . . . . 0.0 110.78 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 18' ' ' ILE . 42.9 mt -58.22 -46.72 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.559 0.743 . . . . 0.0 110.547 177.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.63 -51.28 65.89 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.031 0.933 . . . . 0.0 112.628 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -73.96 -31.37 62.99 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.2 m -74.45 -57.5 3.89 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.546 ' SG ' HD11 ' A' ' 43' ' ' ILE . 76.1 m -85.23 -5.79 59.3 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 60.0 66.43 0.98 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 122.002 0.906 . . . . 0.0 109.729 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 12' ' ' ILE . 12.5 pt -141.72 152.0 61.59 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.835 1.254 . . . . 0.0 108.56 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' O ' HG22 ' A' ' 22' ' ' THR . 37.9 Cg_endo -66.61 125.1 13.28 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.047 1.831 . . . . 0.0 111.334 175.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.545 ' HA ' HD13 ' A' ' 23' ' ' ILE . 58.6 ttt180 -53.44 -29.1 33.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.17 0.988 . . . . 0.0 112.565 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.1 pt-20 -65.88 -23.67 66.7 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.487 0.715 . . . . 0.0 112.155 -172.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 19' ' ' PRO . 9.3 t -88.11 2.49 51.89 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.705 0.402 . . . . 0.0 111.512 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.545 HD13 ' HA ' ' A' ' 20' ' ' ARG . 3.6 mp -102.0 94.15 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.6 p -88.52 163.76 34.87 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -62.45 -19.67 68.18 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.213 1.942 . . . . 0.0 113.131 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -95.85 3.86 53.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.761 0.424 . . . . 0.0 110.814 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -75.54 130.86 39.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.855 0.359 . . . . 0.0 110.093 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -85.59 122.69 30.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 168.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.73 -41.11 30.97 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.043 0.937 . . . . 0.0 112.817 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.4 mt -93.13 -53.23 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.06 -44.74 65.14 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.707 0.803 . . . . 0.0 111.787 -171.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -89.32 -59.86 2.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.93 0.492 . . . . 0.0 110.372 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 29' ' ' ALA . 71.1 mt -76.04 -10.9 59.79 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.815 0.846 . . . . 0.0 112.902 -171.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.29 33.04 85.65 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 123.316 0.385 . . . . 0.0 113.671 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 82.8 mt -94.13 122.57 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.14 157.88 32.59 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.198 0.599 . . . . 0.0 109.551 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.498 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 27.3 m -59.72 -27.56 66.57 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.444 0.697 . . . . 0.0 111.732 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.12 -40.85 64.59 Favored 'General case' 0 C--N 1.362 1.131 0 C-N-CA 122.928 0.491 . . . . 0.0 110.336 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.71 -36.18 81.87 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.238 0.615 . . . . 0.0 109.63 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -70.13 -27.88 64.92 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 123.762 0.664 . . . . 0.0 110.611 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.2 mt -61.88 -40.33 95.04 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.069 0.395 . . . . 0.0 110.235 173.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -71.84 -39.05 70.02 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 124.021 0.826 . . . . 0.0 110.677 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.546 HD11 ' SG ' ' A' ' 16' ' ' CYS . 77.4 mt -61.94 -47.41 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.114 0.565 . . . . 0.0 109.908 174.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.5 -34.38 72.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.797 0.839 . . . . 0.0 110.341 -173.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -69.01 -37.24 78.58 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.896 0.878 . . . . 0.0 110.721 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.88 -35.83 74.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.662 0.385 . . . . 0.0 110.751 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.411 HD11 HG13 ' A' ' 8' ' ' VAL . 96.5 mt -66.88 -46.24 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.033 0.933 . . . . 0.0 109.891 173.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -51.46 -51.12 57.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.363 1.465 . . . . 0.0 110.357 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -69.13 -47.23 65.62 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.863 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.45 92.87 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.408 0.683 . . . . 0.0 112.464 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.32 -4.43 58.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.548 0.739 . . . . 0.0 111.219 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.45 30.36 77.65 Favored Glycine 0 C--N 1.357 1.719 0 O-C-N 123.233 0.333 . . . . 0.0 113.465 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.3 pt -119.37 163.39 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.45 1.1 . . . . 0.0 109.68 -175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 123.19 42.4 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 164.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.457 HD21 HG12 ' A' ' 84' ' ' ILE . 54.0 mt -78.45 135.67 60.83 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 171.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.51 ' HD3' HD11 ' A' ' 87' ' ' LEU . 4.4 Cg_exo -79.18 44.16 1.64 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 123.302 2.668 . . . . 0.0 111.301 170.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -57.15 -38.4 73.47 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.528 1.131 . . . . 0.0 109.785 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -53.91 -51.49 63.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.985 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 49.9 tptt -66.35 -41.18 89.93 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.585 1.154 . . . . 0.0 110.888 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.429 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 52.2 m0 -59.94 -45.21 93.35 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.167 0.987 . . . . 0.0 110.58 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.7 m -63.62 -39.0 93.26 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.848 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -65.37 -39.51 92.37 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.185 0.594 . . . . 0.0 110.658 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 27.4 mm-40 -56.17 -48.49 76.22 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.215 0.606 . . . . 0.0 111.063 175.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.99 -41.46 89.8 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.124 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -60.0 -43.65 95.05 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.992 0.917 . . . . 0.0 111.785 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -83.01 6.17 19.71 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.41 19.39 64.39 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 114.494 0.558 . . . . 0.0 114.494 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -76.12 -59.47 2.75 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.927 0.891 . . . . 0.0 108.686 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.38 172.04 7.03 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.207 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 p -107.26 170.78 7.75 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.83 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.6 p -62.16 -46.19 90.08 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 119.537 -0.268 . . . . 0.0 110.701 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -53.07 -36.64 60.88 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.574 0.75 . . . . 0.0 112.932 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -25.98 58.83 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.491 1.116 . . . . 0.0 111.346 -175.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -128.96 -7.43 4.94 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -115.48 16.68 16.6 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.226 0.611 . . . . 0.0 111.244 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.459 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.3 t -103.16 141.33 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 166.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.442 HD11 HD12 ' A' ' 12' ' ' ILE . 4.1 mm? -53.61 -42.29 67.55 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.188 1.395 . . . . 0.0 114.246 -172.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.459 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.7 pttt -68.59 -40.05 80.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.826 0.45 . . . . 0.0 110.843 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.425 ' OD1' ' HG3' ' A' ' 78' ' ' LYS . 2.1 m-20 -68.36 -46.2 70.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.049 0.94 . . . . 0.0 109.853 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.4 tp -58.84 -50.47 73.86 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.01 1.324 . . . . 0.0 109.973 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.64 75.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.595 0.758 . . . . 0.0 111.749 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.33 68.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.721 0.408 . . . . 0.0 110.063 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -56.4 -48.24 77.32 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.784 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.457 HG12 HD21 ' A' ' 55' ' ' LEU . 90.3 mt -61.8 -51.36 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.532 1.133 . . . . 0.0 111.227 -175.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.83 -39.58 85.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.888 0.875 . . . . 0.0 111.34 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -63.73 -40.49 96.87 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.038 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.51 HD11 ' HD3' ' A' ' 56' ' ' PRO . 91.7 mt -67.34 -34.44 77.33 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.194 0.598 . . . . 0.0 111.492 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 84' ' ' ILE . 57.9 t -65.77 -42.28 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.18 -43.19 98.94 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.536 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.18 -39.67 89.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.097 0.959 . . . . 0.0 112.284 -177.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 41.3 pttt -74.83 -21.25 59.39 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.545 0.338 . . . . 0.0 110.117 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.0 -40.98 96.15 Favored Glycine 0 C--N 1.363 2.05 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.02 -175.47 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.453 1.101 . . . . 0.0 113.078 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.37 -28.86 59.68 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.517 172.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -150.45 95.54 2.26 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.27 0.628 . . . . 0.0 109.819 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -85.64 -43.64 13.27 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.681 0.792 . . . . 0.0 108.977 166.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -155.91 -58.18 0.1 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.421 1.088 . . . . 0.0 108.397 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -173.4 121.78 0.35 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -76.68 73.32 3.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.277 0.631 . . . . 0.0 111.741 -170.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -160.78 -57.63 0.05 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.261 1.824 . . . . 0.0 106.785 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 . . . . . 0 CA--C 1.562 1.408 0 C-N-CA 125.384 1.474 . . . . 0.0 111.616 178.802 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mtp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.9 p -75.81 77.37 2.74 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.909 0.883 . . . . 0.0 111.869 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.4 p -82.74 175.79 9.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.286 1.035 . . . . 0.0 108.656 169.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.588 HG21 ' HB2' ' A' ' 85' ' ' ASP . 24.2 m -58.53 -48.34 81.19 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.749 0.704 . . . . 0.0 110.446 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -58.51 -51.57 69.32 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.452 0.701 . . . . 0.0 111.559 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -58.85 -42.92 90.46 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.698 0.624 . . . . 0.0 111.076 -175.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 11' ' ' ILE . 92.1 mtt-85 -62.02 -46.81 87.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.691 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 4' ' ' THR . 53.8 t -64.33 -44.53 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.312 0.645 . . . . 0.0 110.367 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.99 85.11 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.231 1.012 . . . . 0.0 110.856 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.1 m -68.72 -41.33 79.19 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.466 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 7' ' ' ARG . 74.2 mt -60.61 -43.98 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.609 0.364 . . . . 0.0 110.766 176.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.617 HG22 HD11 ' A' ' 18' ' ' ILE . 56.2 mt -56.71 -47.48 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.463 0.705 . . . . 0.0 110.194 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . . . -56.75 -51.86 67.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.544 1.138 . . . . 0.0 113.376 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.64 -30.4 71.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.172 0.989 . . . . 0.0 111.865 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -82.81 -46.62 12.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.581 0.352 . . . . 0.0 111.087 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.7 t -93.3 -7.78 43.95 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.483 0.713 . . . . 0.0 112.182 -169.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 56.78 70.18 0.67 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.55 1.14 . . . . 0.0 111.574 -172.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.617 HD11 HG22 ' A' ' 12' ' ' ILE . 10.2 pt -143.75 152.0 54.76 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 125.143 1.377 . . . . 0.0 108.641 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.09 116.77 4.76 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 121.93 1.754 . . . . 0.0 111.709 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -62.93 -17.17 61.51 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.996 0.919 . . . . 0.0 113.034 -178.254 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.98 -27.18 60.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.329 0.651 . . . . 0.0 110.243 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -83.8 -5.57 59.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.096 0.558 . . . . 0.0 110.724 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 20' ' ' ARG . 1.9 mp -87.81 120.39 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.9 p -101.53 166.99 11.3 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.724 0.81 . . . . 0.0 109.427 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.14 -17.26 54.51 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 121.889 1.726 . . . . 0.0 112.763 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.66 0.27 49.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.572 0.349 . . . . 0.0 110.331 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -72.6 128.08 34.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.879 0.872 . . . . 0.0 110.109 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -87.3 117.11 25.85 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.518 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -55.16 -35.93 65.29 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -93.04 -44.85 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 121.392 0.615 . . . . 0.0 110.374 -170.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -94.88 -38.38 10.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.13 0.972 . . . . 0.0 111.593 -168.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.24 -50.8 5.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.833 0.453 . . . . 0.0 110.659 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 29' ' ' ALA . 88.8 mt -77.71 -14.59 59.57 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.417 0.687 . . . . 0.0 111.145 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.89 27.97 72.02 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.798 0.686 . . . . 0.0 114.255 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.488 HG21 HD12 ' A' ' 43' ' ' ILE . 89.3 mt -76.77 124.88 35.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.01 152.87 44.98 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.115 0.885 . . . . 0.0 109.805 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.2 m -66.31 -25.96 67.09 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.599 0.759 . . . . 0.0 112.278 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.77 -33.68 62.33 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.34 -42.44 59.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.734 0.814 . . . . 0.0 110.117 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -71.26 -21.95 62.03 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 123.593 0.558 . . . . 0.0 110.603 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.49 -47.14 86.65 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 170.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -71.55 -36.91 71.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.954 0.902 . . . . 0.0 111.437 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.488 HD12 HG21 ' A' ' 35' ' ' ILE . 52.8 mt -63.4 -50.24 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 123.636 0.585 . . . . 0.0 110.1 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.94 -33.42 72.1 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 123.782 0.676 . . . . 0.0 109.905 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.512 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 45.0 t80 -60.95 -40.84 94.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.401 1.081 . . . . 0.0 111.003 173.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.78 -35.88 59.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.626 0.37 . . . . 0.0 111.317 -178.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.412 HD13 HG13 ' A' ' 8' ' ' VAL . 92.6 mt -65.43 -43.05 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.543 0.737 . . . . 0.0 109.958 174.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 45' ' ' PHE . 9.8 t70 -50.69 -52.55 39.08 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.665 1.586 . . . . 0.0 110.692 177.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 57.8 mmtt -74.15 -35.66 64.06 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.259 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.03 -43.99 97.18 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.071 0.548 . . . . 0.0 111.812 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -93.01 -0.62 57.14 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.907 0.883 . . . . 0.0 111.556 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.13 43.61 96.94 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 123.754 0.659 . . . . 0.0 113.174 172.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 pt -135.53 173.57 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.245 1.418 . . . . 0.0 109.177 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -104.49 108.53 20.01 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 167.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD21 HG12 ' A' ' 84' ' ' ILE . 51.9 mt -68.74 121.77 82.41 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 167.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 93.5 Cg_endo -78.56 57.57 6.37 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.692 2.261 . . . . 0.0 111.682 176.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.99 -37.81 80.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.013 1.325 . . . . 0.0 109.589 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.37 -46.14 89.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.573 1.149 . . . . 0.0 111.264 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 22.1 tptm -68.88 -39.1 79.97 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.169 0.988 . . . . 0.0 111.102 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.445 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 54.5 m0 -62.51 -41.55 98.91 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.62 0.768 . . . . 0.0 109.886 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.9 m -63.01 -39.61 95.29 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.166 0.916 . . . . 0.0 110.498 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.38 -47.71 75.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.051 0.541 . . . . 0.0 110.654 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -58.17 -44.93 88.21 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.98 0.912 . . . . 0.0 112.288 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.9 t -67.5 -50.36 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 122.629 0.372 . . . . 0.0 111.072 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -67.56 -29.7 69.15 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.371 0.669 . . . . 0.0 112.689 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -94.09 5.2 52.47 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.486 0.714 . . . . 0.0 111.428 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.32 21.77 66.72 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 115.802 1.081 . . . . 0.0 115.802 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -79.57 -22.85 43.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.315 0.646 . . . . 0.0 110.88 173.44 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.04 177.57 9.47 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.738 1.215 . . . . 0.0 108.339 175.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.21 164.89 20.67 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.102 0.961 . . . . 0.0 109.073 173.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.0 p -54.93 -52.21 63.68 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.202 0.938 . . . . 0.0 113.107 -165.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -35.49 63.21 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -172.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -53.22 -27.93 24.45 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.229 1.012 . . . . 0.0 113.02 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -115.75 -31.28 5.86 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.398 0.679 . . . . 0.0 111.834 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -110.98 21.52 16.34 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.866 0.467 . . . . 0.0 112.033 -165.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.513 HG12 ' HG2' ' A' ' 78' ' ' LYS . 24.8 t -106.82 138.24 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 164.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.442 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -51.62 -37.87 52.13 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -170.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.513 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.8 pttt -69.32 -41.92 76.05 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.059 0.391 . . . . 0.0 110.619 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 76.0 m-20 -76.97 -33.79 57.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.422 1.089 . . . . 0.0 110.04 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -68.04 -54.03 21.35 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.287 1.435 . . . . 0.0 108.331 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.58 -31.01 69.06 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.1 0.875 . . . . 0.0 111.499 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 -52.37 53.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.883 0.473 . . . . 0.0 110.634 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 13.9 mmp_? -54.1 -49.9 68.08 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.233 0.613 . . . . 0.0 110.73 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.605 HG12 HD21 ' A' ' 55' ' ' LEU . 91.9 mt -57.5 -53.65 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 125.246 1.418 . . . . 0.0 110.948 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.588 ' HB2' HG21 ' A' ' 4' ' ' THR . 25.9 t70 -63.18 -34.78 78.39 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.781 0.832 . . . . 0.0 111.831 -176.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -68.15 -36.68 80.05 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.333 0.653 . . . . 0.0 111.128 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.4 mt -68.2 -37.95 81.45 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.867 0.467 . . . . 0.0 110.617 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.497 HG13 ' HE2' ' A' ' 91' ' ' LYS . 58.4 t -68.98 -32.33 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 CA-C-O 121.45 0.643 . . . . 0.0 109.783 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.469 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . . . -68.93 -40.84 78.81 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.378 173.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.69 92.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.239 1.016 . . . . 0.0 111.561 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.497 ' HE2' HG13 ' A' ' 88' ' ' VAL . 56.0 pttt -83.14 -14.75 52.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.524 0.329 . . . . 0.0 110.353 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.428 ' HA3' ' NE2' ' A' ' 99' ' ' HIS . . . -73.1 -24.33 75.95 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 172.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.37 -9.12 58.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.714 0.806 . . . . 0.0 111.385 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.419 ' HG ' ' HG3' ' A' ' 95' ' ' GLU . 31.5 tp -76.31 -76.22 0.17 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.575 0.75 . . . . 0.0 109.698 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.419 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -162.07 -26.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.204 1.002 . . . . 0.0 110.325 177.272 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -83.22 177.94 8.31 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.289 0.635 . . . . 0.0 110.091 168.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -121.56 -86.82 0.65 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.293 0.637 . . . . 0.0 109.658 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 55.0 22.43 4.39 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.167 1.387 . . . . 0.0 114.391 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.469 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 30.1 m170 -71.17 -11.52 60.98 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 67.76 -87.6 0.03 OUTLIER 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.322 1.049 . . . . 0.0 109.555 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 . . . . . 0 C--O 1.25 1.091 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -173.422 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 8' ' ' VAL . 88.3 m . . . . . 0 CA--C 1.542 0.636 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -52.81 -47.64 67.5 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.23 1.012 . . . . 0.0 110.834 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.97 -47.65 77.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 124.004 0.815 . . . . 0.0 111.645 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -66.07 -38.09 87.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.86 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.436 HG13 HD11 ' A' ' 47' ' ' ILE . 96.4 t -72.24 -37.48 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.177 0.591 . . . . 0.0 110.329 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.19 -35.46 80.88 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.104 0.962 . . . . 0.0 110.41 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 59.8 m -66.98 -44.66 79.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.926 173.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.4 -47.09 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.274 0.629 . . . . 0.0 110.896 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.575 HG12 HD13 ' A' ' 43' ' ' ILE . 36.6 mt -61.26 -44.28 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.385 1.074 . . . . 0.0 111.071 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.08 -48.14 64.84 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.015 0.926 . . . . 0.0 112.632 174.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 10' ' ' THR . 46.4 mt-10 -66.64 -32.39 73.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.945 0.898 . . . . 0.0 111.557 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.1 m -71.22 -58.4 3.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.382 0.673 . . . . 0.0 111.591 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.4 m -103.65 15.66 28.32 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -167.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 49.83 64.14 1.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.415 1.086 . . . . 0.0 112.051 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.9 pt -142.53 146.07 37.18 Favored Pre-proline 0 N--CA 1.481 1.122 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.688 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.97 125.55 14.36 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.31 2.006 . . . . 0.0 112.162 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -31.79 48.92 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.949 1.3 . . . . 0.0 113.03 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.39 -23.65 60.2 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.378 0.671 . . . . 0.0 111.226 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -84.7 -11.62 55.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.8 0.44 . . . . 0.0 110.933 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mp -83.62 111.84 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.5 p -94.93 161.52 28.14 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 123.41 0.684 . . . . 0.0 109.556 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.17 -25.41 64.08 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.358 2.039 . . . . 0.0 113.668 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.579 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 32.1 mt-10 -102.89 17.66 23.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.947 -0.47 . . . . 0.0 110.734 -175.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -78.38 129.62 35.17 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.263 0.625 . . . . 0.0 110.259 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.465 ' HE2' ' HB ' ' A' ' 71' ' ' THR . 64.3 t-80 -88.55 120.83 30.3 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.11 -41.98 27.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.355 1.062 . . . . 0.0 113.471 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.2 mt -93.22 -60.11 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -63.63 -46.44 85.66 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.207 1.003 . . . . 0.0 111.989 -174.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.7 -64.37 1.15 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.197 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 29' ' ' ALA . 86.1 mt -71.39 -17.6 62.4 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.635 0.774 . . . . 0.0 112.542 -173.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.38 30.57 64.49 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.169 0.293 . . . . 0.0 113.792 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.6 mt -101.98 123.04 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.43 1.092 . . . . 0.0 108.915 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.44 158.88 32.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.081 0.467 . . . . 0.0 110.713 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.2 p -64.46 -23.54 67.32 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.601 0.76 . . . . 0.0 112.222 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 pp -70.53 -39.56 73.98 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -68.03 -35.96 79.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.595 0.758 . . . . 0.0 109.461 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -65.56 -27.35 68.37 Favored 'General case' 0 CA--C 1.555 1.152 0 O-C-N 124.06 0.85 . . . . 0.0 111.264 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.425 HD23 HD12 ' A' ' 57' ' ' LEU . 92.5 mt -62.74 -45.38 93.01 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.061 0.544 . . . . 0.0 110.272 171.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -65.81 -40.12 91.55 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.989 0.916 . . . . 0.0 110.455 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.575 HD13 HG12 ' A' ' 12' ' ' ILE . 97.3 mt -60.83 -44.99 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.653 0.781 . . . . 0.0 109.784 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -68.95 -32.8 72.66 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.854 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -72.03 -31.44 66.18 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.361 1.064 . . . . 0.0 110.886 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.2 65.78 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.547 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.444 HD13 HD11 ' A' ' 84' ' ' ILE . 96.0 mt -68.09 -39.14 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 124.002 0.921 . . . . 0.0 110.362 172.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.44 -43.37 75.34 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.697 1.199 . . . . 0.0 110.134 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.08 -53.84 11.61 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.463 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.86 -56.84 12.9 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.53 1.132 . . . . 0.0 113.129 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -88.14 -11.82 45.81 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.956 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.12 32.19 76.15 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.312 0.383 . . . . 0.0 112.342 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.543 HD13 HG23 ' A' ' 84' ' ' ILE . 42.6 pt -110.08 163.91 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.258 1.023 . . . . 0.0 110.056 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -110.75 95.55 5.62 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD23 HD12 ' A' ' 87' ' ' LEU . 70.1 mt -72.59 118.88 71.65 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.429 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 2.7 Cg_exo -78.88 59.85 7.5 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.115 2.544 . . . . 0.0 110.139 168.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.425 HD12 HD23 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -65.12 -35.68 81.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.397 -174.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -57.42 -40.55 78.59 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.78 0.832 . . . . 0.0 112.205 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 56' ' ' PRO . 9.6 ptmm? -77.44 -34.81 54.46 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.442 ' O ' HG23 ' A' ' 64' ' ' VAL . 50.6 m0 -66.67 -43.89 83.31 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.509 0.724 . . . . 0.0 110.704 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.8 m -64.5 -37.37 87.31 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.939 0.896 . . . . 0.0 110.269 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -66.22 -41.73 89.7 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.928 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -62.37 -43.06 99.71 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.802 0.841 . . . . 0.0 110.854 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 60' ' ' TRP . 77.6 t -55.56 -57.22 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 O-C-N 124.149 0.906 . . . . 0.0 110.533 175.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -66.75 -28.96 68.83 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.145 0.978 . . . . 0.0 112.984 -174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -93.18 7.24 45.09 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.456 0.703 . . . . 0.0 111.555 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.19 11.54 67.52 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 115.017 0.767 . . . . 0.0 115.017 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -70.64 -35.53 72.94 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.235 0.614 . . . . 0.0 109.951 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.07 164.77 29.14 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.721 1.208 . . . . 0.0 109.204 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.6 p -97.92 158.46 15.52 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.259 0.624 . . . . 0.0 109.801 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.465 ' HB ' ' HE2' ' A' ' 28' ' ' HIS . 0.7 OUTLIER -59.54 -43.86 93.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 124.158 0.912 . . . . 0.0 110.567 -175.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.558 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.1 mp0 -46.74 -49.1 20.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.374 1.47 . . . . 0.0 112.972 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -54.55 -25.44 25.99 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -121.37 -22.17 6.07 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -109.32 12.06 24.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.246 0.618 . . . . 0.0 111.771 -169.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 72' ' ' GLU . 80.2 t -105.58 138.04 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.538 HD11 HD12 ' A' ' 12' ' ' ILE . 4.4 mm? -52.91 -38.38 61.77 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.025 1.33 . . . . 0.0 114.312 -171.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.579 ' HD3' ' HG2' ' A' ' 26' ' ' GLU . 60.1 pttt -71.21 -40.7 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.095 0.558 . . . . 0.0 110.609 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 77.5 m-20 -74.58 -47.16 34.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.238 1.015 . . . . 0.0 109.788 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.6 tp -57.1 -49.43 75.89 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.705 1.202 . . . . 0.0 110.089 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.39 78.61 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.834 0.709 . . . . 0.0 110.939 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -67.44 -44.76 77.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.585 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 18.2 mmm180 -56.73 -44.31 81.52 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.298 0.639 . . . . 0.0 110.738 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.543 HG23 HD13 ' A' ' 53' ' ' ILE . 90.3 mt -62.54 -49.52 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.029 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.04 -32.69 74.32 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.521 1.138 . . . . 0.0 110.625 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 65.6 mt-10 -62.47 -47.14 85.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.839 0.856 . . . . 0.0 110.143 172.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.465 HD12 HD23 ' A' ' 55' ' ' LEU . 81.1 mt -69.16 -31.31 69.87 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.153 0.581 . . . . 0.0 111.552 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 84' ' ' ILE . 77.0 t -68.67 -41.31 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.422 0.689 . . . . 0.0 109.665 176.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.83 -41.49 78.5 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.457 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.39 -39.02 91.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.026 0.93 . . . . 0.0 111.802 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 pttp . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 122.825 0.45 . . . . 0.0 110.301 -177.286 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 8' ' ' VAL . 20.0 m . . . . . 0 N--CA 1.47 0.532 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -55.82 -43.9 77.39 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.911 0.757 . . . . 0.0 111.226 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -52.84 -49.74 65.14 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 123.73 0.643 . . . . 0.0 110.736 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -65.88 -40.21 91.4 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.071 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 4' ' ' THR . 67.2 t -66.71 -44.27 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 122.871 0.468 . . . . 0.0 110.315 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.01 96.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.15 0.98 . . . . 0.0 110.877 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -60.92 -47.69 85.27 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.644 0.778 . . . . 0.0 110.925 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.54 -50.77 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.445 0.698 . . . . 0.0 111.418 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.467 HG12 HG21 ' A' ' 43' ' ' ILE . 50.9 mt -57.46 -45.62 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.672 0.789 . . . . 0.0 110.553 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.14 -58.17 7.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.352 1.061 . . . . 0.0 112.662 174.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -64.84 -26.91 68.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.229 1.011 . . . . 0.0 112.052 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -76.88 -53.47 7.84 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.256 0.623 . . . . 0.0 110.695 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.483 ' SG ' HG12 ' A' ' 35' ' ' ILE . 37.7 t -100.04 9.2 43.25 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -166.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t70 55.65 59.83 3.64 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.761 0.791 . . . . 0.0 111.151 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.532 HG13 ' HA ' ' A' ' 13' ' ' ALA . 11.5 pt -141.78 148.19 48.42 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 123.729 0.812 . . . . 0.0 109.712 -177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.24 125.41 11.34 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.661 2.241 . . . . 0.0 110.568 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.647 ' HA ' HD13 ' A' ' 23' ' ' ILE . 7.6 ptt180 -68.61 -17.07 64.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.07 -24.85 60.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.388 0.675 . . . . 0.0 110.479 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -80.95 -13.24 59.08 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.613 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.647 HD13 ' HA ' ' A' ' 20' ' ' ARG . 2.7 mp -86.64 117.7 31.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.5 p -100.32 161.69 23.28 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.802 0.841 . . . . 0.0 109.045 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.7 -16.05 50.52 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 121.733 1.622 . . . . 0.0 112.823 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.69 3.33 50.26 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.791 -0.568 . . . . 0.0 111.064 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.7 m -77.78 135.81 38.03 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.433 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 59.5 t-80 -81.07 113.81 19.51 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.24 -23.17 55.02 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.433 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 61.9 mt -97.79 -54.13 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.171 0.588 . . . . 0.0 110.007 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.23 -43.67 41.08 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.826 0.851 . . . . 0.0 112.563 -167.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.81 -51.55 11.14 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.788 0.435 . . . . 0.0 110.049 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.9 mt -78.02 -5.78 52.43 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.926 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.65 27.93 73.57 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.566 0.541 . . . . 0.0 113.246 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.483 HG12 ' SG ' ' A' ' 16' ' ' CYS . 81.4 mt -95.86 124.29 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.976 0.911 . . . . 0.0 108.615 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.52 157.46 34.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.489 0.316 . . . . 0.0 110.999 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.449 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.6 m -63.02 -22.78 67.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.632 0.773 . . . . 0.0 110.75 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.5 mt -65.31 -51.37 61.08 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.75 0.82 . . . . 0.0 109.908 174.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.52 -31.46 71.58 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.58 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.405 ' CE2' HD21 ' A' ' 57' ' ' LEU . 30.0 t80 -74.91 -24.99 58.6 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.305 0.642 . . . . 0.0 110.973 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.503 HD23 HD12 ' A' ' 57' ' ' LEU . 80.1 mt -61.63 -42.27 98.65 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.061 0.544 . . . . 0.0 109.86 169.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -72.27 -37.42 69.05 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.888 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.467 HG21 HG12 ' A' ' 12' ' ' ILE . 67.5 mt -58.85 -50.74 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.817 174.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.24 -27.5 63.51 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.533 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -61.01 -46.35 91.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.803 0.841 . . . . 0.0 110.483 169.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.27 -34.87 76.96 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.141 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.2 mt -69.0 -44.04 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.932 0.893 . . . . 0.0 110.679 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -51.35 -48.6 62.39 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.388 1.475 . . . . 0.0 110.257 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -76.84 -38.58 53.55 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.572 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.87 -54.92 38.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.286 0.634 . . . . 0.0 112.304 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -84.58 -9.93 57.85 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.616 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.65 29.78 69.27 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 123.53 0.519 . . . . 0.0 112.858 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.544 HD13 HG23 ' A' ' 84' ' ' ILE . 42.6 pt -107.53 176.5 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.506 1.122 . . . . 0.0 109.735 -174.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.54 96.26 5.06 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.65 116.79 61.06 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 123.705 0.802 . . . . 0.0 109.859 171.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -84.3 57.4 5.24 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 122.651 2.234 . . . . 0.0 110.41 168.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.503 HD12 HD23 ' A' ' 41' ' ' LEU . 2.0 tm? -59.7 -41.76 91.46 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.516 1.127 . . . . 0.0 109.931 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 11.6 pt-20 -61.39 -39.27 90.1 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 124.24 0.963 . . . . 0.0 110.959 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -46.76 79.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.777 0.831 . . . . 0.0 110.107 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.466 ' O ' HG23 ' A' ' 64' ' ' VAL . 52.5 m0 -60.16 -40.14 88.88 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.936 1.397 . . . . 0.0 110.861 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 34.8 m -68.21 -35.15 77.52 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.494 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 17.0 mm100 -73.15 -29.69 63.05 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.855 0.462 . . . . 0.0 110.521 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.464 ' HG2' ' HE3' ' A' ' 68' ' ' LYS . 49.0 mt-10 -65.78 -41.54 91.9 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.747 0.419 . . . . 0.0 110.199 173.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.663 HG11 HG23 ' A' ' 71' ' ' THR . 98.7 t -61.07 -43.15 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.6 175.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -62.08 -39.64 93.14 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.107 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -87.55 -5.18 58.88 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.674 0.79 . . . . 0.0 112.586 -174.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.96 12.01 85.03 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 115.042 0.777 . . . . 0.0 115.042 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HE3' ' HG2' ' A' ' 63' ' ' GLU . 55.1 mtmt -79.68 -26.97 40.81 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 117.725 0.762 . . . . 0.0 111.059 172.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -136.53 174.54 10.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.056 0.942 . . . . 0.0 109.327 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.7 m -133.86 148.57 51.29 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.485 1.114 . . . . 0.0 108.757 174.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.663 HG23 HG11 ' A' ' 64' ' ' VAL . 4.1 p -58.42 93.1 0.02 OUTLIER 'General case' 0 C--N 1.362 1.146 0 C-N-CA 123.512 0.725 . . . . 0.0 109.887 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.486 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.0 tm-20 175.86 -63.81 0.01 OUTLIER 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.134 1.374 . . . . 0.0 107.978 -174.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -51.26 -29.36 14.35 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.763 -1.562 . . . . 0.0 114.06 -173.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -132.92 0.61 3.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.061 0.544 . . . . 0.0 111.136 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -121.28 5.35 10.25 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.29 0.636 . . . . 0.0 111.295 -165.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 72' ' ' GLU . 71.7 t -105.34 146.1 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.464 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -52.39 -43.77 64.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.901 1.28 . . . . 0.0 114.251 -174.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -68.95 -42.32 76.83 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.754 0.422 . . . . 0.0 110.322 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 5.6 m120 -65.32 -47.33 76.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.447 0.699 . . . . 0.0 110.597 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.88 -50.77 69.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 110.223 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -62.43 -28.25 69.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.665 0.786 . . . . 0.0 111.261 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -69.99 -45.35 67.47 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.736 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 15.3 mmm180 -57.71 -46.63 84.13 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.331 0.652 . . . . 0.0 110.383 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.544 HG23 HD13 ' A' ' 53' ' ' ILE . 89.9 mt -59.08 -47.94 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 113.778 -1.556 . . . . 0.0 110.694 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.07 -46.34 82.57 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.079 0.862 . . . . 0.0 111.205 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 49.1 mt-10 -63.76 -35.28 80.08 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.101 0.56 . . . . 0.0 111.111 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.4 -32.09 62.57 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.976 0.51 . . . . 0.0 112.154 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 84' ' ' ILE . 98.0 t -64.72 -41.47 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-O 121.732 0.777 . . . . 0.0 109.405 171.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.62 -45.52 78.84 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.648 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.71 90.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.31 1.044 . . . . 0.0 112.145 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 88' ' ' VAL . 20.6 pttp . . . . . 0 N--CA 1.477 0.919 0 C-N-CA 122.453 0.301 . . . . 0.0 110.415 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.0 m . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 110.623 -0.14 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -54.39 -50.26 67.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.35 0.66 . . . . 0.0 111.247 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.01 -42.0 98.68 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.574 0.546 . . . . 0.0 110.721 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -58.84 -48.27 81.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.724 0.81 . . . . 0.0 111.082 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 4' ' ' THR . 94.9 t -67.48 -44.87 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.57 0.748 . . . . 0.0 110.852 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.46 90.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.288 1.035 . . . . 0.0 110.375 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 92.8 m -63.4 -44.9 93.35 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.758 0.823 . . . . 0.0 111.29 175.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.596 HD13 ' HA ' ' A' ' 47' ' ' ILE . 95.2 mt -58.71 -48.16 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 122.967 0.507 . . . . 0.0 111.485 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 18' ' ' ILE . 57.1 mt -58.46 -45.88 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.645 0.778 . . . . 0.0 109.996 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.49 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.77 -51.84 62.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.853 1.261 . . . . 0.0 113.683 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 10' ' ' THR . 22.2 mm-40 -66.26 -27.78 68.21 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.386 0.675 . . . . 0.0 112.129 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 43' ' ' ILE . 96.1 m -76.56 -51.63 11.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.929 0.492 . . . . 0.0 111.054 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.6 m -99.59 7.03 45.59 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.59 0.756 . . . . 0.0 112.515 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 48.25 70.6 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.526 1.13 . . . . 0.0 111.749 -174.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.49 HG13 ' HA ' ' A' ' 13' ' ' ALA . 10.3 pt -144.78 146.58 32.24 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 124.138 0.975 . . . . 0.0 109.605 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.45 116.69 4.2 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.919 2.413 . . . . 0.0 112.207 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -23.91 67.44 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -170.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -90.76 -6.36 54.48 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.142 0.577 . . . . 0.0 110.891 -171.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -89.02 -13.03 39.72 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 167.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.422 HD11 HD12 ' A' ' 18' ' ' ILE . 2.0 mp -79.19 105.77 9.1 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 171.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -77.25 159.94 76.74 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.435 0.694 . . . . 0.0 109.735 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.57 -17.02 58.13 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 121.988 1.792 . . . . 0.0 112.196 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -99.74 9.85 42.36 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 122.909 0.484 . . . . 0.0 110.427 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.0 m -72.13 124.33 24.77 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 122.57 0.348 . . . . 0.0 110.07 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -83.6 117.09 22.93 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.71 -41.43 15.05 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.206 1.003 . . . . 0.0 113.37 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.71 -50.2 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 122.464 0.306 . . . . 0.0 110.457 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.27 -38.33 24.56 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.943 0.897 . . . . 0.0 112.397 -171.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.17 -57.05 2.83 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.186 0.595 . . . . 0.0 110.35 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 29' ' ' ALA . 88.7 mt -76.29 -10.53 59.47 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.888 0.875 . . . . 0.0 111.977 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.26 30.38 77.61 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 123.412 0.445 . . . . 0.0 113.993 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.1 mt -89.39 126.24 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.27 147.92 38.54 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.213 0.605 . . . . 0.0 110.692 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -60.56 -35.74 76.77 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.726 0.41 . . . . 0.0 111.144 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 39' ' ' ASP . 3.0 pp -73.86 -31.65 63.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.186 0.594 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.454 ' N ' HD12 ' A' ' 38' ' ' LEU . 15.5 t70 -72.82 -35.99 67.41 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.483 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -71.72 -21.78 61.72 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.075 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.8 mt -56.85 -41.72 78.4 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 122.625 0.37 . . . . 0.0 110.426 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.09 -32.62 63.32 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.057 0.943 . . . . 0.0 111.51 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.539 HG12 HG21 ' A' ' 15' ' ' THR . 37.9 mt -65.26 -46.59 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.13 -29.15 67.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.907 0.883 . . . . 0.0 111.143 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -58.21 -50.87 72.04 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.006 1.322 . . . . 0.0 110.786 170.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.92 -33.49 74.78 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.871 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.596 ' HA ' HD13 ' A' ' 11' ' ' ILE . 85.9 mt -67.47 -51.32 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.186 0.594 . . . . 0.0 110.888 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.85 -37.33 86.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.039 0.535 . . . . 0.0 110.344 -170.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -81.38 -29.04 34.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.4 -48.24 76.17 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.322 0.388 . . . . 0.0 111.592 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.406 ' HB2' HG12 ' A' ' 53' ' ' ILE . 86.7 m-85 -83.12 -16.47 46.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.508 0.723 . . . . 0.0 111.821 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.12 37.58 87.25 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.382 0.426 . . . . 0.0 112.519 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.479 HG22 ' HG2' ' A' ' 91' ' ' LYS . 46.3 pt -116.35 172.82 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.585 1.154 . . . . 0.0 111.026 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.62 97.82 6.36 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.385 1.074 . . . . 0.0 108.454 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.545 HD21 HG12 ' A' ' 84' ' ' ILE . 79.3 mt -73.18 120.42 80.9 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 123.035 0.534 . . . . 0.0 110.071 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.56 57.82 6.7 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.758 2.305 . . . . 0.0 110.835 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -63.83 -40.99 97.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.416 1.086 . . . . 0.0 109.818 -173.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.26 -37.88 88.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.502 0.721 . . . . 0.0 111.371 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -71.01 -37.97 72.63 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.853 0.861 . . . . 0.0 110.238 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -63.59 -52.79 59.42 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.944 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.3 m -62.52 -33.3 74.62 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.084 0.954 . . . . 0.0 110.895 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -63.22 -58.65 6.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.429 0.691 . . . . 0.0 109.837 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 44.4 mt-10 -66.04 -32.23 73.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.854 0.862 . . . . 0.0 111.82 -176.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.8 t -61.63 -55.01 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.683 0.793 . . . . 0.0 110.165 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -78.97 -7.7 58.27 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.699 0.399 . . . . 0.0 111.787 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -92.85 -2.92 55.47 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.342 0.657 . . . . 0.0 110.74 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.71 5.24 86.19 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 115.888 1.115 . . . . 0.0 115.888 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 60.6 mttp -70.43 -31.59 68.84 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.075 0.937 . . . . 0.0 110.277 171.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.43 163.27 32.96 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.326 1.051 . . . . 0.0 108.819 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 p -104.72 162.28 13.43 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.442 0.697 . . . . 0.0 109.643 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.5 p -59.38 -52.5 65.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.157 0.583 . . . . 0.0 112.332 -169.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -56.02 -31.52 63.17 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -50.07 -33.59 18.91 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.36 1.064 . . . . 0.0 113.318 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -122.12 -19.59 6.53 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -111.91 23.4 13.83 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 122.571 0.348 . . . . 0.0 111.198 -171.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 78' ' ' LYS . 40.3 t -110.27 142.26 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 162.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.17 -41.4 68.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.389 1.476 . . . . 0.0 114.267 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HG2' HG12 ' A' ' 76' ' ' VAL . 58.9 pttt -66.77 -37.79 85.29 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 120.786 0.327 . . . . 0.0 110.954 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 73.3 m-20 -80.39 -37.93 31.3 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.878 0.871 . . . . 0.0 110.817 -176.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.38 -53.21 52.07 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.242 1.017 . . . . 0.0 108.857 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.47 -22.58 65.47 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.689 0.795 . . . . 0.0 111.914 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.11 -53.94 37.66 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.66 0.384 . . . . 0.0 110.058 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 28.1 mmm180 -60.92 -40.37 92.93 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 124.101 0.876 . . . . 0.0 111.205 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.545 HG12 HD21 ' A' ' 55' ' ' LEU . 92.3 mt -61.52 -50.31 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.281 1.032 . . . . 0.0 110.31 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.402 ' HB2' HG21 ' A' ' 4' ' ' THR . 27.6 t70 -63.34 -34.94 78.8 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.118 0.567 . . . . 0.0 111.496 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.85 -44.12 90.94 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.487 0.715 . . . . 0.0 109.981 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.2 -42.04 76.3 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.16 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 84' ' ' ILE . 61.6 t -61.65 -45.69 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 123.464 0.706 . . . . 0.0 110.333 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.98 -43.11 99.3 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.511 176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.01 -42.67 76.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.621 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 C-N-CA 122.668 0.387 . . . . 0.0 110.146 -174.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.6 m . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -54.89 -48.13 73.4 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.736 0.647 . . . . 0.0 111.016 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.93 -42.85 94.87 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.785 0.678 . . . . 0.0 110.934 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -57.44 -45.76 84.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.498 0.719 . . . . 0.0 111.221 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.8 t -71.4 -33.97 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 123.712 0.632 . . . . 0.0 110.77 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.86 -36.42 83.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.549 0.739 . . . . 0.0 110.481 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 m -66.82 -44.01 82.27 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.56 0.744 . . . . 0.0 110.739 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.8 mt -56.42 -54.53 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.646 0.778 . . . . 0.0 110.724 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.578 HD12 HD11 ' A' ' 77' ' ' LEU . 35.8 mt -60.08 -45.38 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.15 0.98 . . . . 0.0 110.66 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -51.88 -51.27 57.98 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 123.825 0.703 . . . . 0.0 112.319 174.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -67.86 -30.17 69.47 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.499 0.72 . . . . 0.0 112.332 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -74.81 -61.0 2.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.254 0.622 . . . . 0.0 110.938 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.8 m -90.49 10.79 23.93 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.016 0.927 . . . . 0.0 112.953 -168.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.4 t70 48.7 68.09 0.76 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.651 1.18 . . . . 0.0 111.565 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.467 HG13 ' HA ' ' A' ' 13' ' ' ALA . 12.1 pt -145.26 142.96 18.95 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.718 1.207 . . . . 0.0 108.699 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.67 139.36 69.08 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.523 2.149 . . . . 0.0 112.55 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -56.33 -31.5 63.78 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.144 1.378 . . . . 0.0 111.952 -173.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -77.25 -18.81 57.33 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.99 0.516 . . . . 0.0 111.901 -172.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -78.93 -11.32 60.0 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.046 0.385 . . . . 0.0 111.398 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.4 mp -86.18 102.05 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 27' ' ' SER . 64.3 p -81.18 154.04 72.07 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.118 0.567 . . . . 0.0 109.77 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.94 -30.22 83.22 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.335 2.024 . . . . 0.0 112.524 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -97.8 13.08 31.73 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.824 0.45 . . . . 0.0 110.947 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.419 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 46.9 t -72.24 129.67 38.98 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.968 0.507 . . . . 0.0 109.69 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -83.21 114.62 21.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 167.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.69 -41.66 10.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.022 0.929 . . . . 0.0 112.977 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.6 mt -88.62 -59.63 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -172.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.19 -36.46 84.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.739 1.216 . . . . 0.0 112.728 -173.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -98.39 -65.59 0.95 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.282 0.633 . . . . 0.0 110.759 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.48 -18.49 62.98 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.37 41.66 36.83 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 112.366 -0.293 . . . . 0.0 112.366 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.5 mt -99.75 107.88 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.25 168.32 18.54 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.4 t -52.46 -37.93 58.14 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.466 1.106 . . . . 0.0 111.783 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.23 -26.06 58.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.056 0.543 . . . . 0.0 111.898 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.4 -41.38 47.98 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 175.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -68.95 -23.13 64.11 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.889 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.4 mt -52.27 -49.86 63.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.159 0.583 . . . . 0.0 111.207 171.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.34 -38.02 71.68 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.826 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.533 HD13 HG12 ' A' ' 12' ' ' ILE . 81.5 mt -65.26 -44.79 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.519 0.728 . . . . 0.0 110.614 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -70.34 -37.16 74.62 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.284 0.633 . . . . 0.0 110.293 -177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -71.63 -27.57 63.19 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.367 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.72 63.92 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.837 0.351 . . . . 0.0 110.627 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 84' ' ' ILE . 87.0 mt -69.37 -38.19 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.072 0.949 . . . . 0.0 109.793 171.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 5.9 t70 -58.09 -42.81 86.44 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.823 0.849 . . . . 0.0 111.137 174.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -67.94 -54.06 21.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.931 0.892 . . . . 0.0 110.561 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.13 -55.7 31.7 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.19 0.996 . . . . 0.0 112.605 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -91.05 -13.74 32.64 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.489 0.716 . . . . 0.0 112.433 -171.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.53 34.63 79.47 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-O 121.202 0.335 . . . . 0.0 113.494 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.638 HG22 ' HG2' ' A' ' 91' ' ' LYS . 44.6 pt -120.21 153.03 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.18 0.992 . . . . 0.0 109.149 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -100.59 106.95 18.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.4 mt -69.96 125.05 91.8 Favored Pre-proline 0 C--N 1.348 0.513 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 170.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 78.0 Cg_endo -78.17 57.25 6.1 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.387 2.058 . . . . 0.0 111.104 172.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.54 -38.37 89.72 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.346 1.058 . . . . 0.0 110.425 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.98 -36.52 79.65 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.638 0.375 . . . . 0.0 111.833 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.31 -37.37 60.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.498 0.719 . . . . 0.0 110.374 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.436 ' O ' HG23 ' A' ' 64' ' ' VAL . 48.1 m0 -62.93 -50.97 68.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.925 0.89 . . . . 0.0 110.569 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.3 m -64.0 -31.85 73.18 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.259 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -68.62 -42.89 77.45 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.012 0.525 . . . . 0.0 110.84 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.33 -42.53 99.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.905 0.482 . . . . 0.0 110.615 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 60' ' ' TRP . 61.2 t -61.05 -49.96 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.593 0.711 . . . . 0.0 110.161 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -56.76 -41.44 77.59 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.421 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -99.62 17.38 20.65 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.094 0.958 . . . . 0.0 111.48 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.29 14.22 52.85 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 115.107 0.803 . . . . 0.0 115.107 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -80.78 -24.73 38.4 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.795 0.838 . . . . 0.0 110.396 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.85 173.33 12.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.173 0.989 . . . . 0.0 109.874 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.8 p -106.89 164.76 11.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.293 0.637 . . . . 0.0 109.694 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.0 p -57.45 -49.67 75.51 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.428 0.455 . . . . 0.0 110.475 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.483 ' HA ' HG23 ' A' ' 76' ' ' VAL . 29.8 mt-10 -39.1 -50.99 1.89 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.711 1.604 . . . . 0.0 113.26 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -59.59 -24.21 63.58 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.334 -1.303 . . . . 0.0 113.288 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -120.01 -22.79 6.57 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.935 0.494 . . . . 0.0 112.026 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.85 19.71 14.98 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.281 0.632 . . . . 0.0 110.749 -167.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' ' 72' ' ' GLU . 79.8 t -105.63 139.97 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 161.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.578 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -56.52 -40.48 75.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.837 1.255 . . . . 0.0 113.936 -172.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.3 pttt -72.58 -38.7 67.82 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.586 0.355 . . . . 0.0 111.216 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -71.97 -45.69 60.1 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.544 0.738 . . . . 0.0 109.888 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.2 tp -53.73 -48.05 70.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.913 1.285 . . . . 0.0 110.299 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -31.98 73.21 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.673 0.608 . . . . 0.0 111.759 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.98 77.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.769 0.427 . . . . 0.0 110.479 175.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -60.28 -44.75 95.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.319 0.58 . . . . 0.0 111.234 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 47' ' ' ILE . 90.3 mt -65.52 -46.64 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.276 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.54 -38.71 88.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.395 0.678 . . . . 0.0 110.991 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -59.41 -50.87 72.29 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.578 0.549 . . . . 0.0 110.733 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.04 -35.68 81.2 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.69 0.619 . . . . 0.0 112.219 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 84' ' ' ILE . 70.6 t -67.17 -47.26 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.395 0.678 . . . . 0.0 110.546 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.79 -32.4 73.67 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.712 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -46.91 68.93 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 123.482 0.713 . . . . 0.0 111.434 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.638 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 C-N-CA 123.042 0.537 . . . . 0.0 110.626 -174.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 110.597 -0.149 . . . . 0.0 110.597 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -52.9 -51.23 61.95 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.715 0.806 . . . . 0.0 110.866 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -60.86 -44.9 96.41 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.163 0.914 . . . . 0.0 111.421 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -64.81 -40.58 95.45 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.329 0.651 . . . . 0.0 111.44 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.469 HG13 HD11 ' A' ' 47' ' ' ILE . 69.6 t -72.39 -36.57 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.193 0.597 . . . . 0.0 110.474 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.34 -35.47 80.98 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.721 0.808 . . . . 0.0 110.64 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.7 m -65.24 -48.07 74.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.818 0.847 . . . . 0.0 110.896 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.411 HG22 HG23 ' A' ' 43' ' ' ILE . 78.5 mt -58.0 -46.86 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.494 0.718 . . . . 0.0 110.776 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.454 HD12 HD11 ' A' ' 77' ' ' LEU . 55.4 mt -61.89 -48.93 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.673 0.789 . . . . 0.0 110.854 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.57 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.18 -44.46 64.68 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.212 1.005 . . . . 0.0 112.575 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -66.25 -43.74 85.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.143 0.977 . . . . 0.0 111.798 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.9 m -75.49 -50.95 14.15 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.727 0.411 . . . . 0.0 111.527 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.8 m -89.67 3.82 51.47 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.265 1.026 . . . . 0.0 111.886 -174.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.0 t70 50.54 75.0 0.19 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.256 1.422 . . . . 0.0 112.416 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.57 HG13 ' HA ' ' A' ' 13' ' ' ALA . 3.4 pt -148.21 157.5 42.53 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 124.629 1.172 . . . . 0.0 109.474 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.58 137.7 47.18 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.361 2.041 . . . . 0.0 110.993 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.422 ' HA ' HD13 ' A' ' 23' ' ' ILE . 25.5 ttm180 -57.63 -30.54 65.45 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.973 0.909 . . . . 0.0 112.5 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.86 -21.65 60.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.994 0.918 . . . . 0.0 111.26 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -80.66 -6.7 58.73 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 122.777 0.431 . . . . 0.0 111.146 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 20' ' ' ARG . 3.8 mp -90.99 112.04 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 170.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.4 p -95.65 160.73 29.72 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 123.32 0.648 . . . . 0.0 110.425 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -60.16 -33.31 95.07 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.23 1.953 . . . . 0.0 112.877 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -94.49 11.24 31.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.945 0.898 . . . . 0.0 110.954 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.8 t -79.22 128.52 33.41 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 123.177 0.591 . . . . 0.0 110.324 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -83.18 118.9 23.92 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.97 -40.77 23.35 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.55 -45.39 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 O-C-N 122.187 -0.32 . . . . 0.0 110.211 -169.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -82.99 -32.8 26.8 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.818 0.847 . . . . 0.0 112.316 -173.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.91 -64.25 1.06 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.366 0.666 . . . . 0.0 109.965 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.439 HD13 HG21 ' A' ' 12' ' ' ILE . 82.8 mt -69.77 -11.19 60.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.155 0.582 . . . . 0.0 111.489 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.84 31.91 79.59 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.55 0.531 . . . . 0.0 113.153 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -82.97 122.95 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -61.36 146.1 49.31 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.746 0.419 . . . . 0.0 110.063 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.437 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 37.3 m -59.65 -34.68 73.12 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.506 0.722 . . . . 0.0 111.807 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.1 mt -73.7 -34.48 64.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.439 0.696 . . . . 0.0 110.032 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -73.89 -30.63 62.72 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.461 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -75.76 -23.67 55.99 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.661 0.384 . . . . 0.0 110.54 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 37' ' ' SER . 96.5 mt -63.76 -39.46 94.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.862 0.465 . . . . 0.0 109.84 169.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -65.97 -45.56 81.23 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.89 0.876 . . . . 0.0 110.619 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.411 HG23 HG22 ' A' ' 11' ' ' ILE . 63.4 mt -62.97 -40.21 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.622 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.94 -35.93 77.35 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.431 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -74.63 -25.17 59.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.609 0.764 . . . . 0.0 110.941 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.97 -41.15 68.06 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.996 0.518 . . . . 0.0 110.559 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.469 HD11 HG13 ' A' ' 8' ' ' VAL . 89.8 mt -65.55 -40.48 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.295 1.038 . . . . 0.0 110.061 173.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -55.27 -47.74 75.05 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.02 1.328 . . . . 0.0 109.714 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -67.84 -50.58 55.87 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.52 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.02 -51.77 68.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.963 0.905 . . . . 0.0 112.114 -172.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.17 -5.26 59.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.908 0.883 . . . . 0.0 111.456 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.3 30.81 75.85 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.193 0.308 . . . . 0.0 113.64 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.36 170.66 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.41 1.084 . . . . 0.0 109.869 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -104.97 111.03 23.66 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 168.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.591 HD21 HG12 ' A' ' 84' ' ' ILE . 42.6 mt -73.9 118.28 68.08 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -79.25 58.38 6.92 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.626 2.217 . . . . 0.0 109.706 170.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.58 -37.15 85.08 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.053 0.941 . . . . 0.0 109.118 -174.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.3 -45.58 90.74 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.383 0.673 . . . . 0.0 111.143 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -62.23 -40.71 97.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.866 0.866 . . . . 0.0 110.462 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.45 ' O ' HG23 ' A' ' 64' ' ' VAL . 54.1 m0 -63.66 -45.87 88.18 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.318 1.011 . . . . 0.0 109.87 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.5 m -62.06 -33.96 75.39 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.054 0.846 . . . . 0.0 110.932 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -72.2 -44.58 62.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.937 0.495 . . . . 0.0 110.513 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.26 -36.39 77.68 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.393 0.677 . . . . 0.0 110.816 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 60' ' ' TRP . 72.9 t -67.14 -49.94 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.829 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -59.23 -44.87 92.31 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.721 0.808 . . . . 0.0 112.063 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -86.35 6.67 28.92 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.981 0.912 . . . . 0.0 111.538 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.94 23.05 67.24 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.461 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -75.65 -30.53 59.47 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.372 0.669 . . . . 0.0 109.554 174.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.79 160.47 42.22 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.545 1.138 . . . . 0.0 109.371 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.4 p -83.85 162.83 20.43 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.117 0.567 . . . . 0.0 110.251 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 82.4 p -58.53 -55.43 35.19 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.53 0.681 . . . . 0.0 109.859 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.5 -33.86 64.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.299 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -55.57 -26.74 45.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 123.877 0.736 . . . . 0.0 112.529 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -119.6 -28.69 5.24 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.88 0.472 . . . . 0.0 112.156 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.59 16.95 25.06 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.99 0.516 . . . . 0.0 112.025 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.487 HG12 ' HG2' ' A' ' 78' ' ' LYS . 22.9 t -107.5 142.68 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 167.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -56.99 -41.69 78.88 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.001 1.32 . . . . 0.0 114.509 -170.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.9 pttt -65.65 -40.72 92.78 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.357 0.599 . . . . 0.0 110.312 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.34 -44.48 44.94 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.735 1.214 . . . . 0.0 110.499 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.69 -51.14 70.74 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.218 1.407 . . . . 0.0 109.977 176.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.85 -33.37 74.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.737 0.815 . . . . 0.0 111.658 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.67 -50.17 65.92 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.566 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -55.1 -46.65 75.53 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.594 1.158 . . . . 0.0 111.688 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.591 HG12 HD21 ' A' ' 55' ' ' LEU . 93.2 mt -60.26 -48.71 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.787 1.235 . . . . 0.0 110.464 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.15 -31.23 71.96 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.884 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.91 -41.86 95.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.116 0.566 . . . . 0.0 110.302 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.94 -27.93 65.16 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.429 0.692 . . . . 0.0 111.186 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.425 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 61.0 t -71.22 -36.36 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.623 0.769 . . . . 0.0 110.234 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.67 84.34 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.007 173.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.25 -40.07 82.07 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.721 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 13.5 ptmm? . . . . . 0 N--CA 1.487 1.386 0 CA-C-N 118.064 0.393 . . . . 0.0 111.334 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 8' ' ' VAL . 90.5 m . . . . . 0 CA--C 1.54 0.593 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -55.15 -40.45 70.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.994 0.918 . . . . 0.0 111.799 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -56.61 -47.57 79.37 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.295 0.638 . . . . 0.0 110.537 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -66.77 -38.31 86.33 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.82 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 4' ' ' THR . 87.1 t -66.81 -44.16 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.309 0.644 . . . . 0.0 110.616 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.54 -44.91 85.52 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.442 1.097 . . . . 0.0 110.107 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 57.7 m -59.89 -48.34 82.11 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.559 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -57.83 -47.69 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.743 0.817 . . . . 0.0 111.828 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.478 HG22 HD11 ' A' ' 18' ' ' ILE . 41.0 mt -58.3 -44.27 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.812 0.845 . . . . 0.0 110.526 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . . . -57.87 -44.3 86.55 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.143 0.977 . . . . 0.0 112.569 174.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.1 mm-40 -63.1 -36.22 82.87 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.421 0.688 . . . . 0.0 111.632 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -78.72 -59.44 2.78 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.817 -173.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -101.1 18.13 20.6 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.466 0.706 . . . . 0.0 112.853 -166.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.2 t70 47.72 66.1 1.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.304 1.041 . . . . 0.0 111.9 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 12' ' ' ILE . 3.5 pt -142.54 147.34 42.4 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 123.804 0.841 . . . . 0.0 109.739 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.02 116.17 4.57 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.656 2.237 . . . . 0.0 112.361 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.559 ' HA ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -63.41 -17.29 62.5 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -176.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.53 -30.89 70.66 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.729 0.812 . . . . 0.0 110.525 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -85.25 -14.42 46.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.341 0.656 . . . . 0.0 110.781 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.559 HD13 ' HA ' ' A' ' 20' ' ' ARG . 1.8 mp -78.01 108.41 11.3 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.8 p -91.27 157.46 42.57 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 123.573 0.749 . . . . 0.0 109.672 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.95 -17.92 56.4 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.237 1.958 . . . . 0.0 112.456 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -100.05 6.53 45.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.192 0.597 . . . . 0.0 110.489 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -78.85 138.72 38.29 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.37 0.668 . . . . 0.0 110.516 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.411 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 50.7 t-80 -86.28 114.04 22.77 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.547 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -51.05 -37.24 44.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.854 0.862 . . . . 0.0 113.212 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.411 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 63.7 mt -89.88 -54.06 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -174.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.76 -39.17 27.34 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.416 0.687 . . . . 0.0 112.544 -168.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -88.25 -55.11 3.88 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 29' ' ' ALA . 73.7 mt -75.09 -8.66 57.19 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.79 29.01 74.18 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.446 0.466 . . . . 0.0 113.82 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -88.04 124.98 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -75.87 160.51 29.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.125 0.57 . . . . 0.0 110.109 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.464 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 15.3 m -57.69 -34.08 69.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.998 0.919 . . . . 0.0 111.782 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.71 -37.61 76.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.86 0.464 . . . . 0.0 110.686 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -67.48 -42.35 83.12 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.54 0.736 . . . . 0.0 109.95 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -65.46 -28.59 69.33 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 124.392 1.057 . . . . 0.0 110.967 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 37' ' ' SER . 70.7 mt -61.79 -42.15 98.63 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.895 0.478 . . . . 0.0 110.749 174.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.46 -35.21 60.94 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.063 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.7 -47.75 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.781 0.676 . . . . 0.0 109.384 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.37 -30.08 63.06 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.098 0.959 . . . . 0.0 110.654 -174.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -62.59 -43.68 98.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.644 0.778 . . . . 0.0 110.89 171.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.4 -31.84 65.88 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.099 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.15 -45.41 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.468 0.707 . . . . 0.0 110.314 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -52.01 -49.29 63.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.877 1.271 . . . . 0.0 110.312 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -72.34 -49.62 32.92 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.014 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.06 98.78 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -89.77 -3.78 57.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.382 0.673 . . . . 0.0 112.378 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.4 45.45 96.38 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 123.779 0.674 . . . . 0.0 113.072 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.54 179.73 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.555 1.142 . . . . 0.0 110.186 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -122.35 113.2 19.07 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.422 HD22 ' HH2' ' A' ' 60' ' ' TRP . 83.4 mt -78.63 125.81 83.78 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 122.797 0.439 . . . . 0.0 110.41 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.19 54.95 5.41 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.205 2.603 . . . . 0.0 110.422 166.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.68 -39.94 86.19 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.91 1.284 . . . . 0.0 109.591 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -56.73 -41.81 78.16 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 124.259 0.974 . . . . 0.0 111.813 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -65.81 -43.48 88.52 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.156 0.582 . . . . 0.0 110.13 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.422 ' HH2' HD22 ' A' ' 55' ' ' LEU . 42.1 m0 -60.73 -50.14 74.66 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.627 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.1 m -60.89 -43.83 97.95 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.134 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -70.38 -40.32 74.03 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.765 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -60.43 -39.6 88.04 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.974 0.51 . . . . 0.0 111.446 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.06 -48.89 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.372 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -66.72 -28.71 68.65 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.133 0.973 . . . . 0.0 112.804 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -80.89 -3.4 51.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.181 0.592 . . . . 0.0 112.474 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.67 21.29 72.79 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 117.465 0.121 . . . . 0.0 113.333 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -79.46 -25.83 41.85 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.727 0.811 . . . . 0.0 110.239 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.71 171.15 19.3 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.27 1.028 . . . . 0.0 108.992 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.9 p -104.81 168.02 9.34 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 171.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.7 p -56.48 -41.78 77.16 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.314 0.384 . . . . 0.0 111.888 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HA ' HG23 ' A' ' 76' ' ' VAL . 14.0 pt-20 -51.09 -40.84 59.34 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -175.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -57.45 -28.77 63.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.594 0.757 . . . . 0.0 112.773 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -114.5 -29.59 6.8 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.748 0.419 . . . . 0.0 112.092 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.08 24.67 12.62 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.556 0.742 . . . . 0.0 111.114 -166.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.518 HG12 ' HG2' ' A' ' 78' ' ' LYS . 43.7 t -104.64 141.25 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 160.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -54.52 -39.59 67.78 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.172 1.389 . . . . 0.0 114.584 -169.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.7 pttt -64.39 -42.19 96.25 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -75.38 -40.49 57.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.435 1.094 . . . . 0.0 110.155 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.3 tp -61.08 -53.36 58.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.436 1.094 . . . . 0.0 109.453 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.21 -27.36 68.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.618 0.767 . . . . 0.0 112.037 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.66 -48.59 63.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.008 0.523 . . . . 0.0 110.409 174.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.4 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 1.1 mmp_? -56.88 -46.07 82.09 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 124.443 1.089 . . . . 0.0 110.801 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 88' ' ' VAL . 84.1 mt -64.03 -52.82 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.203 1.001 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.5 -41.77 90.65 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.076 0.95 . . . . 0.0 112.456 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.19 -30.21 68.35 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.376 0.423 . . . . 0.0 110.339 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.92 -35.74 69.76 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.745 0.418 . . . . 0.0 111.666 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 84' ' ' ILE . 61.6 t -65.28 -41.32 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.473 0.654 . . . . 0.0 109.487 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.17 -37.52 81.08 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.85 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.47 97.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.458 0.703 . . . . 0.0 111.587 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.946 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.468 -174.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 8' ' ' VAL . 86.6 m . . . . . 0 CA--C 1.54 0.56 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -54.88 -45.18 74.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.507 1.123 . . . . 0.0 111.447 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.54 -47.03 85.55 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.786 0.679 . . . . 0.0 110.573 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.405 ' HB2' ' HZ ' ' A' ' 51' ' ' PHE . 39.1 mmt-85 -67.22 -37.85 84.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.056 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 4' ' ' THR . 97.8 t -73.36 -35.15 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.352 0.661 . . . . 0.0 110.511 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.69 91.9 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.554 0.742 . . . . 0.0 109.953 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 56.0 m -63.15 -46.26 88.05 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.013 0.821 . . . . 0.0 110.455 172.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.2 mt -57.8 -46.56 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.211 1.004 . . . . 0.0 111.154 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.544 HG22 HD11 ' A' ' 18' ' ' ILE . 50.6 mt -58.12 -49.81 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.039 0.936 . . . . 0.0 110.747 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.07 -44.4 71.11 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.989 0.916 . . . . 0.0 112.974 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 10' ' ' THR . 18.2 mm-40 -63.84 -32.14 73.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.916 0.886 . . . . 0.0 111.753 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.8 m -86.65 -34.3 19.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.408 0.683 . . . . 0.0 112.095 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.2 m -113.16 1.42 15.25 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.842 0.457 . . . . 0.0 112.167 -164.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 50.27 68.25 0.79 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.259 1.423 . . . . 0.0 112.246 -177.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.561 HD12 HD11 ' A' ' 23' ' ' ILE . 11.6 pt -145.97 157.86 49.75 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 124.551 1.14 . . . . 0.0 109.269 -177.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.43 120.71 6.65 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.772 2.315 . . . . 0.0 110.768 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HA ' HD13 ' A' ' 23' ' ' ILE . 1.2 ppt_? -64.66 -25.18 67.84 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -170.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -82.98 -11.97 57.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.605 0.762 . . . . 0.0 111.381 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -83.0 -18.38 40.03 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.459 0.303 . . . . 0.0 110.38 173.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.561 HD11 HD12 ' A' ' 18' ' ' ILE . 2.0 mp -74.76 117.06 18.31 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.1 p -91.54 158.84 39.97 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.133 0.973 . . . . 0.0 109.719 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.72 -21.56 56.72 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.414 2.076 . . . . 0.0 113.257 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -92.28 3.75 54.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.287 0.635 . . . . 0.0 111.161 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -71.99 123.15 22.15 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -84.0 119.47 24.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 169.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.63 -44.02 12.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.252 1.021 . . . . 0.0 112.722 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.19 -46.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 120.681 0.277 . . . . 0.0 110.322 -168.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.43 -35.79 24.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.338 0.655 . . . . 0.0 111.978 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -93.59 -55.45 3.27 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.313 0.645 . . . . 0.0 110.612 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.8 mt -82.21 -12.58 58.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.509 0.724 . . . . 0.0 112.218 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.86 34.21 86.47 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 113.897 0.319 . . . . 0.0 113.897 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 12' ' ' ILE . 90.1 mt -88.09 125.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.976 0.91 . . . . 0.0 108.675 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -72.39 158.99 34.73 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 37.6 m -62.21 -26.64 68.47 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.07 0.548 . . . . 0.0 111.637 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.65 -33.76 60.46 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 122.904 0.482 . . . . 0.0 110.384 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.27 -39.18 75.11 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.172 0.589 . . . . 0.0 109.519 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -66.15 -23.65 66.51 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.503 0.721 . . . . 0.0 110.236 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 37' ' ' SER . 90.7 mt -62.61 -37.0 84.56 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.064 0.546 . . . . 0.0 110.714 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -69.99 -39.16 76.06 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.312 0.645 . . . . 0.0 110.2 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 12' ' ' ILE . 2.4 mp -60.43 -47.32 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 123.617 0.573 . . . . 0.0 109.661 174.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.78 -37.7 82.4 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.724 0.809 . . . . 0.0 111.173 -174.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.76 -50.18 74.83 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.76 1.224 . . . . 0.0 111.068 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.83 -30.84 70.34 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.729 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.503 HD13 HD11 ' A' ' 84' ' ' ILE . 97.2 mt -65.77 -44.73 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.59 0.756 . . . . 0.0 110.646 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.53 -49.72 64.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.484 1.114 . . . . 0.0 110.803 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -76.52 -48.47 19.33 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.754 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.93 74.81 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.074 0.55 . . . . 0.0 112.375 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.405 ' HZ ' ' HB2' ' A' ' 7' ' ' ARG . 98.5 m-85 -86.74 -3.24 59.02 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.852 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.16 35.52 91.65 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.651 0.594 . . . . 0.0 113.003 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.9 pt -124.94 -177.13 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.712 1.205 . . . . 0.0 109.209 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -130.04 126.06 36.76 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 168.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.9 mt -80.81 128.18 72.52 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -73.02 59.33 3.6 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.933 2.422 . . . . 0.0 110.702 165.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.68 -39.66 89.25 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.368 1.067 . . . . 0.0 109.748 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.77 -44.96 82.31 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 124.005 0.815 . . . . 0.0 110.463 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.7 tppt? -68.8 -44.49 73.46 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 111.259 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -57.61 -52.39 65.6 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.039 0.837 . . . . 0.0 110.55 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.2 m -71.06 -24.78 62.4 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.481 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -69.27 -47.63 64.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.652 0.781 . . . . 0.0 110.725 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 21.2 mm-40 -60.17 -40.57 90.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.499 0.72 . . . . 0.0 110.735 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 53.4 t -59.78 -56.34 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.905 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -62.23 -33.49 74.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.647 0.779 . . . . 0.0 111.908 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -87.44 4.99 41.09 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.347 0.659 . . . . 0.0 111.754 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.45 25.87 70.35 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -91.67 -27.58 18.01 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.275 0.63 . . . . 0.0 110.731 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -139.18 152.06 47.09 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 m -81.57 156.47 25.19 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.007 0.523 . . . . 0.0 109.639 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.5 p -52.93 -46.58 68.16 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.853 0.861 . . . . 0.0 110.856 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.544 ' HA ' HG23 ' A' ' 76' ' ' VAL . 9.3 mm-40 -42.83 -52.75 4.93 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.152 1.381 . . . . 0.0 112.588 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -54.76 -21.25 10.47 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.271 -1.331 . . . . 0.0 114.021 -169.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -121.71 -29.79 4.28 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -108.03 15.04 24.68 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -168.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 72' ' ' GLU . 71.6 t -103.22 139.56 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.408 HD11 HD12 ' A' ' 12' ' ' ILE . 3.9 mm? -53.35 -38.15 63.03 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.233 1.413 . . . . 0.0 114.023 -173.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.9 pttp -70.33 -41.0 73.81 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 120.769 0.318 . . . . 0.0 111.097 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 80.1 m-20 -74.81 -34.67 62.42 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.926 0.89 . . . . 0.0 110.241 -177.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.97 -44.76 72.27 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.821 1.248 . . . . 0.0 108.871 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.51 -37.54 78.55 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.877 0.735 . . . . 0.0 111.098 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.73 71.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.672 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 9.6 mmp_? -50.54 -53.01 33.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.197 0.936 . . . . 0.0 111.419 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.503 HD11 HD13 ' A' ' 47' ' ' ILE . 71.2 mt -65.6 -43.9 93.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.625 -175.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.58 -39.64 88.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.623 0.769 . . . . 0.0 111.223 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.91 -35.05 77.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.524 0.73 . . . . 0.0 110.841 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.2 mt -73.67 -30.29 62.81 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.02 0.528 . . . . 0.0 111.352 176.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.497 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 69.5 t -71.02 -36.93 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.637 0.775 . . . . 0.0 109.455 172.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.76 -41.11 83.85 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.23 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.12 -42.63 93.75 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.154 0.981 . . . . 0.0 111.13 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.497 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 43.7 pttt . . . . . 0 C--N 1.357 0.895 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 8' ' ' VAL . 61.8 m . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.23 -46.1 79.68 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.728 0.411 . . . . 0.0 111.602 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.489 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 28.6 m-20 -59.56 -44.87 93.14 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.743 0.652 . . . . 0.0 110.688 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -64.74 -45.9 84.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.169 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 4' ' ' THR . 79.8 t -65.36 -43.89 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.625 0.77 . . . . 0.0 110.458 -175.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.86 97.16 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.132 0.973 . . . . 0.0 111.008 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.2 m -63.83 -42.72 97.56 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.18 0.925 . . . . 0.0 111.258 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 47' ' ' ILE . 96.7 mt -59.18 -51.01 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.578 0.751 . . . . 0.0 111.122 175.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.67 HG22 HD11 ' A' ' 18' ' ' ILE . 58.4 mt -59.8 -42.35 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.648 0.779 . . . . 0.0 110.534 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.485 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -56.39 -52.51 64.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.729 0.812 . . . . 0.0 112.713 173.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.47 -22.19 63.65 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.631 0.772 . . . . 0.0 112.327 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 m -85.06 -51.05 6.93 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.614 0.366 . . . . 0.0 111.11 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.604 ' SG ' HD11 ' A' ' 43' ' ' ILE . 74.7 m -100.29 7.59 44.29 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -168.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.8 t70 53.44 65.16 1.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.242 1.017 . . . . 0.0 111.871 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.67 HD11 HG22 ' A' ' 12' ' ' ILE . 10.1 pt -141.19 146.49 43.18 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.089 0.955 . . . . 0.0 109.418 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.28 114.33 2.62 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.716 2.277 . . . . 0.0 111.431 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.489 ' NH2' ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -53.61 -29.76 39.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.359 1.064 . . . . 0.0 113.175 -177.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.83 -27.53 62.96 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.191 0.597 . . . . 0.0 111.729 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -81.68 -5.56 58.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.825 0.45 . . . . 0.0 110.717 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.48 HD11 HD12 ' A' ' 18' ' ' ILE . 1.9 mp -86.36 113.49 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 174.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -95.16 165.9 15.95 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.843 0.857 . . . . 0.0 109.243 173.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.08 -18.47 61.94 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.291 1.994 . . . . 0.0 112.336 172.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -94.68 -0.21 54.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 122.948 0.499 . . . . 0.0 110.509 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.4 m -71.74 124.18 24.23 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.015 0.526 . . . . 0.0 110.383 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -85.66 123.18 30.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.83 -45.96 15.28 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.142 0.977 . . . . 0.0 112.207 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 mt -92.59 -48.16 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.86 -37.32 55.78 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.664 0.785 . . . . 0.0 112.357 -171.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.71 -59.21 1.86 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.587 0.355 . . . . 0.0 110.563 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.1 mt -75.92 -16.31 60.05 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.023 0.529 . . . . 0.0 112.417 -171.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.82 37.96 56.79 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.124 0.265 . . . . 0.0 113.303 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.51 HG23 ' HB2' ' A' ' 39' ' ' ASP . 93.5 mt -96.7 116.5 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.287 1.035 . . . . 0.0 108.928 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.46 164.56 26.45 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.8 m -56.41 -31.95 64.37 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.74 0.816 . . . . 0.0 111.614 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.76 -32.77 65.88 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 122.952 0.501 . . . . 0.0 111.088 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.51 ' HB2' HG23 ' A' ' 35' ' ' ILE . 28.6 m-20 -71.43 -40.99 70.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.965 0.506 . . . . 0.0 109.755 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.54 -22.01 64.52 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.212 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.62 -50.94 68.83 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.327 0.584 . . . . 0.0 110.439 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.42 -34.77 70.62 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.086 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.604 HD11 ' SG ' ' A' ' 16' ' ' CYS . 62.3 mt -63.92 -42.7 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 123.578 0.549 . . . . 0.0 110.192 173.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.46 -36.25 76.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.599 0.76 . . . . 0.0 110.645 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.44 -42.51 98.68 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.023 0.929 . . . . 0.0 110.272 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -42.02 84.16 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.137 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.408 ' HA ' HD13 ' A' ' 11' ' ' ILE . 84.1 mt -64.82 -43.71 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.763 0.825 . . . . 0.0 110.824 175.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -50.17 -54.09 23.26 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.076 1.35 . . . . 0.0 110.961 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -38.99 53.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.843 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.97 -45.37 86.85 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -88.43 -10.61 48.61 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.706 0.802 . . . . 0.0 112.562 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.23 48.57 81.82 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.396 0.435 . . . . 0.0 112.24 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.401 HG22 ' HG2' ' A' ' 91' ' ' LYS . 44.8 pt -131.26 169.18 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.95 1.3 . . . . 0.0 109.315 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -110.82 100.8 9.48 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.449 HD23 HD12 ' A' ' 87' ' ' LEU . 83.8 mt -67.94 123.07 86.26 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 122.695 0.398 . . . . 0.0 110.222 174.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.98 61.0 7.71 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.839 2.36 . . . . 0.0 110.124 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.08 -36.88 83.03 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.042 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -58.94 -42.3 89.44 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.553 0.741 . . . . 0.0 110.887 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.58 -52.12 66.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.652 0.781 . . . . 0.0 109.925 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -58.03 -43.77 86.97 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 124.474 1.108 . . . . 0.0 111.036 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -60.26 -47.74 84.7 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.904 0.882 . . . . 0.0 110.718 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -62.84 -40.26 96.9 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.272 0.629 . . . . 0.0 110.779 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG2' ' HD2' ' A' ' 68' ' ' LYS . 48.5 mt-10 -65.28 -41.65 93.96 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.189 0.931 . . . . 0.0 112.031 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.96 -47.4 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.436 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -57.31 -46.71 82.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.246 0.618 . . . . 0.0 111.669 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.08 0.02 50.04 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.239 0.616 . . . . 0.0 112.421 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.09 18.92 75.14 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.436 0.535 . . . . 0.0 114.436 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.432 ' HD2' ' HG2' ' A' ' 63' ' ' GLU . 62.3 mttm -69.76 -33.93 73.1 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 172.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.83 169.04 19.93 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.993 1.317 . . . . 0.0 108.397 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.5 p -116.12 163.45 15.93 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.08 0.952 . . . . 0.0 109.432 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p -55.71 -54.17 47.56 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 124.057 0.848 . . . . 0.0 112.746 -168.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -30.07 40.22 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.504 ' HA ' HD22 ' A' ' 79' ' ' ASN . 0.1 OUTLIER -62.37 -26.81 68.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.814 1.246 . . . . 0.0 111.797 -178.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -115.39 -26.98 7.36 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.215 0.606 . . . . 0.0 111.938 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -108.22 17.98 21.62 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.186 0.595 . . . . 0.0 112.277 -165.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.51 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.0 t -105.71 139.73 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 165.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 12' ' ' ILE . 3.8 mm? -52.68 -37.91 59.61 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.917 1.287 . . . . 0.0 114.308 -171.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.51 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.4 pttt -69.76 -45.19 68.63 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 123.163 0.29 . . . . 0.0 110.531 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.504 HD22 ' HA ' ' A' ' 73' ' ' GLN . 2.3 m-20 -68.08 -41.43 81.93 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.165 0.586 . . . . 0.0 110.616 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.09 -50.21 69.21 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.89 1.276 . . . . 0.0 109.536 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.94 71.86 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 123.615 0.572 . . . . 0.0 111.158 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -66.65 -50.6 62.42 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.853 0.461 . . . . 0.0 110.26 175.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.435 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 3.7 mmp_? -53.35 -50.19 65.56 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.861 0.864 . . . . 0.0 111.211 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 88' ' ' VAL . 87.7 mt -64.16 -45.65 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.948 1.299 . . . . 0.0 110.395 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.66 -36.43 78.68 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.155 0.982 . . . . 0.0 111.394 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 29.9 mm-40 -64.94 -43.76 91.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.581 0.752 . . . . 0.0 110.839 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.449 HD12 HD23 ' A' ' 55' ' ' LEU . 67.1 mt -70.89 -27.64 63.95 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.16 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 84' ' ' ILE . 78.7 t -67.83 -37.09 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.504 0.722 . . . . 0.0 110.114 172.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.3 75.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.068 0.547 . . . . 0.0 110.569 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.48 87.28 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.398 0.679 . . . . 0.0 111.275 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.401 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 8' ' ' VAL . 43.4 m . . . . . 0 CA--C 1.54 0.562 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -55.93 -48.85 74.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.314 0.646 . . . . 0.0 110.881 173.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.16 -50.11 59.58 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.022 0.826 . . . . 0.0 110.158 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.414 ' O ' HG13 ' A' ' 11' ' ' ILE . 6.1 mmp_? -70.34 -41.4 73.24 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.889 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 4' ' ' THR . 55.3 t -67.99 -40.98 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.162 0.585 . . . . 0.0 110.408 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.02 -37.97 89.38 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.086 0.954 . . . . 0.0 109.98 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.478 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 90.4 m -63.27 -44.21 95.74 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.52 174.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 7' ' ' ARG . 95.7 mt -58.81 -47.35 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.23 0.612 . . . . 0.0 111.359 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 18' ' ' ILE . 58.8 mt -57.44 -43.81 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.992 0.517 . . . . 0.0 110.102 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.494 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -57.76 -49.46 76.51 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.729 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 10' ' ' THR . 46.4 mm-40 -66.64 -33.46 75.71 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.297 0.639 . . . . 0.0 111.806 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.5 m -74.03 -50.72 18.49 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.502 0.721 . . . . 0.0 110.933 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 43' ' ' ILE . 39.8 m -97.37 3.95 50.88 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.812 0.845 . . . . 0.0 113.211 -169.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 45.67 77.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.418 1.087 . . . . 0.0 112.006 -171.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 12' ' ' ILE . 7.3 pt -147.74 147.59 27.81 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.021 0.929 . . . . 0.0 109.967 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.14 122.11 10.21 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.911 2.408 . . . . 0.0 111.561 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HG3' ' HA ' ' A' ' 10' ' ' THR . 2.5 tmm_? -64.46 -19.92 65.86 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.538 1.135 . . . . 0.0 112.453 -173.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.55 -22.41 60.09 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.842 0.857 . . . . 0.0 110.557 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.8 p -86.51 -10.68 53.58 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.158 0.583 . . . . 0.0 110.902 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.423 HD11 HD12 ' A' ' 18' ' ' ILE . 2.3 mp -91.76 93.48 4.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.1 p -82.7 164.12 48.44 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 124.107 0.963 . . . . 0.0 109.989 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.85 -21.13 72.87 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.162 1.908 . . . . 0.0 113.172 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -106.85 17.5 23.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.89 0.476 . . . . 0.0 110.409 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.9 m -72.33 120.3 17.74 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.112 0.565 . . . . 0.0 109.65 170.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -84.0 121.97 28.13 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 170.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -40.28 -50.71 2.77 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.886 1.274 . . . . 0.0 113.041 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.0 mt -92.85 -47.43 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 121.109 0.48 . . . . 0.0 110.188 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.51 -38.13 55.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.235 1.014 . . . . 0.0 112.221 -172.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.24 -65.2 0.98 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.359 0.664 . . . . 0.0 110.421 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.37 -12.71 61.57 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.76 0.824 . . . . 0.0 112.633 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.39 24.41 76.76 Favored Glycine 0 C--N 1.354 1.563 0 O-C-N 123.466 0.479 . . . . 0.0 114.235 174.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.9 mt -78.87 124.89 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.441 1.097 . . . . 0.0 109.371 -175.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.14 156.23 39.04 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.231 0.612 . . . . 0.0 110.987 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.8 m -63.55 -41.07 98.45 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.826 0.85 . . . . 0.0 111.863 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 pp -71.62 -28.86 64.08 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.927 0.394 . . . . 0.0 110.043 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.71 -36.9 59.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.185 0.994 . . . . 0.0 110.118 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -70.9 -23.32 62.25 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.482 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.64 -41.31 94.68 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.152 0.581 . . . . 0.0 111.091 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.66 -42.82 90.91 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.403 0.681 . . . . 0.0 110.305 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.446 HD11 ' SG ' ' A' ' 16' ' ' CYS . 59.6 mt -62.89 -45.03 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.755 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.81 -33.82 68.85 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.293 0.637 . . . . 0.0 110.532 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -59.9 -39.79 86.57 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.321 1.048 . . . . 0.0 110.435 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.46 -38.03 71.32 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.537 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.405 ' HA ' HD13 ' A' ' 11' ' ' ILE . 97.6 mt -66.69 -41.71 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.657 0.783 . . . . 0.0 110.383 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -52.11 -47.66 65.19 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.792 1.237 . . . . 0.0 110.694 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.29 -56.05 22.25 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.121 0.888 . . . . 0.0 110.846 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.71 -51.8 68.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.047 0.939 . . . . 0.0 112.302 -171.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -87.49 -14.54 40.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.286 0.634 . . . . 0.0 111.561 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.69 30.43 74.67 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 117.716 0.234 . . . . 0.0 113.329 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.412 HD13 HG23 ' A' ' 84' ' ' ILE . 32.7 pt -109.55 151.14 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.863 0.865 . . . . 0.0 110.967 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -93.34 95.67 9.47 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.455 HD21 HG12 ' A' ' 84' ' ' ILE . 83.8 mt -73.03 119.34 75.08 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.916 173.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -85.7 58.33 4.6 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.618 2.212 . . . . 0.0 109.152 165.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.71 -38.96 89.79 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.819 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -35.89 79.25 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.928 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.57 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.17 -51.13 41.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.221 0.608 . . . . 0.0 109.876 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.437 ' O ' HG23 ' A' ' 64' ' ' VAL . 51.4 m0 -55.57 -48.41 74.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.158 0.983 . . . . 0.0 111.349 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.7 m -62.82 -37.45 86.82 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.574 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -66.7 -43.15 85.17 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.253 0.621 . . . . 0.0 110.637 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 4.9 mm-40 -66.66 -33.88 76.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.589 0.756 . . . . 0.0 110.719 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 60' ' ' TRP . 54.4 t -61.38 -52.73 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.142 172.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -65.51 -27.04 68.19 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.098 0.559 . . . . 0.0 111.599 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.84 1.79 56.66 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.15 0.58 . . . . 0.0 111.702 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.93 12.93 71.89 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.8 mttp -72.6 -26.69 61.78 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 117.722 0.761 . . . . 0.0 110.119 172.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 168.03 22.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.32 1.048 . . . . 0.0 109.684 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.543 ' H ' HE21 ' A' ' 73' ' ' GLN . 51.5 p -100.28 163.53 12.35 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 124.266 1.027 . . . . 0.0 108.858 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.423 HG22 HG11 ' A' ' 64' ' ' VAL . 72.1 p -57.33 -43.28 83.22 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.626 0.579 . . . . 0.0 110.356 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' A' ' 76' ' ' VAL . 22.2 mm-40 -41.4 -53.61 3.29 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.369 1.467 . . . . 0.0 112.786 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.543 HE21 ' H ' ' A' ' 70' ' ' THR . 50.2 mt-30 -60.75 -21.36 62.92 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.318 -1.31 . . . . 0.0 114.106 -171.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -128.81 -4.38 5.18 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.89 20.09 7.74 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.994 0.518 . . . . 0.0 111.217 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 72' ' ' GLU . 95.8 t -108.99 144.36 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 164.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.86 -35.98 71.71 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -67.67 -40.18 84.49 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 120.889 0.376 . . . . 0.0 110.096 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.1 m120 -73.5 -47.31 42.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.087 0.955 . . . . 0.0 110.316 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.03 -47.88 84.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.954 1.302 . . . . 0.0 109.897 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.07 -36.38 81.49 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.556 0.743 . . . . 0.0 111.841 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.68 81.38 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.06 0.544 . . . . 0.0 110.654 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 24.7 mmm180 -59.39 -48.48 81.49 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.772 0.829 . . . . 0.0 110.637 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 88' ' ' VAL . 97.0 mt -63.87 -43.1 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.699 1.2 . . . . 0.0 110.863 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.06 -39.06 93.6 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.567 0.747 . . . . 0.0 111.045 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -63.58 -40.88 98.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.547 0.739 . . . . 0.0 110.711 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 75.2 mt -70.57 -34.32 72.08 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.963 0.505 . . . . 0.0 112.019 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 84' ' ' ILE . 91.9 t -64.56 -42.64 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-O 121.454 0.645 . . . . 0.0 109.512 174.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.74 -37.63 79.56 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.176 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.36 -44.63 87.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.105 0.962 . . . . 0.0 111.413 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.1 pttp . . . . . 0 CA--C 1.542 0.671 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.287 -178.459 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 8' ' ' VAL . 10.3 m . . . . . 0 N--CA 1.474 0.749 0 CA-C-O 119.824 -0.131 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -57.56 -48.8 78.33 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 123.007 0.523 . . . . 0.0 111.166 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.81 -44.5 70.25 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.386 0.674 . . . . 0.0 110.862 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -60.2 -54.05 50.47 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.479 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 4' ' ' THR . 95.6 t -67.55 -38.98 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.419 0.688 . . . . 0.0 111.245 -172.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.64 92.13 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.673 1.189 . . . . 0.0 110.339 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 85.9 m -66.63 -40.46 88.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.554 176.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.49 -49.81 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.15 0.432 . . . . 0.0 111.383 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.567 HG12 HG21 ' A' ' 43' ' ' ILE . 51.8 mt -58.79 -41.03 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 122.789 0.435 . . . . 0.0 110.166 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.74 -60.27 3.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.803 0.841 . . . . 0.0 112.542 173.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 10' ' ' THR . 17.3 mm-40 -65.43 -34.6 78.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.196 0.598 . . . . 0.0 112.146 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.4 m -72.87 -58.6 3.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.189 0.595 . . . . 0.0 110.331 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.7 t -84.99 3.5 38.21 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.06 65.91 1.37 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.405 1.082 . . . . 0.0 111.577 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.545 HG13 ' HA ' ' A' ' 13' ' ' ALA . 10.4 pt -145.3 159.33 49.2 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.801 1.24 . . . . 0.0 109.023 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -75.09 133.77 16.85 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.767 2.312 . . . . 0.0 111.802 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -18.9 65.63 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -81.87 -19.79 40.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.485 0.714 . . . . 0.0 109.873 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 p -79.88 -7.75 58.91 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 122.568 0.347 . . . . 0.0 110.851 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.1 114.06 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.1 p -100.25 160.58 26.67 Favored Pre-proline 0 N--CA 1.488 1.437 0 C-N-CA 123.302 0.641 . . . . 0.0 110.471 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.05 -25.83 58.57 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 122.718 2.278 . . . . 0.0 112.671 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -91.77 1.97 56.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.671 0.788 . . . . 0.0 111.114 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 t -83.01 137.83 33.98 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.302 0.641 . . . . 0.0 111.345 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.516 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 54.7 t-80 -82.8 111.86 19.1 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 165.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.38 -20.25 28.28 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.516 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 84.6 mt -99.57 -41.25 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.599 0.76 . . . . 0.0 110.586 -177.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 32.4 t70 -79.98 -52.0 8.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.416 0.686 . . . . 0.0 112.227 -173.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -74.94 -48.95 21.84 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.365 0.602 . . . . 0.0 111.164 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.5 mt -73.23 -12.78 60.98 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.49 -176.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.17 35.57 88.75 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 121.296 0.387 . . . . 0.0 112.662 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.5 mt -99.84 126.08 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -61.34 153.35 26.91 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 118.144 0.429 . . . . 0.0 110.73 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.4 m -63.61 -29.09 70.38 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.008 0.523 . . . . 0.0 109.988 176.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.57 -39.26 62.36 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.718 0.807 . . . . 0.0 109.96 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.18 -26.65 61.26 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.549 0.74 . . . . 0.0 110.11 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -74.34 -27.67 60.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.722 0.809 . . . . 0.0 110.504 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' SER . 89.8 mt -56.43 -33.44 65.84 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 122.632 0.373 . . . . 0.0 110.869 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.92 -41.61 64.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.666 0.786 . . . . 0.0 110.631 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.567 HG21 HG12 ' A' ' 12' ' ' ILE . 47.9 mt -62.81 -41.06 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.062 0.458 . . . . 0.0 110.175 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.14 -29.95 63.25 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.29 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -59.01 -42.23 89.63 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.969 0.908 . . . . 0.0 109.892 170.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.6 -42.43 74.41 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.338 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.46 -42.84 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.762 0.825 . . . . 0.0 110.597 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.59 -48.22 69.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.892 1.277 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -72.52 -42.77 64.42 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.2 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.44 77.02 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.834 0.854 . . . . 0.0 112.463 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -87.11 -7.94 57.52 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 111.449 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.65 32.82 85.48 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.328 0.392 . . . . 0.0 113.194 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 pt -112.61 169.59 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.198 0.999 . . . . 0.0 110.761 -173.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -104.83 101.71 11.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.516 HD21 HG12 ' A' ' 84' ' ' ILE . 95.7 mt -72.43 114.49 30.28 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 167.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.534 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 87.7 Cg_endo -81.94 63.86 8.4 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.037 1.824 . . . . 0.0 109.833 168.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.5 -38.16 88.81 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.035 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.23 -42.67 99.26 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.898 0.479 . . . . 0.0 111.027 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 54.3 tptt -58.75 -47.3 85.13 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.366 1.066 . . . . 0.0 110.79 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.414 ' O ' HG23 ' A' ' 64' ' ' VAL . 53.4 m0 -63.48 -46.03 88.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.554 0.742 . . . . 0.0 110.867 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.5 m -64.85 -32.94 74.87 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.367 1.067 . . . . 0.0 110.965 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.21 -42.32 62.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.438 0.695 . . . . 0.0 109.734 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.32 -35.41 75.57 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.654 0.781 . . . . 0.0 111.046 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' TRP . 85.0 t -64.97 -46.16 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 173.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.31 -40.27 96.87 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.137 0.975 . . . . 0.0 112.825 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.04 -1.67 58.05 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.42 0.688 . . . . 0.0 112.646 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.67 30.52 77.89 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 11.3 mmpt? -77.18 -33.21 56.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.951 0.901 . . . . 0.0 109.444 171.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.64 168.45 20.13 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.673 1.189 . . . . 0.0 108.747 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.5 p -108.9 162.11 14.5 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.61 0.764 . . . . 0.0 111.149 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.0 p -58.07 -64.47 0.9 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.74 0.816 . . . . 0.0 111.797 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -30.49 62.0 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -55.74 -24.84 37.43 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.545 1.138 . . . . 0.0 112.861 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -111.36 -44.0 3.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.313 0.645 . . . . 0.0 111.095 173.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -97.94 21.76 10.21 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.994 0.518 . . . . 0.0 112.306 -163.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.575 HG12 ' HG2' ' A' ' 78' ' ' LYS . 25.5 t -106.01 140.63 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 165.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.459 HD11 HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -55.37 -39.49 70.16 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -167.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.575 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.9 pttt -61.34 -43.12 99.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.608 0.718 . . . . 0.0 110.191 176.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 83.9 m-20 -75.96 -44.97 37.32 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.888 1.275 . . . . 0.0 109.967 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.74 -53.46 57.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.187 1.395 . . . . 0.0 109.836 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.27 70.69 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.453 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.09 76.57 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.978 0.511 . . . . 0.0 111.678 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 3.6 mmp_? -59.81 -49.59 77.12 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.723 0.773 . . . . 0.0 109.806 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.516 HG12 HD21 ' A' ' 55' ' ' LEU . 88.6 mt -58.89 -45.64 91.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.587 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -64.64 -37.23 86.85 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.964 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -66.68 -32.87 74.47 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.803 0.441 . . . . 0.0 110.818 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.16 -30.92 60.87 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.278 0.631 . . . . 0.0 111.702 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.2 t -69.28 -35.57 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.385 0.674 . . . . 0.0 110.119 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.35 -37.92 77.89 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.484 173.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.69 -39.01 93.26 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.865 0.866 . . . . 0.0 111.933 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt . . . . . 0 N--CA 1.477 0.886 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.475 -179.854 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 8' ' ' VAL . 28.0 m . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 119.556 -0.259 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -53.69 -49.04 68.87 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 0.0 111.486 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.36 -42.29 98.46 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.636 0.774 . . . . 0.0 110.795 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -64.24 -42.11 96.68 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.25 0.969 . . . . 0.0 111.22 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 4' ' ' THR . 89.0 t -69.93 -38.26 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.732 0.813 . . . . 0.0 110.685 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.91 81.08 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.229 1.011 . . . . 0.0 110.133 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.4 m -63.89 -44.42 93.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.614 0.766 . . . . 0.0 110.615 171.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 47' ' ' ILE . 95.3 mt -57.39 -50.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.754 0.822 . . . . 0.0 111.269 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.619 HG22 HD11 ' A' ' 18' ' ' ILE . 51.8 mt -60.09 -48.05 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.32 0.648 . . . . 0.0 110.405 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.533 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.73 -49.96 64.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.161 0.985 . . . . 0.0 112.675 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -68.19 -42.31 80.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.437 0.695 . . . . 0.0 112.19 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.9 m -68.02 -48.33 66.0 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.646 0.378 . . . . 0.0 110.585 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 43' ' ' ILE . 34.2 m -91.88 -2.52 56.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.88 0.872 . . . . 0.0 113.157 -171.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.2 t70 52.83 69.64 0.67 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.998 0.919 . . . . 0.0 111.56 -171.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.619 HD11 HG22 ' A' ' 12' ' ' ILE . 9.6 pt -143.53 156.86 59.98 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.782 1.233 . . . . 0.0 108.748 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.95 137.96 39.22 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.58 2.187 . . . . 0.0 111.546 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -62.65 -28.47 69.94 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.722 0.809 . . . . 0.0 111.349 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.85 -21.58 57.1 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.0 0.52 . . . . 0.0 111.071 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.2 p -83.97 1.65 42.62 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.547 0.339 . . . . 0.0 111.101 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.75 111.5 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 168.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.4 p -101.46 161.57 23.18 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.663 0.785 . . . . 0.0 109.869 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.66 -27.2 75.87 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.007 1.805 . . . . 0.0 112.347 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -96.27 2.66 53.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.98 0.512 . . . . 0.0 110.846 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.3 p -74.22 129.33 37.61 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -83.97 115.63 22.41 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -44.61 -39.46 5.02 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.812 1.245 . . . . 0.0 113.96 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.9 mt -95.31 -56.73 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 122.731 0.413 . . . . 0.0 110.486 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -80.01 -23.45 41.49 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.798 0.839 . . . . 0.0 112.965 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -108.25 -61.01 1.65 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.967 0.507 . . . . 0.0 110.915 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.52 -20.01 62.1 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.614 0.765 . . . . 0.0 111.902 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.91 36.42 92.08 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.656 0.598 . . . . 0.0 114.509 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.469 HG21 HD12 ' A' ' 43' ' ' ILE . 61.1 mt -84.22 123.67 39.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 123.569 0.747 . . . . 0.0 109.038 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.08 149.24 33.07 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.303 0.641 . . . . 0.0 110.323 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.408 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 23.9 m -60.46 -38.66 84.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.203 0.601 . . . . 0.0 110.533 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 39' ' ' ASP . 3.4 pp -71.29 -29.94 65.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.182 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.405 ' N ' HD12 ' A' ' 38' ' ' LEU . 20.9 t70 -78.28 -36.18 46.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.456 0.703 . . . . 0.0 109.893 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -71.08 -21.99 62.16 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.388 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 37' ' ' SER . 96.3 mt -60.56 -37.87 82.68 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.796 0.438 . . . . 0.0 110.92 170.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -72.9 -40.46 65.53 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.142 0.577 . . . . 0.0 110.391 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.651 HD11 ' SG ' ' A' ' 16' ' ' CYS . 46.4 mt -61.25 -46.31 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 123.694 0.622 . . . . 0.0 110.408 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -70.78 -35.27 72.5 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.126 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -65.09 -38.44 90.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.52 0.728 . . . . 0.0 110.813 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.92 -28.11 64.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.365 0.666 . . . . 0.0 111.037 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 53' ' ' ILE . 96.9 mt -68.96 -41.42 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.965 0.906 . . . . 0.0 109.602 171.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.2 -39.53 93.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.673 0.789 . . . . 0.0 111.109 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -67.83 -52.19 39.71 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.677 0.791 . . . . 0.0 111.112 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.82 -48.02 75.91 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.255 0.622 . . . . 0.0 112.591 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -90.11 -11.16 42.08 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.548 0.739 . . . . 0.0 112.386 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.2 74.46 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 123.361 0.413 . . . . 0.0 113.08 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 47' ' ' ILE . 45.5 pt -108.22 -175.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.157 0.983 . . . . 0.0 110.015 -174.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -138.53 107.9 6.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 167.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.595 HD21 HG12 ' A' ' 84' ' ' ILE . 93.8 mt -69.72 130.4 90.35 Favored Pre-proline 0 C--O 1.243 0.738 0 C-N-CA 123.076 0.55 . . . . 0.0 109.733 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -72.43 59.71 3.25 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 123.344 2.696 . . . . 0.0 110.493 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.71 -45.44 78.74 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.785 0.834 . . . . 0.0 109.866 -171.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -39.57 92.21 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 123.856 0.722 . . . . 0.0 110.926 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.59 -45.33 92.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.227 1.011 . . . . 0.0 110.59 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.429 ' O ' HG23 ' A' ' 64' ' ' VAL . 52.6 m0 -65.74 -45.29 83.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.605 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.5 m -64.43 -31.52 72.76 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.862 0.865 . . . . 0.0 110.221 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.72 -44.57 70.04 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.39 -42.7 96.44 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.753 0.821 . . . . 0.0 111.305 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 60' ' ' TRP . 78.2 t -62.59 -53.82 42.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.342 0.657 . . . . 0.0 110.741 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -66.28 -22.56 66.3 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.836 0.854 . . . . 0.0 112.768 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -98.99 4.72 47.31 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.452 0.701 . . . . 0.0 112.045 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 15.3 65.69 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 115.181 0.833 . . . . 0.0 115.181 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -78.61 -23.81 45.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.456 0.703 . . . . 0.0 110.588 174.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -146.53 163.14 36.69 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.865 0.866 . . . . 0.0 109.253 173.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.0 p -91.65 165.12 13.48 Favored 'General case' 0 C--O 1.247 0.955 0 C-N-CA 123.404 0.682 . . . . 0.0 110.131 172.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.4 p -57.86 -55.02 40.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.99 0.806 . . . . 0.0 109.896 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.417 ' HA ' HG23 ' A' ' 76' ' ' VAL . 14.8 pt-20 -52.77 -35.6 56.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.872 1.269 . . . . 0.0 113.831 -175.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -55.01 -33.74 62.86 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.878 0.871 . . . . 0.0 112.844 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -117.52 -24.4 7.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.921 0.488 . . . . 0.0 112.085 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.73 26.68 10.38 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.459 0.704 . . . . 0.0 110.494 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 78' ' ' LYS . 52.3 t -109.76 143.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 158.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.4 -37.6 81.32 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.499 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.2 pttp -68.87 -41.88 77.77 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 120.891 0.377 . . . . 0.0 110.286 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.5 m120 -68.2 -47.82 66.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.808 0.843 . . . . 0.0 110.191 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -57.76 -49.18 77.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.14 1.376 . . . . 0.0 110.51 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.51 -34.19 73.73 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.707 0.803 . . . . 0.0 111.975 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.86 87.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.836 0.454 . . . . 0.0 110.931 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 9.1 mmm180 -66.21 -41.33 90.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.52 0.728 . . . . 0.0 111.479 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.595 HG12 HD21 ' A' ' 55' ' ' LEU . 96.4 mt -63.19 -50.08 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.242 1.017 . . . . 0.0 110.517 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -60.6 -44.25 96.5 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.946 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.46 -31.49 70.82 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.753 0.421 . . . . 0.0 110.765 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.435 HD12 HD23 ' A' ' 55' ' ' LEU . 54.7 mt -67.32 -39.88 85.89 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.869 0.467 . . . . 0.0 111.568 173.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.454 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 60.5 t -63.54 -44.1 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.47 94.77 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.567 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.27 -39.11 55.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.517 0.727 . . . . 0.0 112.824 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 88' ' ' VAL . 20.7 pttp . . . . . 0 N--CA 1.488 1.44 0 C-N-CA 122.585 0.354 . . . . 0.0 110.541 -176.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.4 m . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 119.675 -0.203 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -54.87 -47.82 73.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.475 0.71 . . . . 0.0 111.763 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.07 -43.58 98.68 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.658 0.599 . . . . 0.0 110.951 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -61.73 -44.08 97.62 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.361 0.665 . . . . 0.0 111.823 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 4' ' ' THR . 89.1 t -69.71 -41.32 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.879 0.872 . . . . 0.0 110.46 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.03 93.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.71 0.804 . . . . 0.0 110.85 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.5 m -64.51 -44.75 89.92 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 124.0 0.813 . . . . 0.0 111.227 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 47' ' ' ILE . 96.8 mt -57.26 -51.23 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.001 0.52 . . . . 0.0 110.908 176.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.6 HG12 HG21 ' A' ' 43' ' ' ILE . 32.1 mt -56.67 -48.02 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.986 0.914 . . . . 0.0 110.511 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . . . -52.66 -59.39 4.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.467 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.48 -24.22 56.89 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.426 -171.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.7 m -82.79 -44.25 15.75 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 117.864 0.302 . . . . 0.0 110.734 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.537 ' HB2' HD11 ' A' ' 43' ' ' ILE . 49.5 t -96.46 -3.71 42.92 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.655 0.782 . . . . 0.0 112.977 -172.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t70 59.65 65.68 1.11 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.455 1.102 . . . . 0.0 111.57 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.1 pt -146.47 150.48 40.7 Favored Pre-proline 0 N--CA 1.486 1.352 0 C-N-CA 124.555 1.142 . . . . 0.0 108.861 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.95 128.69 19.2 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.41 2.073 . . . . 0.0 111.929 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -65.29 -18.25 65.16 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.883 0.473 . . . . 0.0 111.77 178.081 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -79.65 -22.17 43.9 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.512 0.725 . . . . 0.0 109.95 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.0 p -87.21 5.23 39.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.705 0.402 . . . . 0.0 110.75 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.603 HG23 ' HG ' ' A' ' 77' ' ' LEU . 1.8 mp -95.01 130.98 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 166.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -124.15 159.75 55.43 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 123.802 0.841 . . . . 0.0 110.165 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.87 -44.87 44.94 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.284 2.656 . . . . 0.0 113.677 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.96 11.61 29.0 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.906 0.482 . . . . 0.0 110.602 -173.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 t -72.92 130.91 41.45 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 123.606 0.762 . . . . 0.0 109.717 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -84.85 117.01 23.62 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -49.56 -35.11 19.47 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.37 -55.21 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -78.8 -38.16 39.02 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -170.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -87.62 -59.63 2.19 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.732 0.413 . . . . 0.0 110.015 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 29' ' ' ALA . 90.4 mt -70.17 -23.66 63.02 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.38 0.672 . . . . 0.0 111.423 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.2 39.82 96.36 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.781 0.676 . . . . 0.0 113.16 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -72.91 115.34 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.08 144.11 24.81 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.91 0.884 . . . . 0.0 110.226 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 p -55.0 -42.84 72.98 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.957 0.903 . . . . 0.0 112.116 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.1 mt -67.39 -44.79 78.01 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.569 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -64.21 -26.86 68.7 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.984 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -74.06 -34.0 63.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.55 -38.54 90.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.102 0.561 . . . . 0.0 110.189 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.43 -46.0 88.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.029 0.932 . . . . 0.0 110.697 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.6 HG21 HG12 ' A' ' 12' ' ' ILE . 68.2 mt -65.61 -41.64 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.33 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.42 -39.56 74.36 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -54.75 -43.34 72.61 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.483 1.113 . . . . 0.0 110.907 171.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.23 -30.8 66.78 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.195 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.428 ' HA ' HD13 ' A' ' 11' ' ' ILE . 83.8 mt -67.79 -46.1 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.241 0.617 . . . . 0.0 110.438 175.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -56.88 -46.2 82.03 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.723 0.809 . . . . 0.0 110.727 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -67.92 -47.04 69.85 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.014 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.34 99.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.188 0.595 . . . . 0.0 112.322 -175.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -92.22 -11.33 35.68 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.498 0.719 . . . . 0.0 112.328 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.98 31.34 69.69 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-O 121.133 0.296 . . . . 0.0 113.171 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.3 pt -119.79 -177.27 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.641 1.176 . . . . 0.0 109.892 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -135.73 107.88 7.22 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 166.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.651 HD21 HG12 ' A' ' 84' ' ' ILE . 88.4 mt -61.77 128.33 90.23 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 168.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.76 59.17 2.73 Favored 'Trans proline' 0 C--N 1.367 1.515 0 C-N-CA 122.946 2.431 . . . . 0.0 111.624 170.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.0 -40.74 94.7 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.056 1.342 . . . . 0.0 109.629 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -57.28 -45.78 83.74 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.006 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -68.79 -43.89 74.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.277 0.631 . . . . 0.0 110.53 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.448 ' HH2' HD22 ' A' ' 55' ' ' LEU . 50.4 m0 -59.98 -48.53 81.34 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.308 1.005 . . . . 0.0 111.252 -176.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.2 m -63.97 -35.58 81.15 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 124.258 0.974 . . . . 0.0 110.167 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.38 -38.22 71.55 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.082 0.553 . . . . 0.0 110.86 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.25 -38.25 90.42 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.835 0.854 . . . . 0.0 110.942 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 60' ' ' TRP . 91.6 t -64.53 -44.89 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.825 174.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.81 -46.22 88.12 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.63 0.772 . . . . 0.0 112.437 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 50.9 m-20 -81.01 -2.54 48.39 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.462 0.705 . . . . 0.0 112.673 -176.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.23 28.89 74.09 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 114.0 0.36 . . . . 0.0 114.0 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HG3' ' HB2' ' A' ' 66' ' ' ASP . 95.4 mttt -74.77 -34.01 62.39 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.577 0.751 . . . . 0.0 109.723 171.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.6 163.58 36.81 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.591 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -88.63 154.74 20.07 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.603 1.161 . . . . 0.0 109.493 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -38.85 87.29 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.682 0.793 . . . . 0.0 110.343 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -43.76 -50.74 7.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.618 1.567 . . . . 0.0 111.761 172.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.418 ' HA ' ' ND2' ' A' ' 79' ' ' ASN . 44.0 mt-30 -61.04 -16.12 39.93 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.526 -1.216 . . . . 0.0 114.198 -170.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -126.52 -20.86 4.27 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -117.12 20.73 13.62 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.977 0.511 . . . . 0.0 111.846 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.405 HG12 ' HG2' ' A' ' 78' ' ' LYS . 24.4 t -97.71 147.17 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 163.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.603 ' HG ' HG23 ' A' ' 23' ' ' ILE . 4.0 mm? -57.69 -54.51 46.01 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.743 1.217 . . . . 0.0 114.225 -172.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.9 pttt -61.1 -36.74 80.48 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.165 0.586 . . . . 0.0 110.776 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 41.3 t-20 -76.33 -46.95 25.29 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.739 -171.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.62 -46.94 85.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.565 1.546 . . . . 0.0 109.716 173.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.59 -33.04 73.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.868 0.867 . . . . 0.0 111.189 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.04 -46.45 71.11 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.766 0.426 . . . . 0.0 110.386 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 12.9 mmp_? -55.87 -46.28 78.3 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.469 0.707 . . . . 0.0 110.753 177.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.651 HG12 HD21 ' A' ' 55' ' ' LEU . 90.1 mt -61.31 -49.55 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.877 1.271 . . . . 0.0 110.205 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.63 -37.81 79.67 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.394 1.077 . . . . 0.0 111.396 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -69.87 -39.53 76.26 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.113 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.5 HD12 HD23 ' A' ' 55' ' ' LEU . 79.9 mt -67.8 -34.29 76.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 123.417 0.448 . . . . 0.0 110.811 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 84' ' ' ILE . 96.8 t -68.98 -40.25 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.712 0.805 . . . . 0.0 109.526 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.86 -40.53 87.91 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.609 0.764 . . . . 0.0 111.546 177.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.71 -36.35 78.35 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.139 0.975 . . . . 0.0 111.789 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.2 pttp . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 122.384 0.274 . . . . 0.0 110.835 -177.984 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 8' ' ' VAL . 24.9 m . . . . . 0 CA--C 1.548 0.892 0 CA-C-O 120.15 0.024 . . . . 0.0 111.059 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -56.89 -51.93 67.15 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.377 0.671 . . . . 0.0 110.468 171.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -58.52 -39.04 79.02 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.82 0.848 . . . . 0.0 111.552 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.0 mmt180 -57.64 -51.12 70.81 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.894 0.878 . . . . 0.0 111.324 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 4' ' ' THR . 81.0 t -72.26 -36.27 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.717 0.807 . . . . 0.0 111.274 -173.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.0 -42.44 80.32 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.889 0.876 . . . . 0.0 110.488 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 m -65.94 -47.63 74.04 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.796 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.8 mt -55.42 -54.75 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 123.409 0.684 . . . . 0.0 111.462 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.699 HG12 HG21 ' A' ' 43' ' ' ILE . 37.5 mt -57.57 -45.27 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.165 0.986 . . . . 0.0 110.959 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.424 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.19 -54.8 30.7 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.946 0.899 . . . . 0.0 112.812 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.53 -35.99 82.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.607 0.763 . . . . 0.0 111.94 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.0 m -69.59 -57.86 4.67 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 123.715 0.635 . . . . 0.0 110.387 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.573 ' SG ' HD11 ' A' ' 43' ' ' ILE . 81.1 m -96.1 11.97 32.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.553 0.741 . . . . 0.0 112.858 -170.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 42.63 67.69 0.58 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.975 1.31 . . . . 0.0 112.23 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.621 HD11 HG22 ' A' ' 12' ' ' ILE . 17.3 pt -137.61 146.03 51.49 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 124.809 1.244 . . . . 0.0 108.174 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.64 120.26 7.71 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.703 2.268 . . . . 0.0 112.845 -174.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -51.43 -39.91 58.29 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.477 1.511 . . . . 0.0 113.153 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.49 -14.1 58.55 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.241 0.216 . . . . 0.0 111.57 -172.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 p -83.87 1.51 42.87 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-O 120.616 0.246 . . . . 0.0 110.557 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.493 HG23 ' HG ' ' A' ' 77' ' ' LEU . 1.9 mp -86.84 137.6 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 165.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 p -125.98 161.69 49.97 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 123.663 0.785 . . . . 0.0 109.403 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.8 -29.44 80.99 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 121.933 1.755 . . . . 0.0 112.372 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.38 0.78 51.06 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.863 0.465 . . . . 0.0 111.393 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.6 p -75.98 132.67 40.34 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.758 0.253 . . . . 0.0 110.49 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -85.6 118.64 25.24 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.507 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -50.44 -27.88 7.27 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 55.2 mt -101.37 -55.12 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.133 0.492 . . . . 0.0 110.298 -175.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.17 -37.73 81.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.978 0.911 . . . . 0.0 112.018 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -95.7 -60.04 1.74 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.115 0.566 . . . . 0.0 110.859 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 29' ' ' ALA . 90.9 mt -71.87 -8.17 52.77 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.29 34.63 75.27 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.071 0.232 . . . . 0.0 113.52 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 88.3 mt -110.94 114.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.016 0.926 . . . . 0.0 108.802 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.46 156.73 28.59 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.957 0.503 . . . . 0.0 110.335 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.445 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 22.4 m -58.73 -27.89 65.32 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.664 0.786 . . . . 0.0 112.226 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.39 -48.49 67.22 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.014 0.526 . . . . 0.0 109.855 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.51 -33.27 75.51 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.001 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -72.04 -28.45 63.36 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.902 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 37' ' ' SER . 87.8 mt -61.04 -44.76 96.92 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.24 -41.3 98.3 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.161 0.984 . . . . 0.0 111.338 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.699 HG21 HG12 ' A' ' 12' ' ' ILE . 63.3 mt -65.58 -45.18 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-O 121.048 0.452 . . . . 0.0 110.665 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.48 -32.54 70.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.325 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -66.5 -36.72 83.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.582 0.753 . . . . 0.0 110.485 173.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.85 -34.23 77.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.914 0.486 . . . . 0.0 110.63 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.32 -38.45 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.712 0.805 . . . . 0.0 110.381 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -58.2 -44.69 88.23 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.571 0.748 . . . . 0.0 111.314 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -70.73 -44.46 66.78 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.535 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.78 -55.86 22.62 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.785 0.834 . . . . 0.0 112.827 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.517 ' HB2' HG12 ' A' ' 53' ' ' ILE . 97.4 m-85 -90.33 -10.98 42.07 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.326 0.65 . . . . 0.0 112.175 -177.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.14 70.18 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 -173.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 51' ' ' PHE . 43.9 pt -109.22 -176.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.083 0.953 . . . . 0.0 109.859 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -139.24 110.56 6.97 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 172.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.461 HD21 HG12 ' A' ' 84' ' ' ILE . 84.4 mt -83.58 120.04 74.74 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 170.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.71 58.77 1.12 Allowed 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.952 2.435 . . . . 0.0 112.113 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.443 HD22 ' CE3' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -66.18 -37.69 86.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.804 0.842 . . . . 0.0 110.195 -169.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -35.62 73.06 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.373 0.421 . . . . 0.0 111.203 175.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.451 ' NZ ' ' HB2' ' A' ' 59' ' ' LYS . 3.6 ttmp? -82.39 -29.15 31.03 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 123.253 0.621 . . . . 0.0 110.674 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.443 ' CE3' HD22 ' A' ' 57' ' ' LEU . 45.7 m0 -69.58 -40.62 76.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.365 0.666 . . . . 0.0 109.729 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.4 m -64.22 -34.78 78.89 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.502 173.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -69.33 -47.82 63.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.415 1.086 . . . . 0.0 110.259 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 45.9 mt-10 -61.06 -49.23 78.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.446 1.098 . . . . 0.0 111.56 -177.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.47 -37.54 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.509 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -64.19 -40.06 95.3 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.463 0.705 . . . . 0.0 111.129 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.84 1.67 51.64 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.153 0.981 . . . . 0.0 112.244 -172.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.25 18.49 75.04 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.58 -31.96 67.54 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.72 169.83 17.01 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.581 1.153 . . . . 0.0 109.638 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.8 m -105.15 160.23 15.23 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.467 1.107 . . . . 0.0 110.458 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.0 p -62.63 77.39 0.02 OUTLIER 'General case' 0 C--N 1.364 1.219 0 C-N-CA 124.385 1.074 . . . . 0.0 110.542 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -178.97 -61.78 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.726 -169.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -58.55 -23.96 59.62 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.963 -165.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -119.21 -16.23 9.09 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -111.68 13.11 21.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.907 0.483 . . . . 0.0 112.186 -168.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.456 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.0 t -106.15 143.04 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 171.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.493 ' HG ' HG23 ' A' ' 23' ' ' ILE . 3.5 mm? -54.67 -42.54 71.48 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.212 1.405 . . . . 0.0 114.094 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.1 pttt -68.38 -39.84 81.6 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 117.712 0.233 . . . . 0.0 111.393 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.24 -44.06 69.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.4 0.68 . . . . 0.0 110.368 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.6 tp -58.17 -52.94 63.46 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.553 1.141 . . . . 0.0 109.896 177.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.19 72.19 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.939 0.895 . . . . 0.0 112.334 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.61 -50.42 58.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -53.95 -48.08 70.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.225 1.01 . . . . 0.0 111.403 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.467 HG23 HD13 ' A' ' 53' ' ' ILE . 96.7 mt -58.21 -53.28 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.435 1.094 . . . . 0.0 110.4 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -62.64 -33.24 74.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.01 0.924 . . . . 0.0 112.384 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -64.4 -42.2 96.24 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.287 0.635 . . . . 0.0 110.427 174.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.5 -39.36 77.66 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.58 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 84' ' ' ILE . 87.5 t -66.36 -39.44 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.835 0.854 . . . . 0.0 110.278 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.65 -37.57 88.05 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.307 173.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.67 73.71 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.832 0.853 . . . . 0.0 111.534 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.899 0.381 . . . . 0.0 110.85 -176.488 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 8' ' ' VAL . 58.3 m . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 111.363 0.134 . . . . 0.0 111.363 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -56.28 -46.9 79.53 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.266 0.627 . . . . 0.0 111.499 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.29 -46.17 86.58 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.559 0.537 . . . . 0.0 110.859 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -60.71 -45.33 94.61 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.24 0.963 . . . . 0.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 4' ' ' THR . 88.5 t -67.37 -41.01 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.579 0.752 . . . . 0.0 110.288 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.2 99.24 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.902 0.881 . . . . 0.0 111.113 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 84.5 m -62.73 -47.57 82.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.092 0.957 . . . . 0.0 111.255 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 47' ' ' ILE . 88.2 mt -61.04 -50.05 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.318 0.647 . . . . 0.0 111.188 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.455 HD12 HD11 ' A' ' 77' ' ' LEU . 56.6 mt -57.78 -48.95 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.061 0.544 . . . . 0.0 110.225 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.83 -51.24 30.55 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.64 1.176 . . . . 0.0 112.589 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.29 -32.47 73.21 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.796 0.838 . . . . 0.0 111.962 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 m -89.39 -19.06 25.66 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 122.82 0.448 . . . . 0.0 111.766 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.431 ' SG ' HD13 ' A' ' 43' ' ' ILE . 67.0 m -115.17 -9.49 12.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -168.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 60.1 53.49 4.53 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.223 1.009 . . . . 0.0 111.566 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.51 HD12 HD11 ' A' ' 23' ' ' ILE . 21.7 pt -137.32 149.73 66.62 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 123.268 0.627 . . . . 0.0 110.246 -176.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.62 115.17 4.22 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.69 2.26 . . . . 0.0 111.888 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.412 ' HA ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -60.59 -16.45 38.22 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -173.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.34 -27.32 62.34 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.647 0.779 . . . . 0.0 111.303 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 p -90.84 -2.17 57.78 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.173 0.589 . . . . 0.0 110.604 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 18' ' ' ILE . 1.7 mp -88.17 97.86 7.13 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.9 p -89.51 160.1 42.66 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.062 0.945 . . . . 0.0 110.757 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.13 -26.43 75.81 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.68 2.253 . . . . 0.0 113.044 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.25 1.53 52.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.972 0.509 . . . . 0.0 110.963 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.1 t -77.94 131.33 37.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.126 0.57 . . . . 0.0 109.917 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.403 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 58.0 t-80 -87.14 123.59 32.35 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.447 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -49.12 -39.71 29.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.314 1.046 . . . . 0.0 113.094 175.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 54.5 mt -91.84 -51.16 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -77.4 -33.45 55.03 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.597 0.759 . . . . 0.0 112.266 -168.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -100.77 -55.52 2.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.983 0.513 . . . . 0.0 110.792 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 29' ' ' ALA . 65.4 mt -75.06 -6.93 52.09 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.596 0.358 . . . . 0.0 111.893 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.03 33.41 74.39 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.394 0.434 . . . . 0.0 113.816 172.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.448 HG21 HD12 ' A' ' 43' ' ' ILE . 78.3 mt -99.69 121.47 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.614 0.765 . . . . 0.0 108.977 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.59 160.05 33.23 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.681 0.392 . . . . 0.0 110.195 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.2 m -58.51 -44.11 89.37 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.5 0.72 . . . . 0.0 111.857 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 39' ' ' ASP . 3.8 pp -71.94 -30.98 65.88 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.127 0.489 . . . . 0.0 110.33 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.435 ' N ' HD12 ' A' ' 38' ' ' LEU . 18.7 t70 -70.22 -37.06 74.94 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.6 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -74.82 -21.84 59.06 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.271 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.625 HD23 HD12 ' A' ' 57' ' ' LEU . 96.1 mt -56.13 -45.11 79.66 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 122.942 0.497 . . . . 0.0 111.328 173.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -66.0 -39.44 90.29 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.729 0.812 . . . . 0.0 110.775 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.448 HD12 HG21 ' A' ' 35' ' ' ILE . 34.9 mt -68.26 -39.32 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.305 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.77 -28.51 60.77 Favored 'General case' 0 C--O 1.209 -1.033 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.66 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -63.55 -41.36 98.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.752 0.821 . . . . 0.0 110.023 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.98 92.76 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.899 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.437 ' HA ' HD13 ' A' ' 11' ' ' ILE . 80.6 mt -72.93 -48.08 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.71 0.804 . . . . 0.0 110.562 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -46.6 -55.45 7.63 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.958 1.703 . . . . 0.0 111.055 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -73.3 -36.06 66.21 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.359 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.45 -37.41 86.8 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.118 0.567 . . . . 0.0 112.342 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -93.28 -6.04 48.42 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.627 0.771 . . . . 0.0 112.087 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.63 34.3 88.04 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.316 0.385 . . . . 0.0 113.234 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.4 pt -121.14 171.09 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.526 1.13 . . . . 0.0 109.573 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -106.99 100.81 10.29 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.576 HD21 HG12 ' A' ' 84' ' ' ILE . 69.6 mt -73.21 117.87 63.89 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 169.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.424 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 3.3 Cg_exo -77.74 50.38 3.23 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.897 2.398 . . . . 0.0 111.318 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.625 HD12 HD23 ' A' ' 41' ' ' LEU . 1.4 tm? -64.33 -43.17 95.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.775 0.83 . . . . 0.0 109.801 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.01 -36.18 82.7 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.888 0.742 . . . . 0.0 110.1 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 85.1 tttt -71.75 -38.56 70.39 Favored 'General case' 0 C--O 1.211 -0.962 0 O-C-N 123.533 0.521 . . . . 0.0 109.752 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.424 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 50.1 m0 -64.56 -33.47 75.99 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.889 0.876 . . . . 0.0 110.866 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.6 m -63.8 -43.48 96.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.477 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -71.63 -31.51 66.95 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.837 0.855 . . . . 0.0 110.998 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 17.8 mm-40 -59.71 -53.89 52.7 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.607 0.763 . . . . 0.0 110.273 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.5 t -61.19 -37.31 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.413 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -61.89 -43.11 99.51 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.593 0.757 . . . . 0.0 111.752 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -88.39 2.16 53.21 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.159 0.584 . . . . 0.0 111.266 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.87 17.96 73.87 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 115.109 0.803 . . . . 0.0 115.109 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -60.4 -40.99 92.94 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.59 0.756 . . . . 0.0 110.169 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.23 174.14 14.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.442 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.0 p -106.45 164.67 11.86 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.645 0.778 . . . . 0.0 109.969 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.4 p -59.11 -50.3 74.57 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.415 0.686 . . . . 0.0 112.759 -168.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.8 pm0 -50.18 -38.44 39.76 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -172.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -55.67 -27.23 48.89 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.443 1.097 . . . . 0.0 112.903 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -117.42 -27.97 6.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.335 0.654 . . . . 0.0 111.647 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -111.3 20.58 17.18 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.071 0.548 . . . . 0.0 112.218 -167.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.467 HG12 ' HG2' ' A' ' 78' ' ' LYS . 51.9 t -107.4 141.39 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 164.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.455 HD11 HD12 ' A' ' 12' ' ' ILE . 4.4 mm? -55.19 -39.17 69.28 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -171.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.8 pttt -65.43 -40.96 93.96 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.098 0.475 . . . . 0.0 110.422 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 92.7 m-20 -77.19 -45.62 26.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.677 1.191 . . . . 0.0 110.34 -173.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.94 -53.21 60.92 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 125.195 1.398 . . . . 0.0 109.782 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.49 -26.7 68.55 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.166 0.586 . . . . 0.0 111.633 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.69 -45.67 71.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.06 0.544 . . . . 0.0 110.369 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 3.5 mmp_? -58.76 -49.56 77.18 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.089 0.556 . . . . 0.0 109.838 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.576 HG12 HD21 ' A' ' 55' ' ' LEU . 83.5 mt -61.19 -52.88 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.59 -176.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.64 -44.27 85.47 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.718 0.807 . . . . 0.0 111.52 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -71.3 -30.15 65.9 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.765 0.666 . . . . 0.0 111.436 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 81.8 mt -68.55 -41.82 79.26 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 117.968 0.349 . . . . 0.0 110.577 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 84' ' ' ILE . 39.4 t -69.43 -30.73 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.82 -36.04 57.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.75 0.82 . . . . 0.0 111.446 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.35 -37.19 84.76 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.773 0.829 . . . . 0.0 110.674 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.2 pttt . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.05 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.2 m . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 110.766 -0.087 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -53.7 -47.94 70.02 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.923 0.764 . . . . 0.0 111.211 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.44 -46.22 86.98 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.828 0.705 . . . . 0.0 110.185 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -69.09 -38.87 79.21 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.319 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.2 t -73.16 -37.96 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.621 0.768 . . . . 0.0 111.034 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.51 -32.36 73.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.065 0.946 . . . . 0.0 110.032 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 98.4 m -65.06 -48.17 74.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.162 170.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.0 mt -58.22 -47.37 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.726 0.41 . . . . 0.0 110.802 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.535 HD12 HD11 ' A' ' 77' ' ' LEU . 42.4 mt -57.47 -49.13 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.179 0.991 . . . . 0.0 110.819 175.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.23 -51.47 62.05 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.126 0.97 . . . . 0.0 113.085 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 10' ' ' THR . 14.0 mm-40 -73.73 -28.38 61.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.191 0.596 . . . . 0.0 111.933 -176.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 83.6 m -75.31 -50.72 15.14 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.942 0.497 . . . . 0.0 110.999 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -94.4 5.11 52.8 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.699 0.799 . . . . 0.0 112.454 -172.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.9 t70 48.85 64.8 1.56 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.912 1.285 . . . . 0.0 111.778 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 12' ' ' ILE . 22.9 pt -141.23 145.69 39.6 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 123.94 0.896 . . . . 0.0 109.424 -174.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.47 119.55 6.85 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.065 2.51 . . . . 0.0 112.283 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -50.06 -34.66 22.36 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.882 1.273 . . . . 0.0 111.976 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.01 -25.52 61.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.54 0.736 . . . . 0.0 111.904 -172.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -79.05 -11.71 60.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.804 0.442 . . . . 0.0 111.171 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mp -89.69 101.72 12.43 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 p -80.93 161.35 63.65 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.601 0.76 . . . . 0.0 109.891 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.26 -29.82 85.24 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.44 2.093 . . . . 0.0 112.402 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -105.03 20.14 19.37 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 122.931 0.492 . . . . 0.0 111.072 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.5 m -71.65 128.32 35.43 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -80.93 111.76 17.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.54 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.56 -37.79 8.53 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.439 1.096 . . . . 0.0 113.832 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 55.9 mt -91.34 -58.43 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.53 -46.0 42.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.036 0.934 . . . . 0.0 112.242 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -81.54 -56.46 4.01 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.325 0.65 . . . . 0.0 109.698 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 29' ' ' ALA . 88.4 mt -74.37 -12.77 60.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.233 0.613 . . . . 0.0 111.922 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.3 33.58 82.87 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 113.42 0.128 . . . . 0.0 113.42 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 82.3 mt -104.05 117.17 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.79 156.25 39.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.0 p -58.88 -29.68 67.18 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.936 0.894 . . . . 0.0 111.887 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 39' ' ' ASP . 4.4 pp -71.96 -31.26 66.13 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.144 0.497 . . . . 0.0 110.597 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.413 ' N ' HD12 ' A' ' 38' ' ' LEU . 16.0 t70 -81.91 -35.87 28.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.072 0.949 . . . . 0.0 109.483 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -68.63 -21.39 64.48 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.811 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.3 mt -51.39 -43.52 61.92 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.181 0.593 . . . . 0.0 111.245 171.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.0 -41.37 71.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.719 0.808 . . . . 0.0 111.136 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.462 HD13 HG12 ' A' ' 12' ' ' ILE . 57.3 mt -58.8 -47.79 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 123.449 0.468 . . . . 0.0 110.069 176.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 55' ' ' LEU . . . -71.84 -34.43 69.28 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.772 0.829 . . . . 0.0 110.523 -174.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -62.55 -37.88 87.88 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.614 0.766 . . . . 0.0 110.746 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.89 -40.08 72.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.945 0.498 . . . . 0.0 111.115 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.493 HG21 HD13 ' A' ' 84' ' ' ILE . 84.9 mt -63.07 -45.99 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.673 0.789 . . . . 0.0 110.228 176.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -50.67 -52.33 40.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.478 1.511 . . . . 0.0 110.75 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -69.95 -42.83 72.69 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.577 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.74 -49.78 73.68 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.589 0.756 . . . . 0.0 111.841 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.432 ' HB3' HG22 ' A' ' 88' ' ' VAL . 83.5 m-85 -86.32 -6.72 58.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.567 0.747 . . . . 0.0 111.182 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.44 29.77 73.11 Favored Glycine 0 C--N 1.356 1.659 0 O-C-N 123.432 0.457 . . . . 0.0 113.229 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.459 HG22 ' HG2' ' A' ' 91' ' ' LYS . 47.5 pt -113.23 174.62 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.261 1.024 . . . . 0.0 110.228 -175.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -113.32 108.58 17.44 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 169.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.552 HD21 HG12 ' A' ' 84' ' ' ILE . 60.0 mt -79.7 115.61 54.91 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.496 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 82.3 Cg_endo -76.85 54.68 4.62 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 122.211 1.941 . . . . 0.0 111.029 169.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.38 -40.16 95.56 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.387 1.075 . . . . 0.0 109.325 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.24 -40.02 84.62 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.282 175.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 27.1 tptp -71.76 -38.34 70.38 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.967 0.907 . . . . 0.0 110.702 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.496 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 54.6 m0 -65.02 -45.84 83.8 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.899 0.88 . . . . 0.0 110.555 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.7 m -64.42 -33.71 76.5 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.686 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -66.98 -38.89 86.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.05 0.54 . . . . 0.0 110.143 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 19.0 mm-40 -60.16 -41.39 92.7 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.123 0.569 . . . . 0.0 110.845 175.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.445 HG11 HG23 ' A' ' 71' ' ' THR . 59.2 t -64.04 -54.28 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.828 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -65.51 -30.84 71.65 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.53 0.732 . . . . 0.0 112.602 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -90.16 3.63 52.87 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.951 0.5 . . . . 0.0 111.109 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.94 13.16 69.15 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -75.39 -28.2 59.37 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.146 0.578 . . . . 0.0 111.384 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -153.85 171.29 19.18 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.38 0.672 . . . . 0.0 109.817 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.8 m -101.19 157.06 17.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.901 0.88 . . . . 0.0 109.284 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.445 HG23 HG11 ' A' ' 64' ' ' VAL . 13.5 p -52.8 -47.35 67.65 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.617 0.767 . . . . 0.0 111.546 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.479 ' HA ' HG23 ' A' ' 76' ' ' VAL . 12.9 pt-20 -47.11 -41.9 18.14 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -173.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -26.27 67.67 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.197 0.999 . . . . 0.0 111.583 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -113.9 -26.34 8.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.113 0.565 . . . . 0.0 112.423 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.5 23.75 11.04 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.307 0.643 . . . . 0.0 111.116 -164.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.479 HG23 ' HA ' ' A' ' 72' ' ' GLU . 55.0 t -107.3 132.22 55.34 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.338 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 162.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.535 HD11 HD12 ' A' ' 12' ' ' ILE . 3.7 mm? -49.8 -32.95 15.22 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.147 1.379 . . . . 0.0 114.693 -168.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.404 ' HG3' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -80.74 -38.17 29.18 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.732 0.413 . . . . 0.0 111.746 177.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 93.1 m-20 -70.13 -49.92 45.85 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.074 0.55 . . . . 0.0 109.738 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.2 tp -49.7 -50.51 43.54 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.085 1.754 . . . . 0.0 110.981 170.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.59 -36.82 74.6 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.653 0.596 . . . . 0.0 110.826 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.95 79.82 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.866 0.729 . . . . 0.0 111.023 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 5.6 mmp_? -56.36 -53.33 58.61 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.671 0.748 . . . . 0.0 110.438 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.552 HG12 HD21 ' A' ' 55' ' ' LEU . 66.7 mt -64.94 -45.42 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.41 -176.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.29 -41.44 93.41 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.269 1.028 . . . . 0.0 111.676 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -67.83 -35.13 78.05 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.817 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.0 -31.31 67.79 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.214 0.321 . . . . 0.0 111.227 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 84' ' ' ILE . 60.6 t -69.74 -40.27 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-O 121.262 0.553 . . . . 0.0 109.741 175.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.17 93.84 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.915 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.66 83.41 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.77 0.828 . . . . 0.0 111.469 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.459 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.228 0 C-N-CA 122.841 0.457 . . . . 0.0 110.291 -175.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.0 m . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -56.17 -42.68 77.44 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.411 0.684 . . . . 0.0 111.623 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -52.94 -51.39 61.53 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.675 0.79 . . . . 0.0 110.31 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 11' ' ' ILE . 37.8 mmt180 -64.7 -43.37 93.69 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.84 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.437 ' HA ' HD12 ' A' ' 11' ' ' ILE . 67.4 t -70.0 -36.45 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.941 0.896 . . . . 0.0 111.246 -175.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.02 -36.53 83.5 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.691 0.796 . . . . 0.0 110.309 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.5 m -66.04 -41.36 90.97 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.254 0.622 . . . . 0.0 111.175 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 7' ' ' ARG . 82.8 mt -56.85 -52.92 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.923 0.489 . . . . 0.0 110.353 174.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.557 HD12 HD11 ' A' ' 77' ' ' LEU . 39.9 mt -59.67 -44.62 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.8 0.84 . . . . 0.0 110.931 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.564 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -50.11 -63.24 1.18 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.415 1.086 . . . . 0.0 113.119 175.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.03 -25.15 66.93 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.722 -174.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.9 m -78.82 -46.64 18.26 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.468 0.707 . . . . 0.0 111.53 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.7 t -102.26 4.61 39.42 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.443 0.697 . . . . 0.0 111.867 -170.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 t70 48.1 76.76 0.11 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.264 1.426 . . . . 0.0 112.185 -170.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 13' ' ' ALA . 3.3 pt -147.4 141.61 15.97 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.536 1.134 . . . . 0.0 108.765 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.67 125.88 17.06 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.34 2.026 . . . . 0.0 110.741 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.583 ' HA ' HD13 ' A' ' 23' ' ' ILE . 2.2 ppt_? -70.23 -16.15 63.01 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -88.17 -1.76 58.2 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.979 0.512 . . . . 0.0 110.503 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.9 p -89.09 -17.77 28.61 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 117.743 0.247 . . . . 0.0 110.428 165.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.583 HD13 ' HA ' ' A' ' 20' ' ' ARG . 2.1 mp -80.51 111.89 17.81 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.1 p -90.25 158.94 43.03 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.607 0.763 . . . . 0.0 109.188 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.05 -19.52 66.42 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 121.974 1.783 . . . . 0.0 112.128 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.53 8.76 44.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.384 0.674 . . . . 0.0 110.495 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.0 m -70.89 124.87 25.35 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.417 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 64.6 t-80 -80.05 111.82 16.75 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 167.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.05 -36.49 29.29 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mt -93.53 -45.04 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 122.306 0.242 . . . . 0.0 110.871 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.93 -44.19 11.22 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.449 0.7 . . . . 0.0 111.796 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.98 -60.1 2.21 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.362 0.665 . . . . 0.0 109.984 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.82 -17.18 63.38 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.871 0.468 . . . . 0.0 111.543 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.31 37.36 90.68 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.576 0.548 . . . . 0.0 113.812 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.3 mt -93.59 114.67 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.61 156.41 38.16 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 m -57.91 -31.53 66.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.928 0.891 . . . . 0.0 112.637 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.57 -31.83 62.19 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.801 0.44 . . . . 0.0 111.253 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -75.1 -32.69 61.49 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.224 0.61 . . . . 0.0 110.01 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -71.42 -28.5 64.04 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.836 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.78 -41.85 87.64 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.75 0.42 . . . . 0.0 110.38 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.9 -44.18 81.47 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.12 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.417 HD13 HG12 ' A' ' 12' ' ' ILE . 58.6 mt -65.27 -46.14 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 122.855 0.462 . . . . 0.0 110.805 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.56 76.36 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.182 0.593 . . . . 0.0 110.549 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -73.43 -25.25 60.44 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.747 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.7 -41.15 72.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.503 0.321 . . . . 0.0 110.324 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.85 -44.5 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.135 0.974 . . . . 0.0 110.218 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -51.47 -48.15 62.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.5 1.52 . . . . 0.0 110.647 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.14 -50.07 65.25 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.19 175.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.44 -51.49 66.75 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.008 0.923 . . . . 0.0 113.253 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -89.45 -6.56 56.4 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.513 0.725 . . . . 0.0 111.683 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.81 39.83 95.32 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-O 121.189 0.327 . . . . 0.0 112.534 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.478 HG22 ' HG2' ' A' ' 91' ' ' LYS . 41.8 pt -122.61 169.64 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.41 1.084 . . . . 0.0 109.493 -175.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -107.45 120.88 43.41 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.403 HD22 ' HH2' ' A' ' 60' ' ' TRP . 57.1 mt -90.26 113.61 58.0 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.81 57.1 3.7 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.446 2.764 . . . . 0.0 111.292 171.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.5 -38.68 90.82 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.227 1.011 . . . . 0.0 110.259 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 8.4 pt-20 -58.97 -45.74 89.8 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 124.01 0.819 . . . . 0.0 110.985 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -63.67 -48.23 78.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.814 0.846 . . . . 0.0 109.86 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.416 ' O ' HG23 ' A' ' 64' ' ' VAL . 48.2 m0 -53.69 -44.53 69.83 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.366 1.041 . . . . 0.0 110.744 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.1 m -64.42 -45.6 86.86 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.047 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 13.7 mm100 -68.79 -37.51 79.32 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.6 0.36 . . . . 0.0 110.872 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -57.64 -48.06 80.51 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.155 0.982 . . . . 0.0 110.374 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.513 HG11 HG23 ' A' ' 71' ' ' THR . 78.8 t -59.24 -46.73 92.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.304 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -61.06 -37.11 81.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.917 0.487 . . . . 0.0 111.551 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.6 6.15 39.53 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.892 0.877 . . . . 0.0 112.115 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.53 20.85 74.15 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.68 -23.4 45.67 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.317 0.647 . . . . 0.0 110.196 171.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.0 175.07 14.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.176 0.99 . . . . 0.0 109.742 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.8 m -111.57 156.63 21.46 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.513 HG23 HG11 ' A' ' 64' ' ' VAL . 4.6 p -51.28 -40.91 59.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.3 mp0 -47.82 -46.98 31.41 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.574 0.75 . . . . 0.0 112.426 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -26.4 62.64 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.243 1.017 . . . . 0.0 113.049 -172.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -117.81 -21.29 8.49 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -119.28 20.72 12.49 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.195 0.598 . . . . 0.0 111.819 -166.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.523 HG12 ' HG2' ' A' ' 78' ' ' LYS . 30.8 t -102.75 139.98 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 163.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.557 HD11 HD12 ' A' ' 12' ' ' ILE . 3.5 mm? -53.99 -37.21 63.77 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.146 1.379 . . . . 0.0 114.304 -168.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HG2' HG12 ' A' ' 76' ' ' VAL . 57.0 pttt -71.86 -37.14 70.28 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.661 0.384 . . . . 0.0 111.294 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -79.26 -35.24 41.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.714 0.806 . . . . 0.0 110.49 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.93 -52.48 59.62 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.568 1.147 . . . . 0.0 108.445 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.24 69.8 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.019 0.824 . . . . 0.0 111.508 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.84 -54.13 30.83 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.531 0.519 . . . . 0.0 109.751 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -50.66 -50.04 55.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.247 0.967 . . . . 0.0 111.111 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.508 ' O ' HG23 ' A' ' 88' ' ' VAL . 72.2 mt -61.34 -48.33 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.122 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.96 -39.71 94.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.912 0.885 . . . . 0.0 111.625 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.37 -40.62 97.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.01 0.924 . . . . 0.0 109.849 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.6 mt -72.89 -28.64 62.6 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.815 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 84' ' ' ILE . 80.2 t -67.86 -37.83 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 123.311 0.644 . . . . 0.0 109.796 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.56 80.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.404 0.682 . . . . 0.0 110.712 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.76 -38.77 80.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.506 0.722 . . . . 0.0 111.255 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.478 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 8' ' ' VAL . 30.7 m . . . . . 0 CA--C 1.548 0.881 0 CA-C-O 119.748 -0.167 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.35 -44.43 92.68 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.915 0.486 . . . . 0.0 111.077 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -54.34 -41.04 68.62 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.934 0.771 . . . . 0.0 111.388 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 11' ' ' ILE . 82.6 mtp180 -74.22 -34.24 63.64 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.795 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 4' ' ' THR . 52.8 t -70.21 -36.31 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 118.733 0.697 . . . . 0.0 109.593 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.98 90.43 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.264 1.026 . . . . 0.0 110.749 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 m -61.69 -51.15 69.62 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 123.812 0.695 . . . . 0.0 110.863 173.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 7' ' ' ARG . 96.8 mt -55.7 -51.52 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.431 1.092 . . . . 0.0 111.616 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.53 HD12 HD11 ' A' ' 77' ' ' LEU . 35.6 mt -60.71 -46.35 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.514 0.726 . . . . 0.0 111.016 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.567 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -51.78 -48.31 63.82 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.006 0.816 . . . . 0.0 112.596 175.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.91 -37.04 81.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.711 0.805 . . . . 0.0 112.031 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.8 m -68.44 -54.53 16.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.09 0.556 . . . . 0.0 110.66 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.6 m -91.78 7.49 41.55 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.885 0.874 . . . . 0.0 112.514 -173.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 39.52 74.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.009 1.324 . . . . 0.0 112.469 -170.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.567 HG13 ' HA ' ' A' ' 13' ' ' ALA . 13.8 pt -140.18 142.52 30.34 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.995 1.318 . . . . 0.0 107.838 -177.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.29 131.17 41.43 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.423 2.082 . . . . 0.0 112.322 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -36.38 -42.1 0.31 Allowed 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 126.69 1.996 . . . . 0.0 113.939 176.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.14 -28.98 66.93 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.819 0.848 . . . . 0.0 112.001 -170.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 p -79.36 -4.04 49.06 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.54 97.2 5.96 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.7 p -88.46 162.18 40.31 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.692 0.797 . . . . 0.0 110.213 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.39 -26.76 79.01 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.706 2.271 . . . . 0.0 113.502 176.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.74 5.54 50.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.842 0.857 . . . . 0.0 111.442 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -68.67 120.99 15.54 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.437 0.295 . . . . 0.0 110.305 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -84.36 123.4 30.15 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 167.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -40.27 -50.04 2.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.773 1.229 . . . . 0.0 113.147 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -90.81 -51.34 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.229 0.538 . . . . 0.0 109.908 -169.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.89 -39.57 66.29 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.247 1.019 . . . . 0.0 112.479 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.84 -64.53 1.04 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.365 0.666 . . . . 0.0 110.08 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.47 HD13 HG21 ' A' ' 12' ' ' ILE . 73.2 mt -73.9 -17.6 61.01 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.609 0.763 . . . . 0.0 112.216 -174.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.98 34.33 76.5 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 123.083 0.239 . . . . 0.0 113.651 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.416 HG23 ' HB2' ' A' ' 39' ' ' ASP . 92.5 mt -82.62 139.96 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.574 1.15 . . . . 0.0 109.277 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -92.53 162.16 14.32 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.9 m -54.33 -36.98 64.35 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.317 1.047 . . . . 0.0 112.083 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.38 -40.62 77.3 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.859 0.463 . . . . 0.0 110.364 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.416 ' HB2' HG23 ' A' ' 35' ' ' ILE . 47.4 m-20 -68.63 -35.45 77.31 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.387 0.675 . . . . 0.0 110.459 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.46 -32.71 74.25 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.8 0.687 . . . . 0.0 110.528 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.0 mt -61.21 -42.63 98.94 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.055 0.542 . . . . 0.0 111.255 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -66.97 -42.57 84.91 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.099 0.56 . . . . 0.0 110.723 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.464 HD13 HG12 ' A' ' 12' ' ' ILE . 97.2 mt -57.29 -47.36 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.225 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.13 -38.49 75.56 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.291 -173.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -61.48 -42.56 98.97 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.0 0.92 . . . . 0.0 110.9 174.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.94 -29.26 66.36 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.15 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.473 HD13 HD11 ' A' ' 84' ' ' ILE . 90.3 mt -65.83 -43.52 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.467 0.707 . . . . 0.0 110.307 173.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -58.67 -41.26 85.73 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.425 0.453 . . . . 0.0 110.913 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -69.07 -54.06 17.05 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.556 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.17 -52.8 64.14 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.128 0.971 . . . . 0.0 112.871 -176.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -89.8 -6.75 55.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.843 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.71 31.81 73.65 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.5 0.5 . . . . 0.0 113.448 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.439 HG22 ' HD3' ' A' ' 91' ' ' LYS . 41.3 pt -118.22 -178.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.561 0.745 . . . . 0.0 112.116 -172.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -126.56 106.52 9.49 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.354 1.462 . . . . 0.0 107.489 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.464 HD21 HG12 ' A' ' 84' ' ' ILE . 91.3 mt -72.8 125.99 90.88 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -74.98 60.47 5.43 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.778 2.318 . . . . 0.0 109.634 163.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -40.26 91.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.134 1.374 . . . . 0.0 109.253 -171.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.81 -42.23 92.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.693 0.797 . . . . 0.0 111.012 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -62.75 -47.5 83.29 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.477 1.111 . . . . 0.0 110.031 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -60.07 -44.87 94.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.948 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -65.99 -36.74 84.12 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.9 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -68.66 -37.46 79.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.033 0.533 . . . . 0.0 110.988 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.58 -38.98 92.88 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.546 0.738 . . . . 0.0 111.264 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.9 t -65.51 -49.88 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.457 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -60.47 -32.06 71.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.182 0.993 . . . . 0.0 112.297 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -93.8 0.49 56.31 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.745 0.818 . . . . 0.0 111.871 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.82 16.92 66.7 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.46 -33.73 76.55 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 117.576 0.688 . . . . 0.0 110.156 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.87 166.38 28.69 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.012 0.925 . . . . 0.0 108.967 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 75.2 p -86.37 164.0 17.31 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 122.749 0.42 . . . . 0.0 110.052 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.7 p -54.2 -49.1 70.15 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.151 0.58 . . . . 0.0 109.632 172.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.508 ' HA ' HG23 ' A' ' 76' ' ' VAL . 28.6 mt-10 -43.35 -47.19 6.72 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.955 1.702 . . . . 0.0 113.52 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.402 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 12.0 mm-40 -53.68 -28.95 36.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.99 0.916 . . . . 0.0 113.467 -176.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -121.13 -21.05 6.56 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -110.71 15.81 21.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.47 0.708 . . . . 0.0 110.966 -169.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 72' ' ' GLU . 91.3 t -108.21 139.8 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.53 HD11 HD12 ' A' ' 12' ' ' ILE . 3.6 mm? -54.26 -40.11 67.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.338 1.455 . . . . 0.0 114.108 -172.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.468 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.1 pttt -65.2 -42.02 93.95 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.437 0.461 . . . . 0.0 110.82 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.14 -39.49 40.93 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.537 1.135 . . . . 0.0 111.021 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.2 -49.94 72.24 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.267 1.027 . . . . 0.0 109.248 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.2 -34.68 78.63 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.564 0.746 . . . . 0.0 111.405 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.76 90.05 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.57 0.544 . . . . 0.0 110.505 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.483 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -58.7 -48.86 79.69 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.301 0.641 . . . . 0.0 111.267 175.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.473 HD11 HD13 ' A' ' 47' ' ' ILE . 91.2 mt -59.63 -43.02 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.654 1.182 . . . . 0.0 110.292 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.37 -45.38 91.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 110.912 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.39 -33.3 72.82 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.463 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 62.5 mt -70.99 -36.39 72.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.078 0.551 . . . . 0.0 111.742 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 84' ' ' ILE . 94.8 t -64.94 -41.81 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-O 121.657 0.741 . . . . 0.0 109.499 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.94 75.84 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.733 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.7 94.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.147 0.979 . . . . 0.0 112.076 -176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.439 ' HD3' HG22 ' A' ' 53' ' ' ILE . 60.1 pttt . . . . . 0 N--CA 1.48 1.027 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.431 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' HG23 ' A' ' 8' ' ' VAL . 65.2 m . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -56.76 -42.16 78.85 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.315 0.646 . . . . 0.0 112.013 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.63 -42.19 92.17 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.973 0.509 . . . . 0.0 110.662 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -61.7 -46.3 90.27 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.643 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 4' ' ' THR . 99.5 t -70.0 -38.93 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.113 0.965 . . . . 0.0 111.191 -173.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.2 96.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.98 0.912 . . . . 0.0 110.028 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -63.62 -44.89 92.61 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 111.308 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.49 -51.7 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.394 0.678 . . . . 0.0 110.815 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.587 HG12 HG21 ' A' ' 43' ' ' ILE . 38.7 mt -57.72 -52.83 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.487 0.715 . . . . 0.0 110.664 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.78 -54.93 8.74 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.914 1.286 . . . . 0.0 113.01 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.59 -22.86 60.92 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.255 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.8 m -88.13 -25.64 22.88 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.78 0.432 . . . . 0.0 111.786 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.5 t -113.23 -1.4 14.33 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.91 0.484 . . . . 0.0 111.823 -167.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.31 50.47 7.76 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.191 0.996 . . . . 0.0 111.571 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.554 HD12 HD11 ' A' ' 23' ' ' ILE . 16.3 pt -138.17 156.09 73.99 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 123.761 0.825 . . . . 0.0 109.987 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.77 131.15 16.71 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.591 2.194 . . . . 0.0 110.73 172.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HA ' HD13 ' A' ' 23' ' ' ILE . 6.5 ppt_? -68.22 -16.22 63.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.729 0.412 . . . . 0.0 111.312 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.26 -20.63 54.86 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 123.538 0.735 . . . . 0.0 110.487 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -92.05 10.34 29.54 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.083 0.553 . . . . 0.0 110.421 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.554 HD11 HD12 ' A' ' 18' ' ' ILE . 1.9 mp -104.92 127.28 59.56 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 168.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.1 p -121.87 158.22 55.3 Favored Pre-proline 0 N--CA 1.484 1.225 0 C-N-CA 123.981 0.912 . . . . 0.0 109.668 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.53 -32.7 35.93 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.788 2.325 . . . . 0.0 113.399 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.84 -5.87 56.43 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.941 -0.474 . . . . 0.0 111.429 -173.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.8 p -77.19 132.87 38.98 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 122.541 0.336 . . . . 0.0 110.185 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -85.33 126.14 33.5 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 173.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.43 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.54 -39.6 11.21 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.083 0.953 . . . . 0.0 113.236 175.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.8 mt -96.57 -55.88 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -171.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.37 -43.84 80.41 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.506 0.723 . . . . 0.0 112.578 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -93.57 -57.23 2.64 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.868 0.467 . . . . 0.0 110.302 -172.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 29' ' ' ALA . 62.8 mt -78.91 -7.77 58.27 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.565 0.746 . . . . 0.0 112.44 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.04 25.07 72.0 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 114.443 0.537 . . . . 0.0 114.443 174.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.32 121.56 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.787 0.835 . . . . 0.0 108.776 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.45 157.19 37.57 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 t -58.29 -35.13 71.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.741 0.817 . . . . 0.0 111.701 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 41' ' ' LEU . 4.5 pp -71.7 -30.92 66.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.517 0.327 . . . . 0.0 111.076 -177.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -73.24 -39.76 65.21 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.118 0.567 . . . . 0.0 109.91 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -69.88 -25.9 63.92 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.783 0.677 . . . . 0.0 110.89 -176.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.653 HD23 HD12 ' A' ' 57' ' ' LEU . 93.7 mt -56.83 -42.6 79.92 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.051 0.54 . . . . 0.0 110.615 170.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -75.14 -40.95 59.3 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.064 0.946 . . . . 0.0 110.627 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.587 HG21 HG12 ' A' ' 12' ' ' ILE . 57.0 mt -61.22 -43.61 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.227 0.537 . . . . 0.0 110.319 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 -33.29 63.0 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.963 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -62.69 -34.35 76.95 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.595 0.358 . . . . 0.0 110.347 172.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.95 -34.5 73.5 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.92 0.488 . . . . 0.0 110.8 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.12 -42.87 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.627 0.771 . . . . 0.0 110.35 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -53.08 -51.3 62.29 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.659 0.784 . . . . 0.0 110.635 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -63.46 -50.15 70.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.056 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.88 -48.76 77.61 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.737 0.815 . . . . 0.0 112.395 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -83.61 -10.21 58.39 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.513 0.725 . . . . 0.0 112.22 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.38 30.27 71.43 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.418 0.449 . . . . 0.0 112.988 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 pt -120.01 -176.18 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.022 1.329 . . . . 0.0 109.622 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -137.1 98.63 3.79 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.498 HD23 HD12 ' A' ' 87' ' ' LEU . 85.2 mt -64.01 123.64 82.66 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.5 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 98.2 Cg_endo -76.21 62.08 6.73 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 122.485 2.124 . . . . 0.0 110.587 170.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.653 HD12 HD23 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -62.44 -34.66 77.22 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.348 1.059 . . . . 0.0 109.14 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.52 -43.38 97.17 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.763 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 56.9 tptt -69.09 -39.71 78.84 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 123.632 0.773 . . . . 0.0 110.49 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.414 ' HH2' HD22 ' A' ' 55' ' ' LEU . 54.6 m0 -67.5 -39.84 85.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.494 0.718 . . . . 0.0 110.643 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -61.02 -39.37 89.47 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 124.078 0.861 . . . . 0.0 110.223 173.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -70.13 -43.98 69.84 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.201 1.0 . . . . 0.0 110.157 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.03 -46.81 88.29 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.566 1.147 . . . . 0.0 111.126 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 89.9 t -61.11 -40.0 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -67.92 -30.33 69.62 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.247 0.619 . . . . 0.0 111.767 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -85.04 -1.15 56.5 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.34 15.85 68.49 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 114.198 0.439 . . . . 0.0 114.198 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -72.6 -31.84 65.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.473 0.709 . . . . 0.0 110.779 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -149.07 166.27 29.23 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.756 0.822 . . . . 0.0 109.73 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.1 m -103.16 154.85 18.88 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.4 p -47.04 -49.08 21.94 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 124.209 1.003 . . . . 0.0 112.451 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.549 ' HA ' HG23 ' A' ' 76' ' ' VAL . 40.7 mt-10 -44.82 -42.63 8.04 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -56.46 -27.38 56.74 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.193 0.997 . . . . 0.0 112.818 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -121.7 -22.35 5.86 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.081 0.552 . . . . 0.0 112.037 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -114.7 14.49 17.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.462 0.705 . . . . 0.0 111.31 -167.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.549 HG23 ' HA ' ' A' ' 72' ' ' GLU . 53.5 t -107.78 137.03 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 165.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.492 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -55.3 -33.88 63.67 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -169.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.0 pttt -71.65 -44.41 64.35 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.559 0.344 . . . . 0.0 110.389 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 60.0 m-80 -72.2 -38.02 69.13 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 123.608 0.763 . . . . 0.0 109.972 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.4 tp -62.5 -48.71 78.36 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 124.984 1.314 . . . . 0.0 109.454 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.31 -33.96 71.74 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.681 0.613 . . . . 0.0 111.146 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.86 -40.48 75.75 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.207 0.603 . . . . 0.0 111.426 175.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 13.6 mmp_? -60.59 -48.27 82.53 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.558 0.743 . . . . 0.0 110.867 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 88' ' ' VAL . 86.7 mt -63.22 -51.46 70.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.689 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.72 -39.55 94.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.441 0.696 . . . . 0.0 112.115 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.43 -37.79 83.55 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.34 0.4 . . . . 0.0 110.264 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.498 HD12 HD23 ' A' ' 55' ' ' LEU . 84.2 mt -71.03 -32.8 69.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.791 0.436 . . . . 0.0 111.534 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 84' ' ' ILE . 73.4 t -65.92 -43.37 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.321 0.581 . . . . 0.0 109.479 173.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.7 -45.9 87.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.163 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.82 89.29 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.318 1.047 . . . . 0.0 111.674 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.093 0 O-C-N 123.535 0.522 . . . . 0.0 110.283 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 8' ' ' VAL . 17.9 m . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.93 -45.39 90.52 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.765 0.426 . . . . 0.0 111.179 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.93 -42.86 90.78 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.261 0.624 . . . . 0.0 110.902 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 10.9 mmt180 -65.87 -41.73 91.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.234 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 4' ' ' THR . 72.7 t -68.83 -40.57 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.436 0.695 . . . . 0.0 110.589 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.67 94.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.841 0.856 . . . . 0.0 110.817 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.8 m -66.41 -41.9 88.59 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.162 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.46 -47.02 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.313 0.645 . . . . 0.0 110.78 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 18' ' ' ILE . 42.9 mt -58.22 -46.72 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.559 0.743 . . . . 0.0 110.547 177.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.63 -51.28 65.89 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.031 0.933 . . . . 0.0 112.628 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -73.96 -31.37 62.99 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.2 m -74.45 -57.5 3.89 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.546 ' SG ' HD11 ' A' ' 43' ' ' ILE . 76.1 m -85.23 -5.79 59.3 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 60.0 66.43 0.98 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 122.002 0.906 . . . . 0.0 109.729 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 12' ' ' ILE . 12.5 pt -141.72 152.0 61.59 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.835 1.254 . . . . 0.0 108.56 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.524 ' O ' HG22 ' A' ' 22' ' ' THR . 37.9 Cg_endo -66.61 125.1 13.28 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.047 1.831 . . . . 0.0 111.334 175.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.545 ' HA ' HD13 ' A' ' 23' ' ' ILE . 58.6 ttt180 -53.44 -29.1 33.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.17 0.988 . . . . 0.0 112.565 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.1 pt-20 -65.88 -23.67 66.7 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.487 0.715 . . . . 0.0 112.155 -172.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 19' ' ' PRO . 9.3 t -88.11 2.49 51.89 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.705 0.402 . . . . 0.0 111.512 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.545 HD13 ' HA ' ' A' ' 20' ' ' ARG . 3.6 mp -102.0 94.15 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.6 p -88.52 163.76 34.87 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -62.45 -19.67 68.18 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.213 1.942 . . . . 0.0 113.131 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -95.85 3.86 53.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.761 0.424 . . . . 0.0 110.814 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -75.54 130.86 39.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.855 0.359 . . . . 0.0 110.093 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -85.59 122.69 30.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 168.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.73 -41.11 30.97 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.043 0.937 . . . . 0.0 112.817 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.4 mt -93.13 -53.23 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.06 -44.74 65.14 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.707 0.803 . . . . 0.0 111.787 -171.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -89.32 -59.86 2.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.93 0.492 . . . . 0.0 110.372 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 29' ' ' ALA . 71.1 mt -76.04 -10.9 59.79 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.815 0.846 . . . . 0.0 112.902 -171.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.29 33.04 85.65 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 123.316 0.385 . . . . 0.0 113.671 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 82.8 mt -94.13 122.57 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.14 157.88 32.59 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.198 0.599 . . . . 0.0 109.551 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.498 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 27.3 m -59.72 -27.56 66.57 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.444 0.697 . . . . 0.0 111.732 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.12 -40.85 64.59 Favored 'General case' 0 C--N 1.362 1.131 0 C-N-CA 122.928 0.491 . . . . 0.0 110.336 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.71 -36.18 81.87 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.238 0.615 . . . . 0.0 109.63 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -70.13 -27.88 64.92 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 123.762 0.664 . . . . 0.0 110.611 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.2 mt -61.88 -40.33 95.04 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.069 0.395 . . . . 0.0 110.235 173.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -71.84 -39.05 70.02 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 124.021 0.826 . . . . 0.0 110.677 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.546 HD11 ' SG ' ' A' ' 16' ' ' CYS . 77.4 mt -61.94 -47.41 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.114 0.565 . . . . 0.0 109.908 174.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.5 -34.38 72.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.797 0.839 . . . . 0.0 110.341 -173.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -69.01 -37.24 78.58 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.896 0.878 . . . . 0.0 110.721 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.88 -35.83 74.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.662 0.385 . . . . 0.0 110.751 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.411 HD11 HG13 ' A' ' 8' ' ' VAL . 96.5 mt -66.88 -46.24 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.033 0.933 . . . . 0.0 109.891 173.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -51.46 -51.12 57.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.363 1.465 . . . . 0.0 110.357 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -69.13 -47.23 65.62 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.863 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.45 92.87 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.408 0.683 . . . . 0.0 112.464 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.32 -4.43 58.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.548 0.739 . . . . 0.0 111.219 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.45 30.36 77.65 Favored Glycine 0 C--N 1.357 1.719 0 O-C-N 123.233 0.333 . . . . 0.0 113.465 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.3 pt -119.37 163.39 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.45 1.1 . . . . 0.0 109.68 -175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 123.19 42.4 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 164.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.457 HD21 HG12 ' A' ' 84' ' ' ILE . 54.0 mt -78.45 135.67 60.83 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 171.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.51 ' HD3' HD11 ' A' ' 87' ' ' LEU . 4.4 Cg_exo -79.18 44.16 1.64 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 123.302 2.668 . . . . 0.0 111.301 170.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -57.15 -38.4 73.47 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.528 1.131 . . . . 0.0 109.785 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -53.91 -51.49 63.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.985 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 49.9 tptt -66.35 -41.18 89.93 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.585 1.154 . . . . 0.0 110.888 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.429 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 52.2 m0 -59.94 -45.21 93.35 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.167 0.987 . . . . 0.0 110.58 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.7 m -63.62 -39.0 93.26 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.848 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -65.37 -39.51 92.37 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.185 0.594 . . . . 0.0 110.658 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 27.4 mm-40 -56.17 -48.49 76.22 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.215 0.606 . . . . 0.0 111.063 175.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.99 -41.46 89.8 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.124 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -60.0 -43.65 95.05 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.992 0.917 . . . . 0.0 111.785 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -83.01 6.17 19.71 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.41 19.39 64.39 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 114.494 0.558 . . . . 0.0 114.494 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -76.12 -59.47 2.75 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.927 0.891 . . . . 0.0 108.686 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.38 172.04 7.03 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.207 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 p -107.26 170.78 7.75 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.83 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.6 p -62.16 -46.19 90.08 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 119.537 -0.268 . . . . 0.0 110.701 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -53.07 -36.64 60.88 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.574 0.75 . . . . 0.0 112.932 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -25.98 58.83 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.491 1.116 . . . . 0.0 111.346 -175.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -128.96 -7.43 4.94 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -115.48 16.68 16.6 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.226 0.611 . . . . 0.0 111.244 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.459 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.3 t -103.16 141.33 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 166.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.442 HD11 HD12 ' A' ' 12' ' ' ILE . 4.1 mm? -53.61 -42.29 67.55 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.188 1.395 . . . . 0.0 114.246 -172.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.459 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.7 pttt -68.59 -40.05 80.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.826 0.45 . . . . 0.0 110.843 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.425 ' OD1' ' HG3' ' A' ' 78' ' ' LYS . 2.1 m-20 -68.36 -46.2 70.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.049 0.94 . . . . 0.0 109.853 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.4 tp -58.84 -50.47 73.86 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.01 1.324 . . . . 0.0 109.973 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.64 75.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.595 0.758 . . . . 0.0 111.749 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.33 68.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.721 0.408 . . . . 0.0 110.063 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -56.4 -48.24 77.32 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.784 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.457 HG12 HD21 ' A' ' 55' ' ' LEU . 90.3 mt -61.8 -51.36 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.532 1.133 . . . . 0.0 111.227 -175.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.83 -39.58 85.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.888 0.875 . . . . 0.0 111.34 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -63.73 -40.49 96.87 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.038 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.51 HD11 ' HD3' ' A' ' 56' ' ' PRO . 91.7 mt -67.34 -34.44 77.33 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.194 0.598 . . . . 0.0 111.492 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 84' ' ' ILE . 57.9 t -65.77 -42.28 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.18 -43.19 98.94 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.536 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.18 -39.67 89.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.097 0.959 . . . . 0.0 112.284 -177.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 41.3 pttt . . . . . 0 N--CA 1.479 0.997 0 C-N-CA 122.545 0.338 . . . . 0.0 110.117 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.588 HG21 ' HB2' ' A' ' 85' ' ' ASP . 24.2 m . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -58.51 -51.57 69.32 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.452 0.701 . . . . 0.0 111.559 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -58.85 -42.92 90.46 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.698 0.624 . . . . 0.0 111.076 -175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 11' ' ' ILE . 92.1 mtt-85 -62.02 -46.81 87.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.691 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 4' ' ' THR . 53.8 t -64.33 -44.53 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.312 0.645 . . . . 0.0 110.367 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.99 85.11 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.231 1.012 . . . . 0.0 110.856 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.1 m -68.72 -41.33 79.19 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.466 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 7' ' ' ARG . 74.2 mt -60.61 -43.98 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.609 0.364 . . . . 0.0 110.766 176.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.617 HG22 HD11 ' A' ' 18' ' ' ILE . 56.2 mt -56.71 -47.48 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.463 0.705 . . . . 0.0 110.194 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . . . -56.75 -51.86 67.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.544 1.138 . . . . 0.0 113.376 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.64 -30.4 71.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.172 0.989 . . . . 0.0 111.865 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -82.81 -46.62 12.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.581 0.352 . . . . 0.0 111.087 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.7 t -93.3 -7.78 43.95 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.483 0.713 . . . . 0.0 112.182 -169.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 56.78 70.18 0.67 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.55 1.14 . . . . 0.0 111.574 -172.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.617 HD11 HG22 ' A' ' 12' ' ' ILE . 10.2 pt -143.75 152.0 54.76 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 125.143 1.377 . . . . 0.0 108.641 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.09 116.77 4.76 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 121.93 1.754 . . . . 0.0 111.709 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -62.93 -17.17 61.51 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.996 0.919 . . . . 0.0 113.034 -178.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.98 -27.18 60.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.329 0.651 . . . . 0.0 110.243 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -83.8 -5.57 59.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.096 0.558 . . . . 0.0 110.724 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 20' ' ' ARG . 1.9 mp -87.81 120.39 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.9 p -101.53 166.99 11.3 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.724 0.81 . . . . 0.0 109.427 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.14 -17.26 54.51 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 121.889 1.726 . . . . 0.0 112.763 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.66 0.27 49.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.572 0.349 . . . . 0.0 110.331 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -72.6 128.08 34.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.879 0.872 . . . . 0.0 110.109 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -87.3 117.11 25.85 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.518 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -55.16 -35.93 65.29 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -93.04 -44.85 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 121.392 0.615 . . . . 0.0 110.374 -170.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -94.88 -38.38 10.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.13 0.972 . . . . 0.0 111.593 -168.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.24 -50.8 5.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.833 0.453 . . . . 0.0 110.659 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 29' ' ' ALA . 88.8 mt -77.71 -14.59 59.57 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.417 0.687 . . . . 0.0 111.145 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.89 27.97 72.02 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.798 0.686 . . . . 0.0 114.255 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.488 HG21 HD12 ' A' ' 43' ' ' ILE . 89.3 mt -76.77 124.88 35.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.01 152.87 44.98 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.115 0.885 . . . . 0.0 109.805 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.2 m -66.31 -25.96 67.09 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.599 0.759 . . . . 0.0 112.278 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.77 -33.68 62.33 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.34 -42.44 59.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.734 0.814 . . . . 0.0 110.117 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -71.26 -21.95 62.03 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 123.593 0.558 . . . . 0.0 110.603 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.49 -47.14 86.65 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 170.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -71.55 -36.91 71.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.954 0.902 . . . . 0.0 111.437 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.488 HD12 HG21 ' A' ' 35' ' ' ILE . 52.8 mt -63.4 -50.24 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 123.636 0.585 . . . . 0.0 110.1 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.94 -33.42 72.1 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 123.782 0.676 . . . . 0.0 109.905 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.512 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 45.0 t80 -60.95 -40.84 94.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.401 1.081 . . . . 0.0 111.003 173.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.78 -35.88 59.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.626 0.37 . . . . 0.0 111.317 -178.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.412 HD13 HG13 ' A' ' 8' ' ' VAL . 92.6 mt -65.43 -43.05 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.543 0.737 . . . . 0.0 109.958 174.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 45' ' ' PHE . 9.8 t70 -50.69 -52.55 39.08 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.665 1.586 . . . . 0.0 110.692 177.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 57.8 mmtt -74.15 -35.66 64.06 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.259 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.03 -43.99 97.18 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.071 0.548 . . . . 0.0 111.812 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -93.01 -0.62 57.14 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.907 0.883 . . . . 0.0 111.556 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.13 43.61 96.94 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 123.754 0.659 . . . . 0.0 113.174 172.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 pt -135.53 173.57 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.245 1.418 . . . . 0.0 109.177 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -104.49 108.53 20.01 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 167.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.605 HD21 HG12 ' A' ' 84' ' ' ILE . 51.9 mt -68.74 121.77 82.41 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 167.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 93.5 Cg_endo -78.56 57.57 6.37 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.692 2.261 . . . . 0.0 111.682 176.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.99 -37.81 80.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.013 1.325 . . . . 0.0 109.589 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.37 -46.14 89.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.573 1.149 . . . . 0.0 111.264 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 22.1 tptm -68.88 -39.1 79.97 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.169 0.988 . . . . 0.0 111.102 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.445 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 54.5 m0 -62.51 -41.55 98.91 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.62 0.768 . . . . 0.0 109.886 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.9 m -63.01 -39.61 95.29 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.166 0.916 . . . . 0.0 110.498 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.38 -47.71 75.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.051 0.541 . . . . 0.0 110.654 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -58.17 -44.93 88.21 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.98 0.912 . . . . 0.0 112.288 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.9 t -67.5 -50.36 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 122.629 0.372 . . . . 0.0 111.072 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -67.56 -29.7 69.15 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.371 0.669 . . . . 0.0 112.689 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -94.09 5.2 52.47 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.486 0.714 . . . . 0.0 111.428 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.32 21.77 66.72 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 115.802 1.081 . . . . 0.0 115.802 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -79.57 -22.85 43.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.315 0.646 . . . . 0.0 110.88 173.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.04 177.57 9.47 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.738 1.215 . . . . 0.0 108.339 175.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.21 164.89 20.67 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.102 0.961 . . . . 0.0 109.073 173.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.0 p -54.93 -52.21 63.68 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.202 0.938 . . . . 0.0 113.107 -165.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -35.49 63.21 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -172.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -53.22 -27.93 24.45 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.229 1.012 . . . . 0.0 113.02 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -115.75 -31.28 5.86 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.398 0.679 . . . . 0.0 111.834 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -110.98 21.52 16.34 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.866 0.467 . . . . 0.0 112.033 -165.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.513 HG12 ' HG2' ' A' ' 78' ' ' LYS . 24.8 t -106.82 138.24 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 164.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.442 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -51.62 -37.87 52.13 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -170.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.513 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.8 pttt -69.32 -41.92 76.05 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.059 0.391 . . . . 0.0 110.619 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 76.0 m-20 -76.97 -33.79 57.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.422 1.089 . . . . 0.0 110.04 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -68.04 -54.03 21.35 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.287 1.435 . . . . 0.0 108.331 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.58 -31.01 69.06 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.1 0.875 . . . . 0.0 111.499 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 -52.37 53.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.883 0.473 . . . . 0.0 110.634 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 13.9 mmp_? -54.1 -49.9 68.08 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.233 0.613 . . . . 0.0 110.73 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.605 HG12 HD21 ' A' ' 55' ' ' LEU . 91.9 mt -57.5 -53.65 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 125.246 1.418 . . . . 0.0 110.948 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.588 ' HB2' HG21 ' A' ' 4' ' ' THR . 25.9 t70 -63.18 -34.78 78.39 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.781 0.832 . . . . 0.0 111.831 -176.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -68.15 -36.68 80.05 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.333 0.653 . . . . 0.0 111.128 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.4 mt -68.2 -37.95 81.45 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.867 0.467 . . . . 0.0 110.617 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.497 HG13 ' HE2' ' A' ' 91' ' ' LYS . 58.4 t -68.98 -32.33 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 CA-C-O 121.45 0.643 . . . . 0.0 109.783 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.93 -40.84 78.81 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.378 173.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.69 92.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.239 1.016 . . . . 0.0 111.561 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.497 ' HE2' HG13 ' A' ' 88' ' ' VAL . 56.0 pttt . . . . . 0 N--CA 1.48 1.05 0 C-N-CA 122.524 0.329 . . . . 0.0 110.353 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.006 0.432 . . . . 0.0 110.384 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.0 m -78.09 91.6 4.31 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 169.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.4 m -78.38 74.9 4.91 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.106 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 8' ' ' VAL . 88.3 m -64.58 -46.36 83.07 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.009 -1.45 . . . . 0.0 110.15 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -52.81 -47.64 67.5 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.23 1.012 . . . . 0.0 110.834 173.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -55.97 -47.65 77.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 124.004 0.815 . . . . 0.0 111.645 -176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -66.07 -38.09 87.45 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.86 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.436 HG13 HD11 ' A' ' 47' ' ' ILE . 96.4 t -72.24 -37.48 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.177 0.591 . . . . 0.0 110.329 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.19 -35.46 80.88 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.104 0.962 . . . . 0.0 110.41 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.403 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 59.8 m -66.98 -44.66 79.88 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.926 173.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.2 mt -56.4 -47.09 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 123.274 0.629 . . . . 0.0 110.896 175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.575 HG12 HD13 ' A' ' 43' ' ' ILE . 36.6 mt -61.26 -44.28 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.385 1.074 . . . . 0.0 111.071 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.08 -48.14 64.84 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.015 0.926 . . . . 0.0 112.632 174.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 10' ' ' THR . 46.4 mt-10 -66.64 -32.39 73.69 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.945 0.898 . . . . 0.0 111.557 178.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 60.1 m -71.22 -58.4 3.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.382 0.673 . . . . 0.0 111.591 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 86.4 m -103.65 15.66 28.32 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.434 0.901 . . . . 0.0 113.434 -167.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 49.83 64.14 1.89 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.415 1.086 . . . . 0.0 112.051 -178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.9 pt -142.53 146.07 37.18 Favored Pre-proline 0 N--CA 1.481 1.122 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.688 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.97 125.55 14.36 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 122.31 2.006 . . . . 0.0 112.162 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.65 -31.79 48.92 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 124.949 1.3 . . . . 0.0 113.03 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.39 -23.65 60.2 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.378 0.671 . . . . 0.0 111.226 -169.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -84.7 -11.62 55.49 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 122.8 0.44 . . . . 0.0 110.933 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mp -83.62 111.84 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.5 p -94.93 161.52 28.14 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 123.41 0.684 . . . . 0.0 109.556 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -57.17 -25.41 64.08 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.358 2.039 . . . . 0.0 113.668 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.579 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 32.1 mt-10 -102.89 17.66 23.43 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 121.947 -0.47 . . . . 0.0 110.734 -175.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 75.1 m -78.38 129.62 35.17 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.263 0.625 . . . . 0.0 110.259 172.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.465 ' HE2' ' HB ' ' A' ' 71' ' ' THR . 64.3 t-80 -88.55 120.83 30.3 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 173.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.11 -41.98 27.88 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.355 1.062 . . . . 0.0 113.471 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.2 mt -93.22 -60.11 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -170.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -63.63 -46.44 85.66 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.207 1.003 . . . . 0.0 111.989 -174.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -89.7 -64.37 1.15 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.197 -171.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.5 HD12 ' HA ' ' A' ' 29' ' ' ALA . 86.1 mt -71.39 -17.6 62.4 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.635 0.774 . . . . 0.0 112.542 -173.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.38 30.57 64.49 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 123.169 0.293 . . . . 0.0 113.792 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.6 mt -101.98 123.04 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.43 1.092 . . . . 0.0 108.915 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -68.44 158.88 32.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.081 0.467 . . . . 0.0 110.713 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.2 p -64.46 -23.54 67.32 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.601 0.76 . . . . 0.0 112.222 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 pp -70.53 -39.56 73.98 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -68.03 -35.96 79.13 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.595 0.758 . . . . 0.0 109.461 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -65.56 -27.35 68.37 Favored 'General case' 0 CA--C 1.555 1.152 0 O-C-N 124.06 0.85 . . . . 0.0 111.264 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.425 HD23 HD12 ' A' ' 57' ' ' LEU . 92.5 mt -62.74 -45.38 93.01 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 123.061 0.544 . . . . 0.0 110.272 171.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -65.81 -40.12 91.55 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.989 0.916 . . . . 0.0 110.455 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.575 HD13 HG12 ' A' ' 12' ' ' ILE . 97.3 mt -60.83 -44.99 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.653 0.781 . . . . 0.0 109.784 177.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -68.95 -32.8 72.66 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.854 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -72.03 -31.44 66.18 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.361 1.064 . . . . 0.0 110.886 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.2 65.78 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.547 174.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.444 HD13 HD11 ' A' ' 84' ' ' ILE . 96.0 mt -68.09 -39.14 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 124.002 0.921 . . . . 0.0 110.362 172.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.44 -43.37 75.34 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.697 1.199 . . . . 0.0 110.134 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.08 -53.84 11.61 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.463 175.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.86 -56.84 12.9 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.53 1.132 . . . . 0.0 113.129 -174.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -88.14 -11.82 45.81 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.956 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.12 32.19 76.15 Favored Glycine 0 C--N 1.351 1.375 0 O-C-N 123.312 0.383 . . . . 0.0 112.342 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.543 HD13 HG23 ' A' ' 84' ' ' ILE . 42.6 pt -110.08 163.91 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.258 1.023 . . . . 0.0 110.056 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -110.75 95.55 5.62 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD23 HD12 ' A' ' 87' ' ' LEU . 70.1 mt -72.59 118.88 71.65 Favored Pre-proline 0 N--CA 1.475 0.819 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.429 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 2.7 Cg_exo -78.88 59.85 7.5 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 123.115 2.544 . . . . 0.0 110.139 168.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.425 HD12 HD23 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -65.12 -35.68 81.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.397 -174.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -57.42 -40.55 78.59 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.78 0.832 . . . . 0.0 112.205 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 56' ' ' PRO . 9.6 ptmm? -77.44 -34.81 54.46 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.442 ' O ' HG23 ' A' ' 64' ' ' VAL . 50.6 m0 -66.67 -43.89 83.31 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.509 0.724 . . . . 0.0 110.704 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.8 m -64.5 -37.37 87.31 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.939 0.896 . . . . 0.0 110.269 175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -66.22 -41.73 89.7 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.928 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -62.37 -43.06 99.71 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.802 0.841 . . . . 0.0 110.854 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 60' ' ' TRP . 77.6 t -55.56 -57.22 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 O-C-N 124.149 0.906 . . . . 0.0 110.533 175.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -66.75 -28.96 68.83 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.145 0.978 . . . . 0.0 112.984 -174.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -93.18 7.24 45.09 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.456 0.703 . . . . 0.0 111.555 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.19 11.54 67.52 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 115.017 0.767 . . . . 0.0 115.017 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -70.64 -35.53 72.94 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.235 0.614 . . . . 0.0 109.951 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -140.07 164.77 29.14 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.721 1.208 . . . . 0.0 109.204 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.6 p -97.92 158.46 15.52 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 123.259 0.624 . . . . 0.0 109.801 170.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.465 ' HB ' ' HE2' ' A' ' 28' ' ' HIS . 0.7 OUTLIER -59.54 -43.86 93.39 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 124.158 0.912 . . . . 0.0 110.567 -175.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.558 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.1 mp0 -46.74 -49.1 20.16 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.374 1.47 . . . . 0.0 112.972 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -54.55 -25.44 25.99 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -173.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -121.37 -22.17 6.07 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -109.32 12.06 24.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.246 0.618 . . . . 0.0 111.771 -169.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 72' ' ' GLU . 80.2 t -105.58 138.04 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 169.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.538 HD11 HD12 ' A' ' 12' ' ' ILE . 4.4 mm? -52.91 -38.38 61.77 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.025 1.33 . . . . 0.0 114.312 -171.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.579 ' HD3' ' HG2' ' A' ' 26' ' ' GLU . 60.1 pttt -71.21 -40.7 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.095 0.558 . . . . 0.0 110.609 -177.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 77.5 m-20 -74.58 -47.16 34.1 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.238 1.015 . . . . 0.0 109.788 -176.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.6 tp -57.1 -49.43 75.89 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.705 1.202 . . . . 0.0 110.089 175.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.39 78.61 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 123.834 0.709 . . . . 0.0 110.939 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -67.44 -44.76 77.9 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.585 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 18.2 mmm180 -56.73 -44.31 81.52 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.298 0.639 . . . . 0.0 110.738 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.543 HG23 HD13 ' A' ' 53' ' ' ILE . 90.3 mt -62.54 -49.52 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.029 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -66.04 -32.69 74.32 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.521 1.138 . . . . 0.0 110.625 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 65.6 mt-10 -62.47 -47.14 85.3 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.839 0.856 . . . . 0.0 110.143 172.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.465 HD12 HD23 ' A' ' 55' ' ' LEU . 81.1 mt -69.16 -31.31 69.87 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.153 0.581 . . . . 0.0 111.552 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 84' ' ' ILE . 77.0 t -68.67 -41.31 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.422 0.689 . . . . 0.0 109.665 176.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.83 -41.49 78.5 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.457 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.39 -39.02 91.7 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.026 0.93 . . . . 0.0 111.802 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -85.33 -26.95 26.24 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.825 0.45 . . . . 0.0 110.301 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -78.12 -40.0 21.79 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.466 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 71.23 -55.65 0.65 Allowed 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 125.829 1.651 . . . . 0.0 111.33 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -74.64 163.42 27.74 Favored 'General case' 0 C--O 1.247 0.93 0 C-N-CA 124.539 1.136 . . . . 0.0 109.262 168.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.97 132.95 55.51 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.287 0.635 . . . . 0.0 111.472 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -90.0 20.4 4.28 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.123 0.969 . . . . 0.0 111.348 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.7 m170 -58.33 123.49 16.28 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.761 0.824 . . . . 0.0 111.022 177.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -141.03 112.61 7.53 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.991 0.917 . . . . 0.0 109.216 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -80.6 151.66 28.95 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.798 0.839 . . . . 0.0 109.408 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -159.27 171.55 19.64 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.492 0.717 . . . . 0.0 109.669 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 . . . . . 0 C--O 1.251 1.133 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 172.824 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' HG23 ' A' ' 2' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.488 HG23 ' SD ' ' A' ' 1' ' ' MET . 39.7 p -88.67 94.43 9.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.045 0.538 . . . . 0.0 109.725 177.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.1 p -72.32 172.0 11.13 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 122.751 0.42 . . . . 0.0 110.407 175.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 8' ' ' VAL . 20.0 m -61.55 -50.79 71.23 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -55.82 -43.9 77.39 Favored 'General case' 0 N--CA 1.482 1.143 0 O-C-N 123.911 0.757 . . . . 0.0 111.226 175.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -52.84 -49.74 65.14 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 123.73 0.643 . . . . 0.0 110.736 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -65.88 -40.21 91.4 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.071 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 4' ' ' THR . 67.2 t -66.71 -44.27 89.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 122.871 0.468 . . . . 0.0 110.315 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.56 -41.01 96.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.15 0.98 . . . . 0.0 110.877 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -60.92 -47.69 85.27 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.644 0.778 . . . . 0.0 110.925 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.1 mt -59.54 -50.77 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.445 0.698 . . . . 0.0 111.418 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.467 HG12 HG21 ' A' ' 43' ' ' ILE . 50.9 mt -57.46 -45.62 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 123.672 0.789 . . . . 0.0 110.553 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.532 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.14 -58.17 7.41 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.352 1.061 . . . . 0.0 112.662 174.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -64.84 -26.91 68.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.229 1.011 . . . . 0.0 112.052 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.8 m -76.88 -53.47 7.84 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.256 0.623 . . . . 0.0 110.695 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.483 ' SG ' HG12 ' A' ' 35' ' ' ILE . 37.7 t -100.04 9.2 43.25 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -166.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.6 t70 55.65 59.83 3.64 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.761 0.791 . . . . 0.0 111.151 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.532 HG13 ' HA ' ' A' ' 13' ' ' ALA . 11.5 pt -141.78 148.19 48.42 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 123.729 0.812 . . . . 0.0 109.712 -177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -71.24 125.41 11.34 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.661 2.241 . . . . 0.0 110.568 177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.647 ' HA ' HD13 ' A' ' 23' ' ' ILE . 7.6 ptt180 -68.61 -17.07 64.05 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.07 -24.85 60.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.388 0.675 . . . . 0.0 110.479 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -80.95 -13.24 59.08 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.613 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.647 HD13 ' HA ' ' A' ' 20' ' ' ARG . 2.7 mp -86.64 117.7 31.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.5 p -100.32 161.69 23.28 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.802 0.841 . . . . 0.0 109.045 172.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -62.7 -16.05 50.52 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 121.733 1.622 . . . . 0.0 112.823 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -97.69 3.33 50.26 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.791 -0.568 . . . . 0.0 111.064 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.7 m -77.78 135.81 38.03 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.433 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 59.5 t-80 -81.07 113.81 19.51 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 170.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.24 -23.17 55.02 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -173.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.433 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 61.9 mt -97.79 -54.13 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.171 0.588 . . . . 0.0 110.007 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -76.23 -43.67 41.08 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.826 0.851 . . . . 0.0 112.563 -167.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.81 -51.55 11.14 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 122.788 0.435 . . . . 0.0 110.049 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.9 mt -78.02 -5.78 52.43 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.926 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.65 27.93 73.57 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.566 0.541 . . . . 0.0 113.246 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.483 HG12 ' SG ' ' A' ' 16' ' ' CYS . 81.4 mt -95.86 124.29 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.976 0.911 . . . . 0.0 108.615 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -67.52 157.46 34.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.489 0.316 . . . . 0.0 110.999 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.449 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.6 m -63.02 -22.78 67.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.632 0.773 . . . . 0.0 110.75 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.5 mt -65.31 -51.37 61.08 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.75 0.82 . . . . 0.0 109.908 174.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.52 -31.46 71.58 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.58 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.405 ' CE2' HD21 ' A' ' 57' ' ' LEU . 30.0 t80 -74.91 -24.99 58.6 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.305 0.642 . . . . 0.0 110.973 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.503 HD23 HD12 ' A' ' 57' ' ' LEU . 80.1 mt -61.63 -42.27 98.65 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.061 0.544 . . . . 0.0 109.86 169.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -72.27 -37.42 69.05 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.888 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.467 HG21 HG12 ' A' ' 12' ' ' ILE . 67.5 mt -58.85 -50.74 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.817 174.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.24 -27.5 63.51 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.533 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -61.01 -46.35 91.1 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.803 0.841 . . . . 0.0 110.483 169.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.27 -34.87 76.96 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.141 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.2 mt -69.0 -44.04 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.932 0.893 . . . . 0.0 110.679 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -51.35 -48.6 62.39 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.388 1.475 . . . . 0.0 110.257 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -76.84 -38.58 53.55 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.572 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.87 -54.92 38.69 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.286 0.634 . . . . 0.0 112.304 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -84.58 -9.93 57.85 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.616 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.65 29.78 69.27 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 123.53 0.519 . . . . 0.0 112.858 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.544 HD13 HG23 ' A' ' 84' ' ' ILE . 42.6 pt -107.53 176.5 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.506 1.122 . . . . 0.0 109.735 -174.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.54 96.26 5.06 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.65 116.79 61.06 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 123.705 0.802 . . . . 0.0 109.859 171.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -84.3 57.4 5.24 Favored 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 122.651 2.234 . . . . 0.0 110.41 168.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.503 HD12 HD23 ' A' ' 41' ' ' LEU . 2.0 tm? -59.7 -41.76 91.46 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.516 1.127 . . . . 0.0 109.931 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 11.6 pt-20 -61.39 -39.27 90.1 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 124.24 0.963 . . . . 0.0 110.959 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -46.76 79.02 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.777 0.831 . . . . 0.0 110.107 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.466 ' O ' HG23 ' A' ' 64' ' ' VAL . 52.5 m0 -60.16 -40.14 88.88 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 124.936 1.397 . . . . 0.0 110.861 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 34.8 m -68.21 -35.15 77.52 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.494 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 17.0 mm100 -73.15 -29.69 63.05 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.855 0.462 . . . . 0.0 110.521 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.464 ' HG2' ' HE3' ' A' ' 68' ' ' LYS . 49.0 mt-10 -65.78 -41.54 91.9 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.747 0.419 . . . . 0.0 110.199 173.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.663 HG11 HG23 ' A' ' 71' ' ' THR . 98.7 t -61.07 -43.15 95.64 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.6 175.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -62.08 -39.64 93.14 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.107 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -87.55 -5.18 58.88 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.674 0.79 . . . . 0.0 112.586 -174.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.96 12.01 85.03 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 115.042 0.777 . . . . 0.0 115.042 -176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.464 ' HE3' ' HG2' ' A' ' 63' ' ' GLU . 55.1 mtmt -79.68 -26.97 40.81 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 117.725 0.762 . . . . 0.0 111.059 172.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -136.53 174.54 10.51 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.056 0.942 . . . . 0.0 109.327 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.7 m -133.86 148.57 51.29 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 124.485 1.114 . . . . 0.0 108.757 174.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.663 HG23 HG11 ' A' ' 64' ' ' VAL . 4.1 p -58.42 93.1 0.02 OUTLIER 'General case' 0 C--N 1.362 1.146 0 C-N-CA 123.512 0.725 . . . . 0.0 109.887 174.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.486 ' HA ' HG23 ' A' ' 76' ' ' VAL . 3.0 tm-20 175.86 -63.81 0.01 OUTLIER 'General case' 0 C--O 1.241 0.634 0 C-N-CA 125.134 1.374 . . . . 0.0 107.978 -174.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -51.26 -29.36 14.35 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.763 -1.562 . . . . 0.0 114.06 -173.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -132.92 0.61 3.51 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.061 0.544 . . . . 0.0 111.136 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -121.28 5.35 10.25 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.29 0.636 . . . . 0.0 111.295 -165.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 72' ' ' GLU . 71.7 t -105.34 146.1 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.464 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -52.39 -43.77 64.94 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.901 1.28 . . . . 0.0 114.251 -174.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -68.95 -42.32 76.83 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.754 0.422 . . . . 0.0 110.322 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 5.6 m120 -65.32 -47.33 76.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.447 0.699 . . . . 0.0 110.597 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -62.88 -50.77 69.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 110.223 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 84' ' ' ILE . . . -62.43 -28.25 69.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.665 0.786 . . . . 0.0 111.261 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 86' ' ' GLU . . . -69.99 -45.35 67.47 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.736 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 15.3 mmm180 -57.71 -46.63 84.13 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.331 0.652 . . . . 0.0 110.383 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.544 HG23 HD13 ' A' ' 53' ' ' ILE . 89.9 mt -59.08 -47.94 88.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 113.778 -1.556 . . . . 0.0 110.694 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -57.07 -46.34 82.57 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.079 0.862 . . . . 0.0 111.205 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 82' ' ' ALA . 49.1 mt-10 -63.76 -35.28 80.08 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.101 0.56 . . . . 0.0 111.111 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -74.4 -32.09 62.57 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.976 0.51 . . . . 0.0 112.154 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 84' ' ' ILE . 98.0 t -64.72 -41.47 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-O 121.732 0.777 . . . . 0.0 109.405 171.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.62 -45.52 78.84 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.648 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.93 -39.71 90.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.31 1.044 . . . . 0.0 112.145 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 88' ' ' VAL . 20.6 pttp -77.75 -18.83 56.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.453 0.301 . . . . 0.0 110.415 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -94.74 -4.63 61.81 Favored Glycine 0 C--N 1.349 1.253 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 174.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.12 10.02 31.06 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.673 0.789 . . . . 0.0 111.427 -177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.3 mp -73.13 166.73 22.57 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.476 0.71 . . . . 0.0 111.027 174.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -57.91 -46.9 84.27 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.889 0.876 . . . . 0.0 112.498 -168.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -74.86 98.42 3.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.0 t60 66.48 93.25 0.07 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.977 1.311 . . . . 0.0 110.641 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -79.18 -10.3 59.78 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.223 0.609 . . . . 0.0 111.674 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 77.72 -64.85 0.28 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.866 1.667 . . . . 0.0 111.586 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -72.14 130.96 42.12 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.518 0.727 . . . . 0.0 111.896 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 . . . . . 0 C--O 1.253 1.258 0 CA-C-O 118.195 -0.907 . . . . 0.0 108.98 171.1 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 tmm? . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.7 t -63.6 87.25 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 122.25 1.024 . . . . 0.0 111.29 -176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.1 m -76.67 175.6 9.19 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.327 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.0 m -56.36 -42.7 78.22 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.767 0.427 . . . . 0.0 110.623 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -54.39 -50.26 67.95 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.35 0.66 . . . . 0.0 111.247 173.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -62.01 -42.0 98.68 Favored 'General case' 0 N--CA 1.478 0.945 0 O-C-N 123.574 0.546 . . . . 0.0 110.721 -175.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -58.84 -48.27 81.95 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.724 0.81 . . . . 0.0 111.082 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 4' ' ' THR . 94.9 t -67.48 -44.87 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.57 0.748 . . . . 0.0 110.852 -177.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.46 90.51 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.288 1.035 . . . . 0.0 110.375 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.484 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 92.8 m -63.4 -44.9 93.35 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.758 0.823 . . . . 0.0 111.29 175.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.596 HD13 ' HA ' ' A' ' 47' ' ' ILE . 95.2 mt -58.71 -48.16 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 122.967 0.507 . . . . 0.0 111.485 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.469 HG22 HD11 ' A' ' 18' ' ' ILE . 57.1 mt -58.46 -45.88 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.645 0.778 . . . . 0.0 109.996 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.49 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.77 -51.84 62.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.853 1.261 . . . . 0.0 113.683 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 10' ' ' THR . 22.2 mm-40 -66.26 -27.78 68.21 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.386 0.675 . . . . 0.0 112.129 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 43' ' ' ILE . 96.1 m -76.56 -51.63 11.3 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 122.929 0.492 . . . . 0.0 111.054 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.6 m -99.59 7.03 45.59 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.59 0.756 . . . . 0.0 112.515 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 48.25 70.6 0.43 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.526 1.13 . . . . 0.0 111.749 -174.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.49 HG13 ' HA ' ' A' ' 13' ' ' ALA . 10.3 pt -144.78 146.58 32.24 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 124.138 0.975 . . . . 0.0 109.605 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -66.45 116.69 4.2 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.919 2.413 . . . . 0.0 112.207 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -23.91 67.44 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -170.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -90.76 -6.36 54.48 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.142 0.577 . . . . 0.0 110.891 -171.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -89.02 -13.03 39.72 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 167.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.422 HD11 HD12 ' A' ' 18' ' ' ILE . 2.0 mp -79.19 105.77 9.1 Favored 'Isoleucine or valine' 0 C--N 1.358 0.953 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 171.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.3 p -77.25 159.94 76.74 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.435 0.694 . . . . 0.0 109.735 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -63.57 -17.02 58.13 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 121.988 1.792 . . . . 0.0 112.196 172.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -99.74 9.85 42.36 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 122.909 0.484 . . . . 0.0 110.427 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.0 m -72.13 124.33 24.77 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 122.57 0.348 . . . . 0.0 110.07 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -83.6 117.09 22.93 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.471 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.71 -41.43 15.05 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.206 1.003 . . . . 0.0 113.37 178.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.71 -50.2 11.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 122.464 0.306 . . . . 0.0 110.457 -170.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -82.27 -38.33 24.56 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.943 0.897 . . . . 0.0 112.397 -171.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.17 -57.05 2.83 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.186 0.595 . . . . 0.0 110.35 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.471 HD12 ' HA ' ' A' ' 29' ' ' ALA . 88.7 mt -76.29 -10.53 59.47 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.888 0.875 . . . . 0.0 111.977 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.26 30.38 77.61 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 123.412 0.445 . . . . 0.0 113.993 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.1 mt -89.39 126.24 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -60.27 147.92 38.54 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.213 0.605 . . . . 0.0 110.692 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -60.56 -35.74 76.77 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.726 0.41 . . . . 0.0 111.144 178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 39' ' ' ASP . 3.0 pp -73.86 -31.65 63.27 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.186 0.594 . . . . 0.0 110.902 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.454 ' N ' HD12 ' A' ' 38' ' ' LEU . 15.5 t70 -72.82 -35.99 67.41 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.483 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -71.72 -21.78 61.72 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.075 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 70.8 mt -56.85 -41.72 78.4 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 122.625 0.37 . . . . 0.0 110.426 170.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -74.09 -32.62 63.32 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.057 0.943 . . . . 0.0 111.51 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.539 HG12 HG21 ' A' ' 15' ' ' THR . 37.9 mt -65.26 -46.59 90.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.13 -29.15 67.14 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.907 0.883 . . . . 0.0 111.143 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -58.21 -50.87 72.04 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.006 1.322 . . . . 0.0 110.786 170.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.92 -33.49 74.78 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.871 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.596 ' HA ' HD13 ' A' ' 11' ' ' ILE . 85.9 mt -67.47 -51.32 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.186 0.594 . . . . 0.0 110.888 177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.85 -37.33 86.39 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.039 0.535 . . . . 0.0 110.344 -170.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -81.38 -29.04 34.13 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.4 -48.24 76.17 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 123.322 0.388 . . . . 0.0 111.592 173.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.406 ' HB2' HG12 ' A' ' 53' ' ' ILE . 86.7 m-85 -83.12 -16.47 46.69 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.508 0.723 . . . . 0.0 111.821 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.12 37.58 87.25 Favored Glycine 0 C--N 1.348 1.219 0 O-C-N 123.382 0.426 . . . . 0.0 112.519 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.479 HG22 ' HG2' ' A' ' 91' ' ' LYS . 46.3 pt -116.35 172.82 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.585 1.154 . . . . 0.0 111.026 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -115.62 97.82 6.36 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.385 1.074 . . . . 0.0 108.454 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.545 HD21 HG12 ' A' ' 84' ' ' ILE . 79.3 mt -73.18 120.42 80.9 Favored Pre-proline 0 N--CA 1.468 0.469 0 C-N-CA 123.035 0.534 . . . . 0.0 110.071 174.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.56 57.82 6.7 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 122.758 2.305 . . . . 0.0 110.835 169.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -63.83 -40.99 97.92 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.416 1.086 . . . . 0.0 109.818 -173.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.26 -37.88 88.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.502 0.721 . . . . 0.0 111.371 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -71.01 -37.97 72.63 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.853 0.861 . . . . 0.0 110.238 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -63.59 -52.79 59.42 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.944 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 56.3 m -62.52 -33.3 74.62 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.084 0.954 . . . . 0.0 110.895 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -63.22 -58.65 6.5 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.429 0.691 . . . . 0.0 109.837 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 44.4 mt-10 -66.04 -32.23 73.58 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.854 0.862 . . . . 0.0 111.82 -176.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.8 t -61.63 -55.01 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.683 0.793 . . . . 0.0 110.165 175.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -78.97 -7.7 58.27 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.699 0.399 . . . . 0.0 111.787 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -92.85 -2.92 55.47 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.342 0.657 . . . . 0.0 110.74 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.71 5.24 86.19 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 115.888 1.115 . . . . 0.0 115.888 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 60.6 mttp -70.43 -31.59 68.84 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.075 0.937 . . . . 0.0 110.277 171.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.43 163.27 32.96 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.326 1.051 . . . . 0.0 108.819 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.0 p -104.72 162.28 13.43 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.442 0.697 . . . . 0.0 109.643 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 74.5 p -59.38 -52.5 65.38 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.157 0.583 . . . . 0.0 112.332 -169.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -56.02 -31.52 63.17 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -172.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -50.07 -33.59 18.91 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.36 1.064 . . . . 0.0 113.318 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -122.12 -19.59 6.53 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -111.91 23.4 13.83 Favored 'General case' 0 C--O 1.214 -0.79 0 C-N-CA 122.571 0.348 . . . . 0.0 111.198 -171.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 78' ' ' LYS . 40.3 t -110.27 142.26 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 162.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.17 -41.4 68.48 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 125.389 1.476 . . . . 0.0 114.267 -171.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.517 ' HG2' HG12 ' A' ' 76' ' ' VAL . 58.9 pttt -66.77 -37.79 85.29 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 120.786 0.327 . . . . 0.0 110.954 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 73.3 m-20 -80.39 -37.93 31.3 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.878 0.871 . . . . 0.0 110.817 -176.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.38 -53.21 52.07 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.242 1.017 . . . . 0.0 108.857 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.47 -22.58 65.47 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.689 0.795 . . . . 0.0 111.914 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.11 -53.94 37.66 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.66 0.384 . . . . 0.0 110.058 170.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 28.1 mmm180 -60.92 -40.37 92.93 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 124.101 0.876 . . . . 0.0 111.205 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.545 HG12 HD21 ' A' ' 55' ' ' LEU . 92.3 mt -61.52 -50.31 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.281 1.032 . . . . 0.0 110.31 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.402 ' HB2' HG21 ' A' ' 4' ' ' THR . 27.6 t70 -63.34 -34.94 78.8 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.118 0.567 . . . . 0.0 111.496 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -58.85 -44.12 90.94 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.487 0.715 . . . . 0.0 109.981 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.9 mt -69.2 -42.04 76.3 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.16 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 84' ' ' ILE . 61.6 t -61.65 -45.69 98.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 123.464 0.706 . . . . 0.0 110.333 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.98 -43.11 99.3 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.511 176.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.01 -42.67 76.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.621 -176.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -83.53 -32.17 26.03 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.668 0.387 . . . . 0.0 110.146 -174.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.37 -25.74 74.6 Favored Glycine 0 C--N 1.355 1.625 0 O-C-N 124.088 0.868 . . . . 0.0 112.566 -177.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.57 -37.81 80.21 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.326 0.65 . . . . 0.0 111.235 173.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.5 mp -73.99 -34.79 64.33 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.75 0.82 . . . . 0.0 110.644 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.4 mt-10 -66.14 -39.17 89.65 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.047 174.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.6 t60 68.68 -70.31 0.14 Allowed 'General case' 0 C--N 1.361 1.108 0 C-N-CA 125.635 1.574 . . . . 0.0 110.445 -178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -68.16 118.14 10.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.587 1.155 . . . . 0.0 110.585 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.35 166.16 23.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.637 0.775 . . . . 0.0 110.109 170.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -66.29 153.85 41.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.097 0.159 . . . . 0.0 111.015 175.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -63.89 107.42 1.22 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 . . . . . 0 CA--C 1.561 1.385 0 O-C-N 124.346 1.029 . . . . 0.0 110.833 -176.695 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 75.1 p 48.87 27.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 125.076 1.35 . . . . 0.0 112.819 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -72.83 128.98 37.11 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.156 0.982 . . . . 0.0 110.01 -171.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.6 m -57.58 -54.08 50.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.185 0.994 . . . . 0.0 111.652 -172.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -54.89 -48.13 73.4 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.736 0.647 . . . . 0.0 111.016 175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.93 -42.85 94.87 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 123.785 0.678 . . . . 0.0 110.934 -174.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -57.44 -45.76 84.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.498 0.719 . . . . 0.0 111.221 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.8 t -71.4 -33.97 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 123.712 0.632 . . . . 0.0 110.77 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.86 -36.42 83.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.549 0.739 . . . . 0.0 110.481 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.1 m -66.82 -44.01 82.27 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.56 0.744 . . . . 0.0 110.739 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.8 mt -56.42 -54.53 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 123.646 0.778 . . . . 0.0 110.724 175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.578 HD12 HD11 ' A' ' 77' ' ' LEU . 35.8 mt -60.08 -45.38 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.15 0.98 . . . . 0.0 110.66 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.467 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -51.88 -51.27 57.98 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 123.825 0.703 . . . . 0.0 112.319 174.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -67.86 -30.17 69.47 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.499 0.72 . . . . 0.0 112.332 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.7 m -74.81 -61.0 2.03 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.254 0.622 . . . . 0.0 110.938 -176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.8 m -90.49 10.79 23.93 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.016 0.927 . . . . 0.0 112.953 -168.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.4 t70 48.7 68.09 0.76 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.651 1.18 . . . . 0.0 111.565 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.467 HG13 ' HA ' ' A' ' 13' ' ' ALA . 12.1 pt -145.26 142.96 18.95 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.718 1.207 . . . . 0.0 108.699 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.67 139.36 69.08 Favored 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.523 2.149 . . . . 0.0 112.55 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -56.33 -31.5 63.78 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 125.144 1.378 . . . . 0.0 111.952 -173.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -77.25 -18.81 57.33 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.99 0.516 . . . . 0.0 111.901 -172.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.2 p -78.93 -11.32 60.0 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 118.046 0.385 . . . . 0.0 111.398 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.4 mp -86.18 102.05 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 27' ' ' SER . 64.3 p -81.18 154.04 72.07 Favored Pre-proline 0 CA--C 1.551 1.017 0 C-N-CA 123.118 0.567 . . . . 0.0 109.77 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.94 -30.22 83.22 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.335 2.024 . . . . 0.0 112.524 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -97.8 13.08 31.73 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 122.824 0.45 . . . . 0.0 110.947 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.419 ' HB2' ' OG1' ' A' ' 24' ' ' THR . 46.9 t -72.24 129.67 38.98 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 122.968 0.507 . . . . 0.0 109.69 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 62.0 t-80 -83.21 114.62 21.48 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 167.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.69 -41.66 10.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.022 0.929 . . . . 0.0 112.977 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.6 mt -88.62 -59.63 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -172.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -64.19 -36.46 84.13 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.739 1.216 . . . . 0.0 112.728 -173.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -98.39 -65.59 0.95 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.282 0.633 . . . . 0.0 110.759 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.6 mt -70.48 -18.49 62.98 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 -173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.37 41.66 36.83 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 112.366 -0.293 . . . . 0.0 112.366 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.5 mt -99.75 107.88 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.25 168.32 18.54 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.4 t -52.46 -37.93 58.14 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.466 1.106 . . . . 0.0 111.783 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.7 pp -75.23 -26.06 58.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.056 0.543 . . . . 0.0 111.898 -176.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -76.4 -41.38 47.98 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 175.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.9 t80 -68.95 -23.13 64.11 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.889 -175.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 82.4 mt -52.27 -49.86 63.23 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.159 0.583 . . . . 0.0 111.207 171.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.34 -38.02 71.68 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.826 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.533 HD13 HG12 ' A' ' 12' ' ' ILE . 81.5 mt -65.26 -44.79 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.519 0.728 . . . . 0.0 110.614 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -70.34 -37.16 74.62 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.284 0.633 . . . . 0.0 110.293 -177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -71.63 -27.57 63.19 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.367 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.06 -30.72 63.92 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 120.837 0.351 . . . . 0.0 110.627 175.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 84' ' ' ILE . 87.0 mt -69.37 -38.19 76.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.072 0.949 . . . . 0.0 109.793 171.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 5.9 t70 -58.09 -42.81 86.44 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.823 0.849 . . . . 0.0 111.137 174.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -67.94 -54.06 21.56 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.931 0.892 . . . . 0.0 110.561 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.13 -55.7 31.7 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.19 0.996 . . . . 0.0 112.605 -175.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -91.05 -13.74 32.64 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.489 0.716 . . . . 0.0 112.433 -171.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 100' ' ' HIS . . . 68.53 34.63 79.47 Favored Glycine 0 N--CA 1.473 1.114 0 CA-C-O 121.202 0.335 . . . . 0.0 113.494 -178.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.638 HG22 ' HG2' ' A' ' 91' ' ' LYS . 44.6 pt -120.21 153.03 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.18 0.992 . . . . 0.0 109.149 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.553 ' HD2' ' HB2' ' A' ' 98' ' ' HIS . 14.0 ptmm? -100.59 106.95 18.5 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 172.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 52.4 mt -69.96 125.05 91.8 Favored Pre-proline 0 C--N 1.348 0.513 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 170.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 78.0 Cg_endo -78.17 57.25 6.1 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.387 2.058 . . . . 0.0 111.104 172.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.54 -38.37 89.72 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.346 1.058 . . . . 0.0 110.425 -175.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.98 -36.52 79.65 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.638 0.375 . . . . 0.0 111.833 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.31 -37.37 60.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.498 0.719 . . . . 0.0 110.374 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.436 ' O ' HG23 ' A' ' 64' ' ' VAL . 48.1 m0 -62.93 -50.97 68.74 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.925 0.89 . . . . 0.0 110.569 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.3 m -64.0 -31.85 73.18 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.259 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -68.62 -42.89 77.45 Favored 'General case' 0 C--N 1.353 0.737 0 C-N-CA 123.012 0.525 . . . . 0.0 110.84 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.33 -42.53 99.46 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.905 0.482 . . . . 0.0 110.615 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 60' ' ' TRP . 61.2 t -61.05 -49.96 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.593 0.711 . . . . 0.0 110.161 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -56.76 -41.44 77.59 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.421 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -99.62 17.38 20.65 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.094 0.958 . . . . 0.0 111.48 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.29 14.22 52.85 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 115.107 0.803 . . . . 0.0 115.107 175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -80.78 -24.73 38.4 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.795 0.838 . . . . 0.0 110.396 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.85 173.33 12.94 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.173 0.989 . . . . 0.0 109.874 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 72.8 p -106.89 164.76 11.85 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.293 0.637 . . . . 0.0 109.694 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.0 p -57.45 -49.67 75.51 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.428 0.455 . . . . 0.0 110.475 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.483 ' HA ' HG23 ' A' ' 76' ' ' VAL . 29.8 mt-10 -39.1 -50.99 1.89 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.711 1.604 . . . . 0.0 113.26 -176.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -59.59 -24.21 63.58 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 114.334 -1.303 . . . . 0.0 113.288 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -120.01 -22.79 6.57 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.935 0.494 . . . . 0.0 112.026 178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -115.85 19.71 14.98 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.281 0.632 . . . . 0.0 110.749 -167.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.483 HG23 ' HA ' ' A' ' 72' ' ' GLU . 79.8 t -105.63 139.97 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 161.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.578 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -56.52 -40.48 75.13 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.837 1.255 . . . . 0.0 113.936 -172.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.449 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.3 pttt -72.58 -38.7 67.82 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.586 0.355 . . . . 0.0 111.216 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -71.97 -45.69 60.1 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.544 0.738 . . . . 0.0 109.888 -178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 68.2 tp -53.73 -48.05 70.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.913 1.285 . . . . 0.0 110.299 171.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.97 -31.98 73.21 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.673 0.608 . . . . 0.0 111.759 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.89 -41.98 77.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.769 0.427 . . . . 0.0 110.479 175.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -60.28 -44.75 95.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.319 0.58 . . . . 0.0 111.234 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 47' ' ' ILE . 90.3 mt -65.52 -46.64 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.276 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -61.54 -38.71 88.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.395 0.678 . . . . 0.0 110.991 -177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -59.41 -50.87 72.29 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.578 0.549 . . . . 0.0 110.733 174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.04 -35.68 81.2 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 123.69 0.619 . . . . 0.0 112.219 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 84' ' ' ILE . 70.6 t -67.17 -47.26 82.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 123.395 0.678 . . . . 0.0 110.546 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.79 -32.4 73.67 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.712 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.33 -46.91 68.93 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 123.482 0.713 . . . . 0.0 111.434 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.638 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -79.43 -24.43 42.48 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.042 0.537 . . . . 0.0 110.626 -174.566 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.3 -28.38 73.67 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.887 0.742 . . . . 0.0 112.312 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -104.04 -63.92 1.15 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.818 0.847 . . . . 0.0 109.661 175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.1 tt -107.13 82.04 1.63 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.29 1.036 . . . . 0.0 108.406 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -62.72 111.77 2.24 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.343 175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 -128.52 123.89 34.67 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.934 0.494 . . . . 0.0 111.133 -171.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 64.24 8.51 4.18 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 125.145 1.378 . . . . 0.0 114.076 163.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.553 ' HB2' ' HD2' ' A' ' 54' ' ' LYS . 81.2 t60 -171.74 141.02 1.38 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.577 0.751 . . . . 0.0 110.731 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -133.84 170.96 14.83 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.373 1.069 . . . . 0.0 109.387 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.409 ' HB3' ' HA2' ' A' ' 52' ' ' GLY . 58.7 t-80 -167.74 104.95 0.5 Allowed 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 172.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 . . . . . 0 C--O 1.253 1.27 0 C-N-CA 123.342 0.657 . . . . 0.0 110.665 176.029 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtm . . . . . 0 N--CA 1.481 1.093 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.0 p -63.74 96.03 0.12 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.371 0.669 . . . . 0.0 110.143 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 45.0 t -146.99 163.87 34.83 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.775 0.83 . . . . 0.0 109.994 -172.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.9 m -59.52 -41.84 90.9 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 124.013 0.821 . . . . 0.0 110.597 178.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -52.9 -51.23 61.95 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.715 0.806 . . . . 0.0 110.866 173.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -60.86 -44.9 96.41 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 124.163 0.914 . . . . 0.0 111.421 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 3' ' ' SER . 36.7 mmt180 -64.81 -40.58 95.45 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.329 0.651 . . . . 0.0 111.44 -178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.469 HG13 HD11 ' A' ' 47' ' ' ILE . 69.6 t -72.39 -36.57 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.193 0.597 . . . . 0.0 110.474 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.34 -35.47 80.98 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.721 0.808 . . . . 0.0 110.64 175.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.7 m -65.24 -48.07 74.56 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.818 0.847 . . . . 0.0 110.896 172.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.411 HG22 HG23 ' A' ' 43' ' ' ILE . 78.5 mt -58.0 -46.86 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.494 0.718 . . . . 0.0 110.776 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.454 HD12 HD11 ' A' ' 77' ' ' LEU . 55.4 mt -61.89 -48.93 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.673 0.789 . . . . 0.0 110.854 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.57 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.18 -44.46 64.68 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.212 1.005 . . . . 0.0 112.575 176.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -66.25 -43.74 85.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.143 0.977 . . . . 0.0 111.798 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 34.9 m -75.49 -50.95 14.15 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 122.727 0.411 . . . . 0.0 111.527 -170.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.8 m -89.67 3.82 51.47 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.265 1.026 . . . . 0.0 111.886 -174.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.0 t70 50.54 75.0 0.19 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 125.256 1.422 . . . . 0.0 112.416 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.57 HG13 ' HA ' ' A' ' 13' ' ' ALA . 3.4 pt -148.21 157.5 42.53 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 124.629 1.172 . . . . 0.0 109.474 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.58 137.7 47.18 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.361 2.041 . . . . 0.0 110.993 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.422 ' HA ' HD13 ' A' ' 23' ' ' ILE . 25.5 ttm180 -57.63 -30.54 65.45 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.973 0.909 . . . . 0.0 112.5 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -72.86 -21.65 60.9 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.994 0.918 . . . . 0.0 111.26 -173.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.6 p -80.66 -6.7 58.73 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 122.777 0.431 . . . . 0.0 111.146 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 20' ' ' ARG . 3.8 mp -90.99 112.04 24.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 170.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.4 p -95.65 160.73 29.72 Favored Pre-proline 0 N--CA 1.484 1.253 0 C-N-CA 123.32 0.648 . . . . 0.0 110.425 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -60.16 -33.31 95.07 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 122.23 1.953 . . . . 0.0 112.877 175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -94.49 11.24 31.5 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.945 0.898 . . . . 0.0 110.954 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.8 t -79.22 128.52 33.41 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 123.177 0.591 . . . . 0.0 110.324 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -83.18 118.9 23.92 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.97 -40.77 23.35 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.55 -45.39 13.83 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 O-C-N 122.187 -0.32 . . . . 0.0 110.211 -169.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -82.99 -32.8 26.8 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.818 0.847 . . . . 0.0 112.316 -173.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -96.91 -64.25 1.06 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.366 0.666 . . . . 0.0 109.965 -176.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.439 HD13 HG21 ' A' ' 12' ' ' ILE . 82.8 mt -69.77 -11.19 60.66 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.155 0.582 . . . . 0.0 111.489 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.84 31.91 79.59 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.55 0.531 . . . . 0.0 113.153 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -82.97 122.95 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -61.36 146.1 49.31 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.746 0.419 . . . . 0.0 110.063 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.437 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 37.3 m -59.65 -34.68 73.12 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.506 0.722 . . . . 0.0 111.807 -175.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.1 mt -73.7 -34.48 64.86 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.439 0.696 . . . . 0.0 110.032 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -73.89 -30.63 62.72 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.461 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -75.76 -23.67 55.99 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.661 0.384 . . . . 0.0 110.54 178.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 37' ' ' SER . 96.5 mt -63.76 -39.46 94.33 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.862 0.465 . . . . 0.0 109.84 169.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -65.97 -45.56 81.23 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.89 0.876 . . . . 0.0 110.619 176.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.411 HG23 HG22 ' A' ' 11' ' ' ILE . 63.4 mt -62.97 -40.21 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.622 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.94 -35.93 77.35 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.431 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -74.63 -25.17 59.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.609 0.764 . . . . 0.0 110.941 177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.97 -41.15 68.06 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.996 0.518 . . . . 0.0 110.559 173.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.469 HD11 HG13 ' A' ' 8' ' ' VAL . 89.8 mt -65.55 -40.48 88.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.295 1.038 . . . . 0.0 110.061 173.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -55.27 -47.74 75.05 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.02 1.328 . . . . 0.0 109.714 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' HG2' ' HB2' ' A' ' 100' ' ' HIS . 99.5 mttt -67.84 -50.58 55.87 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.52 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.02 -51.77 68.65 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.963 0.905 . . . . 0.0 112.114 -172.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.17 -5.26 59.05 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.908 0.883 . . . . 0.0 111.456 -176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.3 30.81 75.85 Favored Glycine 0 C--N 1.352 1.437 0 O-C-N 123.193 0.308 . . . . 0.0 113.64 175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.7 pt -121.36 170.66 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.41 1.084 . . . . 0.0 109.869 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -104.97 111.03 23.66 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 168.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.591 HD21 HG12 ' A' ' 84' ' ' ILE . 42.6 mt -73.9 118.28 68.08 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 165.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -79.25 58.38 6.92 Favored 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.626 2.217 . . . . 0.0 109.706 170.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.58 -37.15 85.08 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.053 0.941 . . . . 0.0 109.118 -174.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.3 -45.58 90.74 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.383 0.673 . . . . 0.0 111.143 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -62.23 -40.71 97.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.866 0.866 . . . . 0.0 110.462 178.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.45 ' O ' HG23 ' A' ' 64' ' ' VAL . 54.1 m0 -63.66 -45.87 88.18 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 124.318 1.011 . . . . 0.0 109.87 178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.5 m -62.06 -33.96 75.39 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 124.054 0.846 . . . . 0.0 110.932 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -72.2 -44.58 62.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.937 0.495 . . . . 0.0 110.513 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.26 -36.39 77.68 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.393 0.677 . . . . 0.0 110.816 176.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 60' ' ' TRP . 72.9 t -67.14 -49.94 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.829 176.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -59.23 -44.87 92.31 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.721 0.808 . . . . 0.0 112.063 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -86.35 6.67 28.92 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.981 0.912 . . . . 0.0 111.538 -174.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.94 23.05 67.24 Favored Glycine 0 C--N 1.354 1.562 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.461 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -75.65 -30.53 59.47 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.372 0.669 . . . . 0.0 109.554 174.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.79 160.47 42.22 Favored 'General case' 0 C--N 1.347 0.462 0 C-N-CA 124.545 1.138 . . . . 0.0 109.371 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.4 p -83.85 162.83 20.43 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.117 0.567 . . . . 0.0 110.251 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 82.4 p -58.53 -55.43 35.19 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.53 0.681 . . . . 0.0 109.859 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.5 -33.86 64.1 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.314 -1.312 . . . . 0.0 113.299 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -55.57 -26.74 45.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 123.877 0.736 . . . . 0.0 112.529 -176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -119.6 -28.69 5.24 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.88 0.472 . . . . 0.0 112.156 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -104.59 16.95 25.06 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 122.99 0.516 . . . . 0.0 112.025 -169.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.487 HG12 ' HG2' ' A' ' 78' ' ' LYS . 22.9 t -107.5 142.68 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 167.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -56.99 -41.69 78.88 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.001 1.32 . . . . 0.0 114.509 -170.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.9 pttt -65.65 -40.72 92.78 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.357 0.599 . . . . 0.0 110.312 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -75.34 -44.48 44.94 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.735 1.214 . . . . 0.0 110.499 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.3 tp -57.69 -51.14 70.74 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.218 1.407 . . . . 0.0 109.977 176.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.85 -33.37 74.05 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.737 0.815 . . . . 0.0 111.658 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.67 -50.17 65.92 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.566 175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -55.1 -46.65 75.53 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 124.594 1.158 . . . . 0.0 111.688 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.591 HG12 HD21 ' A' ' 55' ' ' LEU . 93.2 mt -60.26 -48.71 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.787 1.235 . . . . 0.0 110.464 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.15 -31.23 71.96 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.884 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -64.91 -41.86 95.21 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.116 0.566 . . . . 0.0 110.302 173.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.94 -27.93 65.16 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.429 0.692 . . . . 0.0 111.186 177.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.425 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 61.0 t -71.22 -36.36 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.623 0.769 . . . . 0.0 110.234 172.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.66 -36.67 84.34 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.007 173.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.25 -40.07 82.07 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.721 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 13.5 ptmm? -73.31 -19.38 61.05 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 118.064 0.393 . . . . 0.0 111.334 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -58.41 -18.01 34.77 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 115.123 0.809 . . . . 0.0 115.123 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -148.6 -42.03 0.15 Allowed 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 117.423 0.611 . . . . 0.0 111.491 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.3 mt -92.09 -71.68 0.63 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.768 0.827 . . . . 0.0 112.31 -172.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 91' ' ' LYS . 72.2 mm-40 -62.73 101.71 0.28 Allowed 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.595 0.712 . . . . 0.0 112.442 -172.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -128.26 35.51 4.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 167.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.4 t-160 -105.99 111.83 24.63 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.068 1.347 . . . . 0.0 108.665 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -80.72 116.33 20.67 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 121.228 0.537 . . . . 0.0 110.85 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -94.38 -39.04 10.67 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.894 1.278 . . . . 0.0 108.55 165.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.402 ' HB2' ' HG2' ' A' ' 49' ' ' LYS . 2.8 p-80 -75.71 162.99 27.74 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.09 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 . . . . . 0 C--O 1.25 1.086 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 170.139 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttp . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.2 m -149.97 95.58 2.32 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.876 0.87 . . . . 0.0 108.924 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.3 p -90.66 177.06 6.44 Favored 'General case' 0 C--O 1.247 0.97 0 C-N-CA 123.746 0.818 . . . . 0.0 110.447 172.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 8' ' ' VAL . 90.5 m -60.3 -46.4 89.98 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.356 168.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -55.15 -40.45 70.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.994 0.918 . . . . 0.0 111.799 174.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -56.61 -47.57 79.37 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.295 0.638 . . . . 0.0 110.537 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.2 mmt180 -66.77 -38.31 86.33 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.82 176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 4' ' ' THR . 87.1 t -66.81 -44.16 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.309 0.644 . . . . 0.0 110.616 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.54 -44.91 85.52 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.442 1.097 . . . . 0.0 110.107 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.516 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 57.7 m -59.89 -48.34 82.11 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.559 176.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.7 mt -57.83 -47.69 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.743 0.817 . . . . 0.0 111.828 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.478 HG22 HD11 ' A' ' 18' ' ' ILE . 41.0 mt -58.3 -44.27 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.812 0.845 . . . . 0.0 110.526 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . . . -57.87 -44.3 86.55 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.143 0.977 . . . . 0.0 112.569 174.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.1 mm-40 -63.1 -36.22 82.87 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.421 0.688 . . . . 0.0 111.632 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -78.72 -59.44 2.78 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.817 -173.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.7 m -101.1 18.13 20.6 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.466 0.706 . . . . 0.0 112.853 -166.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.2 t70 47.72 66.1 1.12 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.304 1.041 . . . . 0.0 111.9 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 12' ' ' ILE . 3.5 pt -142.54 147.34 42.4 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 123.804 0.841 . . . . 0.0 109.739 -176.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.02 116.17 4.57 Favored 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 122.656 2.237 . . . . 0.0 112.361 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.559 ' HA ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -63.41 -17.29 62.5 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -176.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -67.53 -30.89 70.66 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.729 0.812 . . . . 0.0 110.525 -177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.7 p -85.25 -14.42 46.77 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.341 0.656 . . . . 0.0 110.781 -178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.559 HD13 ' HA ' ' A' ' 20' ' ' ARG . 1.8 mp -78.01 108.41 11.3 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 61.8 p -91.27 157.46 42.57 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 123.573 0.749 . . . . 0.0 109.672 178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.95 -17.92 56.4 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.237 1.958 . . . . 0.0 112.456 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -100.05 6.53 45.01 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.192 0.597 . . . . 0.0 110.489 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.6 t -78.85 138.72 38.29 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.37 0.668 . . . . 0.0 110.516 179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.411 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 50.7 t-80 -86.28 114.04 22.77 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.547 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -51.05 -37.24 44.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.854 0.862 . . . . 0.0 113.212 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.411 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 63.7 mt -89.88 -54.06 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -174.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -80.76 -39.17 27.34 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.416 0.687 . . . . 0.0 112.544 -168.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -88.25 -55.11 3.88 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.547 HD12 ' HA ' ' A' ' 29' ' ' ALA . 73.7 mt -75.09 -8.66 57.19 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.79 29.01 74.18 Favored Glycine 0 C--N 1.35 1.316 0 O-C-N 123.446 0.466 . . . . 0.0 113.82 176.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 96.8 mt -88.04 124.98 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -75.87 160.51 29.86 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.125 0.57 . . . . 0.0 110.109 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.464 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 15.3 m -57.69 -34.08 69.05 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.998 0.919 . . . . 0.0 111.782 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.71 -37.61 76.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.86 0.464 . . . . 0.0 110.686 -177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -67.48 -42.35 83.12 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.54 0.736 . . . . 0.0 109.95 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -65.46 -28.59 69.33 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 124.392 1.057 . . . . 0.0 110.967 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 37' ' ' SER . 70.7 mt -61.79 -42.15 98.63 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.895 0.478 . . . . 0.0 110.749 174.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.46 -35.21 60.94 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.063 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.8 mt -59.7 -47.75 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.781 0.676 . . . . 0.0 109.384 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.37 -30.08 63.06 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.098 0.959 . . . . 0.0 110.654 -174.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -62.59 -43.68 98.19 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.644 0.778 . . . . 0.0 110.89 171.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.4 -31.84 65.88 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.099 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 79.9 mt -67.15 -45.41 86.61 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 123.468 0.707 . . . . 0.0 110.314 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -52.01 -49.29 63.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.877 1.271 . . . . 0.0 110.312 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -72.34 -49.62 32.92 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.014 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.62 -41.06 98.78 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -173.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -89.77 -3.78 57.99 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.382 0.673 . . . . 0.0 112.378 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.4 45.45 96.38 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 123.779 0.674 . . . . 0.0 113.072 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.54 179.73 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.555 1.142 . . . . 0.0 110.186 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -122.35 113.2 19.07 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.422 HD22 ' HH2' ' A' ' 60' ' ' TRP . 83.4 mt -78.63 125.81 83.78 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 122.797 0.439 . . . . 0.0 110.41 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -79.19 54.95 5.41 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.205 2.603 . . . . 0.0 110.422 166.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.68 -39.94 86.19 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.91 1.284 . . . . 0.0 109.591 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -56.73 -41.81 78.16 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 124.259 0.974 . . . . 0.0 111.813 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -65.81 -43.48 88.52 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.156 0.582 . . . . 0.0 110.13 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.422 ' HH2' HD22 ' A' ' 55' ' ' LEU . 42.1 m0 -60.73 -50.14 74.66 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.627 -178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.1 m -60.89 -43.83 97.95 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.134 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -70.38 -40.32 74.03 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.765 -175.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -60.43 -39.6 88.04 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.974 0.51 . . . . 0.0 111.446 178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 93.2 t -58.06 -48.89 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.372 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -66.72 -28.71 68.65 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.133 0.973 . . . . 0.0 112.804 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -80.89 -3.4 51.21 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.181 0.592 . . . . 0.0 112.474 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.67 21.29 72.79 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 117.465 0.121 . . . . 0.0 113.333 -172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -79.46 -25.83 41.85 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.727 0.811 . . . . 0.0 110.239 174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.71 171.15 19.3 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.27 1.028 . . . . 0.0 108.992 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 69.9 p -104.81 168.02 9.34 Favored 'General case' 0 C--O 1.246 0.899 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 171.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.7 p -56.48 -41.78 77.16 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 123.314 0.384 . . . . 0.0 111.888 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.415 ' HA ' HG23 ' A' ' 76' ' ' VAL . 14.0 pt-20 -51.09 -40.84 59.34 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -175.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -57.45 -28.77 63.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.594 0.757 . . . . 0.0 112.773 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -114.5 -29.59 6.8 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.748 0.419 . . . . 0.0 112.092 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -111.08 24.67 12.62 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.556 0.742 . . . . 0.0 111.114 -166.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.518 HG12 ' HG2' ' A' ' 78' ' ' LYS . 43.7 t -104.64 141.25 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 160.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -54.52 -39.59 67.78 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.172 1.389 . . . . 0.0 114.584 -169.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.518 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.7 pttt -64.39 -42.19 96.25 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 120.991 0.424 . . . . 0.0 110.761 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -75.38 -40.49 57.95 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.435 1.094 . . . . 0.0 110.155 -174.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.3 tp -61.08 -53.36 58.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.436 1.094 . . . . 0.0 109.453 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.21 -27.36 68.93 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.618 0.767 . . . . 0.0 112.037 178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.66 -48.59 63.57 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.008 0.523 . . . . 0.0 110.409 174.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.4 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 1.1 mmp_? -56.88 -46.07 82.09 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 124.443 1.089 . . . . 0.0 110.801 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 88' ' ' VAL . 84.1 mt -64.03 -52.82 51.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.203 1.001 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -59.5 -41.77 90.65 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.076 0.95 . . . . 0.0 112.456 -176.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.19 -30.21 68.35 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.376 0.423 . . . . 0.0 110.339 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.9 mt -71.92 -35.74 69.76 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.745 0.418 . . . . 0.0 111.666 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 84' ' ' ILE . 61.6 t -65.28 -41.32 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.473 0.654 . . . . 0.0 109.487 176.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.17 -37.52 81.08 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 114.498 -1.228 . . . . 0.0 110.85 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.47 97.53 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.458 0.703 . . . . 0.0 111.587 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.38 -17.58 34.07 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.468 -174.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -51.87 -25.82 16.9 Favored Glycine 0 C--N 1.358 1.751 0 N-CA-C 115.91 1.124 . . . . 0.0 115.91 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.16 -8.61 56.8 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.49 0.716 . . . . 0.0 111.872 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.7 mt -120.54 172.55 7.76 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.682 1.593 . . . . 0.0 109.725 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.75 -89.14 0.1 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.51 1.124 . . . . 0.0 110.465 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 64.85 -78.32 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 125.622 1.569 . . . . 0.0 110.623 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -153.15 43.29 0.61 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -63.11 -77.28 0.05 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.523 -0.762 . . . . 0.0 108.967 176.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -163.87 113.16 1.23 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.096 0.958 . . . . 0.0 109.969 173.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -155.85 156.32 34.48 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.816 0.846 . . . . 0.0 109.6 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 24.4 p80 . . . . . 0 C--O 1.254 1.29 0 C-N-CA 124.028 0.931 . . . . 0.0 109.706 176.83 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 mtt . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.4 m -83.36 62.14 6.56 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 121.805 0.812 . . . . 0.0 108.937 173.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.0 t -69.21 130.07 41.62 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.762 -177.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 8' ' ' VAL . 86.6 m -56.62 -47.75 78.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.915 0.886 . . . . 0.0 109.968 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -54.88 -45.18 74.61 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.507 1.123 . . . . 0.0 111.447 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.54 -47.03 85.55 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 123.786 0.679 . . . . 0.0 110.573 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.405 ' HB2' ' HZ ' ' A' ' 51' ' ' PHE . 39.1 mmt-85 -67.22 -37.85 84.27 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.056 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 4' ' ' THR . 97.8 t -73.36 -35.15 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.352 0.661 . . . . 0.0 110.511 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.39 -38.69 91.9 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.554 0.742 . . . . 0.0 109.953 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.438 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 56.0 m -63.15 -46.26 88.05 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.013 0.821 . . . . 0.0 110.455 172.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.2 mt -57.8 -46.56 87.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.211 1.004 . . . . 0.0 111.154 178.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.544 HG22 HD11 ' A' ' 18' ' ' ILE . 50.6 mt -58.12 -49.81 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.039 0.936 . . . . 0.0 110.747 175.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.07 -44.4 71.11 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.989 0.916 . . . . 0.0 112.974 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 10' ' ' THR . 18.2 mm-40 -63.84 -32.14 73.56 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.916 0.886 . . . . 0.0 111.753 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.8 m -86.65 -34.3 19.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.408 0.683 . . . . 0.0 112.095 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.2 m -113.16 1.42 15.25 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 122.842 0.457 . . . . 0.0 112.167 -164.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 50.27 68.25 0.79 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.259 1.423 . . . . 0.0 112.246 -177.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.561 HD12 HD11 ' A' ' 23' ' ' ILE . 11.6 pt -145.97 157.86 49.75 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 124.551 1.14 . . . . 0.0 109.269 -177.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -73.43 120.71 6.65 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.772 2.315 . . . . 0.0 110.768 174.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HA ' HD13 ' A' ' 23' ' ' ILE . 1.2 ppt_? -64.66 -25.18 67.84 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -170.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -82.98 -11.97 57.68 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.605 0.762 . . . . 0.0 111.381 -173.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.5 p -83.0 -18.38 40.03 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.459 0.303 . . . . 0.0 110.38 173.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.561 HD11 HD12 ' A' ' 18' ' ' ILE . 2.0 mp -74.76 117.06 18.31 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.1 p -91.54 158.84 39.97 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 124.133 0.973 . . . . 0.0 109.719 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -58.72 -21.56 56.72 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 122.414 2.076 . . . . 0.0 113.257 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -92.28 3.75 54.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.287 0.635 . . . . 0.0 111.161 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 m -71.99 123.15 22.15 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.8 t-80 -84.0 119.47 24.97 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 169.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.63 -44.02 12.86 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.252 1.021 . . . . 0.0 112.722 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -95.19 -46.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 120.681 0.277 . . . . 0.0 110.322 -168.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -83.43 -35.79 24.74 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.338 0.655 . . . . 0.0 111.978 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -93.59 -55.45 3.27 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.313 0.645 . . . . 0.0 110.612 -176.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.8 mt -82.21 -12.58 58.02 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.509 0.724 . . . . 0.0 112.218 -176.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.86 34.21 86.47 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 113.897 0.319 . . . . 0.0 113.897 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 12' ' ' ILE . 90.1 mt -88.09 125.06 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.976 0.91 . . . . 0.0 108.675 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -72.39 158.99 34.73 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 37.6 m -62.21 -26.64 68.47 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.07 0.548 . . . . 0.0 111.637 178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.5 pp -75.65 -33.76 60.46 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 122.904 0.482 . . . . 0.0 110.384 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -70.27 -39.18 75.11 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 123.172 0.589 . . . . 0.0 109.519 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -66.15 -23.65 66.51 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.503 0.721 . . . . 0.0 110.236 -177.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 37' ' ' SER . 90.7 mt -62.61 -37.0 84.56 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.064 0.546 . . . . 0.0 110.714 171.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -69.99 -39.16 76.06 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.312 0.645 . . . . 0.0 110.2 176.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 12' ' ' ILE . 2.4 mp -60.43 -47.32 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 123.617 0.573 . . . . 0.0 109.661 174.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.78 -37.7 82.4 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.724 0.809 . . . . 0.0 111.173 -174.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -59.76 -50.18 74.83 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.76 1.224 . . . . 0.0 111.068 176.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.83 -30.84 70.34 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.729 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.503 HD13 HD11 ' A' ' 84' ' ' ILE . 97.2 mt -65.77 -44.73 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.59 0.756 . . . . 0.0 110.646 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -52.53 -49.72 64.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.484 1.114 . . . . 0.0 110.803 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -76.52 -48.47 19.33 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.754 -177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.93 74.81 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.074 0.55 . . . . 0.0 112.375 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.405 ' HZ ' ' HB2' ' A' ' 7' ' ' ARG . 98.5 m-85 -86.74 -3.24 59.02 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.852 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.16 35.52 91.65 Favored Glycine 0 C--N 1.354 1.539 0 O-C-N 123.651 0.594 . . . . 0.0 113.003 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.9 pt -124.94 -177.13 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.712 1.205 . . . . 0.0 109.209 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -130.04 126.06 36.76 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 168.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 38.9 mt -80.81 128.18 72.52 Favored Pre-proline 0 CA--C 1.542 0.658 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -73.02 59.33 3.6 Favored 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.933 2.422 . . . . 0.0 110.702 165.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -60.68 -39.66 89.25 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.368 1.067 . . . . 0.0 109.748 -174.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -56.77 -44.96 82.31 Favored 'General case' 0 CA--C 1.55 0.945 0 O-C-N 124.005 0.815 . . . . 0.0 110.463 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.7 tppt? -68.8 -44.49 73.46 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 111.259 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 48.0 m0 -57.61 -52.39 65.6 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.039 0.837 . . . . 0.0 110.55 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.2 m -71.06 -24.78 62.4 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.481 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -69.27 -47.63 64.05 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.652 0.781 . . . . 0.0 110.725 177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 21.2 mm-40 -60.17 -40.57 90.43 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.499 0.72 . . . . 0.0 110.735 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 53.4 t -59.78 -56.34 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.905 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -62.23 -33.49 74.68 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.647 0.779 . . . . 0.0 111.908 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -87.44 4.99 41.09 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.347 0.659 . . . . 0.0 111.754 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.45 25.87 70.35 Favored Glycine 0 C--N 1.354 1.542 0 N-CA-C 114.603 0.601 . . . . 0.0 114.603 175.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -91.67 -27.58 18.01 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.275 0.63 . . . . 0.0 110.731 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -139.18 152.06 47.09 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.5 m -81.57 156.47 25.19 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.007 0.523 . . . . 0.0 109.639 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.5 p -52.93 -46.58 68.16 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.853 0.861 . . . . 0.0 110.856 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.544 ' HA ' HG23 ' A' ' 76' ' ' VAL . 9.3 mm-40 -42.83 -52.75 4.93 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.152 1.381 . . . . 0.0 112.588 177.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -54.76 -21.25 10.47 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.271 -1.331 . . . . 0.0 114.021 -169.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -121.71 -29.79 4.28 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -108.03 15.04 24.68 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -168.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 72' ' ' GLU . 71.6 t -103.22 139.56 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 167.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.408 HD11 HD12 ' A' ' 12' ' ' ILE . 3.9 mm? -53.35 -38.15 63.03 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.233 1.413 . . . . 0.0 114.023 -173.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.9 pttp -70.33 -41.0 73.81 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 120.769 0.318 . . . . 0.0 111.097 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 80.1 m-20 -74.81 -34.67 62.42 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.926 0.89 . . . . 0.0 110.241 -177.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.97 -44.76 72.27 Favored 'General case' 0 C--O 1.222 -0.392 0 C-N-CA 124.821 1.248 . . . . 0.0 108.871 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.51 -37.54 78.55 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 123.877 0.735 . . . . 0.0 111.098 175.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.91 -49.73 71.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.672 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 9.6 mmp_? -50.54 -53.01 33.57 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 124.197 0.936 . . . . 0.0 111.419 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.503 HD11 HD13 ' A' ' 47' ' ' ILE . 71.2 mt -65.6 -43.9 93.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.625 -175.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -60.58 -39.64 88.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.623 0.769 . . . . 0.0 111.223 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -67.91 -35.05 77.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.524 0.73 . . . . 0.0 110.841 178.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.2 mt -73.67 -30.29 62.81 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.02 0.528 . . . . 0.0 111.352 176.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.497 ' HA ' ' HG2' ' A' ' 91' ' ' LYS . 69.5 t -71.02 -36.93 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.637 0.775 . . . . 0.0 109.455 172.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.76 -41.11 83.85 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.23 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.12 -42.63 93.75 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 124.154 0.981 . . . . 0.0 111.13 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.497 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 43.7 pttt -76.24 -18.4 59.03 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.23 -31.6 79.62 Favored Glycine 0 C--N 1.358 1.766 0 O-C-N 123.588 0.555 . . . . 0.0 112.231 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.26 65.58 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.09 0.556 . . . . 0.0 110.148 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 8.7 mp -87.98 76.94 8.54 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.913 0.885 . . . . 0.0 110.016 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.29 90.34 2.61 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.922 177.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -63.05 133.42 54.49 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.363 172.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 75.1 t60 84.34 -35.63 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 126.27 1.828 . . . . 0.0 111.169 -171.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 49.4 t60 72.44 -62.02 0.48 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.711 1.604 . . . . 0.0 113.358 176.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -54.79 103.99 0.1 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.893 1.277 . . . . 0.0 112.326 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -117.4 146.82 43.19 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.474 171.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 65.9 t60 . . . . . 0 C--O 1.254 1.328 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.36 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 30.5 p -137.91 30.62 2.51 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.305 0.642 . . . . 0.0 111.265 -173.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.9 p -74.16 -177.92 3.16 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.63 0.372 . . . . 0.0 110.596 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 8' ' ' VAL . 61.8 m -53.52 -48.58 68.89 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.452 0.701 . . . . 0.0 112.17 -173.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -56.23 -46.1 79.68 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.728 0.411 . . . . 0.0 111.602 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.489 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 28.6 m-20 -59.56 -44.87 93.14 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.743 0.652 . . . . 0.0 110.688 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.9 mmt180 -64.74 -45.9 84.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.169 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 4' ' ' THR . 79.8 t -65.36 -43.89 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 123.625 0.77 . . . . 0.0 110.458 -175.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.02 -40.86 97.16 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.132 0.973 . . . . 0.0 111.008 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.2 m -63.83 -42.72 97.56 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.18 0.925 . . . . 0.0 111.258 175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.408 HD13 ' HA ' ' A' ' 47' ' ' ILE . 96.7 mt -59.18 -51.01 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.578 0.751 . . . . 0.0 111.122 175.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.67 HG22 HD11 ' A' ' 18' ' ' ILE . 58.4 mt -59.8 -42.35 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.648 0.779 . . . . 0.0 110.534 -178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.485 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -56.39 -52.51 64.34 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.729 0.812 . . . . 0.0 112.713 173.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.47 -22.19 63.65 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.631 0.772 . . . . 0.0 112.327 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.3 m -85.06 -51.05 6.93 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.614 0.366 . . . . 0.0 111.11 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.604 ' SG ' HD11 ' A' ' 43' ' ' ILE . 74.7 m -100.29 7.59 44.29 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -168.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.8 t70 53.44 65.16 1.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.242 1.017 . . . . 0.0 111.871 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.67 HD11 HG22 ' A' ' 12' ' ' ILE . 10.1 pt -141.19 146.49 43.18 Favored Pre-proline 0 N--CA 1.482 1.161 0 C-N-CA 124.089 0.955 . . . . 0.0 109.418 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -64.28 114.33 2.62 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.716 2.277 . . . . 0.0 111.431 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.489 ' NH2' ' HA ' ' A' ' 6' ' ' ASP . 0.3 OUTLIER -53.61 -29.76 39.36 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.359 1.064 . . . . 0.0 113.175 -177.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -71.83 -27.53 62.96 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.191 0.597 . . . . 0.0 111.729 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -81.68 -5.56 58.21 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.825 0.45 . . . . 0.0 110.717 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.48 HD11 HD12 ' A' ' 18' ' ' ILE . 1.9 mp -86.36 113.49 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 174.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.5 p -95.16 165.9 15.95 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.843 0.857 . . . . 0.0 109.243 173.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.08 -18.47 61.94 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.291 1.994 . . . . 0.0 112.336 172.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -94.68 -0.21 54.53 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 122.948 0.499 . . . . 0.0 110.509 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.4 m -71.74 124.18 24.23 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.015 0.526 . . . . 0.0 110.383 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -85.66 123.18 30.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 170.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -45.83 -45.96 15.28 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.142 0.977 . . . . 0.0 112.207 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 mt -92.59 -48.16 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -76.86 -37.32 55.78 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.664 0.785 . . . . 0.0 112.357 -171.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -96.71 -59.21 1.86 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.587 0.355 . . . . 0.0 110.563 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 66.1 mt -75.92 -16.31 60.05 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.023 0.529 . . . . 0.0 112.417 -171.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.82 37.96 56.79 Favored Glycine 0 C--N 1.351 1.379 0 O-C-N 123.124 0.265 . . . . 0.0 113.303 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.51 HG23 ' HB2' ' A' ' 39' ' ' ASP . 93.5 mt -96.7 116.5 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.287 1.035 . . . . 0.0 108.928 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -74.46 164.56 26.45 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.8 m -56.41 -31.95 64.37 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.74 0.816 . . . . 0.0 111.614 178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.76 -32.77 65.88 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 122.952 0.501 . . . . 0.0 111.088 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.51 ' HB2' HG23 ' A' ' 35' ' ' ILE . 28.6 m-20 -71.43 -40.99 70.05 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.965 0.506 . . . . 0.0 109.755 176.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -68.54 -22.01 64.52 Favored 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.212 -175.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.62 -50.94 68.83 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.327 0.584 . . . . 0.0 110.439 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.42 -34.77 70.62 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.086 -177.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.604 HD11 ' SG ' ' A' ' 16' ' ' CYS . 62.3 mt -63.92 -42.7 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 123.578 0.549 . . . . 0.0 110.192 173.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.46 -36.25 76.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.599 0.76 . . . . 0.0 110.645 -176.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -63.44 -42.51 98.68 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.023 0.929 . . . . 0.0 110.272 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -42.02 84.16 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.137 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.408 ' HA ' HD13 ' A' ' 11' ' ' ILE . 84.1 mt -64.82 -43.71 96.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.763 0.825 . . . . 0.0 110.824 175.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -50.17 -54.09 23.26 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.076 1.35 . . . . 0.0 110.961 -177.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.79 -38.99 53.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.843 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.97 -45.37 86.85 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -88.43 -10.61 48.61 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.706 0.802 . . . . 0.0 112.562 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.23 48.57 81.82 Favored Glycine 0 C--N 1.346 1.101 0 O-C-N 123.396 0.435 . . . . 0.0 112.24 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.401 HG22 ' HG2' ' A' ' 91' ' ' LYS . 44.8 pt -131.26 169.18 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.95 1.3 . . . . 0.0 109.315 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -110.82 100.8 9.48 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 172.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.449 HD23 HD12 ' A' ' 87' ' ' LEU . 83.8 mt -67.94 123.07 86.26 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 122.695 0.398 . . . . 0.0 110.222 174.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -81.98 61.0 7.71 Favored 'Trans proline' 0 C--N 1.371 1.719 0 C-N-CA 122.839 2.36 . . . . 0.0 110.124 169.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.08 -36.88 83.03 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.042 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -58.94 -42.3 89.44 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.553 0.741 . . . . 0.0 110.887 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -60.58 -52.12 66.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.652 0.781 . . . . 0.0 109.925 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -58.03 -43.77 86.97 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 124.474 1.108 . . . . 0.0 111.036 -177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -60.26 -47.74 84.7 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.904 0.882 . . . . 0.0 110.718 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -62.84 -40.26 96.9 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 123.272 0.629 . . . . 0.0 110.779 -177.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.432 ' HG2' ' HD2' ' A' ' 68' ' ' LYS . 48.5 mt-10 -65.28 -41.65 93.96 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.189 0.931 . . . . 0.0 112.031 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.96 -47.4 85.39 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.436 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -57.31 -46.71 82.93 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.246 0.618 . . . . 0.0 111.669 175.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -84.08 0.02 50.04 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.239 0.616 . . . . 0.0 112.421 -171.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.09 18.92 75.14 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 114.436 0.535 . . . . 0.0 114.436 -178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' HD2' ' HG2' ' A' ' 63' ' ' GLU . 62.3 mttm -69.76 -33.93 73.1 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 172.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.83 169.04 19.93 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.993 1.317 . . . . 0.0 108.397 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.5 p -116.12 163.45 15.93 Favored 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.08 0.952 . . . . 0.0 109.432 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.6 p -55.71 -54.17 47.56 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 124.057 0.848 . . . . 0.0 112.746 -168.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.56 -30.07 40.22 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.504 ' HA ' HD22 ' A' ' 79' ' ' ASN . 0.1 OUTLIER -62.37 -26.81 68.66 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.814 1.246 . . . . 0.0 111.797 -178.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -115.39 -26.98 7.36 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.215 0.606 . . . . 0.0 111.938 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -108.22 17.98 21.62 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.186 0.595 . . . . 0.0 112.277 -165.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.51 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.0 t -105.71 139.73 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 165.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.446 HD11 HD12 ' A' ' 12' ' ' ILE . 3.8 mm? -52.68 -37.91 59.61 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.917 1.287 . . . . 0.0 114.308 -171.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.51 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.4 pttt -69.76 -45.19 68.63 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 123.163 0.29 . . . . 0.0 110.531 177.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.504 HD22 ' HA ' ' A' ' 73' ' ' GLN . 2.3 m-20 -68.08 -41.43 81.93 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.165 0.586 . . . . 0.0 110.616 -177.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.3 tp -64.09 -50.21 69.21 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.89 1.276 . . . . 0.0 109.536 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.45 -32.94 71.86 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 123.615 0.572 . . . . 0.0 111.158 178.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 86' ' ' GLU . . . -66.65 -50.6 62.42 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.853 0.461 . . . . 0.0 110.26 175.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.435 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 3.7 mmp_? -53.35 -50.19 65.56 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 123.861 0.864 . . . . 0.0 111.211 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.461 ' O ' HG23 ' A' ' 88' ' ' VAL . 87.7 mt -64.16 -45.65 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.948 1.299 . . . . 0.0 110.395 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.66 -36.43 78.68 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.155 0.982 . . . . 0.0 111.394 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 82' ' ' ALA . 29.9 mm-40 -64.94 -43.76 91.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.581 0.752 . . . . 0.0 110.839 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.449 HD12 HD23 ' A' ' 55' ' ' LEU . 67.1 mt -70.89 -27.64 63.95 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.16 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 84' ' ' ILE . 78.7 t -67.83 -37.09 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.504 0.722 . . . . 0.0 110.114 172.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.49 -35.3 75.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.068 0.547 . . . . 0.0 110.569 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.48 87.28 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.398 0.679 . . . . 0.0 111.275 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.401 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -81.47 -24.98 36.42 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.1 -23.55 77.98 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.335 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.34 -76.95 0.28 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 164.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 12.4 mt -173.31 123.36 0.39 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 125.931 1.692 . . . . 0.0 108.089 173.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -121.25 -60.02 1.67 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.889 0.875 . . . . 0.0 108.922 174.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -145.89 46.46 1.26 Allowed 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 83.3 t60 75.73 -43.87 0.5 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 125.486 1.514 . . . . 0.0 113.581 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -71.7 103.63 3.12 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.417 0.687 . . . . 0.0 111.399 -172.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -86.75 -176.95 5.99 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.874 170.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -109.83 83.45 1.76 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 170.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 52.0 t60 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 124.407 1.083 . . . . 0.0 108.936 179.25 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.4 m 61.77 84.21 0.14 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.448 1.099 . . . . 0.0 110.283 -177.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 p -77.18 178.0 7.41 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.711 0.804 . . . . 0.0 111.176 -178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.415 ' O ' HG23 ' A' ' 8' ' ' VAL . 43.4 m -64.94 -40.14 94.58 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 171.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -55.93 -48.85 74.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.314 0.646 . . . . 0.0 110.881 173.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -51.16 -50.11 59.58 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.022 0.826 . . . . 0.0 110.158 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' O ' HG13 ' A' ' 11' ' ' ILE . 6.1 mmp_? -70.34 -41.4 73.24 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.975 -1.011 . . . . 0.0 112.889 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 4' ' ' THR . 55.3 t -67.99 -40.98 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 123.162 0.585 . . . . 0.0 110.408 -177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.02 -37.97 89.38 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.086 0.954 . . . . 0.0 109.98 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.478 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 90.4 m -63.27 -44.21 95.74 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.52 174.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 7' ' ' ARG . 95.7 mt -58.81 -47.35 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 123.23 0.612 . . . . 0.0 111.359 176.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 18' ' ' ILE . 58.8 mt -57.44 -43.81 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 122.992 0.517 . . . . 0.0 110.102 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.494 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -57.76 -49.46 76.51 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.729 175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 10' ' ' THR . 46.4 mm-40 -66.64 -33.46 75.71 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.297 0.639 . . . . 0.0 111.806 -178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 46.5 m -74.03 -50.72 18.49 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.502 0.721 . . . . 0.0 110.933 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 43' ' ' ILE . 39.8 m -97.37 3.95 50.88 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.812 0.845 . . . . 0.0 113.211 -169.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 45.67 77.85 0.07 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.418 1.087 . . . . 0.0 112.006 -171.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 12' ' ' ILE . 7.3 pt -147.74 147.59 27.81 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.021 0.929 . . . . 0.0 109.967 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.14 122.11 10.21 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.911 2.408 . . . . 0.0 111.561 174.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' HG3' ' HA ' ' A' ' 10' ' ' THR . 2.5 tmm_? -64.46 -19.92 65.86 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.538 1.135 . . . . 0.0 112.453 -173.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -73.55 -22.41 60.09 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.842 0.857 . . . . 0.0 110.557 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.8 p -86.51 -10.68 53.58 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.158 0.583 . . . . 0.0 110.902 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.423 HD11 HD12 ' A' ' 18' ' ' ILE . 2.3 mp -91.76 93.48 4.32 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.1 p -82.7 164.12 48.44 Favored Pre-proline 0 CA--C 1.555 1.139 0 C-N-CA 124.107 0.963 . . . . 0.0 109.989 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.85 -21.13 72.87 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.162 1.908 . . . . 0.0 113.172 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -106.85 17.5 23.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.89 0.476 . . . . 0.0 110.409 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.9 m -72.33 120.3 17.74 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.112 0.565 . . . . 0.0 109.65 170.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.6 t-80 -84.0 121.97 28.13 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 170.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -40.28 -50.71 2.77 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.886 1.274 . . . . 0.0 113.041 175.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.0 mt -92.85 -47.43 13.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.039 0 CA-C-O 121.109 0.48 . . . . 0.0 110.188 -168.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -76.51 -38.13 55.67 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.235 1.014 . . . . 0.0 112.221 -172.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -99.24 -65.2 0.98 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.359 0.664 . . . . 0.0 110.421 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.37 -12.71 61.57 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.76 0.824 . . . . 0.0 112.633 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.39 24.41 76.76 Favored Glycine 0 C--N 1.354 1.563 0 O-C-N 123.466 0.479 . . . . 0.0 114.235 174.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.9 mt -78.87 124.89 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.441 1.097 . . . . 0.0 109.371 -175.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -69.14 156.23 39.04 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.231 0.612 . . . . 0.0 110.987 175.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.8 m -63.55 -41.07 98.45 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.826 0.85 . . . . 0.0 111.863 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 pp -71.62 -28.86 64.08 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 120.927 0.394 . . . . 0.0 110.043 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -75.71 -36.9 59.87 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.185 0.994 . . . . 0.0 110.118 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -70.9 -23.32 62.25 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.482 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.64 -41.31 94.68 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.152 0.581 . . . . 0.0 111.091 169.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.66 -42.82 90.91 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 123.403 0.681 . . . . 0.0 110.305 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.446 HD11 ' SG ' ' A' ' 16' ' ' CYS . 59.6 mt -62.89 -45.03 99.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.755 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.81 -33.82 68.85 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.293 0.637 . . . . 0.0 110.532 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -59.9 -39.79 86.57 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.321 1.048 . . . . 0.0 110.435 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.46 -38.03 71.32 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.537 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.405 ' HA ' HD13 ' A' ' 11' ' ' ILE . 97.6 mt -66.69 -41.71 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.657 0.783 . . . . 0.0 110.383 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -52.11 -47.66 65.19 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.792 1.237 . . . . 0.0 110.694 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.29 -56.05 22.25 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.121 0.888 . . . . 0.0 110.846 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.71 -51.8 68.06 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.047 0.939 . . . . 0.0 112.302 -171.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -87.49 -14.54 40.1 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.286 0.634 . . . . 0.0 111.561 -176.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.69 30.43 74.67 Favored Glycine 0 N--CA 1.475 1.256 0 CA-C-N 117.716 0.234 . . . . 0.0 113.329 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.412 HD13 HG23 ' A' ' 84' ' ' ILE . 32.7 pt -109.55 151.14 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.863 0.865 . . . . 0.0 110.967 -174.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -93.34 95.67 9.47 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 175.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.455 HD21 HG12 ' A' ' 84' ' ' ILE . 83.8 mt -73.03 119.34 75.08 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.916 173.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -85.7 58.33 4.6 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.618 2.212 . . . . 0.0 109.152 165.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -61.71 -38.96 89.79 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.352 -1.294 . . . . 0.0 108.819 -177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.66 -35.89 79.25 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.928 177.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.57 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -69.17 -51.13 41.24 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.221 0.608 . . . . 0.0 109.876 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.437 ' O ' HG23 ' A' ' 64' ' ' VAL . 51.4 m0 -55.57 -48.41 74.83 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.158 0.983 . . . . 0.0 111.349 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.7 m -62.82 -37.45 86.82 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.574 177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -66.7 -43.15 85.17 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.253 0.621 . . . . 0.0 110.637 -177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 4.9 mm-40 -66.66 -33.88 76.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.589 0.756 . . . . 0.0 110.719 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 60' ' ' TRP . 54.4 t -61.38 -52.73 57.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.142 172.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -65.51 -27.04 68.19 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.098 0.559 . . . . 0.0 111.599 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.84 1.79 56.66 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.15 0.58 . . . . 0.0 111.702 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.93 12.93 71.89 Favored Glycine 0 C--N 1.349 1.277 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 35.8 mttp -72.6 -26.69 61.78 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 117.722 0.761 . . . . 0.0 110.119 172.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.37 168.03 22.85 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.32 1.048 . . . . 0.0 109.684 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.543 ' H ' HE21 ' A' ' 73' ' ' GLN . 51.5 p -100.28 163.53 12.35 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 124.266 1.027 . . . . 0.0 108.858 172.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.423 HG22 HG11 ' A' ' 64' ' ' VAL . 72.1 p -57.33 -43.28 83.22 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.626 0.579 . . . . 0.0 110.356 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.475 ' HA ' HG23 ' A' ' 76' ' ' VAL . 22.2 mm-40 -41.4 -53.61 3.29 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.369 1.467 . . . . 0.0 112.786 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.543 HE21 ' H ' ' A' ' 70' ' ' THR . 50.2 mt-30 -60.75 -21.36 62.92 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.318 -1.31 . . . . 0.0 114.106 -171.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -128.81 -4.38 5.18 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 113.021 0.749 . . . . 0.0 113.021 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -125.89 20.09 7.74 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 122.994 0.518 . . . . 0.0 111.217 -175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 72' ' ' GLU . 95.8 t -108.99 144.36 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 164.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.86 -35.98 71.71 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -67.67 -40.18 84.49 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 120.889 0.376 . . . . 0.0 110.096 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.1 m120 -73.5 -47.31 42.2 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.087 0.955 . . . . 0.0 110.316 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 tp -60.03 -47.88 84.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.954 1.302 . . . . 0.0 109.897 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.07 -36.38 81.49 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.556 0.743 . . . . 0.0 111.841 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.68 -46.68 81.38 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.06 0.544 . . . . 0.0 110.654 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 24.7 mmm180 -59.39 -48.48 81.49 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.772 0.829 . . . . 0.0 110.637 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 88' ' ' VAL . 97.0 mt -63.87 -43.1 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 124.699 1.2 . . . . 0.0 110.863 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -63.06 -39.06 93.6 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.567 0.747 . . . . 0.0 111.045 177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -63.58 -40.88 98.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.547 0.739 . . . . 0.0 110.711 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 75.2 mt -70.57 -34.32 72.08 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.963 0.505 . . . . 0.0 112.019 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 84' ' ' ILE . 91.9 t -64.56 -42.64 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 CA-C-O 121.454 0.645 . . . . 0.0 109.512 174.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.74 -37.63 79.56 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.176 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.36 -44.63 87.04 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.105 0.962 . . . . 0.0 111.413 -179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -79.42 -17.72 53.74 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.287 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -85.43 -26.54 35.72 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 175.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.98 9.11 20.53 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.572 1.149 . . . . 0.0 111.932 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.85 169.29 5.3 Favored 'General case' 0 C--O 1.246 0.903 0 C-N-CA 123.027 0.531 . . . . 0.0 109.763 169.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.95 146.56 52.74 Favored 'General case' 0 CA--C 1.548 0.904 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -83.15 16.08 2.57 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.02 0.928 . . . . 0.0 112.048 -166.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 65.1 m80 58.42 54.59 5.48 Favored 'General case' 0 C--N 1.356 0.858 0 C-N-CA 124.476 1.11 . . . . 0.0 110.513 176.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -56.15 -34.24 65.95 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.022 175.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -163.89 104.48 0.91 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 171.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -154.91 86.76 1.12 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.557 1.143 . . . . 0.0 108.298 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.8 t60 . . . . . 0 C--O 1.249 1.047 0 C-N-CA 124.24 1.016 . . . . 0.0 108.415 -177.299 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.746 0.308 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.4 t -140.58 -164.83 1.81 Allowed 'General case' 0 C--O 1.25 1.107 0 C-N-CA 123.771 0.828 . . . . 0.0 109.364 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -58.49 127.56 32.76 Favored 'General case' 0 C--O 1.25 1.118 0 C-N-CA 122.898 0.479 . . . . 0.0 110.335 171.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 8' ' ' VAL . 10.3 m -58.1 -34.71 70.48 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.781 0.832 . . . . 0.0 111.097 -177.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -57.56 -48.8 78.33 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 123.007 0.523 . . . . 0.0 111.166 174.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.81 -44.5 70.25 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.386 0.674 . . . . 0.0 110.862 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.1 mmt85 -60.2 -54.05 50.47 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.533 -1.212 . . . . 0.0 112.479 174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 4' ' ' THR . 95.6 t -67.55 -38.98 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 C-N-CA 123.419 0.688 . . . . 0.0 111.245 -172.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.16 -44.64 92.13 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.673 1.189 . . . . 0.0 110.339 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.426 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 85.9 m -66.63 -40.46 88.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.554 176.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.49 -49.81 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.15 0.432 . . . . 0.0 111.383 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.567 HG12 HG21 ' A' ' 43' ' ' ILE . 51.8 mt -58.79 -41.03 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 122.789 0.435 . . . . 0.0 110.166 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.74 -60.27 3.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.803 0.841 . . . . 0.0 112.542 173.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 10' ' ' THR . 17.3 mm-40 -65.43 -34.6 78.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.196 0.598 . . . . 0.0 112.146 -173.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.4 m -72.87 -58.6 3.21 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.189 0.595 . . . . 0.0 110.331 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 21.7 t -84.99 3.5 38.21 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -170.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 55.06 65.91 1.37 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.405 1.082 . . . . 0.0 111.577 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.545 HG13 ' HA ' ' A' ' 13' ' ' ALA . 10.4 pt -145.3 159.33 49.2 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 124.801 1.24 . . . . 0.0 109.023 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -75.09 133.77 16.85 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 122.767 2.312 . . . . 0.0 111.802 175.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -18.9 65.63 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -81.87 -19.79 40.22 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.485 0.714 . . . . 0.0 109.873 -174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.9 p -79.88 -7.75 58.91 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 122.568 0.347 . . . . 0.0 110.851 173.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.2 mp -94.1 114.06 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.1 p -100.25 160.58 26.67 Favored Pre-proline 0 N--CA 1.488 1.437 0 C-N-CA 123.302 0.641 . . . . 0.0 110.471 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.05 -25.83 58.57 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 122.718 2.278 . . . . 0.0 112.671 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -91.77 1.97 56.81 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.671 0.788 . . . . 0.0 111.114 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.7 t -83.01 137.83 33.98 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.302 0.641 . . . . 0.0 111.345 -175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.516 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 54.7 t-80 -82.8 111.86 19.1 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 165.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.38 -20.25 28.28 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.516 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 84.6 mt -99.57 -41.25 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.599 0.76 . . . . 0.0 110.586 -177.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 32.4 t70 -79.98 -52.0 8.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.416 0.686 . . . . 0.0 112.227 -173.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -74.94 -48.95 21.84 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.365 0.602 . . . . 0.0 111.164 -173.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 67.5 mt -73.23 -12.78 60.98 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.49 -176.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.17 35.57 88.75 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 121.296 0.387 . . . . 0.0 112.662 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.5 mt -99.84 126.08 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -61.34 153.35 26.91 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 118.144 0.429 . . . . 0.0 110.73 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 40.4 m -63.61 -29.09 70.38 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.008 0.523 . . . . 0.0 109.988 176.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.57 -39.26 62.36 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 123.718 0.807 . . . . 0.0 109.96 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.18 -26.65 61.26 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.549 0.74 . . . . 0.0 110.11 177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -74.34 -27.67 60.79 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.722 0.809 . . . . 0.0 110.504 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' SER . 89.8 mt -56.43 -33.44 65.84 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 122.632 0.373 . . . . 0.0 110.869 173.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.92 -41.61 64.38 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.666 0.786 . . . . 0.0 110.631 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.567 HG21 HG12 ' A' ' 12' ' ' ILE . 47.9 mt -62.81 -41.06 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-O 121.062 0.458 . . . . 0.0 110.175 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.14 -29.95 63.25 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.29 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -59.01 -42.23 89.63 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.969 0.908 . . . . 0.0 109.892 170.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.6 -42.43 74.41 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.338 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.7 mt -65.46 -42.84 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.762 0.825 . . . . 0.0 110.597 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -53.59 -48.22 69.44 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.892 1.277 . . . . 0.0 110.4 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -72.52 -42.77 64.42 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.2 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.44 -48.44 77.02 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.834 0.854 . . . . 0.0 112.463 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -87.11 -7.94 57.52 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.234 0.614 . . . . 0.0 111.449 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.65 32.82 85.48 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 123.328 0.392 . . . . 0.0 113.194 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.6 pt -112.61 169.59 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.198 0.999 . . . . 0.0 110.761 -173.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -104.83 101.71 11.29 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.516 HD21 HG12 ' A' ' 84' ' ' ILE . 95.7 mt -72.43 114.49 30.28 Favored Pre-proline 0 C--O 1.237 0.428 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 167.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.534 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 87.7 Cg_endo -81.94 63.86 8.4 Favored 'Trans proline' 0 C--N 1.367 1.53 0 C-N-CA 122.037 1.824 . . . . 0.0 109.833 168.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.5 -38.16 88.81 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.035 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.23 -42.67 99.26 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.898 0.479 . . . . 0.0 111.027 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 54.3 tptt -58.75 -47.3 85.13 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.366 1.066 . . . . 0.0 110.79 176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.414 ' O ' HG23 ' A' ' 64' ' ' VAL . 53.4 m0 -63.48 -46.03 88.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.554 0.742 . . . . 0.0 110.867 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.5 m -64.85 -32.94 74.87 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.367 1.067 . . . . 0.0 110.965 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.21 -42.32 62.77 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.438 0.695 . . . . 0.0 109.734 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -60.32 -35.41 75.57 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.654 0.781 . . . . 0.0 111.046 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 60' ' ' TRP . 85.0 t -64.97 -46.16 92.48 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 173.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.31 -40.27 96.87 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.137 0.975 . . . . 0.0 112.825 -178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -87.04 -1.67 58.05 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.42 0.688 . . . . 0.0 112.646 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 63.67 30.52 77.89 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.427 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 11.3 mmpt? -77.18 -33.21 56.47 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.951 0.901 . . . . 0.0 109.444 171.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.64 168.45 20.13 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.673 1.189 . . . . 0.0 108.747 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.5 p -108.9 162.11 14.5 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 123.61 0.764 . . . . 0.0 111.149 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.0 p -58.07 -64.47 0.9 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.74 0.816 . . . . 0.0 111.797 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.04 -30.49 62.0 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -55.74 -24.84 37.43 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.545 1.138 . . . . 0.0 112.861 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -111.36 -44.0 3.61 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.313 0.645 . . . . 0.0 111.095 173.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -97.94 21.76 10.21 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.994 0.518 . . . . 0.0 112.306 -163.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.575 HG12 ' HG2' ' A' ' 78' ' ' LYS . 25.5 t -106.01 140.63 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 165.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.459 HD11 HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -55.37 -39.49 70.16 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -167.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.575 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.9 pttt -61.34 -43.12 99.4 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.608 0.718 . . . . 0.0 110.191 176.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 83.9 m-20 -75.96 -44.97 37.32 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.888 1.275 . . . . 0.0 109.967 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -59.74 -53.46 57.69 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.187 1.395 . . . . 0.0 109.836 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.27 70.69 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.453 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.1 -42.09 76.57 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 122.978 0.511 . . . . 0.0 111.678 174.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 3.6 mmp_? -59.81 -49.59 77.12 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.723 0.773 . . . . 0.0 109.806 177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.516 HG12 HD21 ' A' ' 55' ' ' LEU . 88.6 mt -58.89 -45.64 91.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 113.376 -1.738 . . . . 0.0 110.587 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -64.64 -37.23 86.85 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.964 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -66.68 -32.87 74.47 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.803 0.441 . . . . 0.0 110.818 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 65.3 mt -75.16 -30.92 60.87 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.278 0.631 . . . . 0.0 111.702 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 71.2 t -69.28 -35.57 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.385 0.674 . . . . 0.0 110.119 172.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.35 -37.92 77.89 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.484 173.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.69 -39.01 93.26 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.865 0.866 . . . . 0.0 111.933 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -81.71 -25.03 35.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.475 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.97 -38.95 55.54 Favored Glycine 0 C--N 1.354 1.576 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.48 109.81 14.2 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 173.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.0 tp 60.79 -84.08 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.407 1.083 . . . . 0.0 110.596 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 175.69 -53.28 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.624 1.569 . . . . 0.0 107.012 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 77.9 m80 73.57 155.7 0.17 Allowed 'General case' 0 C--N 1.358 0.961 0 C-N-CA 125.568 1.547 . . . . 0.0 112.507 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.7 m80 -71.33 118.81 14.6 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.515 172.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -86.71 61.9 7.08 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.603 0.716 . . . . 0.0 111.296 -170.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -176.96 151.73 0.87 Allowed 'General case' 0 C--O 1.242 0.679 0 C-N-CA 125.317 1.447 . . . . 0.0 108.815 173.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -128.37 72.33 1.43 Allowed 'General case' 0 C--O 1.243 0.717 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 171.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.6 t60 . . . . . 0 CA--C 1.55 0.949 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.955 179.669 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.4 p -138.56 1.82 2.17 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.856 0.862 . . . . 0.0 111.521 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.8 m -66.91 175.16 2.6 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.949 0.5 . . . . 0.0 112.151 -174.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.515 ' O ' HG23 ' A' ' 8' ' ' VAL . 28.0 m -51.71 -48.7 63.46 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.504 0.722 . . . . 0.0 111.102 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -53.69 -49.04 68.87 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.515 0.726 . . . . 0.0 111.486 176.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -61.36 -42.29 98.46 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.636 0.774 . . . . 0.0 110.795 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -64.24 -42.11 96.68 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.25 0.969 . . . . 0.0 111.22 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 4' ' ' THR . 89.0 t -69.93 -38.26 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.732 0.813 . . . . 0.0 110.685 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.91 -35.91 81.08 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.229 1.011 . . . . 0.0 110.133 179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.4 m -63.89 -44.42 93.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.614 0.766 . . . . 0.0 110.615 171.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.466 HD13 ' HA ' ' A' ' 47' ' ' ILE . 95.3 mt -57.39 -50.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.754 0.822 . . . . 0.0 111.269 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.619 HG22 HD11 ' A' ' 18' ' ' ILE . 51.8 mt -60.09 -48.05 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.32 0.648 . . . . 0.0 110.405 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.533 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -52.73 -49.96 64.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.161 0.985 . . . . 0.0 112.675 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -68.19 -42.31 80.09 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.437 0.695 . . . . 0.0 112.19 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.9 m -68.02 -48.33 66.0 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.646 0.378 . . . . 0.0 110.585 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.651 ' SG ' HD11 ' A' ' 43' ' ' ILE . 34.2 m -91.88 -2.52 56.8 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.88 0.872 . . . . 0.0 113.157 -171.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.2 t70 52.83 69.64 0.67 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.998 0.919 . . . . 0.0 111.56 -171.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.619 HD11 HG22 ' A' ' 12' ' ' ILE . 9.6 pt -143.53 156.86 59.98 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.782 1.233 . . . . 0.0 108.748 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.95 137.96 39.22 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.58 2.187 . . . . 0.0 111.546 177.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -62.65 -28.47 69.94 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.722 0.809 . . . . 0.0 111.349 -176.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -75.85 -21.58 57.1 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.0 0.52 . . . . 0.0 111.071 -174.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.2 p -83.97 1.65 42.62 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.547 0.339 . . . . 0.0 111.101 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.75 111.5 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 168.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.4 p -101.46 161.57 23.18 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.663 0.785 . . . . 0.0 109.869 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.66 -27.2 75.87 Favored 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 122.007 1.805 . . . . 0.0 112.347 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -96.27 2.66 53.08 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.98 0.512 . . . . 0.0 110.846 -177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.3 p -74.22 129.33 37.61 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -83.97 115.63 22.41 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -44.61 -39.46 5.02 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.812 1.245 . . . . 0.0 113.96 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.9 mt -95.31 -56.73 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 122.731 0.413 . . . . 0.0 110.486 -173.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -80.01 -23.45 41.49 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.798 0.839 . . . . 0.0 112.965 -171.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -108.25 -61.01 1.65 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.967 0.507 . . . . 0.0 110.915 -176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.2 mt -71.52 -20.01 62.1 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.614 0.765 . . . . 0.0 111.902 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.91 36.42 92.08 Favored Glycine 0 C--N 1.349 1.282 0 O-C-N 123.656 0.598 . . . . 0.0 114.509 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.469 HG21 HD12 ' A' ' 43' ' ' ILE . 61.1 mt -84.22 123.67 39.16 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 C-N-CA 123.569 0.747 . . . . 0.0 109.038 179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.08 149.24 33.07 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.303 0.641 . . . . 0.0 110.323 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.408 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 23.9 m -60.46 -38.66 84.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.203 0.601 . . . . 0.0 110.533 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 39' ' ' ASP . 3.4 pp -71.29 -29.94 65.66 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.182 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.405 ' N ' HD12 ' A' ' 38' ' ' LEU . 20.9 t70 -78.28 -36.18 46.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.456 0.703 . . . . 0.0 109.893 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -71.08 -21.99 62.16 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.388 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 37' ' ' SER . 96.3 mt -60.56 -37.87 82.68 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.796 0.438 . . . . 0.0 110.92 170.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -72.9 -40.46 65.53 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.142 0.577 . . . . 0.0 110.391 177.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.651 HD11 ' SG ' ' A' ' 16' ' ' CYS . 46.4 mt -61.25 -46.31 96.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 123.694 0.622 . . . . 0.0 110.408 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -70.78 -35.27 72.5 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.126 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -65.09 -38.44 90.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.52 0.728 . . . . 0.0 110.813 172.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.92 -28.11 64.27 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.365 0.666 . . . . 0.0 111.037 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 53' ' ' ILE . 96.9 mt -68.96 -41.42 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.965 0.906 . . . . 0.0 109.602 171.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -62.2 -39.53 93.05 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.673 0.789 . . . . 0.0 111.109 176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -67.83 -52.19 39.71 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.677 0.791 . . . . 0.0 111.112 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.82 -48.02 75.91 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.255 0.622 . . . . 0.0 112.591 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -90.11 -11.16 42.08 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.548 0.739 . . . . 0.0 112.386 -175.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.2 74.46 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 123.361 0.413 . . . . 0.0 113.08 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.508 HD11 HG22 ' A' ' 47' ' ' ILE . 45.5 pt -108.22 -175.9 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.157 0.983 . . . . 0.0 110.015 -174.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -138.53 107.9 6.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 167.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.595 HD21 HG12 ' A' ' 84' ' ' ILE . 93.8 mt -69.72 130.4 90.35 Favored Pre-proline 0 C--O 1.243 0.738 0 C-N-CA 123.076 0.55 . . . . 0.0 109.733 175.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -72.43 59.71 3.25 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 123.344 2.696 . . . . 0.0 110.493 168.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -66.71 -45.44 78.74 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.785 0.834 . . . . 0.0 109.866 -171.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.45 -39.57 92.21 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 123.856 0.722 . . . . 0.0 110.926 178.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -59.59 -45.33 92.21 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.227 1.011 . . . . 0.0 110.59 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.429 ' O ' HG23 ' A' ' 64' ' ' VAL . 52.6 m0 -65.74 -45.29 83.2 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.605 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.5 m -64.43 -31.52 72.76 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.862 0.865 . . . . 0.0 110.221 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.72 -44.57 70.04 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.39 -42.7 96.44 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.753 0.821 . . . . 0.0 111.305 176.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 60' ' ' TRP . 78.2 t -62.59 -53.82 42.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.342 0.657 . . . . 0.0 110.741 179.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -66.28 -22.56 66.3 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.836 0.854 . . . . 0.0 112.768 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -98.99 4.72 47.31 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.452 0.701 . . . . 0.0 112.045 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 15.3 65.69 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 115.181 0.833 . . . . 0.0 115.181 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.48 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -78.61 -23.81 45.7 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.456 0.703 . . . . 0.0 110.588 174.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -146.53 163.14 36.69 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.865 0.866 . . . . 0.0 109.253 173.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.0 p -91.65 165.12 13.48 Favored 'General case' 0 C--O 1.247 0.955 0 C-N-CA 123.404 0.682 . . . . 0.0 110.131 172.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.4 p -57.86 -55.02 40.26 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 123.99 0.806 . . . . 0.0 109.896 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.417 ' HA ' HG23 ' A' ' 76' ' ' VAL . 14.8 pt-20 -52.77 -35.6 56.66 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.872 1.269 . . . . 0.0 113.831 -175.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -55.01 -33.74 62.86 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.878 0.871 . . . . 0.0 112.844 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -117.52 -24.4 7.33 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.921 0.488 . . . . 0.0 112.085 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.73 26.68 10.38 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.459 0.704 . . . . 0.0 110.494 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 78' ' ' LYS . 52.3 t -109.76 143.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 158.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.4 -37.6 81.32 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -171.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.499 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.2 pttp -68.87 -41.88 77.77 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 120.891 0.377 . . . . 0.0 110.286 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 15.5 m120 -68.2 -47.82 66.87 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.808 0.843 . . . . 0.0 110.191 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.8 tp -57.76 -49.18 77.44 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.14 1.376 . . . . 0.0 110.51 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.51 -34.19 73.73 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.707 0.803 . . . . 0.0 111.975 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.86 87.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.836 0.454 . . . . 0.0 110.931 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 9.1 mmm180 -66.21 -41.33 90.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.52 0.728 . . . . 0.0 111.479 178.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.595 HG12 HD21 ' A' ' 55' ' ' LEU . 96.4 mt -63.19 -50.08 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 124.242 1.017 . . . . 0.0 110.517 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -60.6 -44.25 96.5 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.946 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -68.46 -31.49 70.82 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.753 0.421 . . . . 0.0 110.765 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.435 HD12 HD23 ' A' ' 55' ' ' LEU . 54.7 mt -67.32 -39.88 85.89 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.869 0.467 . . . . 0.0 111.568 173.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.454 ' HA ' ' HE3' ' A' ' 91' ' ' LYS . 60.5 t -63.54 -44.1 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 176.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.47 94.77 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.567 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.27 -39.11 55.15 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.517 0.727 . . . . 0.0 112.824 -177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 88' ' ' VAL . 20.7 pttp -72.47 -33.48 67.03 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 122.585 0.354 . . . . 0.0 110.541 -176.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -93.68 -26.37 15.33 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.053 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 57.75 -165.74 0.16 Allowed 'General case' 0 C--N 1.362 1.134 0 C-N-CA 124.494 1.117 . . . . 0.0 110.682 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.2 mt -81.9 119.48 23.99 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 170.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.46 -27.85 64.78 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.239 0.616 . . . . 0.0 111.24 -177.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -133.38 133.45 42.45 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 166.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 13.6 m170 -75.91 76.16 2.82 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.359 0.6 . . . . 0.0 110.839 -176.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -141.89 -178.03 5.49 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 125.422 1.489 . . . . 0.0 108.271 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 50.3 m-70 -76.96 -15.06 59.77 Favored 'General case' 0 N--CA 1.484 1.269 0 O-C-N 122.108 -0.37 . . . . 0.0 111.763 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 67.07 14.11 9.7 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.021 1.328 . . . . 0.0 111.132 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 C--O 1.249 1.059 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -177.932 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.8 p -82.17 132.5 35.24 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.7 m -67.1 126.87 30.54 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.505 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.4 m -58.13 -41.2 83.13 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.734 0.814 . . . . 0.0 111.042 -176.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -54.87 -47.82 73.74 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.475 0.71 . . . . 0.0 111.763 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.07 -43.58 98.68 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.658 0.599 . . . . 0.0 110.951 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -61.73 -44.08 97.62 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.361 0.665 . . . . 0.0 111.823 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 4' ' ' THR . 89.1 t -69.71 -41.32 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.879 0.872 . . . . 0.0 110.46 -178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.03 93.92 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.71 0.804 . . . . 0.0 110.85 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.5 m -64.51 -44.75 89.92 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 124.0 0.813 . . . . 0.0 111.227 175.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.428 HD13 ' HA ' ' A' ' 47' ' ' ILE . 96.8 mt -57.26 -51.23 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.001 0.52 . . . . 0.0 110.908 176.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.6 HG12 HG21 ' A' ' 43' ' ' ILE . 32.1 mt -56.67 -48.02 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.986 0.914 . . . . 0.0 110.511 178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . . . -52.66 -59.39 4.53 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 114.907 -1.042 . . . . 0.0 113.467 177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -75.48 -24.22 56.89 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.426 -171.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.7 m -82.79 -44.25 15.75 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 117.864 0.302 . . . . 0.0 110.734 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.537 ' HB2' HD11 ' A' ' 43' ' ' ILE . 49.5 t -96.46 -3.71 42.92 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.655 0.782 . . . . 0.0 112.977 -172.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.5 t70 59.65 65.68 1.11 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.455 1.102 . . . . 0.0 111.57 -176.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.1 pt -146.47 150.48 40.7 Favored Pre-proline 0 N--CA 1.486 1.352 0 C-N-CA 124.555 1.142 . . . . 0.0 108.861 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -66.95 128.69 19.2 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 122.41 2.073 . . . . 0.0 111.929 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -65.29 -18.25 65.16 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.883 0.473 . . . . 0.0 111.77 178.081 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -79.65 -22.17 43.9 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.512 0.725 . . . . 0.0 109.95 -178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.0 p -87.21 5.23 39.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.705 0.402 . . . . 0.0 110.75 172.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.603 HG23 ' HG ' ' A' ' 77' ' ' LEU . 1.8 mp -95.01 130.98 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 166.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 63.0 p -124.15 159.75 55.43 Favored Pre-proline 0 N--CA 1.489 1.493 0 C-N-CA 123.802 0.841 . . . . 0.0 110.165 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -52.87 -44.87 44.94 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.284 2.656 . . . . 0.0 113.677 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.96 11.61 29.0 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.906 0.482 . . . . 0.0 110.602 -173.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 t -72.92 130.91 41.45 Favored 'General case' 0 C--N 1.347 0.468 0 C-N-CA 123.606 0.762 . . . . 0.0 109.717 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -84.85 117.01 23.62 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 169.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.466 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -49.56 -35.11 19.47 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.37 -55.21 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -78.8 -38.16 39.02 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -170.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -87.62 -59.63 2.19 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.732 0.413 . . . . 0.0 110.015 -173.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 29' ' ' ALA . 90.4 mt -70.17 -23.66 63.02 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.38 0.672 . . . . 0.0 111.423 -178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.2 39.82 96.36 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.781 0.676 . . . . 0.0 113.16 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -72.91 115.34 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.08 144.11 24.81 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.91 0.884 . . . . 0.0 110.226 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 p -55.0 -42.84 72.98 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.957 0.903 . . . . 0.0 112.116 -173.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.1 mt -67.39 -44.79 78.01 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.569 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -64.21 -26.86 68.7 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.984 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -74.06 -34.0 63.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.55 -38.54 90.42 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.102 0.561 . . . . 0.0 110.189 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -63.43 -46.0 88.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.029 0.932 . . . . 0.0 110.697 173.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.6 HG21 HG12 ' A' ' 12' ' ' ILE . 68.2 mt -65.61 -41.64 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.33 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.42 -39.56 74.36 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -175.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -54.75 -43.34 72.61 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.483 1.113 . . . . 0.0 110.907 171.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.23 -30.8 66.78 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.195 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.428 ' HA ' HD13 ' A' ' 11' ' ' ILE . 83.8 mt -67.79 -46.1 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 123.241 0.617 . . . . 0.0 110.438 175.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -56.88 -46.2 82.03 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.723 0.809 . . . . 0.0 110.727 -178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -67.92 -47.04 69.85 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.014 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.34 99.03 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.188 0.595 . . . . 0.0 112.322 -175.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -92.22 -11.33 35.68 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.498 0.719 . . . . 0.0 112.328 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.98 31.34 69.69 Favored Glycine 0 N--CA 1.477 1.388 0 CA-C-O 121.133 0.296 . . . . 0.0 113.171 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.3 pt -119.79 -177.27 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.641 1.176 . . . . 0.0 109.892 -178.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -135.73 107.88 7.22 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 166.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.651 HD21 HG12 ' A' ' 84' ' ' ILE . 88.4 mt -61.77 128.33 90.23 Favored Pre-proline 0 C--O 1.241 0.611 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 168.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -71.76 59.17 2.73 Favored 'Trans proline' 0 C--N 1.367 1.515 0 C-N-CA 122.946 2.431 . . . . 0.0 111.624 170.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.0 -40.74 94.7 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.056 1.342 . . . . 0.0 109.629 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -57.28 -45.78 83.74 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.006 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -68.79 -43.89 74.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.277 0.631 . . . . 0.0 110.53 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.448 ' HH2' HD22 ' A' ' 55' ' ' LEU . 50.4 m0 -59.98 -48.53 81.34 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 124.308 1.005 . . . . 0.0 111.252 -176.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 41.2 m -63.97 -35.58 81.15 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 124.258 0.974 . . . . 0.0 110.167 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -71.38 -38.22 71.55 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.082 0.553 . . . . 0.0 110.86 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.25 -38.25 90.42 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.835 0.854 . . . . 0.0 110.942 176.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 60' ' ' TRP . 91.6 t -64.53 -44.89 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.825 174.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -58.81 -46.22 88.12 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.63 0.772 . . . . 0.0 112.437 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 68' ' ' LYS . 50.9 m-20 -81.01 -2.54 48.39 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.462 0.705 . . . . 0.0 112.673 -176.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.23 28.89 74.09 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 114.0 0.36 . . . . 0.0 114.0 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HG3' ' HB2' ' A' ' 66' ' ' ASP . 95.4 mttt -74.77 -34.01 62.39 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.577 0.751 . . . . 0.0 109.723 171.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.6 163.58 36.81 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.591 -178.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.4 m -88.63 154.74 20.07 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.603 1.161 . . . . 0.0 109.493 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -38.85 87.29 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.682 0.793 . . . . 0.0 110.343 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -43.76 -50.74 7.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.618 1.567 . . . . 0.0 111.761 172.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.418 ' HA ' ' ND2' ' A' ' 79' ' ' ASN . 44.0 mt-30 -61.04 -16.12 39.93 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.526 -1.216 . . . . 0.0 114.198 -170.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -126.52 -20.86 4.27 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -117.12 20.73 13.62 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 122.977 0.511 . . . . 0.0 111.846 -167.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.405 HG12 ' HG2' ' A' ' 78' ' ' LYS . 24.4 t -97.71 147.17 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 163.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.603 ' HG ' HG23 ' A' ' 23' ' ' ILE . 4.0 mm? -57.69 -54.51 46.01 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.743 1.217 . . . . 0.0 114.225 -172.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.405 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.9 pttt -61.1 -36.74 80.48 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 123.165 0.586 . . . . 0.0 110.776 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.468 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 41.3 t-20 -76.33 -46.95 25.29 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.739 -171.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.9 tp -58.62 -46.94 85.98 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.565 1.546 . . . . 0.0 109.716 173.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.59 -33.04 73.2 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.868 0.867 . . . . 0.0 111.189 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.04 -46.45 71.11 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.766 0.426 . . . . 0.0 110.386 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 12.9 mmp_? -55.87 -46.28 78.3 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.469 0.707 . . . . 0.0 110.753 177.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.651 HG12 HD21 ' A' ' 55' ' ' LEU . 90.1 mt -61.31 -49.55 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 124.877 1.271 . . . . 0.0 110.205 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.63 -37.81 79.67 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.394 1.077 . . . . 0.0 111.396 -176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -69.87 -39.53 76.26 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.113 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.5 HD12 HD23 ' A' ' 55' ' ' LEU . 79.9 mt -67.8 -34.29 76.48 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 123.417 0.448 . . . . 0.0 110.811 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 84' ' ' ILE . 96.8 t -68.98 -40.25 80.72 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 123.712 0.805 . . . . 0.0 109.526 175.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.86 -40.53 87.91 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.609 0.764 . . . . 0.0 111.546 177.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.71 -36.35 78.35 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.139 0.975 . . . . 0.0 111.789 -177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -83.94 -31.62 25.5 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.384 0.274 . . . . 0.0 110.835 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.4 -26.16 21.6 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 119.834 -0.426 . . . . 0.0 112.796 -172.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 67.33 117.41 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.248 1.419 . . . . 0.0 111.457 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.21 97.94 0.07 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.647 0.779 . . . . 0.0 110.81 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -68.67 -25.21 64.68 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.901 0.88 . . . . 0.0 110.104 172.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -130.59 101.18 5.59 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 169.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 40.1 p-80 -83.87 -138.13 0.05 Allowed 'General case' 0 CA--C 1.558 1.287 0 CA-C-O 118.758 -0.639 . . . . 0.0 109.617 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 76.69 -89.9 0.02 OUTLIER 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.384 1.074 . . . . 0.0 108.424 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.7 t60 60.66 -0.57 0.27 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 173.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -161.49 165.84 28.06 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.885 0.874 . . . . 0.0 109.649 -172.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.162 -0.923 . . . . 0.0 109.16 175.754 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.0 mtp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 37.4 p -85.71 89.17 7.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.422 0.63 . . . . 0.0 109.449 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 7.2 m -70.06 169.12 14.06 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.77 176.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 8' ' ' VAL . 24.9 m -60.56 -35.38 75.9 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.641 0.376 . . . . 0.0 111.059 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -56.89 -51.93 67.15 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.377 0.671 . . . . 0.0 110.468 171.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -58.52 -39.04 79.02 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.82 0.848 . . . . 0.0 111.552 -177.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 3' ' ' SER . 13.0 mmt180 -57.64 -51.12 70.81 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.894 0.878 . . . . 0.0 111.324 174.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 4' ' ' THR . 81.0 t -72.26 -36.27 55.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.717 0.807 . . . . 0.0 111.274 -173.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.0 -42.44 80.32 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.889 0.876 . . . . 0.0 110.488 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 m -65.94 -47.63 74.04 Favored 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.796 174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.8 mt -55.42 -54.75 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 123.409 0.684 . . . . 0.0 111.462 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.699 HG12 HG21 ' A' ' 43' ' ' ILE . 37.5 mt -57.57 -45.27 86.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.165 0.986 . . . . 0.0 110.959 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.424 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -53.19 -54.8 30.7 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.946 0.899 . . . . 0.0 112.812 175.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -64.53 -35.99 82.76 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.607 0.763 . . . . 0.0 111.94 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 59.0 m -69.59 -57.86 4.67 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 123.715 0.635 . . . . 0.0 110.387 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.573 ' SG ' HD11 ' A' ' 43' ' ' ILE . 81.1 m -96.1 11.97 32.35 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.553 0.741 . . . . 0.0 112.858 -170.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 42.63 67.69 0.58 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.975 1.31 . . . . 0.0 112.23 -177.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.621 HD11 HG22 ' A' ' 12' ' ' ILE . 17.3 pt -137.61 146.03 51.49 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 124.809 1.244 . . . . 0.0 108.174 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.64 120.26 7.71 Favored 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.703 2.268 . . . . 0.0 112.845 -174.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -51.43 -39.91 58.29 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 125.477 1.511 . . . . 0.0 113.153 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.49 -14.1 58.55 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.241 0.216 . . . . 0.0 111.57 -172.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 p -83.87 1.51 42.87 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-O 120.616 0.246 . . . . 0.0 110.557 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.493 HG23 ' HG ' ' A' ' 77' ' ' LEU . 1.9 mp -86.84 137.6 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 165.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 p -125.98 161.69 49.97 Favored Pre-proline 0 N--CA 1.482 1.131 0 C-N-CA 123.663 0.785 . . . . 0.0 109.403 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -56.8 -29.44 80.99 Favored 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 121.933 1.755 . . . . 0.0 112.372 175.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.38 0.78 51.06 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 122.863 0.465 . . . . 0.0 111.393 -174.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.6 p -75.98 132.67 40.34 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 117.758 0.253 . . . . 0.0 110.49 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -85.6 118.64 25.24 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -50.44 -27.88 7.27 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 55.2 mt -101.37 -55.12 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 121.133 0.492 . . . . 0.0 110.298 -175.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -68.17 -37.73 81.32 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.978 0.911 . . . . 0.0 112.018 -175.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -95.7 -60.04 1.74 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.115 0.566 . . . . 0.0 110.859 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.507 HD12 ' HA ' ' A' ' 29' ' ' ALA . 90.9 mt -71.87 -8.17 52.77 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -174.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.29 34.63 75.27 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.071 0.232 . . . . 0.0 113.52 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 88.3 mt -110.94 114.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.016 0.926 . . . . 0.0 108.802 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -64.46 156.73 28.59 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.957 0.503 . . . . 0.0 110.335 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.445 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 22.4 m -58.73 -27.89 65.32 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.664 0.786 . . . . 0.0 112.226 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.2 mt -67.39 -48.49 67.22 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.014 0.526 . . . . 0.0 109.855 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.51 -33.27 75.51 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.001 178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -72.04 -28.45 63.36 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.902 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 37' ' ' SER . 87.8 mt -61.04 -44.76 96.92 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 171.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -62.24 -41.3 98.3 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.161 0.984 . . . . 0.0 111.338 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.699 HG21 HG12 ' A' ' 12' ' ' ILE . 63.3 mt -65.58 -45.18 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 CA-C-O 121.048 0.452 . . . . 0.0 110.665 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.48 -32.54 70.11 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.325 -175.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -66.5 -36.72 83.42 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.582 0.753 . . . . 0.0 110.485 173.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.85 -34.23 77.35 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 122.914 0.486 . . . . 0.0 110.63 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.32 -38.45 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.712 0.805 . . . . 0.0 110.381 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -58.2 -44.69 88.23 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.571 0.748 . . . . 0.0 111.314 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -70.73 -44.46 66.78 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.535 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.78 -55.86 22.62 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.785 0.834 . . . . 0.0 112.827 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.517 ' HB2' HG12 ' A' ' 53' ' ' ILE . 97.4 m-85 -90.33 -10.98 42.07 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.326 0.65 . . . . 0.0 112.175 -177.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.14 70.18 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 -173.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 51' ' ' PHE . 43.9 pt -109.22 -176.39 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.083 0.953 . . . . 0.0 109.859 -176.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -139.24 110.56 6.97 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 172.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.461 HD21 HG12 ' A' ' 84' ' ' ILE . 84.4 mt -83.58 120.04 74.74 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 170.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -68.71 58.77 1.12 Allowed 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.952 2.435 . . . . 0.0 112.113 171.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.443 HD22 ' CE3' ' A' ' 60' ' ' TRP . 0.2 OUTLIER -66.18 -37.69 86.23 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.804 0.842 . . . . 0.0 110.195 -169.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -35.62 73.06 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 123.373 0.421 . . . . 0.0 111.203 175.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' NZ ' ' HB2' ' A' ' 59' ' ' LYS . 3.6 ttmp? -82.39 -29.15 31.03 Favored 'General case' 0 C--O 1.211 -0.954 0 C-N-CA 123.253 0.621 . . . . 0.0 110.674 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.443 ' CE3' HD22 ' A' ' 57' ' ' LEU . 45.7 m0 -69.58 -40.62 76.63 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.365 0.666 . . . . 0.0 109.729 175.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.4 m -64.22 -34.78 78.89 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.502 173.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -69.33 -47.82 63.25 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.415 1.086 . . . . 0.0 110.259 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 45.9 mt-10 -61.06 -49.23 78.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.446 1.098 . . . . 0.0 111.56 -177.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.47 -37.54 80.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.509 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -64.19 -40.06 95.3 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.463 0.705 . . . . 0.0 111.129 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -86.84 1.67 51.64 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.153 0.981 . . . . 0.0 112.244 -172.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.25 18.49 75.04 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 114.729 0.652 . . . . 0.0 114.729 -177.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -71.58 -31.96 67.54 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 169.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.72 169.83 17.01 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.581 1.153 . . . . 0.0 109.638 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 21.8 m -105.15 160.23 15.23 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 124.467 1.107 . . . . 0.0 110.458 178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.0 p -62.63 77.39 0.02 OUTLIER 'General case' 0 C--N 1.364 1.219 0 C-N-CA 124.385 1.074 . . . . 0.0 110.542 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -178.97 -61.78 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.726 -169.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -58.55 -23.96 59.62 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.963 -165.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -119.21 -16.23 9.09 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 176.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -111.68 13.11 21.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 122.907 0.483 . . . . 0.0 112.186 -168.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.456 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.0 t -106.15 143.04 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 171.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.493 ' HG ' HG23 ' A' ' 23' ' ' ILE . 3.5 mm? -54.67 -42.54 71.48 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.212 1.405 . . . . 0.0 114.094 -172.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.1 pttt -68.38 -39.84 81.6 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 117.712 0.233 . . . . 0.0 111.393 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -70.24 -44.06 69.29 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.4 0.68 . . . . 0.0 110.368 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.6 tp -58.17 -52.94 63.46 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.553 1.141 . . . . 0.0 109.896 177.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.19 72.19 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.939 0.895 . . . . 0.0 112.334 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.61 -50.42 58.24 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 176.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -53.95 -48.08 70.65 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.225 1.01 . . . . 0.0 111.403 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.467 HG23 HD13 ' A' ' 53' ' ' ILE . 96.7 mt -58.21 -53.28 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.435 1.094 . . . . 0.0 110.4 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -62.64 -33.24 74.63 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.01 0.924 . . . . 0.0 112.384 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -64.4 -42.2 96.24 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.287 0.635 . . . . 0.0 110.427 174.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.1 mt -69.5 -39.36 77.66 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.58 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 84' ' ' ILE . 87.5 t -66.36 -39.44 84.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 123.835 0.854 . . . . 0.0 110.278 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.65 -37.57 88.05 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.307 173.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.71 -42.67 73.71 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.832 0.853 . . . . 0.0 111.534 -177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -85.84 -33.0 21.43 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 120.899 0.381 . . . . 0.0 110.85 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.11 -11.01 84.89 Favored Glycine 0 C--N 1.346 1.1 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.793 -176.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 58.97 43.09 18.3 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-O 122.21 1.005 . . . . 0.0 110.44 -178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.7 mt -83.39 22.92 0.97 Allowed 'General case' 0 CA--C 1.55 0.972 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.667 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -71.84 77.62 0.88 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.869 1.268 . . . . 0.0 109.942 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -161.69 -33.14 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.994 1.318 . . . . 0.0 108.363 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -91.94 124.4 36.02 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 164.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -129.93 3.83 4.9 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.052 0.541 . . . . 0.0 109.83 -176.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 63.29 -175.76 0.15 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.688 1.195 . . . . 0.0 109.58 -159.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 72.95 -65.3 0.36 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.463 1.105 . . . . 0.0 111.979 177.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 . . . . . 0 CA--C 1.556 1.174 0 C-N-CA 124.802 1.241 . . . . 0.0 110.948 175.449 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.1 p -128.86 92.21 3.36 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.75 0.82 . . . . 0.0 109.42 176.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -90.82 -169.44 2.37 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.694 0.798 . . . . 0.0 110.202 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 8' ' ' VAL . 58.3 m -54.24 -46.68 72.64 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.609 0.764 . . . . 0.0 111.363 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -56.28 -46.9 79.53 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.266 0.627 . . . . 0.0 111.499 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -58.29 -46.17 86.58 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 123.559 0.537 . . . . 0.0 110.859 178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 mmt85 -60.71 -45.33 94.61 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.24 0.963 . . . . 0.0 111.206 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 4' ' ' THR . 88.5 t -67.37 -41.01 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 123.579 0.752 . . . . 0.0 110.288 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.2 99.24 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.902 0.881 . . . . 0.0 111.113 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 84.5 m -62.73 -47.57 82.98 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.092 0.957 . . . . 0.0 111.255 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 47' ' ' ILE . 88.2 mt -61.04 -50.05 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.318 0.647 . . . . 0.0 111.188 178.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.455 HD12 HD11 ' A' ' 77' ' ' LEU . 56.6 mt -57.78 -48.95 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.061 0.544 . . . . 0.0 110.225 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -48.83 -51.24 30.55 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.64 1.176 . . . . 0.0 112.589 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.29 -32.47 73.21 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.796 0.838 . . . . 0.0 111.962 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.2 m -89.39 -19.06 25.66 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 122.82 0.448 . . . . 0.0 111.766 -177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.431 ' SG ' HD13 ' A' ' 43' ' ' ILE . 67.0 m -115.17 -9.49 12.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.267 0.839 . . . . 0.0 113.267 -168.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 60.1 53.49 4.53 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.223 1.009 . . . . 0.0 111.566 -174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.51 HD12 HD11 ' A' ' 23' ' ' ILE . 21.7 pt -137.32 149.73 66.62 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 123.268 0.627 . . . . 0.0 110.246 -176.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.62 115.17 4.22 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.69 2.26 . . . . 0.0 111.888 177.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.412 ' HA ' HD13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -60.59 -16.45 38.22 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -173.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.34 -27.32 62.34 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.647 0.779 . . . . 0.0 111.303 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.4 p -90.84 -2.17 57.78 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.173 0.589 . . . . 0.0 110.604 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.51 HD11 HD12 ' A' ' 18' ' ' ILE . 1.7 mp -88.17 97.86 7.13 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.9 p -89.51 160.1 42.66 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.062 0.945 . . . . 0.0 110.757 -175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.13 -26.43 75.81 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.68 2.253 . . . . 0.0 113.044 174.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.25 1.53 52.17 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.972 0.509 . . . . 0.0 110.963 -176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 37.1 t -77.94 131.33 37.4 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.126 0.57 . . . . 0.0 109.917 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.403 ' CE1' ' HB ' ' A' ' 30' ' ' ILE . 58.0 t-80 -87.14 123.59 32.35 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.447 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -49.12 -39.71 29.47 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.314 1.046 . . . . 0.0 113.094 175.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.403 ' HB ' ' CE1' ' A' ' 28' ' ' HIS . 54.5 mt -91.84 -51.16 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -174.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -77.4 -33.45 55.03 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.597 0.759 . . . . 0.0 112.266 -168.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -100.77 -55.52 2.56 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.983 0.513 . . . . 0.0 110.792 -177.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 29' ' ' ALA . 65.4 mt -75.06 -6.93 52.09 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.596 0.358 . . . . 0.0 111.893 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.03 33.41 74.39 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.394 0.434 . . . . 0.0 113.816 172.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.448 HG21 HD12 ' A' ' 43' ' ' ILE . 78.3 mt -99.69 121.47 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.614 0.765 . . . . 0.0 108.977 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.59 160.05 33.23 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.681 0.392 . . . . 0.0 110.195 177.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.2 m -58.51 -44.11 89.37 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.5 0.72 . . . . 0.0 111.857 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 39' ' ' ASP . 3.8 pp -71.94 -30.98 65.88 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.127 0.489 . . . . 0.0 110.33 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.435 ' N ' HD12 ' A' ' 38' ' ' LEU . 18.7 t70 -70.22 -37.06 74.94 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.6 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 29.2 t80 -74.82 -21.84 59.06 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.271 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.625 HD23 HD12 ' A' ' 57' ' ' LEU . 96.1 mt -56.13 -45.11 79.66 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 122.942 0.497 . . . . 0.0 111.328 173.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -66.0 -39.44 90.29 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.729 0.812 . . . . 0.0 110.775 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.448 HD12 HG21 ' A' ' 35' ' ' ILE . 34.9 mt -68.26 -39.32 80.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.305 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.77 -28.51 60.77 Favored 'General case' 0 C--O 1.209 -1.033 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.66 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -63.55 -41.36 98.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.752 0.821 . . . . 0.0 110.023 169.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.96 -38.98 92.76 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.899 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.437 ' HA ' HD13 ' A' ' 11' ' ' ILE . 80.6 mt -72.93 -48.08 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 123.71 0.804 . . . . 0.0 110.562 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -46.6 -55.45 7.63 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 125.958 1.703 . . . . 0.0 111.055 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -73.3 -36.06 66.21 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.359 -175.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.45 -37.41 86.8 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.118 0.567 . . . . 0.0 112.342 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -93.28 -6.04 48.42 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.627 0.771 . . . . 0.0 112.087 178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.63 34.3 88.04 Favored Glycine 0 C--N 1.353 1.488 0 O-C-N 123.316 0.385 . . . . 0.0 113.234 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 37.4 pt -121.14 171.09 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.526 1.13 . . . . 0.0 109.573 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -106.99 100.81 10.29 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 174.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.576 HD21 HG12 ' A' ' 84' ' ' ILE . 69.6 mt -73.21 117.87 63.89 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 169.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.424 ' HD2' ' CZ2' ' A' ' 60' ' ' TRP . 3.3 Cg_exo -77.74 50.38 3.23 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.897 2.398 . . . . 0.0 111.318 171.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.625 HD12 HD23 ' A' ' 41' ' ' LEU . 1.4 tm? -64.33 -43.17 95.46 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.775 0.83 . . . . 0.0 109.801 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -63.01 -36.18 82.7 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 123.888 0.742 . . . . 0.0 110.1 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 85.1 tttt -71.75 -38.56 70.39 Favored 'General case' 0 C--O 1.211 -0.962 0 O-C-N 123.533 0.521 . . . . 0.0 109.752 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.424 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 50.1 m0 -64.56 -33.47 75.99 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.889 0.876 . . . . 0.0 110.866 178.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.6 m -63.8 -43.48 96.18 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.477 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -71.63 -31.51 66.95 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.837 0.855 . . . . 0.0 110.998 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 17.8 mm-40 -59.71 -53.89 52.7 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.607 0.763 . . . . 0.0 110.273 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.5 t -61.19 -37.31 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.413 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -61.89 -43.11 99.51 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.593 0.757 . . . . 0.0 111.752 175.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -88.39 2.16 53.21 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.159 0.584 . . . . 0.0 111.266 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.87 17.96 73.87 Favored Glycine 0 C--N 1.348 1.24 0 N-CA-C 115.109 0.803 . . . . 0.0 115.109 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -60.4 -40.99 92.94 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.59 0.756 . . . . 0.0 110.169 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.23 174.14 14.13 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.442 -177.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.0 p -106.45 164.67 11.86 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.645 0.778 . . . . 0.0 109.969 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.4 p -59.11 -50.3 74.57 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.415 0.686 . . . . 0.0 112.759 -168.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.8 pm0 -50.18 -38.44 39.76 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 -172.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -55.67 -27.23 48.89 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.443 1.097 . . . . 0.0 112.903 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -117.42 -27.97 6.23 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.335 0.654 . . . . 0.0 111.647 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -111.3 20.58 17.18 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.071 0.548 . . . . 0.0 112.218 -167.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.467 HG12 ' HG2' ' A' ' 78' ' ' LYS . 51.9 t -107.4 141.39 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 164.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.455 HD11 HD12 ' A' ' 12' ' ' ILE . 4.4 mm? -55.19 -39.17 69.28 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -171.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.8 pttt -65.43 -40.96 93.96 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.098 0.475 . . . . 0.0 110.422 177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 92.7 m-20 -77.19 -45.62 26.04 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.677 1.191 . . . . 0.0 110.34 -173.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.94 -53.21 60.92 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 125.195 1.398 . . . . 0.0 109.782 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.49 -26.7 68.55 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.166 0.586 . . . . 0.0 111.633 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.69 -45.67 71.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.06 0.544 . . . . 0.0 110.369 173.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 3.5 mmp_? -58.76 -49.56 77.18 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.089 0.556 . . . . 0.0 109.838 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.576 HG12 HD21 ' A' ' 55' ' ' LEU . 83.5 mt -61.19 -52.88 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 114.482 -1.236 . . . . 0.0 110.59 -176.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -57.64 -44.27 85.47 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.718 0.807 . . . . 0.0 111.52 -177.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -71.3 -30.15 65.9 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.765 0.666 . . . . 0.0 111.436 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 81.8 mt -68.55 -41.82 79.26 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 117.968 0.349 . . . . 0.0 110.577 172.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 84' ' ' ILE . 39.4 t -69.43 -30.73 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.82 -36.04 57.18 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.75 0.82 . . . . 0.0 111.446 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.35 -37.19 84.76 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.773 0.829 . . . . 0.0 110.674 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -85.5 -20.86 29.05 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.662 ' HA2' ' HB2' ' A' ' 95' ' ' GLU . . . -71.57 -10.25 70.68 Favored Glycine 0 C--N 1.353 1.504 0 C-N-CA 123.762 0.696 . . . . 0.0 113.328 -177.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.59 84.1 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.671 0.748 . . . . 0.0 109.725 167.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 40.2 tp -89.27 -29.68 19.03 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.334 1.054 . . . . 0.0 110.84 176.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.662 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . 15.6 mm-40 -92.04 -158.08 0.56 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.85 0.86 . . . . 0.0 110.056 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 4.1 p80 -67.15 144.11 56.22 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.981 0.512 . . . . 0.0 110.436 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -83.51 120.7 26.25 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -65.12 163.24 15.36 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.02 0.528 . . . . 0.0 111.731 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -75.25 100.33 4.31 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.375 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -160.34 133.27 6.56 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.135 0.974 . . . . 0.0 109.068 172.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 . . . . . 0 C--O 1.253 1.263 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.514 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 3.2 m 49.03 30.79 2.99 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 125.099 1.36 . . . . 0.0 112.382 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.4 t -68.91 156.91 37.67 Favored 'General case' 0 C--O 1.248 1.025 0 CA-C-O 121.355 0.598 . . . . 0.0 111.994 -170.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.2 m -54.8 -44.97 74.25 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 113.984 -1.462 . . . . 0.0 110.766 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -53.7 -47.94 70.02 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.923 0.764 . . . . 0.0 111.211 177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.44 -46.22 86.98 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.828 0.705 . . . . 0.0 110.185 -175.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -69.09 -38.87 79.21 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.319 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.2 t -73.16 -37.96 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.621 0.768 . . . . 0.0 111.034 -177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.51 -32.36 73.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.065 0.946 . . . . 0.0 110.032 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.408 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 98.4 m -65.06 -48.17 74.73 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.162 170.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.0 mt -58.22 -47.37 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 122.726 0.41 . . . . 0.0 110.802 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.535 HD12 HD11 ' A' ' 77' ' ' LEU . 42.4 mt -57.47 -49.13 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.179 0.991 . . . . 0.0 110.819 175.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.23 -51.47 62.05 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.126 0.97 . . . . 0.0 113.085 177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.408 ' HG2' ' O ' ' A' ' 10' ' ' THR . 14.0 mm-40 -73.73 -28.38 61.67 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.191 0.596 . . . . 0.0 111.933 -176.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 83.6 m -75.31 -50.72 15.14 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.942 0.497 . . . . 0.0 110.999 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.3 m -94.4 5.11 52.8 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.699 0.799 . . . . 0.0 112.454 -172.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.9 t70 48.85 64.8 1.56 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.912 1.285 . . . . 0.0 111.778 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 12' ' ' ILE . 22.9 pt -141.23 145.69 39.6 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 123.94 0.896 . . . . 0.0 109.424 -174.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -59.47 119.55 6.85 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.065 2.51 . . . . 0.0 112.283 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -50.06 -34.66 22.36 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.882 1.273 . . . . 0.0 111.976 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.01 -25.52 61.86 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.54 0.736 . . . . 0.0 111.904 -172.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -79.05 -11.71 60.0 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.804 0.442 . . . . 0.0 111.171 -177.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mp -89.69 101.72 12.43 Favored 'Isoleucine or valine' 0 C--N 1.355 0.813 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.6 p -80.93 161.35 63.65 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 123.601 0.76 . . . . 0.0 109.891 178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.26 -29.82 85.24 Favored 'Trans proline' 0 C--N 1.384 2.422 0 C-N-CA 122.44 2.093 . . . . 0.0 112.402 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -105.03 20.14 19.37 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 122.931 0.492 . . . . 0.0 111.072 -175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.5 m -71.65 128.32 35.43 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -80.93 111.76 17.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.54 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.56 -37.79 8.53 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.439 1.096 . . . . 0.0 113.832 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.521 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 55.9 mt -91.34 -58.43 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -175.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.53 -46.0 42.06 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.036 0.934 . . . . 0.0 112.242 -170.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -81.54 -56.46 4.01 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.325 0.65 . . . . 0.0 109.698 -174.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.54 HD12 ' HA ' ' A' ' 29' ' ' ALA . 88.4 mt -74.37 -12.77 60.61 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.233 0.613 . . . . 0.0 111.922 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.3 33.58 82.87 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 113.42 0.128 . . . . 0.0 113.42 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 82.3 mt -104.05 117.17 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.79 156.25 39.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -177.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.0 p -58.88 -29.68 67.18 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.936 0.894 . . . . 0.0 111.887 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 39' ' ' ASP . 4.4 pp -71.96 -31.26 66.13 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.144 0.497 . . . . 0.0 110.597 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.413 ' N ' HD12 ' A' ' 38' ' ' LEU . 16.0 t70 -81.91 -35.87 28.71 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.072 0.949 . . . . 0.0 109.483 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -68.63 -21.39 64.48 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.811 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.3 mt -51.39 -43.52 61.92 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.181 0.593 . . . . 0.0 111.245 171.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.0 -41.37 71.03 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.719 0.808 . . . . 0.0 111.136 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.462 HD13 HG12 ' A' ' 12' ' ' ILE . 57.3 mt -58.8 -47.79 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 O-C-N 123.449 0.468 . . . . 0.0 110.069 176.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.41 ' O ' HD12 ' A' ' 55' ' ' LEU . . . -71.84 -34.43 69.28 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.772 0.829 . . . . 0.0 110.523 -174.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -62.55 -37.88 87.88 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.614 0.766 . . . . 0.0 110.746 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.89 -40.08 72.41 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.945 0.498 . . . . 0.0 111.115 178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.493 HG21 HD13 ' A' ' 84' ' ' ILE . 84.9 mt -63.07 -45.99 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.673 0.789 . . . . 0.0 110.228 176.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -50.67 -52.33 40.93 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.478 1.511 . . . . 0.0 110.75 179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -69.95 -42.83 72.69 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.577 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.74 -49.78 73.68 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.589 0.756 . . . . 0.0 111.841 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.432 ' HB3' HG22 ' A' ' 88' ' ' VAL . 83.5 m-85 -86.32 -6.72 58.89 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.567 0.747 . . . . 0.0 111.182 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.44 29.77 73.11 Favored Glycine 0 C--N 1.356 1.659 0 O-C-N 123.432 0.457 . . . . 0.0 113.229 176.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.459 HG22 ' HG2' ' A' ' 91' ' ' LYS . 47.5 pt -113.23 174.62 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.261 1.024 . . . . 0.0 110.228 -175.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HD3' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -113.32 108.58 17.44 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 169.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.552 HD21 HG12 ' A' ' 84' ' ' ILE . 60.0 mt -79.7 115.61 54.91 Favored Pre-proline 0 N--CA 1.468 0.431 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.496 ' HG2' ' NE1' ' A' ' 60' ' ' TRP . 82.3 Cg_endo -76.85 54.68 4.62 Favored 'Trans proline' 0 C--N 1.366 1.456 0 C-N-CA 122.211 1.941 . . . . 0.0 111.029 169.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.38 -40.16 95.56 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.387 1.075 . . . . 0.0 109.325 -176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.24 -40.02 84.62 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.282 175.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 27.1 tptp -71.76 -38.34 70.38 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.967 0.907 . . . . 0.0 110.702 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.496 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 54.6 m0 -65.02 -45.84 83.8 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.899 0.88 . . . . 0.0 110.555 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 28.7 m -64.42 -33.71 76.5 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.686 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -66.98 -38.89 86.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.05 0.54 . . . . 0.0 110.143 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 19.0 mm-40 -60.16 -41.39 92.7 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.123 0.569 . . . . 0.0 110.845 175.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.445 HG11 HG23 ' A' ' 71' ' ' THR . 59.2 t -64.04 -54.28 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.828 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -65.51 -30.84 71.65 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.53 0.732 . . . . 0.0 112.602 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -90.16 3.63 52.87 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.951 0.5 . . . . 0.0 111.109 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.94 13.16 69.15 Favored Glycine 0 C--N 1.354 1.543 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -75.39 -28.2 59.37 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.146 0.578 . . . . 0.0 111.384 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -153.85 171.29 19.18 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.38 0.672 . . . . 0.0 109.817 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.8 m -101.19 157.06 17.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.901 0.88 . . . . 0.0 109.284 177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.445 HG23 HG11 ' A' ' 64' ' ' VAL . 13.5 p -52.8 -47.35 67.65 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.617 0.767 . . . . 0.0 111.546 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.479 ' HA ' HG23 ' A' ' 76' ' ' VAL . 12.9 pt-20 -47.11 -41.9 18.14 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -173.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -26.27 67.67 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.197 0.999 . . . . 0.0 111.583 -175.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -113.9 -26.34 8.2 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.113 0.565 . . . . 0.0 112.423 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -119.5 23.75 11.04 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.307 0.643 . . . . 0.0 111.116 -164.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.479 HG23 ' HA ' ' A' ' 72' ' ' GLU . 55.0 t -107.3 132.22 55.34 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.338 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 162.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.535 HD11 HD12 ' A' ' 12' ' ' ILE . 3.7 mm? -49.8 -32.95 15.22 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.147 1.379 . . . . 0.0 114.693 -168.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.404 ' HG3' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -80.74 -38.17 29.18 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.732 0.413 . . . . 0.0 111.746 177.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 93.1 m-20 -70.13 -49.92 45.85 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.074 0.55 . . . . 0.0 109.738 176.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.2 tp -49.7 -50.51 43.54 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.085 1.754 . . . . 0.0 110.981 170.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.59 -36.82 74.6 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 123.653 0.596 . . . . 0.0 110.826 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.95 79.82 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 123.866 0.729 . . . . 0.0 111.023 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 5.6 mmp_? -56.36 -53.33 58.61 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.671 0.748 . . . . 0.0 110.438 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.552 HG12 HD21 ' A' ' 55' ' ' LEU . 66.7 mt -64.94 -45.42 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 113.878 -1.51 . . . . 0.0 110.41 -176.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.29 -41.44 93.41 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.269 1.028 . . . . 0.0 111.676 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -67.83 -35.13 78.05 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.817 176.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.0 -31.31 67.79 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.214 0.321 . . . . 0.0 111.227 176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 84' ' ' ILE . 60.6 t -69.74 -40.27 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-O 121.262 0.553 . . . . 0.0 109.741 175.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.17 93.84 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.915 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.9 -40.66 83.41 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.77 0.828 . . . . 0.0 111.469 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.459 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.77 -27.95 50.45 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.841 0.457 . . . . 0.0 110.291 -175.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -80.35 -34.08 30.13 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 123.904 0.752 . . . . 0.0 111.263 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.15 -21.46 50.23 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.636 0.774 . . . . 0.0 110.453 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.9 84.44 0.21 Allowed 'General case' 0 C--N 1.359 1.001 0 C-N-CA 123.814 0.845 . . . . 0.0 109.487 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.42 165.7 22.8 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.965 174.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 m80 60.43 26.95 16.54 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.248 0.619 . . . . 0.0 111.606 -172.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -81.27 -24.92 36.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.19 0.596 . . . . 0.0 110.145 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -71.83 80.29 0.88 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.775 0.83 . . . . 0.0 111.244 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -171.63 142.11 1.55 Allowed 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.648 1.179 . . . . 0.0 109.126 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -169.91 -24.75 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.486 0.714 . . . . 0.0 110.759 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.715 0.806 . . . . 0.0 109.755 177.42 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.428 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' A' ' 6' ' ' ASP . 33.3 m -140.81 -58.63 0.51 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.288 0.635 . . . . 0.0 110.563 -172.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 6' ' ' ASP . 29.3 t -158.54 -176.05 5.67 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.762 0.825 . . . . 0.0 109.911 -169.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.0 m -59.94 -42.2 93.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.196 0.598 . . . . 0.0 110.18 172.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -56.17 -42.68 77.44 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.411 0.684 . . . . 0.0 111.623 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.519 ' HB2' ' HB ' ' A' ' 2' ' ' THR . 8.8 t70 -52.94 -51.39 61.53 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.675 0.79 . . . . 0.0 110.31 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 11' ' ' ILE . 37.8 mmt180 -64.7 -43.37 93.69 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.84 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.437 ' HA ' HD12 ' A' ' 11' ' ' ILE . 67.4 t -70.0 -36.45 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 123.941 0.896 . . . . 0.0 111.246 -175.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.02 -36.53 83.5 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.691 0.796 . . . . 0.0 110.309 177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.5 m -66.04 -41.36 90.97 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.254 0.622 . . . . 0.0 111.175 173.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 7' ' ' ARG . 82.8 mt -56.85 -52.92 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 122.923 0.489 . . . . 0.0 110.353 174.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.557 HD12 HD11 ' A' ' 77' ' ' LEU . 39.9 mt -59.67 -44.62 93.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 123.8 0.84 . . . . 0.0 110.931 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.564 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -50.11 -63.24 1.18 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.415 1.086 . . . . 0.0 113.119 175.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -66.03 -25.15 66.93 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.722 -174.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.9 m -78.82 -46.64 18.26 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.468 0.707 . . . . 0.0 111.53 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 13.7 t -102.26 4.61 39.42 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.443 0.697 . . . . 0.0 111.867 -170.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.8 t70 48.1 76.76 0.11 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 125.264 1.426 . . . . 0.0 112.185 -170.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 13' ' ' ALA . 3.3 pt -147.4 141.61 15.97 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 124.536 1.134 . . . . 0.0 108.765 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -62.67 125.88 17.06 Favored 'Trans proline' 0 C--N 1.375 1.927 0 C-N-CA 122.34 2.026 . . . . 0.0 110.741 171.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.583 ' HA ' HD13 ' A' ' 23' ' ' ILE . 2.2 ppt_? -70.23 -16.15 63.01 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -88.17 -1.76 58.2 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.979 0.512 . . . . 0.0 110.503 -176.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.9 p -89.09 -17.77 28.61 Favored 'General case' 0 C--N 1.357 0.923 0 CA-C-N 117.743 0.247 . . . . 0.0 110.428 165.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.583 HD13 ' HA ' ' A' ' 20' ' ' ARG . 2.1 mp -80.51 111.89 17.81 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.1 p -90.25 158.94 43.03 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.607 0.763 . . . . 0.0 109.188 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.05 -19.52 66.42 Favored 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 121.974 1.783 . . . . 0.0 112.128 175.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.53 8.76 44.04 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.384 0.674 . . . . 0.0 110.495 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 58.0 m -70.89 124.87 25.35 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 174.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.417 ' HD2' ' HG3' ' A' ' 72' ' ' GLU . 64.6 t-80 -80.05 111.82 16.75 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 167.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.05 -36.49 29.29 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.0 mt -93.53 -45.04 13.85 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 122.306 0.242 . . . . 0.0 110.871 -172.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.93 -44.19 11.22 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.449 0.7 . . . . 0.0 111.796 -173.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -83.98 -60.1 2.21 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.362 0.665 . . . . 0.0 109.984 -174.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.82 -17.18 63.38 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 122.871 0.468 . . . . 0.0 111.543 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.31 37.36 90.68 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.576 0.548 . . . . 0.0 113.812 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.3 mt -93.59 114.67 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.61 156.41 38.16 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.1 m -57.91 -31.53 66.87 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.928 0.891 . . . . 0.0 112.637 -172.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.57 -31.83 62.19 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 122.801 0.44 . . . . 0.0 111.253 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -75.1 -32.69 61.49 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.224 0.61 . . . . 0.0 110.01 175.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -71.42 -28.5 64.04 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.836 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.78 -41.85 87.64 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.75 0.42 . . . . 0.0 110.38 172.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -66.9 -44.18 81.47 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.12 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.417 HD13 HG12 ' A' ' 12' ' ' ILE . 58.6 mt -65.27 -46.14 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 122.855 0.462 . . . . 0.0 110.805 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.56 76.36 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.182 0.593 . . . . 0.0 110.549 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -73.43 -25.25 60.44 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.747 177.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.7 -41.15 72.35 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 122.503 0.321 . . . . 0.0 110.324 172.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 95.7 mt -61.85 -44.5 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.135 0.974 . . . . 0.0 110.218 174.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -51.47 -48.15 62.92 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.5 1.52 . . . . 0.0 110.647 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.14 -50.07 65.25 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.19 175.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.44 -51.49 66.75 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.008 0.923 . . . . 0.0 113.253 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -89.45 -6.56 56.4 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.513 0.725 . . . . 0.0 111.683 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.81 39.83 95.32 Favored Glycine 0 C--N 1.352 1.449 0 CA-C-O 121.189 0.327 . . . . 0.0 112.534 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.478 HG22 ' HG2' ' A' ' 91' ' ' LYS . 41.8 pt -122.61 169.64 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.41 1.084 . . . . 0.0 109.493 -175.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -107.45 120.88 43.41 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 169.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.403 HD22 ' HH2' ' A' ' 60' ' ' TRP . 57.1 mt -90.26 113.61 58.0 Favored Pre-proline 0 C--O 1.242 0.677 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.81 57.1 3.7 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.446 2.764 . . . . 0.0 111.292 171.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.5 -38.68 90.82 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.227 1.011 . . . . 0.0 110.259 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 8.4 pt-20 -58.97 -45.74 89.8 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 124.01 0.819 . . . . 0.0 110.985 176.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -63.67 -48.23 78.05 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.814 0.846 . . . . 0.0 109.86 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.416 ' O ' HG23 ' A' ' 64' ' ' VAL . 48.2 m0 -53.69 -44.53 69.83 Favored 'General case' 0 N--CA 1.479 1.009 0 O-C-N 124.366 1.041 . . . . 0.0 110.744 179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.1 m -64.42 -45.6 86.86 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.047 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 58' ' ' GLU . 13.7 mm100 -68.79 -37.51 79.32 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.6 0.36 . . . . 0.0 110.872 -173.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -57.64 -48.06 80.51 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.155 0.982 . . . . 0.0 110.374 173.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.513 HG11 HG23 ' A' ' 71' ' ' THR . 78.8 t -59.24 -46.73 92.04 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.059 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.304 178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -61.06 -37.11 81.49 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 122.917 0.487 . . . . 0.0 111.551 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -88.6 6.15 39.53 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.892 0.877 . . . . 0.0 112.115 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.53 20.85 74.15 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -78.68 -23.4 45.67 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.317 0.647 . . . . 0.0 110.196 171.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.0 175.07 14.44 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.176 0.99 . . . . 0.0 109.742 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.8 m -111.57 156.63 21.46 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.513 HG23 HG11 ' A' ' 64' ' ' VAL . 4.6 p -51.28 -40.91 59.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -175.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HA ' HG23 ' A' ' 76' ' ' VAL . 1.3 mp0 -47.82 -46.98 31.41 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.574 0.75 . . . . 0.0 112.426 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -26.4 62.64 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.243 1.017 . . . . 0.0 113.049 -172.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -117.81 -21.29 8.49 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -119.28 20.72 12.49 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.195 0.598 . . . . 0.0 111.819 -166.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.523 HG12 ' HG2' ' A' ' 78' ' ' LYS . 30.8 t -102.75 139.98 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 163.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.557 HD11 HD12 ' A' ' 12' ' ' ILE . 3.5 mm? -53.99 -37.21 63.77 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.146 1.379 . . . . 0.0 114.304 -168.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.523 ' HG2' HG12 ' A' ' 76' ' ' VAL . 57.0 pttt -71.86 -37.14 70.28 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 122.661 0.384 . . . . 0.0 111.294 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 65.0 m-20 -79.26 -35.24 41.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.714 0.806 . . . . 0.0 110.49 -177.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.93 -52.48 59.62 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.568 1.147 . . . . 0.0 108.445 174.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.56 -28.24 69.8 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 124.019 0.824 . . . . 0.0 111.508 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.84 -54.13 30.83 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.531 0.519 . . . . 0.0 109.751 174.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -50.66 -50.04 55.68 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.247 0.967 . . . . 0.0 111.111 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.508 ' O ' HG23 ' A' ' 88' ' ' VAL . 72.2 mt -61.34 -48.33 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.122 -178.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.96 -39.71 94.77 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.912 0.885 . . . . 0.0 111.625 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -62.37 -40.62 97.03 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.01 0.924 . . . . 0.0 109.849 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.6 mt -72.89 -28.64 62.6 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.815 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 84' ' ' ILE . 80.2 t -67.86 -37.83 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 123.311 0.644 . . . . 0.0 109.796 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.54 -38.56 80.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.404 0.682 . . . . 0.0 110.712 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.76 -38.77 80.34 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.506 0.722 . . . . 0.0 111.255 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.478 ' HG2' HG22 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -83.06 -21.68 33.7 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.17 8.67 23.09 Favored Glycine 0 C--N 1.352 1.46 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.982 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.68 -21.45 40.28 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.406 0.683 . . . . 0.0 111.329 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.7 mp -74.86 -169.54 0.91 Allowed 'General case' 0 CA--C 1.561 1.392 0 C-N-CA 124.331 1.053 . . . . 0.0 110.829 171.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -60.38 120.42 9.84 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.664 0.786 . . . . 0.0 112.544 -173.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.6 m170 -75.29 164.07 26.83 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.602 0.761 . . . . 0.0 110.448 173.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 57.3 52.62 8.56 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.569 1.148 . . . . 0.0 108.971 -172.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -57.78 117.46 4.27 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.385 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -56.15 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.674 1.233 . . . . 0.0 112.309 -165.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 176.06 -33.51 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.648 1.579 . . . . 0.0 108.911 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 82.7 t60 . . . . . 0 CA--C 1.552 1.054 0 C-N-CA 123.799 0.839 . . . . 0.0 110.199 -179.284 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptm . . . . . 0 N--CA 1.481 1.075 0 CA-C-O 120.526 0.203 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.3 t -87.58 163.05 16.83 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.491 0.717 . . . . 0.0 110.291 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.438 ' H ' ' HB3' ' A' ' 6' ' ' ASP . 69.3 m -154.78 178.77 9.76 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.734 1.214 . . . . 0.0 109.698 -177.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.501 ' O ' HG23 ' A' ' 8' ' ' VAL . 30.7 m -58.97 -59.22 5.81 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.061 0.545 . . . . 0.0 111.188 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -59.35 -44.43 92.68 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.915 0.486 . . . . 0.0 111.077 178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 3' ' ' SER . 27.0 t70 -54.34 -41.04 68.62 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.934 0.771 . . . . 0.0 111.388 -178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 11' ' ' ILE . 82.6 mtp180 -74.22 -34.24 63.64 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.795 178.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 4' ' ' THR . 52.8 t -70.21 -36.31 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 118.733 0.697 . . . . 0.0 109.593 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.91 -38.98 90.43 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.264 1.026 . . . . 0.0 110.749 173.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 m -61.69 -51.15 69.62 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 123.812 0.695 . . . . 0.0 110.863 173.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 7' ' ' ARG . 96.8 mt -55.7 -51.52 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.431 1.092 . . . . 0.0 111.616 -178.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.53 HD12 HD11 ' A' ' 77' ' ' LEU . 35.6 mt -60.71 -46.35 96.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.514 0.726 . . . . 0.0 111.016 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.567 ' HA ' HG13 ' A' ' 18' ' ' ILE . . . -51.78 -48.31 63.82 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.006 0.816 . . . . 0.0 112.596 175.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -67.91 -37.04 81.2 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.711 0.805 . . . . 0.0 112.031 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.8 m -68.44 -54.53 16.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.09 0.556 . . . . 0.0 110.66 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 67.6 m -91.78 7.49 41.55 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.885 0.874 . . . . 0.0 112.514 -173.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 39.52 74.49 0.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 125.009 1.324 . . . . 0.0 112.469 -170.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.567 HG13 ' HA ' ' A' ' 13' ' ' ALA . 13.8 pt -140.18 142.52 30.34 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.995 1.318 . . . . 0.0 107.838 -177.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.29 131.17 41.43 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 122.423 2.082 . . . . 0.0 112.322 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -36.38 -42.1 0.31 Allowed 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 126.69 1.996 . . . . 0.0 113.939 176.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.14 -28.98 66.93 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.819 0.848 . . . . 0.0 112.001 -170.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 p -79.36 -4.04 49.06 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.54 97.2 5.96 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 173.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.7 p -88.46 162.18 40.31 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.692 0.797 . . . . 0.0 110.213 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.39 -26.76 79.01 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.706 2.271 . . . . 0.0 113.502 176.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -96.74 5.54 50.43 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.842 0.857 . . . . 0.0 111.442 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -68.67 120.99 15.54 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.437 0.295 . . . . 0.0 110.305 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 66.0 t-80 -84.36 123.4 30.15 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 167.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -40.27 -50.04 2.74 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.773 1.229 . . . . 0.0 113.147 176.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.3 mt -90.81 -51.34 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 121.229 0.538 . . . . 0.0 109.908 -169.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -72.89 -39.57 66.29 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.247 1.019 . . . . 0.0 112.479 -172.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -96.84 -64.53 1.04 Allowed 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.365 0.666 . . . . 0.0 110.08 -173.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.47 HD13 HG21 ' A' ' 12' ' ' ILE . 73.2 mt -73.9 -17.6 61.01 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.609 0.763 . . . . 0.0 112.216 -174.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.98 34.33 76.5 Favored Glycine 0 C--N 1.352 1.417 0 O-C-N 123.083 0.239 . . . . 0.0 113.651 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.416 HG23 ' HB2' ' A' ' 39' ' ' ASP . 92.5 mt -82.62 139.96 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.574 1.15 . . . . 0.0 109.277 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -92.53 162.16 14.32 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.9 m -54.33 -36.98 64.35 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.317 1.047 . . . . 0.0 112.083 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 pp -69.38 -40.62 77.3 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.859 0.463 . . . . 0.0 110.364 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.416 ' HB2' HG23 ' A' ' 35' ' ' ILE . 47.4 m-20 -68.63 -35.45 77.31 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.387 0.675 . . . . 0.0 110.459 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -66.46 -32.71 74.25 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.8 0.687 . . . . 0.0 110.528 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.0 mt -61.21 -42.63 98.94 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.055 0.542 . . . . 0.0 111.255 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -66.97 -42.57 84.91 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.099 0.56 . . . . 0.0 110.723 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.464 HD13 HG12 ' A' ' 12' ' ' ILE . 97.2 mt -57.29 -47.36 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.225 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.13 -38.49 75.56 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.291 -173.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -61.48 -42.56 98.97 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.0 0.92 . . . . 0.0 110.9 174.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.94 -29.26 66.36 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.15 178.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.473 HD13 HD11 ' A' ' 84' ' ' ILE . 90.3 mt -65.83 -43.52 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.467 0.707 . . . . 0.0 110.307 173.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -58.67 -41.26 85.73 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.425 0.453 . . . . 0.0 110.913 178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -69.07 -54.06 17.05 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.556 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.17 -52.8 64.14 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.128 0.971 . . . . 0.0 112.871 -176.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -89.8 -6.75 55.62 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.843 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.71 31.81 73.65 Favored Glycine 0 C--N 1.354 1.577 0 O-C-N 123.5 0.5 . . . . 0.0 113.448 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.439 HG22 ' HD3' ' A' ' 91' ' ' LYS . 41.3 pt -118.22 -178.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.561 0.745 . . . . 0.0 112.116 -172.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -126.56 106.52 9.49 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.354 1.462 . . . . 0.0 107.489 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.464 HD21 HG12 ' A' ' 84' ' ' ILE . 91.3 mt -72.8 125.99 90.88 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 170.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -74.98 60.47 5.43 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.778 2.318 . . . . 0.0 109.634 163.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.97 -40.26 91.1 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.134 1.374 . . . . 0.0 109.253 -171.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.81 -42.23 92.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.693 0.797 . . . . 0.0 111.012 175.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -62.75 -47.5 83.29 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.477 1.111 . . . . 0.0 110.031 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -60.07 -44.87 94.44 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.948 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.3 m -65.99 -36.74 84.12 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.9 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -68.66 -37.46 79.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.033 0.533 . . . . 0.0 110.988 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -64.58 -38.98 92.88 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.546 0.738 . . . . 0.0 111.264 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.9 t -65.51 -49.88 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.457 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -60.47 -32.06 71.04 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.182 0.993 . . . . 0.0 112.297 178.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -93.8 0.49 56.31 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.745 0.818 . . . . 0.0 111.871 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.82 16.92 66.7 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 -178.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -64.46 -33.73 76.55 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 117.576 0.688 . . . . 0.0 110.156 172.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.87 166.38 28.69 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.012 0.925 . . . . 0.0 108.967 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 73' ' ' GLN . 75.2 p -86.37 164.0 17.31 Favored 'General case' 0 C--O 1.246 0.877 0 C-N-CA 122.749 0.42 . . . . 0.0 110.052 177.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.7 p -54.2 -49.1 70.15 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.151 0.58 . . . . 0.0 109.632 172.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.508 ' HA ' HG23 ' A' ' 76' ' ' VAL . 28.6 mt-10 -43.35 -47.19 6.72 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.955 1.702 . . . . 0.0 113.52 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.402 ' HG2' ' OG1' ' A' ' 70' ' ' THR . 12.0 mm-40 -53.68 -28.95 36.56 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.99 0.916 . . . . 0.0 113.467 -176.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -121.13 -21.05 6.56 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -110.71 15.81 21.75 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.47 0.708 . . . . 0.0 110.966 -169.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 72' ' ' GLU . 91.3 t -108.21 139.8 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 166.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.53 HD11 HD12 ' A' ' 12' ' ' ILE . 3.6 mm? -54.26 -40.11 67.47 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.338 1.455 . . . . 0.0 114.108 -172.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.468 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.1 pttt -65.2 -42.02 93.95 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 123.437 0.461 . . . . 0.0 110.82 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -78.14 -39.49 40.93 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.537 1.135 . . . . 0.0 111.021 -174.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.8 tp -63.2 -49.94 72.24 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.267 1.027 . . . . 0.0 109.248 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.2 -34.68 78.63 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.564 0.746 . . . . 0.0 111.405 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.46 -44.76 90.05 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 123.57 0.544 . . . . 0.0 110.505 176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.483 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 0.5 OUTLIER -58.7 -48.86 79.69 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.301 0.641 . . . . 0.0 111.267 175.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.473 HD11 HD13 ' A' ' 47' ' ' ILE . 91.2 mt -59.63 -43.02 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.654 1.182 . . . . 0.0 110.292 -178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.37 -45.38 91.6 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.261 1.024 . . . . 0.0 110.912 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.39 -33.3 72.82 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.463 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 62.5 mt -70.99 -36.39 72.46 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.078 0.551 . . . . 0.0 111.742 178.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 84' ' ' ILE . 94.8 t -64.94 -41.81 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 CA-C-O 121.657 0.741 . . . . 0.0 109.499 175.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.95 -47.94 75.84 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.733 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.67 -39.7 94.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.147 0.979 . . . . 0.0 112.076 -176.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.439 ' HD3' HG22 ' A' ' 53' ' ' ILE . 60.1 pttt -70.15 -27.22 64.37 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 116.713 -0.222 . . . . 0.0 110.431 -178.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -74.91 -27.65 64.22 Favored Glycine 0 C--N 1.362 1.989 0 N-CA-C 111.593 -0.603 . . . . 0.0 111.593 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.3 -82.76 0.02 OUTLIER 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.59 1.556 . . . . 0.0 111.293 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -156.31 89.57 1.13 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -124.69 -94.03 0.49 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 168.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -155.1 177.59 11.16 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.633 1.173 . . . . 0.0 109.314 178.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 72.9 m80 69.67 -75.82 0.07 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.49 1.516 . . . . 0.0 111.387 178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 72.54 -61.0 0.51 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 126.124 1.769 . . . . 0.0 109.821 -173.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -130.81 -66.34 0.76 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 167.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -167.89 104.2 0.48 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 18.8 t60 . . . . . 0 C--O 1.248 1.005 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.925 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.4 mtp . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 33.0 m -139.92 86.09 2.07 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.0 t -82.96 -173.5 4.74 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.873 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' HG23 ' A' ' 8' ' ' VAL . 65.2 m -50.36 -53.17 31.02 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 124.295 1.038 . . . . 0.0 111.944 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -56.76 -42.16 78.85 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.315 0.646 . . . . 0.0 112.013 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.63 -42.19 92.17 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 122.973 0.509 . . . . 0.0 110.662 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -61.7 -46.3 90.27 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.643 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 4' ' ' THR . 99.5 t -70.0 -38.93 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.113 0.965 . . . . 0.0 111.191 -173.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.75 -42.2 96.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.98 0.912 . . . . 0.0 110.028 178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -63.62 -44.89 92.61 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.858 0.863 . . . . 0.0 111.308 175.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 91.1 mt -56.49 -51.7 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.394 0.678 . . . . 0.0 110.815 176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.587 HG12 HG21 ' A' ' 43' ' ' ILE . 38.7 mt -57.72 -52.83 52.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.487 0.715 . . . . 0.0 110.664 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -46.78 -54.93 8.74 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.914 1.286 . . . . 0.0 113.01 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -72.59 -22.86 60.92 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.255 -175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.8 m -88.13 -25.64 22.88 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.78 0.432 . . . . 0.0 111.786 177.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.5 t -113.23 -1.4 14.33 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.91 0.484 . . . . 0.0 111.823 -167.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 59.31 50.47 7.76 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 124.191 0.996 . . . . 0.0 111.571 -178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.554 HD12 HD11 ' A' ' 23' ' ' ILE . 16.3 pt -138.17 156.09 73.99 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 123.761 0.825 . . . . 0.0 109.987 -177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -72.77 131.15 16.71 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.591 2.194 . . . . 0.0 110.73 172.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HA ' HD13 ' A' ' 23' ' ' ILE . 6.5 ppt_? -68.22 -16.22 63.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 122.729 0.412 . . . . 0.0 111.312 -178.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.26 -20.63 54.86 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 123.538 0.735 . . . . 0.0 110.487 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.1 p -92.05 10.34 29.54 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.083 0.553 . . . . 0.0 110.421 174.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.554 HD11 HD12 ' A' ' 18' ' ' ILE . 1.9 mp -104.92 127.28 59.56 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 168.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.1 p -121.87 158.22 55.3 Favored Pre-proline 0 N--CA 1.484 1.225 0 C-N-CA 123.981 0.912 . . . . 0.0 109.668 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -50.53 -32.7 35.93 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.788 2.325 . . . . 0.0 113.399 173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.84 -5.87 56.43 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.941 -0.474 . . . . 0.0 111.429 -173.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 89.8 p -77.19 132.87 38.98 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 122.541 0.336 . . . . 0.0 110.185 -174.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -85.33 126.14 33.5 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 173.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.43 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -46.54 -39.6 11.21 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.083 0.953 . . . . 0.0 113.236 175.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.8 mt -96.57 -55.88 5.7 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -171.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.37 -43.84 80.41 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.506 0.723 . . . . 0.0 112.578 -175.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -93.57 -57.23 2.64 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.868 0.467 . . . . 0.0 110.302 -172.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 29' ' ' ALA . 62.8 mt -78.91 -7.77 58.27 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.565 0.746 . . . . 0.0 112.44 -177.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.04 25.07 72.0 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 114.443 0.537 . . . . 0.0 114.443 174.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 86.9 mt -93.32 121.56 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.787 0.835 . . . . 0.0 108.776 -177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -69.45 157.19 37.57 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.5 t -58.29 -35.13 71.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.741 0.817 . . . . 0.0 111.701 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.427 ' HA ' HD12 ' A' ' 41' ' ' LEU . 4.5 pp -71.7 -30.92 66.19 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.517 0.327 . . . . 0.0 111.076 -177.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -73.24 -39.76 65.21 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.118 0.567 . . . . 0.0 109.91 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -69.88 -25.9 63.92 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 123.783 0.677 . . . . 0.0 110.89 -176.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.653 HD23 HD12 ' A' ' 57' ' ' LEU . 93.7 mt -56.83 -42.6 79.92 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.051 0.54 . . . . 0.0 110.615 170.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -75.14 -40.95 59.3 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.064 0.946 . . . . 0.0 110.627 -178.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.587 HG21 HG12 ' A' ' 12' ' ' ILE . 57.0 mt -61.22 -43.61 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-O 121.227 0.537 . . . . 0.0 110.319 177.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 -33.29 63.0 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.963 -176.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -62.69 -34.35 76.95 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 122.595 0.358 . . . . 0.0 110.347 172.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.95 -34.5 73.5 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.92 0.488 . . . . 0.0 110.8 174.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.12 -42.87 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.627 0.771 . . . . 0.0 110.35 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -53.08 -51.3 62.29 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.659 0.784 . . . . 0.0 110.635 176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -63.46 -50.15 70.83 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 114.614 -1.175 . . . . 0.0 111.056 -176.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.88 -48.76 77.61 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.737 0.815 . . . . 0.0 112.395 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -83.61 -10.21 58.39 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.513 0.725 . . . . 0.0 112.22 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.38 30.27 71.43 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.418 0.449 . . . . 0.0 112.988 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.3 pt -120.01 -176.18 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.022 1.329 . . . . 0.0 109.622 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -137.1 98.63 3.79 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD23 HD12 ' A' ' 87' ' ' LEU . 85.2 mt -64.01 123.64 82.66 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 167.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.5 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 98.2 Cg_endo -76.21 62.08 6.73 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 122.485 2.124 . . . . 0.0 110.587 170.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.653 HD12 HD23 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -62.44 -34.66 77.22 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.348 1.059 . . . . 0.0 109.14 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -60.52 -43.38 97.17 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.763 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.5 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 56.9 tptt -69.09 -39.71 78.84 Favored 'General case' 0 C--O 1.217 -0.618 0 C-N-CA 123.632 0.773 . . . . 0.0 110.49 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.414 ' HH2' HD22 ' A' ' 55' ' ' LEU . 54.6 m0 -67.5 -39.84 85.17 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.494 0.718 . . . . 0.0 110.643 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 73.8 m -61.02 -39.37 89.47 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 124.078 0.861 . . . . 0.0 110.223 173.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -70.13 -43.98 69.84 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.201 1.0 . . . . 0.0 110.157 -177.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.03 -46.81 88.29 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.566 1.147 . . . . 0.0 111.126 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 89.9 t -61.11 -40.0 84.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -67.92 -30.33 69.62 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.247 0.619 . . . . 0.0 111.767 175.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -85.04 -1.15 56.5 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.34 15.85 68.49 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 114.198 0.439 . . . . 0.0 114.198 -173.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -72.6 -31.84 65.49 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.473 0.709 . . . . 0.0 110.779 176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -149.07 166.27 29.23 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.756 0.822 . . . . 0.0 109.73 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 53.1 m -103.16 154.85 18.88 Favored 'General case' 0 C--O 1.244 0.767 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.4 p -47.04 -49.08 21.94 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 124.209 1.003 . . . . 0.0 112.451 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.549 ' HA ' HG23 ' A' ' 76' ' ' VAL . 40.7 mt-10 -44.82 -42.63 8.04 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -175.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -56.46 -27.38 56.74 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.193 0.997 . . . . 0.0 112.818 -176.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -121.7 -22.35 5.86 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.081 0.552 . . . . 0.0 112.037 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -114.7 14.49 17.54 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.462 0.705 . . . . 0.0 111.31 -167.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.549 HG23 ' HA ' ' A' ' 72' ' ' GLU . 53.5 t -107.78 137.03 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 165.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.492 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -55.3 -33.88 63.67 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -169.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.0 pttt -71.65 -44.41 64.35 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.559 0.344 . . . . 0.0 110.389 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.512 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 60.0 m-80 -72.2 -38.02 69.13 Favored 'General case' 0 C--O 1.217 -0.637 0 C-N-CA 123.608 0.763 . . . . 0.0 109.972 -178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.4 tp -62.5 -48.71 78.36 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 124.984 1.314 . . . . 0.0 109.454 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.31 -33.96 71.74 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.681 0.613 . . . . 0.0 111.146 177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.86 -40.48 75.75 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.207 0.603 . . . . 0.0 111.426 175.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 13.6 mmp_? -60.59 -48.27 82.53 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.558 0.743 . . . . 0.0 110.867 176.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.431 ' O ' HG23 ' A' ' 88' ' ' VAL . 86.7 mt -63.22 -51.46 70.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.689 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -63.72 -39.55 94.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.441 0.696 . . . . 0.0 112.115 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -67.43 -37.79 83.55 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 123.34 0.4 . . . . 0.0 110.264 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.498 HD12 HD23 ' A' ' 55' ' ' LEU . 84.2 mt -71.03 -32.8 69.64 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.791 0.436 . . . . 0.0 111.534 176.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 84' ' ' ILE . 73.4 t -65.92 -43.37 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 CA-C-O 121.321 0.581 . . . . 0.0 109.479 173.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.7 -45.9 87.92 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.163 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.43 -43.82 89.29 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.318 1.047 . . . . 0.0 111.674 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.35 -24.37 62.09 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.535 0.522 . . . . 0.0 110.283 -176.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -91.03 -17.06 52.83 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -92.65 5.17 51.97 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.775 0.83 . . . . 0.0 112.465 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.6 mt -69.35 165.05 21.54 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.342 0.657 . . . . 0.0 111.549 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 73.63 5.28 4.89 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.943 1.297 . . . . 0.0 112.0 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 30.7 m170 -97.27 -79.79 0.45 Allowed 'General case' 0 N--CA 1.48 1.03 0 O-C-N 121.487 -0.758 . . . . 0.0 110.485 -177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -147.26 -52.95 0.21 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.352 0.661 . . . . 0.0 110.887 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -155.8 -57.9 0.1 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.596 0.358 . . . . 0.0 110.532 -176.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -164.78 -52.59 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 71.75 -15.66 0.43 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 126.822 2.049 . . . . 0.0 113.761 171.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 CA--C 1.552 1.034 0 CA-C-O 118.069 -0.967 . . . . 0.0 108.847 -176.238 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.401 ' HA ' ' HE ' ' A' ' 7' ' ' ARG . 21.4 m -76.19 80.86 2.99 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.718 0.77 . . . . 0.0 109.674 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.8 p -166.06 145.76 6.2 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.951 1.3 . . . . 0.0 107.698 -176.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.438 ' O ' HG23 ' A' ' 8' ' ' VAL . 17.9 m -54.34 -60.36 3.45 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -164.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -58.93 -45.39 90.52 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 122.765 0.426 . . . . 0.0 111.179 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -58.93 -42.86 90.78 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.261 0.624 . . . . 0.0 110.902 -176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.401 ' HE ' ' HA ' ' A' ' 2' ' ' THR . 10.9 mmt180 -65.87 -41.73 91.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.234 177.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 4' ' ' THR . 72.7 t -68.83 -40.57 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.436 0.695 . . . . 0.0 110.589 -177.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.67 94.87 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.841 0.856 . . . . 0.0 110.817 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.8 m -66.41 -41.9 88.59 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.162 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.46 -47.02 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.313 0.645 . . . . 0.0 110.78 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 18' ' ' ILE . 42.9 mt -58.22 -46.72 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.559 0.743 . . . . 0.0 110.547 177.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.63 -51.28 65.89 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.031 0.933 . . . . 0.0 112.628 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -73.96 -31.37 62.99 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.2 m -74.45 -57.5 3.89 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.546 ' SG ' HD11 ' A' ' 43' ' ' ILE . 76.1 m -85.23 -5.79 59.3 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -171.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.0 t70 60.0 66.43 0.98 Allowed 'General case' 0 N--CA 1.482 1.142 0 CA-C-O 122.002 0.906 . . . . 0.0 109.729 -177.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 12' ' ' ILE . 12.5 pt -141.72 152.0 61.59 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 124.835 1.254 . . . . 0.0 108.56 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.524 ' O ' HG22 ' A' ' 22' ' ' THR . 37.9 Cg_endo -66.61 125.1 13.28 Favored 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 122.047 1.831 . . . . 0.0 111.334 175.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.545 ' HA ' HD13 ' A' ' 23' ' ' ILE . 58.6 ttt180 -53.44 -29.1 33.65 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.17 0.988 . . . . 0.0 112.565 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.45 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.1 pt-20 -65.88 -23.67 66.7 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.487 0.715 . . . . 0.0 112.155 -172.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 19' ' ' PRO . 9.3 t -88.11 2.49 51.89 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 122.705 0.402 . . . . 0.0 111.512 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.545 HD13 ' HA ' ' A' ' 20' ' ' ARG . 3.6 mp -102.0 94.15 3.15 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 70.6 p -88.52 163.76 34.87 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -62.45 -19.67 68.18 Favored 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 122.213 1.942 . . . . 0.0 113.131 178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -95.85 3.86 53.31 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 122.761 0.424 . . . . 0.0 110.814 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 69.0 m -75.54 130.86 39.53 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.855 0.359 . . . . 0.0 110.093 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -85.59 122.69 30.07 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 168.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.523 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -48.73 -41.11 30.97 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.043 0.937 . . . . 0.0 112.817 177.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.4 mt -93.13 -53.23 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -172.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -71.06 -44.74 65.14 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.707 0.803 . . . . 0.0 111.787 -171.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -89.32 -59.86 2.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.93 0.492 . . . . 0.0 110.372 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 29' ' ' ALA . 71.1 mt -76.04 -10.9 59.79 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.815 0.846 . . . . 0.0 112.902 -171.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.29 33.04 85.65 Favored Glycine 0 C--N 1.351 1.414 0 O-C-N 123.316 0.385 . . . . 0.0 113.671 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 82.8 mt -94.13 122.57 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.14 157.88 32.59 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.198 0.599 . . . . 0.0 109.551 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.498 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 27.3 m -59.72 -27.56 66.57 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.444 0.697 . . . . 0.0 111.732 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 pp -73.12 -40.85 64.59 Favored 'General case' 0 C--N 1.362 1.131 0 C-N-CA 122.928 0.491 . . . . 0.0 110.336 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -66.71 -36.18 81.87 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.238 0.615 . . . . 0.0 109.63 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -70.13 -27.88 64.92 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 123.762 0.664 . . . . 0.0 110.611 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 37' ' ' SER . 93.2 mt -61.88 -40.33 95.04 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 118.069 0.395 . . . . 0.0 110.235 173.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -71.84 -39.05 70.02 Favored 'General case' 0 N--CA 1.484 1.274 0 O-C-N 124.021 0.826 . . . . 0.0 110.677 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.546 HD11 ' SG ' ' A' ' 16' ' ' CYS . 77.4 mt -61.94 -47.41 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.114 0.565 . . . . 0.0 109.908 174.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.5 -34.38 72.29 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.797 0.839 . . . . 0.0 110.341 -173.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -69.01 -37.24 78.58 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.896 0.878 . . . . 0.0 110.721 175.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.88 -35.83 74.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.662 0.385 . . . . 0.0 110.751 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.411 HD11 HG13 ' A' ' 8' ' ' VAL . 96.5 mt -66.88 -46.24 85.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 124.033 0.933 . . . . 0.0 109.891 173.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -51.46 -51.12 57.73 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.363 1.465 . . . . 0.0 110.357 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -69.13 -47.23 65.62 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.863 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.55 -45.45 92.87 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 123.408 0.683 . . . . 0.0 112.464 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -88.32 -4.43 58.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.548 0.739 . . . . 0.0 111.219 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.45 30.36 77.65 Favored Glycine 0 C--N 1.357 1.719 0 O-C-N 123.233 0.333 . . . . 0.0 113.465 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.3 pt -119.37 163.39 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.45 1.1 . . . . 0.0 109.68 -175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.41 123.19 42.4 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 164.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.457 HD21 HG12 ' A' ' 84' ' ' ILE . 54.0 mt -78.45 135.67 60.83 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 171.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.51 ' HD3' HD11 ' A' ' 87' ' ' LEU . 4.4 Cg_exo -79.18 44.16 1.64 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 123.302 2.668 . . . . 0.0 111.301 170.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -57.15 -38.4 73.47 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.528 1.131 . . . . 0.0 109.785 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -53.91 -51.49 63.57 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.755 -1.112 . . . . 0.0 110.985 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 49.9 tptt -66.35 -41.18 89.93 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.585 1.154 . . . . 0.0 110.888 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.429 ' CZ2' ' HD2' ' A' ' 56' ' ' PRO . 52.2 m0 -59.94 -45.21 93.35 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.167 0.987 . . . . 0.0 110.58 -178.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.7 m -63.62 -39.0 93.26 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.848 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -65.37 -39.51 92.37 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.185 0.594 . . . . 0.0 110.658 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 27.4 mm-40 -56.17 -48.49 76.22 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.215 0.606 . . . . 0.0 111.063 175.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.99 -41.46 89.8 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.124 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -60.0 -43.65 95.05 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.992 0.917 . . . . 0.0 111.785 177.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -83.01 6.17 19.71 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.41 19.39 64.39 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 114.494 0.558 . . . . 0.0 114.494 -179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -76.12 -59.47 2.75 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.927 0.891 . . . . 0.0 108.686 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.38 172.04 7.03 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.207 173.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 48.5 p -107.26 170.78 7.75 Favored 'General case' 0 C--O 1.247 0.926 0 CA-C-N 113.742 -1.572 . . . . 0.0 107.83 169.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.6 p -62.16 -46.19 90.08 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 119.537 -0.268 . . . . 0.0 110.701 -178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -53.07 -36.64 60.88 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.574 0.75 . . . . 0.0 112.932 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.95 -25.98 58.83 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.491 1.116 . . . . 0.0 111.346 -175.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -128.96 -7.43 4.94 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -115.48 16.68 16.6 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.226 0.611 . . . . 0.0 111.244 -174.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.459 HG12 ' HG2' ' A' ' 78' ' ' LYS . 54.3 t -103.16 141.33 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 166.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.442 HD11 HD12 ' A' ' 12' ' ' ILE . 4.1 mm? -53.61 -42.29 67.55 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.188 1.395 . . . . 0.0 114.246 -172.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.459 ' HG2' HG12 ' A' ' 76' ' ' VAL . 60.7 pttt -68.59 -40.05 80.67 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 122.826 0.45 . . . . 0.0 110.843 -178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.425 ' OD1' ' HG3' ' A' ' 78' ' ' LYS . 2.1 m-20 -68.36 -46.2 70.76 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.049 0.94 . . . . 0.0 109.853 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.4 tp -58.84 -50.47 73.86 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.01 1.324 . . . . 0.0 109.973 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.64 75.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.595 0.758 . . . . 0.0 111.749 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.1 -51.33 68.34 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.721 0.408 . . . . 0.0 110.063 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -56.4 -48.24 77.32 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.784 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.457 HG12 HD21 ' A' ' 55' ' ' LEU . 90.3 mt -61.8 -51.36 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.532 1.133 . . . . 0.0 111.227 -175.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -59.83 -39.58 85.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.888 0.875 . . . . 0.0 111.34 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -63.73 -40.49 96.87 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.038 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.51 HD11 ' HD3' ' A' ' 56' ' ' PRO . 91.7 mt -67.34 -34.44 77.33 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.194 0.598 . . . . 0.0 111.492 177.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 84' ' ' ILE . 57.9 t -65.77 -42.28 92.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 176.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.18 -43.19 98.94 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.536 175.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.18 -39.67 89.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.097 0.959 . . . . 0.0 112.284 -177.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 88' ' ' VAL . 41.3 pttt -74.83 -21.25 59.39 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.545 0.338 . . . . 0.0 110.117 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.0 -40.98 96.15 Favored Glycine 0 C--N 1.363 2.05 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.02 -175.47 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.453 1.101 . . . . 0.0 113.078 169.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 80.3 mt -75.37 -28.86 59.68 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.517 172.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -150.45 95.54 2.26 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.27 0.628 . . . . 0.0 109.819 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -85.64 -43.64 13.27 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.681 0.792 . . . . 0.0 108.977 166.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -155.91 -58.18 0.1 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.421 1.088 . . . . 0.0 108.397 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -173.4 121.78 0.35 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 176.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -76.68 73.32 3.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.277 0.631 . . . . 0.0 111.741 -170.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -160.78 -57.63 0.05 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.261 1.824 . . . . 0.0 106.785 175.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 . . . . . 0 CA--C 1.562 1.408 0 C-N-CA 125.384 1.474 . . . . 0.0 111.616 178.802 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.7 mtp . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.9 p -75.81 77.37 2.74 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.909 0.883 . . . . 0.0 111.869 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.4 p -82.74 175.79 9.85 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.286 1.035 . . . . 0.0 108.656 169.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.588 HG21 ' HB2' ' A' ' 85' ' ' ASP . 24.2 m -58.53 -48.34 81.19 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 118.749 0.704 . . . . 0.0 110.446 178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -58.51 -51.57 69.32 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.452 0.701 . . . . 0.0 111.559 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -58.85 -42.92 90.46 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 123.698 0.624 . . . . 0.0 111.076 -175.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 11' ' ' ILE . 92.1 mtt-85 -62.02 -46.81 87.53 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.691 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 4' ' ' THR . 53.8 t -64.33 -44.53 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.312 0.645 . . . . 0.0 110.367 -176.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.76 -42.99 85.11 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.231 1.012 . . . . 0.0 110.856 178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.1 m -68.72 -41.33 79.19 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.466 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 7' ' ' ARG . 74.2 mt -60.61 -43.98 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.609 0.364 . . . . 0.0 110.766 176.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.617 HG22 HD11 ' A' ' 18' ' ' ILE . 56.2 mt -56.71 -47.48 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.463 0.705 . . . . 0.0 110.194 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . . . -56.75 -51.86 67.25 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.544 1.138 . . . . 0.0 113.376 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -65.64 -30.4 71.11 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.172 0.989 . . . . 0.0 111.865 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 19.2 m -82.81 -46.62 12.85 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 122.581 0.352 . . . . 0.0 111.087 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 41.7 t -93.3 -7.78 43.95 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.483 0.713 . . . . 0.0 112.182 -169.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 56.78 70.18 0.67 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 124.55 1.14 . . . . 0.0 111.574 -172.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.617 HD11 HG22 ' A' ' 12' ' ' ILE . 10.2 pt -143.75 152.0 54.76 Favored Pre-proline 0 N--CA 1.48 1.03 0 C-N-CA 125.143 1.377 . . . . 0.0 108.641 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.09 116.77 4.76 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 121.93 1.754 . . . . 0.0 111.709 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -62.93 -17.17 61.51 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.996 0.919 . . . . 0.0 113.034 -178.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.98 -27.18 60.05 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.329 0.651 . . . . 0.0 110.243 -176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -83.8 -5.57 59.23 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.096 0.558 . . . . 0.0 110.724 178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 20' ' ' ARG . 1.9 mp -87.81 120.39 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 174.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 80.9 p -101.53 166.99 11.3 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.724 0.81 . . . . 0.0 109.427 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -66.14 -17.26 54.51 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 121.889 1.726 . . . . 0.0 112.763 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -96.66 0.27 49.51 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 122.572 0.349 . . . . 0.0 110.331 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.7 t -72.6 128.08 34.48 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.879 0.872 . . . . 0.0 110.109 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -87.3 117.11 25.85 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.518 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -55.16 -35.93 65.29 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.5 mm -93.04 -44.85 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-O 121.392 0.615 . . . . 0.0 110.374 -170.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -94.88 -38.38 10.75 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.13 0.972 . . . . 0.0 111.593 -168.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.24 -50.8 5.92 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.833 0.453 . . . . 0.0 110.659 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 29' ' ' ALA . 88.8 mt -77.71 -14.59 59.57 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.417 0.687 . . . . 0.0 111.145 178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.89 27.97 72.02 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 123.798 0.686 . . . . 0.0 114.255 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.488 HG21 HD12 ' A' ' 43' ' ' ILE . 89.3 mt -76.77 124.88 35.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -67.01 152.87 44.98 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 124.115 0.885 . . . . 0.0 109.805 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.2 m -66.31 -25.96 67.09 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.599 0.759 . . . . 0.0 112.278 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 pp -74.77 -33.68 62.33 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.34 -42.44 59.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.734 0.814 . . . . 0.0 110.117 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -71.26 -21.95 62.03 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 123.593 0.558 . . . . 0.0 110.603 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.49 -47.14 86.65 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 170.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -71.55 -36.91 71.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.954 0.902 . . . . 0.0 111.437 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.488 HD12 HG21 ' A' ' 35' ' ' ILE . 52.8 mt -63.4 -50.24 79.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 123.636 0.585 . . . . 0.0 110.1 178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.94 -33.42 72.1 Favored 'General case' 0 C--O 1.216 -0.672 0 O-C-N 123.782 0.676 . . . . 0.0 109.905 -177.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.512 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 45.0 t80 -60.95 -40.84 94.84 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.401 1.081 . . . . 0.0 111.003 173.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.78 -35.88 59.97 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.626 0.37 . . . . 0.0 111.317 -178.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.412 HD13 HG13 ' A' ' 8' ' ' VAL . 92.6 mt -65.43 -43.05 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 C-N-CA 123.543 0.737 . . . . 0.0 109.958 174.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 45' ' ' PHE . 9.8 t70 -50.69 -52.55 39.08 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.665 1.586 . . . . 0.0 110.692 177.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 45' ' ' PHE . 57.8 mmtt -74.15 -35.66 64.06 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.259 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.03 -43.99 97.18 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.071 0.548 . . . . 0.0 111.812 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -93.01 -0.62 57.14 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.907 0.883 . . . . 0.0 111.556 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 59.13 43.61 96.94 Favored Glycine 0 C--N 1.353 1.524 0 O-C-N 123.754 0.659 . . . . 0.0 113.174 172.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 pt -135.53 173.57 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.245 1.418 . . . . 0.0 109.177 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -104.49 108.53 20.01 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 167.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.605 HD21 HG12 ' A' ' 84' ' ' ILE . 51.9 mt -68.74 121.77 82.41 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 167.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 93.5 Cg_endo -78.56 57.57 6.37 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.692 2.261 . . . . 0.0 111.682 176.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -59.99 -37.81 80.73 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 125.013 1.325 . . . . 0.0 109.589 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.37 -46.14 89.47 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.573 1.149 . . . . 0.0 111.264 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 56' ' ' PRO . 22.1 tptm -68.88 -39.1 79.97 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.169 0.988 . . . . 0.0 111.102 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.445 ' NE1' ' HG2' ' A' ' 56' ' ' PRO . 54.5 m0 -62.51 -41.55 98.91 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.62 0.768 . . . . 0.0 109.886 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 90.9 m -63.01 -39.61 95.29 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 124.166 0.916 . . . . 0.0 110.498 176.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.38 -47.71 75.42 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.051 0.541 . . . . 0.0 110.654 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -58.17 -44.93 88.21 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.98 0.912 . . . . 0.0 112.288 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 85.9 t -67.5 -50.36 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 122.629 0.372 . . . . 0.0 111.072 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.7 m-80 -67.56 -29.7 69.15 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.371 0.669 . . . . 0.0 112.689 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -94.09 5.2 52.47 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.486 0.714 . . . . 0.0 111.428 177.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.32 21.77 66.72 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 115.802 1.081 . . . . 0.0 115.802 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -79.57 -22.85 43.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.315 0.646 . . . . 0.0 110.88 173.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.04 177.57 9.47 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.738 1.215 . . . . 0.0 108.339 175.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -127.21 164.89 20.67 Favored 'General case' 0 C--O 1.245 0.831 0 C-N-CA 124.102 0.961 . . . . 0.0 109.073 173.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.0 p -54.93 -52.21 63.68 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 124.202 0.938 . . . . 0.0 113.107 -165.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -35.49 63.21 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -172.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -53.22 -27.93 24.45 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 124.229 1.012 . . . . 0.0 113.02 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -115.75 -31.28 5.86 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.398 0.679 . . . . 0.0 111.834 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -110.98 21.52 16.34 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.866 0.467 . . . . 0.0 112.033 -165.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.513 HG12 ' HG2' ' A' ' 78' ' ' LYS . 24.8 t -106.82 138.24 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 164.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.442 HD11 HD12 ' A' ' 12' ' ' ILE . 4.2 mm? -51.62 -37.87 52.13 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -170.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.513 ' HG2' HG12 ' A' ' 76' ' ' VAL . 61.8 pttt -69.32 -41.92 76.05 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 118.059 0.391 . . . . 0.0 110.619 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 76.0 m-20 -76.97 -33.79 57.62 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.422 1.089 . . . . 0.0 110.04 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -68.04 -54.03 21.35 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.287 1.435 . . . . 0.0 108.331 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.58 -31.01 69.06 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.1 0.875 . . . . 0.0 111.499 177.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.39 -52.37 53.95 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 122.883 0.473 . . . . 0.0 110.634 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 13.9 mmp_? -54.1 -49.9 68.08 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 123.233 0.613 . . . . 0.0 110.73 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.605 HG12 HD21 ' A' ' 55' ' ' LEU . 91.9 mt -57.5 -53.65 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 125.246 1.418 . . . . 0.0 110.948 -178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.588 ' HB2' HG21 ' A' ' 4' ' ' THR . 25.9 t70 -63.18 -34.78 78.39 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.781 0.832 . . . . 0.0 111.831 -176.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -68.15 -36.68 80.05 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.333 0.653 . . . . 0.0 111.128 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.4 mt -68.2 -37.95 81.45 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 122.867 0.467 . . . . 0.0 110.617 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.497 HG13 ' HE2' ' A' ' 91' ' ' LYS . 58.4 t -68.98 -32.33 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.196 0 CA-C-O 121.45 0.643 . . . . 0.0 109.783 176.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.469 ' HA ' ' CD2' ' A' ' 99' ' ' HIS . . . -68.93 -40.84 78.81 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.378 173.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.16 -38.69 92.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.239 1.016 . . . . 0.0 111.561 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.497 ' HE2' HG13 ' A' ' 88' ' ' VAL . 56.0 pttt -83.14 -14.75 52.94 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.524 0.329 . . . . 0.0 110.353 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.428 ' HA3' ' NE2' ' A' ' 99' ' ' HIS . . . -73.1 -24.33 75.95 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 111.411 -0.676 . . . . 0.0 111.411 172.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.37 -9.12 58.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.714 0.806 . . . . 0.0 111.385 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.419 ' HG ' ' HG3' ' A' ' 95' ' ' GLU . 31.5 tp -76.31 -76.22 0.17 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.575 0.75 . . . . 0.0 109.698 -176.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.419 ' HG3' ' HG ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -162.07 -26.71 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.204 1.002 . . . . 0.0 110.325 177.272 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -83.22 177.94 8.31 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.289 0.635 . . . . 0.0 110.091 168.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -121.56 -86.82 0.65 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.293 0.637 . . . . 0.0 109.658 -174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 77.8 m-70 55.0 22.43 4.39 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.167 1.387 . . . . 0.0 114.391 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.469 ' CD2' ' HA ' ' A' ' 89' ' ' ALA . 30.1 m170 -71.17 -11.52 60.98 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 67.76 -87.6 0.03 OUTLIER 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.322 1.049 . . . . 0.0 109.555 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 . . . . . 0 C--O 1.25 1.091 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -173.422 . . . . . . . . 0 0 . 1 stop_ save_